data_2rtt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rtt _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.802 0.334 . . . . 73.31 111.119 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.52 163.7 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.34 111.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.53 147.63 27.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.44 111.153 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -88.77 146.28 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.96 163.36 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.31 111.053 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.32 138.78 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 75.44 110.977 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.85 -60.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 64.31 111.165 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.27 131.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.43 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.94 127.3 53.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 75.04 110.908 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.25 88.17 2.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.983 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -93.22 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.75 . . . . 73.24 112.453 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.39 -17.7 17.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 73.44 111.141 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.61 148.59 20.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.778 -0.725 . . . . 71.5 112.489 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -138.08 143.75 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 72.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.29 3.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.77 139.27 21.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 51.43 112.504 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.34 95.51 3.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 72.22 110.815 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.25 145.13 25.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.932 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.27 124.73 52.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.32 111.085 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.08 131.56 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.42 111.116 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.77 118.1 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.883 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.73 101.54 9.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.903 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.9 p -146.05 134.06 21.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 71.44 111.101 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -57.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 62.54 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.81 168.25 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 73.32 111.12 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.0 p -63.17 -174.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 70.13 111.125 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.53 125.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.857 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.65 -176.23 4.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.91 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.5 -52.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.821 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.79 157.54 38.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 61.11 110.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -114.46 126.84 55.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.888 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.47 100.79 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 74.11 111.142 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -101.39 120.83 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 72.41 111.094 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -128.38 156.09 43.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.879 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 170.16 21.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.35 110.907 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.14 130.78 44.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 63.03 110.927 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -111.94 78.53 2.32 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.633 0.73 . . . . 75.41 110.928 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -49.28 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.734 2.289 . . . . 71.34 112.335 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -73.12 144.46 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.92 97.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.478 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.4 m -156.07 154.55 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 60.24 111.195 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.99 131.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 75.35 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.23 95.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.452 . . . . 72.43 111.12 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.6 m -63.19 -42.51 99.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 72.21 111.189 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.68 140.13 31.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 60.55 110.782 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.85 137.89 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 74.53 111.125 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.39 142.48 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.951 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.84 13.99 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.73 120.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 64.03 111.131 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.2 99.98 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 62.31 111.136 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -89.29 119.5 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.116 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -106.82 171.13 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 71.43 111.156 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.85 156.37 46.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 75.42 110.953 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 t -158.23 85.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 71.15 110.858 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.37 0.89 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 55.44 112.515 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 51.25 110.902 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -108.73 146.92 32.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -131.28 155.6 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.96 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -148.46 149.05 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 75.21 111.12 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.9 124.61 37.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 75.45 111.071 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.27 157.77 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.916 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.35 -51.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.14 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.45 40.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.099 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.13 0.86 72.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.468 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.336 . . . . 72.11 110.878 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.55 -45.06 3.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 72.04 110.868 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 55.25 20.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.772 -0.728 . . . . 74.52 112.432 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -133.17 94.66 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.341 . . . . 72.33 111.205 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.51 160.83 38.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.5 110.846 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.43 162.31 54.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 72.44 111.075 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.708 2.272 . . . . 75.32 112.341 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.53 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 64.24 112.445 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 74.24 111.098 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.75 131.51 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.848 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.87 149.8 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 75.43 111.15 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.78 154.26 47.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.14 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.93 139.02 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 72.23 110.833 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.64 174.33 15.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 74.03 112.483 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -168.81 177.8 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 74.4 110.855 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.01 125.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.2 110.885 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.96 154.2 20.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 70.01 112.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -95.89 109.53 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.379 . . . . 75.24 110.837 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -160.28 30.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.79 -0.719 . . . . 73.14 112.481 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -41.73 4.12 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.712 2.274 . . . . 75.41 112.306 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.73 26.65 24.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.2 112.467 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 m -113.3 73.56 1.87 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.694 0.759 . . . . 45.42 110.891 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 163.31 38.75 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 74.22 112.381 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -148.26 173.37 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.3 110.87 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.23 49.31 3.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 65.34 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.5 m -68.57 97.34 0.77 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 118.97 25.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.915 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.93 155.94 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.858 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.34 13.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 65.31 110.807 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.15 42.15 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 75.23 112.479 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.7 70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 73.11 112.479 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.22 132.61 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 71.34 110.866 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.887 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.803 0.335 . . . . 75.32 111.202 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.45 163.8 31.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.081 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 147.63 27.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.128 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.76 146.22 25.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 74.5 110.905 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.86 163.45 35.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 61.14 111.164 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 138.86 45.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 73.35 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.95 -60.92 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 75.05 111.11 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.32 131.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.868 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.99 127.24 53.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.847 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -111.28 88.23 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 -93.16 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 52.14 112.486 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.33 -17.74 17.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.784 0.326 . . . . 74.43 111.162 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.63 148.67 20.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 73.22 112.429 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.11 143.67 40.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 71.01 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.25 3.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 72.14 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 139.23 21.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 74.52 112.438 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.36 95.57 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.366 . . . . 73.22 110.894 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.31 145.2 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.857 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.3 124.66 52.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.22 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.98 131.59 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.149 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.84 118.12 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.44 110.888 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.74 101.46 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 71.41 110.89 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.7 p -146.0 134.12 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 71.04 111.096 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.87 -57.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.672 -0.775 . . . . 63.11 112.488 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.87 168.22 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 74.2 111.12 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -63.15 -174.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.23 111.204 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.52 125.58 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 63.14 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.64 -176.24 4.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 65.1 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.49 -52.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.34 110.892 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.84 157.55 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 75.33 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -114.45 126.94 55.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 73.14 110.917 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.62 100.75 6.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.456 . . . . 75.21 111.195 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.33 120.78 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 75.43 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -128.37 156.1 43.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.2 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.05 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.13 130.88 44.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.851 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.09 78.55 2.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 73.33 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.2 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.615 2.21 . . . . 74.52 112.36 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.8 p -73.15 144.34 46.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 75.42 111.136 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.78 97.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 42.22 112.508 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.1 m -156.13 154.55 31.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 65.13 111.182 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 131.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 71.34 110.852 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.13 95.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.15 111.105 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -63.13 -42.65 99.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 60.35 111.138 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.6 140.03 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.864 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 137.97 48.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 72.1 111.091 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.41 142.48 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.3 110.907 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.82 14.04 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 73.41 110.866 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.76 120.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.22 111.111 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.21 100.0 5.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 63.13 111.146 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.31 119.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 65.41 111.12 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -106.86 171.12 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 111.1 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.84 156.37 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.92 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -158.25 85.74 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.846 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 62.12 112.539 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 63.02 110.902 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -108.7 146.92 32.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -131.31 155.5 47.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.937 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.7 m -148.4 149.1 31.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 64.44 111.142 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.91 124.63 37.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.066 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.32 157.78 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.31 -51.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 72.55 110.965 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.44 40.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 73.52 111.138 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.14 0.86 72.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 73.24 112.486 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.69 -24.64 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 74.31 110.918 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.51 -45.05 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 62.05 110.929 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.44 55.27 20.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.485 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -133.23 94.7 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 75.42 111.088 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.46 160.88 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 70.34 110.954 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.49 162.33 53.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.569 0.7 . . . . 71.44 111.107 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -8.45 23.64 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.711 2.274 . . . . 61.33 112.354 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.52 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 72.2 112.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 74.34 111.098 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.73 131.46 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 73.12 110.858 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.88 149.8 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.42 111.105 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.73 154.25 47.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.912 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -141.97 139.0 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.2 110.866 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.52 174.27 15.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 71.34 112.55 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -168.73 177.82 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.25 110.893 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.02 125.72 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 63.31 110.871 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.94 154.18 20.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.672 -0.775 . . . . 70.0 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -95.84 109.53 21.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.888 0.375 . . . . 72.32 110.901 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.03 -160.23 30.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.75 -0.738 . . . . 55.15 112.522 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -41.55 4.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 72.22 112.36 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 26.73 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 72.34 112.442 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 m -113.42 73.61 1.98 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.742 0.782 . . . . 73.52 110.897 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 163.35 38.64 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.693 2.262 . . . . 34.32 112.381 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.0 p -148.39 173.33 13.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 74.13 110.82 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.25 49.28 3.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.3 m -68.5 97.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.922 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.13 119.06 25.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.01 155.93 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 72.15 110.898 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.35 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.818 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.11 42.23 8.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.708 -0.758 . . . . 74.22 112.493 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.64 70.02 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 71.12 112.495 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.23 132.62 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 72.54 110.873 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.127 -0.488 . . . . 54.24 110.944 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.789 0.328 . . . . 75.23 111.092 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.71 163.83 33.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 72.23 111.09 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 m -139.91 137.38 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 64.11 111.093 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -76.76 139.03 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.43 110.856 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.14 150.75 41.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 71.13 111.123 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.67 142.11 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.848 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.51 -56.49 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 75.11 111.09 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.25 132.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 70.11 110.902 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.46 127.65 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 64.33 110.793 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.42 84.87 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.903 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 -91.11 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 73.32 112.46 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.5 -17.6 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.347 . . . . 73.12 111.092 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.16 148.41 20.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 75.12 112.504 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -135.15 141.69 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 74.42 110.832 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.84 108.83 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 75.11 112.453 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.54 130.51 10.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 71.01 112.496 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.85 99.46 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 75.25 110.899 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.29 117.93 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.54 110.893 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.5 m -95.52 110.09 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 73.42 111.164 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -106.71 131.89 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 74.32 111.161 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -143.4 127.97 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 73.43 110.888 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.25 133.44 55.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.873 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.47 151.67 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.31 111.172 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -41.08 2.36 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.645 -0.788 . . . . 75.51 112.535 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 169.1 14.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 75.43 111.163 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -172.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 65.43 111.083 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -51.43 129.71 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 55.12 110.867 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -176.24 4.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.93 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -52.94 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.05 110.904 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.77 176.23 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.837 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -135.68 127.09 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 74.43 110.894 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.64 105.83 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 75.33 111.138 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.4 105.92 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 72.44 111.11 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -116.76 153.07 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.84 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.82 169.61 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.911 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.08 129.94 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.841 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.76 75.38 1.88 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 72.25 110.86 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -49.78 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.641 2.227 . . . . 64.23 112.407 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -71.07 144.56 50.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.202 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.9 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.15 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -156.57 154.71 30.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 72.4 111.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.67 131.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 75.23 110.913 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.6 t -75.18 101.41 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.21 111.063 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -45.69 91.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 72.24 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.12 148.5 33.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.15 110.846 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.62 137.08 39.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.093 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -119.51 148.17 43.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.903 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.52 14.53 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 65.12 110.871 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 134.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 54.22 111.092 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -86.56 95.01 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.137 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.34 138.33 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 74.44 111.07 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -128.31 171.03 12.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.168 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -136.07 157.39 46.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 85.74 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 74.14 110.877 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.98 -91.77 0.71 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 62.21 112.522 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.21 8.23 7.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 73.14 110.916 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -119.23 146.68 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 72.42 110.873 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -130.88 157.53 42.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.894 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -152.53 148.46 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 72.0 111.163 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.46 134.84 47.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 70.01 111.135 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.36 160.84 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.923 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.95 -51.46 0.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.43 110.902 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.93 39.3 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 65.03 111.11 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.26 -0.73 72.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.772 -0.727 . . . . 53.23 112.535 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -113.53 -25.2 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.806 0.336 . . . . 73.02 110.947 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.04 -47.0 3.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 74.41 110.874 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.86 56.3 14.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.774 -0.726 . . . . 54.15 112.438 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.71 95.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 55.44 111.093 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.24 160.55 38.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.922 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.97 72.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.718 . . . . 74.13 111.151 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.727 2.284 . . . . 74.35 112.29 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.9 119.0 1.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 44.53 112.498 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.41 172.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 74.41 111.022 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -131.02 131.64 44.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.848 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.31 114.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.188 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 p -111.83 134.36 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.89 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.67 138.64 45.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.45 110.918 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.16 -179.77 19.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.761 -0.733 . . . . 72.32 112.469 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -174.45 174.02 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 75.3 110.862 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -129.83 125.79 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.838 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.49 152.22 19.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.546 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.4 t -97.87 109.38 22.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 71.15 110.894 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.51 -156.52 27.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.457 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -42.04 3.66 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 74.2 112.314 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.11 26.49 31.02 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.702 -0.761 . . . . 43.25 112.55 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 m -113.09 74.74 1.91 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.678 0.752 . . . . 62.53 110.908 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 162.55 41.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 73.3 112.375 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -148.34 171.29 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.836 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 60.01 58.47 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 73.35 110.846 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.33 92.06 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 62.02 110.857 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 118.94 33.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.427 . . . . 72.41 110.9 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 155.78 44.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.944 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.12 22.69 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.828 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.34 41.85 5.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 75.11 112.474 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.65 71.54 1.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 53.52 112.485 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.1 m -156.23 104.15 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 73.1 110.885 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 73.44 110.857 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.789 0.328 . . . . 75.31 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.35 163.82 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.33 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -141.79 147.69 37.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.154 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -91.21 145.4 24.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.839 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.68 149.86 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 74.21 111.105 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 147.33 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.888 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.27 -61.92 1.59 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 73.31 111.114 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -179.39 146.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.15 110.893 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -117.86 126.85 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.906 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -111.14 86.79 2.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.973 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.66 -82.97 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 71.24 112.508 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 t -115.66 -17.52 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 65.1 111.089 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.9 159.26 30.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 64.43 112.461 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.99 160.45 39.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 73.12 110.886 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.47 121.89 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 62.21 112.432 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.29 146.49 18.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 64.22 112.513 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -138.98 94.57 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 63.34 110.825 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.2 136.46 33.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 73.52 110.915 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -111.68 123.85 51.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 61.12 111.207 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.36 131.69 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.202 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.64 118.06 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 70.21 110.934 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -105.85 119.8 40.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 64.31 110.914 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -158.07 159.89 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.147 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -59.0 3.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 74.41 112.547 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 175.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.825 0.345 . . . . 74.23 111.173 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 175.04 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 71.34 111.165 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 p -52.58 131.66 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.34 110.857 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.69 -169.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 75.04 110.961 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.47 -52.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.823 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.94 154.42 40.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 75.41 110.86 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -107.41 126.94 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 74.0 110.97 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 103.77 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 74.23 111.12 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.55 105.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 73.41 111.082 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.85 155.8 34.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.4 169.28 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.95 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -97.82 132.35 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 61.44 110.92 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.23 80.42 2.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.616 0.722 . . . . 73.1 110.807 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 73.1 112.394 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -73.37 144.56 46.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 72.11 111.158 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.48 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.815 -0.707 . . . . 62.31 112.448 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.4 m -156.24 143.5 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.361 . . . . 74.32 111.151 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -155.55 130.91 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 74.24 110.921 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.94 92.5 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.13 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.9 m -77.08 -31.21 55.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.163 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.23 149.96 48.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.836 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.78 146.21 21.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 64.33 111.088 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -143.95 141.24 30.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.926 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.82 15.56 9.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.893 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.54 120.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 73.41 111.161 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.5 m -80.15 109.8 14.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 75.11 111.094 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -93.65 138.63 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.21 111.101 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.0 m -128.13 142.27 51.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.34 111.228 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.69 157.08 18.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 75.35 110.875 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -160.6 85.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.13 110.816 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.44 -90.83 0.46 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 74.35 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.31 6.3 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 65.24 110.87 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -119.85 146.79 45.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.852 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -129.19 164.21 23.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.966 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -151.32 149.37 29.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.44 111.168 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.29 114.98 17.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 70.24 111.133 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 154.75 47.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 75.45 110.884 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -131.32 -51.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.878 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.05 39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 75.24 111.146 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.2 68.52 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.737 -0.744 . . . . 71.52 112.454 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -112.08 -30.45 7.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 73.45 110.919 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.49 -46.06 4.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.861 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.98 55.84 16.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.696 -0.764 . . . . 75.3 112.492 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -135.19 94.6 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.834 0.349 . . . . 63.41 111.194 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.37 161.17 36.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.3 163.45 26.78 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.534 0.683 . . . . 73.41 111.109 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -7.92 22.28 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.632 2.222 . . . . 71.12 112.352 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 115.17 1.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 72.3 112.492 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.75 172.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 75.02 111.12 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.89 131.58 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.43 110.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.8 t -149.41 137.39 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.515 . . . . 62.15 111.149 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -124.22 136.59 54.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 74.53 110.828 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -125.25 135.81 52.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 72.43 110.865 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.89 171.13 13.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 73.45 112.394 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -162.42 179.59 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 73.2 110.951 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -136.67 131.07 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 61.43 110.872 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 153.84 23.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 61.42 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -91.28 116.78 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 74.55 110.881 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -161.58 29.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 72.14 112.485 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -45.51 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 73.14 112.342 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 27.55 9.81 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 63.35 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 t -112.37 75.13 1.64 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.57 0.7 . . . . 73.03 110.867 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 165.29 31.43 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.705 2.27 . . . . 75.1 112.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -148.59 -177.42 5.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.5 110.834 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m120 51.85 60.98 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.901 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -76.66 105.88 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.91 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 144.16 41.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 74.42 110.954 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 pp -153.12 156.15 38.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.893 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.94 43.73 2.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.918 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.8 42.13 61.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.706 -0.759 . . . . 74.52 112.525 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 70.89 1.33 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.749 -0.738 . . . . 63.52 112.492 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -156.43 104.35 2.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 61.41 110.841 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.889 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.747 0.308 . . . . 75.42 111.18 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.85 29.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 62.42 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -137.46 132.89 34.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.53 111.185 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.09 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 71.25 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.91 154.0 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -99.2 145.58 27.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 73.23 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -105.85 -58.64 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 65.35 111.122 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -179.42 131.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 72.02 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.59 127.29 53.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.31 88.99 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.2 -92.96 0.76 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 63.22 112.462 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.51 -17.76 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 74.03 111.181 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.36 148.62 20.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 63.12 112.495 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -136.87 145.1 43.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 74.13 110.887 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.52 112.53 4.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 64.21 112.491 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.77 145.44 24.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 62.22 112.524 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.92 98.7 3.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 75.32 110.826 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.79 124.46 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.52 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.9 m -105.27 101.81 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 62.53 111.174 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.37 131.98 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 75.33 111.075 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -139.81 118.19 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.86 101.46 9.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 62.21 110.866 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -131.15 136.22 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.15 111.193 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.36 -35.53 4.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.679 -0.772 . . . . 52.31 112.492 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 177.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 63.45 111.209 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.34 173.41 12.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 72.55 111.149 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.76 108.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 70.13 110.886 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.09 -177.66 6.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 75.13 110.957 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.7 p -141.71 -53.44 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 72.54 110.822 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.53 152.63 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.889 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -115.3 126.78 54.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 62.41 110.931 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -135.9 118.13 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.13 111.155 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -114.91 125.46 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.176 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.39 153.71 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.825 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.55 169.45 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 64.21 110.88 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 132.45 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 55.53 110.834 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.83 79.5 2.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.603 0.716 . . . . 74.32 110.859 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 75.3 112.364 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' THR . 69.9 p -73.36 144.82 46.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.42 96.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.485 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 43' ' ' THR . 57.4 m -156.94 149.41 23.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 73.54 111.154 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.68 131.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.937 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.79 100.15 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.3 m -63.16 -46.02 89.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.124 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 m -141.44 142.12 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 64.51 110.897 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.46 147.69 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -131.58 143.99 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.925 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t0 64.8 14.07 8.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.935 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.96 106.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.068 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -64.95 91.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 73.0 111.141 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -88.96 113.27 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.11 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -107.19 179.08 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 73.01 111.181 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.21 159.97 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.921 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -158.6 85.21 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 65.32 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.17 -90.99 1.01 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.442 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -126.75 2.0 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 70.41 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -111.56 146.88 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.12 110.88 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -130.29 152.9 49.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.903 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 t -149.07 148.58 29.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.4 111.146 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.41 135.49 50.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.089 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.59 135.21 15.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.872 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -111.77 -32.09 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.11 110.907 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.32 40.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 72.12 111.152 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.03 1.89 72.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 72.31 112.52 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -117.78 -34.05 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 71.4 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.0 -68.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 73.03 110.89 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.96 45.44 8.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 74.43 112.479 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -127.03 120.72 29.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.816 0.341 . . . . 71.41 111.166 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.25 161.43 40.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 74.43 110.97 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.02 164.0 17.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 73.05 111.034 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -8.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.702 2.268 . . . . 65.12 112.326 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.63 114.29 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 71.12 112.484 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.99 172.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.711 0.291 . . . . 75.25 111.143 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -129.33 131.28 46.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 71.42 110.825 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.42 128.29 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -132.74 140.85 48.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 60.14 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.32 153.76 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.873 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.53 175.83 17.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.787 -0.721 . . . . 54.33 112.486 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -174.21 177.32 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 74.52 110.907 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -130.64 125.77 34.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.55 110.879 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.51 151.62 18.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 71.11 112.474 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 109.57 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 63.51 110.845 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.47 -157.22 27.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.706 -0.759 . . . . 72.42 112.426 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -42.49 3.33 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.591 2.194 . . . . 73.03 112.373 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.9 26.97 25.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 62.42 112.508 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -113.03 73.95 1.72 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.742 . . . . 71.15 110.828 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 156.02 64.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.669 2.246 . . . . 74.51 112.343 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.845 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 63.14 62.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.858 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.54 131.75 34.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 63.51 110.936 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 121.37 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.898 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.48 155.88 49.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.4 110.935 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.11 39.79 7.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.937 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 23.36 60.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 65.4 112.531 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.37 71.53 1.16 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 55.42 112.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -156.19 104.24 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 70.15 110.891 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 73.42 110.873 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.742 0.306 . . . . 72.14 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.37 163.77 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 71.03 111.095 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.41 141.93 26.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 70.04 111.128 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -84.73 145.53 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 71.21 110.884 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.77 164.1 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 71.43 111.153 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.74 163.95 12.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.879 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -61.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 73.21 111.121 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.22 135.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 75.51 110.905 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.92 127.14 53.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 70.54 110.93 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.14 92.91 4.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.926 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -90.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.794 -0.717 . . . . 72.32 112.477 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -106.98 -17.56 14.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 74.2 111.127 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.82 153.56 27.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 64.41 112.516 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -140.94 146.55 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 63.44 110.928 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.22 127.93 9.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.774 -0.727 . . . . 70.35 112.543 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 145.95 16.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.758 . . . . 74.35 112.507 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.76 100.09 4.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 54.4 110.845 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.29 139.91 30.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 72.24 110.921 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -114.73 119.54 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 63.5 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.96 131.78 62.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -138.29 127.5 24.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 74.32 110.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -118.2 129.73 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 63.2 110.899 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -172.6 159.76 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 74.31 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.1 9.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 71.51 112.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.48 171.01 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 73.12 111.144 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -172.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.152 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -51.54 128.06 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 70.43 110.844 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.1 -175.94 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.895 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.99 -53.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.13 110.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 p -155.82 176.38 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 65.04 110.864 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -139.66 126.89 21.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 72.33 110.878 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -114.04 104.55 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 74.22 111.099 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.45 108.31 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.144 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -130.15 136.17 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 63.02 110.833 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.58 169.89 15.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 74.12 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.21 129.19 44.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 52.1 110.862 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -113.03 76.43 2.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.31 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -49.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 72.31 112.394 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -72.03 145.19 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 75.41 111.132 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.39 98.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 44.13 112.471 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -154.56 155.07 34.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 64.41 111.115 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.55 130.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.864 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.02 109.08 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.12 111.114 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.04 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 65.43 111.085 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -145.85 154.56 42.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 74.45 110.811 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.73 143.9 35.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 72.25 111.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -128.07 145.38 51.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.99 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.98 13.8 8.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.306 -0.406 . . . . 74.03 110.84 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 73.25 111.083 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.0 m -60.29 96.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 75.52 111.158 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -92.54 112.6 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 75.35 111.046 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -105.51 174.84 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 72.53 111.146 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -135.9 158.14 45.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.84 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -158.51 85.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 73.51 110.918 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.04 -91.59 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 74.52 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.57 4.92 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 74.1 110.882 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -132.64 139.08 47.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.913 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -139.21 148.85 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.134 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -133.66 144.4 49.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 74.12 111.066 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 161.08 39.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.33 110.947 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -131.62 -51.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.896 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.1 39.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 74.1 111.117 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.6 1.17 83.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 74.33 112.491 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -115.13 -20.82 10.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.32 . . . . 71.44 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -115.33 -44.35 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 63.31 110.916 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.95 56.73 11.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.501 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -145.93 96.55 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.43 111.13 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.27 160.27 39.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 72.14 111.021 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 161.52 60.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 64.51 111.036 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -19.73 36.03 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 74.34 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.08 116.24 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.779 -0.724 . . . . 73.43 112.528 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.82 172.08 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.42 111.108 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 86.7 p -136.24 131.63 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.876 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.08 117.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.106 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -110.4 134.8 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.868 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -122.74 146.44 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.918 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.02 173.32 14.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 73.41 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -171.18 -179.5 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.22 110.867 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -131.43 125.95 33.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 53.41 110.873 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.03 156.64 20.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 64.33 112.471 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.17 116.57 32.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 74.32 110.891 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.35 28.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 55.52 112.486 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -33.74 16.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.744 2.296 . . . . 74.33 112.324 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.46 26.93 28.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 72.03 112.494 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -112.28 76.03 1.82 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.727 0.775 . . . . 74.41 110.898 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 157.94 58.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 74.12 112.356 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -147.44 173.12 12.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 74.41 110.849 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.61 46.82 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 72.34 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.6 m -65.75 100.61 0.56 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.841 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.45 144.04 47.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.876 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.19 145.84 15.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.54 110.92 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.4 t30 60.67 54.82 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.13 110.885 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.9 39.53 46.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 70.35 112.514 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.56 65.24 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.73 104.62 2.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 72.42 110.852 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 72.23 110.908 -179.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 71.4 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.89 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 74.1 111.086 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -153.0 138.24 17.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 73.2 111.153 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -83.47 138.46 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.08 158.95 43.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.32 111.15 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -104.47 139.8 38.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 75.41 110.897 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -99.7 -62.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 72.04 111.16 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.82 143.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.865 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.15 125.9 51.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 75.35 110.851 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -112.2 107.04 15.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 73.54 110.989 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 64.51 112.511 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -117.61 -17.52 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 75.1 111.164 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 140.88 16.87 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 55.23 112.537 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.76 149.61 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.829 0.347 . . . . 74.13 110.888 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.1 106.14 2.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 74.13 112.469 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.27 138.22 18.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 52.35 112.453 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.34 100.67 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 71.35 110.819 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -90.17 132.67 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 74.44 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.5 m -110.48 122.99 49.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 73.12 111.129 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.47 131.78 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.11 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.71 126.95 18.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.921 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -119.42 135.02 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 71.13 110.885 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 t -168.2 140.65 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 65.1 111.141 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.29 -61.88 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 72.14 112.513 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -60.2 165.83 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 72.14 111.162 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.5 p -59.92 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.14 111.178 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 127.15 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.854 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -176.29 4.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.941 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -140.91 -52.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 72.35 110.885 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.47 174.51 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 53.25 110.854 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -132.2 126.99 34.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.498 . . . . 74.21 110.932 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.31 105.69 12.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 64.11 111.113 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -105.0 120.66 55.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 75.35 111.13 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -133.48 156.52 47.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 64.41 110.866 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.82 168.76 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.902 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.24 133.19 43.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.803 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -113.53 73.42 2.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 75.32 110.926 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -50.14 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.66 2.24 . . . . 73.44 112.387 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -74.05 145.56 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.4 111.115 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -38.24 99.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 41.1 112.504 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -154.82 157.86 38.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 72.43 111.186 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -173.34 130.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.97 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 81.3 t -81.69 107.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.3 111.119 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -48.34 79.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 64.24 111.165 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.32 156.22 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.787 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 134.56 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 64.42 111.128 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -118.59 145.66 45.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.35 110.863 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.27 13.49 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 71.1 110.854 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 103.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 70.03 111.153 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -63.2 97.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 71.2 111.139 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -89.1 131.09 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 65.21 111.125 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -119.7 172.53 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -134.03 155.98 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 65.52 110.893 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.76 85.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 45.4 110.919 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.83 -93.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.23 112.52 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.26 17.09 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 73.31 110.823 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -129.56 146.71 51.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.869 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -130.67 160.46 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.894 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -152.71 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.152 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.18 134.63 48.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 156.53 47.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 75.22 110.895 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -131.43 -51.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 73.23 110.884 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.9 39.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.11 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -0.29 75.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 72.13 112.496 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -114.2 -25.39 8.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 73.51 110.92 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -108.58 -47.36 3.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 71.24 110.841 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.79 55.6 19.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 74.43 112.479 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -136.51 94.84 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 62.25 111.175 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.13 160.77 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 64.24 110.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.64 162.28 71.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 71.32 111.049 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -8.37 23.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.633 2.222 . . . . 74.43 112.319 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.6 115.83 0.86 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.713 -0.756 . . . . 72.45 112.523 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.81 172.16 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 71.4 111.046 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -131.63 131.62 43.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.795 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.05 141.49 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 74.33 111.162 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -132.91 164.31 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.806 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -156.33 143.15 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 73.41 110.886 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.41 172.29 14.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 73.41 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -170.0 178.91 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.369 . . . . 73.55 110.895 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.14 149.42 50.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 73.35 110.852 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.68 160.6 29.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.712 -0.756 . . . . 75.43 112.461 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 73.11 110.837 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.84 -159.9 29.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.783 -0.722 . . . . 74.21 112.488 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -37.24 9.66 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.724 2.283 . . . . 72.25 112.406 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.84 28.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 75.13 112.495 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 78.99 2.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.71 0.767 . . . . 74.44 110.785 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 168.14 22.43 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 75.52 112.386 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 m -146.68 170.33 17.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 72.35 110.869 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.37 44.35 9.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.917 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.2 m -64.53 92.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 144.06 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.76 155.86 28.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.31 110.909 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 64.67 46.66 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 71.24 110.914 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.84 41.88 54.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 65.33 112.493 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.05 67.05 1.8 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.67 -0.776 . . . . 73.5 112.517 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.3 m -156.35 108.87 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 71.13 110.761 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 73.13 110.839 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.779 0.323 . . . . 64.01 111.184 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.55 41.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 75.44 111.114 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -138.83 132.41 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.124 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -78.02 146.15 35.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.925 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.23 150.73 29.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 64.33 111.044 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -92.33 141.81 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.01 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -102.83 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 74.13 111.165 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -174.14 127.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 74.05 110.864 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.64 127.71 55.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -110.59 83.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.962 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.8 -87.02 0.65 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 64.33 112.505 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -102.31 -17.58 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 73.05 111.13 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.3 153.68 23.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.489 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -140.61 145.19 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 73.51 110.903 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.54 113.84 4.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 72.31 112.479 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.21 136.67 19.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 50.45 112.479 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.72 94.45 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 71.25 110.882 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.47 136.63 39.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.473 . . . . 73.43 110.964 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 m -113.87 105.19 12.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.12 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.37 131.72 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 75.44 111.061 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -136.48 121.29 18.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.03 110.868 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.47 119.75 37.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 73.52 110.889 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.93 157.91 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 72.22 111.138 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.25 -28.32 15.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 72.32 112.475 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.4 p -103.81 170.19 8.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 75.45 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -171.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 70.44 111.12 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 t -51.57 125.09 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.787 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 -176.31 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 72.51 110.902 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -142.88 -52.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 51.01 110.868 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.79 175.78 13.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 73.03 110.921 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -144.26 127.09 16.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.928 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 m -118.34 100.78 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 74.32 111.116 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -101.48 116.12 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.15 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -126.17 158.97 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.42 110.87 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.56 171.11 17.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 130.49 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 71.43 110.84 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.68 75.43 1.85 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.69 0.757 . . . . 75.32 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 -49.61 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 74.3 112.33 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.8 p -73.92 144.47 45.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.11 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.66 98.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.478 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -156.1 153.25 29.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 73.22 111.176 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.15 131.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.927 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.64 96.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.52 111.088 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -63.26 -41.22 99.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.41 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -135.58 148.92 49.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 64.23 110.787 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.89 160.48 39.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 74.32 111.085 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -147.55 142.07 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.877 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.36 20.28 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.86 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -171.97 107.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.43 111.1 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.5 m -68.34 95.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 73.25 111.216 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.6 140.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.17 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.9 m -129.96 141.67 50.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 62.53 111.192 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.93 156.58 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.909 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -161.7 85.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.35 110.884 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.86 -92.3 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 65.42 112.558 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.24 18.09 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 75.23 110.816 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -131.22 146.05 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.822 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -131.29 160.69 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.867 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -148.95 148.97 30.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 65.33 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.43 127.99 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 75.15 111.135 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 156.65 48.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 74.4 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.36 -49.28 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.977 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.71 38.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 72.31 111.146 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.79 1.38 83.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 64.13 112.461 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.76 -25.24 7.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.736 0.303 . . . . 75.12 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.19 -37.79 5.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.884 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.46 54.83 14.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.462 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.08 96.82 3.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 64.13 111.142 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 tt -138.78 160.35 39.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 71.4 110.928 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 160.86 81.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.541 0.686 . . . . 63.11 111.147 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -20.77 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.618 2.212 . . . . 74.23 112.343 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.9 116.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 75.31 112.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.43 172.05 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.326 . . . . 74.43 111.099 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -138.15 131.62 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.43 110.921 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.08 114.27 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.125 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -103.15 125.77 50.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.849 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -114.55 152.87 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 75.22 110.864 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.54 167.59 24.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.654 -0.784 . . . . 55.03 112.458 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -160.42 -176.27 5.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.361 . . . . 74.33 110.93 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -132.04 133.62 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 71.54 110.886 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.67 158.65 27.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 74.12 112.499 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.19 117.82 35.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 75.11 110.918 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -161.65 29.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.78 -0.724 . . . . 73.45 112.542 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -39.9 5.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 63.14 112.328 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.61 26.68 26.73 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.722 -0.751 . . . . 72.21 112.497 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -111.91 78.45 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.674 0.749 . . . . 63.22 110.86 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 165.8 29.61 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.693 2.262 . . . . 74.41 112.43 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.6 p -148.48 174.85 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.838 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 58.13 49.54 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 m -64.59 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 143.98 49.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.897 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -157.21 155.79 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.89 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 65.09 45.83 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.61 42.03 55.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 72.31 112.453 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.92 67.82 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.688 -0.767 . . . . 71.25 112.517 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.9 t -156.33 105.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 73.44 110.89 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.928 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.714 0.292 . . . . 75.45 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.76 162.25 35.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.32 111.111 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.5 147.64 32.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 111.112 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -88.26 146.19 25.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.855 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.6 173.03 11.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 52.3 111.125 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 159.8 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.96 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.81 -58.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.409 . . . . 64.03 111.111 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -178.59 132.14 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.88 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.22 127.85 55.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.839 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -110.57 82.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.924 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.56 -86.74 0.62 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 72.13 112.464 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -101.35 -17.46 16.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 64.54 111.218 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.4 155.48 25.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 64.51 112.443 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -143.22 143.3 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 74.23 110.948 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.62 117.51 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 64.42 112.533 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.36 143.58 16.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 44.43 112.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.4 112.81 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 70.15 110.873 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -97.33 134.42 40.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.987 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 m -116.3 108.41 16.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 74.45 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.14 131.96 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 73.51 111.145 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.63 118.41 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -118.59 101.37 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 75.34 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.49 155.66 34.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 74.44 111.19 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 52.05 28.27 24.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 74.35 112.448 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -114.23 158.64 21.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 72.05 111.147 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.66 157.0 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 70.02 111.14 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 m -52.0 112.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 71.24 110.874 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.11 174.62 7.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.956 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -137.42 -52.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.861 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.55 152.94 49.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.852 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -119.29 127.17 52.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 74.13 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -125.28 108.12 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.53 111.115 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 p -102.39 111.29 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.24 111.067 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.92 138.69 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 71.03 110.883 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.2 171.53 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.885 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.5 129.26 45.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.14 110.875 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -113.31 75.67 2.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 75.34 110.822 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -49.74 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.687 2.258 . . . . 63.44 112.3 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -71.36 145.05 49.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 61.51 111.153 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.26 100.07 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 73.44 112.515 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -154.61 155.81 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.847 0.356 . . . . 74.35 111.164 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -173.55 130.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.96 112.28 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.52 111.138 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -87.51 -32.71 19.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.42 111.143 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.05 149.55 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 63.2 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.27 133.23 5.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.116 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -133.06 147.96 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.937 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.77 16.42 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 74.42 110.868 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.04 95.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 51.33 111.148 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.5 m -56.17 99.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 53.45 111.1 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -91.37 124.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.099 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -115.9 172.07 7.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.096 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -133.54 154.39 50.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.862 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.7 m -159.23 85.63 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.843 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.35 -93.33 0.79 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.24 112.546 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -126.51 15.0 7.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 72.11 110.825 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -126.83 146.86 50.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 74.33 110.838 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -131.54 150.6 52.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 72.12 111.002 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.5 m -140.0 147.76 40.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.288 -0.414 . . . . 71.11 111.207 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.59 127.29 47.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.117 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 126.26 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 61.03 110.89 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -106.34 -45.38 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.08 39.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 73.25 111.081 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.17 -0.61 66.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 61.43 112.504 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -115.42 -33.78 5.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.793 0.33 . . . . 70.45 110.893 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.94 -48.09 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.21 110.902 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.58 52.12 54.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.2 112.506 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -124.66 117.66 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.94 0.4 . . . . 71.35 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.75 160.92 39.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 65.34 110.856 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.51 163.61 17.09 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 72.52 111.155 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -7.89 22.22 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.746 2.297 . . . . 75.34 112.289 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.94 114.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.42 112.462 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.64 172.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 75.31 111.089 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -121.36 131.19 54.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 70.34 110.815 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.4 125.88 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 63.43 111.083 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 p -129.86 156.59 44.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.827 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -149.41 139.19 21.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 75.53 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.46 168.84 15.7 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.729 -0.748 . . . . 52.4 112.42 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -173.81 176.2 2.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 74.41 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -125.84 173.12 9.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 65.23 110.823 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.34 167.66 40.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 72.33 112.486 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -120.05 109.52 15.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 73.13 110.844 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.02 -159.8 31.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 70.04 112.419 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.61 10.46 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.631 2.221 . . . . 75.33 112.368 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.32 26.67 29.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.752 . . . . 72.43 112.483 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 m -112.28 76.67 1.97 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.669 0.747 . . . . 74.43 110.879 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 159.26 54.1 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 75.32 112.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.58 171.37 15.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.44 110.884 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 58.68 47.61 12.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 75.51 110.893 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.0 m -66.61 101.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.827 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.25 141.76 51.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.953 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.25 148.11 19.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 65.14 110.927 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 58.47 56.11 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 72.4 110.929 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.37 41.5 30.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 51.11 112.511 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.55 58.09 15.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 74.33 112.459 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.36 105.66 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 72.52 110.884 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 72.34 110.883 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.791 0.329 . . . . 74.4 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.69 141.35 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 62.34 111.1 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -130.81 109.7 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 72.32 111.116 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.75 141.05 57.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 73.54 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.55 32.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 63.3 111.119 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.74 122.71 41.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 75.5 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -58.47 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 62.44 111.169 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.52 138.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.877 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.58 127.06 54.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 75.14 110.892 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.66 85.96 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 75.35 110.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.55 -88.99 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 73.5 112.512 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -107.88 -17.59 14.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 75.13 111.126 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.7 144.9 19.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.493 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -128.77 139.75 52.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 70.22 110.882 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.94 105.57 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 72.33 112.503 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.63 141.18 25.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.34 94.48 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 73.34 110.914 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -90.35 136.86 32.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.933 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -112.9 105.85 14.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 73.52 111.193 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.7 131.79 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.13 111.163 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.66 123.42 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.939 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.96 103.88 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 72.31 110.888 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -159.59 130.33 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.48 -28.99 3.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 72.15 112.451 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -108.63 177.37 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 71.41 111.101 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -60.01 -172.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.133 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -51.19 131.54 27.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 73.11 110.874 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.94 -176.52 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.1 110.945 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 -53.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 62.14 110.902 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 p -153.55 176.11 12.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 75.3 110.81 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -139.04 127.12 22.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 74.33 110.941 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.3 m -113.49 105.07 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.22 111.161 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.1 105.75 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 75.1 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 152.61 44.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.868 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.77 170.74 19.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.92 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.97 131.38 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.14 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -111.75 78.99 2.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.656 0.741 . . . . 63.42 110.889 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.96 0.61 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.729 2.286 . . . . 74.23 112.401 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.0 p -72.72 144.47 47.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.23 111.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 64.22 112.548 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.5 m -156.49 142.69 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 73.34 111.122 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -154.87 130.84 10.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 72.24 110.933 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.04 97.43 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 72.31 111.13 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 m -62.64 -43.97 97.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 73.31 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 143.74 30.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 73.2 110.832 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.57 139.87 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 72.41 111.054 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -123.65 143.56 50.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.44 12.97 8.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.848 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.03 104.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 71.22 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.3 m -63.32 97.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 75.02 111.179 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -87.34 134.19 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 72.12 111.111 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -122.9 171.14 9.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 71.23 111.178 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -131.79 153.67 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.44 110.899 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -158.62 85.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 54.2 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.23 -94.24 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.688 -0.768 . . . . 65.4 112.494 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.26 13.42 7.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.825 0.345 . . . . 75.23 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -128.03 146.88 50.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.55 110.879 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -128.57 159.16 36.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 75.12 110.843 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.0 m -145.95 149.16 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 71.21 111.114 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.4 129.78 45.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 74.43 111.157 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.73 155.94 49.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 72.52 110.912 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -131.48 -52.01 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 74.02 110.913 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.07 39.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.1 111.134 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.25 0.14 75.35 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.495 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -114.55 -26.5 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 74.1 110.878 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.31 -46.95 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 73.24 110.905 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.76 55.55 20.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.452 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.05 95.61 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 72.51 111.083 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.98 160.68 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.914 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 162.12 75.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.684 . . . . 74.31 111.119 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -8.43 23.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.713 2.275 . . . . 64.12 112.332 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.75 116.16 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.77 -0.729 . . . . 75.3 112.511 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.25 172.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 62.35 111.081 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 p -145.86 131.7 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 53.32 110.845 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.01 118.18 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.074 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 121.84 42.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.866 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.24 135.27 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.44 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.15 -179.95 19.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 72.4 112.483 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -174.07 175.74 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 70.21 110.907 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -131.15 125.82 34.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 75.44 110.849 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.45 151.02 19.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 72.43 112.451 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.6 112.17 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 61.33 110.842 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.85 -160.3 29.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 71.02 112.473 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -44.96 1.78 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.67 2.247 . . . . 73.32 112.384 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.02 27.15 11.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 63.1 112.477 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -112.17 76.09 1.78 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 64.44 110.848 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 166.7 26.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 74.3 112.323 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -148.53 179.86 7.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 71.04 110.867 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 51.87 62.44 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.851 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 16.1 m -79.13 102.99 8.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 65.3 110.878 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.91 140.43 42.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 71.32 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -148.82 155.94 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.954 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.29 43.66 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 72.54 110.914 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.42 42.03 50.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 73.42 112.435 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.24 71.78 1.25 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 71.33 112.477 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 t -156.16 104.52 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 70.23 110.87 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 73.13 110.907 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.774 0.321 . . . . 62.41 111.141 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.52 163.77 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.083 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -153.03 147.66 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.55 111.194 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -85.97 146.34 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.845 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.94 9.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.32 111.1 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 166.74 12.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 65.51 110.867 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 75.1 111.145 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.72 134.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.847 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 127.54 55.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 74.14 110.79 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.8 p90 -110.51 82.67 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.96 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.57 -85.87 0.63 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 72.34 112.546 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -102.82 -17.46 15.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.846 0.355 . . . . 70.4 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.07 154.31 24.36 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 71.53 112.534 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.41 143.42 31.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 73.54 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 122.87 7.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 63.24 112.467 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 139.13 14.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.746 . . . . 70.52 112.544 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.38 110.4 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 73.15 110.847 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.4 135.27 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 65.13 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -109.95 129.52 55.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 74.33 111.074 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.47 131.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 74.21 111.12 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -141.7 118.25 10.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.972 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.52 143.65 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.9 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 155.65 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.109 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.93 5.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 61.42 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.54 159.12 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 74.05 111.166 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.01 111.143 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -51.57 129.14 25.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.52 110.86 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.05 -176.61 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 73.45 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -141.01 -52.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.904 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 p -154.22 171.09 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 64.13 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -130.63 127.01 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.927 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.4 m -116.25 104.98 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.216 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.4 112.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.41 111.085 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -133.61 141.09 47.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.915 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.72 169.96 16.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.899 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.49 128.03 44.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 64.13 110.846 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.69 77.08 2.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 75.44 110.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -49.63 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 62.33 112.415 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -72.69 145.2 47.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 70.24 111.218 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 98.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 71.21 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -154.58 153.51 31.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.828 0.347 . . . . 74.01 111.098 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -173.68 131.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 71.42 110.917 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.78 106.81 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 75.21 111.204 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -48.65 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.147 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 m -146.47 151.48 37.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 75.21 110.821 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.21 42.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 74.44 111.066 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -142.69 145.24 33.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 72.01 110.978 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.88 13.92 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 73.35 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.95 95.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 71.2 111.137 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.5 m -59.03 97.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.16 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.69 112.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 75.04 111.135 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -102.35 175.01 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 73.21 111.16 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -133.51 157.51 45.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.03 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.5 m -158.69 85.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 73.03 110.854 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.49 0.9 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.24 112.538 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.76 11.75 7.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 74.24 110.835 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -120.45 147.0 45.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 64.33 110.848 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -132.98 142.66 48.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.93 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -141.14 147.12 37.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 72.53 111.131 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.35 140.77 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.153 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.53 159.0 43.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 74.43 110.939 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.45 -52.17 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.89 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.48 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.155 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.52 0.48 75.78 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 75.42 112.467 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -114.5 -22.8 9.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.312 . . . . 70.41 110.881 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.48 -47.18 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.44 110.897 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.01 55.04 23.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.668 -0.777 . . . . 71.24 112.542 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -137.04 95.1 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 65.42 111.123 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.18 160.73 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.868 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 162.21 64.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.63 0.728 . . . . 73.12 111.058 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 -8.46 23.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.722 2.282 . . . . 74.03 112.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.06 115.55 0.89 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 65.13 112.479 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.33 172.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 73.21 111.088 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.1 p -129.2 131.48 47.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 64.43 110.833 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.82 138.42 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.104 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 p -137.22 158.78 43.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.15 110.922 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -148.13 144.68 27.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.77 174.25 15.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.797 -0.716 . . . . 70.31 112.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -174.48 175.09 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 73.11 110.837 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -125.54 134.59 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 74.15 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.0 158.28 23.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.468 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 p -109.84 115.68 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 73.03 110.87 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.84 27.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 52.1 112.439 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -35.6 12.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 74.11 112.387 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.97 31.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.729 . . . . 41.51 112.519 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -112.5 75.45 1.78 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 64.52 110.831 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 155.85 64.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.645 2.23 . . . . 73.52 112.356 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.31 177.12 9.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.42 110.881 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 58.57 41.07 22.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.877 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.2 p -64.45 122.79 17.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.22 110.873 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 134.78 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 73.43 110.92 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.06 149.07 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 73.4 110.94 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 t30 63.05 47.69 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.92 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.23 17.76 73.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.729 -0.748 . . . . 71.23 112.465 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.14 70.67 1.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.68 -0.772 . . . . 74.4 112.497 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.09 104.32 2.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 74.13 110.946 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.85 -179.865 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.862 0.363 . . . . 74.53 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.5 163.85 34.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.13 111.105 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.99 147.7 30.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.138 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -88.01 146.29 25.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 72.52 110.887 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.18 42.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 52.13 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 156.64 17.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.918 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 -60.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 74.31 111.126 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.58 145.72 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.821 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.64 126.87 53.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.917 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.2 86.1 2.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 75.45 110.875 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.59 -85.86 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 74.3 112.438 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -111.76 -17.6 12.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 72.54 111.126 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.76 151.03 22.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 62.34 112.463 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -131.53 154.95 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 75.41 110.869 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.93 118.86 4.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 71.44 112.508 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.32 148.78 18.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.685 -0.769 . . . . 54.34 112.498 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.95 102.29 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 72.13 110.837 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.18 144.29 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 75.32 110.939 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.7 m -120.52 121.57 38.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 65.52 111.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.09 131.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.11 111.118 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 118.18 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.905 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -111.26 137.76 48.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 73.04 110.909 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 t -172.36 135.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.12 111.098 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.96 -56.73 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.723 . . . . 71.25 112.531 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -63.88 172.26 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 65.23 111.098 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -66.45 -174.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.054 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 t -51.36 127.49 19.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.797 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 -176.52 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 75.4 110.933 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.63 -53.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 62.43 110.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.91 164.84 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.81 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -120.56 126.87 51.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.903 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.8 m -115.74 100.5 8.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.17 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -102.15 109.44 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.156 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.91 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 73.51 110.89 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.18 171.93 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 74.1 110.981 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.35 132.02 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.862 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.82 73.65 2.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 72.33 110.898 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -50.23 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 75.33 112.315 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.9 p -72.34 145.77 47.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 75.41 111.098 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.72 97.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.81 -0.71 . . . . 74.43 112.454 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -155.12 156.45 35.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.341 . . . . 72.04 111.078 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.58 131.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 73.42 110.916 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.08 103.12 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 71.35 111.18 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -75.38 -36.69 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.182 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.82 150.54 51.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 62.15 110.82 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.8 140.01 16.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.098 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -138.3 149.04 45.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.84 15.75 9.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 64.4 110.883 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.36 108.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.045 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.9 m -66.5 94.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.23 111.16 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.17 144.38 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 55.11 111.101 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 m -135.38 141.85 45.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.458 . . . . 74.2 111.209 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.89 155.24 21.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.44 110.927 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.18 85.72 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 70.11 110.878 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.37 -92.77 0.42 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.77 -0.728 . . . . 53.4 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -126.22 20.95 7.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.371 . . . . 72.22 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -134.15 146.45 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.841 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -133.34 150.55 51.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -138.04 149.38 45.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.207 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.25 125.39 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 75.32 111.094 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 134.16 32.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.938 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -111.0 -51.64 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.51 39.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 75.32 111.081 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.49 -0.82 74.13 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 61.24 112.506 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -113.59 -26.02 8.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 75.44 110.957 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -107.23 -47.1 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.52 110.916 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.68 56.24 14.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 60.35 112.481 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.6 p -136.94 95.04 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.339 . . . . 74.03 111.188 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 tt -137.16 160.87 37.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 63.22 110.966 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.53 64.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 72.4 111.109 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.59 24.0 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 61.14 112.351 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.87 115.75 0.88 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 64.14 112.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.49 172.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 73.34 111.123 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -131.15 131.57 44.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 62.53 110.931 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.7 137.42 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.42 111.076 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.69 154.76 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.9 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -145.31 142.21 29.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.898 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 176.32 17.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.501 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -174.34 179.12 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 75.12 110.872 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -133.8 144.53 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 74.45 110.884 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.92 160.38 28.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.799 -0.715 . . . . 63.44 112.531 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.96 109.63 21.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 74.02 110.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.6 -158.89 28.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 45.14 112.483 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -35.72 11.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 71.22 112.349 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.58 31.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 72.55 112.523 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 m -112.63 76.91 2.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 71.31 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 158.85 55.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.742 2.295 . . . . 73.01 112.35 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 174.76 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 75.31 110.879 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 m120 56.27 47.5 19.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 64.21 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -67.22 95.78 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 143.76 45.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.99 147.76 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 75.14 110.953 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.29 52.13 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.862 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.82 19.9 77.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.743 . . . . 74.23 112.458 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.13 68.26 1.33 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 71.42 112.468 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.0 105.07 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.02 110.871 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 71.5 110.877 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.807 0.337 . . . . 74.11 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.31 112.56 20.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.01 111.118 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.84 118.7 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 72.14 111.165 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.16 143.75 48.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.923 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.14 161.36 38.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.125 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.17 151.11 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.893 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -63.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 73.4 111.109 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 p -178.79 149.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.903 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.69 126.74 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.21 110.884 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.4 p90 -111.42 87.19 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.22 110.933 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.65 -81.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.746 -0.74 . . . . 74.22 112.484 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -117.04 -17.51 10.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 74.14 111.202 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.09 161.57 33.09 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 54.21 112.484 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -143.78 161.07 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 74.41 110.843 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.3 133.38 9.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 65.33 112.527 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 154.45 17.64 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 63.35 112.529 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 t -141.8 95.74 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 73.34 110.854 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -90.24 124.83 35.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 74.52 110.902 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 84.4 m -110.26 101.68 10.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 71.12 111.181 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 131.52 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.24 111.172 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -135.7 118.05 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.806 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.21 127.52 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.01 110.947 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -172.71 120.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 55.43 111.165 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.73 -50.9 0.87 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 73.41 112.473 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -75.34 171.97 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 74.52 111.143 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.0 p -64.4 178.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -51.95 107.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 54.34 110.841 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -173.59 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 75.22 110.879 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -143.56 -53.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.88 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -138.77 159.44 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 75.1 110.823 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -128.69 127.22 41.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.2 m -134.21 112.12 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 72.14 111.092 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 t -101.43 105.65 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.105 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.03 144.44 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.44 110.896 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.92 168.92 19.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.936 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.24 129.36 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 63.41 110.87 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.85 76.62 2.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.609 0.719 . . . . 74.34 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -49.91 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.697 2.265 . . . . 74.41 112.319 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 1.2 p -71.65 144.96 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 75.3 111.147 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.19 98.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 75.15 112.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -154.7 155.4 34.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 74.42 111.137 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.78 130.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 73.31 110.912 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.58 91.76 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.126 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 t -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.34 154.1 50.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.42 110.883 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.37 146.17 25.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 74.25 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -135.99 143.52 44.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.922 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.06 15.25 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.5 109.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.081 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -69.49 103.26 2.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.11 111.089 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.52 137.37 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 63.3 111.091 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -129.25 141.38 51.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 62.12 111.162 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -104.77 156.92 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 74.24 110.907 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -160.47 85.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.942 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.49 -91.97 0.58 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 51.35 112.47 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -126.37 8.17 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 75.12 110.843 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -123.27 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 62.32 110.892 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -128.18 157.52 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.929 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -141.18 149.71 41.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 72.31 111.086 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.59 131.32 48.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.127 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.41 138.22 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.5 110.912 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -117.44 -25.12 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.885 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 m -102.77 39.28 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.32 111.157 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.74 2.04 70.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 64.21 112.555 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -33.89 4.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 74.24 110.97 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -55.24 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.907 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.85 47.44 60.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 71.11 112.532 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -127.8 120.3 27.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 74.34 111.115 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.6 tp -146.49 161.01 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.984 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.69 163.23 18.5 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.549 0.69 . . . . 74.42 111.106 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.44 23.61 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.672 2.248 . . . . 74.34 112.318 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.72 114.52 0.7 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 44.44 112.517 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.93 172.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 73.54 111.137 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.69 131.45 43.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 64.1 110.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.56 110.17 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 73.45 111.089 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.84 132.84 50.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.867 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.18 132.96 48.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 74.32 110.826 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.29 175.94 19.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 73.11 112.521 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -169.37 -175.31 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 71.31 110.858 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -139.0 138.31 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 63.41 110.893 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.79 163.96 28.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 63.42 112.507 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -105.81 110.33 22.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.32 110.866 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.0 -163.68 36.59 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.817 -0.706 . . . . 75.14 112.537 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -34.2 15.2 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.284 . . . . 65.41 112.309 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.49 26.38 27.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.468 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -112.61 76.27 2.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 75.13 110.861 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 159.93 51.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.628 2.219 . . . . 74.32 112.345 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 t -148.25 174.92 11.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.427 . . . . 75.43 110.908 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.87 54.51 5.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.44 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.94 108.36 3.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 73.13 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 143.89 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 75.22 110.893 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pp -157.08 153.71 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.888 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 55.01 54.9 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.51 110.935 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.38 18.92 75.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.719 -0.753 . . . . 73.34 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 70.86 1.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.844 -0.693 . . . . 60.24 112.499 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.44 104.5 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 75.24 110.844 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 74.02 110.825 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.796 0.331 . . . . 71.44 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.39 115.52 21.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 74.12 111.084 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 131.56 34.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 70.41 111.155 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -76.23 139.87 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 72.44 110.886 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.32 166.61 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 71.44 111.145 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.91 163.78 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 71.52 110.981 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 -56.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 51.51 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 131.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.76 127.55 55.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 74.1 110.892 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.54 82.18 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.901 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.53 -86.77 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 61.32 112.494 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -101.36 -17.6 16.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 75.42 111.084 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 154.81 24.47 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.725 . . . . 64.43 112.457 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -143.11 143.85 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 75.12 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 120.94 7.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 64.34 112.45 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.83 145.24 17.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.752 . . . . 42.01 112.465 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -140.84 94.7 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 71.31 110.9 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -90.28 122.95 33.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.937 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 101.53 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 72.32 111.124 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.47 131.58 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.12 111.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -137.89 117.99 13.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.45 110.938 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -111.88 131.3 55.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 75.31 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -168.97 126.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 74.33 111.198 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.65 -19.0 16.75 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.782 -0.723 . . . . 74.44 112.492 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.1 t -95.27 175.2 6.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 75.21 111.102 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -70.17 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 73.12 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.47 108.5 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.11 110.824 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -174.0 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.903 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.0 -54.19 0.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.794 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 159.04 43.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 71.34 110.847 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -128.65 127.1 41.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.914 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -122.61 110.64 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.33 111.205 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.9 105.47 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 73.12 111.176 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -126.35 154.9 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.888 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.2 169.32 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 75.52 110.962 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.14 128.33 44.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 64.13 110.91 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.78 76.82 2.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 72.55 110.946 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -49.78 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.684 2.256 . . . . 71.24 112.292 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.99 145.23 48.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.117 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 75.21 112.475 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -154.58 154.32 32.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.797 0.332 . . . . 74.55 111.15 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.71 130.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.88 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.98 100.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 61.24 111.12 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -45.86 89.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.136 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -144.77 147.43 32.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 71.33 110.946 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.62 161.83 36.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.04 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.47 145.33 31.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.931 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.34 14.65 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.85 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.98 103.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.12 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 m -61.67 94.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.148 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.1 t -91.5 112.43 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.55 111.1 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -106.4 174.57 5.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.088 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.08 156.45 44.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.844 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.02 85.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 62.13 110.845 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.68 -92.48 0.8 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 71.35 112.513 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.2 12.66 7.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 73.05 110.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -124.24 147.01 48.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -131.45 146.33 52.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.904 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -141.53 144.16 34.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.96 133.26 55.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 72.01 111.033 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.08 127.65 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.889 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -108.61 -32.05 7.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 65.11 110.91 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -103.72 39.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.083 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.14 2.51 69.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.825 -0.702 . . . . 75.23 112.456 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 -33.97 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.772 0.32 . . . . 74.23 110.979 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.44 -56.1 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.03 43.9 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.49 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -125.66 121.45 33.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.336 . . . . 75.43 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.68 161.16 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 75.22 110.897 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.14 163.6 18.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 74.32 111.118 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.2 22.98 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.677 2.251 . . . . 73.31 112.322 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.86 114.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 74.21 112.475 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.88 172.47 0.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.802 0.334 . . . . 61.44 111.11 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.1 p -128.63 131.3 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.872 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.4 111.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.137 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -110.46 141.56 43.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 54.12 110.892 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.58 129.2 38.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 65.21 110.887 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.59 174.48 22.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 62.44 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -174.45 175.95 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 73.55 110.935 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -124.55 126.75 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.872 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.64 151.86 19.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 72.02 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.84 117.3 34.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 73.01 110.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.44 -159.25 28.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 54.22 112.502 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -35.41 12.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.254 . . . . 72.24 112.34 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.85 26.89 30.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 44.41 112.46 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.73 75.15 1.8 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.636 0.731 . . . . 75.43 110.805 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 153.85 68.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 72.3 112.335 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 -177.53 5.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.83 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 52.0 52.49 14.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 73.51 110.819 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.18 128.45 34.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.859 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 123.01 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.97 155.75 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 t30 63.71 38.65 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.855 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.61 30.1 53.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 73.14 112.499 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 75.52 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.801 -0.714 . . . . 73.14 112.508 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.3 104.25 2.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 74.21 110.834 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 74.01 110.882 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.807 0.337 . . . . 62.01 111.105 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.2 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 72.32 111.096 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.28 142.5 51.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.55 111.119 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -91.03 135.05 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.94 147.75 40.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 54.02 111.099 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.77 140.66 29.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 74.35 110.901 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 -56.13 2.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.112 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.96 147.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.823 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.94 126.58 52.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.836 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -111.71 86.55 2.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 75.53 110.96 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.86 -83.13 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 43.13 112.421 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 t -115.79 -17.71 10.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.42 111.15 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.47 164.65 38.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 55.44 112.499 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.06 157.99 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.947 0.403 . . . . 73.23 110.877 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.42 128.97 8.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 62.12 112.506 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.74 148.8 17.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 72.22 112.501 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.45 96.08 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.937 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -89.78 118.52 29.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 101.85 13.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 71.34 111.121 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.74 131.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 73.03 111.154 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -133.42 117.96 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.956 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -118.07 101.37 8.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 74.43 110.962 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.5 t -143.89 146.78 33.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.51 111.124 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.42 -65.11 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 75.5 112.563 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.0 p -61.43 167.5 3.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 70.42 111.107 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.12 111.116 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -51.5 123.41 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.904 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -176.02 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 74.21 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.17 -52.46 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.53 110.837 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.99 174.47 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 75.03 110.877 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -140.68 127.24 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 70.24 110.897 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 m -114.75 104.7 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 62.4 111.152 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -101.27 114.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 73.43 111.16 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -134.41 137.02 43.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 65.5 110.916 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.03 173.6 11.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.949 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -98.19 130.97 44.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 74.41 110.806 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.65 74.25 2.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.651 0.739 . . . . 75.4 110.871 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -50.05 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 62.05 112.339 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.6 p -72.77 145.95 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.11 111.207 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 97.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.757 . . . . 70.24 112.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -155.07 154.06 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 73.13 111.122 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 131.18 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 75.14 110.948 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.07 102.94 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 72.02 111.154 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -63.66 -40.12 96.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.142 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -148.0 161.98 40.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.883 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 160.65 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 71.35 111.127 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.99 144.51 30.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.34 110.92 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.05 13.97 9.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.833 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.0 99.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 75.02 111.046 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.1 m -59.19 97.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 61.33 111.111 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.02 112.43 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.166 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -105.12 175.09 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 75.03 111.079 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -136.2 160.03 39.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 71.53 110.871 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -161.02 85.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 74.35 110.866 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.16 -92.09 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.531 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.67 9.89 7.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 70.34 110.8 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -117.74 146.85 43.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.02 110.935 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -133.49 139.78 46.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.966 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -140.54 147.8 40.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 64.1 111.098 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.14 143.1 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.54 111.039 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 160.77 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 74.33 110.918 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -131.23 -51.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 73.03 110.895 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.16 38.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 72.44 111.14 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.89 1.51 83.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 64.11 112.511 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.98 -25.2 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 74.44 110.886 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.52 -38.06 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 65.12 110.883 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.56 53.78 23.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 71.44 112.461 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -131.61 94.58 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 74.34 111.186 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.25 160.57 39.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.45 . . . . 75.4 110.96 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.98 161.82 64.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 72.3 111.12 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -22.9 31.75 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.638 2.226 . . . . 73.31 112.374 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.24 115.47 1.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 74.14 112.466 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.54 172.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.761 0.315 . . . . 73.24 111.07 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -137.86 131.62 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 65.04 110.886 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.42 113.17 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 75.13 111.103 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.2 p -105.19 120.53 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 65.45 110.928 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -104.3 146.0 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.79 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.98 173.39 14.73 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.741 -0.742 . . . . 72.32 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -169.79 175.94 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 73.43 110.912 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 71.01 110.859 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.17 163.53 27.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.725 -0.75 . . . . 73.41 112.444 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -115.62 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 74.23 110.907 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.42 -159.79 30.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 61.41 112.488 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.63 10.46 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.707 2.271 . . . . 73.53 112.346 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.33 26.69 27.4 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 62.22 112.462 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.47 77.05 2.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.636 0.732 . . . . 73.35 110.9 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 162.6 41.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.737 2.291 . . . . 73.51 112.307 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.42 176.1 9.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.85 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 54.16 44.83 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.7 t -64.63 101.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.89 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 143.83 49.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 73.54 110.942 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -155.76 153.07 29.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 110.863 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 58.68 52.04 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.865 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.48 41.26 45.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.73 . . . . 72.01 112.491 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.6 68.74 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.79 -0.719 . . . . 74.45 112.525 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.1 m -156.01 104.48 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 60.51 110.814 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.3 110.873 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.733 0.301 . . . . 73.11 111.212 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 73.21 111.063 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.41 138.83 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 74.53 111.104 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.58 135.29 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.6 168.52 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.52 111.102 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.14 148.07 30.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.897 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.16 -57.62 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 73.53 111.13 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -179.42 132.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.816 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.08 127.13 53.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 74.2 110.845 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.41 90.48 3.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 73.23 110.93 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.97 -94.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 74.04 112.465 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -101.28 -17.63 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 74.3 111.17 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.25 148.15 20.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 63.14 112.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -135.93 148.0 48.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 75.23 110.901 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.94 115.18 4.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 52.5 112.496 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.24 147.35 20.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.698 -0.763 . . . . 53.34 112.494 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.57 98.6 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 73.13 110.855 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.18 123.62 34.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 65.31 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 m -102.84 101.88 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 61.1 111.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.83 131.81 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.17 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.84 123.75 15.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.909 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -119.54 127.58 53.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.93 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.9 t -152.9 170.39 20.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.489 . . . . 70.52 111.088 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.9 28.19 23.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 43.3 112.407 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -128.56 165.03 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 75.13 111.173 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.5 p -67.05 -179.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.423 . . . . 75.02 111.12 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.52 129.86 26.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 64.54 110.831 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.51 -179.97 4.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 73.23 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.97 -53.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 74.43 110.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.52 164.84 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.848 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -125.26 126.98 46.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.91 106.34 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 73.02 111.169 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 105.53 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.12 111.089 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -119.56 153.42 35.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.74 169.11 23.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 75.24 110.886 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.33 128.19 44.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.24 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.37 77.77 2.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 73.33 110.872 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -49.84 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.653 2.236 . . . . 70.3 112.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 19.6 p -72.02 145.31 48.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 75.45 111.141 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.57 98.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 73.21 112.461 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.79 153.39 31.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 74.33 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.67 130.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.931 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.06 89.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 65.45 111.097 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.3 m -63.62 -39.12 93.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 73.22 111.101 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.32 147.11 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 70.32 110.901 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.92 130.0 17.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 75.52 111.067 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -128.55 142.93 50.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 64.45 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.08 15.19 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.863 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.54 120.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 72.33 111.061 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -79.26 106.33 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 64.41 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.72 140.05 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.133 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 m -128.1 142.08 51.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 75.2 111.148 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.97 156.13 20.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.409 . . . . 73.44 110.874 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.05 85.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.846 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.95 -91.51 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 42.13 112.511 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.36 9.14 7.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.53 110.852 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -122.15 146.75 46.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.33 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -129.7 162.24 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 74.55 110.901 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -149.54 149.67 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.42 111.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.88 128.36 45.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 63.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 153.88 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.918 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -131.2 -51.33 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.23 110.863 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.68 39.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.116 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.75 -0.49 74.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 75.5 112.462 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 -113.79 -29.43 7.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 75.15 110.951 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -104.32 -41.05 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.871 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.02 54.28 23.51 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 74.1 112.5 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -129.43 94.85 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.323 . . . . 75.13 111.156 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.75 160.77 38.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.925 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.94 161.4 52.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 71.1 111.056 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -8.35 23.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 74.31 112.368 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.88 115.36 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 71.25 112.482 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 179.88 172.27 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 71.43 111.118 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.22 131.47 48.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 65.4 110.841 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.72 119.54 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -117.19 135.53 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 71.24 110.855 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -130.06 142.05 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.45 110.837 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.7 162.39 12.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 54.33 112.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -156.66 177.84 11.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 73.42 110.913 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -133.24 127.44 33.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.2 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.4 151.79 20.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 64.34 112.512 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -93.57 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 73.21 110.89 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.21 -162.85 35.62 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.666 -0.778 . . . . 74.32 112.423 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -36.09 11.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 74.11 112.371 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.45 25.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 64.51 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m -112.74 76.24 2.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 71.44 110.844 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 155.66 65.26 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.655 2.237 . . . . 73.15 112.324 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -146.68 175.41 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.888 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 51.81 61.91 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.2 110.899 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.04 130.84 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.23 110.876 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.83 143.89 23.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 74.31 110.878 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -151.55 156.51 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 73.22 110.941 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 66.1 42.94 3.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.898 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.85 41.98 61.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 73.11 112.479 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.87 71.97 1.3 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.677 -0.773 . . . . 74.42 112.455 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.28 104.17 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 75.14 110.914 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 55.13 110.875 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.799 0.333 . . . . 75.53 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.84 36.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 73.24 111.09 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -141.32 128.97 21.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -67.03 143.98 56.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.52 110.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.53 156.75 42.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.34 111.127 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -106.74 116.61 32.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 74.02 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 74.14 111.174 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -179.72 141.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 74.03 110.832 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.49 126.32 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 71.32 110.835 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -112.46 107.06 15.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.928 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.21 -91.7 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.492 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -117.45 -17.5 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 63.34 111.171 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.57 147.41 21.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 55.14 112.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -128.53 155.0 45.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 73.43 110.936 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.36 106.94 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 71.35 112.514 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.48 116.94 5.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.724 -0.75 . . . . 60.33 112.454 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -106.85 95.96 6.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 71.02 110.849 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -95.07 121.19 36.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.917 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -100.44 115.74 30.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 74.34 111.195 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.78 132.76 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.106 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.25 141.83 32.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.965 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -119.34 136.57 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.883 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.94 161.12 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 72.15 111.128 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.99 -101.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.792 -0.718 . . . . 73.11 112.467 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.33 177.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 73.21 111.094 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -58.49 -175.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 61.3 111.11 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.92 145.65 9.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 64.03 110.865 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.86 -175.98 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 74.25 110.891 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -28.99 9.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.875 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.8 163.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 71.22 110.848 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -130.26 128.73 42.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.88 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.5 m -152.65 125.53 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.1 111.172 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.26 113.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.121 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -120.79 152.02 38.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 64.43 110.819 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.29 167.2 30.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.54 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.24 130.03 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.896 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.23 78.5 2.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.63 0.729 . . . . 74.34 110.911 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 -49.82 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.65 2.233 . . . . 74.42 112.319 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' GLY . 21.9 p -72.82 145.27 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.153 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.59 98.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.31 112.45 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 p -154.74 152.77 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 73.52 111.107 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -173.83 131.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.926 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.73 108.18 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 73.33 111.06 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -50.48 70.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.175 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.01 139.61 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 53.11 110.899 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.2 143.85 48.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.088 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -130.96 140.87 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.912 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 t0 65.09 13.43 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.2 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.92 107.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.111 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -61.78 93.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.43 111.145 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.98 121.59 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 72.41 111.192 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -118.18 172.39 7.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.15 111.15 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.43 159.31 39.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 74.4 110.896 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.61 85.76 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.839 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 63.24 112.506 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.27 3.13 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.51 110.845 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -114.72 147.04 40.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 75.34 110.879 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -127.48 160.17 32.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.21 110.887 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -152.62 149.17 28.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 73.31 111.146 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.99 115.87 15.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 71.31 111.114 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 147.95 50.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.94 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.35 -37.51 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 71.42 110.906 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.3 m -90.21 41.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 73.01 111.12 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.15 70.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 71.23 112.477 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -110.97 -19.57 12.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.74 0.305 . . . . 73.32 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -132.62 -70.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.22 110.882 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.28 -38.33 3.23 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.76 . . . . 41.12 112.425 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -51.43 103.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 71.31 111.077 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.24 160.21 23.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 75.04 110.91 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.61 161.65 77.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.703 . . . . 70.43 111.079 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -15.83 37.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.617 2.211 . . . . 74.31 112.349 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.34 115.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 74.0 112.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.94 172.41 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 74.11 111.12 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -129.39 131.29 46.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 61.53 110.867 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.42 113.96 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.105 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.93 134.66 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.857 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -139.36 137.16 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.886 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.55 170.92 21.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 70.22 112.495 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -159.08 -179.61 8.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.371 . . . . 64.52 110.901 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.25 126.04 44.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.866 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.78 158.22 22.74 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 75.53 112.458 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.0 m -103.36 109.43 21.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 75.41 110.832 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.73 -161.58 34.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.576 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -36.43 10.84 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.688 2.259 . . . . 74.25 112.324 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.62 27.04 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.701 -0.761 . . . . 74.32 112.432 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.25 76.9 2.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.695 0.759 . . . . 75.51 110.871 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 164.35 34.86 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.238 . . . . 72.44 112.33 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.35 169.59 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 75.34 110.89 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 58.9 56.75 3.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 72.31 110.861 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.1 m -75.74 92.49 3.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 71.35 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.95 120.85 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 74.55 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.91 155.7 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 74.4 110.881 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 62.79 26.7 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.843 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.44 42.77 7.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 52.25 112.447 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.3 70.74 1.11 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.819 -0.705 . . . . 72.11 112.479 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.19 129.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 64.52 110.872 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.4 110.837 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.867 0.365 . . . . 70.35 111.112 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.52 152.88 47.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.04 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -135.51 121.0 19.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.163 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -65.66 146.33 54.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.871 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.27 160.24 42.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 74.04 111.079 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.3 141.93 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.43 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.67 -62.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 73.04 111.199 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -175.84 135.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.13 110.863 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -119.62 126.65 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 72.51 110.89 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -111.74 97.67 6.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.949 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.82 -92.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 54.5 112.529 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 t -108.15 -17.6 13.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 63.41 111.119 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.21 149.32 22.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 75.41 112.466 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -134.63 150.71 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 75.01 110.87 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.41 113.38 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 70.53 112.473 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.07 147.26 22.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 73.31 112.453 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.66 96.59 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 71.42 110.905 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.23 124.13 34.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 m -101.96 101.91 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.183 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.6 131.87 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.072 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -141.97 128.06 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.53 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -119.4 132.08 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.863 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.55 129.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 64.33 111.188 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -48.31 0.98 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 71.54 112.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.64 176.65 9.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 64.1 111.184 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -174.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 75.52 111.177 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -51.45 125.42 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 75.02 110.923 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.02 -174.74 5.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.14 110.969 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.68 -53.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.846 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.16 171.44 19.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 55.0 110.939 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -129.0 127.03 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.919 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 101.93 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.32 111.138 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.45 105.63 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 72.43 111.176 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -120.08 151.6 38.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.12 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.42 168.13 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.91 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.31 128.79 44.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.41 110.892 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.44 77.46 2.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.644 0.735 . . . . 74.4 110.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.98 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.717 2.278 . . . . 75.41 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 7.1 m -71.94 145.26 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 70.21 111.162 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.684 -0.769 . . . . 70.02 112.509 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -154.82 153.5 31.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 74.04 111.127 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -173.67 130.63 0.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.33 110.883 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.09 89.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.098 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.25 -39.54 94.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 64.33 111.192 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t -129.52 147.69 51.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.875 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.23 130.06 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 74.22 111.139 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -127.18 144.08 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.967 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.63 15.9 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.884 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.29 121.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.42 111.08 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -78.56 101.9 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.54 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.7 t -87.35 147.23 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 71.43 111.16 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 m -139.1 140.53 38.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 71.2 111.16 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -107.68 157.48 18.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 75.22 110.908 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -160.68 85.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.835 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.29 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 74.31 112.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.18 6.92 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.78 0.324 . . . . 52.04 110.862 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -120.74 146.99 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 65.31 110.853 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -128.9 159.09 36.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.898 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 t -145.99 149.83 34.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 75.31 111.066 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.23 120.31 24.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.078 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 153.62 51.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.18 -51.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 44.44 110.937 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.12 39.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.15 111.181 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.63 -1.07 75.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 63.13 112.489 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -113.76 -25.37 8.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 74.32 110.848 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.75 -47.17 3.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.13 110.857 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.36 56.37 13.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 54.22 112.484 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 96.35 2.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 74.42 111.161 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.7 160.62 38.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.959 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.34 161.93 75.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.57 0.7 . . . . 64.54 111.1 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.87 24.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.697 2.265 . . . . 74.2 112.41 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.54 118.35 1.08 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 65.12 112.461 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.02 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 63.4 111.132 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.69 131.57 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.846 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.1 113.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 74.24 111.116 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 p -109.18 125.63 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 61.03 110.883 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -120.46 141.35 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 70.41 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.36 12.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 63.44 112.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -159.68 176.92 11.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 73.22 110.85 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -132.4 125.87 31.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 72.03 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.94 151.44 20.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.731 . . . . 44.02 112.501 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.19 109.55 20.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 72.41 110.88 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.65 -162.67 34.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 73.05 112.495 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.27 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 75.24 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.11 26.6 23.47 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 70.34 112.455 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.2 m -112.67 76.6 2.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.683 0.754 . . . . 73.34 110.879 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.95 55.26 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 74.45 112.298 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.48 174.56 11.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.87 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 m120 51.6 63.6 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 74.32 110.89 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.0 p -82.73 128.63 34.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.34 110.947 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 144.02 23.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.911 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -149.56 156.63 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 72.35 110.9 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 41.77 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.851 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.08 61.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.11 112.478 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.82 71.85 1.3 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 74.41 112.415 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.32 104.18 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 75.24 110.841 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.848 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.802 0.334 . . . . 64.44 111.103 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.3 139.7 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 43.21 111.142 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -134.48 115.76 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.32 111.114 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.54 145.4 54.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.36 164.07 33.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 55.22 111.109 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.23 140.28 40.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.81 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -107.01 -62.42 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 74.53 111.15 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.82 133.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 61.42 110.868 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.79 127.05 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 64.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -111.4 91.44 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.843 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 -93.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 72.31 112.498 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -103.11 -17.61 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 74.42 111.097 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.78 148.58 21.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.805 -0.712 . . . . 75.3 112.406 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -135.53 148.49 49.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 75.32 110.895 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.36 114.19 4.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 53.22 112.446 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.39 148.15 22.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 72.24 112.494 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 t -141.64 98.36 3.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 73.2 110.891 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.23 137.06 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 75.21 110.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.22 107.07 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 73.25 111.175 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.48 131.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.417 . . . . 73.41 111.188 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 123.08 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -112.69 125.92 54.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 71.1 110.916 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -167.27 148.98 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.21 111.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.62 -39.63 2.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.517 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -88.86 169.5 11.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 75.21 111.109 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.7 p -60.66 -172.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 74.43 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -51.49 127.13 19.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 73.3 110.871 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -175.67 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 74.45 110.93 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.63 -53.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.25 -0.432 . . . . 74.43 110.872 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.99 176.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 65.02 110.779 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.1 p-90 -134.53 127.05 30.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 73.32 110.862 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 101.35 7.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.52 111.159 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.4 111.172 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.02 147.66 43.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 63.1 110.887 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.29 168.18 23.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.891 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.06 129.06 44.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 74.43 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.59 77.52 2.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.712 0.768 . . . . 71.15 110.906 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -50.03 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 73.12 112.321 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.82 145.35 48.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.53 111.14 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.49 98.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 71.21 112.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -154.74 153.78 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 75.14 111.114 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -173.74 130.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 71.41 110.844 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.2 t -79.37 88.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.11 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.1 m -63.48 -39.0 93.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 73.02 111.162 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.32 145.99 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.25 110.837 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.46 130.07 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.112 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -129.4 143.11 50.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.78 15.66 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.39 119.34 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.31 111.074 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -77.55 105.34 8.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.43 111.13 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.95 139.94 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 64.12 111.152 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -131.7 141.62 49.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.122 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -109.51 155.59 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.86 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -158.9 85.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.3 110.836 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.43 -93.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 75.4 112.452 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.44 7.8 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 72.24 110.858 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -121.47 145.39 47.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 73.31 110.844 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -126.3 158.75 34.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.885 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -144.24 150.11 37.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 73.51 111.161 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.32 121.84 26.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 63.44 111.094 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 153.47 51.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 74.1 110.888 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -131.23 -51.51 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.43 39.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 74.4 111.086 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.92 -0.56 75.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 73.44 112.498 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -115.05 -22.36 9.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 65.41 110.901 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.56 -47.2 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 72.51 110.901 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.91 56.81 10.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.818 -0.706 . . . . 71.15 112.483 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 95.92 2.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 72.35 111.121 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tt -137.99 160.64 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 70.24 110.942 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.79 162.0 74.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.614 0.721 . . . . 75.34 111.066 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -17.84 37.04 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.672 2.248 . . . . 72.12 112.37 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.75 115.94 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 63.24 112.535 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.66 172.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 74.14 111.049 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -133.12 131.65 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.03 110.857 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.53 118.06 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 74.31 111.121 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.17 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 75.03 110.877 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -132.16 140.11 48.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.895 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.72 163.4 12.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 72.14 112.448 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -157.75 177.32 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 75.34 110.825 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -133.14 127.68 34.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 73.31 110.896 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.86 151.67 20.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 64.03 112.543 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.88 109.55 20.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 65.44 110.879 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.37 -163.03 35.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 72.15 112.48 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -36.48 10.75 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 75.55 112.353 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.97 26.49 24.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 60.14 112.512 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -112.78 75.94 2.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.636 0.731 . . . . 72.12 110.851 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 155.43 65.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.68 2.253 . . . . 73.22 112.32 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -147.97 169.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 72.44 110.806 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 56.3 65.33 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.32 110.862 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.5 t -89.27 104.84 17.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 53.03 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 118.98 27.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.88 155.8 42.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.905 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.74 27.79 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.53 110.871 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.23 42.06 8.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.736 . . . . 72.11 112.543 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.6 70.59 1.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 72.31 112.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.24 132.08 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 70.53 110.877 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.871 -179.932 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.796 0.332 . . . . 63.35 111.151 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.66 159.38 42.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.1 111.079 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.78 147.72 37.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 73.51 111.126 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -87.23 146.22 26.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.33 175.98 9.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.42 111.115 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.82 156.87 23.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.92 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.66 -55.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 73.4 111.217 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.41 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.23 110.869 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -116.75 127.61 54.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 72.11 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.71 82.58 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.91 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 72.32 112.471 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -100.99 -17.57 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.2 111.128 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.79 156.12 26.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 71.24 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -144.52 145.28 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 75.24 110.855 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 121.14 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.32 112.458 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.37 149.05 19.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 51.42 112.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -141.65 99.1 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 74.12 110.92 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.24 118.85 30.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 74.03 110.985 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -99.97 113.95 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 71.33 111.073 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -106.51 131.77 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.203 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -141.07 118.48 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.827 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.8 129.68 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.35 110.868 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -164.89 139.54 5.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.43 111.172 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.41 -46.59 3.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.667 -0.777 . . . . 73.12 112.48 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.55 177.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 75.22 111.18 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -79.78 173.12 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 61.51 111.157 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -51.72 109.18 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.848 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -175.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.941 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 m -145.87 -52.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.66 140.97 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 65.22 110.855 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -111.29 127.11 55.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 75.11 110.932 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.3 m -126.18 113.26 16.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.34 111.187 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 t -101.14 105.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 71.41 111.119 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -123.21 154.23 39.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.874 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.72 168.43 26.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.17 130.64 44.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 70.01 110.848 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.09 75.77 2.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.61 0.719 . . . . 74.14 110.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.75 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.745 2.296 . . . . 71.41 112.338 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLY . 43.1 p -71.32 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.44 111.098 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 99.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 72.32 112.513 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -154.46 157.44 38.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 74.33 111.157 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 130.76 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.854 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.61 106.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 73.34 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -80.09 -36.0 36.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.076 -0.511 . . . . 55.45 111.146 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.42 147.6 49.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.832 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.2 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.085 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -142.65 152.57 42.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.93 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.68 14.51 9.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 72.22 110.84 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.7 113.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.11 111.126 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -65.25 90.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.51 111.111 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.37 112.34 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 72.41 111.114 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -116.26 118.87 33.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.141 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -78.86 161.02 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 74.45 110.933 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.02 85.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.13 110.862 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.29 -88.85 0.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 65.31 112.498 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -126.77 6.64 6.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 72.54 110.831 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -115.22 146.98 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 71.03 110.873 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -135.19 120.2 18.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.959 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 t -121.7 148.15 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.13 111.191 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.6 141.96 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 72.31 111.053 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.45 121.75 7.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.844 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -94.46 -31.66 13.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.898 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.78 38.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 75.45 111.134 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.42 81.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 62.12 112.521 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -115.84 -32.7 5.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.286 . . . . 74.04 110.914 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -36.63 8.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.92 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.28 47.87 41.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 75.23 112.474 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -124.84 116.89 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 61.31 111.172 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -149.29 161.11 42.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 74.01 110.949 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.11 163.45 17.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.609 0.718 . . . . 73.23 111.113 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -8.1 22.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 74.33 112.346 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.05 114.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 53.24 112.515 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 178.84 172.49 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 73.13 111.098 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -133.37 131.54 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 63.34 110.837 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.3 132.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.22 111.172 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.0 p -127.86 137.98 52.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.862 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -129.53 134.98 48.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.915 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.24 178.57 22.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 61.54 112.487 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -174.58 173.54 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 75.21 110.859 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -124.99 133.93 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.52 110.896 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.41 153.47 23.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 63.42 112.455 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 117.87 35.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 71.01 110.844 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.34 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 72.42 112.499 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.01 13.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 75.35 112.336 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.1 27.18 29.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.762 -0.732 . . . . 74.3 112.464 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -112.48 75.35 1.74 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 60.41 110.896 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 160.04 51.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.641 2.228 . . . . 75.12 112.32 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 m -148.6 175.68 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.1 110.834 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 58.73 53.52 5.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 72.24 110.913 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.6 m -73.44 101.75 3.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 61.53 110.846 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 119.31 22.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 72.21 110.928 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.95 155.74 43.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 71.54 110.922 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 63.73 26.32 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.85 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.76 42.17 7.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 73.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.62 73.95 1.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.552 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 130.04 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 65.43 110.813 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.852 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.744 0.307 . . . . 74.14 111.18 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.16 163.86 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.063 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -132.45 147.72 52.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 64.01 111.155 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -86.89 146.29 26.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 61.22 110.961 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.54 147.54 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 72.54 111.144 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.25 145.73 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.88 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 m -105.62 -63.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.181 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.39 127.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.834 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -116.04 127.62 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 75.33 110.859 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -110.53 81.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 64.42 110.971 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.67 -90.09 0.65 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 63.02 112.483 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -97.29 -16.36 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 71.4 111.192 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.14 155.52 23.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.726 -0.75 . . . . 75.43 112.463 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.73 143.72 31.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 71.24 110.888 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.27 115.44 4.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 74.41 112.527 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.2 140.62 24.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 71.55 112.493 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 94.54 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 63.41 110.859 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.03 149.93 22.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 75.13 110.902 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -129.81 108.15 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.141 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.53 132.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 73.24 111.12 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.43 127.07 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.892 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.6 122.61 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.3 110.861 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -172.59 156.7 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.229 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -21.36 17.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.699 -0.762 . . . . 63.53 112.507 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.85 177.18 7.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 63.22 111.196 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -171.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 74.03 111.19 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 120.18 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.12 110.854 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 179.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 75.11 110.896 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -120.8 -32.07 4.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 63.44 110.883 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 p 179.3 160.4 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.878 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -137.89 129.03 27.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.2 110.921 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 m -149.81 131.19 14.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 63.14 111.121 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.87 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 64.13 111.067 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.28 135.07 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.861 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 173.76 11.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 74.33 110.92 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.16 134.34 41.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 60.4 110.92 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.44 77.73 27.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.669 0.747 . . . . 74.43 110.91 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -49.64 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 73.32 112.358 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 2.3 p -73.09 145.24 46.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.178 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.22 100.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 70.34 112.47 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -154.81 150.56 27.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.346 . . . . 64.53 111.192 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 130.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.15 110.924 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.26 98.03 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.136 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -63.5 -42.15 98.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 71.52 111.161 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -136.72 145.42 44.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.9 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.48 167.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 111.128 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -153.31 141.42 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.14 110.882 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.36 13.84 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.884 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.35 107.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.096 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -63.26 92.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.23 111.123 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.78 112.55 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 71.14 111.135 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -105.1 172.27 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.12 111.056 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -134.19 158.53 43.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.852 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -162.5 85.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.903 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.63 -92.25 0.6 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 55.41 112.48 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -126.28 15.94 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 74.14 110.899 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -125.42 147.02 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.88 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -133.1 141.58 48.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.955 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 72.34 111.164 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.09 116.74 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 75.34 111.136 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.09 142.15 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.873 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.84 -35.99 3.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 62.41 110.858 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -92.44 42.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.154 -0.475 . . . . 75.5 111.123 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 2.13 69.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.687 -0.768 . . . . 73.54 112.542 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.63 -33.81 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 75.43 110.905 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.72 -70.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.879 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.96 -38.21 3.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 71.41 112.498 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -52.66 110.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.909 0.385 . . . . 72.51 111.179 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.23 144.23 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.942 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.02 160.38 1.55 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 75.2 111.115 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.747 2.298 . . . . 74.14 112.321 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 115.57 0.66 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.757 . . . . 71.12 112.532 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.55 172.34 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 71.42 111.166 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.24 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 74.5 110.803 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.05 110.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 73.55 111.082 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.0 p -99.83 148.87 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 71.23 110.812 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -146.58 135.12 22.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 72.12 110.917 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.32 177.3 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 71.34 112.434 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -171.64 175.94 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 74.14 110.864 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -122.74 128.31 50.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.929 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.12 149.38 19.6 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 74.23 112.487 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 109.46 21.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.5 110.876 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.78 -162.15 34.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 53.01 112.475 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -36.7 10.55 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 73.12 112.349 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.56 26.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 73.51 112.508 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -112.36 77.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.698 0.761 . . . . 73.01 110.883 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 163.5 38.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.713 2.275 . . . . 73.22 112.288 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -148.31 170.23 18.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 55.54 110.86 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.76 50.53 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.866 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.8 m -66.48 96.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 74.41 110.896 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -121.31 143.84 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 75.4 110.899 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.48 155.55 33.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.968 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.4 t30 63.22 39.87 9.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 73.4 110.884 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.06 41.6 11.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.42 112.521 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 63.32 2.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 62.41 112.484 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.5 t -155.99 104.49 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 75.31 110.804 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 73.43 110.858 -179.968 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.773 0.321 . . . . 75.35 111.116 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.79 163.44 39.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.43 111.077 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -140.68 141.69 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 73.45 111.137 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -79.38 140.45 37.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.45 110.891 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.41 162.19 35.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 62.02 111.129 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.29 154.54 22.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.852 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 -58.66 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 71.11 111.159 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.8 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 43.42 110.878 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -115.45 127.92 55.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 72.22 110.874 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.65 81.76 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.978 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.64 -87.27 0.63 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 73.43 112.473 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -100.32 -17.59 17.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 73.21 111.168 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 155.55 25.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 52.13 112.488 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -143.6 143.04 31.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 75.51 110.895 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.85 115.81 5.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.705 -0.76 . . . . 75.3 112.479 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 143.84 17.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.696 -0.764 . . . . 62.13 112.542 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -144.22 95.48 2.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 72.44 110.844 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.44 132.56 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.116 -0.493 . . . . 71.24 110.885 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.4 m -110.61 117.45 33.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.141 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.72 131.94 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.152 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -138.01 136.98 37.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 70.14 110.865 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.93 136.48 54.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.874 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.53 162.23 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.5 111.176 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.37 -98.12 2.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 64.51 112.524 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 p -56.34 170.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.12 111.134 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 p -59.4 -175.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 75.34 111.176 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.2 144.45 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 71.43 110.792 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.44 -174.61 5.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 75.31 110.912 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 -27.64 6.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.847 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t 178.88 154.92 0.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.52 110.896 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -125.05 129.41 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 75.11 110.921 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.6 m -152.42 122.0 6.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.166 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 t -101.72 110.68 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 74.31 111.182 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -117.66 152.4 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 63.15 110.88 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.23 20.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 73.31 110.911 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.98 131.67 44.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.874 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.8 74.05 2.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.659 0.742 . . . . 74.03 110.85 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.691 2.261 . . . . 74.11 112.34 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -74.18 145.79 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.23 111.128 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.36 98.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 64.44 112.513 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 p -154.9 154.62 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.332 . . . . 73.34 111.166 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.76 131.13 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.408 . . . . 75.23 110.931 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.1 104.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.13 111.078 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -47.89 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.178 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -144.39 152.37 40.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 63.33 110.87 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.17 162.47 35.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 70.32 111.074 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -146.99 144.95 29.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.988 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 64.05 15.18 9.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 62.45 110.85 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.55 104.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.02 111.127 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 m -61.8 93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 72.54 111.201 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.22 112.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 71.15 111.084 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -113.44 164.28 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.52 111.172 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -121.79 160.98 23.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.942 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -159.26 85.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.799 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.72 -93.27 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.756 -0.735 . . . . 65.42 112.442 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -126.54 11.42 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 75.42 110.877 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -123.53 147.03 47.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.25 110.864 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -127.98 156.32 42.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 74.55 110.936 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 t -150.35 148.7 29.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 64.05 111.149 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.97 119.95 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.25 111.083 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.32 144.4 40.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 72.24 110.881 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -123.08 -35.06 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.42 110.901 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.6 41.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.34 111.124 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.69 1.92 70.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 72.41 112.523 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.44 -21.49 11.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 74.14 110.918 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -129.54 -70.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 64.24 110.898 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.65 -38.07 3.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 70.51 112.535 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -50.74 107.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 62.13 111.097 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.69 146.93 47.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.993 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.53 160.31 26.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 64.12 111.06 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -8.43 23.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 75.24 112.319 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.9 116.03 0.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 62.55 112.436 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.17 172.13 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.868 0.366 . . . . 64.44 111.072 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.68 131.33 43.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 62.1 110.85 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.25 109.9 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 72.41 111.114 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 t -109.98 134.38 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 61.23 110.88 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -123.47 134.88 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 74.45 110.899 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.3 175.52 19.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 70.13 112.532 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -174.84 175.87 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.933 0.397 . . . . 75.55 110.899 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -124.97 125.89 44.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 75.31 110.873 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.56 152.98 17.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 62.35 112.496 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.82 109.49 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 54.41 110.814 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -158.02 27.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.21 112.449 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -37.26 9.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 71.0 112.409 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.24 27.04 29.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.443 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.71 78.92 2.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 71.4 110.849 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 171.79 13.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 74.21 112.374 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -148.5 170.4 18.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.818 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 54.52 52.13 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 63.55 110.934 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.8 m -68.75 92.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 71.43 110.845 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.86 144.0 49.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.13 110.87 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.12 156.79 44.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.42 110.884 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 66.43 32.63 7.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.845 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.79 42.41 25.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 30.31 112.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 71.58 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 73.32 112.517 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.52 130.57 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.821 0.343 . . . . 73.44 110.841 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 75.13 110.811 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.828 0.347 . . . . 74.22 111.129 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.92 163.93 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 63.41 111.105 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.38 144.89 27.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 74.31 111.164 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.41 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 75.05 110.93 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.45 152.56 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 64.42 111.094 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.03 146.66 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 73.14 110.965 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.29 -59.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 70.32 111.092 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.4 138.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.876 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.13 127.43 54.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 75.4 110.83 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.67 92.97 4.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.927 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.25 -90.34 0.71 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 75.01 112.504 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 t -110.6 -17.55 13.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 73.41 111.176 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.6 146.76 20.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.761 -0.733 . . . . 75.15 112.466 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -125.42 149.72 47.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 74.34 110.87 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.99 110.41 3.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.76 . . . . 74.12 112.499 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.75 142.62 21.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 71.44 112.454 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -139.54 94.66 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 63.03 110.839 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -90.37 149.28 22.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 75.44 110.933 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m -128.18 132.01 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.17 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.37 132.42 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 74.33 111.095 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -142.38 129.17 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.933 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -104.53 148.99 25.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 71.24 110.851 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.4 t -172.57 162.59 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.155 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.89 -77.04 1.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 74.53 112.489 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -57.91 172.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 73.35 111.146 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.1 p -68.43 -172.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 65.13 111.059 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.12 122.79 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.842 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.79 169.18 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.905 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.4 -16.89 10.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.43 110.798 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.87 147.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.45 110.815 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -124.62 129.76 51.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.893 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -151.24 123.26 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 74.02 111.083 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.69 105.83 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 70.14 111.092 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.21 151.09 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.21 110.925 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.03 171.17 17.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 73.4 110.926 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.95 130.25 44.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 72.35 110.856 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.59 73.67 2.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.717 0.77 . . . . 64.31 110.943 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -50.07 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.727 2.285 . . . . 65.3 112.39 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -72.77 145.59 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.42 111.134 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.16 98.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.714 . . . . 45.11 112.482 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -155.03 154.9 33.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 51.5 111.123 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -173.58 131.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 73.14 110.916 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.8 107.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.1 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 m -62.87 -49.54 74.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.116 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.28 140.42 27.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.31 110.871 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.13 137.16 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 71.03 111.08 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -121.52 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.88 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.53 12.62 8.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 71.02 110.907 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.16 102.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.22 111.151 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -60.05 95.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.51 111.153 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -90.37 112.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.32 111.149 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -106.52 177.49 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 72.41 111.128 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -133.46 160.55 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.838 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -160.37 85.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 74.5 110.884 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.74 -93.3 0.83 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 45.51 112.45 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -126.53 14.55 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 75.23 110.857 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -126.94 146.89 50.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.12 110.861 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -129.45 155.95 44.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.908 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -149.02 143.45 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 62.45 111.127 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.4 122.73 41.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.11 111.095 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 137.79 34.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.878 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -119.41 -30.52 4.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.944 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 m -90.99 42.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 74.42 111.152 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.11 2.97 67.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 73.3 112.511 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.27 -34.08 4.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 74.3 110.881 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.79 -70.24 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 74.12 110.881 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.0 -37.75 3.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 72.13 112.509 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -49.43 117.41 2.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 71.12 111.156 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.46 131.79 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 73.22 110.957 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.65 5.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.566 0.698 . . . . 70.15 111.099 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -16.14 37.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.693 2.262 . . . . 73.02 112.284 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.51 115.44 0.77 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 70.22 112.533 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.08 172.54 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 64.32 111.084 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.83 131.16 56.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 51.42 110.781 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.23 109.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 72.11 111.118 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 m -113.53 164.38 13.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.867 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.88 134.27 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.901 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.55 177.25 19.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.433 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -174.43 178.31 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 73.12 110.939 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -130.96 125.85 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.11 110.85 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.04 155.34 20.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.44 112.527 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.26 109.65 22.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 71.12 110.859 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.14 -157.58 27.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 71.03 112.495 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -39.0 7.03 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.231 . . . . 73.34 112.372 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.6 32.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 64.44 112.477 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 75.78 2.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.661 0.744 . . . . 72.13 110.903 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 160.61 49.05 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.725 2.283 . . . . 72.55 112.297 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 m -148.32 171.37 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.01 110.878 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 63.35 53.42 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.24 110.85 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.14 126.72 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.89 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 118.77 6.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.34 110.907 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.24 155.64 45.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 75.51 110.889 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.56 36.58 19.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 74.02 110.937 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.28 55.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 65.43 112.516 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.5 69.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 60.13 112.45 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 t -156.18 104.26 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 70.21 110.873 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.1 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 72.03 110.871 -179.957 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.775 0.321 . . . . 63.25 111.14 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.27 163.84 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 71.01 111.09 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 142.99 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 65.55 111.198 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -94.35 125.75 39.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 72.12 110.852 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.48 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 71.34 111.117 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 170.21 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 73.33 110.863 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 -59.12 0.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.093 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.48 135.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 61.41 110.923 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.43 127.53 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 71.35 110.867 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.46 83.34 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.175 -0.466 . . . . 73.44 110.95 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.87 -86.32 0.66 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.72 -0.752 . . . . 61.11 112.533 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -103.97 -17.45 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 75.42 111.122 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.38 153.66 24.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 74.3 112.464 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -140.56 143.9 35.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 73.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.3 127.26 9.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 73.33 112.447 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.82 132.21 10.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 64.34 112.453 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.91 103.71 7.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 61.13 110.87 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -92.11 141.27 28.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 74.54 110.973 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 m -118.55 127.45 53.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.32 111.082 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.91 131.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.13 111.16 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -144.16 119.08 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -111.94 133.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.86 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -172.7 129.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 71.21 111.08 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.53 -19.49 19.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 65.41 112.445 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.39 177.1 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.381 . . . . 73.51 111.118 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -67.98 174.83 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 64.13 111.191 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 t -51.37 118.93 3.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.825 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -176.14 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.01 110.917 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -142.66 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 72.44 110.927 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -152.38 147.52 26.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 74.24 110.863 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -110.36 126.44 54.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.905 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -118.86 108.61 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 63.14 111.149 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 p -101.46 109.56 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 74.31 111.116 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.22 136.92 47.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.875 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.01 172.19 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.992 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.93 130.42 44.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 75.44 110.855 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.51 80.1 2.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 71.52 110.829 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -48.59 0.68 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.729 2.286 . . . . 71.22 112.328 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -74.65 144.73 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 71.31 111.118 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.87 96.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.718 -0.753 . . . . 72.24 112.416 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.5 m -156.81 137.84 13.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 75.12 111.119 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -151.95 131.2 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 72.42 110.865 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.37 102.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.158 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -62.89 -46.78 86.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.104 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.64 147.77 34.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 61.24 110.885 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.17 144.31 40.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.062 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -129.41 142.59 50.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.05 110.91 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.42 13.04 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.816 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.2 92.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.31 111.08 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -55.39 99.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.55 111.086 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.47 112.6 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 73.32 111.118 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -102.59 175.43 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 64.13 111.16 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.33 157.34 45.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.34 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -159.25 85.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.883 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.69 -92.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 51.25 112.42 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.95 9.89 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 75.33 110.888 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -120.09 146.89 45.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.871 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -132.3 146.57 52.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.911 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -143.05 148.48 36.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.25 111.129 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.96 141.75 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 70.35 111.155 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 160.8 39.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 72.04 110.952 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -132.02 -52.43 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.842 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.07 39.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.117 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.76 4.68 56.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 75.32 112.512 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -111.46 -25.68 9.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 74.42 110.82 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.11 -38.73 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.32 110.874 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.32 56.87 8.71 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.792 -0.718 . . . . 64.42 112.495 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -135.07 94.85 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 75.33 111.198 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.3 160.96 36.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.939 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.2 162.76 47.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 75.45 111.051 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 65.43 112.352 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.88 115.59 0.94 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.727 . . . . 65.31 112.499 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.7 172.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 54.23 111.079 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 p -133.18 131.55 40.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.34 110.831 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.14 136.17 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.163 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -132.99 149.11 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.866 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -139.43 156.47 46.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.873 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.84 175.47 18.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 54.3 112.467 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -173.41 -176.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 73.44 110.871 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -139.39 125.88 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.05 110.876 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.94 17.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 61.23 112.559 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.84 111.22 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.372 . . . . 71.15 110.838 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.56 26.54 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 62.13 112.456 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -40.27 5.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 72.2 112.337 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.59 27.56 21.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 73.03 112.526 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -112.07 76.07 1.72 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 73.4 110.859 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.41 57.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.643 2.229 . . . . 71.05 112.313 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.55 172.41 14.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.871 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 58.1 50.2 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.882 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.51 104.05 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.884 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.1 143.97 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.874 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pp -160.32 146.61 15.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.938 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.83 55.33 3.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.852 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.1 39.81 36.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 63.31 112.418 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.44 62.91 5.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 73.22 112.493 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.3 107.74 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 71.42 110.935 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.979 -179.929 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.804 0.335 . . . . 65.31 111.11 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.63 163.85 32.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.14 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -152.15 132.52 13.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.175 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -73.66 146.06 44.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 72.32 110.901 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.46 170.99 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.35 111.093 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -120.96 134.64 55.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.962 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 -60.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 73.21 111.191 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.47 145.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.869 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.59 125.99 49.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 72.24 110.819 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -112.28 102.23 10.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.972 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.22 -92.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.756 -0.735 . . . . 64.33 112.513 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -118.24 -17.47 9.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 72.13 111.04 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.68 117.93 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.792 -0.718 . . . . 73.42 112.45 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -99.06 156.74 16.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 71.03 110.847 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.71 109.22 2.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.761 -0.733 . . . . 75.42 112.424 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.67 141.13 20.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.742 . . . . 62.43 112.457 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.12 98.75 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 72.21 110.849 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -90.17 123.75 34.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.955 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 m -96.06 119.98 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 74.13 111.026 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.66 131.64 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.086 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -139.44 118.15 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.899 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.49 119.21 38.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.35 110.836 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.4 t -172.18 143.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 62.04 111.166 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.45 -30.83 7.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.467 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -100.8 173.58 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.351 . . . . 75.23 111.109 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 p -62.05 -174.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 74.22 111.124 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -51.36 121.97 7.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 72.53 110.807 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 -175.7 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 75.3 110.918 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -143.55 -53.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 65.23 110.882 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.31 166.6 32.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.845 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -122.94 126.64 47.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.519 . . . . 74.43 110.934 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 m -120.78 100.86 7.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 72.52 111.14 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.8 119.17 50.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 71.32 111.151 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.41 141.22 49.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.35 110.838 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.85 167.61 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.914 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.08 130.07 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 71.41 110.826 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.76 76.21 2.1 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 73.03 110.93 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -50.06 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.694 2.263 . . . . 72.5 112.343 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.143 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.31 97.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 74.41 112.486 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.64 155.74 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 75.14 111.12 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.74 130.59 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.862 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.92 99.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 73.42 111.189 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -62.99 -44.68 95.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 72.11 111.186 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m -143.64 159.97 41.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.892 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.04 144.73 25.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 73.14 111.062 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -128.44 146.36 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.887 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 14.94 9.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.831 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.44 120.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 64.22 111.057 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -78.65 108.15 11.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.53 111.109 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.73 147.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.133 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -139.68 141.42 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.151 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.46 153.36 24.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 63.24 110.951 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -157.07 85.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 53.4 110.808 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.7 -93.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 73.33 112.489 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -126.46 6.31 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 74.43 110.876 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -120.09 145.7 46.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.812 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -126.79 152.87 46.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 75.44 110.894 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -138.48 150.4 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 74.3 111.111 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.86 125.9 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.111 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 141.04 32.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 74.32 110.928 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -116.99 -52.07 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.908 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.82 39.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.128 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.29 -1.59 70.26 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.753 -0.737 . . . . 75.21 112.432 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.47 -30.96 6.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 71.34 110.93 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -101.55 -47.06 4.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 73.53 110.931 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.39 55.77 18.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.488 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -132.65 94.8 3.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 74.33 111.128 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.64 160.9 37.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 75.23 110.896 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.39 162.5 56.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 75.33 111.164 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -8.36 23.41 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.61 2.207 . . . . 75.54 112.359 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.89 115.72 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 73.42 112.501 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.96 172.14 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.375 . . . . 71.21 111.02 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -145.51 131.68 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.761 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.07 149.19 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 75.15 111.111 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 p -130.52 135.93 48.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.874 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -122.79 135.18 54.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 73.3 110.862 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.86 178.26 20.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 64.34 112.491 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -174.26 -179.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 72.24 110.882 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.03 149.66 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.893 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.67 157.36 27.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 73.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 m -102.48 109.62 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 65.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -160.73 30.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.522 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -38.36 7.95 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.647 2.232 . . . . 75.53 112.359 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.2 26.68 27.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 63.13 112.515 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.78 75.27 1.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.1 110.854 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 160.69 48.75 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.59 2.193 . . . . 64.2 112.372 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 p -148.52 161.71 41.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 70.45 110.9 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 62.99 65.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 64.23 110.832 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.9 t -91.4 94.05 9.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 73.31 110.946 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 118.73 35.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 75.11 110.882 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -126.72 155.81 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.04 110.93 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.9 19.94 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 65.14 110.892 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.88 4.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.467 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.7 71.28 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 71.52 112.484 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -156.25 104.17 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.02 110.851 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 72.53 110.905 -179.998 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.78 0.324 . . . . 71.12 111.141 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.64 163.82 34.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.25 111.132 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 m -153.5 147.7 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.161 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -80.61 144.27 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 75.1 110.898 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.18 165.16 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 73.13 111.135 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.09 136.24 50.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 72.41 110.924 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m -101.22 -68.3 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 74.42 111.125 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.85 138.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.909 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.24 126.24 51.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 74.23 110.919 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -111.92 105.74 14.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.24 110.948 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.44 -91.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.807 -0.711 . . . . 71.15 112.499 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -117.26 -17.49 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 71.54 111.223 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.76 146.87 20.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 63.4 112.424 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -128.85 145.73 51.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 72.3 110.851 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.17 109.69 3.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.752 . . . . 74.23 112.47 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.78 133.09 11.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.471 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.05 99.28 6.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 71.04 110.865 -179.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -90.24 129.73 36.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.41 110.916 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -105.99 128.16 53.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 55.14 111.077 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 t -133.19 132.6 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 73.14 111.176 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -143.89 138.12 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.5 110.923 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -119.44 131.24 55.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 71.23 110.855 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -159.0 161.0 36.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.13 111.155 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.37 -58.57 4.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 73.54 112.471 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 t -62.73 161.18 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 63.11 111.097 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 p -57.87 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 61.43 111.163 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -54.07 123.05 11.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.21 110.805 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.73 151.97 43.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 65.12 110.95 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -116.51 -18.19 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 61.25 110.874 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.48 151.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 73.13 110.86 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -132.37 127.64 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.98 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 m -142.92 124.95 15.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 74.14 111.147 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 t -110.38 105.8 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.23 111.132 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.17 150.98 37.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.871 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.43 166.54 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.941 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.17 132.69 43.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 73.14 110.84 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.02 76.23 2.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.635 0.731 . . . . 75.24 110.859 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.251 . . . . 63.33 112.31 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 55.9 p -70.4 145.37 51.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 74.02 111.168 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.53 97.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.793 -0.718 . . . . 60.11 112.386 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.72 157.7 38.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.372 . . . . 73.11 111.134 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -173.59 130.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.1 110.934 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.2 t -84.17 104.14 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 71.41 111.17 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -47.39 83.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 73.33 111.185 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -141.51 164.43 30.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.926 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.87 140.71 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.05 111.13 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -127.57 143.6 51.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.957 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.31 14.86 9.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 64.15 110.892 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.62 100.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.151 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.9 m -60.43 95.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 74.5 111.112 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.29 134.26 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.114 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -124.28 170.09 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.04 111.156 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -131.33 154.2 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.93 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 t -159.42 85.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.5 110.845 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.82 -94.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.684 -0.77 . . . . 64.42 112.513 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.29 14.36 7.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 72.32 110.886 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -128.69 146.84 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.805 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -129.0 164.07 24.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 74.02 110.855 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.7 m -152.67 144.13 23.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.143 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.49 123.61 41.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 73.41 111.122 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 139.22 40.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.906 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.76 -37.74 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 65.33 110.916 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.98 42.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 71.31 111.115 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.56 2.0 69.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.703 -0.76 . . . . 72.01 112.492 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.86 -33.84 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 74.44 110.921 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.68 -71.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 71.01 110.952 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.71 -38.18 3.23 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 75.44 112.523 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -50.95 113.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 74.24 111.149 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -141.15 133.07 27.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.866 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.06 160.36 1.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.512 0.672 . . . . 75.1 111.155 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 -15.93 37.58 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.672 2.248 . . . . 74.4 112.394 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.58 115.61 1.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.8 -0.715 . . . . 72.24 112.495 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.58 172.39 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.793 0.33 . . . . 62.13 111.073 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.62 131.24 52.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.801 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 p -129.48 118.78 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 111.128 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.99 138.59 52.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.13 110.872 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.2 136.31 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 71.42 110.911 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.57 -178.62 19.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.502 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -174.47 175.72 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 74.1 110.861 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.54 127.03 45.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 65.44 110.912 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.15 157.48 21.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.42 112.507 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -108.16 109.44 20.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 75.12 110.899 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.54 -158.74 29.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 72.33 112.502 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -35.22 12.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 73.35 112.327 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.97 26.78 28.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 64.42 112.448 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.22 76.49 1.89 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.588 0.709 . . . . 53.14 110.846 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 160.72 48.65 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.675 2.25 . . . . 71.33 112.299 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -148.53 174.21 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.41 110.891 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 51.88 64.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 71.13 110.921 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.8 t -86.51 130.3 34.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.894 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 144.0 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.14 110.946 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.67 156.73 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.89 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 67.28 40.51 2.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 71.13 110.895 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.09 42.13 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.677 -0.773 . . . . 72.5 112.543 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.31 71.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 55.53 112.493 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.6 138.03 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.341 . . . . 74.33 110.906 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 71.14 110.884 -179.934 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.788 0.328 . . . . 75.01 111.098 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.8 154.76 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 52.31 111.1 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 111.93 11.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 72.35 111.114 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -74.7 126.69 31.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 74.31 110.915 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.3 161.34 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.07 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.09 155.21 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.908 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.09 -57.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.101 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.38 130.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 74.54 110.825 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.91 127.51 55.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.843 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -110.5 82.05 1.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.901 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.74 -87.28 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 72.11 112.464 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 t -100.69 -17.55 16.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.73 0.3 . . . . 73.32 111.095 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.15 155.94 25.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.53 112.516 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.43 143.44 30.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 75.23 110.936 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 117.34 5.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 62.51 112.524 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 151.91 20.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.773 -0.727 . . . . 74.34 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.79 96.56 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 75.33 110.926 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -90.09 136.29 33.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 75.4 110.886 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -114.72 101.9 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 71.32 111.124 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.88 131.72 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 75.04 111.119 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.75 128.19 36.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.15 110.868 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.43 132.24 54.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.21 110.899 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -172.07 121.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.11 111.138 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.74 -80.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 62.22 112.421 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.51 168.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.338 . . . . 74.45 111.228 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 p -60.54 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 74.55 111.144 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.92 121.73 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 72.13 110.827 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.36 126.16 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 72.25 110.87 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.96 -23.99 28.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.876 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.0 170.13 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.825 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -136.04 136.71 40.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.906 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -152.69 144.23 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 71.1 111.222 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.91 105.83 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 72.33 111.147 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.9 134.24 55.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.911 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.08 173.32 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.849 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 130.35 44.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 75.14 110.906 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.45 73.92 2.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.647 0.737 . . . . 72.23 110.865 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.16 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 74.15 112.302 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.1 p -73.05 145.72 46.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 70.0 111.13 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 98.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.826 -0.702 . . . . 74.13 112.456 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -154.92 154.62 32.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 72.21 111.106 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 130.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 70.34 110.928 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.92 108.5 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 74.1 111.116 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -45.9 70.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 73.25 111.143 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -141.67 157.0 45.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 70.3 110.842 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.06 157.39 40.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 75.1 111.163 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -141.0 146.61 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.911 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.23 14.81 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.42 110.845 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 105.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 62.22 111.149 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -65.48 90.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 65.51 111.132 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.9 118.42 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.122 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -110.9 175.14 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.085 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -134.21 160.15 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.86 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.17 85.88 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 75.35 110.866 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 -92.73 0.57 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 71.11 112.444 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -126.03 17.36 7.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 73.41 110.953 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -128.57 146.83 50.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.489 . . . . 73.2 110.809 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -132.13 150.08 52.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -142.49 145.25 33.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 72.3 111.119 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.88 114.66 21.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.13 111.084 179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 136.25 48.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.859 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.56 -51.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.95 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.66 40.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.12 111.152 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.22 -0.71 54.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 51.4 112.433 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.44 ' CE3' ' HB2' ' A' ' 70' ' ' ASN . 3.5 p-90 -104.44 -27.83 11.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.778 0.323 . . . . 72.12 110.899 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.44 ' HB2' ' CE3' ' A' ' 69' ' ' TRP . 12.7 m-20 -132.89 -70.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.899 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.3 50.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 41.3 112.488 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.4 t -73.3 94.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 72.11 111.152 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.54 151.45 44.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.855 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.99 163.52 0.84 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.576 0.703 . . . . 64.43 111.115 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -8.14 22.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 72.14 112.327 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.22 115.75 1.81 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.524 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.48 172.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 70.44 111.083 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -137.22 131.71 32.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.23 110.919 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 t -143.42 110.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.33 111.068 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.0 p -103.99 135.0 46.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.905 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -118.39 126.44 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.82 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.81 173.59 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 74.15 112.495 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -174.73 176.62 2.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.34 110.865 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.99 125.82 40.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.54 110.862 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -125.27 161.79 19.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.573 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 t -109.32 110.28 21.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 74.44 110.918 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.53 -158.7 28.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 74.12 112.435 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -36.08 11.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 70.04 112.382 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.83 27.08 30.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -112.36 77.02 2.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.728 0.775 . . . . 74.42 110.841 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 168.46 21.49 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.729 2.286 . . . . 63.53 112.335 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -148.43 169.17 20.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.25 110.84 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.07 48.92 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.818 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.2 m -65.46 96.53 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 72.32 110.897 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -121.2 121.29 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 74.55 110.937 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.74 155.71 38.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 65.13 110.957 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.33 27.22 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.866 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.06 42.05 7.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 51.11 112.493 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 70.1 1.12 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.701 -0.762 . . . . 63.13 112.469 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 131.59 9.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 71.22 110.85 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.884 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.86 0.362 . . . . 75.43 111.107 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.98 123.55 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 73.33 111.069 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -99.07 139.61 34.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.209 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.56 143.86 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.9 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.77 154.97 43.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 65.53 111.063 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.49 144.51 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 75.32 110.876 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 -59.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.171 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -179.99 149.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 55.2 110.896 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -117.73 126.46 52.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 73.33 110.898 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -111.74 86.71 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 75.44 110.916 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.94 -82.15 0.87 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 74.21 112.498 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -117.35 -17.56 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 72.11 111.136 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.17 166.63 38.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 73.53 112.472 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -148.59 157.54 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.22 110.876 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.59 130.62 9.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.797 -0.716 . . . . 73.54 112.537 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.91 145.89 17.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 71.22 112.473 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.22 95.46 3.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 72.22 110.841 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -89.81 125.58 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 73.51 110.921 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.3 m -110.9 101.85 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.04 111.159 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.1 t -94.12 131.22 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.13 111.099 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.2 117.89 11.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.889 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.61 125.51 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.21 110.91 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -164.91 139.18 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 75.03 111.158 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.44 9.81 54.63 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.683 -0.77 . . . . 71.35 112.445 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 t -130.98 174.53 9.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 75.13 111.206 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.39 165.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 75.21 111.142 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 p -69.07 99.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.28 178.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.11 110.933 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.56 -52.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.834 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -133.75 140.4 46.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 44.22 110.834 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -115.38 127.09 55.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 62.35 110.863 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 m -134.09 116.94 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 74.21 111.098 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.88 105.5 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.31 111.142 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -120.38 136.86 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 70.13 110.861 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.38 170.26 16.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 75.02 110.823 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.45 129.83 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 64.52 110.85 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -113.1 76.41 2.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.678 0.752 . . . . 74.41 110.847 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -49.83 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 73.23 112.27 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.42 99.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 64.44 112.538 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -154.55 155.36 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 74.14 111.162 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -173.73 130.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 75.04 110.889 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.0 t -85.44 97.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.098 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -44.15 94.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.139 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -136.8 161.25 36.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 162.08 41.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 65.54 111.12 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -148.63 142.59 25.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 75.13 110.962 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t0 64.39 14.55 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.883 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.097 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -62.72 97.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 71.41 111.134 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -87.13 128.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 61.21 111.093 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -117.2 168.8 9.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 72.04 111.171 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -130.43 153.24 48.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.879 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 m -159.43 85.66 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 61.41 110.849 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.34 -93.94 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 73.52 112.442 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.4 14.8 7.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 65.34 110.845 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -128.83 146.93 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.13 110.894 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -129.77 155.03 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.42 110.962 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.3 m -139.71 148.49 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 73.32 111.197 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.76 136.34 54.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 73.35 111.17 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.4 131.43 10.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.423 . . . . 74.53 110.828 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -114.31 -28.95 7.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 71.01 110.846 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.7 m -105.67 39.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 72.15 111.142 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.54 4.14 65.41 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.673 -0.775 . . . . 75.42 112.494 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.471 ' CE3' ' HB3' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -118.21 -32.94 4.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.782 0.325 . . . . 73.35 110.96 -179.965 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.471 ' HB3' ' CE3' ' A' ' 69' ' ' TRP . 6.1 p30 -105.48 -37.25 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 71.33 110.951 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.68 54.36 25.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.743 -0.741 . . . . 63.42 112.508 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -124.07 118.84 27.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 75.31 111.151 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.6 tp -138.56 160.91 38.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.916 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.4 162.9 18.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.701 . . . . 60.01 111.064 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.637 2.225 . . . . 54.33 112.341 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.37 114.53 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.77 -0.729 . . . . 75.11 112.494 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 178.37 172.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 72.11 111.083 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -131.54 131.37 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.15 110.898 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.05 115.55 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.34 111.183 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.94 142.46 38.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 61.53 110.893 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -136.27 133.8 37.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 74.03 110.909 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.32 -179.37 20.17 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 74.44 112.413 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -171.84 176.77 3.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 75.02 110.842 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.62 125.68 36.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 75.31 110.931 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.78 161.92 26.67 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.678 -0.773 . . . . 75.25 112.491 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 p -105.61 125.47 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.37 . . . . 64.22 110.88 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.35 -163.3 30.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 72.32 112.484 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -36.16 11.53 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.697 2.265 . . . . 75.25 112.405 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.43 28.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 61.41 112.52 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -112.78 75.7 1.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.659 0.742 . . . . 72.12 110.834 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 157.0 61.88 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 71.03 112.321 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -145.88 177.09 9.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.889 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 m120 52.54 58.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.939 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.0 t -76.98 110.06 11.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.13 110.931 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -131.95 143.96 50.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.859 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.04 154.44 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.43 110.937 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 63.31 47.33 4.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 75.35 110.874 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.35 18.51 73.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 70.41 112.517 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.96 69.74 1.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 61.13 112.513 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -156.05 104.7 2.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 73.43 110.846 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 75.31 110.913 -179.982 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.771 0.32 . . . . 63.21 111.164 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.86 31.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 64.24 111.064 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.03 147.52 47.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.175 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.43 142.4 31.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.937 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.52 152.01 40.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 72.4 111.116 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 147.93 25.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 74.14 110.932 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 -59.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.44 111.136 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.55 129.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 75.34 110.831 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.99 127.82 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 74.33 110.863 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.66 82.22 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.875 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.63 0.63 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 70.31 112.48 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -100.39 -17.68 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 72.22 111.113 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.9 152.81 22.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 62.22 112.431 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -141.95 142.51 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.002 0.43 . . . . 75.44 110.884 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.54 112.97 4.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 73.5 112.425 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.26 131.48 10.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.493 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.1 t -131.43 98.68 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 73.43 110.906 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -92.36 143.28 26.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.867 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 m -123.88 111.53 16.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 72.42 111.154 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.57 132.58 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 72.43 111.12 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -137.68 130.28 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.927 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.68 144.91 34.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.881 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -172.67 162.23 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.11 111.13 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.05 -62.72 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 42.51 112.508 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 p -64.98 163.43 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 63.34 111.222 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -174.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 65.35 111.129 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -57.19 120.18 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.34 110.836 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mp -56.84 153.53 10.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.48 . . . . 64.1 110.87 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.14 -15.3 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.3 110.829 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.02 152.63 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.868 -179.746 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -136.97 129.53 30.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.4 110.922 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -152.89 122.37 6.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 74.41 111.137 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.76 115.95 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 71.25 111.065 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.5 152.32 36.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 70.54 110.858 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.0 167.22 31.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 75.12 110.907 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.99 133.68 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 72.2 110.823 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -112.02 76.72 1.84 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.42 110.86 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -49.57 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.65 2.234 . . . . 74.13 112.335 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -73.38 144.74 46.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 73.52 111.124 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.19 96.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.15 112.466 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 43' ' ' THR . 6.5 m -156.66 155.95 32.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 72.04 111.116 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.26 131.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.853 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.06 99.79 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 75.12 111.133 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 t -67.53 -40.69 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 63.24 111.133 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -142.95 148.55 37.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 75.55 110.786 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.11 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 70.14 111.063 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -148.51 144.9 27.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 74.1 110.957 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 63.24 16.28 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 74.31 110.849 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.1 95.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 72.2 111.12 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -54.6 100.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 75.23 111.126 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.29 128.43 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.24 111.087 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -126.89 141.69 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 70.1 111.075 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -108.43 159.89 16.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.31 110.876 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 85.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.869 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.81 -90.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 54.14 112.521 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.22 7.51 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 75.41 110.822 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -119.15 146.89 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.41 110.852 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -128.06 160.09 33.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.4 110.86 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 t -148.77 149.48 31.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 73.21 111.103 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.86 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 61.23 111.103 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 142.84 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.889 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -120.26 -33.07 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.954 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.56 42.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 75.32 111.126 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.29 1.88 68.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 61.41 112.486 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.74 -34.09 4.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.822 0.344 . . . . 75.52 110.976 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.24 -70.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 73.22 110.897 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.06 -37.65 3.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 72.13 112.487 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 t -49.92 117.66 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 71.11 111.122 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.1 143.31 31.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 75.2 110.972 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.45 160.51 33.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.565 0.698 . . . . 71.13 111.121 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -18.31 36.74 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.739 2.292 . . . . 73.3 112.326 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.99 115.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 54.11 112.472 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.8 172.41 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 64.34 111.087 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -120.78 131.02 54.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.879 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.2 109.43 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.41 111.119 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.6 p -113.74 164.36 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 63.01 110.886 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.93 132.52 11.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.882 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.45 173.28 18.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 73.43 112.472 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -174.83 176.73 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 75.33 110.85 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -129.92 139.04 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 61.35 110.906 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.2 159.49 27.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 72.41 112.493 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.43 112.08 24.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 72.44 110.888 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.5 -157.81 27.62 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.669 -0.777 . . . . 75.43 112.443 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -42.31 3.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 71.42 112.382 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.94 30.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 73.23 112.458 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.6 t -112.79 75.29 1.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.675 0.75 . . . . 73.22 110.842 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 159.02 54.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 72.1 112.343 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 m -142.72 165.92 26.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 65.21 110.938 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 m120 58.67 63.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 62.33 110.893 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.2 t -79.51 92.23 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 72.42 110.858 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 118.72 37.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 74.03 110.922 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 pp -130.27 155.76 45.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.925 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 42.4 t30 62.41 20.79 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 71.11 110.903 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.58 24.83 10.52 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.715 -0.755 . . . . 70.12 112.495 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.52 71.37 1.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.35 112.486 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 t -156.31 103.94 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 65.23 110.923 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 65.33 110.842 -179.904 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.819 0.343 . . . . 72.44 111.163 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.51 43.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.126 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 119.25 16.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.155 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -69.5 146.25 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.871 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.25 154.87 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 53.23 111.081 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.33 156.05 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 65.32 110.931 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -58.94 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 71.24 111.119 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 129.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 74.25 110.865 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -115.83 127.98 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.32 110.9 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.59 82.94 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.901 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.48 -85.12 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.741 . . . . 63.32 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -103.29 -17.57 15.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 73.44 111.123 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 156.11 26.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.804 -0.712 . . . . 54.01 112.515 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.16 142.91 30.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.885 0.374 . . . . 74.33 110.864 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.57 122.12 7.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 54.15 112.506 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.7 150.02 20.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 72.13 112.562 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -147.05 94.59 2.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.38 . . . . 71.34 110.816 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.27 134.87 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.902 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 m -113.12 102.1 10.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.111 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.68 131.59 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.162 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.48 118.12 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.895 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -116.0 133.21 56.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 75.15 110.884 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -172.04 153.72 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 74.41 111.08 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.93 -18.14 54.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.821 -0.704 . . . . 74.3 112.454 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 171.18 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 75.13 111.117 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -171.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.13 111.19 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.65 125.67 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 63.52 110.828 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.36 179.16 5.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.953 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -143.66 -52.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.84 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.91 174.42 14.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.923 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -140.25 127.35 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 74.15 110.907 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -113.74 102.14 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 70.11 111.116 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 p -101.26 115.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 74.54 111.178 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.92 151.45 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.3 110.865 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.12 169.68 18.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 74.32 110.937 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.19 128.11 44.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 63.14 110.898 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -112.59 77.15 2.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.633 0.73 . . . . 74.24 110.855 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.275 . . . . 75.44 112.264 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 26.5 m -71.93 145.35 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 71.14 111.163 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.36 98.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 70.21 112.433 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.75 153.49 31.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 71.24 111.163 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.75 130.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 74.3 110.882 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.53 96.59 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 71.23 111.154 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -63.57 -40.98 98.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 75.52 111.183 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 m -144.98 147.96 33.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.887 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.39 157.78 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 52.54 111.08 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -142.33 143.22 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.31 110.957 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.55 14.36 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 73.34 110.845 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 94.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.35 111.05 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -56.68 99.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.121 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.27 121.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.13 111.095 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -111.56 172.05 7.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 74.14 111.142 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 155.26 48.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.01 110.927 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.85 85.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.821 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -93.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.675 -0.774 . . . . 75.23 112.443 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -126.25 10.25 7.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.4 110.795 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -124.3 147.02 48.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 75.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.77 159.86 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.959 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.5 m -147.8 148.82 31.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 73.01 111.133 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.88 135.18 48.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.13 111.071 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.88 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 73.3 110.889 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -131.47 -51.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 64.42 110.879 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.62 37.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 75.11 111.156 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.59 0.91 84.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 54.24 112.45 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -116.44 -24.27 7.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 74.24 110.889 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.17 -38.42 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 73.22 110.889 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.42 53.5 28.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.743 . . . . 75.41 112.487 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 t -130.18 94.95 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 74.34 111.212 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -138.61 160.72 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 71.33 110.897 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.12 161.31 52.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 71.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -8.45 23.63 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 74.54 112.351 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.21 115.54 0.75 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 74.04 112.484 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.53 172.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 72.53 111.11 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -134.19 131.62 38.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.849 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.88 116.98 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.164 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 p -108.41 125.95 52.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 72.12 110.872 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -111.55 137.31 49.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 74.5 110.818 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.64 174.5 17.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.31 112.458 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -174.32 179.07 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 71.23 110.878 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.5 140.86 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.856 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.65 159.9 28.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 72.45 112.48 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.1 m -105.37 113.72 27.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 74.23 110.87 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.52 31.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 71.4 112.501 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -37.35 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.655 2.237 . . . . 73.24 112.359 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.74 25.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.55 112.525 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -112.84 75.12 1.84 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.599 0.714 . . . . 75.32 110.834 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 156.71 62.74 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.652 2.234 . . . . 75.11 112.397 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 168.77 21.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 74.52 110.82 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 60.14 62.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.24 110.907 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t -84.9 95.55 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 74.42 110.812 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 125.52 48.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.904 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.3 155.61 50.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 73.53 110.988 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.08 25.76 15.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.88 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.58 28.66 13.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 73.14 112.458 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.35 74.79 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 54.22 112.476 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.18 104.35 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 73.44 110.862 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.11 110.88 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.916 0.389 . . . . 72.41 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 p 49.83 42.62 24.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.32 111.089 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -174.62 -170.33 0.49 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 73.34 110.835 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.3 133.02 35.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 72.15 111.096 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p -132.38 153.2 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 73.31 111.119 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.52 163.7 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.34 111.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.53 147.63 27.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.44 111.153 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -88.77 146.28 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.96 163.36 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 74.31 111.053 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.32 138.78 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 75.44 110.977 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.85 -60.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 64.31 111.165 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.27 131.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.43 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.94 127.3 53.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 75.04 110.908 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.25 88.17 2.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.983 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -93.22 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.75 . . . . 73.24 112.453 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.39 -17.7 17.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 73.44 111.141 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.61 148.59 20.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.778 -0.725 . . . . 71.5 112.489 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -138.08 143.75 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 72.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.29 3.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.77 139.27 21.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 51.43 112.504 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.34 95.51 3.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 72.22 110.815 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.25 145.13 25.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.932 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.27 124.73 52.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.32 111.085 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.08 131.56 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.42 111.116 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.77 118.1 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.883 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.73 101.54 9.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.903 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.9 p -146.05 134.06 21.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 71.44 111.101 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -57.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 62.54 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.81 168.25 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 73.32 111.12 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.0 p -63.17 -174.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 70.13 111.125 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.53 125.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 74.12 110.857 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.65 -176.23 4.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.91 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.5 -52.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.821 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.79 157.54 38.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 61.11 110.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -114.46 126.84 55.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.888 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.47 100.79 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 74.11 111.142 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.0 p -101.39 120.83 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 72.41 111.094 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -128.38 156.09 43.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.879 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 170.16 21.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.35 110.907 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.14 130.78 44.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 63.03 110.927 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -111.94 78.53 2.32 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.633 0.73 . . . . 75.41 110.928 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -49.28 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.734 2.289 . . . . 71.34 112.335 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -73.12 144.46 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.92 97.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.478 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.4 m -156.07 154.55 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 60.24 111.195 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.99 131.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 75.35 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.23 95.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.452 . . . . 72.43 111.12 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.6 m -63.19 -42.51 99.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 72.21 111.189 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.68 140.13 31.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 60.55 110.782 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.85 137.89 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 74.53 111.125 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.39 142.48 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.951 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.84 13.99 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.73 120.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 64.03 111.131 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.2 99.98 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 62.31 111.136 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.5 t -89.29 119.5 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.116 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -106.82 171.13 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 71.43 111.156 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.85 156.37 46.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 75.42 110.953 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 t -158.23 85.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 71.15 110.858 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.37 0.89 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 55.44 112.515 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 51.25 110.902 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -108.73 146.92 32.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -131.28 155.6 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.96 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 m -148.46 149.05 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 75.21 111.12 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.9 124.61 37.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 75.45 111.071 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.27 157.77 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.44 110.916 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.35 -51.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.14 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.45 40.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.099 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.13 0.86 72.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.468 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.336 . . . . 72.11 110.878 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.55 -45.06 3.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 72.04 110.868 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.49 55.25 20.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.772 -0.728 . . . . 74.52 112.432 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -133.17 94.66 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.341 . . . . 72.33 111.205 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.51 160.83 38.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 73.5 110.846 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.43 162.31 54.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 72.44 111.075 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.708 2.272 . . . . 75.32 112.341 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.53 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 64.24 112.445 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 74.24 111.098 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.75 131.51 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.848 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.87 149.8 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 75.43 111.15 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.78 154.26 47.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.14 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.93 139.02 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 72.23 110.833 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.64 174.33 15.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 74.03 112.483 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -168.81 177.8 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 74.4 110.855 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.01 125.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.2 110.885 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.96 154.2 20.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 70.01 112.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -95.89 109.53 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.379 . . . . 75.24 110.837 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -160.28 30.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.79 -0.719 . . . . 73.14 112.481 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -41.73 4.12 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.712 2.274 . . . . 75.41 112.306 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.73 26.65 24.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 71.2 112.467 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 m -113.3 73.56 1.87 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.694 0.759 . . . . 45.42 110.891 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 163.31 38.75 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 74.22 112.381 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -148.26 173.37 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.3 110.87 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.23 49.31 3.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 65.34 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.5 m -68.57 97.34 0.77 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 118.97 25.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.915 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.93 155.94 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 73.4 110.858 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.34 13.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 65.31 110.807 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.15 42.15 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 75.23 112.479 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.7 70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 73.11 112.479 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.22 132.61 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 71.34 110.866 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.25 123.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.887 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -116.72 156.88 26.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.856 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.14 19.53 66.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 30.43 112.559 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.12 178.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 73.13 111.175 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 64.32 110.84 -179.808 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.861 0.362 . . . . 71.22 111.16 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 p 49.88 42.56 24.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 74.33 111.179 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -174.55 -170.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 61.41 110.88 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.36 133.1 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.055 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p -132.45 153.17 51.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 75.32 111.202 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.45 163.8 31.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.081 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 147.63 27.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.128 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.76 146.22 25.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 74.5 110.905 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.86 163.45 35.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 61.14 111.164 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 138.86 45.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 73.35 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.95 -60.92 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 75.05 111.11 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.32 131.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.868 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.99 127.24 53.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.847 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -111.28 88.23 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 -93.16 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 52.14 112.486 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.33 -17.74 17.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.784 0.326 . . . . 74.43 111.162 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.63 148.67 20.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 73.22 112.429 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.11 143.67 40.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 71.01 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.25 3.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 72.14 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 139.23 21.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 74.52 112.438 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.36 95.57 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.366 . . . . 73.22 110.894 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.31 145.2 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.857 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.3 124.66 52.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.44 111.22 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.98 131.59 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.149 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.84 118.12 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.44 110.888 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.74 101.46 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 71.41 110.89 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.7 p -146.0 134.12 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 71.04 111.096 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.87 -57.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.672 -0.775 . . . . 63.11 112.488 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.87 168.22 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 74.2 111.12 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -63.15 -174.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.23 111.204 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.52 125.58 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 63.14 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.64 -176.24 4.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 65.1 110.884 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.49 -52.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.34 110.892 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.84 157.55 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 75.33 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -114.45 126.94 55.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 73.14 110.917 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.62 100.75 6.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.456 . . . . 75.21 111.195 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.33 120.78 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 75.43 111.148 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -128.37 156.1 43.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.2 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.05 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.13 130.88 44.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.851 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -112.09 78.55 2.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 73.33 110.92 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.2 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.615 2.21 . . . . 74.52 112.36 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.8 p -73.15 144.34 46.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 75.42 111.136 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.78 97.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 42.22 112.508 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.1 m -156.13 154.55 31.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 65.13 111.182 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 131.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 71.34 110.852 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.8 t -74.13 95.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.15 111.105 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -63.13 -42.65 99.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 60.35 111.138 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.6 140.03 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.864 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 137.97 48.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 72.1 111.091 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.41 142.48 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.3 110.907 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.82 14.04 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 73.41 110.866 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.76 120.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.22 111.111 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.21 100.0 5.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 63.13 111.146 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.6 t -89.31 119.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 65.41 111.12 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -106.86 171.12 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 111.1 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.84 156.37 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.92 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -158.25 85.74 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.846 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 62.12 112.539 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 63.02 110.902 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -108.7 146.92 32.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -131.31 155.5 47.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.937 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.7 m -148.4 149.1 31.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 64.44 111.142 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.91 124.63 37.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.066 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.32 157.78 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.838 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.31 -51.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 72.55 110.965 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.44 40.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 73.52 111.138 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.14 0.86 72.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 73.24 112.486 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.69 -24.64 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 74.31 110.918 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -110.51 -45.05 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 62.05 110.929 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.44 55.27 20.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.705 -0.76 . . . . 74.15 112.485 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -133.23 94.7 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 75.42 111.088 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.46 160.88 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 70.34 110.954 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.49 162.33 53.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.569 0.7 . . . . 71.44 111.107 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -8.45 23.64 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.711 2.274 . . . . 61.33 112.354 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.52 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 72.2 112.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 74.34 111.098 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.73 131.46 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 73.12 110.858 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.88 149.8 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 74.42 111.105 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.73 154.25 47.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.912 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -141.97 139.0 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.2 110.866 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.52 174.27 15.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 71.34 112.55 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -168.73 177.82 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.25 110.893 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.02 125.72 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 63.31 110.871 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.94 154.18 20.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.672 -0.775 . . . . 70.0 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -95.84 109.53 21.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.888 0.375 . . . . 72.32 110.901 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.03 -160.23 30.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.75 -0.738 . . . . 55.15 112.522 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -41.55 4.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 72.22 112.36 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 26.73 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 72.34 112.442 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 m -113.42 73.61 1.98 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.742 0.782 . . . . 73.52 110.897 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 163.35 38.64 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.693 2.262 . . . . 34.32 112.381 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.0 p -148.39 173.33 13.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 74.13 110.82 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.25 49.28 3.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.3 m -68.5 97.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.922 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.13 119.06 25.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.01 155.93 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 72.15 110.898 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.35 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.818 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.11 42.23 8.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.708 -0.758 . . . . 74.22 112.493 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.64 70.02 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 71.12 112.495 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.23 132.62 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 72.54 110.873 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.25 123.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.127 -0.488 . . . . 54.24 110.944 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -116.82 156.89 26.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.819 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.23 19.45 66.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 75.05 112.447 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.02 178.61 0.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 64.42 111.171 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 71.11 110.842 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.883 0.373 . . . . 73.31 111.06 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -115.16 40.38 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 64.51 111.13 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.67 -170.26 3.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.893 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.53 136.59 33.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 72.2 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.6 p -146.06 159.96 42.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 75.23 111.092 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.71 163.83 33.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 72.23 111.09 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 m -139.91 137.38 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 64.11 111.093 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -76.76 139.03 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.43 110.856 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.14 150.75 41.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 71.13 111.123 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.67 142.11 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.848 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.51 -56.49 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 75.11 111.09 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.25 132.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 70.11 110.902 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.46 127.65 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 64.33 110.793 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.42 84.87 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.903 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 -91.11 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 73.32 112.46 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.5 -17.6 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.347 . . . . 73.12 111.092 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.16 148.41 20.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 75.12 112.504 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -135.15 141.69 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 74.42 110.832 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.84 108.83 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 75.11 112.453 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.54 130.51 10.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 71.01 112.496 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.85 99.46 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 75.25 110.899 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.29 117.93 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.54 110.893 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.5 m -95.52 110.09 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 73.42 111.164 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -106.71 131.89 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 74.32 111.161 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -143.4 127.97 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 73.43 110.888 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.25 133.44 55.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.873 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.47 151.67 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.31 111.172 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -41.08 2.36 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.645 -0.788 . . . . 75.51 112.535 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 169.1 14.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 75.43 111.163 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -172.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 65.43 111.083 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -51.43 129.71 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 55.12 110.867 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -176.24 4.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 74.32 110.93 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -52.94 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.05 110.904 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.77 176.23 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.837 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -135.68 127.09 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 74.43 110.894 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.64 105.83 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 75.33 111.138 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.2 t -101.4 105.92 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 72.44 111.11 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -116.76 153.07 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.84 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.82 169.61 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.911 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.08 129.94 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.841 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.76 75.38 1.88 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 72.25 110.86 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -49.78 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.641 2.227 . . . . 64.23 112.407 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -71.07 144.56 50.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.202 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.9 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.15 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -156.57 154.71 30.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 72.4 111.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.67 131.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 75.23 110.913 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.6 t -75.18 101.41 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.21 111.063 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -45.69 91.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 72.24 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.12 148.5 33.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.15 110.846 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.62 137.08 39.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.093 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -119.51 148.17 43.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.903 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.52 14.53 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 65.12 110.871 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 134.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 54.22 111.092 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -86.56 95.01 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.137 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.34 138.33 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 74.44 111.07 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -128.31 171.03 12.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.168 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -136.07 157.39 46.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 73.4 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 85.74 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 74.14 110.877 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.98 -91.77 0.71 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 62.21 112.522 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.21 8.23 7.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 73.14 110.916 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -119.23 146.68 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 72.42 110.873 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -130.88 157.53 42.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.894 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.9 m -152.53 148.46 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 72.0 111.163 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.46 134.84 47.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 70.01 111.135 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.36 160.84 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.923 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.95 -51.46 0.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.43 110.902 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.93 39.3 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 65.03 111.11 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.26 -0.73 72.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.772 -0.727 . . . . 53.23 112.535 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -113.53 -25.2 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.806 0.336 . . . . 73.02 110.947 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.04 -47.0 3.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 74.41 110.874 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.86 56.3 14.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.774 -0.726 . . . . 54.15 112.438 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.71 95.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 55.44 111.093 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.24 160.55 38.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 73.44 110.922 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.17 161.97 72.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.718 . . . . 74.13 111.151 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.77 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.727 2.284 . . . . 74.35 112.29 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.9 119.0 1.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 44.53 112.498 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.41 172.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 74.41 111.022 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -131.02 131.64 44.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.848 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.31 114.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.188 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 p -111.83 134.36 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.89 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.67 138.64 45.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.45 110.918 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.16 -179.77 19.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.761 -0.733 . . . . 72.32 112.469 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -174.45 174.02 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 75.3 110.862 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -129.83 125.79 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.838 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.49 152.22 19.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 72.25 112.546 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.4 t -97.87 109.38 22.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 71.15 110.894 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.51 -156.52 27.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.457 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -42.04 3.66 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 74.2 112.314 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.11 26.49 31.02 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.702 -0.761 . . . . 43.25 112.55 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 m -113.09 74.74 1.91 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.678 0.752 . . . . 62.53 110.908 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 162.55 41.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 73.3 112.375 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -148.34 171.29 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.836 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 60.01 58.47 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 73.35 110.846 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.33 92.06 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 62.02 110.857 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 118.94 33.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.427 . . . . 72.41 110.9 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -128.71 155.78 44.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.944 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.12 22.69 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.828 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.34 41.85 5.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 75.11 112.474 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.65 71.54 1.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 53.52 112.485 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.1 m -156.23 104.15 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 73.1 110.885 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.8 t -149.56 137.56 20.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 73.44 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -127.15 154.76 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 65.22 110.798 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.78 -30.03 7.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.738 -0.744 . . . . 73.14 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.44 -178.64 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 72.13 111.087 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 75.43 110.865 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.883 0.373 . . . . 72.24 111.095 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.5 t -139.39 33.74 2.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 65.51 111.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.5 -177.81 2.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 65.12 110.836 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.33 135.18 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 72.23 111.064 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.7 p -143.4 177.83 8.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 75.31 111.185 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.35 163.82 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.33 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -141.79 147.69 37.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.154 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -91.21 145.4 24.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.839 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.68 149.86 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 74.21 111.105 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 147.33 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 74.53 110.888 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.27 -61.92 1.59 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 73.31 111.114 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -179.39 146.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.15 110.893 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -117.86 126.85 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.906 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -111.14 86.79 2.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.973 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.66 -82.97 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 71.24 112.508 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 t -115.66 -17.52 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 65.1 111.089 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.9 159.26 30.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 64.43 112.461 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -139.99 160.45 39.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 73.12 110.886 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.47 121.89 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 62.21 112.432 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.29 146.49 18.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 64.22 112.513 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -138.98 94.57 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 63.34 110.825 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.2 136.46 33.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 73.52 110.915 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -111.68 123.85 51.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 61.12 111.207 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.36 131.69 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 73.24 111.202 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.64 118.06 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 70.21 110.934 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -105.85 119.8 40.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 64.31 110.914 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -158.07 159.89 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.147 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -59.0 3.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 74.41 112.547 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 175.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.825 0.345 . . . . 74.23 111.173 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 175.04 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 71.34 111.165 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 p -52.58 131.66 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.34 110.857 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.69 -169.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 75.04 110.961 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.47 -52.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.823 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.94 154.42 40.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 75.41 110.86 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -107.41 126.94 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 74.0 110.97 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 103.77 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 74.23 111.12 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.55 105.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 73.41 111.082 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.85 155.8 34.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.4 169.28 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.95 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -97.82 132.35 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 61.44 110.92 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.23 80.42 2.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.616 0.722 . . . . 73.1 110.807 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 73.1 112.394 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -73.37 144.56 46.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 72.11 111.158 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.48 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.815 -0.707 . . . . 62.31 112.448 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.4 m -156.24 143.5 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.361 . . . . 74.32 111.151 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -155.55 130.91 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 74.24 110.921 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.94 92.5 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.13 111.099 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.9 m -77.08 -31.21 55.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.163 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.23 149.96 48.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.836 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.78 146.21 21.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 64.33 111.088 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -143.95 141.24 30.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.926 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.82 15.56 9.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.893 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.54 120.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 73.41 111.161 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.5 m -80.15 109.8 14.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 75.11 111.094 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -93.65 138.63 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.21 111.101 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.0 m -128.13 142.27 51.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.34 111.228 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.69 157.08 18.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 75.35 110.875 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -160.6 85.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.13 110.816 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.44 -90.83 0.46 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 74.35 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.31 6.3 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 65.24 110.87 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -119.85 146.79 45.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.852 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -129.19 164.21 23.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.966 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -151.32 149.37 29.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.44 111.168 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.29 114.98 17.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 70.24 111.133 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 154.75 47.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 75.45 110.884 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -131.32 -51.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.878 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -97.05 39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 75.24 111.146 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.2 68.52 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.737 -0.744 . . . . 71.52 112.454 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -112.08 -30.45 7.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 73.45 110.919 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.49 -46.06 4.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.861 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.98 55.84 16.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.696 -0.764 . . . . 75.3 112.492 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -135.19 94.6 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.834 0.349 . . . . 63.41 111.194 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.37 161.17 36.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.3 163.45 26.78 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.534 0.683 . . . . 73.41 111.109 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -7.92 22.28 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.632 2.222 . . . . 71.12 112.352 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 115.17 1.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 72.3 112.492 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.75 172.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 75.02 111.12 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.89 131.58 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.43 110.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.8 t -149.41 137.39 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.515 . . . . 62.15 111.149 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -124.22 136.59 54.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 74.53 110.828 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -125.25 135.81 52.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 72.43 110.865 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.89 171.13 13.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 73.45 112.394 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -162.42 179.59 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 73.2 110.951 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -136.67 131.07 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 61.43 110.872 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 153.84 23.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 61.42 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -91.28 116.78 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 74.55 110.881 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -161.58 29.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 72.14 112.485 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -45.51 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 73.14 112.342 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 27.55 9.81 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 63.35 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 t -112.37 75.13 1.64 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.57 0.7 . . . . 73.03 110.867 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 165.29 31.43 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.705 2.27 . . . . 75.1 112.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -148.59 -177.42 5.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 75.5 110.834 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m120 51.85 60.98 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.901 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -76.66 105.88 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.91 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 144.16 41.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 74.42 110.954 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 pp -153.12 156.15 38.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.893 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.94 43.73 2.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.918 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.8 42.13 61.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.706 -0.759 . . . . 74.52 112.525 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 70.89 1.33 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.749 -0.738 . . . . 63.52 112.492 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -156.43 104.35 2.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 61.41 110.841 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 121.86 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.889 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.6 132.03 54.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.892 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.01 30.96 56.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 55.32 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.39 168.31 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 72.13 111.183 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 74.22 110.918 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.861 0.362 . . . . 71.44 111.125 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.4 p -96.5 95.34 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 74.22 111.125 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.65 -178.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 70.33 110.859 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.57 132.76 36.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 61.11 111.108 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.7 m -149.96 144.62 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 75.42 111.18 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.85 29.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 62.42 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -137.46 132.89 34.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.53 111.185 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.09 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 71.25 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.91 154.0 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -99.2 145.58 27.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 73.23 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -105.85 -58.64 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 65.35 111.122 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -179.42 131.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 72.02 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.59 127.29 53.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.31 88.99 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.2 -92.96 0.76 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 63.22 112.462 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.51 -17.76 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 74.03 111.181 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.36 148.62 20.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 63.12 112.495 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -136.87 145.1 43.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 74.13 110.887 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.52 112.53 4.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 64.21 112.491 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.77 145.44 24.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 62.22 112.524 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.92 98.7 3.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 75.32 110.826 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.79 124.46 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.52 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.9 m -105.27 101.81 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 62.53 111.174 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.5 t -99.37 131.98 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 75.33 111.075 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -139.81 118.19 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.86 101.46 9.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 62.21 110.866 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -131.15 136.22 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.15 111.193 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.36 -35.53 4.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.679 -0.772 . . . . 52.31 112.492 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 177.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 63.45 111.209 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.34 173.41 12.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 72.55 111.149 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.76 108.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 70.13 110.886 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.09 -177.66 6.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 75.13 110.957 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.7 p -141.71 -53.44 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 72.54 110.822 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.53 152.63 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 74.11 110.889 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -115.3 126.78 54.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 62.41 110.931 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -135.9 118.13 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 73.13 111.155 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -114.91 125.46 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.176 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.39 153.71 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.825 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.55 169.45 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 64.21 110.88 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 132.45 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 55.53 110.834 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -111.83 79.5 2.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.603 0.716 . . . . 74.32 110.859 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 75.3 112.364 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' THR . 69.9 p -73.36 144.82 46.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.42 96.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 72.32 112.485 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 43' ' ' THR . 57.4 m -156.94 149.41 23.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 73.54 111.154 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.68 131.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.937 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.5 t -74.79 100.15 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.157 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.3 m -63.16 -46.02 89.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.124 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 m -141.44 142.12 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 64.51 110.897 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.46 147.69 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -131.58 143.99 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.925 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t0 64.8 14.07 8.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.935 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.96 106.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.068 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -64.95 91.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 73.0 111.141 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -88.96 113.27 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.11 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -107.19 179.08 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 73.01 111.181 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.21 159.97 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.921 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -158.6 85.21 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 65.32 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.17 -90.99 1.01 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.442 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -126.75 2.0 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 70.41 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -111.56 146.88 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.12 110.88 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -130.29 152.9 49.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.903 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 t -149.07 148.58 29.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.4 111.146 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.41 135.49 50.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.089 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.59 135.21 15.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.872 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -111.77 -32.09 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.11 110.907 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.32 40.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 72.12 111.152 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.03 1.89 72.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 72.31 112.52 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -117.78 -34.05 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 71.4 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -102.0 -68.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 73.03 110.89 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.96 45.44 8.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 74.43 112.479 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -127.03 120.72 29.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.816 0.341 . . . . 71.41 111.166 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.25 161.43 40.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 74.43 110.97 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.02 164.0 17.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 73.05 111.034 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -8.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.702 2.268 . . . . 65.12 112.326 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.63 114.29 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 71.12 112.484 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.99 172.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.711 0.291 . . . . 75.25 111.143 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -129.33 131.28 46.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 71.42 110.825 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.2 p -133.42 128.29 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.181 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -132.74 140.85 48.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 60.14 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.32 153.76 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 73.45 110.873 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.53 175.83 17.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.787 -0.721 . . . . 54.33 112.486 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -174.21 177.32 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 74.52 110.907 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -130.64 125.77 34.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.55 110.879 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.51 151.62 18.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 71.11 112.474 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 109.57 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 63.51 110.845 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.47 -157.22 27.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.706 -0.759 . . . . 72.42 112.426 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -42.49 3.33 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.591 2.194 . . . . 73.03 112.373 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.9 26.97 25.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 62.42 112.508 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -113.03 73.95 1.72 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.742 . . . . 71.15 110.828 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 156.02 64.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.669 2.246 . . . . 74.51 112.343 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.845 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 63.14 62.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 72.2 110.858 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.54 131.75 34.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 63.51 110.936 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 121.37 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.898 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -136.48 155.88 49.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.4 110.935 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 64.11 39.79 7.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.937 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 23.36 60.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 65.4 112.531 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.37 71.53 1.16 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 55.42 112.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -156.19 104.24 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 70.15 110.891 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.2 t -168.27 112.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 73.42 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.37 156.39 19.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 70.41 110.851 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.55 49.26 19.75 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.769 -0.729 . . . . 61.5 112.508 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -172.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.13 111.169 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 74.12 110.885 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.801 0.334 . . . . 74.42 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.66 169.84 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.147 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -118.88 97.5 5.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.429 . . . . 72.24 110.887 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.06 132.79 14.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 75.54 111.116 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -122.18 170.79 9.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 72.14 111.08 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.37 163.77 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 71.03 111.095 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.41 141.93 26.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 70.04 111.128 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -84.73 145.53 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 71.21 110.884 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.77 164.1 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 71.43 111.153 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.74 163.95 12.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.879 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -61.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 73.21 111.121 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.22 135.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 75.51 110.905 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.92 127.14 53.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 70.54 110.93 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.14 92.91 4.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.926 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -90.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.794 -0.717 . . . . 72.32 112.477 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -106.98 -17.56 14.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 74.2 111.127 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.82 153.56 27.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 64.41 112.516 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -140.94 146.55 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 63.44 110.928 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.22 127.93 9.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.774 -0.727 . . . . 70.35 112.543 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 145.95 16.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.758 . . . . 74.35 112.507 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.76 100.09 4.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 54.4 110.845 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.29 139.91 30.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 72.24 110.921 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -114.73 119.54 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 63.5 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.96 131.78 62.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -138.29 127.5 24.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 74.32 110.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -118.2 129.73 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 63.2 110.899 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -172.6 159.76 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 74.31 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.1 9.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 71.51 112.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.48 171.01 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 73.12 111.144 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -172.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.152 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -51.54 128.06 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 70.43 110.844 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.1 -175.94 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 73.12 110.895 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.99 -53.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.13 110.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 p -155.82 176.38 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 65.04 110.864 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -139.66 126.89 21.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 72.33 110.878 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -114.04 104.55 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 74.22 111.099 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.45 108.31 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.144 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -130.15 136.17 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 63.02 110.833 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.58 169.89 15.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 74.12 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.21 129.19 44.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 52.1 110.862 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -113.03 76.43 2.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.31 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -49.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 72.31 112.394 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -72.03 145.19 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 75.41 111.132 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.39 98.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 44.13 112.471 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -154.56 155.07 34.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 64.41 111.115 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.55 130.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.864 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.7 t -82.02 109.08 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.12 111.114 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.04 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 65.43 111.085 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -145.85 154.56 42.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 74.45 110.811 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.73 143.9 35.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 72.25 111.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -128.07 145.38 51.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.99 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.98 13.8 8.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.306 -0.406 . . . . 74.03 110.84 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 73.25 111.083 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.0 m -60.29 96.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 75.52 111.158 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -92.54 112.6 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 75.35 111.046 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.0 t -105.51 174.84 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 72.53 111.146 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -135.9 158.14 45.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.84 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -158.51 85.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 73.51 110.918 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.04 -91.59 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 74.52 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.57 4.92 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 74.1 110.882 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -132.64 139.08 47.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.913 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -139.21 148.85 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.134 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -133.66 144.4 49.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 74.12 111.066 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 161.08 39.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.33 110.947 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -131.62 -51.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.896 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.1 39.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 74.1 111.117 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.6 1.17 83.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 74.33 112.491 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -115.13 -20.82 10.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.32 . . . . 71.44 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -115.33 -44.35 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 63.31 110.916 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.95 56.73 11.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.501 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -145.93 96.55 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.43 111.13 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 tt -138.27 160.27 39.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 72.14 111.021 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 161.52 60.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 64.51 111.036 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -19.73 36.03 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 74.34 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.08 116.24 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.779 -0.724 . . . . 73.43 112.528 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.82 172.08 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.42 111.108 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 86.7 p -136.24 131.63 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.876 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.08 117.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.106 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -110.4 134.8 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.868 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -122.74 146.44 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 72.12 110.918 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.02 173.32 14.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 73.41 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -171.18 -179.5 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.22 110.867 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -131.43 125.95 33.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 53.41 110.873 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.03 156.64 20.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 64.33 112.471 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.17 116.57 32.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 74.32 110.891 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.35 28.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 55.52 112.486 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -33.74 16.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.744 2.296 . . . . 74.33 112.324 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.46 26.93 28.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 72.03 112.494 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -112.28 76.03 1.82 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.727 0.775 . . . . 74.41 110.898 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 157.94 58.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 74.12 112.356 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -147.44 173.12 12.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 74.41 110.849 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.61 46.82 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 72.34 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.6 m -65.75 100.61 0.56 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.841 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.45 144.04 47.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 75.51 110.876 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.19 145.84 15.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.54 110.92 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.4 t30 60.67 54.82 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.13 110.885 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.9 39.53 46.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 70.35 112.514 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.56 65.24 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.73 104.62 2.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 72.42 110.852 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.35 132.49 19.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 72.23 110.908 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.66 156.49 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 51.12 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.96 -25.86 25.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 53.23 112.535 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.2 10.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.815 0.341 . . . . 72.24 111.146 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 62.54 110.856 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.864 0.364 . . . . 75.24 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 p 49.89 40.3 20.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 75.2 111.105 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 p -165.9 175.32 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 64.23 110.871 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 72.13 111.138 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 178.53 6.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 71.4 111.147 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -162.36 163.89 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 74.1 111.086 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -153.0 138.24 17.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 73.2 111.153 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -83.47 138.46 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.08 158.95 43.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.32 111.15 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -104.47 139.8 38.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 75.41 110.897 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -99.7 -62.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 72.04 111.16 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.82 143.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.865 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.15 125.9 51.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 75.35 110.851 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -112.2 107.04 15.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 73.54 110.989 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 64.51 112.511 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -117.61 -17.52 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 75.1 111.164 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 140.88 16.87 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 55.23 112.537 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.76 149.61 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.829 0.347 . . . . 74.13 110.888 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.1 106.14 2.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 74.13 112.469 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.27 138.22 18.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 52.35 112.453 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.34 100.67 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 71.35 110.819 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -90.17 132.67 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 74.44 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.5 m -110.48 122.99 49.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 73.12 111.129 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.47 131.78 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.11 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.71 126.95 18.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.921 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -119.42 135.02 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 71.13 110.885 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 t -168.2 140.65 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 65.1 111.141 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.29 -61.88 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 72.14 112.513 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -60.2 165.83 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 72.14 111.162 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.5 p -59.92 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.14 111.178 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 127.15 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.854 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -176.29 4.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 75.13 110.941 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -140.91 -52.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 72.35 110.885 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.47 174.51 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 53.25 110.854 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -132.2 126.99 34.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.498 . . . . 74.21 110.932 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.31 105.69 12.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 64.11 111.113 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -105.0 120.66 55.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 75.35 111.13 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -133.48 156.52 47.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 64.41 110.866 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.82 168.76 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.902 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.24 133.19 43.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.803 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -113.53 73.42 2.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 75.32 110.926 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -50.14 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.66 2.24 . . . . 73.44 112.387 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -74.05 145.56 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.4 111.115 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -38.24 99.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 41.1 112.504 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -154.82 157.86 38.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 72.43 111.186 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -173.34 130.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.97 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 81.3 t -81.69 107.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.3 111.119 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -48.34 79.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 64.24 111.165 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.32 156.22 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.787 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 134.56 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 64.42 111.128 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -118.59 145.66 45.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.35 110.863 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.27 13.49 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 71.1 110.854 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 103.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 70.03 111.153 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -63.2 97.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 71.2 111.139 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -89.1 131.09 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 65.21 111.125 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -119.7 172.53 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -134.03 155.98 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 65.52 110.893 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.76 85.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 45.4 110.919 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.83 -93.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.23 112.52 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.26 17.09 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 73.31 110.823 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -129.56 146.71 51.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.869 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -130.67 160.46 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.894 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.1 m -152.71 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 74.44 111.152 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.18 134.63 48.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 156.53 47.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 75.22 110.895 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -131.43 -51.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 73.23 110.884 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.9 39.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.11 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -0.29 75.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 72.13 112.496 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -114.2 -25.39 8.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 73.51 110.92 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -108.58 -47.36 3.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 71.24 110.841 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.79 55.6 19.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 74.43 112.479 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -136.51 94.84 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 62.25 111.175 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 tt -137.13 160.77 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 64.24 110.93 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.64 162.28 71.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 71.32 111.049 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -8.37 23.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.633 2.222 . . . . 74.43 112.319 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.6 115.83 0.86 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.713 -0.756 . . . . 72.45 112.523 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.81 172.16 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 71.4 111.046 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -131.63 131.62 43.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.795 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.05 141.49 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 74.33 111.162 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -132.91 164.31 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.806 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -156.33 143.15 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 73.41 110.886 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.41 172.29 14.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 73.41 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -170.0 178.91 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.369 . . . . 73.55 110.895 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.14 149.42 50.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 73.35 110.852 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.68 160.6 29.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.712 -0.756 . . . . 75.43 112.461 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 73.11 110.837 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.84 -159.9 29.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.783 -0.722 . . . . 74.21 112.488 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -37.24 9.66 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.724 2.283 . . . . 72.25 112.406 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.84 28.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 75.13 112.495 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 78.99 2.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.71 0.767 . . . . 74.44 110.785 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 168.14 22.43 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 75.52 112.386 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 m -146.68 170.33 17.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 72.35 110.869 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.37 44.35 9.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.917 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.2 m -64.53 92.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 144.06 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 pp -158.76 155.86 28.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.31 110.909 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 64.67 46.66 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 71.24 110.914 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.84 41.88 54.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 65.33 112.493 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.05 67.05 1.8 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.67 -0.776 . . . . 73.5 112.517 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.3 m -156.35 108.87 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 71.13 110.761 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.4 t -172.69 112.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 73.13 110.839 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 166.69 23.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 74.32 110.893 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.05 25.18 73.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 72.22 112.466 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.62 175.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 60.03 111.092 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 73.42 110.882 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.347 . . . . 64.31 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.6 p -137.89 32.51 2.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.13 111.139 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -176.88 -170.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 63.43 110.911 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.89 132.65 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 71.11 111.073 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.82 169.38 21.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 64.01 111.184 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.55 41.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 75.44 111.114 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -138.83 132.41 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.124 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -78.02 146.15 35.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.925 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.23 150.73 29.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 64.33 111.044 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -92.33 141.81 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.01 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -102.83 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 74.13 111.165 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -174.14 127.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 74.05 110.864 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.64 127.71 55.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -110.59 83.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 74.14 110.962 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.8 -87.02 0.65 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 64.33 112.505 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -102.31 -17.58 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 73.05 111.13 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.3 153.68 23.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.489 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -140.61 145.19 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 73.51 110.903 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.54 113.84 4.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 72.31 112.479 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.21 136.67 19.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 50.45 112.479 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.72 94.45 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 71.25 110.882 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.47 136.63 39.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.473 . . . . 73.43 110.964 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 m -113.87 105.19 12.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.12 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.37 131.72 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 75.44 111.061 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -136.48 121.29 18.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.03 110.868 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.47 119.75 37.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 73.52 110.889 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.93 157.91 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 72.22 111.138 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.25 -28.32 15.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 72.32 112.475 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.4 p -103.81 170.19 8.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 75.45 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -171.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 70.44 111.12 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 t -51.57 125.09 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.787 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 -176.31 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 72.51 110.902 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -142.88 -52.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 51.01 110.868 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.79 175.78 13.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 73.03 110.921 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -144.26 127.09 16.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.928 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 m -118.34 100.78 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 74.32 111.116 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 p -101.48 116.12 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.15 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -126.17 158.97 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.42 110.87 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.56 171.11 17.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 130.49 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 71.43 110.84 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.68 75.43 1.85 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.69 0.757 . . . . 75.32 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 -49.61 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 74.3 112.33 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.8 p -73.92 144.47 45.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.11 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.66 98.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.478 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -156.1 153.25 29.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 73.22 111.176 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.15 131.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.927 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.4 t -79.64 96.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.52 111.088 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -63.26 -41.22 99.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.41 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -135.58 148.92 49.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 64.23 110.787 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.89 160.48 39.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 74.32 111.085 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -147.55 142.07 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.877 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.36 20.28 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.86 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -171.97 107.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 73.43 111.1 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.5 m -68.34 95.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 73.25 111.216 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.6 140.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.17 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.9 m -129.96 141.67 50.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 62.53 111.192 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.93 156.58 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 74.14 110.909 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -161.7 85.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 74.35 110.884 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.86 -92.3 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 65.42 112.558 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.24 18.09 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 75.23 110.816 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -131.22 146.05 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.822 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -131.29 160.69 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.867 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -148.95 148.97 30.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 65.33 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.43 127.99 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 75.15 111.135 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 156.65 48.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 74.4 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.36 -49.28 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.977 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.71 38.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 72.31 111.146 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.79 1.38 83.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 64.13 112.461 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.76 -25.24 7.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.736 0.303 . . . . 75.12 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.19 -37.79 5.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.884 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.46 54.83 14.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.462 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.08 96.82 3.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 64.13 111.142 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 tt -138.78 160.35 39.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 71.4 110.928 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 160.86 81.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.541 0.686 . . . . 63.11 111.147 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -20.77 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.618 2.212 . . . . 74.23 112.343 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.9 116.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 75.31 112.47 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.43 172.05 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.326 . . . . 74.43 111.099 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -138.15 131.62 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.43 110.921 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.08 114.27 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.125 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -103.15 125.77 50.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 74.11 110.849 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -114.55 152.87 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 75.22 110.864 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.54 167.59 24.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.654 -0.784 . . . . 55.03 112.458 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -160.42 -176.27 5.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.361 . . . . 74.33 110.93 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -132.04 133.62 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 71.54 110.886 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.67 158.65 27.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 74.12 112.499 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.19 117.82 35.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 75.11 110.918 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -161.65 29.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.78 -0.724 . . . . 73.45 112.542 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -39.9 5.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 63.14 112.328 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.61 26.68 26.73 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.722 -0.751 . . . . 72.21 112.497 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -111.91 78.45 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.674 0.749 . . . . 63.22 110.86 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 165.8 29.61 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.693 2.262 . . . . 74.41 112.43 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.6 p -148.48 174.85 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.838 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 58.13 49.54 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 71.15 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 m -64.59 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 143.98 49.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.897 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -157.21 155.79 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.11 110.89 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 65.09 45.83 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.903 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.61 42.03 55.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 72.31 112.453 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.92 67.82 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.688 -0.767 . . . . 71.25 112.517 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.9 t -156.33 105.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 73.44 110.89 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.84 112.8 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -73.59 133.8 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 72.41 110.883 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.12 40.1 11.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 64.22 112.454 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.56 177.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 74.42 111.078 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 72.33 110.771 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.859 0.361 . . . . 74.23 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.2 p -123.16 140.27 53.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 74.2 111.1 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.53 95.31 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 71.35 110.877 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.73 132.97 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 72.33 111.124 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.6 p -150.01 165.74 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 75.45 111.176 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.76 162.25 35.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.32 111.111 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.5 147.64 32.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 111.112 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -88.26 146.19 25.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.855 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.6 173.03 11.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 52.3 111.125 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 159.8 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.96 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.81 -58.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.409 . . . . 64.03 111.111 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -178.59 132.14 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.88 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.22 127.85 55.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.839 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -110.57 82.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.924 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.56 -86.74 0.62 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 72.13 112.464 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -101.35 -17.46 16.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 64.54 111.218 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.4 155.48 25.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 64.51 112.443 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -143.22 143.3 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 74.23 110.948 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.62 117.51 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 64.42 112.533 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.36 143.58 16.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 44.43 112.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.4 112.81 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 70.15 110.873 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -97.33 134.42 40.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 75.23 110.987 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 m -116.3 108.41 16.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 74.45 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.14 131.96 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 73.51 111.145 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.63 118.41 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -118.59 101.37 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 75.34 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.49 155.66 34.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 74.44 111.19 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 52.05 28.27 24.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 74.35 112.448 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -114.23 158.64 21.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 72.05 111.147 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.66 157.0 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 70.02 111.14 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 m -52.0 112.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 71.24 110.874 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.11 174.62 7.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.956 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -137.42 -52.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.861 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.55 152.94 49.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.852 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -119.29 127.17 52.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 74.13 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -125.28 108.12 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.53 111.115 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 p -102.39 111.29 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 73.24 111.067 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.92 138.69 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 71.03 110.883 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.2 171.53 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.885 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.5 129.26 45.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 70.14 110.875 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -113.31 75.67 2.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 75.34 110.822 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -49.74 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.687 2.258 . . . . 63.44 112.3 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -71.36 145.05 49.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 61.51 111.153 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.26 100.07 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 73.44 112.515 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -154.61 155.81 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.847 0.356 . . . . 74.35 111.164 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -173.55 130.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 75.21 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.96 112.28 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.52 111.138 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -87.51 -32.71 19.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 74.42 111.143 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.05 149.55 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 63.2 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.27 133.23 5.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.116 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -133.06 147.96 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.937 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.77 16.42 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 74.42 110.868 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.04 95.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 51.33 111.148 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.5 m -56.17 99.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 53.45 111.1 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.4 t -91.37 124.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.099 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -115.9 172.07 7.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.096 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -133.54 154.39 50.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.862 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.7 m -159.23 85.63 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.843 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.35 -93.33 0.79 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.24 112.546 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -126.51 15.0 7.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 72.11 110.825 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -126.83 146.86 50.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 74.33 110.838 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -131.54 150.6 52.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 72.12 111.002 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.5 m -140.0 147.76 40.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.288 -0.414 . . . . 71.11 111.207 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.59 127.29 47.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.117 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 126.26 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 61.03 110.89 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -106.34 -45.38 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 75.21 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.08 39.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 73.25 111.081 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.17 -0.61 66.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 61.43 112.504 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -115.42 -33.78 5.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.793 0.33 . . . . 70.45 110.893 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.94 -48.09 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.21 110.902 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.58 52.12 54.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.2 112.506 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -124.66 117.66 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.94 0.4 . . . . 71.35 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.75 160.92 39.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 65.34 110.856 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.51 163.61 17.09 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 72.52 111.155 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -7.89 22.22 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.746 2.297 . . . . 75.34 112.289 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.94 114.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.42 112.462 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.64 172.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 75.31 111.089 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -121.36 131.19 54.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 70.34 110.815 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.4 125.88 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 63.43 111.083 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 p -129.86 156.59 44.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.827 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -149.41 139.19 21.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 75.53 110.856 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.46 168.84 15.7 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.729 -0.748 . . . . 52.4 112.42 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -173.81 176.2 2.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 74.41 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -125.84 173.12 9.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 65.23 110.823 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.34 167.66 40.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 72.33 112.486 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -120.05 109.52 15.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 73.13 110.844 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.02 -159.8 31.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 70.04 112.419 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.61 10.46 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.631 2.221 . . . . 75.33 112.368 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.32 26.67 29.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.752 . . . . 72.43 112.483 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 m -112.28 76.67 1.97 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.669 0.747 . . . . 74.43 110.879 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 159.26 54.1 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 75.32 112.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.58 171.37 15.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 72.44 110.884 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 58.68 47.61 12.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 75.51 110.893 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.0 m -66.61 101.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 75.44 110.827 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.25 141.76 51.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.953 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 pp -158.25 148.11 19.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 65.14 110.927 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.0 m-20 58.47 56.11 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 72.4 110.929 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.37 41.5 30.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 51.11 112.511 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.55 58.09 15.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 74.33 112.459 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.36 105.66 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 72.52 110.884 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 37.4 t -154.72 140.57 18.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 72.34 110.883 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.6 157.31 37.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 73.32 110.795 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.87 -24.76 20.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 70.22 112.449 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.98 155.16 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 73.3 111.141 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 75.15 110.857 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.95 0.405 . . . . 74.11 111.114 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p -64.03 -176.96 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 74.1 111.144 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -112.29 96.64 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 74.32 110.882 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.41 144.96 50.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 44.11 111.094 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.31 151.93 50.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 74.4 111.161 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -122.69 141.35 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 62.34 111.1 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -130.81 109.7 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 72.32 111.116 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.75 141.05 57.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 73.54 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.55 32.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 63.3 111.119 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.74 122.71 41.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 75.5 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -58.47 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 62.44 111.169 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.52 138.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.877 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.58 127.06 54.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 75.14 110.892 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.66 85.96 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 75.35 110.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.55 -88.99 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 73.5 112.512 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -107.88 -17.59 14.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 75.13 111.126 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.7 144.9 19.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.493 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -128.77 139.75 52.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 70.22 110.882 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.94 105.57 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 72.33 112.503 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.63 141.18 25.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 73.44 112.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.34 94.48 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 73.34 110.914 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -90.35 136.86 32.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.933 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -112.9 105.85 14.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 73.52 111.193 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -96.7 131.79 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.13 111.163 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.66 123.42 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.939 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -116.96 103.88 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 72.31 110.888 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -159.59 130.33 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.48 -28.99 3.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 72.15 112.451 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -108.63 177.37 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 71.41 111.101 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -60.01 -172.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.133 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -51.19 131.54 27.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 73.11 110.874 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.94 -176.52 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.1 110.945 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 -53.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 62.14 110.902 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 p -153.55 176.11 12.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 75.3 110.81 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -139.04 127.12 22.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 74.33 110.941 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.3 m -113.49 105.07 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.22 111.161 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 t -101.1 105.75 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 75.1 111.075 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 152.61 44.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.868 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.77 170.74 19.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.92 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.97 131.38 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.14 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -111.75 78.99 2.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.656 0.741 . . . . 63.42 110.889 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.96 0.61 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.729 2.286 . . . . 74.23 112.401 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.0 p -72.72 144.47 47.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.23 111.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 64.22 112.548 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.5 m -156.49 142.69 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 73.34 111.122 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -154.87 130.84 10.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 72.24 110.933 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.5 t -76.04 97.43 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 72.31 111.13 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 m -62.64 -43.97 97.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 73.31 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 143.74 30.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 73.2 110.832 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.57 139.87 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 72.41 111.054 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -123.65 143.56 50.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.44 12.97 8.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.848 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.03 104.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 71.22 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.3 m -63.32 97.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 75.02 111.179 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -87.34 134.19 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 72.12 111.111 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -122.9 171.14 9.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 71.23 111.178 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -131.79 153.67 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.44 110.899 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -158.62 85.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 54.2 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.23 -94.24 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.688 -0.768 . . . . 65.4 112.494 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.26 13.42 7.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.825 0.345 . . . . 75.23 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -128.03 146.88 50.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 70.55 110.879 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -128.57 159.16 36.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 75.12 110.843 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.0 m -145.95 149.16 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 71.21 111.114 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.4 129.78 45.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 74.43 111.157 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.73 155.94 49.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 72.52 110.912 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -131.48 -52.01 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 74.02 110.913 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.07 39.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.1 111.134 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.25 0.14 75.35 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.495 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -114.55 -26.5 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 74.1 110.878 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.31 -46.95 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 73.24 110.905 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.76 55.55 20.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.452 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.05 95.61 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 72.51 111.083 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tt -135.98 160.68 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.914 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.19 162.12 75.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.684 . . . . 74.31 111.119 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -8.43 23.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.713 2.275 . . . . 64.12 112.332 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.75 116.16 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.77 -0.729 . . . . 75.3 112.511 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.25 172.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 62.35 111.081 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 p -145.86 131.7 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 53.32 110.845 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.01 118.18 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 74.11 111.074 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 121.84 42.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.866 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.24 135.27 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.44 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.15 -179.95 19.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 72.4 112.483 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -174.07 175.74 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 70.21 110.907 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -131.15 125.82 34.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 75.44 110.849 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.45 151.02 19.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 72.43 112.451 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.6 112.17 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 61.33 110.842 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.85 -160.3 29.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 71.02 112.473 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -44.96 1.78 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.67 2.247 . . . . 73.32 112.384 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.02 27.15 11.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 63.1 112.477 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -112.17 76.09 1.78 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 64.44 110.848 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 166.7 26.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 74.3 112.323 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -148.53 179.86 7.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 71.04 110.867 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 51.87 62.44 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 71.34 110.851 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 16.1 m -79.13 102.99 8.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 65.3 110.878 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.91 140.43 42.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 71.32 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -148.82 155.94 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.954 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.29 43.66 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 72.54 110.914 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.42 42.03 50.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 73.42 112.435 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.24 71.78 1.25 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 71.33 112.477 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 t -156.16 104.52 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 70.23 110.87 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 47.8 t -155.44 138.13 15.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 73.13 110.907 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -103.06 104.03 14.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.911 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.67 44.21 0.91 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 43.41 112.524 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.6 176.31 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 64.24 111.144 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.859 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.859 0.361 . . . . 75.24 111.074 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.09 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 72.52 111.228 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.13 -174.15 4.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 55.51 110.894 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.87 141.62 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 73.31 111.135 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.23 176.13 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 62.41 111.141 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.52 163.77 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.083 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -153.03 147.66 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.55 111.194 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -85.97 146.34 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.845 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.94 9.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 73.32 111.1 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 166.74 12.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 65.51 110.867 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 75.1 111.145 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.72 134.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.847 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 127.54 55.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 74.14 110.79 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.8 p90 -110.51 82.67 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.96 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.57 -85.87 0.63 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 72.34 112.546 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -102.82 -17.46 15.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.846 0.355 . . . . 70.4 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.07 154.31 24.36 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 71.53 112.534 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.41 143.42 31.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 73.54 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 122.87 7.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 63.24 112.467 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 139.13 14.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.746 . . . . 70.52 112.544 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.38 110.4 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 73.15 110.847 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.4 135.27 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 65.13 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -109.95 129.52 55.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 74.33 111.074 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.47 131.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 74.21 111.12 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -141.7 118.25 10.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.972 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.52 143.65 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 72.43 110.9 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 155.65 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.109 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.93 5.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 61.42 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.54 159.12 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 74.05 111.166 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.01 111.143 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -51.57 129.14 25.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.52 110.86 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.05 -176.61 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 73.45 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -141.01 -52.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.904 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 p -154.22 171.09 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 64.13 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -130.63 127.01 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.927 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.4 m -116.25 104.98 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 71.32 111.216 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.3 p -101.4 112.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.41 111.085 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -133.61 141.09 47.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.915 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.72 169.96 16.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.899 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.49 128.03 44.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 64.13 110.846 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.69 77.08 2.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 75.44 110.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -49.63 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 62.33 112.415 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -72.69 145.2 47.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 70.24 111.218 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 98.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 71.21 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -154.58 153.51 31.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.828 0.347 . . . . 74.01 111.098 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -173.68 131.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 71.42 110.917 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.4 t -77.78 106.81 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 75.21 111.204 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -48.65 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 73.12 111.147 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 m -146.47 151.48 37.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 75.21 110.821 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.21 42.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 74.44 111.066 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -142.69 145.24 33.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 72.01 110.978 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.88 13.92 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 73.35 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.95 95.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 71.2 111.137 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.5 m -59.03 97.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.16 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.69 112.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 75.04 111.135 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -102.35 175.01 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 73.21 111.16 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -133.51 157.51 45.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.03 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.5 m -158.69 85.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 73.03 110.854 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.49 0.9 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.24 112.538 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.76 11.75 7.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 74.24 110.835 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -120.45 147.0 45.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 64.33 110.848 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -132.98 142.66 48.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.93 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -141.14 147.12 37.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 72.53 111.131 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.35 140.77 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.153 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.53 159.0 43.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 74.43 110.939 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.45 -52.17 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.89 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.48 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.155 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.52 0.48 75.78 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 75.42 112.467 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -114.5 -22.8 9.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.312 . . . . 70.41 110.881 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -112.48 -47.18 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.44 110.897 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.01 55.04 23.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.668 -0.777 . . . . 71.24 112.542 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -137.04 95.1 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 65.42 111.123 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.18 160.73 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 74.12 110.868 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.59 162.21 64.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.63 0.728 . . . . 73.12 111.058 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 -8.46 23.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.722 2.282 . . . . 74.03 112.346 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.06 115.55 0.89 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 65.13 112.479 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.33 172.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 73.21 111.088 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.1 p -129.2 131.48 47.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 64.43 110.833 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.82 138.42 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.104 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 p -137.22 158.78 43.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.15 110.922 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -148.13 144.68 27.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.77 174.25 15.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.797 -0.716 . . . . 70.31 112.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -174.48 175.09 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 73.11 110.837 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -125.54 134.59 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 74.15 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.0 158.28 23.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.468 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 p -109.84 115.68 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 73.03 110.87 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.84 27.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 52.1 112.439 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -35.6 12.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 74.11 112.387 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.97 31.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.729 . . . . 41.51 112.519 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -112.5 75.45 1.78 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 64.52 110.831 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 155.85 64.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.645 2.23 . . . . 73.52 112.356 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.31 177.12 9.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.42 110.881 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 58.57 41.07 22.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.877 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.2 p -64.45 122.79 17.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.22 110.873 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 134.78 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 73.43 110.92 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.06 149.07 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 73.4 110.94 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 t30 63.05 47.69 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.92 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.23 17.76 73.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.729 -0.748 . . . . 71.23 112.465 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.14 70.67 1.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.68 -0.772 . . . . 74.4 112.497 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.09 104.32 2.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 74.13 110.946 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.6 t -151.8 136.6 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.85 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.17 140.99 50.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.94 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.73 -19.6 23.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 74.41 112.508 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.29 172.14 14.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 73.33 111.122 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.874 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.8 0.333 . . . . 75.34 111.139 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.76 106.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 73.45 111.094 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.03 95.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 74.45 110.859 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.78 137.0 26.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 64.14 111.104 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.2 p -131.65 156.31 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 74.53 111.094 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.5 163.85 34.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.13 111.105 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.99 147.7 30.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.138 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -88.01 146.29 25.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 72.52 110.887 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.18 42.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 52.13 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 156.64 17.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.918 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 -60.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 74.31 111.126 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.58 145.72 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.821 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.64 126.87 53.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.917 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.2 86.1 2.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 75.45 110.875 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.59 -85.86 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 74.3 112.438 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -111.76 -17.6 12.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 72.54 111.126 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.76 151.03 22.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 62.34 112.463 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -131.53 154.95 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 75.41 110.869 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.93 118.86 4.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 71.44 112.508 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.32 148.78 18.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.685 -0.769 . . . . 54.34 112.498 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.95 102.29 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 72.13 110.837 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.18 144.29 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 75.32 110.939 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.7 m -120.52 121.57 38.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 65.52 111.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.09 131.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.11 111.118 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 118.18 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.905 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -111.26 137.76 48.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 73.04 110.909 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 t -172.36 135.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.12 111.098 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.96 -56.73 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.723 . . . . 71.25 112.531 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -63.88 172.26 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 65.23 111.098 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -66.45 -174.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.054 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 t -51.36 127.49 19.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.797 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 -176.52 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 75.4 110.933 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.63 -53.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 62.43 110.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.91 164.84 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.81 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -120.56 126.87 51.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.903 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.8 m -115.74 100.5 8.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.17 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 p -102.15 109.44 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 73.13 111.156 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.91 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 73.51 110.89 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.18 171.93 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 74.1 110.981 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.35 132.02 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.862 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.82 73.65 2.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 72.33 110.898 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -50.23 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 75.33 112.315 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.9 p -72.34 145.77 47.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 75.41 111.098 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.72 97.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.81 -0.71 . . . . 74.43 112.454 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -155.12 156.45 35.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.341 . . . . 72.04 111.078 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.58 131.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 73.42 110.916 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 80.4 t -80.08 103.12 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 71.35 111.18 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -75.38 -36.69 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.182 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.82 150.54 51.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 62.15 110.82 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.8 140.01 16.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.098 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -138.3 149.04 45.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.84 15.75 9.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 64.4 110.883 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.36 108.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.045 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.9 m -66.5 94.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 74.23 111.16 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.17 144.38 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 55.11 111.101 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 m -135.38 141.85 45.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.458 . . . . 74.2 111.209 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.89 155.24 21.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.44 110.927 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.18 85.72 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 70.11 110.878 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.37 -92.77 0.42 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.77 -0.728 . . . . 53.4 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -126.22 20.95 7.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.371 . . . . 72.22 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -134.15 146.45 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 73.13 110.841 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -133.34 150.55 51.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -138.04 149.38 45.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.207 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.25 125.39 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 75.32 111.094 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 134.16 32.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.938 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -111.0 -51.64 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.51 39.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 75.32 111.081 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.49 -0.82 74.13 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 61.24 112.506 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -113.59 -26.02 8.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 75.44 110.957 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -107.23 -47.1 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.52 110.916 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.68 56.24 14.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 60.35 112.481 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.6 p -136.94 95.04 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.339 . . . . 74.03 111.188 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 tt -137.16 160.87 37.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 63.22 110.966 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.92 162.53 64.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 72.4 111.109 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.59 24.0 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 61.14 112.351 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.87 115.75 0.88 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 64.14 112.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.49 172.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 73.34 111.123 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -131.15 131.57 44.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 62.53 110.931 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.7 137.42 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.42 111.076 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.69 154.76 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.9 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -145.31 142.21 29.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.898 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 176.32 17.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.501 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -174.34 179.12 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 75.12 110.872 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -133.8 144.53 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 74.45 110.884 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.92 160.38 28.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.799 -0.715 . . . . 63.44 112.531 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.96 109.63 21.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 74.02 110.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.6 -158.89 28.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 45.14 112.483 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -35.72 11.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 71.22 112.349 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.58 31.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 72.55 112.523 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 m -112.63 76.91 2.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 71.31 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 158.85 55.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.742 2.295 . . . . 73.01 112.35 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 174.76 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 75.31 110.879 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 m120 56.27 47.5 19.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 64.21 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -67.22 95.78 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 143.76 45.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.99 147.76 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 75.14 110.953 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 63.29 52.13 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.862 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.82 19.9 77.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.743 . . . . 74.23 112.458 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.13 68.26 1.33 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 71.42 112.468 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.0 105.07 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.02 110.871 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 t -146.42 141.76 27.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 71.5 110.877 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.88 148.2 47.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 70.34 110.905 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.07 20.22 59.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 71.13 112.512 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -177.12 4.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 75.13 111.15 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.851 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 73.44 111.126 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.497 ' HG1' ' ND2' ' A' ' 97' ' ' ASN . 2.1 t 179.3 116.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.1 111.175 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -139.16 95.23 2.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 73.4 110.885 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.08 132.68 47.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 73.41 111.112 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -109.58 127.2 54.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.187 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -117.31 112.56 20.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 71.01 111.118 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.84 118.7 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 72.14 111.165 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.16 143.75 48.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.923 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.14 161.36 38.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.125 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.17 151.11 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.893 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -63.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 73.4 111.109 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 p -178.79 149.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.903 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.69 126.74 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.21 110.884 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.4 p90 -111.42 87.19 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 72.22 110.933 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.65 -81.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.746 -0.74 . . . . 74.22 112.484 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -117.04 -17.51 10.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 74.14 111.202 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.09 161.57 33.09 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 54.21 112.484 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -143.78 161.07 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 74.41 110.843 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.3 133.38 9.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 65.33 112.527 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 154.45 17.64 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 63.35 112.529 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 t -141.8 95.74 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 73.34 110.854 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -90.24 124.83 35.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 74.52 110.902 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 84.4 m -110.26 101.68 10.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 71.12 111.181 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 131.52 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 72.24 111.172 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -135.7 118.05 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.806 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.21 127.52 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.01 110.947 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -172.71 120.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 55.43 111.165 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.73 -50.9 0.87 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 73.41 112.473 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -75.34 171.97 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 74.52 111.143 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.0 p -64.4 178.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -51.95 107.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 54.34 110.841 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -173.59 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 75.22 110.879 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -143.56 -53.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.88 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 t -138.77 159.44 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 75.1 110.823 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -128.69 127.22 41.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.2 m -134.21 112.12 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 72.14 111.092 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.2 t -101.43 105.65 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.105 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.03 144.44 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.44 110.896 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.92 168.92 19.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.936 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.24 129.36 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 63.41 110.87 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.85 76.62 2.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.609 0.719 . . . . 74.34 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -49.91 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.697 2.265 . . . . 74.41 112.319 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 1.2 p -71.65 144.96 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 75.3 111.147 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.19 98.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 75.15 112.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -154.7 155.4 34.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 74.42 111.137 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.78 130.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 73.31 110.912 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.0 t -80.58 91.76 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.126 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 t -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.34 154.1 50.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.42 110.883 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.37 146.17 25.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 74.25 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -135.99 143.52 44.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.922 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.06 15.25 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.5 109.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.081 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -69.49 103.26 2.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.11 111.089 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.52 137.37 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 63.3 111.091 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -129.25 141.38 51.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 62.12 111.162 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -104.77 156.92 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 74.24 110.907 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -160.47 85.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.942 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.49 -91.97 0.58 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 51.35 112.47 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -126.37 8.17 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 75.12 110.843 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -123.27 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 62.32 110.892 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -128.18 157.52 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.929 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -141.18 149.71 41.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 72.31 111.086 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.59 131.32 48.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.127 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.41 138.22 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.5 110.912 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -117.44 -25.12 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 74.43 110.885 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.1 m -102.77 39.28 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.32 111.157 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.74 2.04 70.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 64.21 112.555 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -33.89 4.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 74.24 110.97 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.5 -55.24 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.907 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.85 47.44 60.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 71.11 112.532 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -127.8 120.3 27.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 74.34 111.115 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.6 tp -146.49 161.01 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.984 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.69 163.23 18.5 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.549 0.69 . . . . 74.42 111.106 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -8.44 23.61 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.672 2.248 . . . . 74.34 112.318 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.72 114.52 0.7 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 44.44 112.517 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.93 172.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 73.54 111.137 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.69 131.45 43.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 64.1 110.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.56 110.17 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 73.45 111.089 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.84 132.84 50.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.867 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.18 132.96 48.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 74.32 110.826 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.29 175.94 19.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 73.11 112.521 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -169.37 -175.31 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 71.31 110.858 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -139.0 138.31 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 63.41 110.893 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.79 163.96 28.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 63.42 112.507 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -105.81 110.33 22.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.32 110.866 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.0 -163.68 36.59 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.817 -0.706 . . . . 75.14 112.537 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -34.2 15.2 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.284 . . . . 65.41 112.309 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.49 26.38 27.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.468 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -112.61 76.27 2.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 75.13 110.861 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 159.93 51.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.628 2.219 . . . . 74.32 112.345 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 t -148.25 174.92 11.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.427 . . . . 75.43 110.908 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.87 54.51 5.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.44 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.94 108.36 3.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 73.13 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 143.89 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 75.22 110.893 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pp -157.08 153.71 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.888 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.497 ' ND2' ' HG1' ' A' ' 2' ' ' THR . 11.2 t-20 55.01 54.9 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 75.51 110.935 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.38 18.92 75.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.719 -0.753 . . . . 73.34 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 70.86 1.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.844 -0.693 . . . . 60.24 112.499 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.44 104.5 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 75.24 110.844 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.1 p -132.2 148.02 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 74.02 110.825 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.57 95.23 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.875 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.48 45.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 74.31 112.524 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.55 171.32 5.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 61.31 111.109 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 71.31 110.827 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.924 0.392 . . . . 65.13 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.1 t -136.07 141.56 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 53.55 111.153 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -160.96 95.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 75.11 110.843 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.93 139.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.111 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -150.13 155.62 40.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 71.44 111.153 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.39 115.52 21.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 74.12 111.084 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 131.56 34.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 70.41 111.155 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -76.23 139.87 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 72.44 110.886 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.32 166.61 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 71.44 111.145 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.91 163.78 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 71.52 110.981 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 -56.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 51.51 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 131.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.76 127.55 55.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 74.1 110.892 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.54 82.18 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.901 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.53 -86.77 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 61.32 112.494 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -101.36 -17.6 16.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 75.42 111.084 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 154.81 24.47 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.725 . . . . 64.43 112.457 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -143.11 143.85 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 75.12 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 120.94 7.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 64.34 112.45 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.83 145.24 17.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.752 . . . . 42.01 112.465 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -140.84 94.7 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 71.31 110.9 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -90.28 122.95 33.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.937 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 101.53 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 72.32 111.124 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -93.47 131.58 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.12 111.195 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -137.89 117.99 13.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.45 110.938 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -111.88 131.3 55.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 75.31 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -168.97 126.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 74.33 111.198 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.65 -19.0 16.75 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.782 -0.723 . . . . 74.44 112.492 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.1 t -95.27 175.2 6.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 75.21 111.102 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -70.17 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 73.12 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.47 108.5 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.11 110.824 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.34 -174.0 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.903 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.0 -54.19 0.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.794 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 159.04 43.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 71.34 110.847 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -128.65 127.1 41.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.914 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -122.61 110.64 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.33 111.205 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.9 105.47 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 73.12 111.176 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -126.35 154.9 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.888 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.2 169.32 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 75.52 110.962 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.14 128.33 44.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 64.13 110.91 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.78 76.82 2.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 72.55 110.946 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -49.78 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.684 2.256 . . . . 71.24 112.292 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.99 145.23 48.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.117 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 75.21 112.475 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -154.58 154.32 32.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.797 0.332 . . . . 74.55 111.15 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.71 130.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 74.32 110.88 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.7 t -79.98 100.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 61.24 111.12 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -45.86 89.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 73.35 111.136 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -144.77 147.43 32.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 71.33 110.946 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.62 161.83 36.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 74.13 111.04 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.47 145.33 31.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.931 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.34 14.65 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.85 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.98 103.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.12 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 m -61.67 94.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.148 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.1 t -91.5 112.43 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.55 111.1 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -106.4 174.57 5.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 73.43 111.088 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.08 156.45 44.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.844 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.02 85.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 62.13 110.845 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.68 -92.48 0.8 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 71.35 112.513 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.2 12.66 7.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 73.05 110.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -124.24 147.01 48.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -131.45 146.33 52.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.904 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -141.53 144.16 34.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -119.96 133.26 55.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 72.01 111.033 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.08 127.65 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.889 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -108.61 -32.05 7.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 65.11 110.91 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -103.72 39.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.083 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.14 2.51 69.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.825 -0.702 . . . . 75.23 112.456 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 -33.97 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.772 0.32 . . . . 74.23 110.979 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.44 -56.1 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.03 43.9 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.49 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -125.66 121.45 33.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.336 . . . . 75.43 111.196 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.68 161.16 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 75.22 110.897 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.14 163.6 18.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 74.32 111.118 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.2 22.98 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.677 2.251 . . . . 73.31 112.322 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.86 114.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 74.21 112.475 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 177.88 172.47 0.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.802 0.334 . . . . 61.44 111.11 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.1 p -128.63 131.3 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 72.0 110.872 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.4 111.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.137 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -110.46 141.56 43.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 54.12 110.892 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -132.58 129.2 38.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 65.21 110.887 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.59 174.48 22.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 62.44 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -174.45 175.95 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 73.55 110.935 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -124.55 126.75 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.872 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.64 151.86 19.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 72.02 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.84 117.3 34.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 73.01 110.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.44 -159.25 28.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 54.22 112.502 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -35.41 12.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.254 . . . . 72.24 112.34 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.85 26.89 30.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 44.41 112.46 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.73 75.15 1.8 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.636 0.731 . . . . 75.43 110.805 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 153.85 68.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 72.3 112.335 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 -177.53 5.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.83 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 52.0 52.49 14.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 73.51 110.819 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.18 128.45 34.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.859 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 123.01 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -133.97 155.75 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.875 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 t30 63.71 38.65 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.855 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.61 30.1 53.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 73.14 112.499 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 75.52 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.801 -0.714 . . . . 73.14 112.508 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.3 104.25 2.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 74.21 110.834 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.71 -173.04 3.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 74.01 110.882 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -127.37 131.66 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.88 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.11 50.47 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.702 -0.761 . . . . 72.45 112.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 m -52.07 103.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 73.2 111.222 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 73.14 110.886 -179.84 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.823 0.344 . . . . 72.3 111.075 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.4 t -146.38 34.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 72.32 111.116 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -171.74 -169.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 75.33 110.884 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.65 132.74 44.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 71.41 111.064 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -149.12 147.73 28.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 62.01 111.105 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.39 151.2 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 72.32 111.096 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.28 142.5 51.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.55 111.119 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -91.03 135.05 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 73.22 110.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.94 147.75 40.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 54.02 111.099 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.77 140.66 29.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 74.35 110.901 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 -56.13 2.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.112 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.96 147.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.823 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.94 126.58 52.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.836 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -111.71 86.55 2.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 75.53 110.96 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.86 -83.13 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 43.13 112.421 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 t -115.79 -17.71 10.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.42 111.15 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.47 164.65 38.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 55.44 112.499 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.06 157.99 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.947 0.403 . . . . 73.23 110.877 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.42 128.97 8.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 62.12 112.506 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.74 148.8 17.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 72.22 112.501 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.45 96.08 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 74.22 110.937 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -89.78 118.52 29.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.73 101.85 13.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 71.34 111.121 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.74 131.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 73.03 111.154 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -133.42 117.96 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.956 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -118.07 101.37 8.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 74.43 110.962 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.5 t -143.89 146.78 33.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.51 111.124 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.42 -65.11 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 75.5 112.563 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.0 p -61.43 167.5 3.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 70.42 111.107 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.12 111.116 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -51.5 123.41 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.904 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -176.02 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 74.21 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.17 -52.46 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.53 110.837 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.99 174.47 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 75.03 110.877 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -140.68 127.24 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 70.24 110.897 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 m -114.75 104.7 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 62.4 111.152 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -101.27 114.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 73.43 111.16 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -134.41 137.02 43.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 65.5 110.916 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.03 173.6 11.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 75.35 110.949 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -98.19 130.97 44.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 74.41 110.806 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.65 74.25 2.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.651 0.739 . . . . 75.4 110.871 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -50.05 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 62.05 112.339 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.6 p -72.77 145.95 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.11 111.207 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 97.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.757 . . . . 70.24 112.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -155.07 154.06 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 73.13 111.122 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 131.18 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 75.14 110.948 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 72.9 t -79.07 102.94 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 72.02 111.154 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -63.66 -40.12 96.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.142 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -148.0 161.98 40.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.883 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 160.65 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 71.35 111.127 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.99 144.51 30.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.34 110.92 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.05 13.97 9.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 73.4 110.833 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.0 99.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 75.02 111.046 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.1 m -59.19 97.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 61.33 111.111 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.02 112.43 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.166 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.9 t -105.12 175.09 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 75.03 111.079 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -136.2 160.03 39.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 71.53 110.871 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -161.02 85.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 74.35 110.866 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.16 -92.09 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.531 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.67 9.89 7.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 70.34 110.8 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -117.74 146.85 43.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.02 110.935 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -133.49 139.78 46.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.966 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 t -140.54 147.8 40.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 64.1 111.098 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.14 143.1 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.54 111.039 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 160.77 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 74.33 110.918 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -131.23 -51.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 73.03 110.895 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.16 38.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 72.44 111.14 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.89 1.51 83.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 64.11 112.511 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.98 -25.2 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 74.44 110.886 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.52 -38.06 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 65.12 110.883 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.56 53.78 23.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 71.44 112.461 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -131.61 94.58 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 74.34 111.186 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.25 160.57 39.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.45 . . . . 75.4 110.96 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.98 161.82 64.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 72.3 111.12 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 -22.9 31.75 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.638 2.226 . . . . 73.31 112.374 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.24 115.47 1.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 74.14 112.466 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.54 172.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.761 0.315 . . . . 73.24 111.07 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -137.86 131.62 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 65.04 110.886 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.42 113.17 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 75.13 111.103 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.2 p -105.19 120.53 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 65.45 110.928 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -104.3 146.0 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.79 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.98 173.39 14.73 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.741 -0.742 . . . . 72.32 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -169.79 175.94 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 73.43 110.912 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 71.01 110.859 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.17 163.53 27.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.725 -0.75 . . . . 73.41 112.444 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -115.62 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 74.23 110.907 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.42 -159.79 30.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 61.41 112.488 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.63 10.46 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.707 2.271 . . . . 73.53 112.346 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.33 26.69 27.4 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 62.22 112.462 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.47 77.05 2.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.636 0.732 . . . . 73.35 110.9 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 162.6 41.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.737 2.291 . . . . 73.51 112.307 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.42 176.1 9.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.85 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 54.16 44.83 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.7 t -64.63 101.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.89 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 143.83 49.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 73.54 110.942 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -155.76 153.07 29.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 110.863 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 58.68 52.04 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.865 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.48 41.26 45.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.73 . . . . 72.01 112.491 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.6 68.74 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.79 -0.719 . . . . 74.45 112.525 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.1 m -156.01 104.48 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 60.51 110.814 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.0 t -153.16 112.77 3.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.3 110.873 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.91 105.96 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 62.11 110.865 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.96 37.4 1.54 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 64.43 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.4 t -86.55 163.68 17.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 72.23 111.131 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 71.44 110.848 -179.812 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.855 0.359 . . . . 73.35 111.071 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.8 p -132.77 173.54 11.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.25 111.141 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -179.45 95.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.44 110.825 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.65 138.43 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 61.23 111.154 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.03 158.71 44.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 73.11 111.212 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 73.21 111.063 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.41 138.83 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 74.53 111.104 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.58 135.29 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.6 168.52 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.52 111.102 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.14 148.07 30.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.897 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.16 -57.62 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 73.53 111.13 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -179.42 132.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.816 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.08 127.13 53.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 74.2 110.845 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.41 90.48 3.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 73.23 110.93 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.97 -94.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 74.04 112.465 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -101.28 -17.63 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 74.3 111.17 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.25 148.15 20.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 63.14 112.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -135.93 148.0 48.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 75.23 110.901 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.94 115.18 4.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 52.5 112.496 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.24 147.35 20.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.698 -0.763 . . . . 53.34 112.494 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.57 98.6 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 73.13 110.855 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.18 123.62 34.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 65.31 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 m -102.84 101.88 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 61.1 111.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.83 131.81 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.17 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.84 123.75 15.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.909 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -119.54 127.58 53.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.93 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.9 t -152.9 170.39 20.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.489 . . . . 70.52 111.088 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.9 28.19 23.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 43.3 112.407 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -128.56 165.03 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 75.13 111.173 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.5 p -67.05 -179.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.423 . . . . 75.02 111.12 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.52 129.86 26.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 64.54 110.831 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.51 -179.97 4.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 73.23 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.97 -53.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 74.43 110.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.52 164.84 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 73.12 110.848 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -125.26 126.98 46.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.91 106.34 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 73.02 111.169 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 105.53 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.12 111.089 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -119.56 153.42 35.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.74 169.11 23.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 75.24 110.886 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.33 128.19 44.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.24 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.37 77.77 2.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 73.33 110.872 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -49.84 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.653 2.236 . . . . 70.3 112.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 19.6 p -72.02 145.31 48.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 75.45 111.141 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.57 98.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 73.21 112.461 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.79 153.39 31.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 74.33 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.67 130.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.42 110.931 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.06 89.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 65.45 111.097 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.3 m -63.62 -39.12 93.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 73.22 111.101 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.32 147.11 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 70.32 110.901 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.92 130.0 17.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 75.52 111.067 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -128.55 142.93 50.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 64.45 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.08 15.19 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.863 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.54 120.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 72.33 111.061 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -79.26 106.33 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 64.41 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.72 140.05 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.133 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 m -128.1 142.08 51.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 75.2 111.148 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.97 156.13 20.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.409 . . . . 73.44 110.874 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.05 85.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.846 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.95 -91.51 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 42.13 112.511 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.36 9.14 7.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.53 110.852 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -122.15 146.75 46.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.33 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -129.7 162.24 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 74.55 110.901 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -149.54 149.67 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.42 111.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.88 128.36 45.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 63.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 153.88 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.918 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -131.2 -51.33 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.23 110.863 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.68 39.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.116 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.75 -0.49 74.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 75.5 112.462 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 -113.79 -29.43 7.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 75.15 110.951 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -104.32 -41.05 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.871 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.02 54.28 23.51 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 74.1 112.5 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -129.43 94.85 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.323 . . . . 75.13 111.156 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.75 160.77 38.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.32 110.925 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.94 161.4 52.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 71.1 111.056 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -8.35 23.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 74.31 112.368 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.88 115.36 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 71.25 112.482 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 179.88 172.27 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 71.43 111.118 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.22 131.47 48.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 65.4 110.841 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.72 119.54 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.14 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -117.19 135.53 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 71.24 110.855 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -130.06 142.05 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.45 110.837 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.7 162.39 12.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 54.33 112.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -156.66 177.84 11.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 73.42 110.913 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -133.24 127.44 33.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.2 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.4 151.79 20.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 64.34 112.512 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -93.57 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 73.21 110.89 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.21 -162.85 35.62 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.666 -0.778 . . . . 74.32 112.423 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -36.09 11.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 74.11 112.371 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.45 25.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 64.51 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m -112.74 76.24 2.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 71.44 110.844 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 155.66 65.26 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.655 2.237 . . . . 73.15 112.324 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -146.68 175.41 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.888 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 51.81 61.91 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.2 110.899 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.04 130.84 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.23 110.876 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.83 143.89 23.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 74.31 110.878 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -151.55 156.51 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 73.22 110.941 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 66.1 42.94 3.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.898 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.85 41.98 61.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 73.11 112.479 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.87 71.97 1.3 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.677 -0.773 . . . . 74.42 112.455 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.28 104.17 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 75.14 110.914 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.87 115.75 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 55.13 110.875 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -79.12 146.93 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 63.25 110.864 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 47.33 10.74 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.749 . . . . 74.32 112.507 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.92 159.87 2.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 72.51 111.173 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 75.32 110.845 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.762 0.315 . . . . 65.43 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.6 p -144.88 83.5 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 74.22 111.167 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 p -172.63 -170.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.813 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.45 134.41 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 43.45 111.123 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.05 168.63 23.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 75.53 111.127 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.84 36.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 73.24 111.09 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -141.32 128.97 21.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -67.03 143.98 56.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.52 110.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.53 156.75 42.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.34 111.127 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -106.74 116.61 32.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 74.02 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 74.14 111.174 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -179.72 141.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 74.03 110.832 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.49 126.32 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 71.32 110.835 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -112.46 107.06 15.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.928 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.21 -91.7 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 73.22 112.492 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -117.45 -17.5 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 63.34 111.171 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.57 147.41 21.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 55.14 112.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -128.53 155.0 45.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 73.43 110.936 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.36 106.94 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 71.35 112.514 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.48 116.94 5.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.724 -0.75 . . . . 60.33 112.454 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -106.85 95.96 6.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 71.02 110.849 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -95.07 121.19 36.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.917 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -100.44 115.74 30.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 74.34 111.195 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.78 132.76 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.106 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.25 141.83 32.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.965 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -119.34 136.57 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.883 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.94 161.12 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 72.15 111.128 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.99 -101.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.792 -0.718 . . . . 73.11 112.467 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.33 177.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 73.21 111.094 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -58.49 -175.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 61.3 111.11 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.92 145.65 9.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 64.03 110.865 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.86 -175.98 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 74.25 110.891 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -28.99 9.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.875 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.8 163.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 71.22 110.848 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -130.26 128.73 42.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.88 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.5 m -152.65 125.53 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.1 111.172 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.26 113.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.121 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -120.79 152.02 38.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 64.43 110.819 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.29 167.2 30.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.54 110.911 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.24 130.03 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.896 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.23 78.5 2.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.63 0.729 . . . . 74.34 110.911 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 -49.82 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.65 2.233 . . . . 74.42 112.319 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' GLY . 21.9 p -72.82 145.27 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 71.43 111.153 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.59 98.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.31 112.45 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 p -154.74 152.77 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 73.52 111.107 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -173.83 131.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.926 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.73 108.18 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 73.33 111.06 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -50.48 70.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.175 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.01 139.61 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 53.11 110.899 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.2 143.85 48.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.088 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -130.96 140.87 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.912 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 t0 65.09 13.43 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.2 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.92 107.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 75.04 111.111 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -61.78 93.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.43 111.145 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.98 121.59 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 72.41 111.192 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -118.18 172.39 7.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.15 111.15 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.43 159.31 39.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 74.4 110.896 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.61 85.76 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.839 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 63.24 112.506 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.27 3.13 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.51 110.845 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -114.72 147.04 40.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 75.34 110.879 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -127.48 160.17 32.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 75.21 110.887 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 m -152.62 149.17 28.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 73.31 111.146 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.99 115.87 15.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 71.31 111.114 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 147.95 50.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.94 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.35 -37.51 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 71.42 110.906 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.3 m -90.21 41.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 73.01 111.12 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.15 70.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 71.23 112.477 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -110.97 -19.57 12.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.74 0.305 . . . . 73.32 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -132.62 -70.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.22 110.882 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.28 -38.33 3.23 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.76 . . . . 41.12 112.425 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -51.43 103.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 71.31 111.077 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.24 160.21 23.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 75.04 110.91 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.61 161.65 77.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.703 . . . . 70.43 111.079 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -15.83 37.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.617 2.211 . . . . 74.31 112.349 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.34 115.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 74.0 112.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.94 172.41 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 74.11 111.12 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -129.39 131.29 46.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 61.53 110.867 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.7 p -127.42 113.96 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.105 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.93 134.66 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.857 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -139.36 137.16 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.886 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.55 170.92 21.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 70.22 112.495 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -159.08 -179.61 8.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.371 . . . . 64.52 110.901 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.25 126.04 44.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.21 110.866 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.78 158.22 22.74 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 75.53 112.458 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.0 m -103.36 109.43 21.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 75.41 110.832 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.73 -161.58 34.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.576 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -36.43 10.84 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.688 2.259 . . . . 74.25 112.324 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.62 27.04 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.701 -0.761 . . . . 74.32 112.432 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.25 76.9 2.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.695 0.759 . . . . 75.51 110.871 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 164.35 34.86 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.238 . . . . 72.44 112.33 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.35 169.59 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 75.34 110.89 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 58.9 56.75 3.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 72.31 110.861 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.1 m -75.74 92.49 3.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 71.35 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.95 120.85 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 74.55 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.91 155.7 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 74.4 110.881 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 62.79 26.7 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.843 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.44 42.77 7.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 52.25 112.447 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.3 70.74 1.11 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.819 -0.705 . . . . 72.11 112.479 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.19 129.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 64.52 110.872 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 p -158.28 167.58 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.4 110.837 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.55 69.91 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.89 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 23.71 45.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 75.32 112.478 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.41 157.35 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 72.14 111.153 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.798 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.896 0.379 . . . . 73.42 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.53 108.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 72.44 111.143 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -117.8 95.43 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.896 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.78 138.65 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 64.52 111.071 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.58 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 70.35 111.112 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.52 152.88 47.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 74.04 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -135.51 121.0 19.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.163 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -65.66 146.33 54.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.871 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.27 160.24 42.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 74.04 111.079 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.3 141.93 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.43 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.67 -62.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 73.04 111.199 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -175.84 135.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.13 110.863 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -119.62 126.65 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 72.51 110.89 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -111.74 97.67 6.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.949 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.82 -92.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 54.5 112.529 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 t -108.15 -17.6 13.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 63.41 111.119 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.21 149.32 22.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 75.41 112.466 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -134.63 150.71 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 75.01 110.87 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.41 113.38 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 70.53 112.473 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.07 147.26 22.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 73.31 112.453 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.66 96.59 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 71.42 110.905 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.23 124.13 34.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 m -101.96 101.91 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.183 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.6 131.87 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.072 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -141.97 128.06 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.53 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -119.4 132.08 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.863 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.55 129.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 64.33 111.188 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -48.31 0.98 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 71.54 112.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.64 176.65 9.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 64.1 111.184 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -174.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 75.52 111.177 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -51.45 125.42 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 75.02 110.923 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.02 -174.74 5.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.14 110.969 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.68 -53.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.846 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.16 171.44 19.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 55.0 110.939 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -129.0 127.03 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 72.31 110.919 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 101.93 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.32 111.138 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 t -101.45 105.63 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 72.43 111.176 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -120.08 151.6 38.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.12 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.42 168.13 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 73.13 110.91 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.31 128.79 44.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.41 110.892 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.44 77.46 2.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.644 0.735 . . . . 74.4 110.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.98 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.717 2.278 . . . . 75.41 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 7.1 m -71.94 145.26 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 70.21 111.162 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.684 -0.769 . . . . 70.02 112.509 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -154.82 153.5 31.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 74.04 111.127 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -173.67 130.63 0.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.33 110.883 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.9 t -79.09 89.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.098 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.25 -39.54 94.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 64.33 111.192 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t -129.52 147.69 51.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.875 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.23 130.06 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 74.22 111.139 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -127.18 144.08 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.967 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.63 15.9 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.884 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.29 121.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.42 111.08 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -78.56 101.9 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.54 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.7 t -87.35 147.23 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 71.43 111.16 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 m -139.1 140.53 38.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 71.2 111.16 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -107.68 157.48 18.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 75.22 110.908 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -160.68 85.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.835 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.29 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 74.31 112.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.18 6.92 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.78 0.324 . . . . 52.04 110.862 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -120.74 146.99 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 65.31 110.853 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -128.9 159.09 36.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.898 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 t -145.99 149.83 34.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 75.31 111.066 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.23 120.31 24.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.078 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 153.62 51.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.18 -51.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 44.44 110.937 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.12 39.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.15 111.181 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.63 -1.07 75.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 63.13 112.489 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -113.76 -25.37 8.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 74.32 110.848 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.75 -47.17 3.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.13 110.857 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.36 56.37 13.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 54.22 112.484 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 96.35 2.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 74.42 111.161 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tt -137.7 160.62 38.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.959 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.34 161.93 75.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.57 0.7 . . . . 64.54 111.1 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.87 24.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.697 2.265 . . . . 74.2 112.41 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.54 118.35 1.08 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 65.12 112.461 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.54 172.02 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 63.4 111.132 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.69 131.57 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.846 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.1 113.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 74.24 111.116 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 p -109.18 125.63 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 61.03 110.883 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -120.46 141.35 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 70.41 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.36 12.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 63.44 112.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -159.68 176.92 11.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 73.22 110.85 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -132.4 125.87 31.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 72.03 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.94 151.44 20.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.731 . . . . 44.02 112.501 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.19 109.55 20.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 72.41 110.88 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.65 -162.67 34.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 73.05 112.495 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.27 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 75.24 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.11 26.6 23.47 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 70.34 112.455 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.2 m -112.67 76.6 2.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.683 0.754 . . . . 73.34 110.879 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.95 55.26 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 74.45 112.298 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.48 174.56 11.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.87 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 m120 51.6 63.6 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 74.32 110.89 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.0 p -82.73 128.63 34.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.34 110.947 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 144.02 23.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.911 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -149.56 156.63 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 72.35 110.9 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 41.77 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.851 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.08 61.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.11 112.478 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.82 71.85 1.3 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 74.41 112.415 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.32 104.18 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 75.24 110.841 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 t -165.95 113.06 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.848 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -75.67 162.26 28.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.888 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.02 37.32 70.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.781 -0.723 . . . . 62.53 112.471 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.6 t -84.33 148.62 26.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 72.1 111.155 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.4 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.84 -179.799 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.865 0.364 . . . . 70.31 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.37 119.52 6.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.14 111.159 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.38 95.41 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 54.22 110.814 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.13 133.39 55.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 75.42 111.108 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 p -114.0 143.82 44.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 64.44 111.103 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -125.3 139.7 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 43.21 111.142 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -134.48 115.76 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.32 111.114 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.54 145.4 54.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.36 164.07 33.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 55.22 111.109 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.23 140.28 40.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.81 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -107.01 -62.42 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 74.53 111.15 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.82 133.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 61.42 110.868 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.79 127.05 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 64.0 110.844 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -111.4 91.44 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.843 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 -93.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 72.31 112.498 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -103.11 -17.61 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 74.42 111.097 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.78 148.58 21.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.805 -0.712 . . . . 75.3 112.406 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -135.53 148.49 49.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 75.32 110.895 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.36 114.19 4.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 53.22 112.446 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.39 148.15 22.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 72.24 112.494 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 t -141.64 98.36 3.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 73.2 110.891 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.23 137.06 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 75.21 110.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.22 107.07 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 73.25 111.175 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.48 131.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.417 . . . . 73.41 111.188 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 123.08 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -112.69 125.92 54.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 71.1 110.916 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -167.27 148.98 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.21 111.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.62 -39.63 2.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 75.33 112.517 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -88.86 169.5 11.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 75.21 111.109 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.7 p -60.66 -172.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 74.43 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -51.49 127.13 19.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 73.3 110.871 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.84 -175.67 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 74.45 110.93 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.63 -53.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.25 -0.432 . . . . 74.43 110.872 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.99 176.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 65.02 110.779 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.1 p-90 -134.53 127.05 30.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 73.32 110.862 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 101.35 7.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.52 111.159 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.3 t -101.01 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.4 111.172 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.02 147.66 43.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 63.1 110.887 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.29 168.18 23.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.891 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.06 129.06 44.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 74.43 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.59 77.52 2.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.712 0.768 . . . . 71.15 110.906 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -50.03 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 73.12 112.321 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.82 145.35 48.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.53 111.14 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.49 98.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 71.21 112.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -154.74 153.78 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 75.14 111.114 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -173.74 130.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 71.41 110.844 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.2 t -79.37 88.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.44 111.11 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.1 m -63.48 -39.0 93.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 73.02 111.162 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.32 145.99 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 74.25 110.837 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.46 130.07 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.112 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -129.4 143.11 50.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.78 15.66 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.39 119.34 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.31 111.074 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -77.55 105.34 8.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.43 111.13 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.0 t -92.95 139.94 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 64.12 111.152 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -131.7 141.62 49.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.122 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -109.51 155.59 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 73.52 110.86 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -158.9 85.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.3 110.836 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.43 -93.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 75.4 112.452 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.44 7.8 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 72.24 110.858 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -121.47 145.39 47.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 73.31 110.844 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -126.3 158.75 34.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.885 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -144.24 150.11 37.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 73.51 111.161 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.32 121.84 26.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 63.44 111.094 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 153.47 51.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 74.1 110.888 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -131.23 -51.51 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.43 39.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 74.4 111.086 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.92 -0.56 75.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 73.44 112.498 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -115.05 -22.36 9.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 65.41 110.901 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.56 -47.2 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 72.51 110.901 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.91 56.81 10.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.818 -0.706 . . . . 71.15 112.483 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 95.92 2.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 72.35 111.121 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tt -137.99 160.64 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 70.24 110.942 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.79 162.0 74.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.614 0.721 . . . . 75.34 111.066 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -17.84 37.04 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.672 2.248 . . . . 72.12 112.37 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.75 115.94 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 63.24 112.535 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.66 172.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 74.14 111.049 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -133.12 131.65 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.03 110.857 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.53 118.06 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 74.31 111.121 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.17 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 75.03 110.877 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -132.16 140.11 48.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.895 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.72 163.4 12.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 72.14 112.448 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -157.75 177.32 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 75.34 110.825 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -133.14 127.68 34.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 73.31 110.896 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.86 151.67 20.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 64.03 112.543 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.88 109.55 20.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 65.44 110.879 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.37 -163.03 35.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 72.15 112.48 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -36.48 10.75 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 75.55 112.353 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.97 26.49 24.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 60.14 112.512 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -112.78 75.94 2.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.636 0.731 . . . . 72.12 110.851 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 155.43 65.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.68 2.253 . . . . 73.22 112.32 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -147.97 169.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 72.44 110.806 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 56.3 65.33 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 72.32 110.862 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.5 t -89.27 104.84 17.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 53.03 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 118.98 27.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.88 155.8 42.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.905 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.74 27.79 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.53 110.871 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.23 42.06 8.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.736 . . . . 72.11 112.543 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.6 70.59 1.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 72.31 112.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.24 132.08 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 70.53 110.877 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.9 t -173.24 135.79 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.871 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -126.82 158.18 37.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 72.34 110.836 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.49 19.55 62.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 74.25 112.482 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.41 -176.61 2.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.32 . . . . 65.33 111.179 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 61.44 110.861 -179.874 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 72.43 111.05 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -129.74 38.27 3.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 72.5 111.186 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -159.18 -176.73 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 64.51 110.873 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.56 135.47 33.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 71.33 111.099 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.17 165.67 29.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 63.35 111.151 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.66 159.38 42.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.1 111.079 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.78 147.72 37.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 73.51 111.126 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -87.23 146.22 26.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.33 175.98 9.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.42 111.115 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.82 156.87 23.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.25 110.92 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.66 -55.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 73.4 111.217 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.41 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.23 110.869 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -116.75 127.61 54.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 72.11 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.71 82.58 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.91 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 72.32 112.471 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -100.99 -17.57 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 75.2 111.128 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.79 156.12 26.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 71.24 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -144.52 145.28 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 75.24 110.855 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 121.14 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.32 112.458 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.37 149.05 19.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 51.42 112.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -141.65 99.1 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 74.12 110.92 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.24 118.85 30.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 74.03 110.985 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -99.97 113.95 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 71.33 111.073 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -106.51 131.77 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 71.41 111.203 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -141.07 118.48 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.827 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -105.8 129.68 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.35 110.868 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -164.89 139.54 5.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 75.43 111.172 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.41 -46.59 3.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.667 -0.777 . . . . 73.12 112.48 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.55 177.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 75.22 111.18 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -79.78 173.12 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 61.51 111.157 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -51.72 109.18 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.848 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -175.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.941 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 m -145.87 -52.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.66 140.97 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 65.22 110.855 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -111.29 127.11 55.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 75.11 110.932 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.3 m -126.18 113.26 16.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.34 111.187 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 t -101.14 105.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 71.41 111.119 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -123.21 154.23 39.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.874 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.72 168.43 26.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.17 130.64 44.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 70.01 110.848 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.09 75.77 2.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.61 0.719 . . . . 74.14 110.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.75 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.745 2.296 . . . . 71.41 112.338 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLY . 43.1 p -71.32 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.44 111.098 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 99.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 72.32 112.513 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -154.46 157.44 38.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 74.33 111.157 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 130.76 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.854 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.61 106.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 73.34 111.084 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -80.09 -36.0 36.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.076 -0.511 . . . . 55.45 111.146 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.42 147.6 49.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.832 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.2 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.085 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -142.65 152.57 42.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.93 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.68 14.51 9.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 72.22 110.84 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.7 113.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.11 111.126 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -65.25 90.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.51 111.111 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.37 112.34 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 72.41 111.114 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -116.26 118.87 33.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.141 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -78.86 161.02 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 74.45 110.933 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.02 85.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.13 110.862 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.29 -88.85 0.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 65.31 112.498 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -126.77 6.64 6.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 72.54 110.831 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -115.22 146.98 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 71.03 110.873 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -135.19 120.2 18.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 72.23 110.959 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 t -121.7 148.15 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.13 111.191 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.6 141.96 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 72.31 111.053 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.45 121.75 7.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.844 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -94.46 -31.66 13.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.898 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.78 38.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 75.45 111.134 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.42 81.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 62.12 112.521 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -115.84 -32.7 5.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.286 . . . . 74.04 110.914 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -102.66 -36.63 8.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.22 110.92 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.28 47.87 41.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 75.23 112.474 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.8 p -124.84 116.89 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 61.31 111.172 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -149.29 161.11 42.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 74.01 110.949 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.11 163.45 17.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.609 0.718 . . . . 73.23 111.113 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -8.1 22.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 74.33 112.346 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.05 114.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 53.24 112.515 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 178.84 172.49 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 73.13 111.098 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -133.37 131.54 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 63.34 110.837 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.3 132.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.22 111.172 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.0 p -127.86 137.98 52.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.862 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -129.53 134.98 48.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.915 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.24 178.57 22.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 61.54 112.487 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -174.58 173.54 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 75.21 110.859 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -124.99 133.93 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.52 110.896 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.41 153.47 23.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 63.42 112.455 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 117.87 35.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 71.01 110.844 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.34 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 72.42 112.499 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.01 13.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 75.35 112.336 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.1 27.18 29.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.762 -0.732 . . . . 74.3 112.464 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -112.48 75.35 1.74 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 60.41 110.896 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 160.04 51.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.641 2.228 . . . . 75.12 112.32 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 m -148.6 175.68 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.1 110.834 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 58.73 53.52 5.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 72.24 110.913 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.6 m -73.44 101.75 3.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 61.53 110.846 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 119.31 22.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 72.21 110.928 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.95 155.74 43.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 71.54 110.922 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 63.73 26.32 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.85 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.76 42.17 7.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 73.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.62 73.95 1.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.552 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 130.04 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 65.43 110.813 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.43 161.1 1.03 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.852 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -127.52 97.78 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.11 110.928 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 41.09 1.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.788 -0.72 . . . . 74.2 112.52 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.44 163.07 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 73.13 111.195 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 73.21 110.861 -179.859 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.859 0.361 . . . . 63.24 111.082 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.8 p -133.71 159.9 39.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 73.25 111.173 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -94.33 102.14 14.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 73.35 110.873 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.12 134.5 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 64.13 111.082 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.05 166.64 29.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 74.14 111.18 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.16 163.86 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.063 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -132.45 147.72 52.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 64.01 111.155 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -86.89 146.29 26.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 61.22 110.961 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.54 147.54 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 72.54 111.144 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.25 145.73 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 71.35 110.88 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 m -105.62 -63.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.181 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.39 127.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.834 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -116.04 127.62 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 75.33 110.859 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -110.53 81.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 64.42 110.971 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.67 -90.09 0.65 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 63.02 112.483 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -97.29 -16.36 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 71.4 111.192 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.14 155.52 23.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.726 -0.75 . . . . 75.43 112.463 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.73 143.72 31.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 71.24 110.888 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.27 115.44 4.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 74.41 112.527 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.2 140.62 24.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 71.55 112.493 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 94.54 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 63.41 110.859 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.03 149.93 22.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 75.13 110.902 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -129.81 108.15 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.141 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.53 132.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 73.24 111.12 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.43 127.07 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.892 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.6 122.61 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.3 110.861 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -172.59 156.7 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.229 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -21.36 17.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.699 -0.762 . . . . 63.53 112.507 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.85 177.18 7.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 63.22 111.196 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -171.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 74.03 111.19 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 120.18 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.12 110.854 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 179.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 75.11 110.896 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -120.8 -32.07 4.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 63.44 110.883 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 p 179.3 160.4 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.878 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -137.89 129.03 27.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.2 110.921 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.7 m -149.81 131.19 14.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 63.14 111.121 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.87 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 64.13 111.067 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.28 135.07 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.861 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.2 173.76 11.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 74.33 110.92 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.16 134.34 41.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 60.4 110.92 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.44 77.73 27.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.669 0.747 . . . . 74.43 110.91 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -49.64 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 73.32 112.358 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 2.3 p -73.09 145.24 46.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.178 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.22 100.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 70.34 112.47 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -154.81 150.56 27.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.346 . . . . 64.53 111.192 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 130.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.15 110.924 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.9 t -84.26 98.03 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.136 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.3 t -63.5 -42.15 98.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 71.52 111.161 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -136.72 145.42 44.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.9 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.48 167.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 74.42 111.128 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -153.31 141.42 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 72.14 110.882 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.36 13.84 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.884 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.35 107.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.096 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -63.26 92.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.23 111.123 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -81.78 112.55 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 71.14 111.135 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -105.1 172.27 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.12 111.056 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -134.19 158.53 43.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.02 110.852 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -162.5 85.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.903 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.63 -92.25 0.6 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 55.41 112.48 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -126.28 15.94 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 74.14 110.899 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -125.42 147.02 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.88 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -133.1 141.58 48.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.955 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.0 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 72.34 111.164 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.09 116.74 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 75.34 111.136 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.09 142.15 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.873 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.84 -35.99 3.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 62.41 110.858 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -92.44 42.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.154 -0.475 . . . . 75.5 111.123 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 2.13 69.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.687 -0.768 . . . . 73.54 112.542 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.63 -33.81 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 75.43 110.905 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.72 -70.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.879 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.96 -38.21 3.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 71.41 112.498 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -52.66 110.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.909 0.385 . . . . 72.51 111.179 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.23 144.23 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.942 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.02 160.38 1.55 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 75.2 111.115 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.747 2.298 . . . . 74.14 112.321 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 115.57 0.66 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.757 . . . . 71.12 112.532 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.55 172.34 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 71.42 111.166 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.24 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 74.5 110.803 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.05 110.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 73.55 111.082 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.0 p -99.83 148.87 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 71.23 110.812 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -146.58 135.12 22.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 72.12 110.917 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.32 177.3 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 71.34 112.434 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -171.64 175.94 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 74.14 110.864 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -122.74 128.31 50.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 75.42 110.929 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.12 149.38 19.6 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 74.23 112.487 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 109.46 21.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 74.5 110.876 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.78 -162.15 34.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 53.01 112.475 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -36.7 10.55 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 73.12 112.349 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.56 26.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 73.51 112.508 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -112.36 77.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.698 0.761 . . . . 73.01 110.883 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 163.5 38.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.713 2.275 . . . . 73.22 112.288 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -148.31 170.23 18.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 55.54 110.86 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.76 50.53 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.866 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.8 m -66.48 96.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 74.41 110.896 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -121.31 143.84 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 75.4 110.899 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.48 155.55 33.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.968 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.4 t30 63.22 39.87 9.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 73.4 110.884 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.06 41.6 11.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.42 112.521 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 63.32 2.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 62.41 112.484 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.5 t -155.99 104.49 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 75.31 110.804 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.1 t -150.41 141.57 23.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 73.43 110.858 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -126.27 157.22 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 75.22 110.808 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.16 -25.02 24.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.76 -0.733 . . . . 74.1 112.456 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.16 171.09 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 72.51 111.204 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 63.15 110.842 -179.882 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 72.52 111.034 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.67 95.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 75.12 111.126 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -176.97 -170.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 72.23 110.856 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.63 134.59 34.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.098 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.51 171.35 14.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 75.35 111.116 -179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.79 163.44 39.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.43 111.077 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -140.68 141.69 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 73.45 111.137 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -79.38 140.45 37.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 71.45 110.891 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.41 162.19 35.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 62.02 111.129 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.29 154.54 22.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.852 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 -58.66 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 71.11 111.159 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.8 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 43.42 110.878 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -115.45 127.92 55.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 72.22 110.874 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.65 81.76 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.978 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.64 -87.27 0.63 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 73.43 112.473 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -100.32 -17.59 17.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 73.21 111.168 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 155.55 25.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 52.13 112.488 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -143.6 143.04 31.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 75.51 110.895 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.85 115.81 5.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.705 -0.76 . . . . 75.3 112.479 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 143.84 17.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.696 -0.764 . . . . 62.13 112.542 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.1 m -144.22 95.48 2.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 72.44 110.844 -179.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.44 132.56 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.116 -0.493 . . . . 71.24 110.885 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.4 m -110.61 117.45 33.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.141 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.72 131.94 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.44 111.152 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -138.01 136.98 37.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 70.14 110.865 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.93 136.48 54.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.874 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -167.53 162.23 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.5 111.176 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.37 -98.12 2.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 64.51 112.524 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 p -56.34 170.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 71.12 111.134 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 p -59.4 -175.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 75.34 111.176 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.2 144.45 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 71.43 110.792 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.44 -174.61 5.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 75.31 110.912 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 -27.64 6.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.847 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t 178.88 154.92 0.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.52 110.896 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -125.05 129.41 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 75.11 110.921 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.6 m -152.42 122.0 6.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.166 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 t -101.72 110.68 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 74.31 111.182 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -117.66 152.4 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 63.15 110.88 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.23 20.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 73.31 110.911 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.98 131.67 44.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.874 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.8 74.05 2.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.659 0.742 . . . . 74.03 110.85 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.691 2.261 . . . . 74.11 112.34 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -74.18 145.79 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.23 111.128 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.36 98.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 64.44 112.513 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 p -154.9 154.62 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.332 . . . . 73.34 111.166 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.76 131.13 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.408 . . . . 75.23 110.931 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.0 t -76.1 104.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.13 111.078 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -47.89 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.178 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -144.39 152.37 40.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 63.33 110.87 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.17 162.47 35.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 70.32 111.074 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -146.99 144.95 29.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.988 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 64.05 15.18 9.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 62.45 110.85 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.55 104.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.02 111.127 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 m -61.8 93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 72.54 111.201 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.22 112.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 71.15 111.084 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -113.44 164.28 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.52 111.172 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -121.79 160.98 23.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.942 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -159.26 85.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.799 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.72 -93.27 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.756 -0.735 . . . . 65.42 112.442 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -126.54 11.42 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 75.42 110.877 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -123.53 147.03 47.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 72.25 110.864 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -127.98 156.32 42.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 74.55 110.936 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 t -150.35 148.7 29.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 64.05 111.149 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.97 119.95 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.25 111.083 179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.32 144.4 40.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 72.24 110.881 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -123.08 -35.06 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.42 110.901 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -89.6 41.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 74.34 111.124 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.69 1.92 70.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 72.41 112.523 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.44 -21.49 11.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 74.14 110.918 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -129.54 -70.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 64.24 110.898 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.65 -38.07 3.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 70.51 112.535 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -50.74 107.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 62.13 111.097 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tp -123.69 146.93 47.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.993 179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.53 160.31 26.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 64.12 111.06 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.8 -8.43 23.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 75.24 112.319 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.9 116.03 0.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 62.55 112.436 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.17 172.13 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.868 0.366 . . . . 64.44 111.072 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.68 131.33 43.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 62.1 110.85 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.25 109.9 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 72.41 111.114 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 t -109.98 134.38 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 61.23 110.88 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -123.47 134.88 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 74.45 110.899 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.3 175.52 19.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 70.13 112.532 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -174.84 175.87 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.933 0.397 . . . . 75.55 110.899 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -124.97 125.89 44.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 75.31 110.873 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.56 152.98 17.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 62.35 112.496 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.82 109.49 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 54.41 110.814 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -158.02 27.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.21 112.449 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -37.26 9.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 71.0 112.409 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.24 27.04 29.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.443 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.71 78.92 2.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 71.4 110.849 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 171.79 13.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 74.21 112.374 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -148.5 170.4 18.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.818 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 54.52 52.13 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 63.55 110.934 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.8 m -68.75 92.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 71.43 110.845 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.86 144.0 49.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.13 110.87 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.12 156.79 44.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.42 110.884 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 66.43 32.63 7.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.845 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.79 42.41 25.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 30.31 112.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 71.58 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 73.32 112.517 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.52 130.57 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.821 0.343 . . . . 73.44 110.841 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.26 150.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 75.13 110.811 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -127.49 90.98 3.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.12 110.836 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.61 33.36 1.59 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.739 . . . . 63.22 112.45 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 t -79.73 162.37 25.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 73.54 111.083 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.844 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.91 0.386 . . . . 70.13 111.093 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -89.21 134.36 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 74.52 111.099 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -97.17 95.31 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 73.13 110.833 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.18 139.17 51.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 73.25 111.122 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.57 155.47 32.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.22 111.129 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.92 163.93 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 63.41 111.105 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.38 144.89 27.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 74.31 111.164 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.41 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 75.05 110.93 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.45 152.56 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 64.42 111.094 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.03 146.66 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 73.14 110.965 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.29 -59.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 70.32 111.092 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.4 138.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 73.5 110.876 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.13 127.43 54.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 75.4 110.83 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.67 92.97 4.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.927 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.25 -90.34 0.71 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 75.01 112.504 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 t -110.6 -17.55 13.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 73.41 111.176 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.6 146.76 20.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.761 -0.733 . . . . 75.15 112.466 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -125.42 149.72 47.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 74.34 110.87 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.99 110.41 3.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.76 . . . . 74.12 112.499 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.75 142.62 21.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 71.44 112.454 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -139.54 94.66 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 63.03 110.839 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -90.37 149.28 22.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 75.44 110.933 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m -128.18 132.01 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.17 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.37 132.42 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 74.33 111.095 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -142.38 129.17 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.933 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -104.53 148.99 25.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 71.24 110.851 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.4 t -172.57 162.59 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.155 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.89 -77.04 1.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 74.53 112.489 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -57.91 172.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 73.35 111.146 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.1 p -68.43 -172.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 65.13 111.059 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.12 122.79 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 72.04 110.842 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -62.79 169.18 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 75.44 110.905 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.4 -16.89 10.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.43 110.798 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.87 147.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.45 110.815 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -124.62 129.76 51.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.33 110.893 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -151.24 123.26 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 74.02 111.083 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.69 105.83 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 70.14 111.092 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.21 151.09 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.21 110.925 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -151.03 171.17 17.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 73.4 110.926 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.95 130.25 44.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 72.35 110.856 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.59 73.67 2.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.717 0.77 . . . . 64.31 110.943 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -50.07 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.727 2.285 . . . . 65.3 112.39 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -72.77 145.59 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.42 111.134 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.16 98.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.714 . . . . 45.11 112.482 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -155.03 154.9 33.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 51.5 111.123 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -173.58 131.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 73.14 110.916 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -78.8 107.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.1 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 m -62.87 -49.54 74.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.116 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.28 140.42 27.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 72.31 110.871 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.13 137.16 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 71.03 111.08 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -121.52 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.88 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.53 12.62 8.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 71.02 110.907 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.16 102.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.22 111.151 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -60.05 95.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.51 111.153 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -90.37 112.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 75.32 111.149 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.3 t -106.52 177.49 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 72.41 111.128 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -133.46 160.55 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.838 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -160.37 85.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 74.5 110.884 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.74 -93.3 0.83 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 45.51 112.45 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -126.53 14.55 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 75.23 110.857 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -126.94 146.89 50.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.12 110.861 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -129.45 155.95 44.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.908 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.8 t -149.02 143.45 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 62.45 111.127 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.4 122.73 41.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.11 111.095 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 137.79 34.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.878 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -119.41 -30.52 4.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.944 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 m -90.99 42.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 74.42 111.152 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.11 2.97 67.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 73.3 112.511 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.27 -34.08 4.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 74.3 110.881 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.79 -70.24 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 74.12 110.881 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.0 -37.75 3.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 72.13 112.509 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -49.43 117.41 2.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 71.12 111.156 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.46 131.79 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 73.22 110.957 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.87 160.65 5.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.566 0.698 . . . . 70.15 111.099 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -16.14 37.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.693 2.262 . . . . 73.02 112.284 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.51 115.44 0.77 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 70.22 112.533 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.08 172.54 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 64.32 111.084 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.83 131.16 56.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 51.42 110.781 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.23 109.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 72.11 111.118 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 m -113.53 164.38 13.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.867 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.88 134.27 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.901 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.55 177.25 19.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.433 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -174.43 178.31 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 73.12 110.939 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -130.96 125.85 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.11 110.85 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.04 155.34 20.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.44 112.527 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.26 109.65 22.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 71.12 110.859 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.14 -157.58 27.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 71.03 112.495 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -39.0 7.03 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.231 . . . . 73.34 112.372 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.6 32.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 64.44 112.477 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 75.78 2.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.661 0.744 . . . . 72.13 110.903 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 160.61 49.05 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.725 2.283 . . . . 72.55 112.297 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 m -148.32 171.37 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.01 110.878 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 63.35 53.42 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.24 110.85 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.14 126.72 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.89 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 118.77 6.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.34 110.907 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.24 155.64 45.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 75.51 110.889 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.56 36.58 19.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 74.02 110.937 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.28 55.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 65.43 112.516 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.5 69.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 60.13 112.45 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 t -156.18 104.26 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 70.21 110.873 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.1 t -156.57 112.48 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 72.03 110.871 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.49 112.25 5.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 64.01 110.907 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.58 50.62 0.52 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.743 . . . . 74.21 112.519 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 t -52.02 163.56 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 72.33 111.097 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.881 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.878 0.37 . . . . 70.43 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m -155.58 108.96 2.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 73.51 111.089 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.49 95.26 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.817 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.77 152.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 64.45 111.158 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p -146.97 163.02 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 63.25 111.14 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.27 163.84 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 71.01 111.09 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 142.99 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 65.55 111.198 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -94.35 125.75 39.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 72.12 110.852 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.48 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 71.34 111.117 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 170.21 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 73.33 110.863 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 -59.12 0.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.093 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.48 135.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 61.41 110.923 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.43 127.53 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 71.35 110.867 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.46 83.34 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.175 -0.466 . . . . 73.44 110.95 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.87 -86.32 0.66 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.72 -0.752 . . . . 61.11 112.533 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -103.97 -17.45 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 75.42 111.122 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.38 153.66 24.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 74.3 112.464 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -140.56 143.9 35.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 73.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.3 127.26 9.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 73.33 112.447 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.82 132.21 10.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 64.34 112.453 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.91 103.71 7.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 61.13 110.87 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -92.11 141.27 28.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 74.54 110.973 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 m -118.55 127.45 53.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 74.32 111.082 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.91 131.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.13 111.16 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -144.16 119.08 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -111.94 133.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.86 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -172.7 129.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 71.21 111.08 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.53 -19.49 19.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 65.41 112.445 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.39 177.1 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.381 . . . . 73.51 111.118 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -67.98 174.83 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 64.13 111.191 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 t -51.37 118.93 3.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.825 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -176.14 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 72.01 110.917 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -142.66 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 72.44 110.927 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -152.38 147.52 26.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 74.24 110.863 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -110.36 126.44 54.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.905 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -118.86 108.61 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 63.14 111.149 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 p -101.46 109.56 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 74.31 111.116 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.22 136.92 47.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.875 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.01 172.19 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.992 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.93 130.42 44.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 75.44 110.855 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -111.51 80.1 2.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 71.52 110.829 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -48.59 0.68 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.729 2.286 . . . . 71.22 112.328 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -74.65 144.73 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 71.31 111.118 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.87 96.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.718 -0.753 . . . . 72.24 112.416 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 99.5 m -156.81 137.84 13.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 75.12 111.119 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -151.95 131.2 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 72.42 110.865 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.4 t -72.37 102.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.158 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -62.89 -46.78 86.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.104 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.64 147.77 34.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 61.24 110.885 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.17 144.31 40.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.062 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -129.41 142.59 50.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.05 110.91 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.42 13.04 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.816 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.2 92.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.31 111.08 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -55.39 99.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.55 111.086 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -94.47 112.6 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 73.32 111.118 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -102.59 175.43 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 64.13 111.16 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.33 157.34 45.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 71.34 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -159.25 85.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.883 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.69 -92.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 51.25 112.42 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.95 9.89 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 75.33 110.888 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -120.09 146.89 45.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.871 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -132.3 146.57 52.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.911 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -143.05 148.48 36.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.25 111.129 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.96 141.75 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 70.35 111.155 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 160.8 39.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 72.04 110.952 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -132.02 -52.43 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.842 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.8 p -108.07 39.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.117 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.76 4.68 56.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 75.32 112.512 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -111.46 -25.68 9.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 74.42 110.82 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.11 -38.73 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.32 110.874 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.32 56.87 8.71 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.792 -0.718 . . . . 64.42 112.495 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -135.07 94.85 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 75.33 111.198 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.3 160.96 36.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.939 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.2 162.76 47.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 75.45 111.051 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 65.43 112.352 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.88 115.59 0.94 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.727 . . . . 65.31 112.499 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.7 172.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 54.23 111.079 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 p -133.18 131.55 40.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.34 110.831 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.14 136.17 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.3 111.163 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -132.99 149.11 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.866 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -139.43 156.47 46.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.13 110.873 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.84 175.47 18.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 54.3 112.467 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -173.41 -176.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 73.44 110.871 -179.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -139.39 125.88 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 74.05 110.876 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.94 17.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 61.23 112.559 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.84 111.22 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.372 . . . . 71.15 110.838 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.56 26.54 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 62.13 112.456 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -40.27 5.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 72.2 112.337 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.59 27.56 21.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 73.03 112.526 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -112.07 76.07 1.72 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 73.4 110.859 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.41 57.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.643 2.229 . . . . 71.05 112.313 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.55 172.41 14.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.871 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 58.1 50.2 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 72.4 110.882 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.51 104.05 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 75.42 110.884 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.1 143.97 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.874 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 pp -160.32 146.61 15.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.938 179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 61.0 t30 60.83 55.33 3.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.852 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.1 39.81 36.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 63.31 112.418 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.44 62.91 5.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 73.22 112.493 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.3 107.74 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 71.42 110.935 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.12 138.51 25.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.979 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -118.53 147.28 43.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 70.22 110.814 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.08 -27.32 19.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.746 . . . . 73.54 112.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -170.26 159.38 7.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.77 0.319 . . . . 74.13 111.17 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 71.31 110.907 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.908 0.385 . . . . 74.22 111.154 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.96 141.65 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.106 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -143.47 95.26 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 73.12 110.846 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.57 132.73 44.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.5 . . . . 74.2 111.133 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.89 147.8 37.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 65.31 111.11 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.63 163.85 32.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 74.13 111.14 179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -152.15 132.52 13.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.175 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -73.66 146.06 44.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 72.32 110.901 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.46 170.99 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.35 111.093 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -120.96 134.64 55.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.962 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 -60.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 73.21 111.191 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.47 145.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.869 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.59 125.99 49.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 72.24 110.819 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -112.28 102.23 10.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.972 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.22 -92.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.756 -0.735 . . . . 64.33 112.513 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -118.24 -17.47 9.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 72.13 111.04 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.68 117.93 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.792 -0.718 . . . . 73.42 112.45 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -99.06 156.74 16.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 71.03 110.847 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.71 109.22 2.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.761 -0.733 . . . . 75.42 112.424 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.67 141.13 20.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.742 . . . . 62.43 112.457 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.12 98.75 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 72.21 110.849 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -90.17 123.75 34.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.955 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 m -96.06 119.98 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 74.13 111.026 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.66 131.64 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.086 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -139.44 118.15 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 74.01 110.899 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.49 119.21 38.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.35 110.836 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.4 t -172.18 143.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 62.04 111.166 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.45 -30.83 7.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.467 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -100.8 173.58 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.351 . . . . 75.23 111.109 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 p -62.05 -174.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 74.22 111.124 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -51.36 121.97 7.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 72.53 110.807 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 -175.7 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 75.3 110.918 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -143.55 -53.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 65.23 110.882 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.31 166.6 32.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.845 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -122.94 126.64 47.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.519 . . . . 74.43 110.934 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 m -120.78 100.86 7.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 72.52 111.14 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.8 119.17 50.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 71.32 111.151 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.41 141.22 49.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.35 110.838 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.85 167.61 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.914 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.08 130.07 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 71.41 110.826 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.76 76.21 2.1 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 73.03 110.93 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -50.06 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.694 2.263 . . . . 72.5 112.343 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 73.23 111.143 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.31 97.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 74.41 112.486 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.64 155.74 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 75.14 111.12 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.74 130.59 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.862 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -79.92 99.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 73.42 111.189 179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -62.99 -44.68 95.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 72.11 111.186 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m -143.64 159.97 41.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.892 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.04 144.73 25.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 73.14 111.062 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -128.44 146.36 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.887 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 14.94 9.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.831 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.44 120.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 64.22 111.057 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -78.65 108.15 11.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.53 111.109 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.73 147.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.133 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -139.68 141.42 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.151 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.46 153.36 24.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 63.24 110.951 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -157.07 85.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 53.4 110.808 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.7 -93.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 73.33 112.489 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -126.46 6.31 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 74.43 110.876 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -120.09 145.7 46.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.812 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -126.79 152.87 46.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 75.44 110.894 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -138.48 150.4 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 74.3 111.111 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.86 125.9 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.111 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 141.04 32.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 74.32 110.928 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -116.99 -52.07 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.908 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.82 39.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.128 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.29 -1.59 70.26 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.753 -0.737 . . . . 75.21 112.432 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.47 -30.96 6.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 71.34 110.93 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -101.55 -47.06 4.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 73.53 110.931 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.39 55.77 18.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.488 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 t -132.65 94.8 3.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 74.33 111.128 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.64 160.9 37.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 75.23 110.896 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.39 162.5 56.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 75.33 111.164 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -8.36 23.41 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.61 2.207 . . . . 75.54 112.359 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.89 115.72 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 73.42 112.501 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.96 172.14 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.375 . . . . 71.21 111.02 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -145.51 131.68 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 73.11 110.761 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.07 149.19 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 75.15 111.111 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 p -130.52 135.93 48.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.874 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -122.79 135.18 54.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 73.3 110.862 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.86 178.26 20.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 64.34 112.491 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -174.26 -179.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 72.24 110.882 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.03 149.66 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.893 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.67 157.36 27.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 73.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 m -102.48 109.62 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 65.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -160.73 30.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 75.23 112.522 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -38.36 7.95 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.647 2.232 . . . . 75.53 112.359 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.2 26.68 27.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 63.13 112.515 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.78 75.27 1.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.1 110.854 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 160.69 48.75 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.59 2.193 . . . . 64.2 112.372 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 p -148.52 161.71 41.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 70.45 110.9 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 62.99 65.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 64.23 110.832 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.9 t -91.4 94.05 9.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 73.31 110.946 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 118.73 35.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 75.11 110.882 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -126.72 155.81 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.04 110.93 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.9 19.94 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 65.14 110.892 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.88 4.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.467 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.7 71.28 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 71.52 112.484 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -156.25 104.17 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.02 110.851 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -160.75 112.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 72.53 110.905 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.18 164.95 12.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 62.21 110.869 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.07 37.61 80.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 62.43 112.461 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.6 p -150.83 -176.39 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 71.34 111.154 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.22 110.826 -179.83 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.882 0.372 . . . . 75.14 111.12 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -145.01 43.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 64.05 111.181 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 p -157.73 -175.6 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 55.13 110.801 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.93 143.64 26.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 73.04 111.14 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.5 p -136.96 149.58 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 71.12 111.141 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.64 163.82 34.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 64.25 111.132 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 m -153.5 147.7 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.161 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -80.61 144.27 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 75.1 110.898 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.18 165.16 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 73.13 111.135 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.09 136.24 50.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 72.41 110.924 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m -101.22 -68.3 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 74.42 111.125 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.85 138.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 73.43 110.909 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.24 126.24 51.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 74.23 110.919 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -111.92 105.74 14.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.24 110.948 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.44 -91.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.807 -0.711 . . . . 71.15 112.499 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -117.26 -17.49 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 71.54 111.223 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.76 146.87 20.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 63.4 112.424 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -128.85 145.73 51.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 72.3 110.851 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.17 109.69 3.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.752 . . . . 74.23 112.47 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.78 133.09 11.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.471 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.05 99.28 6.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 71.04 110.865 -179.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -90.24 129.73 36.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.41 110.916 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -105.99 128.16 53.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 55.14 111.077 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 t -133.19 132.6 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 73.14 111.176 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -143.89 138.12 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.5 110.923 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -119.44 131.24 55.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 71.23 110.855 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -159.0 161.0 36.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.13 111.155 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.37 -58.57 4.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 73.54 112.471 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 t -62.73 161.18 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 63.11 111.097 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 p -57.87 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 61.43 111.163 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -54.07 123.05 11.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 74.21 110.805 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.73 151.97 43.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 65.12 110.95 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -116.51 -18.19 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 61.25 110.874 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.48 151.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 73.13 110.86 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -132.37 127.64 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.98 179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.0 m -142.92 124.95 15.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 74.14 111.147 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.4 t -110.38 105.8 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.23 111.132 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.17 150.98 37.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.871 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.43 166.54 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.941 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.17 132.69 43.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 73.14 110.84 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.02 76.23 2.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.635 0.731 . . . . 75.24 110.859 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.251 . . . . 63.33 112.31 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 55.9 p -70.4 145.37 51.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 74.02 111.168 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.53 97.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.793 -0.718 . . . . 60.11 112.386 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.72 157.7 38.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.372 . . . . 73.11 111.134 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -173.59 130.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.1 110.934 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.2 t -84.17 104.14 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 71.41 111.17 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -47.39 83.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 73.33 111.185 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -141.51 164.43 30.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 73.41 110.926 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.87 140.71 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.05 111.13 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -127.57 143.6 51.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.957 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.31 14.86 9.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 64.15 110.892 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.62 100.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.151 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.9 m -60.43 95.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 74.5 111.112 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -87.29 134.26 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.114 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -124.28 170.09 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.04 111.156 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -131.33 154.2 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.93 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 t -159.42 85.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.5 110.845 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.82 -94.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.684 -0.77 . . . . 64.42 112.513 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.29 14.36 7.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 72.32 110.886 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -128.69 146.84 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.805 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -129.0 164.07 24.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 74.02 110.855 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.7 m -152.67 144.13 23.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.143 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.49 123.61 41.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 73.41 111.122 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.55 139.22 40.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.906 179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.76 -37.74 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 65.33 110.916 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.98 42.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 71.31 111.115 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.56 2.0 69.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.703 -0.76 . . . . 72.01 112.492 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.86 -33.84 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 74.44 110.921 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.68 -71.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 71.01 110.952 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.71 -38.18 3.23 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 75.44 112.523 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -50.95 113.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 74.24 111.149 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -141.15 133.07 27.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.866 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.06 160.36 1.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.512 0.672 . . . . 75.1 111.155 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.69 -15.93 37.58 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.672 2.248 . . . . 74.4 112.394 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.58 115.61 1.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.8 -0.715 . . . . 72.24 112.495 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.58 172.39 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.793 0.33 . . . . 62.13 111.073 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.62 131.24 52.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.801 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.1 p -129.48 118.78 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 111.128 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.99 138.59 52.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.13 110.872 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -138.2 136.31 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 71.42 110.911 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.57 -178.62 19.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.502 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -174.47 175.72 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 74.1 110.861 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.54 127.03 45.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 65.44 110.912 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.15 157.48 21.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.42 112.507 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -108.16 109.44 20.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 75.12 110.899 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.54 -158.74 29.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 72.33 112.502 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -35.22 12.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 73.35 112.327 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.97 26.78 28.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 64.42 112.448 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.22 76.49 1.89 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.588 0.709 . . . . 53.14 110.846 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 160.72 48.65 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.675 2.25 . . . . 71.33 112.299 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -148.53 174.21 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.41 110.891 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 51.88 64.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 71.13 110.921 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.8 t -86.51 130.3 34.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.894 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 144.0 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.14 110.946 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.67 156.73 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.89 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 67.28 40.51 2.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 71.13 110.895 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.09 42.13 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.677 -0.773 . . . . 72.5 112.543 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.31 71.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 55.53 112.493 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.6 138.03 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.341 . . . . 74.33 110.906 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.1 p -175.61 129.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 71.14 110.884 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.45 106.4 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.886 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.36 34.24 1.97 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 74.14 112.537 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.09 178.66 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.323 . . . . 74.21 111.091 -179.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 63.12 110.859 -179.818 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.891 0.376 . . . . 64.33 111.076 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 t -156.29 160.64 39.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 62.45 111.126 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.5 96.03 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.828 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.61 142.0 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 53.42 111.139 179.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -122.58 151.65 41.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 75.01 111.098 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.8 154.76 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 52.31 111.1 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 111.93 11.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 72.35 111.114 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -74.7 126.69 31.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 74.31 110.915 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.3 161.34 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.07 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.09 155.21 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.54 110.908 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.09 -57.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.101 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.38 130.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 74.54 110.825 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.91 127.51 55.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.843 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -110.5 82.05 1.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.901 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.74 -87.28 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 72.11 112.464 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 t -100.69 -17.55 16.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.73 0.3 . . . . 73.32 111.095 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.15 155.94 25.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.53 112.516 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.43 143.44 30.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 75.23 110.936 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 117.34 5.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 62.51 112.524 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 151.91 20.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.773 -0.727 . . . . 74.34 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.79 96.56 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 75.33 110.926 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -90.09 136.29 33.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 75.4 110.886 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -114.72 101.9 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 71.32 111.124 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -88.88 131.72 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 75.04 111.119 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.75 128.19 36.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.15 110.868 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.43 132.24 54.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.21 110.899 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -172.07 121.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.11 111.138 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.74 -80.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 62.22 112.421 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.51 168.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.338 . . . . 74.45 111.228 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 p -60.54 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 74.55 111.144 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.92 121.73 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 72.13 110.827 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.36 126.16 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 72.25 110.87 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.96 -23.99 28.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.876 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.0 170.13 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.825 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -136.04 136.71 40.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.906 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.4 m -152.69 144.23 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 71.1 111.222 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.91 105.83 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 72.33 111.147 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.9 134.24 55.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.911 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.08 173.32 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.849 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 130.35 44.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 75.14 110.906 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.45 73.92 2.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.647 0.737 . . . . 72.23 110.865 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.16 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 74.15 112.302 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.1 p -73.05 145.72 46.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 70.0 111.13 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 98.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.826 -0.702 . . . . 74.13 112.456 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -154.92 154.62 32.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 72.21 111.106 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 130.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 70.34 110.928 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.0 t -77.92 108.5 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 74.1 111.116 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -45.9 70.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 73.25 111.143 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -141.67 157.0 45.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 70.3 110.842 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.06 157.39 40.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 75.1 111.163 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -141.0 146.61 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.911 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.23 14.81 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.42 110.845 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 105.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 62.22 111.149 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -65.48 90.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 65.51 111.132 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -80.9 118.42 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.122 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -110.9 175.14 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.085 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -134.21 160.15 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.86 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.17 85.88 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 75.35 110.866 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 -92.73 0.57 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 71.11 112.444 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -126.03 17.36 7.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 73.41 110.953 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -128.57 146.83 50.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.489 . . . . 73.2 110.809 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -132.13 150.08 52.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.7 m -142.49 145.25 33.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 72.3 111.119 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.88 114.66 21.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 75.13 111.084 179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 136.25 48.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.859 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.56 -51.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.95 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.66 40.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.12 111.152 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.22 -0.71 54.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 51.4 112.433 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.44 ' CE3' ' HB2' ' A' ' 70' ' ' ASN . 3.5 p-90 -104.44 -27.83 11.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.778 0.323 . . . . 72.12 110.899 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.44 ' HB2' ' CE3' ' A' ' 69' ' ' TRP . 12.7 m-20 -132.89 -70.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.899 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.3 50.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 41.3 112.488 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.4 t -73.3 94.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 72.11 111.152 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.54 151.45 44.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.855 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.99 163.52 0.84 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.576 0.703 . . . . 64.43 111.115 179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -8.14 22.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 72.14 112.327 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.22 115.75 1.81 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.524 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.48 172.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 70.44 111.083 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -137.22 131.71 32.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.23 110.919 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 t -143.42 110.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.33 111.068 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.0 p -103.99 135.0 46.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.905 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -118.39 126.44 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.82 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.81 173.59 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 74.15 112.495 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -174.73 176.62 2.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.34 110.865 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.99 125.82 40.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.54 110.862 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -125.27 161.79 19.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.781 -0.723 . . . . 73.42 112.573 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 t -109.32 110.28 21.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 74.44 110.918 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.53 -158.7 28.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 74.12 112.435 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -36.08 11.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 70.04 112.382 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.83 27.08 30.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -112.36 77.02 2.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.728 0.775 . . . . 74.42 110.841 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 168.46 21.49 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.729 2.286 . . . . 63.53 112.335 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -148.43 169.17 20.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 75.25 110.84 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.07 48.92 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.818 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.2 m -65.46 96.53 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 72.32 110.897 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -121.2 121.29 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 74.55 110.937 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.74 155.71 38.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 65.13 110.957 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.33 27.22 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.866 179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.06 42.05 7.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 51.11 112.493 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 70.1 1.12 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.701 -0.762 . . . . 63.13 112.469 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 131.59 9.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 71.22 110.85 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.4 172.9 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.884 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.26 83.13 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 73.54 110.889 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.06 48.03 0.68 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 72.32 112.49 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -70.72 154.96 41.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 74.43 111.112 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 62.21 110.885 -179.897 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.86 0.362 . . . . 42.32 111.149 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.78 172.92 6.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 71.34 111.102 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 m -164.7 95.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.3 110.906 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.78 134.61 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 71.45 111.094 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p -145.4 168.91 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.43 111.107 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.98 123.55 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 73.33 111.069 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -99.07 139.61 34.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.209 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.56 143.86 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.9 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.77 154.97 43.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 65.53 111.063 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.49 144.51 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 75.32 110.876 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 -59.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.171 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -179.99 149.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 55.2 110.896 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -117.73 126.46 52.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 73.33 110.898 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -111.74 86.71 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 75.44 110.916 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.94 -82.15 0.87 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 74.21 112.498 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -117.35 -17.56 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 72.11 111.136 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.17 166.63 38.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 73.53 112.472 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -148.59 157.54 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.22 110.876 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.59 130.62 9.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.797 -0.716 . . . . 73.54 112.537 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.91 145.89 17.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 71.22 112.473 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.22 95.46 3.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 72.22 110.841 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -89.81 125.58 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 73.51 110.921 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.3 m -110.9 101.85 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.04 111.159 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.1 t -94.12 131.22 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 75.13 111.099 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.2 117.89 11.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.889 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.61 125.51 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.21 110.91 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -164.91 139.18 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 75.03 111.158 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.44 9.81 54.63 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.683 -0.77 . . . . 71.35 112.445 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 t -130.98 174.53 9.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 75.13 111.206 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.39 165.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 75.21 111.142 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 p -69.07 99.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.28 178.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 74.11 110.933 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.56 -52.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.834 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -133.75 140.4 46.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 44.22 110.834 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -115.38 127.09 55.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 62.35 110.863 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 m -134.09 116.94 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 74.21 111.098 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 t -103.88 105.5 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.31 111.142 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -120.38 136.86 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 70.13 110.861 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.38 170.26 16.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 75.02 110.823 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.45 129.83 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 64.52 110.85 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -113.1 76.41 2.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.678 0.752 . . . . 74.41 110.847 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -49.83 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 73.23 112.27 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.42 99.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 64.44 112.538 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -154.55 155.36 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 74.14 111.162 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -173.73 130.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 75.04 110.889 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.0 t -85.44 97.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.098 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -44.15 94.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.139 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -136.8 161.25 36.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 162.08 41.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 65.54 111.12 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -148.63 142.59 25.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 75.13 110.962 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t0 64.39 14.55 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.883 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.097 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -62.72 97.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 71.41 111.134 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -87.13 128.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 61.21 111.093 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -117.2 168.8 9.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 72.04 111.171 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -130.43 153.24 48.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.879 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 m -159.43 85.66 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 61.41 110.849 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.34 -93.94 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 73.52 112.442 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.4 14.8 7.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 65.34 110.845 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -128.83 146.93 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.13 110.894 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -129.77 155.03 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.42 110.962 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.3 m -139.71 148.49 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 73.32 111.197 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.76 136.34 54.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 73.35 111.17 179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.4 131.43 10.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.423 . . . . 74.53 110.828 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -114.31 -28.95 7.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 71.01 110.846 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.7 m -105.67 39.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 72.15 111.142 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.54 4.14 65.41 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.673 -0.775 . . . . 75.42 112.494 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.471 ' CE3' ' HB3' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -118.21 -32.94 4.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.782 0.325 . . . . 73.35 110.96 -179.965 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.471 ' HB3' ' CE3' ' A' ' 69' ' ' TRP . 6.1 p30 -105.48 -37.25 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 71.33 110.951 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.68 54.36 25.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.743 -0.741 . . . . 63.42 112.508 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -124.07 118.84 27.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 75.31 111.151 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.6 tp -138.56 160.91 38.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.916 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.4 162.9 18.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.701 . . . . 60.01 111.064 179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.637 2.225 . . . . 54.33 112.341 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.37 114.53 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.77 -0.729 . . . . 75.11 112.494 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 178.37 172.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 72.11 111.083 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -131.54 131.37 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.15 110.898 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.05 115.55 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.34 111.183 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.94 142.46 38.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 61.53 110.893 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -136.27 133.8 37.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 74.03 110.909 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.32 -179.37 20.17 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 74.44 112.413 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -171.84 176.77 3.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 75.02 110.842 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.62 125.68 36.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 75.31 110.931 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.78 161.92 26.67 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.678 -0.773 . . . . 75.25 112.491 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 p -105.61 125.47 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.37 . . . . 64.22 110.88 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.35 -163.3 30.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 72.32 112.484 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -36.16 11.53 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.697 2.265 . . . . 75.25 112.405 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.43 28.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 61.41 112.52 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -112.78 75.7 1.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.659 0.742 . . . . 72.12 110.834 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 157.0 61.88 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 71.03 112.321 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -145.88 177.09 9.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.889 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 m120 52.54 58.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.939 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.0 t -76.98 110.06 11.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.13 110.931 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -131.95 143.96 50.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.859 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.04 154.44 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.43 110.937 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 51.0 t30 63.31 47.33 4.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 75.35 110.874 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.35 18.51 73.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 70.41 112.517 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.96 69.74 1.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 61.13 112.513 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -156.05 104.7 2.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 73.43 110.846 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.6 t -151.42 112.6 4.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 75.31 110.913 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.81 134.89 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.895 -179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.07 -26.19 22.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.769 . . . . 74.52 112.493 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.58 142.04 29.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 75.43 111.156 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 62.12 110.858 -179.842 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.882 0.372 . . . . 74.11 111.134 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.1 p -109.31 38.23 2.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 61.51 111.174 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.3 p -151.69 -172.96 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.862 -179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.45 134.29 35.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 75.11 111.122 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.11 158.67 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 63.21 111.164 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.86 31.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 64.24 111.064 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.03 147.52 47.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.175 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.43 142.4 31.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 74.34 110.937 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.52 152.01 40.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 72.4 111.116 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 147.93 25.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 74.14 110.932 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 -59.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.44 111.136 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.55 129.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 75.34 110.831 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.99 127.82 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 74.33 110.863 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.66 82.22 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.875 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.63 0.63 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 70.31 112.48 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -100.39 -17.68 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 72.22 111.113 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.9 152.81 22.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 62.22 112.431 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -141.95 142.51 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.002 0.43 . . . . 75.44 110.884 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.54 112.97 4.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 73.5 112.425 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.26 131.48 10.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.493 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.1 t -131.43 98.68 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 73.43 110.906 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -92.36 143.28 26.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.867 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 m -123.88 111.53 16.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 72.42 111.154 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.7 t -109.57 132.58 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 72.43 111.12 179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -137.68 130.28 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.927 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.68 144.91 34.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.881 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -172.67 162.23 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.11 111.13 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.05 -62.72 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 42.51 112.508 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 p -64.98 163.43 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 63.34 111.222 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -174.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 65.35 111.129 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -57.19 120.18 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.34 110.836 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mp -56.84 153.53 10.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.48 . . . . 64.1 110.87 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.14 -15.3 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.3 110.829 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.02 152.63 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.868 -179.746 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -136.97 129.53 30.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.4 110.922 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -152.89 122.37 6.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 74.41 111.137 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 t -102.76 115.95 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 71.25 111.065 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.5 152.32 36.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 70.54 110.858 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.0 167.22 31.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 75.12 110.907 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.99 133.68 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 72.2 110.823 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -112.02 76.72 1.84 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.42 110.86 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -49.57 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.65 2.234 . . . . 74.13 112.335 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -73.38 144.74 46.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 73.52 111.124 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.19 96.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.15 112.466 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 43' ' ' THR . 6.5 m -156.66 155.95 32.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 72.04 111.116 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.26 131.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.853 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.6 t -75.06 99.79 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 75.12 111.133 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 t -67.53 -40.69 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 63.24 111.133 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -142.95 148.55 37.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 75.55 110.786 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.11 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 70.14 111.063 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -148.51 144.9 27.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 74.1 110.957 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 63.24 16.28 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 74.31 110.849 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.1 95.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 72.2 111.12 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -54.6 100.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 75.23 111.126 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.29 128.43 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.24 111.087 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -126.89 141.69 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 70.1 111.075 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -108.43 159.89 16.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.31 110.876 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 85.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.869 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.81 -90.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 54.14 112.521 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.22 7.51 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 75.41 110.822 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -119.15 146.89 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.41 110.852 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -128.06 160.09 33.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.4 110.86 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 t -148.77 149.48 31.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 73.21 111.103 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.86 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 61.23 111.103 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 142.84 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.889 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -120.26 -33.07 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.954 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.56 42.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 75.32 111.126 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.29 1.88 68.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 61.41 112.486 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.74 -34.09 4.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.822 0.344 . . . . 75.52 110.976 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.24 -70.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 73.22 110.897 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.06 -37.65 3.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 72.13 112.487 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 t -49.92 117.66 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 71.11 111.122 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.1 143.31 31.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 75.2 110.972 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.45 160.51 33.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.565 0.698 . . . . 71.13 111.121 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -18.31 36.74 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.739 2.292 . . . . 73.3 112.326 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.99 115.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 54.11 112.472 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.8 172.41 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 64.34 111.087 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -120.78 131.02 54.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.879 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.2 109.43 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 74.41 111.119 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.6 p -113.74 164.36 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 63.01 110.886 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.93 132.52 11.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.882 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.45 173.28 18.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 73.43 112.472 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -174.83 176.73 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 75.33 110.85 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -129.92 139.04 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 61.35 110.906 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.2 159.49 27.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 72.41 112.493 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.43 112.08 24.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 72.44 110.888 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.5 -157.81 27.62 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.669 -0.777 . . . . 75.43 112.443 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -42.31 3.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 71.42 112.382 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.94 30.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 73.23 112.458 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.6 t -112.79 75.29 1.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.675 0.75 . . . . 73.22 110.842 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 159.02 54.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 72.1 112.343 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 m -142.72 165.92 26.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 65.21 110.938 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 m120 58.67 63.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 62.33 110.893 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.2 t -79.51 92.23 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 72.42 110.858 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 118.72 37.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 74.03 110.922 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 pp -130.27 155.76 45.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.925 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 42.4 t30 62.41 20.79 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 71.11 110.903 179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.58 24.83 10.52 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.715 -0.755 . . . . 70.12 112.495 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.52 71.37 1.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.35 112.486 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 t -156.31 103.94 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 65.23 110.923 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.7 t -149.04 137.53 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 65.33 110.842 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -127.42 161.95 27.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 73.15 110.875 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.87 -29.61 8.42 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.85 -0.69 . . . . 74.41 112.522 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -172.8 2.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.8 0.334 . . . . 65.15 111.143 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 75.15 110.883 -179.864 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.895 0.379 . . . . 74.35 111.114 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -165.98 85.86 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 73.05 111.114 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -100.7 95.38 6.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 52.44 110.88 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.21 133.55 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 73.53 111.167 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.87 150.64 52.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 72.44 111.163 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.55 149.51 43.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.13 111.126 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 119.25 16.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.155 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -69.5 146.25 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.871 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.25 154.87 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 53.23 111.081 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.33 156.05 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 65.32 110.931 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -58.94 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 71.24 111.119 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 129.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 74.25 110.865 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -115.83 127.98 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 64.32 110.9 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.59 82.94 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.21 110.901 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.48 -85.12 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.741 . . . . 63.32 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -103.29 -17.57 15.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 73.44 111.123 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 156.11 26.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.804 -0.712 . . . . 54.01 112.515 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.16 142.91 30.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.885 0.374 . . . . 74.33 110.864 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.57 122.12 7.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 54.15 112.506 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.7 150.02 20.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 72.13 112.562 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -147.05 94.59 2.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.38 . . . . 71.34 110.816 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.27 134.87 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.902 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 m -113.12 102.1 10.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.111 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.68 131.59 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.162 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.48 118.12 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.21 110.895 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -116.0 133.21 56.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 75.15 110.884 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -172.04 153.72 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 74.41 111.08 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.93 -18.14 54.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.821 -0.704 . . . . 74.3 112.454 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 171.18 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 75.13 111.117 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -171.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.13 111.19 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.65 125.67 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 63.52 110.828 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.36 179.16 5.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 75.43 110.953 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -143.66 -52.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.84 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.91 174.42 14.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.923 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -140.25 127.35 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 74.15 110.907 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -113.74 102.14 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 70.11 111.116 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 p -101.26 115.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 74.54 111.178 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.92 151.45 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.3 110.865 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.12 169.68 18.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 74.32 110.937 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.19 128.11 44.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 63.14 110.898 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -112.59 77.15 2.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.633 0.73 . . . . 74.24 110.855 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.275 . . . . 75.44 112.264 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 26.5 m -71.93 145.35 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 71.14 111.163 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.36 98.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 70.21 112.433 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.75 153.49 31.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 71.24 111.163 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.75 130.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 74.3 110.882 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.7 t -79.53 96.59 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 71.23 111.154 179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -63.57 -40.98 98.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 75.52 111.183 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 m -144.98 147.96 33.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.887 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.39 157.78 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 52.54 111.08 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -142.33 143.22 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 74.31 110.957 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.55 14.36 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 73.34 110.845 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 94.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.35 111.05 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -56.68 99.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.121 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 96.6 t -90.27 121.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.13 111.095 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -111.56 172.05 7.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 74.14 111.142 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 155.26 48.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.01 110.927 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.85 85.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.821 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -93.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.675 -0.774 . . . . 75.23 112.443 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -126.25 10.25 7.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.4 110.795 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -124.3 147.02 48.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 75.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.77 159.86 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.959 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.5 m -147.8 148.82 31.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 73.01 111.133 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.88 135.18 48.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.13 111.071 179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.88 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 73.3 110.889 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -131.47 -51.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 64.42 110.879 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.62 37.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 75.11 111.156 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.59 0.91 84.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 54.24 112.45 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -116.44 -24.27 7.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 74.24 110.889 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.17 -38.42 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 73.22 110.889 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.42 53.5 28.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.743 . . . . 75.41 112.487 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.3 t -130.18 94.95 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 74.34 111.212 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -138.61 160.72 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 71.33 110.897 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.12 161.31 52.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 71.0 111.089 179.83 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -8.45 23.63 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 74.54 112.351 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.21 115.54 0.75 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 74.04 112.484 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.53 172.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 72.53 111.11 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -134.19 131.62 38.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.849 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.88 116.98 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 73.44 111.164 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 p -108.41 125.95 52.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 72.12 110.872 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -111.55 137.31 49.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 74.5 110.818 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.64 174.5 17.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.31 112.458 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -174.32 179.07 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 71.23 110.878 -179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.5 140.86 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.856 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.65 159.9 28.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 72.45 112.48 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.1 m -105.37 113.72 27.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 74.23 110.87 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.52 31.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 71.4 112.501 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -37.35 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.655 2.237 . . . . 73.24 112.359 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.74 25.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.55 112.525 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -112.84 75.12 1.84 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.599 0.714 . . . . 75.32 110.834 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 156.71 62.74 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.652 2.234 . . . . 75.11 112.397 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 168.77 21.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 74.52 110.82 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 60.14 62.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 72.24 110.907 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t -84.9 95.55 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 74.42 110.812 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 125.52 48.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.904 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 pp -135.3 155.61 50.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 73.53 110.988 179.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.08 25.76 15.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.88 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.58 28.66 13.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 73.14 112.458 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.35 74.79 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 54.22 112.476 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.18 104.35 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 73.44 110.862 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.0 t -154.82 138.87 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 75.11 110.88 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.45 106.09 8.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.864 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.17 50.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.82 -0.705 . . . . 74.24 112.458 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -142.22 173.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 74.45 111.159 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.829 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.802 0.334 . . . . 62.340000000000003 111.119 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.52 163.7 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 44.200000000000003 111.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.53 147.63 27.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 53.0 111.153 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -88.77 146.28 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.96 163.36 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 70.420000000000002 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.32 138.78 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 75.439999999999998 110.977 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.85 -60.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 61.340000000000003 111.165 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.27 131.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.94 127.3 53.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 75.040000000000006 110.908 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.25 88.17 2.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 71.019999999999996 110.983 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -93.22 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.75 . . . . 73.239999999999995 112.453 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.39 -17.7 17.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 73.439999999999998 111.141 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.61 148.59 20.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.778 -0.725 . . . . 52.200000000000003 112.489 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -138.08 143.75 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 70.400000000000006 110.881 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.29 3.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 73.019999999999996 112.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.77 139.27 21.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 42.420000000000002 112.504 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.34 95.51 3.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 40.420000000000002 110.815 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.25 145.13 25.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.17 -0.468 . . . . 53.009999999999998 110.932 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.27 124.73 52.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 111.085 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.08 131.56 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.116 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.77 118.1 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.883 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.73 101.54 9.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 62.409999999999997 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.9 p -146.05 134.06 21.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 42.43 111.101 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -57.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 62.539999999999999 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.81 168.25 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 73.319999999999993 111.12 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.0 p -63.17 -174.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 70.129999999999995 111.125 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.53 125.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 64.439999999999998 110.857 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.65 -176.23 4.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.91 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.5 -52.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 45.229999999999997 110.821 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.79 157.54 38.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 55.340000000000003 110.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -114.46 126.84 55.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.888 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.47 100.79 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 62.020000000000003 111.142 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 37' ' ' VAL . 7.0 p -101.39 120.83 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 51.240000000000002 111.094 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.38 156.09 43.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 170.16 21.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.349999999999994 110.907 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.14 130.78 44.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 54.32 110.927 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -111.94 78.53 2.32 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.633 0.73 . . . . 74.120000000000005 110.928 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -49.28 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.734 2.289 . . . . 51.439999999999998 112.335 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -73.12 144.46 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 111.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.92 97.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.758 . . . . 75.430000000000007 112.478 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.428 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.4 m -156.07 154.55 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 60.240000000000002 111.195 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.99 131.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 72.530000000000001 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.3 t -74.23 95.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.452 . . . . 64.209999999999994 111.12 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.6 m -63.19 -42.51 99.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 71.430000000000007 111.189 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.68 140.13 31.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 60.549999999999997 110.782 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.85 137.89 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 54.420000000000002 111.125 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.39 142.48 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.951 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.84 13.99 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 73.319999999999993 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.73 120.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 64.030000000000001 111.131 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.2 99.98 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 62.039999999999999 111.136 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.703 HG11 HG21 ' A' ' 47' ' ' VAL . 42.5 t -89.29 119.5 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 44.439999999999998 111.116 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -106.82 171.13 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 64.010000000000005 111.156 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.85 156.37 46.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 73.239999999999995 110.953 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 t -158.23 85.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 64.409999999999997 110.858 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.37 0.89 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 55.439999999999998 112.515 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 51.25 110.902 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -108.73 146.92 32.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -131.28 155.6 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 73.129999999999995 110.96 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.8 m -148.46 149.05 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 75.209999999999994 111.12 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.9 124.61 37.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 71.409999999999997 111.071 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.27 157.77 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.150000000000006 110.916 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.35 -51.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 63.32 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.45 40.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.040000000000006 111.099 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.13 0.86 72.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 74.420000000000002 112.468 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.336 . . . . 52.530000000000001 110.878 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.55 -45.06 3.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 72.040000000000006 110.868 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.663 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.49 55.25 20.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.772 -0.728 . . . . 60.219999999999999 112.432 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.17 94.66 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.341 . . . . 72.329999999999998 111.205 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.51 160.83 38.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.099999999999994 110.846 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.43 162.31 54.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 44.229999999999997 111.075 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.71 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.708 2.272 . . . . 75.319999999999993 112.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.53 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 33.420000000000002 112.445 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 74.219999999999999 111.098 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.75 131.51 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 72.310000000000002 110.848 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.87 149.8 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 44.409999999999997 111.15 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.78 154.26 47.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.93 139.02 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 61.100000000000001 110.833 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.64 174.33 15.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 23.129999999999999 112.483 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.9 p90 -168.81 177.8 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 74.400000000000006 110.855 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.01 125.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.200000000000003 110.885 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.96 154.2 20.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 65.349999999999994 112.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -95.89 109.53 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.379 . . . . 34.409999999999997 110.837 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -160.28 30.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.79 -0.719 . . . . 53.340000000000003 112.481 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -41.73 4.12 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.712 2.274 . . . . 75.409999999999997 112.306 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.73 26.65 24.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 42.210000000000001 112.467 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 m -113.3 73.56 1.87 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.694 0.759 . . . . 44.240000000000002 110.891 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 163.31 38.75 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 74.219999999999999 112.381 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -148.26 173.37 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.299999999999997 110.87 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.23 49.31 3.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 65.340000000000003 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.5 m -68.57 97.34 0.77 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.409999999999997 110.854 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 118.97 25.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 65.239999999999995 110.915 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.93 155.94 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 110.858 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.34 13.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 44.350000000000001 110.807 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.15 42.15 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 43.329999999999998 112.479 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.7 70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 73.109999999999999 112.479 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.22 132.61 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 62.25 110.866 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.887 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.803 0.335 . . . . 73.299999999999997 111.202 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.45 163.8 31.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 111.081 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 147.63 27.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 111.128 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.76 146.22 25.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.099999999999994 110.905 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.86 163.45 35.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 61.140000000000001 111.164 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 138.86 45.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 73.349999999999994 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.95 -60.92 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 75.049999999999997 111.11 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.32 131.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 64.239999999999995 110.868 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.99 127.24 53.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.847 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -111.28 88.23 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 70.230000000000004 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 -93.16 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 52.130000000000003 112.486 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.33 -17.74 17.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.784 0.326 . . . . 74.25 111.162 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.63 148.67 20.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 73.219999999999999 112.429 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.11 143.67 40.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 71.010000000000005 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.25 3.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 72.140000000000001 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 139.23 21.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 60.530000000000001 112.438 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.36 95.57 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.366 . . . . 73.219999999999999 110.894 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.31 145.2 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.857 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.3 124.66 52.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.200000000000003 111.22 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.98 131.59 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.149 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.84 118.12 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 62.119999999999997 110.888 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.74 101.46 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 65.409999999999997 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.7 p -146.0 134.12 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 71.040000000000006 111.096 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.87 -57.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.672 -0.775 . . . . 63.109999999999999 112.488 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.87 168.22 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 72.200000000000003 111.12 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -63.15 -174.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 71.099999999999994 111.204 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.52 125.58 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 60.219999999999999 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.64 -176.24 4.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 54.039999999999999 110.884 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.49 -52.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 110.892 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.84 157.55 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 75.329999999999998 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -114.45 126.94 55.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 71.510000000000005 110.917 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.62 100.75 6.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.456 . . . . 44.229999999999997 111.195 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 37' ' ' VAL . 7.1 p -101.33 120.78 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 72.109999999999999 111.148 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.37 156.1 43.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 72.209999999999994 110.886 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.2 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 72.540000000000006 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.13 130.88 44.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.851 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -112.09 78.55 2.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 73.329999999999998 110.92 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.2 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.615 2.21 . . . . 72.530000000000001 112.36 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.8 p -73.15 144.34 46.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 111.136 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.78 97.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 42.219999999999999 112.508 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.43 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.1 m -156.13 154.55 31.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 65.129999999999995 111.182 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 131.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.852 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.771 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.8 t -74.13 95.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 64.150000000000006 111.105 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -63.13 -42.65 99.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 60.350000000000001 111.138 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.6 140.03 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.299999999999997 110.864 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 137.97 48.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 44.219999999999999 111.091 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.41 142.48 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.299999999999997 110.907 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.82 14.04 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 73.409999999999997 110.866 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.76 120.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 51.240000000000002 111.111 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.21 100.0 5.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 63.130000000000003 111.146 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 47' ' ' VAL . 42.6 t -89.31 119.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 65.409999999999997 111.12 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -106.86 171.12 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.239999999999995 111.1 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.84 156.37 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 64.420000000000002 110.92 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -158.25 85.74 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.846 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 62.119999999999997 112.539 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 63.020000000000003 110.902 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -108.7 146.92 32.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -131.31 155.5 47.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.937 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.7 m -148.4 149.1 31.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 64.230000000000004 111.142 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.91 124.63 37.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 73.430000000000007 111.066 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.32 157.78 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 61.409999999999997 110.838 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.31 -51.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 72.219999999999999 110.965 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.44 40.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 73.519999999999996 111.138 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.14 0.86 72.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 73.239999999999995 112.486 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.69 -24.64 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 74.310000000000002 110.918 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.51 -45.05 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 61.049999999999997 110.929 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.662 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.44 55.27 20.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.705 -0.76 . . . . 63.140000000000001 112.485 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.23 94.7 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 75.420000000000002 111.088 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.46 160.88 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.420000000000002 110.954 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.49 162.33 53.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.569 0.7 . . . . 71.439999999999998 111.107 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.74 -8.45 23.64 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.711 2.274 . . . . 44.219999999999999 112.354 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.52 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 72.200000000000003 112.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 74.340000000000003 111.098 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.73 131.46 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 31.239999999999998 110.858 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.88 149.8 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.105 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.73 154.25 47.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.030000000000001 110.912 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -141.97 139.0 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.200000000000003 110.866 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.52 174.27 15.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 71.340000000000003 112.55 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.771 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.7 p90 -168.73 177.82 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 70.239999999999995 110.893 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.02 125.72 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 62.299999999999997 110.871 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.94 154.18 20.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.672 -0.775 . . . . 41.299999999999997 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -95.84 109.53 21.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.888 0.375 . . . . 72.319999999999993 110.901 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.03 -160.23 30.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.75 -0.738 . . . . 54.539999999999999 112.522 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -41.55 4.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 63.030000000000001 112.36 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 26.73 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 72.340000000000003 112.442 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 m -113.42 73.61 1.98 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.742 0.782 . . . . 73.519999999999996 110.897 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 163.35 38.64 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.693 2.262 . . . . 31.329999999999998 112.381 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.0 p -148.39 173.33 13.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 73.310000000000002 110.82 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.25 49.28 3.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.140000000000001 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.3 m -68.5 97.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 73.019999999999996 110.922 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.13 119.06 25.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.924 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.01 155.93 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.230000000000004 110.898 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.35 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 62.100000000000001 110.818 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.11 42.23 8.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.708 -0.758 . . . . 74.219999999999999 112.493 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.64 70.02 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 63.25 112.495 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.23 132.62 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 60.009999999999998 110.873 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.127 -0.488 . . . . 51.130000000000003 110.944 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.789 0.328 . . . . 75.230000000000004 111.092 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.71 163.83 33.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 72.230000000000004 111.09 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 m -139.91 137.38 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 52.399999999999999 111.093 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -76.76 139.03 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.430000000000007 110.856 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.14 150.75 41.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 111.123 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.67 142.11 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.848 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.51 -56.49 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 111.09 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.25 132.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.902 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.46 127.65 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 64.329999999999998 110.793 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.42 84.87 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 75.430000000000007 110.903 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 -91.11 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 64.209999999999994 112.46 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.5 -17.6 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.347 . . . . 62.140000000000001 111.092 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.16 148.41 20.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 75.120000000000005 112.504 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -135.15 141.69 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 74.420000000000002 110.832 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.84 108.83 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 75.109999999999999 112.453 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.54 130.51 10.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 64.340000000000003 112.496 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.85 99.46 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 71.25 110.899 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.29 117.93 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 70.120000000000005 110.893 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.5 m -95.52 110.09 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 53.210000000000001 111.164 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.4 t -106.71 131.89 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 74.319999999999993 111.161 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -143.4 127.97 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 110.888 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.25 133.44 55.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.129999999999995 110.873 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.47 151.67 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.150000000000006 111.172 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -41.08 2.36 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.645 -0.788 . . . . 75.510000000000005 112.535 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 169.1 14.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 74.329999999999998 111.163 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -172.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 65.430000000000007 111.083 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -51.43 129.71 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 55.119999999999997 110.867 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -176.24 4.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 62.420000000000002 110.93 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -52.94 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.049999999999997 110.904 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.77 176.23 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.837 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.492 ' CD1' HG21 ' A' ' 79' ' ' VAL . 29.2 p-90 -135.68 127.09 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 64.230000000000004 110.894 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -124.64 105.83 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 75.329999999999998 111.138 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 14.2 t -101.4 105.92 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 72.439999999999998 111.11 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' A' ' 63' ' ' THR . 11.4 pm0 -116.76 153.07 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.84 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.82 169.61 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.911 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.08 129.94 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.841 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.76 75.38 1.88 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 72.25 110.86 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -49.78 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.641 2.227 . . . . 64.230000000000004 112.407 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -71.07 144.56 50.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 111.202 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.9 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.150000000000006 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -156.57 154.71 30.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 72.400000000000006 111.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.67 131.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 74.329999999999998 110.913 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.733 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.6 t -75.18 101.41 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 45.350000000000001 111.063 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -45.69 91.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 72.239999999999995 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.12 148.5 33.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.150000000000006 110.846 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.62 137.08 39.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 111.093 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -119.51 148.17 43.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.903 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.52 14.53 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 65.120000000000005 110.871 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 134.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 41.240000000000002 111.092 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -86.56 95.01 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 111.137 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 64' ' ' ALA . 98.2 t -86.34 138.33 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 71.129999999999995 111.07 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -128.31 171.03 12.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.168 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -136.07 157.39 46.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 85.74 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 110.877 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.98 -91.77 0.71 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 44.340000000000003 112.522 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.21 8.23 7.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 73.140000000000001 110.916 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -119.23 146.68 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 72.420000000000002 110.873 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -130.88 157.53 42.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.894 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 38' ' ' GLU . 46.9 m -152.53 148.46 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 72.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -130.46 134.84 47.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 53.409999999999997 111.135 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.1 OUTLIER -145.36 160.84 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.923 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.95 -51.46 0.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.430000000000007 110.902 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -98.93 39.3 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.520000000000003 111.11 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.26 -0.73 72.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.772 -0.727 . . . . 53.229999999999997 112.535 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -113.53 -25.2 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.806 0.336 . . . . 71.230000000000004 110.947 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.04 -47.0 3.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 74.409999999999997 110.874 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.86 56.3 14.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.774 -0.726 . . . . 44.43 112.438 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.71 95.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 41.530000000000001 111.093 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.9 tt -137.24 160.55 38.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 110.922 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -70.17 161.97 72.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.718 . . . . 54.299999999999997 111.151 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.77 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.727 2.284 . . . . 74.349999999999994 112.29 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.9 119.0 1.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 44.530000000000001 112.498 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.41 172.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 74.409999999999997 111.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -131.02 131.64 44.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.848 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.1 m -134.31 114.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.188 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 p -111.83 134.36 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 71.129999999999995 110.89 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.67 138.64 45.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.450000000000003 110.918 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.16 -179.77 19.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.761 -0.733 . . . . 72.319999999999993 112.469 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.733 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.1 p90 -174.45 174.02 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 73.329999999999998 110.862 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -129.83 125.79 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.109999999999999 110.838 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.49 152.22 19.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 42.420000000000002 112.546 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.4 t -97.87 109.38 22.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 71.150000000000006 110.894 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.51 -156.52 27.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 72.549999999999997 112.457 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -42.04 3.66 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 74.200000000000003 112.314 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.11 26.49 31.02 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.702 -0.761 . . . . 32.149999999999999 112.55 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 m -113.09 74.74 1.91 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.678 0.752 . . . . 62.530000000000001 110.908 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 162.55 41.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 73.299999999999997 112.375 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -148.34 171.29 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.310000000000002 110.836 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 60.01 58.47 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 73.349999999999994 110.846 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.33 92.06 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 62.020000000000003 110.857 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 118.94 33.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.427 . . . . 72.409999999999997 110.9 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -128.71 155.78 44.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.230000000000004 110.944 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 64.12 22.69 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.828 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.34 41.85 5.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 75.109999999999999 112.474 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.65 71.54 1.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 53.520000000000003 112.485 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.1 m -156.23 104.15 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 63.32 110.885 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 64.120000000000005 110.857 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.789 0.328 . . . . 54.409999999999997 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.35 163.82 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 44.509999999999998 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -141.79 147.69 37.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 111.154 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -91.21 145.4 24.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.439999999999998 110.839 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.68 149.86 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 74.209999999999994 111.105 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 147.33 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 54.5 110.888 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.27 -61.92 1.59 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 72.150000000000006 111.114 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -179.39 146.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.150000000000006 110.893 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -117.86 126.85 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.906 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -111.14 86.79 2.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.230000000000004 110.973 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.66 -82.97 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 51.039999999999999 112.508 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 t -115.66 -17.52 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 62.200000000000003 111.089 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.9 159.26 30.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 64.430000000000007 112.461 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HE2' HG23 ' A' ' 45' ' ' THR . 22.4 p90 -139.99 160.45 39.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 61.299999999999997 110.886 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.47 121.89 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 53.420000000000002 112.432 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.29 146.49 18.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 55.299999999999997 112.513 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -138.98 94.57 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 63.340000000000003 110.825 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.2 136.46 33.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 73.519999999999996 110.915 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -111.68 123.85 51.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 43.119999999999997 111.207 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.36 131.69 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 54.420000000000002 111.202 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.64 118.06 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 70.209999999999994 110.934 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -105.85 119.8 40.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 60.32 110.914 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -158.07 159.89 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 111.147 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -59.0 3.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 40.530000000000001 112.547 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 175.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.825 0.345 . . . . 61.539999999999999 111.173 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 175.04 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 71.340000000000003 111.165 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 p -52.58 131.66 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 41.340000000000003 110.857 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 33' ' ' SER . 0.9 OUTLIER -106.69 -169.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 63.32 110.961 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -133.47 -52.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 110.823 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.94 154.42 40.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 75.409999999999997 110.86 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -107.41 126.94 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 73.200000000000003 110.97 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 103.77 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 73.540000000000006 111.12 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 18.0 t -101.55 105.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 71.450000000000003 111.082 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.85 155.8 34.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 65.400000000000006 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -157.4 169.28 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 72.340000000000003 110.95 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -97.82 132.35 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 55.100000000000001 110.92 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.23 80.42 2.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.616 0.722 . . . . 73.099999999999994 110.807 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 44.020000000000003 112.394 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -73.37 144.56 46.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 64.129999999999995 111.158 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.48 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.815 -0.707 . . . . 62.310000000000002 112.448 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.608 HG23 ' HE2' ' A' ' 18' ' ' PHE . 86.4 m -156.24 143.5 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.361 . . . . 74.319999999999993 111.151 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -155.55 130.91 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.400000000000006 110.921 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 83' ' ' PHE . 57.5 t -77.94 92.5 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.129999999999995 111.099 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.9 m -77.08 -31.21 55.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 64.219999999999999 111.163 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.23 149.96 48.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 44.439999999999998 110.836 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.78 146.21 21.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 64.329999999999998 111.088 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -143.95 141.24 30.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.549999999999997 110.926 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.82 15.56 9.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 110.893 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.54 120.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 73.409999999999997 111.161 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.5 m -80.15 109.8 14.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 111.094 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 47' ' ' VAL . 15.7 t -93.65 138.63 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.140000000000001 111.101 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.0 m -128.13 142.27 51.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.340000000000003 111.228 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.69 157.08 18.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.875 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -160.6 85.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.130000000000003 110.816 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.44 -90.83 0.46 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 74.349999999999994 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.31 6.3 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 65.239999999999995 110.87 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -119.85 146.79 45.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.409999999999997 110.852 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -129.19 164.21 23.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.966 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -151.32 149.37 29.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.439999999999998 111.168 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.29 114.98 17.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 62.030000000000001 111.133 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 154.75 47.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.884 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -131.32 -51.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.878 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -97.05 39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 111.146 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.2 68.52 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.737 -0.744 . . . . 35.039999999999999 112.454 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -112.08 -30.45 7.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 73.450000000000003 110.919 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -102.49 -46.06 4.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 72.329999999999998 110.861 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.98 55.84 16.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.696 -0.764 . . . . 75.299999999999997 112.492 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -135.19 94.6 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.834 0.349 . . . . 63.409999999999997 111.194 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -135.37 161.17 36.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 110.939 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -92.3 163.45 26.78 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.534 0.683 . . . . 55.420000000000002 111.109 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -7.92 22.28 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.632 2.222 . . . . 64.329999999999998 112.352 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 115.17 1.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 72.299999999999997 112.492 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.75 172.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 75.019999999999996 111.12 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.89 131.58 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.430000000000007 110.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.8 t -149.41 137.39 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.515 . . . . 54.219999999999999 111.149 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -124.22 136.59 54.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.828 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 28.4 p90 -125.25 135.81 52.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 52.340000000000003 110.865 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.89 171.13 13.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 72.200000000000003 112.394 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.9 p90 -162.42 179.59 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 72.219999999999999 110.951 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -136.67 131.07 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 54.43 110.872 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 153.84 23.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 61.420000000000002 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -91.28 116.78 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 71.239999999999995 110.881 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -161.58 29.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 45.149999999999999 112.485 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -45.51 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 73.140000000000001 112.342 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 27.55 9.81 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 63.350000000000001 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 t -112.37 75.13 1.64 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.57 0.7 . . . . 73.030000000000001 110.867 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 165.29 31.43 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.705 2.27 . . . . 75.099999999999994 112.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -148.59 -177.42 5.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 55.450000000000003 110.834 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m120 51.85 60.98 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 110.901 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -76.66 105.88 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 110.91 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 144.16 41.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 60.329999999999998 110.954 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 pp -153.12 156.15 38.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.209999999999994 110.893 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.94 43.73 2.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 54.420000000000002 110.918 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.8 42.13 61.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.706 -0.759 . . . . 74.519999999999996 112.525 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 70.89 1.33 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.749 -0.738 . . . . 63.520000000000003 112.492 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -156.43 104.35 2.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 55.350000000000001 110.841 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 70.409999999999997 110.889 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.747 0.308 . . . . 71.140000000000001 111.18 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.85 29.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 53.420000000000002 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -137.46 132.89 34.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.530000000000001 111.185 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.09 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 63.5 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.91 154.0 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -99.2 145.58 27.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 61.420000000000002 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -105.85 -58.64 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 65.349999999999994 111.122 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -179.42 131.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 72.019999999999996 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.59 127.29 53.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.31 88.99 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.2 -92.96 0.76 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 62.439999999999998 112.462 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.51 -17.76 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 64.200000000000003 111.181 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.36 148.62 20.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 63.119999999999997 112.495 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -136.87 145.1 43.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 73.319999999999993 110.887 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.52 112.53 4.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 64.209999999999994 112.491 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.77 145.44 24.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 62.219999999999999 112.524 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.92 98.7 3.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 65.400000000000006 110.826 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.79 124.46 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.400000000000006 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.9 m -105.27 101.81 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 62.530000000000001 111.174 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 79' ' ' VAL . 32.5 t -99.37 131.98 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 111.075 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -139.81 118.19 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.200000000000003 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.86 101.46 9.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 62.210000000000001 110.866 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -131.15 136.22 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 111.193 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.36 -35.53 4.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.679 -0.772 . . . . 52.310000000000002 112.492 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 177.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 63.450000000000003 111.209 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.34 173.41 12.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 72.549999999999997 111.149 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.76 108.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 45.420000000000002 110.886 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.09 -177.66 6.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 75.129999999999995 110.957 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.7 p -141.71 -53.44 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 64.450000000000003 110.822 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.53 152.63 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 72.219999999999999 110.889 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -115.3 126.78 54.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 62.409999999999997 110.931 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -135.9 118.13 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 62.240000000000002 111.155 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -114.91 125.46 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.176 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.39 153.71 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 51.43 110.825 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.55 169.45 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 64.209999999999994 110.88 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 132.45 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 54.229999999999997 110.834 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.9 m-85 -111.83 79.5 2.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.603 0.716 . . . . 71.219999999999999 110.859 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 72.25 112.364 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' THR . 69.9 p -73.36 144.82 46.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 73.409999999999997 111.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.42 96.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 63.109999999999999 112.485 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' CE1' ' A' ' 41' ' ' PHE . 57.4 m -156.94 149.41 23.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 54.420000000000002 111.154 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.68 131.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.937 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 63.5 t -74.79 100.15 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.3 m -63.16 -46.02 89.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.124 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 m -141.44 142.12 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 60.25 110.897 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.46 147.69 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.239999999999995 111.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -131.58 143.99 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.219999999999999 110.925 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t0 64.8 14.07 8.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 110.935 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.41 ' HB3' ' CD1' ' A' ' 81' ' ' PHE . . . -172.96 106.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.450000000000003 111.068 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -64.95 91.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 73.0 111.141 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 64' ' ' ALA . 77.0 t -88.96 113.27 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 111.11 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 63' ' ' THR . 11.4 t -107.19 179.08 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 72.299999999999997 111.181 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.21 159.97 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.921 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -158.6 85.21 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 63.109999999999999 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.17 -90.99 1.01 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.748 -0.739 . . . . 73.200000000000003 112.442 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -126.75 2.0 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 61.109999999999999 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -111.56 146.88 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.120000000000005 110.88 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -130.29 152.9 49.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.903 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.599 HG23 HG22 ' A' ' 56' ' ' THR . 2.3 t -149.07 148.58 29.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.400000000000006 111.146 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -127.41 135.49 50.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.089 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.59 135.21 15.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.872 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -111.77 -32.09 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.109999999999999 110.907 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.32 40.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 71.329999999999998 111.152 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.03 1.89 72.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 72.310000000000002 112.52 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -117.78 -34.05 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 63.340000000000003 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.493 ' HB3' HG22 ' A' ' 72' ' ' THR . 2.0 m-20 -102.0 -68.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 64.430000000000007 110.89 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.96 45.44 8.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 70.219999999999999 112.479 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.03 120.72 29.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.816 0.341 . . . . 54.409999999999997 111.166 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -146.25 161.43 40.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 74.430000000000007 110.97 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.02 164.0 17.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.349999999999994 111.034 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.702 2.268 . . . . 65.120000000000005 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.63 114.29 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 71.120000000000005 112.484 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.99 172.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.711 0.291 . . . . 53.009999999999998 111.143 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -129.33 131.28 46.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 71.200000000000003 110.825 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.533 HG13 ' HB ' ' A' ' 24' ' ' VAL . 8.2 p -133.42 128.29 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.181 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -132.74 140.85 48.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 45.409999999999997 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 20.7 p90 -135.32 153.76 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 72.519999999999996 110.873 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.53 175.83 17.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.787 -0.721 . . . . 54.329999999999998 112.486 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 30.5 p90 -174.21 177.32 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 74.519999999999996 110.907 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -130.64 125.77 34.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.549999999999997 110.879 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.51 151.62 18.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 71.109999999999999 112.474 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 109.57 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 63.509999999999998 110.845 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.47 -157.22 27.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.706 -0.759 . . . . 72.420000000000002 112.426 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -42.49 3.33 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.591 2.194 . . . . 73.030000000000001 112.373 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.9 26.97 25.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 62.420000000000002 112.508 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -113.03 73.95 1.72 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.742 . . . . 71.150000000000006 110.828 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 156.02 64.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.669 2.246 . . . . 62.549999999999997 112.343 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 70.349999999999994 110.845 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 63.14 62.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 63.450000000000003 110.858 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.54 131.75 34.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 54.329999999999998 110.936 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 121.37 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 51.140000000000001 110.898 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.797 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.3 pp -136.48 155.88 49.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.400000000000006 110.935 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.797 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.6 t30 64.11 39.79 7.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.099999999999994 110.937 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 23.36 60.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 50.009999999999998 112.531 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.37 71.53 1.16 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 41.43 112.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -156.19 104.24 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 62.229999999999997 110.891 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 71.209999999999994 110.873 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.742 0.306 . . . . 63.439999999999998 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.37 163.77 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.509999999999998 111.095 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.41 141.93 26.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.128 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -84.73 145.53 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.884 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.77 164.1 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 70.519999999999996 111.153 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.74 163.95 12.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.879 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -61.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 73.209999999999994 111.121 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.22 135.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 51.340000000000003 110.905 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.92 127.14 53.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 53.210000000000001 110.93 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.14 92.91 4.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.926 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -90.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.794 -0.717 . . . . 72.319999999999993 112.477 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -106.98 -17.56 14.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 70.010000000000005 111.127 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.82 153.56 27.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 64.409999999999997 112.516 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -140.94 146.55 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 63.399999999999999 110.928 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.22 127.93 9.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.774 -0.727 . . . . 70.349999999999994 112.543 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 145.95 16.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.758 . . . . 73.109999999999999 112.507 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.76 100.09 4.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 54.399999999999999 110.845 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.29 139.91 30.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 110.921 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -114.73 119.54 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 45.140000000000001 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.96 131.78 62.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.430000000000007 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -138.29 127.5 24.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.716 ' HB3' HD13 ' A' ' 32' ' ' LEU . 70.1 m-80 -118.2 129.73 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 60.439999999999998 110.899 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -172.6 159.76 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 74.310000000000002 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.1 9.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 71.510000000000005 112.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.48 171.01 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 62.329999999999998 111.144 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -172.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.019999999999996 111.152 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -51.54 128.06 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 70.430000000000007 110.844 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -86.1 -175.94 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 61.030000000000001 110.895 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.99 -53.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.129999999999995 110.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 p -155.82 176.38 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 65.040000000000006 110.864 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -139.66 126.89 21.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 72.329999999999998 110.878 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -114.04 104.55 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 64.099999999999994 111.099 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.0 p -101.45 108.31 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 53.039999999999999 111.144 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -130.15 136.17 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 61.310000000000002 110.833 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.58 169.89 15.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 74.120000000000005 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.21 129.19 44.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 51.340000000000003 110.862 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -113.03 76.43 2.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.200000000000003 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -49.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 64.109999999999999 112.394 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -72.03 145.19 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 75.409999999999997 111.132 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.39 98.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 35.119999999999997 112.471 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -154.56 155.07 34.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 64.409999999999997 111.115 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.55 130.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 73.329999999999998 110.864 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.657 HG22 ' CE2' ' A' ' 83' ' ' PHE . 92.7 t -82.02 109.08 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.120000000000005 111.114 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.04 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 65.109999999999999 111.085 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -145.85 154.56 42.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 71.219999999999999 110.811 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.73 143.9 35.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 72.25 111.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -128.07 145.38 51.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 62.229999999999997 110.99 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.98 13.8 8.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.306 -0.406 . . . . 74.030000000000001 110.84 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.84 101.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 51.020000000000003 111.083 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.0 m -60.29 96.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 72.409999999999997 111.158 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 64' ' ' ALA . 97.2 t -92.54 112.6 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 75.349999999999994 111.046 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 HG23 ' A' ' 63' ' ' THR . 14.0 t -105.51 174.84 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 63.240000000000002 111.146 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -135.9 158.14 45.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.84 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -158.51 85.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 71.019999999999996 110.918 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.04 -91.59 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 74.519999999999996 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.57 4.92 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 74.099999999999994 110.882 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 75.219999999999999 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -132.64 139.08 47.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 75.109999999999999 110.913 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 56' ' ' THR . 5.7 t -139.21 148.85 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 111.134 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -133.66 144.4 49.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 111.066 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 161.08 39.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 110.947 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -131.62 -51.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.896 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.1 39.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 64.319999999999993 111.117 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.6 1.17 83.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 64.439999999999998 112.491 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -115.13 -20.82 10.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.32 . . . . 71.340000000000003 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -115.33 -44.35 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 63.310000000000002 110.916 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.521 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.95 56.73 11.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.501 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -145.93 96.55 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.430000000000007 111.13 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.0 tt -138.27 160.27 39.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 72.140000000000001 111.021 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -66.74 161.52 60.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 62.130000000000003 111.036 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.3 Cg_endo -69.7 -19.73 36.03 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 63.25 112.329 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.08 116.24 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.779 -0.724 . . . . 71.540000000000006 112.528 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -177.82 172.08 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.420000000000002 111.108 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 86.7 p -136.24 131.63 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.876 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.08 117.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 111.106 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -110.4 134.8 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 61.109999999999999 110.868 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.645 ' CE2' HG11 ' A' ' 37' ' ' VAL . 27.8 p90 -122.74 146.44 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 52.149999999999999 110.918 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.02 173.32 14.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 73.409999999999997 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.7 p90 -171.18 -179.5 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.219999999999999 110.867 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -131.43 125.95 33.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 53.409999999999997 110.873 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.03 156.64 20.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 64.329999999999998 112.471 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.17 116.57 32.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 74.109999999999999 110.891 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.35 28.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 52.439999999999998 112.486 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -33.74 16.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.744 2.296 . . . . 74.329999999999998 112.324 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.46 26.93 28.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 72.030000000000001 112.494 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -112.28 76.03 1.82 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.727 0.775 . . . . 74.409999999999997 110.898 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 157.94 58.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 74.120000000000005 112.356 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -147.44 173.12 12.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 70.030000000000001 110.849 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.61 46.82 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 72.340000000000003 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.6 m -65.75 100.61 0.56 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.45 144.04 47.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.510000000000005 110.876 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.2 pp -160.19 145.84 15.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 64.540000000000006 110.92 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.68 ' HB2' HD12 ' A' ' 96' ' ' LEU . 6.4 t30 60.67 54.82 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 64.439999999999998 110.885 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.9 39.53 46.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 65.299999999999997 112.514 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.56 65.24 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 70.299999999999997 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.73 104.62 2.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 72.420000000000002 110.852 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 72.230000000000004 110.908 -179.886 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 71.400000000000006 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -162.36 163.89 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 72.349999999999994 111.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -153.0 138.24 17.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 73.200000000000003 111.153 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -83.47 138.46 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.08 158.95 43.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 54.039999999999999 111.15 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -104.47 139.8 38.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 110.897 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -99.7 -62.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 72.040000000000006 111.16 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.82 143.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 75.450000000000003 110.865 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.15 125.9 51.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 75.019999999999996 110.851 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -112.2 107.04 15.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 73.109999999999999 110.989 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 64.510000000000005 112.511 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -117.61 -17.52 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 74.040000000000006 111.164 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 140.88 16.87 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 53.25 112.537 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.76 149.61 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.829 0.347 . . . . 74.129999999999995 110.888 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.1 106.14 2.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 64.239999999999995 112.469 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.27 138.22 18.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 52.350000000000001 112.453 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.34 100.67 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 71.349999999999994 110.819 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -90.17 132.67 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 74.439999999999998 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.5 m -110.48 122.99 49.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.129 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.47 131.78 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 53.310000000000002 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.71 126.95 18.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 71.049999999999997 110.921 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -119.42 135.02 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 71.129999999999995 110.885 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 t -168.2 140.65 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 64.450000000000003 111.141 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.29 -61.88 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 60.009999999999998 112.513 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -60.2 165.83 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 72.140000000000001 111.162 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.5 p -59.92 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 64.200000000000003 111.178 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 127.15 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 70.230000000000004 110.854 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -176.29 4.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 62.130000000000003 110.941 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -140.91 -52.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 72.349999999999994 110.885 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.47 174.51 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 44.109999999999999 110.854 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -132.2 126.99 34.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.498 . . . . 74.209999999999994 110.932 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.31 105.69 12.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 64.109999999999999 111.113 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 81' ' ' PHE . 5.2 p -105.0 120.66 55.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 61.310000000000002 111.13 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 63' ' ' THR . 6.3 pm0 -133.48 156.52 47.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 51.520000000000003 110.866 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.82 168.76 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 74.030000000000001 110.902 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.24 133.19 43.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 110.803 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -113.53 73.42 2.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 74.219999999999999 110.926 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -50.14 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.66 2.24 . . . . 62.32 112.387 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -74.05 145.56 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.400000000000006 111.115 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -38.24 99.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 41.100000000000001 112.504 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -154.82 157.86 38.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 72.430000000000007 111.186 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -173.34 130.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 60.5 110.97 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.644 HG22 ' CE2' ' A' ' 83' ' ' PHE . 81.3 t -81.69 107.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.299999999999997 111.119 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -48.34 79.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 44.25 111.165 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.32 156.22 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.787 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 134.56 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 64.420000000000002 111.128 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -118.59 145.66 45.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.349999999999994 110.863 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.27 13.49 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 71.019999999999996 110.854 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 103.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.030000000000001 111.153 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -63.2 97.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 55.119999999999997 111.139 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 64' ' ' ALA . 84.0 t -89.1 131.09 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.125 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -119.7 172.53 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -134.03 155.98 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 61.229999999999997 110.893 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.76 85.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 45.399999999999999 110.919 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.83 -93.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.229999999999997 112.52 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.26 17.09 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 73.310000000000002 110.823 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -129.56 146.71 51.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.209999999999994 110.869 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -130.67 160.46 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 110.894 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 38' ' ' GLU . 41.1 m -152.71 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 73.299999999999997 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.18 134.63 48.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 111.103 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 156.53 47.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 55.299999999999997 110.895 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -131.43 -51.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 63.100000000000001 110.884 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -101.9 39.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 73.129999999999995 111.11 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -0.29 75.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 33.039999999999999 112.496 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -114.2 -25.39 8.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 64.120000000000005 110.92 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.537 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -108.58 -47.36 3.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 55.43 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.79 55.6 19.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 72.530000000000001 112.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -136.51 94.84 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 62.25 111.175 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.6 tt -137.13 160.77 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 62.5 110.93 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -76.64 162.28 71.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 71.319999999999993 111.049 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.654 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.81 -8.37 23.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.633 2.222 . . . . 74.430000000000007 112.319 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.6 115.83 0.86 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.713 -0.756 . . . . 72.450000000000003 112.523 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.81 172.16 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 71.400000000000006 111.046 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -131.63 131.62 43.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 70.439999999999998 110.795 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.05 141.49 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 73.150000000000006 111.162 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -132.91 164.31 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 75.549999999999997 110.806 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 37' ' ' VAL . 29.3 p90 -156.33 143.15 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 73.409999999999997 110.886 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.41 172.29 14.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 73.409999999999997 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -170.0 178.91 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.369 . . . . 73.549999999999997 110.895 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.14 149.42 50.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 73.349999999999994 110.852 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.68 160.6 29.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.712 -0.756 . . . . 65.209999999999994 112.461 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 71.519999999999996 110.837 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.84 -159.9 29.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.783 -0.722 . . . . 23.140000000000001 112.488 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -37.24 9.66 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.724 2.283 . . . . 71.030000000000001 112.406 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.84 28.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 75.129999999999995 112.495 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 78.99 2.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.71 0.767 . . . . 74.439999999999998 110.785 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 168.14 22.43 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 74.409999999999997 112.386 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 m -146.68 170.33 17.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 63.130000000000003 110.869 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.37 44.35 9.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 73.239999999999995 110.917 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.2 m -64.53 92.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.400000000000006 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 144.06 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 62.310000000000002 110.922 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.1 pp -158.76 155.86 28.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.909 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' HB2' HD12 ' A' ' 96' ' ' LEU . 6.8 t-20 64.67 46.66 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 71.239999999999995 110.914 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.84 41.88 54.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 65.329999999999998 112.493 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.05 67.05 1.8 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.67 -0.776 . . . . 72.549999999999997 112.517 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.3 m -156.35 108.87 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 43.140000000000001 110.761 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 35.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 73.129999999999995 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.779 0.323 . . . . 64.010000000000005 111.184 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.55 41.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 75.439999999999998 111.114 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -138.83 132.41 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.124 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -78.02 146.15 35.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.925 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.23 150.73 29.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 111.044 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -92.33 141.81 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.010000000000005 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -102.83 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 64.409999999999997 111.165 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -174.14 127.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 74.049999999999997 110.864 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.64 127.71 55.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -110.59 83.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.962 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.8 -87.02 0.65 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 64.329999999999998 112.505 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -102.31 -17.58 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 111.13 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.3 153.68 23.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 73.140000000000001 112.489 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -140.61 145.19 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 73.510000000000005 110.903 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.54 113.84 4.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 72.310000000000002 112.479 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.21 136.67 19.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 45.340000000000003 112.479 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.72 94.45 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 71.25 110.882 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.47 136.63 39.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.473 . . . . 73.430000000000007 110.964 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 m -113.87 105.19 12.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.37 131.72 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 75.439999999999998 111.061 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -136.48 121.29 18.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 110.868 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.47 119.75 37.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 73.519999999999996 110.889 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.701 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -166.93 157.91 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 72.219999999999999 111.138 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.25 -28.32 15.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 72.319999999999993 112.475 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.4 p -103.81 170.19 8.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 75.450000000000003 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -171.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 70.439999999999998 111.12 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 t -51.57 125.09 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.510000000000005 110.787 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 -176.31 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 65.430000000000007 110.902 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -142.88 -52.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 32.299999999999997 110.868 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.79 175.78 13.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 64.25 110.921 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -144.26 127.09 16.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 73.519999999999996 110.928 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 65' ' ' LYS . 5.4 m -118.34 100.78 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 72.439999999999998 111.116 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 81' ' ' PHE . 4.5 p -101.48 116.12 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 111.15 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.611 ' OE1' HG22 ' A' ' 36' ' ' THR . 7.5 pm0 -126.17 158.97 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 110.87 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.56 171.11 17.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 75.430000000000007 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 130.49 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 65.530000000000001 110.84 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.68 75.43 1.85 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.69 0.757 . . . . 70.140000000000001 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 -49.61 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 65.409999999999997 112.33 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.8 p -73.92 144.47 45.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 72.549999999999997 111.11 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.66 98.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 73.430000000000007 112.478 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -156.1 153.25 29.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 63.350000000000001 111.176 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.15 131.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.150000000000006 110.927 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.4 t -79.64 96.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.439999999999998 111.088 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -63.26 -41.22 99.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 61.329999999999998 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -135.58 148.92 49.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 64.230000000000004 110.787 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.89 160.48 39.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 71.299999999999997 111.085 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -147.55 142.07 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.877 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.36 20.28 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.86 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -171.97 107.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 53.509999999999998 111.1 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.5 m -68.34 95.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 73.25 111.216 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.6 140.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 64.420000000000002 111.17 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.9 m -129.96 141.67 50.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 60.229999999999997 111.192 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.93 156.58 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 64.239999999999995 110.909 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -161.7 85.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 64.109999999999999 110.884 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.86 -92.3 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 65.420000000000002 112.558 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.24 18.09 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 75.230000000000004 110.816 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -131.22 146.05 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.420000000000002 110.822 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -131.29 160.69 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.867 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -148.95 148.97 30.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 62.130000000000003 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -127.43 127.99 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 75.150000000000006 111.135 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.07 156.65 48.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 74.400000000000006 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.36 -49.28 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.977 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.71 38.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 55.439999999999998 111.146 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.79 1.38 83.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 32.240000000000002 112.461 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.76 -25.24 7.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.736 0.303 . . . . 74.420000000000002 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.19 -37.79 5.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.349999999999994 110.884 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.46 54.83 14.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 53.420000000000002 112.462 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.08 96.82 3.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 54.43 111.142 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.4 tt -138.78 160.35 39.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.530000000000001 110.928 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.99 160.86 81.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.541 0.686 . . . . 44.109999999999999 111.147 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -20.77 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.618 2.212 . . . . 74.230000000000004 112.343 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 27' ' ' THR . . . -135.9 116.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 75.049999999999997 112.47 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.43 172.05 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.326 . . . . 54.219999999999999 111.099 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -138.15 131.62 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.430000000000007 110.921 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.08 114.27 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 111.125 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -103.15 125.77 50.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 54.329999999999998 110.849 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.547 ' HE2' HG11 ' A' ' 37' ' ' VAL . 28.8 p90 -114.55 152.87 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 72.310000000000002 110.864 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.54 167.59 24.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.654 -0.784 . . . . 55.030000000000001 112.458 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CE1' HG22 ' A' ' 47' ' ' VAL . 9.0 p90 -160.42 -176.27 5.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.361 . . . . 54.149999999999999 110.93 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -132.04 133.62 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 63.43 110.886 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.67 158.65 27.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 74.120000000000005 112.499 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.19 117.82 35.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 75.109999999999999 110.918 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -161.65 29.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.78 -0.724 . . . . 73.450000000000003 112.542 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -39.9 5.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 63.140000000000001 112.328 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.61 26.68 26.73 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.722 -0.751 . . . . 72.109999999999999 112.497 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -111.91 78.45 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.674 0.749 . . . . 62.119999999999997 110.86 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 165.8 29.61 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.693 2.262 . . . . 74.409999999999997 112.43 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.6 p -148.48 174.85 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 73.200000000000003 110.838 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 58.13 49.54 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 54.530000000000001 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 m -64.59 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 35.229999999999997 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 143.98 49.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 110.897 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -157.21 155.79 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.89 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.2 t30 65.09 45.83 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 73.420000000000002 110.903 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.61 42.03 55.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 72.310000000000002 112.453 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.92 67.82 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.688 -0.767 . . . . 71.25 112.517 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.9 t -156.33 105.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 72.439999999999998 110.89 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 71.400000000000006 110.928 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.714 0.292 . . . . 75.450000000000003 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.76 162.25 35.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.319999999999993 111.111 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.5 147.64 32.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 111.112 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -88.26 146.19 25.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 110.855 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.6 173.03 11.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 30.309999999999999 111.125 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 159.8 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 51.229999999999997 110.96 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.81 -58.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.409 . . . . 55.009999999999998 111.111 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -178.59 132.14 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 110.88 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.22 127.85 55.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.839 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -110.57 82.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.109999999999999 110.924 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.56 -86.74 0.62 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 72.129999999999995 112.464 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -101.35 -17.46 16.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 64.540000000000006 111.218 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.4 155.48 25.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 54.530000000000001 112.443 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -143.22 143.3 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 72.049999999999997 110.948 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.62 117.51 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 64.420000000000002 112.533 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.36 143.58 16.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 43.340000000000003 112.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.4 112.81 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 64.219999999999999 110.873 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -97.33 134.42 40.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.987 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 m -116.3 108.41 16.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 74.450000000000003 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.3 t -107.14 131.96 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 64.519999999999996 111.145 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.63 118.41 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -118.59 101.37 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 64.129999999999995 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.49 155.66 34.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 74.439999999999998 111.19 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 52.05 28.27 24.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 74.349999999999994 112.448 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -114.23 158.64 21.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 70.349999999999994 111.147 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.66 157.0 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 62.399999999999999 111.14 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 m -52.0 112.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 71.239999999999995 110.874 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HB2' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -91.11 174.62 7.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 110.956 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -137.42 -52.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.861 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.55 152.94 49.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 64.140000000000001 110.852 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -119.29 127.17 52.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 63.350000000000001 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -125.28 108.12 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.530000000000001 111.115 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.2 p -102.39 111.29 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 41.009999999999998 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.0 pt-20 -131.92 138.69 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 110.883 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.2 171.53 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.885 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.5 129.26 45.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 50.049999999999997 110.875 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -113.31 75.67 2.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 64.340000000000003 110.822 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -49.74 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.687 2.258 . . . . 51.130000000000003 112.3 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -71.36 145.05 49.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 53.43 111.153 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.26 100.07 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 73.439999999999998 112.515 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -154.61 155.81 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.847 0.356 . . . . 74.349999999999994 111.164 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -173.55 130.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 71.019999999999996 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG22 ' HE2' ' A' ' 83' ' ' PHE . 71.9 t -85.96 112.28 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.439999999999998 111.138 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -87.51 -32.71 19.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 63.140000000000001 111.143 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.05 149.55 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 63.200000000000003 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.27 133.23 5.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 111.116 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -133.06 147.96 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.937 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.77 16.42 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 74.420000000000002 110.868 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.04 95.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 51.329999999999998 111.148 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.5 m -56.17 99.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 53.450000000000003 111.1 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 53' ' ' ALA . 94.4 t -91.37 124.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 111.099 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -115.9 172.07 7.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.096 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -133.54 154.39 50.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 72.219999999999999 110.862 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.7 m -159.23 85.63 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.319999999999993 110.843 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.35 -93.33 0.79 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.239999999999995 112.546 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -126.51 15.0 7.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 72.109999999999999 110.825 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -126.83 146.86 50.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 72.530000000000001 110.838 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -131.54 150.6 52.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 111.002 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 38' ' ' GLU . 71.5 m -140.0 147.76 40.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.288 -0.414 . . . . 71.109999999999999 111.207 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -124.59 127.29 47.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 74.109999999999999 111.117 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 126.26 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 61.030000000000001 110.89 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -106.34 -45.38 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 73.430000000000007 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.08 39.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 73.25 111.081 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.17 -0.61 66.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 41.140000000000001 112.504 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -115.42 -33.78 5.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.793 0.33 . . . . 70.450000000000003 110.893 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.94 -48.09 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.209999999999994 110.902 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.58 52.12 54.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.200000000000003 112.506 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -124.66 117.66 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.94 0.4 . . . . 71.349999999999994 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -141.75 160.92 39.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 65.120000000000005 110.856 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -103.51 163.61 17.09 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 64.319999999999993 111.155 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.79 -7.89 22.22 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.746 2.297 . . . . 75.340000000000003 112.289 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -155.94 114.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.420000000000002 112.462 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.64 172.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 64.129999999999995 111.089 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -121.36 131.19 54.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.815 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 24' ' ' VAL . 31.6 m -131.4 125.88 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 50.32 111.083 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 p -129.86 156.59 44.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.209999999999994 110.827 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.715 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.4 p90 -149.41 139.19 21.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 71.540000000000006 110.856 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.46 168.84 15.7 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.729 -0.748 . . . . 52.350000000000001 112.42 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' HE2' HG22 ' A' ' 47' ' ' VAL . 12.4 p90 -173.81 176.2 2.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 74.409999999999997 110.891 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -125.84 173.12 9.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 65.230000000000004 110.823 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.34 167.66 40.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 72.329999999999998 112.486 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -120.05 109.52 15.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 51.32 110.844 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.02 -159.8 31.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 70.040000000000006 112.419 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.61 10.46 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.631 2.221 . . . . 70.25 112.368 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.32 26.67 29.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.752 . . . . 64.129999999999995 112.483 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 m -112.28 76.67 1.97 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.669 0.747 . . . . 74.430000000000007 110.879 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 159.26 54.1 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 61.509999999999998 112.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.58 171.37 15.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.240000000000002 110.884 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 58.68 47.61 12.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 62.310000000000002 110.893 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.0 m -66.61 101.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.030000000000001 110.827 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.25 141.76 51.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 110.953 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.5 pp -158.25 148.11 19.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 63.229999999999997 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.569 ' HB2' HD12 ' A' ' 96' ' ' LEU . 31.0 m-20 58.47 56.11 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.929 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.37 41.5 30.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 51.109999999999999 112.511 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.55 58.09 15.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 74.329999999999998 112.459 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.36 105.66 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 72.519999999999996 110.884 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 71.530000000000001 110.883 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.791 0.329 . . . . 51.030000000000001 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.758 ' HB2' HD23 ' A' ' 96' ' ' LEU . . . -122.69 141.35 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 44.439999999999998 111.1 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -130.81 109.7 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 60.32 111.116 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.75 141.05 57.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 73.540000000000006 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.55 32.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 43.140000000000001 111.119 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.74 122.71 41.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 75.239999999999995 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -58.47 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 62.420000000000002 111.169 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.52 138.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.409999999999997 110.877 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.58 127.06 54.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 72.310000000000002 110.892 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.66 85.96 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 75.349999999999994 110.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.55 -88.99 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 52.5 112.512 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -107.88 -17.59 14.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 45.509999999999998 111.126 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.7 144.9 19.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 65.040000000000006 112.493 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.52 ' HE2' HG23 ' A' ' 45' ' ' THR . 24.1 p90 -128.77 139.75 52.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 70.219999999999999 110.882 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.94 105.57 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 51.439999999999998 112.503 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.63 141.18 25.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 40.219999999999999 112.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.34 94.48 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 71.109999999999999 110.914 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -90.35 136.86 32.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.933 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -112.9 105.85 14.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 73.519999999999996 111.193 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG22 HG21 ' A' ' 37' ' ' VAL . 20.3 t -96.7 131.79 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 111.163 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.66 123.42 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 71.420000000000002 110.939 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.411 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.7 m-20 -116.96 103.88 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 71.120000000000005 110.888 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -159.59 130.33 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 74.299999999999997 111.134 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.48 -28.99 3.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 72.150000000000006 112.451 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -108.63 177.37 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 71.409999999999997 111.101 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -60.01 -172.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 74.510000000000005 111.133 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -51.19 131.54 27.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 63.140000000000001 110.874 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.411 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -94.94 -176.52 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 64.109999999999999 110.945 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 -53.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 54.020000000000003 110.902 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 p -153.55 176.11 12.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 64.319999999999993 110.81 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.477 ' HE3' HG23 ' A' ' 37' ' ' VAL . 42.1 p-90 -139.04 127.12 22.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 74.25 110.941 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.3 m -113.49 105.07 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.161 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' HE3' ' A' ' 35' ' ' TRP . 24.0 t -101.1 105.75 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 75.099999999999994 111.075 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.59 152.61 44.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.519999999999996 110.868 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.438 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.77 170.74 19.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 65.109999999999999 110.92 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.97 131.38 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.140000000000001 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.6 m-85 -111.75 78.99 2.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.656 0.741 . . . . 50.450000000000003 110.889 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.96 0.61 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.729 2.286 . . . . 74.230000000000004 112.401 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.0 p -72.72 144.47 47.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 61.439999999999998 111.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 64.219999999999999 112.548 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.52 HG23 ' HE2' ' A' ' 18' ' ' PHE . 99.5 m -156.49 142.69 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 73.340000000000003 111.122 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -154.87 130.84 10.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 54.509999999999998 110.933 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.761 HG22 ' CE1' ' A' ' 83' ' ' PHE . 84.5 t -76.04 97.43 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 72.310000000000002 111.13 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 m -62.64 -43.97 97.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.439999999999998 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 143.74 30.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 53.32 110.832 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.57 139.87 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 70.019999999999996 111.054 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -123.65 143.56 50.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 73.310000000000002 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.44 12.97 8.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.848 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.03 104.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 64.340000000000003 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.3 m -63.32 97.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 63.210000000000001 111.179 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 47' ' ' VAL . 85.1 t -87.34 134.19 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 64.120000000000005 111.111 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -122.9 171.14 9.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 71.230000000000004 111.178 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -131.79 153.67 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 110.899 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -158.62 85.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 54.200000000000003 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.23 -94.24 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.688 -0.768 . . . . 60.420000000000002 112.494 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.26 13.42 7.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.825 0.345 . . . . 75.230000000000004 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -128.03 146.88 50.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 44.219999999999999 110.879 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -128.57 159.16 36.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 73.310000000000002 110.843 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 38' ' ' GLU . 19.0 m -145.95 149.16 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 64.439999999999998 111.114 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.4 129.78 45.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 74.430000000000007 111.157 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.73 155.94 49.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 71.230000000000004 110.912 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -131.48 -52.01 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 74.019999999999996 110.913 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.07 39.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.099999999999994 111.134 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.25 0.14 75.35 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 74.439999999999998 112.495 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -114.55 -26.5 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 74.099999999999994 110.878 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.31 -46.95 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 73.239999999999995 110.905 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.76 55.55 20.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 73.120000000000005 112.452 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.05 95.61 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 111.083 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.5 tt -135.98 160.68 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.914 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -72.19 162.12 75.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.684 . . . . 74.310000000000002 111.119 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.43 23.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.713 2.275 . . . . 64.120000000000005 112.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.75 116.16 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.77 -0.729 . . . . 71.340000000000003 112.511 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.25 172.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 62.350000000000001 111.081 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 p -145.86 131.7 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 41.310000000000002 110.845 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.01 118.18 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 60.130000000000003 111.074 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 121.84 42.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 110.866 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.24 135.27 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.15 -179.95 19.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 72.400000000000006 112.483 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.761 ' CE1' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.07 175.74 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 70.209999999999994 110.907 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -131.15 125.82 34.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 71.150000000000006 110.849 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.45 151.02 19.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 55.350000000000001 112.451 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.6 112.17 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 42.439999999999998 110.842 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.85 -160.3 29.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 71.019999999999996 112.473 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -44.96 1.78 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.67 2.247 . . . . 72.510000000000005 112.384 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.02 27.15 11.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 52.520000000000003 112.477 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -112.17 76.09 1.78 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 54.329999999999998 110.848 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 166.7 26.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 71.430000000000007 112.323 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -148.53 179.86 7.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 110.867 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 51.87 62.44 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.450000000000003 110.851 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 16.1 m -79.13 102.99 8.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 51.409999999999997 110.878 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.91 140.43 42.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 63.539999999999999 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 6' ' ' ALA . 4.4 pp -148.82 155.94 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 61.039999999999999 110.954 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.29 43.66 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.210000000000001 110.914 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.42 42.03 50.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 73.420000000000002 112.435 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.24 71.78 1.25 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 63.43 112.477 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 t -156.16 104.52 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 70.230000000000004 110.87 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 73.129999999999995 110.907 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.774 0.321 . . . . 62.409999999999997 111.141 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.52 163.77 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 111.083 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -153.03 147.66 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 111.194 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -85.97 146.34 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 63.210000000000001 110.845 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -142.41 175.94 9.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 64.349999999999994 111.1 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 166.74 12.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.420000000000002 110.867 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 75.099999999999994 111.145 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.72 134.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 64.340000000000003 110.847 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 127.54 55.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 74.140000000000001 110.79 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.8 p90 -110.51 82.67 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.487 . . . . 72.310000000000002 110.96 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.57 -85.87 0.63 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 72.340000000000003 112.546 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -102.82 -17.46 15.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.846 0.355 . . . . 43.219999999999999 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.07 154.31 24.36 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 71.530000000000001 112.534 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.41 143.42 31.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 73.540000000000006 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 122.87 7.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 63.240000000000002 112.467 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 139.13 14.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.746 . . . . 20.140000000000001 112.544 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -134.38 110.4 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 73.150000000000006 110.847 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.4 135.27 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 65.129999999999995 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -109.95 129.52 55.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 54.049999999999997 111.074 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.47 131.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 61.240000000000002 111.12 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -141.7 118.25 10.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.972 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.52 143.65 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 61.32 110.9 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 155.65 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.319999999999993 111.109 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.93 5.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 61.420000000000002 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.54 159.12 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 74.049999999999997 111.166 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.143 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -51.57 129.14 25.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.519999999999996 110.86 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.05 -176.61 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -141.01 -52.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.904 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 p -154.22 171.09 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 64.129999999999995 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -130.63 127.01 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 110.927 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.4 m -116.25 104.98 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 64.040000000000006 111.216 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.3 p -101.4 112.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 72.540000000000006 111.085 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -133.61 141.09 47.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 72.200000000000003 110.915 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.72 169.96 16.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 71.319999999999993 110.899 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.49 128.03 44.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 64.109999999999999 110.846 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.69 77.08 2.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 74.420000000000002 110.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -49.63 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 62.329999999999998 112.415 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -72.69 145.2 47.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 70.239999999999995 111.218 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 98.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 52.32 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -154.58 153.51 31.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.828 0.347 . . . . 64.040000000000006 111.098 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -173.68 131.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.549999999999997 110.917 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 83' ' ' PHE . 94.4 t -77.78 106.81 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 111.204 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -48.65 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 50.240000000000002 111.147 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 m -146.47 151.48 37.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 110.821 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.21 42.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 71.540000000000006 111.066 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -142.69 145.24 33.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 72.010000000000005 110.978 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.88 13.92 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.95 95.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 55.25 111.137 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.5 m -59.03 97.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 111.16 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 64' ' ' ALA . 23.7 t -92.69 112.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 75.040000000000006 111.135 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -102.35 175.01 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 73.209999999999994 111.16 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -133.51 157.51 45.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.5 m -158.69 85.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.430000000000007 110.854 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.49 0.9 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.239999999999995 112.538 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.76 11.75 7.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 74.239999999999995 110.835 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -120.45 147.0 45.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 64.329999999999998 110.848 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -132.98 142.66 48.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 110.93 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -141.14 147.12 37.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 72.530000000000001 111.131 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.853 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.35 140.77 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.153 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.53 159.0 43.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 74.430000000000007 110.939 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.45 -52.17 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.89 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.48 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.439999999999998 111.155 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.52 0.48 75.78 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 75.420000000000002 112.467 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -114.5 -22.8 9.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.312 . . . . 70.409999999999997 110.881 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -112.48 -47.18 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 110.897 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.62 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 52.01 55.04 23.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.668 -0.777 . . . . 71.239999999999995 112.542 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -137.04 95.1 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 65.420000000000002 111.123 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -136.18 160.73 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 61.43 110.868 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.59 162.21 64.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.63 0.728 . . . . 54.020000000000003 111.058 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.67 -8.46 23.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.722 2.282 . . . . 50.409999999999997 112.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.06 115.55 0.89 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 62.420000000000002 112.479 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.33 172.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 43.130000000000003 111.088 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.1 p -129.2 131.48 47.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 64.430000000000007 110.833 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.82 138.42 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 64.140000000000001 111.104 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 p -137.22 158.78 43.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.150000000000006 110.922 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' A' ' 37' ' ' VAL . 28.1 p90 -148.13 144.68 27.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 110.825 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.77 174.25 15.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.797 -0.716 . . . . 52.340000000000003 112.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.3 p90 -174.48 175.09 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 70.340000000000003 110.837 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -125.54 134.59 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 74.150000000000006 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.0 158.28 23.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 74.010000000000005 112.468 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 p -109.84 115.68 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 73.030000000000001 110.87 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.84 27.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 50.530000000000001 112.439 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -35.6 12.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 74.109999999999999 112.387 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.97 31.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.729 . . . . 41.509999999999998 112.519 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -112.5 75.45 1.78 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 64.519999999999996 110.831 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 155.85 64.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.645 2.23 . . . . 73.040000000000006 112.356 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.31 177.12 9.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 110.881 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 58.57 41.07 22.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 51.310000000000002 110.877 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.2 p -64.45 122.79 17.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 61.32 110.873 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 134.78 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 55.399999999999999 110.92 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.0 OUTLIER -146.06 149.07 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 64.230000000000004 110.94 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' HD12 ' A' ' 96' ' ' LEU . 40.9 t30 63.05 47.69 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.92 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.23 17.76 73.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.729 -0.748 . . . . 61.32 112.465 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.14 70.67 1.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.68 -0.772 . . . . 74.400000000000006 112.497 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.09 104.32 2.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 65.120000000000005 110.946 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 75.209999999999994 110.85 -179.865 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.862 0.363 . . . . 74.530000000000001 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.5 163.85 34.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.129999999999995 111.105 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.99 147.7 30.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.138 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -88.01 146.29 25.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.887 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.18 42.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 52.130000000000003 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 156.64 17.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.349999999999994 110.918 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 -60.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 74.310000000000002 111.126 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.58 145.72 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.821 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.64 126.87 53.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.239999999999995 110.917 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.2 86.1 2.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 75.450000000000003 110.875 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.59 -85.86 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 74.299999999999997 112.438 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -111.76 -17.6 12.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 53.140000000000001 111.126 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.76 151.03 22.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 62.340000000000003 112.463 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -131.53 154.95 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 75.409999999999997 110.869 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.93 118.86 4.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 71.439999999999998 112.508 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.32 148.78 18.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.685 -0.769 . . . . 33.409999999999997 112.498 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.95 102.29 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 72.129999999999995 110.837 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.18 144.29 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 61.420000000000002 110.939 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.7 m -120.52 121.57 38.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 43.450000000000003 111.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.09 131.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 111.118 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 118.18 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 74.010000000000005 110.905 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -111.26 137.76 48.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 73.040000000000006 110.909 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 t -172.36 135.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.120000000000005 111.098 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.96 -56.73 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.723 . . . . 71.239999999999995 112.531 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -63.88 172.26 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 65.230000000000004 111.098 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -66.45 -174.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 111.054 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 t -51.36 127.49 19.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 110.797 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 -176.52 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 75.400000000000006 110.933 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.63 -53.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 62.109999999999999 110.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.91 164.84 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 75.019999999999996 110.81 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -120.56 126.87 51.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.903 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.8 m -115.74 100.5 8.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 111.17 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.1 p -102.15 109.44 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 70.230000000000004 111.156 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.91 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 73.510000000000005 110.89 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.18 171.93 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 74.099999999999994 110.981 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.35 132.02 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 71.530000000000001 110.862 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.82 73.65 2.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 72.329999999999998 110.898 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -50.23 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 75.329999999999998 112.315 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.9 p -72.34 145.77 47.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 75.409999999999997 111.098 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.72 97.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.81 -0.71 . . . . 74.140000000000001 112.454 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -155.12 156.45 35.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.341 . . . . 72.040000000000006 111.078 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.58 131.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 73.420000000000002 110.916 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.66 HG22 ' CE2' ' A' ' 83' ' ' PHE . 80.4 t -80.08 103.12 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 52.420000000000002 111.18 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -75.38 -36.69 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.182 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.82 150.54 51.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 62.149999999999999 110.82 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.8 140.01 16.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 73.219999999999999 111.098 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -138.3 149.04 45.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.84 15.75 9.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 43.229999999999997 110.883 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.36 108.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.519999999999996 111.045 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.9 m -66.5 94.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 63.100000000000001 111.16 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.17 144.38 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 55.109999999999999 111.101 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 m -135.38 141.85 45.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.458 . . . . 62.549999999999997 111.209 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.89 155.24 21.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.439999999999998 110.927 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.18 85.72 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 43.119999999999997 110.878 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.37 -92.77 0.42 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.77 -0.728 . . . . 53.399999999999999 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -126.22 20.95 7.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.371 . . . . 72.099999999999994 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -134.15 146.45 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.841 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -133.34 150.55 51.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 110.922 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -138.04 149.38 45.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 111.207 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.829 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -126.25 125.39 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 75.099999999999994 111.094 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 134.16 32.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.938 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -111.0 -51.64 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.310000000000002 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.51 39.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 75.319999999999993 111.081 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.49 -0.82 74.13 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 61.240000000000002 112.506 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -113.59 -26.02 8.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 75.439999999999998 110.957 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 72' ' ' THR . 1.1 m-20 -107.23 -47.1 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.519999999999996 110.916 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.625 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.68 56.24 14.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 34.509999999999998 112.481 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' ASN . 70.6 p -136.94 95.04 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.339 . . . . 74.030000000000001 111.188 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.4 tt -137.16 160.87 37.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 31.140000000000001 110.966 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -78.92 162.53 64.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 72.400000000000006 111.109 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.76 -8.59 24.0 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 53.240000000000002 112.351 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.87 115.75 0.88 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 54.43 112.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.49 172.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.123 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -131.15 131.57 44.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 62.530000000000001 110.931 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.7 137.42 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.420000000000002 111.076 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.69 154.76 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 72.409999999999997 110.9 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 37' ' ' VAL . 24.1 p90 -145.31 142.21 29.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.898 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 176.32 17.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 75.030000000000001 112.501 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.66 ' CE2' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.34 179.12 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 75.120000000000005 110.872 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -133.8 144.53 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 74.450000000000003 110.884 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.92 160.38 28.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.799 -0.715 . . . . 63.439999999999998 112.531 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.96 109.63 21.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 61.32 110.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.6 -158.89 28.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 45.140000000000001 112.483 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -35.72 11.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 61.200000000000003 112.349 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.58 31.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 72.549999999999997 112.523 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 m -112.63 76.91 2.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 53.43 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 158.85 55.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.742 2.295 . . . . 73.010000000000005 112.35 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 174.76 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 64.040000000000006 110.879 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 m120 56.27 47.5 19.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 62.219999999999999 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -67.22 95.78 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.876 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 143.76 45.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 63.299999999999997 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -156.99 147.76 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 64.439999999999998 110.953 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.547 ' HB2' HD12 ' A' ' 96' ' ' LEU . 2.3 t-20 63.29 52.13 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.049999999999997 110.862 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.82 19.9 77.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.743 . . . . 41.399999999999999 112.458 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.13 68.26 1.33 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 51.130000000000003 112.468 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.0 105.07 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.019999999999996 110.871 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 65.540000000000006 110.877 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.807 0.337 . . . . 74.109999999999999 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -117.31 112.56 20.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 64.209999999999994 111.118 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.84 118.7 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 64.310000000000002 111.165 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.16 143.75 48.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.923 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.14 161.36 38.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 73.150000000000006 111.125 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.17 151.11 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 64.420000000000002 110.893 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -63.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 111.109 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 p -178.79 149.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.903 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.69 126.74 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 62.299999999999997 110.884 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.4 p90 -111.42 87.19 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.129999999999995 110.933 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.65 -81.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.746 -0.74 . . . . 74.219999999999999 112.484 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -117.04 -17.51 10.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 74.140000000000001 111.202 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.09 161.57 33.09 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 53.109999999999999 112.484 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -143.78 161.07 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 72.340000000000003 110.843 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.3 133.38 9.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 34.329999999999998 112.527 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 154.45 17.64 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 63.350000000000001 112.529 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 t -141.8 95.74 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 73.340000000000003 110.854 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -90.24 124.83 35.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.902 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 84.4 m -110.26 101.68 10.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.310000000000002 111.181 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 131.52 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 63.450000000000003 111.172 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -135.7 118.05 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 53.520000000000003 110.806 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.21 127.52 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 54.039999999999999 110.947 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 27' ' ' THR . 4.9 t -172.71 120.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.520000000000003 111.165 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.73 -50.9 0.87 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 53.439999999999998 112.473 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -75.34 171.97 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 72.510000000000005 111.143 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.0 p -64.4 178.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -51.95 107.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 54.340000000000003 110.841 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.686 HD22 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.69 -173.59 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 110.879 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -143.56 -53.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.340000000000003 110.88 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.41 ' OG ' HG23 ' A' ' 67' ' ' VAL . 23.1 t -138.77 159.44 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 75.099999999999994 110.823 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -128.69 127.22 41.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.2 m -134.21 112.12 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.092 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.2 t -101.43 105.65 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.510000000000005 111.105 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.03 144.44 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.439999999999998 110.896 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.92 168.92 19.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 70.120000000000005 110.936 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.24 129.36 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 63.409999999999997 110.87 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.85 76.62 2.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.609 0.719 . . . . 74.340000000000003 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -49.91 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.697 2.265 . . . . 70.010000000000005 112.319 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 1.2 p -71.65 144.96 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 111.147 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.19 98.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 64.549999999999997 112.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -154.7 155.4 34.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 74.049999999999997 111.137 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.78 130.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 63.350000000000001 110.912 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 83' ' ' PHE . 97.0 t -80.58 91.76 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.510000000000005 111.126 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 t -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.34 154.1 50.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.530000000000001 110.883 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.37 146.17 25.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 51.420000000000002 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -135.99 143.52 44.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.922 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.06 15.25 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.5 109.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.540000000000006 111.081 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -69.49 103.26 2.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 111.089 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.52 137.37 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 63.299999999999997 111.091 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -129.25 141.38 51.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 62.119999999999997 111.162 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -104.77 156.92 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 53.43 110.907 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -160.47 85.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 55.520000000000003 110.942 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.49 -91.97 0.58 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 51.350000000000001 112.47 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -126.37 8.17 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 75.120000000000005 110.843 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -123.27 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 53.210000000000001 110.892 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -128.18 157.52 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 110.929 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -141.18 149.71 41.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 42.509999999999998 111.086 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.59 131.32 48.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.127 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.41 138.22 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 62.130000000000003 110.912 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -117.44 -25.12 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 55.420000000000002 110.885 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 ' OG ' ' A' ' 34' ' ' SER . 6.1 m -102.77 39.28 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 63.130000000000003 111.157 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.74 2.04 70.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 63.229999999999997 112.555 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -33.89 4.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 74.239999999999995 110.97 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -101.5 -55.24 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.85 47.44 60.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 71.109999999999999 112.532 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.577 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.8 120.3 27.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 72.120000000000005 111.115 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 HD22 ' A' ' 32' ' ' LEU . 26.6 tp -146.49 161.01 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 70.340000000000003 110.984 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.69 163.23 18.5 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.549 0.69 . . . . 71.209999999999994 111.106 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.78 -8.44 23.61 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.672 2.248 . . . . 74.340000000000003 112.318 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -147.72 114.52 0.7 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 43.329999999999998 112.517 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.93 172.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 73.409999999999997 111.137 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.69 131.45 43.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 62.119999999999997 110.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.56 110.17 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 111.089 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.84 132.84 50.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 110.867 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.18 132.96 48.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 63.039999999999999 110.826 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.29 175.94 19.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 73.109999999999999 112.521 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 47' ' ' VAL . 26.9 p90 -169.37 -175.31 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 71.310000000000002 110.858 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -139.0 138.31 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 63.409999999999997 110.893 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.79 163.96 28.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 63.420000000000002 112.507 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -105.81 110.33 22.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 110.866 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.0 -163.68 36.59 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.817 -0.706 . . . . 71.230000000000004 112.537 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -34.2 15.2 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.284 . . . . 65.409999999999997 112.309 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.49 26.38 27.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 74.239999999999995 112.468 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -112.61 76.27 2.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 75.129999999999995 110.861 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 159.93 51.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.628 2.219 . . . . 62.420000000000002 112.345 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 t -148.25 174.92 11.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.427 . . . . 72.510000000000005 110.908 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.87 54.51 5.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.439999999999998 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.94 108.36 3.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 72.329999999999998 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 143.89 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 74.340000000000003 110.893 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.4 pp -157.08 153.71 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 110.888 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 96' ' ' LEU . 11.2 t-20 55.01 54.9 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 63.240000000000002 110.935 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.38 18.92 75.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.719 -0.753 . . . . 73.340000000000003 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 70.86 1.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.844 -0.693 . . . . 60.240000000000002 112.499 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.44 104.5 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 72.340000000000003 110.844 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 74.019999999999996 110.825 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 101' ' ' CYS . 1.1 m . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.796 0.331 . . . . 55.229999999999997 111.153 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.39 115.52 21.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 64.439999999999998 111.084 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 131.56 34.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 70.409999999999997 111.155 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -76.23 139.87 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 61.030000000000001 110.886 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.32 166.61 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 70.340000000000003 111.145 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.91 163.78 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 64.519999999999996 110.981 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 -56.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 33.240000000000002 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 131.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.76 127.55 55.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 74.099999999999994 110.892 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.54 82.18 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.901 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.53 -86.77 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 61.32 112.494 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -101.36 -17.6 16.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 74.129999999999995 111.084 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 154.81 24.47 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.725 . . . . 54.210000000000001 112.457 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -143.11 143.85 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 75.120000000000005 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 120.94 7.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 64.340000000000003 112.45 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.83 145.24 17.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.752 . . . . 42.009999999999998 112.465 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -140.84 94.7 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 60.32 110.9 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -90.28 122.95 33.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 71.409999999999997 110.937 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 101.53 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 72.319999999999993 111.124 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 37' ' ' VAL . 21.3 t -93.47 131.58 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.195 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -137.89 117.99 13.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.329999999999998 110.938 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -111.88 131.3 55.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -168.97 126.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 74.329999999999998 111.198 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.65 -19.0 16.75 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.782 -0.723 . . . . 74.439999999999998 112.492 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 32' ' ' LEU . 14.1 t -95.27 175.2 6.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 75.209999999999994 111.102 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -70.17 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.47 108.5 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.109999999999999 110.824 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.41 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -74.34 -174.0 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.010000000000005 110.903 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.0 -54.19 0.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.794 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 159.04 43.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 71.340000000000003 110.847 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.402 ' HD1' HD13 ' A' ' 73' ' ' LEU . 51.4 p-90 -128.65 127.1 41.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.145 -0.48 . . . . 74.140000000000001 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -122.61 110.64 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.329999999999998 111.205 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' NE1' ' A' ' 39' ' ' TRP . 22.4 t -103.9 105.47 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 63.549999999999997 111.176 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -126.35 154.9 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 65.329999999999998 110.888 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.422 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -153.2 169.32 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 75.519999999999996 110.962 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.14 128.33 44.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 64.129999999999995 110.91 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.78 76.82 2.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 72.549999999999997 110.946 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -49.78 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.684 2.256 . . . . 70.409999999999997 112.292 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.99 145.23 48.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.310000000000002 111.117 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 61.43 112.475 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -154.58 154.32 32.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.797 0.332 . . . . 74.549999999999997 111.15 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.71 130.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 70.109999999999999 110.88 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 83' ' ' PHE . 93.7 t -79.98 100.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 51.539999999999999 111.12 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -45.86 89.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 64.030000000000001 111.136 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -144.77 147.43 32.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 64.140000000000001 110.946 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.62 161.83 36.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 64.010000000000005 111.04 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.47 145.33 31.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.931 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.34 14.65 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 60.25 110.85 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.98 103.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 111.12 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 m -61.67 94.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.109999999999999 111.148 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 64' ' ' ALA . 92.1 t -91.5 112.43 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 63.039999999999999 111.1 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.4 174.57 5.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 72.040000000000006 111.088 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.08 156.45 44.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 74.400000000000006 110.844 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.02 85.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 62.130000000000003 110.845 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.68 -92.48 0.8 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 55.310000000000002 112.513 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.2 12.66 7.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 73.049999999999997 110.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -124.24 147.01 48.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -131.45 146.33 52.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 65.310000000000002 110.904 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 56' ' ' THR . 2.7 t -141.53 144.16 34.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -119.96 133.26 55.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 72.010000000000005 111.033 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.08 127.65 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 110.889 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -108.61 -32.05 7.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 65.109999999999999 110.91 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -103.72 39.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.083 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.14 2.51 69.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.825 -0.702 . . . . 75.230000000000004 112.456 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 -33.97 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.979 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.56 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -102.44 -56.1 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 110.877 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.03 43.9 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 74.420000000000002 112.49 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.4 t -125.66 121.45 33.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.336 . . . . 75.430000000000007 111.196 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -149.68 161.16 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.430000000000007 110.897 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.14 163.6 18.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 72.010000000000005 111.118 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.2 22.98 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.677 2.251 . . . . 54.130000000000003 112.322 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -148.86 114.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 74.209999999999994 112.475 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.88 172.47 0.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.802 0.334 . . . . 55.100000000000001 111.11 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.1 p -128.63 131.3 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 52.030000000000001 110.872 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.4 111.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 111.137 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -110.46 141.56 43.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 54.119999999999997 110.892 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.421 ' HE1' HG21 ' A' ' 37' ' ' VAL . 51.9 p90 -132.58 129.2 38.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 63.140000000000001 110.887 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.59 174.48 22.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 62.439999999999998 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.4 p90 -174.45 175.95 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 73.549999999999997 110.935 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -124.55 126.75 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 110.872 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.64 151.86 19.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 61.119999999999997 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.84 117.3 34.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 70.430000000000007 110.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.44 -159.25 28.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 54.219999999999999 112.502 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -35.41 12.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.254 . . . . 72.239999999999995 112.34 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.85 26.89 30.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 41.299999999999997 112.46 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.73 75.15 1.8 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.636 0.731 . . . . 75.430000000000007 110.805 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 153.85 68.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 72.299999999999997 112.335 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 -177.53 5.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 70.530000000000001 110.83 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.0 52.49 14.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 110.819 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.18 128.45 34.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.859 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 123.01 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 96' ' ' LEU . 4.2 pp -133.97 155.75 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.875 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 t30 63.71 38.65 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 45.140000000000001 110.855 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.61 30.1 53.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 73.140000000000001 112.499 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 75.52 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.801 -0.714 . . . . 73.140000000000001 112.508 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.3 104.25 2.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 63.520000000000003 110.834 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 72.209999999999994 110.882 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.807 0.337 . . . . 51.210000000000001 111.105 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -129.39 151.2 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 44.210000000000001 111.096 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.28 142.5 51.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.549999999999997 111.119 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -91.03 135.05 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.94 147.75 40.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 54.020000000000003 111.099 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.77 140.66 29.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 72.340000000000003 110.901 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 -56.13 2.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.439999999999998 111.112 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.96 147.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.310000000000002 110.823 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.94 126.58 52.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 70.319999999999993 110.836 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -111.71 86.55 2.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 110.96 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.86 -83.13 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 14.41 112.421 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 t -115.79 -17.71 10.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.420000000000002 111.15 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.47 164.65 38.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 55.439999999999998 112.499 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.06 157.99 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.947 0.403 . . . . 73.230000000000004 110.877 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.42 128.97 8.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 62.119999999999997 112.506 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.74 148.8 17.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 72.219999999999999 112.501 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.45 96.08 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 73.530000000000001 110.937 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -89.78 118.52 29.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -93.73 101.85 13.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.229999999999997 111.121 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.74 131.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 73.030000000000001 111.154 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -133.42 117.96 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.956 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -118.07 101.37 8.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 74.430000000000007 110.962 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.5 t -143.89 146.78 33.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 62.399999999999999 111.124 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.42 -65.11 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 75.5 112.563 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.0 p -61.43 167.5 3.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 65.230000000000004 111.107 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 60.25 111.116 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -51.5 123.41 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 55.119999999999997 110.904 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -176.02 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 74.209999999999994 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.17 -52.46 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.530000000000001 110.837 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.99 174.47 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 75.030000000000001 110.877 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -140.68 127.24 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 70.239999999999995 110.897 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 m -114.75 104.7 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 51.32 111.152 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.5 p -101.27 114.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 73.430000000000007 111.16 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -134.41 137.02 43.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 65.5 110.916 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.03 173.6 11.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 63.450000000000003 110.949 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -98.19 130.97 44.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.806 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.65 74.25 2.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.651 0.739 . . . . 75.400000000000006 110.871 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -50.05 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 62.049999999999997 112.339 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.6 p -72.77 145.95 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.109999999999999 111.207 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 97.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.757 . . . . 63.039999999999999 112.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -155.07 154.06 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 111.122 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 131.18 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 71.030000000000001 110.948 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 72.9 t -79.07 102.94 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 71.150000000000006 111.154 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -63.66 -40.12 96.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 54.020000000000003 111.142 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -148.0 161.98 40.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 70.329999999999998 110.883 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 160.65 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 71.349999999999994 111.127 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.99 144.51 30.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 72.409999999999997 110.92 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.05 13.97 9.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 63.140000000000001 110.833 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.0 99.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.019999999999996 111.046 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.1 m -59.19 97.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 61.329999999999998 111.111 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 64' ' ' ALA . 59.9 t -92.02 112.43 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.524 HG22 HG23 ' A' ' 63' ' ' THR . 13.9 t -105.12 175.09 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 111.079 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -136.2 160.03 39.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 71.530000000000001 110.871 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -161.02 85.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.866 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.16 -92.09 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.099999999999994 112.531 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.67 9.89 7.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 62.539999999999999 110.8 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -117.74 146.85 43.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.019999999999996 110.935 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -133.49 139.78 46.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.966 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 56' ' ' THR . 4.9 t -140.54 147.8 40.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 64.099999999999994 111.098 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.867 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.14 143.1 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 111.039 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 160.77 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 70.209999999999994 110.918 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -131.23 -51.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 73.030000000000001 110.895 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.16 38.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 70.150000000000006 111.14 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.89 1.51 83.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 64.109999999999999 112.511 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.98 -25.2 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 72.299999999999997 110.886 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.661 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -111.52 -38.06 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 65.120000000000005 110.883 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.56 53.78 23.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 71.439999999999998 112.461 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.661 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -131.61 94.58 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 54.340000000000003 111.186 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -138.25 160.57 39.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.96 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.98 161.82 64.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 72.299999999999997 111.12 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.69 -22.9 31.75 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.638 2.226 . . . . 71.409999999999997 112.374 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.24 115.47 1.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 54.240000000000002 112.466 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.54 172.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.761 0.315 . . . . 72.120000000000005 111.07 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -137.86 131.62 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 65.040000000000006 110.886 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.42 113.17 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 75.129999999999995 111.103 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' THR . 19.2 p -105.19 120.53 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 51.039999999999999 110.928 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.7 p90 -104.3 146.0 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.530000000000001 110.79 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.98 173.39 14.73 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.741 -0.742 . . . . 72.319999999999993 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.1 p90 -169.79 175.94 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 54.109999999999999 110.912 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 71.010000000000005 110.859 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.17 163.53 27.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.725 -0.75 . . . . 73.409999999999997 112.444 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -115.62 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 74.230000000000004 110.907 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.42 -159.79 30.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 34.509999999999998 112.488 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.63 10.46 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.707 2.271 . . . . 73.530000000000001 112.346 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.33 26.69 27.4 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.462 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.47 77.05 2.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.636 0.732 . . . . 63.140000000000001 110.9 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 162.6 41.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.737 2.291 . . . . 72.409999999999997 112.307 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.42 176.1 9.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.85 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 54.16 44.83 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.7 t -64.63 101.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.89 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 143.83 49.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 70.219999999999999 110.942 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.41 HD22 ' HB2' ' A' ' 6' ' ' ALA . 1.1 pp -155.76 153.07 29.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.863 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 58.68 52.04 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.865 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.48 41.26 45.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.73 . . . . 72.010000000000005 112.491 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.6 68.74 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.79 -0.719 . . . . 63.130000000000003 112.525 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.1 m -156.01 104.48 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 60.509999999999998 110.814 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 110.873 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.733 0.301 . . . . 73.109999999999999 111.212 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 71.329999999999998 111.063 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.41 138.83 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 74.530000000000001 111.104 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.58 135.29 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 70.5 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.6 168.52 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.519999999999996 111.102 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.14 148.07 30.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 64.200000000000003 110.897 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.16 -57.62 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.13 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -179.42 132.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 63.0 110.816 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.08 127.13 53.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 72.239999999999995 110.845 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.41 90.48 3.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 73.230000000000004 110.93 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.97 -94.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 51.399999999999999 112.465 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -101.28 -17.63 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 74.299999999999997 111.17 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.25 148.15 20.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 51.200000000000003 112.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -135.93 148.0 48.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 75.230000000000004 110.901 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.94 115.18 4.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 52.5 112.496 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.24 147.35 20.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.698 -0.763 . . . . 42.32 112.494 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.57 98.6 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 73.129999999999995 110.855 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.18 123.62 34.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 63.409999999999997 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 m -102.84 101.88 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 61.100000000000001 111.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -96.83 131.81 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 50.039999999999999 111.17 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.84 123.75 15.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 73.239999999999995 110.909 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -119.54 127.58 53.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 65.430000000000007 110.93 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.9 t -152.9 170.39 20.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.489 . . . . 30.309999999999999 111.088 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.9 28.19 23.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 25.350000000000001 112.407 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -128.56 165.03 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 72.319999999999993 111.173 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.5 p -67.05 -179.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.423 . . . . 75.019999999999996 111.12 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.52 129.86 26.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 64.019999999999996 110.831 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.51 -179.97 4.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 61.530000000000001 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.97 -53.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.52 164.84 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 64.239999999999995 110.848 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -125.26 126.98 46.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.409999999999997 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.91 106.34 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 45.109999999999999 111.169 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.4 t -105.57 105.53 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 70.030000000000001 111.089 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -119.56 153.42 35.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 73.219999999999999 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.453 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.74 169.11 23.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 110.886 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.33 128.19 44.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.240000000000002 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.37 77.77 2.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 73.329999999999998 110.872 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -49.84 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.653 2.236 . . . . 70.299999999999997 112.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 19.6 p -72.02 145.31 48.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 72.420000000000002 111.141 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.57 98.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 65.219999999999999 112.461 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.79 153.39 31.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 73.430000000000007 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.67 130.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 62.43 110.931 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.4 t -79.06 89.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 65.450000000000003 111.097 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.3 m -63.62 -39.12 93.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 63.240000000000002 111.101 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.32 147.11 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 70.319999999999993 110.901 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.92 130.0 17.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 73.420000000000002 111.067 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -128.55 142.93 50.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 64.450000000000003 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.08 15.19 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 110.863 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.54 120.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.530000000000001 111.061 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -79.26 106.33 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 64.409999999999997 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.72 140.05 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.239999999999995 111.133 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 m -128.1 142.08 51.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 45.329999999999998 111.148 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.97 156.13 20.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.409 . . . . 72.129999999999995 110.874 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.05 85.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 63.439999999999998 110.846 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.95 -91.51 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 41.130000000000003 112.511 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.36 9.14 7.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.530000000000001 110.852 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -122.15 146.75 46.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -129.7 162.24 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 74.549999999999997 110.901 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -149.54 149.67 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.420000000000002 111.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.88 128.36 45.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 63.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 153.88 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 110.918 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -131.2 -51.33 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.230000000000004 110.863 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.68 39.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 111.116 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.75 -0.49 74.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 75.5 112.462 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 -113.79 -29.43 7.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 62.420000000000002 110.951 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.2 m-20 -104.32 -41.05 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 110.871 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.02 54.28 23.51 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 74.099999999999994 112.5 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.612 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -129.43 94.85 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.323 . . . . 75.129999999999995 111.156 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -137.75 160.77 38.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.329999999999998 110.925 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -84.94 161.4 52.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 71.099999999999994 111.056 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.79 -8.35 23.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 62.119999999999997 112.368 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.88 115.36 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 71.25 112.482 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 179.88 172.27 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 71.430000000000007 111.118 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.22 131.47 48.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 60.039999999999999 110.841 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.2 m -133.72 119.54 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.14 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -117.19 135.53 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 71.239999999999995 110.855 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.7 p90 -130.06 142.05 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.837 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.7 162.39 12.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 54.329999999999998 112.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 23.1 p90 -156.66 177.84 11.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 72.349999999999994 110.913 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -133.24 127.44 33.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.200000000000003 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.4 151.79 20.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 64.340000000000003 112.512 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -93.57 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 72.030000000000001 110.89 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.21 -162.85 35.62 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.666 -0.778 . . . . 74.319999999999993 112.423 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -36.09 11.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 74.109999999999999 112.371 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.45 25.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 63.520000000000003 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m -112.74 76.24 2.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 71.439999999999998 110.844 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 155.66 65.26 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.655 2.237 . . . . 73.150000000000006 112.324 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -146.68 175.41 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.209999999999994 110.888 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 51.81 61.91 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.899 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.04 130.84 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.876 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.83 143.89 23.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 50.32 110.878 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 96' ' ' LEU . 4.2 pp -151.55 156.51 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.200000000000003 110.941 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 66.1 42.94 3.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 73.219999999999999 110.898 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.85 41.98 61.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 61.119999999999997 112.479 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.87 71.97 1.3 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.677 -0.773 . . . . 74.420000000000002 112.455 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.28 104.17 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 75.140000000000001 110.914 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 51.310000000000002 110.875 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.799 0.333 . . . . 40.240000000000002 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.84 36.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 73.239999999999995 111.09 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -141.32 128.97 21.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 45.310000000000002 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -67.03 143.98 56.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 110.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 21' ' ' SER . . . -149.53 156.75 42.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 62.399999999999999 111.127 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -106.74 116.61 32.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 73.319999999999993 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 74.140000000000001 111.174 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -179.72 141.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 74.030000000000001 110.832 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.49 126.32 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 63.200000000000003 110.835 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -112.46 107.06 15.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 72.120000000000005 110.928 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.21 -91.7 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 72.530000000000001 112.492 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -117.45 -17.5 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 63.210000000000001 111.171 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.57 147.41 21.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 34.030000000000001 112.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -128.53 155.0 45.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 63.240000000000002 110.936 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.36 106.94 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 71.349999999999994 112.514 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.48 116.94 5.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.724 -0.75 . . . . 60.329999999999998 112.454 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 1.1 t -106.85 95.96 6.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 110.849 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -95.07 121.19 36.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.329999999999998 110.917 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -100.44 115.74 30.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.195 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 79' ' ' VAL . 17.4 t -118.78 132.76 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 111.106 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.25 141.83 32.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.965 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -119.34 136.57 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.430000000000007 110.883 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.94 161.12 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 71.019999999999996 111.128 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.99 -101.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.792 -0.718 . . . . 73.109999999999999 112.467 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.33 177.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 72.239999999999995 111.094 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -58.49 -175.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 61.299999999999997 111.11 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.92 145.65 9.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 64.030000000000001 110.865 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.86 -175.98 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.530000000000001 110.891 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -28.99 9.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.875 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.8 163.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.329999999999998 110.848 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.464 ' CE2' HG21 ' A' ' 79' ' ' VAL . 61.3 p-90 -130.26 128.73 42.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 75.430000000000007 110.88 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.5 m -152.65 125.53 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.099999999999994 111.172 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.3 t -107.26 113.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.121 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' THR . 5.4 pm0 -120.79 152.02 38.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 64.430000000000007 110.819 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.448 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.29 167.2 30.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.540000000000006 110.911 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.24 130.03 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 55.119999999999997 110.896 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.23 78.5 2.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.63 0.729 . . . . 72.420000000000002 110.911 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 -49.82 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.65 2.233 . . . . 74.420000000000002 112.319 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' GLY . 21.9 p -72.82 145.27 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.439999999999998 111.153 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.59 98.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.310000000000002 112.45 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 p -154.74 152.77 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 73.519999999999996 111.107 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -173.83 131.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.926 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.579 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.9 t -79.73 108.18 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 73.329999999999998 111.06 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -50.48 70.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 71.140000000000001 111.175 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.01 139.61 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 53.109999999999999 110.899 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.2 143.85 48.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.088 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -130.96 140.87 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.912 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 t0 65.09 13.43 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.200000000000003 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.92 107.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 111.111 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -61.78 93.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.200000000000003 111.145 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.1 t -86.98 121.59 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 71.219999999999999 111.192 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -118.18 172.39 7.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.150000000000006 111.15 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.43 159.31 39.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 61.140000000000001 110.896 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.61 85.76 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.299999999999997 110.839 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 61.439999999999998 112.506 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.27 3.13 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.510000000000005 110.845 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -114.72 147.04 40.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.879 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -127.48 160.17 32.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 72.030000000000001 110.887 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 38' ' ' GLU . 30.0 m -152.62 149.17 28.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 54.329999999999998 111.146 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.99 115.87 15.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 50.509999999999998 111.114 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 147.95 50.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.94 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.35 -37.51 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 61.409999999999997 110.906 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.3 m -90.21 41.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 71.239999999999995 111.12 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.15 70.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 71.230000000000004 112.477 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -110.97 -19.57 12.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.74 0.305 . . . . 61.32 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -132.62 -70.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.219999999999999 110.882 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.28 -38.33 3.23 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.76 . . . . 41.119999999999997 112.425 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -51.43 103.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 71.310000000000002 111.077 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.24 160.21 23.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.91 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -71.61 161.65 77.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.703 . . . . 60.200000000000003 111.079 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.75 -15.83 37.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.617 2.211 . . . . 63.310000000000002 112.349 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.34 115.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 74.0 112.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.94 172.41 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 74.109999999999999 111.12 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -129.39 131.29 46.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 51.219999999999999 110.867 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 24' ' ' VAL . 3.7 p -127.42 113.96 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 111.105 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.93 134.66 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 110.857 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 17.9 p90 -139.36 137.16 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 110.886 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.55 170.92 21.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 70.219999999999999 112.495 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.579 ' CE1' HG22 ' A' ' 47' ' ' VAL . 12.0 p90 -159.08 -179.61 8.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.371 . . . . 64.519999999999996 110.901 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -125.25 126.04 44.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 110.866 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.78 158.22 22.74 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 75.530000000000001 112.458 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.0 m -103.36 109.43 21.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 75.409999999999997 110.832 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.73 -161.58 34.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 74.510000000000005 112.576 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -36.43 10.84 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.688 2.259 . . . . 74.25 112.324 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.62 27.04 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.701 -0.761 . . . . 74.319999999999993 112.432 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.25 76.9 2.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.695 0.759 . . . . 71.450000000000003 110.871 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 164.35 34.86 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.238 . . . . 60.299999999999997 112.33 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.35 169.59 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 65.019999999999996 110.89 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 58.9 56.75 3.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 54.43 110.861 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.1 m -75.74 92.49 3.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 71.349999999999994 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.95 120.85 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -125.91 155.7 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 110.881 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB2' HD12 ' A' ' 96' ' ' LEU . 5.2 t-20 62.79 26.7 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.239999999999995 110.843 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.44 42.77 7.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 52.25 112.447 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.3 70.74 1.11 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.819 -0.705 . . . . 41.399999999999999 112.479 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.19 129.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 52.219999999999999 110.872 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 45.399999999999999 110.837 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.867 0.365 . . . . 62.43 111.112 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.52 152.88 47.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 62.119999999999997 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -135.51 121.0 19.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 111.163 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -65.66 146.33 54.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 74.030000000000001 110.871 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -146.27 160.24 42.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 70.150000000000006 111.079 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.3 141.93 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.67 -62.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 73.040000000000006 111.199 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -175.84 135.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 61.350000000000001 110.863 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -119.62 126.65 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 61.530000000000001 110.89 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -111.74 97.67 6.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.949 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.82 -92.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 42.350000000000001 112.529 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 t -108.15 -17.6 13.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 52.549999999999997 111.119 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.21 149.32 22.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 75.409999999999997 112.466 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -134.63 150.71 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 54.240000000000002 110.87 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.41 113.38 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 55.409999999999997 112.473 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.07 147.26 22.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 62.539999999999999 112.453 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -139.66 96.59 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 71.420000000000002 110.905 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.23 124.13 34.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.120000000000005 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 m -101.96 101.91 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 111.183 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.4 t -96.6 131.87 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 52.520000000000003 111.072 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -141.97 128.06 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.530000000000001 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -119.4 132.08 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.430000000000007 110.863 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.55 129.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 62.299999999999997 111.188 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -48.31 0.98 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 71.540000000000006 112.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.64 176.65 9.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 64.099999999999994 111.184 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -174.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.109999999999999 111.177 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -51.45 125.42 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 75.019999999999996 110.923 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.02 -174.74 5.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.969 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.68 -53.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 110.846 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.16 171.44 19.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 45.329999999999998 110.939 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' HG21 ' A' ' 79' ' ' VAL . 35.6 p-90 -129.0 127.03 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.919 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 101.93 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.319999999999993 111.138 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.8 t -101.45 105.63 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.140000000000001 111.176 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -120.08 151.6 38.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.120000000000005 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.42 168.13 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.91 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.31 128.79 44.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.409999999999997 110.892 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.44 77.46 2.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.644 0.735 . . . . 70.150000000000006 110.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.98 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.717 2.278 . . . . 75.409999999999997 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 7.1 m -71.94 145.26 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 70.209999999999994 111.162 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.684 -0.769 . . . . 70.019999999999996 112.509 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -154.82 153.5 31.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 74.040000000000006 111.127 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -173.67 130.63 0.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 45.219999999999999 110.883 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 83' ' ' PHE . 99.9 t -79.09 89.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 111.098 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.25 -39.54 94.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 64.329999999999998 111.192 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t -129.52 147.69 51.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.875 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.23 130.06 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.139 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -127.18 144.08 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.967 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.63 15.9 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 73.120000000000005 110.884 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.29 121.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 111.08 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -78.56 101.9 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.030000000000001 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' HB1' ' A' ' 50' ' ' ALA . 39.7 t -87.35 147.23 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 62.229999999999997 111.16 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 m -139.1 140.53 38.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 63.420000000000002 111.16 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -107.68 157.48 18.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 75.219999999999999 110.908 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -160.68 85.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 110.835 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.29 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 60.420000000000002 112.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.18 6.92 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.78 0.324 . . . . 52.039999999999999 110.862 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -120.74 146.99 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 65.109999999999999 110.853 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -128.9 159.09 36.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.898 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 t -145.99 149.83 34.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 70.209999999999994 111.066 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.23 120.31 24.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 43.439999999999998 111.078 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 153.62 51.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.18 -51.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 44.439999999999998 110.937 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.12 39.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.181 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.63 -1.07 75.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 63.130000000000003 112.489 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -113.76 -25.37 8.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 71.019999999999996 110.848 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.75 -47.17 3.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.129999999999995 110.857 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.36 56.37 13.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 54.219999999999999 112.484 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 96.35 2.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 74.420000000000002 111.161 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.6 tt -137.7 160.62 38.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 52.520000000000003 110.959 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.34 161.93 75.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.57 0.7 . . . . 63.409999999999997 111.1 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.87 24.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.697 2.265 . . . . 63.310000000000002 112.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.54 118.35 1.08 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 65.120000000000005 112.461 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.54 172.02 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 42.409999999999997 111.132 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.69 131.57 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.846 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.4 m -134.1 113.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 65.219999999999999 111.116 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 p -109.18 125.63 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 41.229999999999997 110.883 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -120.46 141.35 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 70.409999999999997 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.36 12.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 63.439999999999998 112.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -159.68 176.92 11.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.85 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -132.4 125.87 31.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 72.030000000000001 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.94 151.44 20.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.731 . . . . 44.020000000000003 112.501 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.19 109.55 20.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.030000000000001 110.88 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.65 -162.67 34.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 73.049999999999997 112.495 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.27 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.340000000000003 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.11 26.6 23.47 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 62.219999999999999 112.455 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.2 m -112.67 76.6 2.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.683 0.754 . . . . 73.340000000000003 110.879 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.95 55.26 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.420000000000002 112.298 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.48 174.56 11.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.87 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 m120 51.6 63.6 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 74.319999999999993 110.89 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.0 p -82.73 128.63 34.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 54.140000000000001 110.947 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 144.02 23.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.911 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -149.56 156.63 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.9 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 41.77 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 61.509999999999998 110.851 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.08 61.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.109999999999999 112.478 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.82 71.85 1.3 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 74.409999999999997 112.415 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.32 104.18 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 55.299999999999997 110.841 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 74.530000000000001 110.848 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.802 0.334 . . . . 63.509999999999998 111.103 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -125.3 139.7 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 34.329999999999998 111.142 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -134.48 115.76 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.319999999999993 111.114 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.54 145.4 54.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 75.200000000000003 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.36 164.07 33.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 40.43 111.109 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.23 140.28 40.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.229999999999997 110.81 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -107.01 -62.42 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 63.210000000000001 111.15 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.82 133.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 61.420000000000002 110.868 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.79 127.05 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 62.299999999999997 110.844 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -111.4 91.44 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 110.843 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 -93.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 72.310000000000002 112.498 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -103.11 -17.61 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 74.420000000000002 111.097 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.78 148.58 21.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.805 -0.712 . . . . 72.219999999999999 112.406 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -135.53 148.49 49.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 75.319999999999993 110.895 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.36 114.19 4.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 53.219999999999999 112.446 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.39 148.15 22.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 71.120000000000005 112.494 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 t -141.64 98.36 3.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 73.200000000000003 110.891 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.23 137.06 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 75.209999999999994 110.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.22 107.07 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 70.439999999999998 111.175 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.2 t -101.48 131.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.417 . . . . 71.239999999999995 111.188 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 123.08 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.209999999999994 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 32' ' ' LEU . 1.8 m120 -112.69 125.92 54.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 51.43 110.916 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -167.27 148.98 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 111.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.62 -39.63 2.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 72.120000000000005 112.517 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -88.86 169.5 11.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 75.209999999999994 111.109 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.7 p -60.66 -172.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 74.430000000000007 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -51.49 127.13 19.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 45.350000000000001 110.871 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD22 ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -86.84 -175.67 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 53.219999999999999 110.93 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.63 -53.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.25 -0.432 . . . . 62.020000000000003 110.872 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.99 176.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 24.510000000000002 110.779 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.42 ' CD1' HG21 ' A' ' 79' ' ' VAL . 34.1 p-90 -134.53 127.05 30.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 73.319999999999993 110.862 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 101.35 7.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 111.159 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG12 ' NE1' ' A' ' 39' ' ' TRP . 13.3 t -101.01 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 64.25 111.172 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.02 147.66 43.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 62.100000000000001 110.887 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.458 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -148.29 168.18 23.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 75.099999999999994 110.891 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.06 129.06 44.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 74.430000000000007 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.59 77.52 2.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.712 0.768 . . . . 71.150000000000006 110.906 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -50.03 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 64.200000000000003 112.321 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.82 145.35 48.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.219999999999999 111.14 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.49 98.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 71.209999999999994 112.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -154.74 153.78 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 75.140000000000001 111.114 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -173.74 130.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.844 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.2 t -79.37 88.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.209999999999994 111.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.1 m -63.48 -39.0 93.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 73.019999999999996 111.162 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.32 145.99 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.329999999999998 110.837 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.46 130.07 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 72.409999999999997 111.112 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -129.4 143.11 50.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.435 . . . . 74.310000000000002 110.922 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.78 15.66 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.39 119.34 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 111.074 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -77.55 105.34 8.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.430000000000007 111.13 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.415 HG23 ' HB1' ' A' ' 50' ' ' ALA . 17.0 t -92.95 139.94 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 111.152 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -131.7 141.62 49.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.210000000000001 111.122 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -109.51 155.59 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 53.030000000000001 110.86 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -158.9 85.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.299999999999997 110.836 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.43 -93.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 72.310000000000002 112.452 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.44 7.8 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 72.239999999999995 110.858 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -121.47 145.39 47.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 61.409999999999997 110.844 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -126.3 158.75 34.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.885 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -144.24 150.11 37.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 73.510000000000005 111.161 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.32 121.84 26.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 52.439999999999998 111.094 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 153.47 51.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 62.25 110.888 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -131.23 -51.51 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.43 39.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 71.140000000000001 111.086 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.92 -0.56 75.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 73.439999999999998 112.498 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -115.05 -22.36 9.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 65.409999999999997 110.901 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.56 -47.2 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 62.340000000000003 110.901 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.629 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.91 56.81 10.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.818 -0.706 . . . . 71.150000000000006 112.483 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 95.92 2.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 72.349999999999994 111.121 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.8 tt -137.99 160.64 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 64.030000000000001 110.942 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -70.79 162.0 74.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.614 0.721 . . . . 75.340000000000003 111.066 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -17.84 37.04 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.672 2.248 . . . . 72.120000000000005 112.37 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.75 115.94 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 63.240000000000002 112.535 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.66 172.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 54.32 111.049 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -133.12 131.65 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.857 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 35' ' ' TRP . 6.2 m -133.53 118.06 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 74.310000000000002 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.17 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 75.030000000000001 110.877 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 31.2 p90 -132.16 140.11 48.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.895 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.72 163.4 12.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.448 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -157.75 177.32 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 63.340000000000003 110.825 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -133.14 127.68 34.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 72.219999999999999 110.896 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.86 151.67 20.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 64.030000000000001 112.543 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.88 109.55 20.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 65.439999999999998 110.879 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.37 -163.03 35.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 61.200000000000003 112.48 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -36.48 10.75 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 75.549999999999997 112.353 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.97 26.49 24.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 60.140000000000001 112.512 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -112.78 75.94 2.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.636 0.731 . . . . 71.319999999999993 110.851 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 155.43 65.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.68 2.253 . . . . 61.509999999999998 112.32 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -147.97 169.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 63.030000000000001 110.806 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 56.3 65.33 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 70.040000000000006 110.862 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.5 t -89.27 104.84 17.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 52.340000000000003 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 118.98 27.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -126.88 155.8 42.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.905 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.7 t-20 63.74 27.79 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.240000000000002 110.871 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.23 42.06 8.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.736 . . . . 53.409999999999997 112.543 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.6 70.59 1.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 55.140000000000001 112.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.24 132.08 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 44.539999999999999 110.877 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.484 . . . . 75.340000000000003 110.871 -179.932 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.796 0.332 . . . . 63.350000000000001 111.151 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.66 159.38 42.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.030000000000001 111.079 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.78 147.72 37.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 73.510000000000005 111.126 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -87.23 146.22 26.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.409999999999997 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.33 175.98 9.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.420000000000002 111.115 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.82 156.87 23.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 70.540000000000006 110.92 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.66 -55.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 62.539999999999999 111.217 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.41 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 54.420000000000002 110.869 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -116.75 127.61 54.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 72.109999999999999 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.71 82.58 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 110.91 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 60.020000000000003 112.471 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -100.99 -17.57 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 63.5 111.128 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.79 156.12 26.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 43.039999999999999 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -144.52 145.28 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.855 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 121.14 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.32 112.458 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.37 149.05 19.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 51.420000000000002 112.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -141.65 99.1 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.92 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.24 118.85 30.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 72.25 110.985 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -99.97 113.95 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 71.329999999999998 111.073 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -106.51 131.77 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 70.140000000000001 111.203 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -141.07 118.48 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.827 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 77' ' ' ALA . 7.5 p30 -105.8 129.68 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 110.868 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -164.89 139.54 5.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 111.172 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.41 -46.59 3.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.667 -0.777 . . . . 73.120000000000005 112.48 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.55 177.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 54.039999999999999 111.18 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -79.78 173.12 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 52.0 111.157 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -51.72 109.18 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 64.230000000000004 110.848 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -175.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 74.439999999999998 110.941 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 m -145.87 -52.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.66 140.97 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 65.219999999999999 110.855 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -111.29 127.11 55.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 74.010000000000005 110.932 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.3 m -126.18 113.26 16.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.340000000000003 111.187 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HE1' ' A' ' 39' ' ' TRP . 9.0 t -101.14 105.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 71.409999999999997 111.119 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -123.21 154.23 39.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.874 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' HE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.72 168.43 26.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 44.020000000000003 110.89 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.17 130.64 44.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.209999999999994 110.848 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.09 75.77 2.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.61 0.719 . . . . 74.140000000000001 110.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.75 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.745 2.296 . . . . 71.200000000000003 112.338 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLY . 43.1 p -71.32 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 65.129999999999995 111.098 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 99.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 34.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -154.46 157.44 38.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 61.310000000000002 111.157 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 130.76 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 110.854 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.608 HG22 ' CE2' ' A' ' 83' ' ' PHE . 84.2 t -89.61 106.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 65.209999999999994 111.084 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -80.09 -36.0 36.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.076 -0.511 . . . . 55.450000000000003 111.146 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.42 147.6 49.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 55.439999999999998 110.832 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.2 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 111.085 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -142.65 152.57 42.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.129999999999995 110.93 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.68 14.51 9.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 50.219999999999999 110.84 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 64' ' ' ALA . . . -172.7 113.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.109999999999999 111.126 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -65.25 90.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.510000000000005 111.111 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 64' ' ' ALA . 47.2 t -81.37 112.34 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 111.114 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -116.26 118.87 33.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 111.141 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -78.86 161.02 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 74.450000000000003 110.933 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.02 85.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 110.862 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.29 -88.85 0.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 65.310000000000002 112.498 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -126.77 6.64 6.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 72.540000000000006 110.831 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -115.22 146.98 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 71.030000000000001 110.873 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -135.19 120.2 18.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.959 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 t -121.7 148.15 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.191 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -128.6 141.96 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 64.230000000000004 111.053 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.45 121.75 7.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 62.439999999999998 110.844 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -94.46 -31.66 13.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 70.129999999999995 110.898 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.78 38.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 62.420000000000002 111.134 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.42 81.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 62.119999999999997 112.521 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -115.84 -32.7 5.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.286 . . . . 71.239999999999995 110.914 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -102.66 -36.63 8.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.539999999999999 110.92 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.28 47.87 41.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 75.230000000000004 112.474 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 70' ' ' ASN . 12.8 p -124.84 116.89 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 60.329999999999998 111.172 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -149.29 161.11 42.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 110.949 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -106.11 163.45 17.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.609 0.718 . . . . 73.230000000000004 111.113 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.78 -8.1 22.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 74.329999999999998 112.346 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.05 114.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 52.340000000000003 112.515 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' HD21 ' A' ' 26' ' ' ASN . . . 178.84 172.49 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 72.120000000000005 111.098 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -133.37 131.54 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 63.340000000000003 110.837 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.3 132.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.219999999999999 111.172 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.0 p -127.86 137.98 52.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 110.862 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -129.53 134.98 48.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.915 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.24 178.57 22.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 45.32 112.487 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.608 ' CE2' HG22 ' A' ' 47' ' ' VAL . 18.5 p90 -174.58 173.54 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 75.209999999999994 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -124.99 133.93 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.519999999999996 110.896 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.41 153.47 23.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 63.420000000000002 112.455 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 117.87 35.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 71.010000000000005 110.844 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.34 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 71.420000000000002 112.499 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.01 13.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 70.239999999999995 112.336 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.1 27.18 29.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.762 -0.732 . . . . 72.109999999999999 112.464 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -112.48 75.35 1.74 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 60.409999999999997 110.896 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 160.04 51.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.641 2.228 . . . . 55.32 112.32 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 m -148.6 175.68 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.299999999999997 110.834 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 58.73 53.52 5.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 72.239999999999995 110.913 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.6 m -73.44 101.75 3.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 61.530000000000001 110.846 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 119.31 22.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 60.219999999999999 110.928 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.95 155.74 43.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 71.540000000000006 110.922 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 63.73 26.32 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.85 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.76 42.17 7.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 73.230000000000004 112.534 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.62 73.95 1.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.409999999999997 112.552 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 130.04 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 64.209999999999994 110.813 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 74.129999999999995 110.852 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.744 0.307 . . . . 74.140000000000001 111.18 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.16 163.86 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.063 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -132.45 147.72 52.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 43.549999999999997 111.155 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -86.89 146.29 26.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 60.509999999999998 110.961 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.54 147.54 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 72.540000000000006 111.144 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.25 145.73 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 71.150000000000006 110.88 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 m -105.62 -63.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 70.340000000000003 111.181 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.39 127.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 53.520000000000003 110.834 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -116.04 127.62 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 71.219999999999999 110.859 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -110.53 81.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 64.420000000000002 110.971 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.67 -90.09 0.65 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 63.020000000000003 112.483 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -97.29 -16.36 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 63.049999999999997 111.192 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.14 155.52 23.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.726 -0.75 . . . . 75.430000000000007 112.463 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.73 143.72 31.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 71.239999999999995 110.888 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.27 115.44 4.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 74.409999999999997 112.527 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.2 140.62 24.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 63.329999999999998 112.493 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 94.54 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 63.409999999999997 110.859 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.03 149.93 22.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.902 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -129.81 108.15 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.141 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.53 132.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 65.299999999999997 111.12 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.43 127.07 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 110.892 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.6 122.61 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 110.861 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -172.59 156.7 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.229 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -21.36 17.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.699 -0.762 . . . . 63.530000000000001 112.507 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.85 177.18 7.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 63.219999999999999 111.196 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -171.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 74.030000000000001 111.19 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 120.18 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 110.854 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 179.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 71.310000000000002 110.896 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -120.8 -32.07 4.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 30.239999999999998 110.883 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 p 179.3 160.4 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 110.878 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -137.89 129.03 27.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 110.921 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.7 m -149.81 131.19 14.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 63.140000000000001 111.121 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG12 ' NE1' ' A' ' 39' ' ' TRP . 19.0 t -112.87 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 61.399999999999999 111.067 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.718 ' HB3' HG23 ' A' ' 63' ' ' THR . 18.9 pt-20 -118.28 135.07 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.040000000000006 110.861 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -135.2 173.76 11.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 74.319999999999993 110.92 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.16 134.34 41.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 60.399999999999999 110.92 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.44 77.73 27.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.669 0.747 . . . . 74.430000000000007 110.91 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -49.64 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 73.319999999999993 112.358 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 2.3 p -73.09 145.24 46.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.178 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.22 100.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 54.25 112.47 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -154.81 150.56 27.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.346 . . . . 62.439999999999998 111.192 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 130.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.150000000000006 110.924 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.9 t -84.26 98.03 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 111.136 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.4 HG23 ' N ' ' A' ' 49' ' ' SER . 6.3 t -63.5 -42.15 98.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 111.161 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.4 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 m -136.72 145.42 44.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.130000000000003 110.9 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.48 167.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 44.240000000000002 111.128 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -153.31 141.42 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 71.140000000000001 110.882 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.36 13.84 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.019999999999996 110.884 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.35 107.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 111.096 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -63.26 92.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 51.049999999999997 111.123 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 47' ' ' VAL . 59.8 t -81.78 112.55 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 71.140000000000001 111.135 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -105.1 172.27 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 111.056 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -134.19 158.53 43.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 70.319999999999993 110.852 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -162.5 85.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.903 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.63 -92.25 0.6 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 51.32 112.48 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -126.28 15.94 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 72.310000000000002 110.899 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -125.42 147.02 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 110.88 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -133.1 141.58 48.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.955 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HB3' ' A' ' 38' ' ' GLU . 39.0 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 64.230000000000004 111.164 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 36' ' ' THR . . . -128.09 116.74 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 62.219999999999999 111.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.09 142.15 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.873 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.84 -35.99 3.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 52.219999999999999 110.858 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -92.44 42.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.154 -0.475 . . . . 64.319999999999993 111.123 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 2.13 69.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.687 -0.768 . . . . 73.540000000000006 112.542 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.555 ' HZ3' HD21 ' A' ' 70' ' ' ASN . 0.4 OUTLIER -115.63 -33.81 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 75.430000000000007 110.905 -179.878 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.555 HD21 ' HZ3' ' A' ' 69' ' ' TRP . 2.6 m-80 -110.72 -70.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 73.030000000000001 110.879 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.96 -38.21 3.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 71.409999999999997 112.498 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -52.66 110.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.909 0.385 . . . . 72.510000000000005 111.179 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.23 144.23 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.942 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.02 160.38 1.55 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 74.230000000000004 111.115 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.747 2.298 . . . . 74.140000000000001 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 115.57 0.66 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.757 . . . . 63.219999999999999 112.532 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.55 172.34 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 63.0 111.166 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.24 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 65.140000000000001 110.803 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.05 110.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 73.310000000000002 111.082 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.0 p -99.83 148.87 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 71.109999999999999 110.812 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -146.58 135.12 22.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 71.129999999999995 110.917 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.32 177.3 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 51.329999999999998 112.434 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 47' ' ' VAL . 10.8 p90 -171.64 175.94 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 74.140000000000001 110.864 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -122.74 128.31 50.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 73.409999999999997 110.929 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.12 149.38 19.6 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 74.230000000000004 112.487 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 109.46 21.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 53.25 110.876 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.78 -162.15 34.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 45.509999999999998 112.475 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -36.7 10.55 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 71.519999999999996 112.349 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.56 26.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 70.540000000000006 112.508 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -112.36 77.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.698 0.761 . . . . 73.010000000000005 110.883 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 163.5 38.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.713 2.275 . . . . 62.340000000000003 112.288 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -148.31 170.23 18.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 55.539999999999999 110.86 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.76 50.53 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 73.239999999999995 110.866 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.8 m -66.48 96.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 74.409999999999997 110.896 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -121.31 143.84 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 61.5 110.899 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -155.48 155.55 33.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 110.968 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.563 ' HB2' HD12 ' A' ' 96' ' ' LEU . 38.4 t30 63.22 39.87 9.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 71.349999999999994 110.884 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.06 41.6 11.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.420000000000002 112.521 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 63.32 2.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 53.439999999999998 112.484 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.5 t -155.99 104.49 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 75.310000000000002 110.804 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 33.509999999999998 110.858 -179.968 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.773 0.321 . . . . 72.219999999999999 111.116 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.79 163.44 39.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.450000000000003 111.077 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -140.68 141.69 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.439999999999998 111.137 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -79.38 140.45 37.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 64.239999999999995 110.891 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -139.41 162.19 35.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 62.020000000000003 111.129 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.29 154.54 22.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.852 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 -58.66 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 52.409999999999997 111.159 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.8 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 43.420000000000002 110.878 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -115.45 127.92 55.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 62.149999999999999 110.874 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.65 81.76 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.978 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.64 -87.27 0.63 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 73.430000000000007 112.473 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -100.32 -17.59 17.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 73.209999999999994 111.168 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 155.55 25.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 52.130000000000003 112.488 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -143.6 143.04 31.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.895 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.85 115.81 5.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.705 -0.76 . . . . 75.299999999999997 112.479 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 143.84 17.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.696 -0.764 . . . . 62.130000000000003 112.542 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.1 m -144.22 95.48 2.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 63.420000000000002 110.844 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.44 132.56 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.116 -0.493 . . . . 71.239999999999995 110.885 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.4 m -110.61 117.45 33.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.049999999999997 111.141 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.72 131.94 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 64.329999999999998 111.152 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -138.01 136.98 37.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 54.509999999999998 110.865 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -119.93 136.48 54.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.409999999999997 110.874 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -167.53 162.23 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.5 111.176 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.37 -98.12 2.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 32.399999999999999 112.524 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 p -56.34 170.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 63.100000000000001 111.134 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 p -59.4 -175.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 32.210000000000001 111.176 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.2 144.45 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 71.430000000000007 110.792 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 26' ' ' ASN . 1.3 mp -84.44 -174.61 5.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.912 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 -27.64 6.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.847 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t 178.88 154.92 0.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.519999999999996 110.896 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.427 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.1 p-90 -125.05 129.41 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.921 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 64' ' ' ALA . 80.6 m -152.42 122.0 6.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 111.166 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.5 t -101.72 110.68 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 74.310000000000002 111.182 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -117.66 152.4 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.100000000000001 110.88 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.442 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.97 170.23 20.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 73.310000000000002 110.911 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.98 131.67 44.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.874 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.8 74.05 2.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.659 0.742 . . . . 74.030000000000001 110.85 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.691 2.261 . . . . 70.329999999999998 112.34 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -74.18 145.79 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.230000000000004 111.128 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.36 98.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 24.329999999999998 112.513 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 p -154.9 154.62 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.332 . . . . 55.149999999999999 111.166 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.76 131.13 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.408 . . . . 74.340000000000003 110.931 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.0 t -76.1 104.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 111.078 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -47.89 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 72.430000000000007 111.178 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -144.39 152.37 40.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 52.210000000000001 110.87 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.17 162.47 35.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 70.319999999999993 111.074 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -146.99 144.95 29.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.988 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 64.05 15.18 9.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 62.450000000000003 110.85 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.55 104.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 62.240000000000002 111.127 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 m -61.8 93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 72.540000000000006 111.201 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 64' ' ' ALA . 95.7 t -86.22 112.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 52.450000000000003 111.084 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.425 ' CG2' HG23 ' A' ' 63' ' ' THR . 7.4 t -113.44 164.28 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.519999999999996 111.172 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -121.79 160.98 23.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 62.119999999999997 110.942 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -159.26 85.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.049999999999997 110.799 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.72 -93.27 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.756 -0.735 . . . . 45.130000000000003 112.442 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -126.54 11.42 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 74.25 110.877 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -123.53 147.03 47.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 62.229999999999997 110.864 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -127.98 156.32 42.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 63.520000000000003 110.936 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.425 HG23 ' CG2' ' A' ' 56' ' ' THR . 1.9 t -150.35 148.7 29.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 64.049999999999997 111.149 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.97 119.95 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 42.100000000000001 111.083 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.32 144.4 40.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 61.210000000000001 110.881 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -123.08 -35.06 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.420000000000002 110.901 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.427 HG13 ' HE1' ' A' ' 35' ' ' TRP . 14.1 m -89.6 41.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 51.109999999999999 111.124 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.69 1.92 70.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 42.240000000000002 112.523 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.44 -21.49 11.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 72.299999999999997 110.918 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -129.54 -70.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 63.539999999999999 110.898 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.65 -38.07 3.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 70.510000000000005 112.535 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -50.74 107.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 54.43 111.097 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.407 HD23 HD13 ' A' ' 32' ' ' LEU . 8.4 tp -123.69 146.93 47.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 64.329999999999998 110.993 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -61.53 160.31 26.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 64.120000000000005 111.06 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.9 Cg_endo -69.8 -8.43 23.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 75.239999999999995 112.319 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.9 116.03 0.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 61.210000000000001 112.436 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.17 172.13 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.868 0.366 . . . . 64.439999999999998 111.072 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.68 131.33 43.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 45.420000000000002 110.85 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.25 109.9 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 71.120000000000005 111.114 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 t -109.98 134.38 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 50.140000000000001 110.88 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -123.47 134.88 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.899 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.3 175.52 19.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 63.5 112.532 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 47' ' ' VAL . 18.1 p90 -174.84 175.87 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.933 0.397 . . . . 65.400000000000006 110.899 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -124.97 125.89 44.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 74.519999999999996 110.873 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.56 152.98 17.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 50.130000000000003 112.496 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.82 109.49 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 54.409999999999997 110.814 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -158.02 27.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.209999999999994 112.449 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -37.26 9.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 71.0 112.409 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.24 27.04 29.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 73.439999999999998 112.443 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.71 78.92 2.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 71.400000000000006 110.849 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 171.79 13.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 65.200000000000003 112.374 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -148.5 170.4 18.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 44.350000000000001 110.818 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.52 52.13 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 63.549999999999997 110.934 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.8 m -68.75 92.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 63.210000000000001 110.845 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.86 144.0 49.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 110.87 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.12 156.79 44.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.420000000000002 110.884 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 66.43 32.63 7.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 71.140000000000001 110.845 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.79 42.41 25.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 30.309999999999999 112.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 71.58 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 55.420000000000002 112.517 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.52 130.57 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.821 0.343 . . . . 73.439999999999998 110.841 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 55.25 110.811 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 111.129 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.92 163.93 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 33.329999999999998 111.105 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.38 144.89 27.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 55.5 111.164 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.41 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 75.049999999999997 110.93 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.45 152.56 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 64.420000000000002 111.094 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.03 146.66 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 72.409999999999997 110.965 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.29 -59.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 70.129999999999995 111.092 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.4 138.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 50.5 110.876 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.13 127.43 54.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 64.430000000000007 110.83 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.67 92.97 4.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 74.329999999999998 110.927 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.25 -90.34 0.71 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 75.010000000000005 112.504 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 t -110.6 -17.55 13.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 73.409999999999997 111.176 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.6 146.76 20.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.761 -0.733 . . . . 75.150000000000006 112.466 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -125.42 149.72 47.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 110.87 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.99 110.41 3.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.76 . . . . 42.329999999999998 112.499 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.75 142.62 21.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 71.439999999999998 112.454 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -139.54 94.66 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 55.399999999999999 110.839 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -90.37 149.28 22.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 75.439999999999998 110.933 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m -128.18 132.01 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 111.17 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 79' ' ' VAL . 14.9 t -130.37 132.42 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 111.095 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -142.38 129.17 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 71.510000000000005 110.933 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.557 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.6 m120 -104.53 148.99 25.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 64.25 110.851 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.4 t -172.57 162.59 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 111.155 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.89 -77.04 1.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 74.530000000000001 112.489 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -57.91 172.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 63.109999999999999 111.146 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.1 p -68.43 -172.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 63.509999999999998 111.059 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.12 122.79 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.842 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.557 HD22 ' CG ' ' A' ' 26' ' ' ASN . 6.2 mp -62.79 169.18 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 72.010000000000005 110.905 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.4 -16.89 10.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.798 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.87 147.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.450000000000003 110.815 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.435 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.6 p-90 -124.62 129.76 51.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.219999999999999 110.893 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 64' ' ' ALA . 93.0 m -151.24 123.26 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 111.083 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.4 t -103.69 105.83 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 111.092 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.21 151.09 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.209999999999994 110.925 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.433 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.03 171.17 17.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.926 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.95 130.25 44.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 72.349999999999994 110.856 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.59 73.67 2.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.717 0.77 . . . . 64.310000000000002 110.943 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -50.07 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.727 2.285 . . . . 65.299999999999997 112.39 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -72.77 145.59 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 62.130000000000003 111.134 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.16 98.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.714 . . . . 45.109999999999999 112.482 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -155.03 154.9 33.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 51.5 111.123 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -173.58 131.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 72.409999999999997 110.916 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -78.8 107.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 74.019999999999996 111.1 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 m -62.87 -49.54 74.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 111.116 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.28 140.42 27.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 63.039999999999999 110.871 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.13 137.16 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 71.030000000000001 111.08 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -121.52 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 70.120000000000005 110.88 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.53 12.62 8.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 65.109999999999999 110.907 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.16 102.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.219999999999999 111.151 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -60.05 95.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.510000000000005 111.153 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 64' ' ' ALA . 85.6 t -90.37 112.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.120000000000005 111.149 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.52 177.49 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 64.409999999999997 111.128 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -133.46 160.55 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 64.540000000000006 110.838 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -160.37 85.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 74.5 110.884 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.74 -93.3 0.83 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 23.199999999999999 112.45 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -126.53 14.55 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 75.230000000000004 110.857 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -126.94 146.89 50.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 110.861 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -129.45 155.95 44.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.239999999999995 110.908 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 56' ' ' THR . 1.8 t -149.02 143.45 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.25 111.127 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -120.4 122.73 41.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 111.095 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 137.79 34.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.878 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -119.41 -30.52 4.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.944 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG13 ' HE1' ' A' ' 35' ' ' TRP . 13.9 m -90.99 42.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 74.030000000000001 111.152 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.11 2.97 67.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 73.299999999999997 112.511 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.533 ' HZ3' HD21 ' A' ' 70' ' ' ASN . 0.4 OUTLIER -117.27 -34.08 4.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 74.299999999999997 110.881 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.533 HD21 ' HZ3' ' A' ' 69' ' ' TRP . 2.3 m-80 -109.79 -70.24 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 72.340000000000003 110.881 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.0 -37.75 3.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 50.32 112.509 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -49.43 117.41 2.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 71.120000000000005 111.156 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -136.46 131.79 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.099999999999994 110.957 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -56.87 160.65 5.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.566 0.698 . . . . 70.150000000000006 111.099 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.82 -16.14 37.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.693 2.262 . . . . 41.109999999999999 112.284 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.51 115.44 0.77 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 65.219999999999999 112.533 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.08 172.54 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 64.319999999999993 111.084 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.83 131.16 56.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 51.420000000000002 110.781 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.5 m -139.23 109.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 62.340000000000003 111.118 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 m -113.53 164.38 13.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 110.867 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 30.8 p90 -155.88 134.27 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.901 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.55 177.25 19.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 55.420000000000002 112.433 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.5 p90 -174.43 178.31 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 72.420000000000002 110.939 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -130.96 125.85 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 45.020000000000003 110.85 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.04 155.34 20.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 53.149999999999999 112.527 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.26 109.65 22.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 53.5 110.859 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.14 -157.58 27.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 62.439999999999998 112.495 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -39.0 7.03 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.231 . . . . 40.200000000000003 112.372 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.6 32.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 64.439999999999998 112.477 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 75.78 2.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.661 0.744 . . . . 54.130000000000003 110.903 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 160.61 49.05 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.725 2.283 . . . . 72.549999999999997 112.297 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 m -148.32 171.37 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 110.878 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 63.35 53.42 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.240000000000002 110.85 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.14 126.72 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.340000000000003 110.89 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 118.77 6.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 71.099999999999994 110.907 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -130.24 155.64 45.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 75.510000000000005 110.889 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 60.56 36.58 19.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.937 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.28 55.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 65.430000000000007 112.516 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.5 69.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 55.219999999999999 112.45 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 t -156.18 104.26 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 63.520000000000003 110.873 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.1 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 64.439999999999998 110.871 -179.957 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.775 0.321 . . . . 63.25 111.14 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.27 163.84 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 32.310000000000002 111.09 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 142.99 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 53.539999999999999 111.198 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -94.35 125.75 39.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 72.120000000000005 110.852 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.48 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 43.229999999999997 111.117 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 170.21 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 62.32 110.863 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 -59.12 0.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.093 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.48 135.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 61.409999999999997 110.923 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.43 127.53 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 71.349999999999994 110.867 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.46 83.34 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.175 -0.466 . . . . 73.439999999999998 110.95 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.87 -86.32 0.66 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.72 -0.752 . . . . 61.109999999999999 112.533 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -103.97 -17.45 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 63.140000000000001 111.122 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.38 153.66 24.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 74.299999999999997 112.464 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -140.56 143.9 35.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 73.129999999999995 110.855 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.3 127.26 9.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 64.310000000000002 112.447 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.82 132.21 10.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 54.409999999999997 112.453 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.91 103.71 7.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 51.130000000000003 110.87 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -92.11 141.27 28.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 45.549999999999997 110.973 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 m -118.55 127.45 53.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 65.209999999999994 111.082 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.91 131.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 111.16 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -144.16 119.08 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 62.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -111.94 133.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.239999999999995 110.86 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -172.7 129.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 61.219999999999999 111.08 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.53 -19.49 19.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 62.549999999999997 112.445 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.39 177.1 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.381 . . . . 73.510000000000005 111.118 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -67.98 174.83 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 61.200000000000003 111.191 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 t -51.37 118.93 3.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.825 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -176.14 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.917 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -142.66 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 63.340000000000003 110.927 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 67' ' ' VAL . 1.4 t -152.38 147.52 26.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 74.239999999999995 110.863 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -110.36 126.44 54.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.905 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -118.86 108.61 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 63.140000000000001 111.149 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.734 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.6 p -101.46 109.56 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 74.310000000000002 111.116 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.22 136.92 47.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.875 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.01 172.19 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.420000000000002 110.992 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.93 130.42 44.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 75.439999999999998 110.855 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.51 80.1 2.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 71.519999999999996 110.829 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -48.59 0.68 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.729 2.286 . . . . 71.219999999999999 112.328 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -74.65 144.73 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 53.450000000000003 111.118 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.87 96.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.718 -0.753 . . . . 64.310000000000002 112.416 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 ' CE1' ' A' ' 41' ' ' PHE . 99.5 m -156.81 137.84 13.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 75.120000000000005 111.119 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -151.95 131.2 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 64.030000000000001 110.865 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG22 ' CE2' ' A' ' 83' ' ' PHE . 91.4 t -72.37 102.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 111.158 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -62.89 -46.78 86.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.104 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.64 147.77 34.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 61.240000000000002 110.885 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.17 144.31 40.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 111.062 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -129.41 142.59 50.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 73.230000000000004 110.91 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.42 13.04 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 110.816 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.2 92.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 41.0 111.08 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -55.39 99.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.549999999999997 111.086 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.981 HG22 ' HB2' ' A' ' 64' ' ' ALA . 63.9 t -94.47 112.6 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 73.319999999999993 111.118 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -102.59 175.43 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 64.129999999999995 111.16 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.33 157.34 45.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 53.140000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -159.25 85.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.883 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.69 -92.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 35.530000000000001 112.42 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.95 9.89 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 75.329999999999998 110.888 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -120.09 146.89 45.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.871 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -132.3 146.57 52.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 75.230000000000004 110.911 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -143.05 148.48 36.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.25 111.129 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.981 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.96 141.75 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 70.349999999999994 111.155 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 160.8 39.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 71.319999999999993 110.952 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -132.02 -52.43 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.842 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.762 HG22 ' H ' ' A' ' 71' ' ' GLY . 7.8 p -108.07 39.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 111.117 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.76 4.68 56.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 71.150000000000006 112.512 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -111.46 -25.68 9.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 74.420000000000002 110.82 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.651 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.11 -38.73 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.319999999999993 110.874 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.762 ' H ' HG22 ' A' ' 67' ' ' VAL . . . 48.32 56.87 8.71 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.792 -0.718 . . . . 64.420000000000002 112.495 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -135.07 94.85 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 74.439999999999998 111.198 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -134.3 160.96 36.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 71.349999999999994 110.939 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.703 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -85.2 162.76 47.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 55.039999999999999 111.051 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.76 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 64.230000000000004 112.352 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.88 115.59 0.94 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.727 . . . . 65.310000000000002 112.499 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.7 172.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 53.340000000000003 111.079 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 p -133.18 131.55 40.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 61.409999999999997 110.831 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.14 136.17 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 111.163 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -132.99 149.11 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.866 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 37' ' ' VAL . 25.6 p90 -139.43 156.47 46.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.099999999999994 110.873 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.84 175.47 18.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 54.299999999999997 112.467 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.694 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -173.41 -176.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 73.439999999999998 110.871 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -139.39 125.88 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 110.876 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.94 17.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 61.229999999999997 112.559 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.84 111.22 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.372 . . . . 71.150000000000006 110.838 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.56 26.54 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 62.130000000000003 112.456 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -40.27 5.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 72.200000000000003 112.337 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.59 27.56 21.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 73.030000000000001 112.526 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -112.07 76.07 1.72 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 73.400000000000006 110.859 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.41 57.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.643 2.229 . . . . 71.049999999999997 112.313 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.55 172.41 14.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.871 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 58.1 50.2 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 61.329999999999998 110.882 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.51 104.05 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 41.409999999999997 110.884 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.1 143.97 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.874 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.4 pp -160.32 146.61 15.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 72.209999999999994 110.938 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 96' ' ' LEU . 61.0 t30 60.83 55.33 3.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 110.852 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.1 39.81 36.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 51.299999999999997 112.418 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.44 62.91 5.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 73.219999999999999 112.493 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.3 107.74 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 71.420000000000002 110.935 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 74.329999999999998 110.979 -179.929 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.804 0.335 . . . . 65.310000000000002 111.11 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -143.63 163.85 32.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 54.229999999999997 111.14 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -152.15 132.52 13.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.109999999999999 111.175 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -73.66 146.06 44.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 72.150000000000006 110.901 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.46 170.99 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 65.25 111.093 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -120.96 134.64 55.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.962 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 -60.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 63.140000000000001 111.191 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.47 145.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 110.869 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.59 125.99 49.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 72.239999999999995 110.819 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -112.28 102.23 10.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 74.319999999999993 110.972 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.22 -92.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.756 -0.735 . . . . 50.200000000000003 112.513 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -118.24 -17.47 9.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 53.100000000000001 111.04 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.68 117.93 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.792 -0.718 . . . . 73.420000000000002 112.45 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -99.06 156.74 16.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 62.009999999999998 110.847 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.71 109.22 2.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.761 -0.733 . . . . 75.420000000000002 112.424 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.67 141.13 20.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.742 . . . . 44.340000000000003 112.457 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.12 98.75 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 62.219999999999999 110.849 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -90.17 123.75 34.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 110.955 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 m -96.06 119.98 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 64.340000000000003 111.026 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.66 131.64 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 111.086 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -139.44 118.15 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.409999999999997 110.899 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.49 119.21 38.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.349999999999994 110.836 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.4 t -172.18 143.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.219999999999999 111.166 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.45 -30.83 7.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 72.439999999999998 112.467 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -100.8 173.58 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.351 . . . . 75.230000000000004 111.109 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 p -62.05 -174.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 73.219999999999999 111.124 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -51.36 121.97 7.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 53.219999999999999 110.807 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 -175.7 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 62.240000000000002 110.918 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -143.55 -53.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 65.230000000000004 110.882 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.31 166.6 32.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.230000000000004 110.845 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -122.94 126.64 47.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.519 . . . . 74.340000000000003 110.934 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 m -120.78 100.86 7.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 71.510000000000005 111.14 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 64' ' ' ALA . 7.7 p -102.8 119.17 50.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 71.040000000000006 111.151 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.41 141.22 49.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.838 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.85 167.61 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 54.530000000000001 110.914 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.08 130.07 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 71.409999999999997 110.826 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.76 76.21 2.1 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 73.030000000000001 110.93 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -50.06 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.694 2.263 . . . . 72.319999999999993 112.343 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 64.340000000000003 111.143 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.31 97.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 74.409999999999997 112.486 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.64 155.74 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 75.140000000000001 111.12 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.74 130.59 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.862 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG22 ' CE2' ' A' ' 83' ' ' PHE . 89.6 t -79.92 99.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 111.189 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -62.99 -44.68 95.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 71.340000000000003 111.186 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m -143.64 159.97 41.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 110.892 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.04 144.73 25.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.230000000000004 111.062 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -128.44 146.36 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 71.549999999999997 110.887 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 14.94 9.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.831 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.44 120.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 64.219999999999999 111.057 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -78.65 108.15 11.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.530000000000001 111.109 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.73 147.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 74.439999999999998 111.133 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -139.68 141.42 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.439999999999998 111.151 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.46 153.36 24.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 53.009999999999998 110.951 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -157.07 85.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 50.229999999999997 110.808 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.7 -93.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 73.329999999999998 112.489 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -126.46 6.31 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 74.230000000000004 110.876 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -120.09 145.7 46.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 110.812 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -126.79 152.87 46.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.894 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -138.48 150.4 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 74.299999999999997 111.111 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.86 125.9 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 111.111 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 141.04 32.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 73.349999999999994 110.928 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -116.99 -52.07 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 62.140000000000001 110.908 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -100.82 39.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.510000000000005 111.128 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.29 -1.59 70.26 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.753 -0.737 . . . . 75.209999999999994 112.432 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.47 -30.96 6.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 71.340000000000003 110.93 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.549 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -101.55 -47.06 4.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 73.530000000000001 110.931 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.39 55.77 18.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 65.040000000000006 112.488 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -132.65 94.8 3.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 74.329999999999998 111.128 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -137.64 160.9 37.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 75.230000000000004 110.896 179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -82.39 162.5 56.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 63.149999999999999 111.164 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.84 -8.36 23.41 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.61 2.207 . . . . 71.010000000000005 112.359 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.89 115.72 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 65.319999999999993 112.501 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.96 172.14 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.375 . . . . 71.209999999999994 111.02 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -145.51 131.68 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 62.049999999999997 110.761 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.07 149.19 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 72.219999999999999 111.111 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 p -130.52 135.93 48.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 71.549999999999997 110.874 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.4 p90 -122.79 135.18 54.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 73.299999999999997 110.862 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.86 178.26 20.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 54.020000000000003 112.491 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CE2' HG22 ' A' ' 47' ' ' VAL . 24.7 p90 -174.26 -179.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 72.239999999999995 110.882 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.03 149.66 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 34.140000000000001 110.893 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.67 157.36 27.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 73.310000000000002 112.515 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 m -102.48 109.62 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 65.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -160.73 30.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 42.140000000000001 112.522 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -38.36 7.95 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.647 2.232 . . . . 75.239999999999995 112.359 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.2 26.68 27.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 62.149999999999999 112.515 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.78 75.27 1.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.099999999999994 110.854 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 160.69 48.75 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.59 2.193 . . . . 63.219999999999999 112.372 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 p -148.52 161.71 41.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 70.450000000000003 110.9 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 62.99 65.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 60.539999999999999 110.832 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.9 t -91.4 94.05 9.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 70.420000000000002 110.946 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 118.73 35.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 73.519999999999996 110.882 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -126.72 155.81 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 110.93 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 63.9 19.94 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 60.210000000000001 110.892 179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.88 4.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 73.540000000000006 112.467 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.7 71.28 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 62.030000000000001 112.484 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -156.25 104.17 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.019999999999996 110.851 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 72.530000000000001 110.905 -179.998 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.78 0.324 . . . . 65.129999999999995 111.141 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.64 163.82 34.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 54.409999999999997 111.132 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 m -153.5 147.7 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 73.140000000000001 111.161 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -80.61 144.27 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 75.099999999999994 110.898 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.18 165.16 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 73.129999999999995 111.135 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.09 136.24 50.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 40.130000000000003 110.924 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m -101.22 -68.3 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 74.420000000000002 111.125 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.85 138.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 50.530000000000001 110.909 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.24 126.24 51.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 74.200000000000003 110.919 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -111.92 105.74 14.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.948 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.44 -91.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.807 -0.711 . . . . 33.240000000000002 112.499 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -117.26 -17.49 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 71.540000000000006 111.223 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.76 146.87 20.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 63.399999999999999 112.424 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -128.85 145.73 51.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 70.109999999999999 110.851 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.17 109.69 3.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.752 . . . . 61.100000000000001 112.47 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.78 133.09 11.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.530000000000001 112.471 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -120.05 99.28 6.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 71.040000000000006 110.865 -179.697 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -90.24 129.73 36.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.409999999999997 110.916 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -105.99 128.16 53.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 55.140000000000001 111.077 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 79' ' ' VAL . 18.2 t -133.19 132.6 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 72.540000000000006 111.176 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -143.89 138.12 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 63.210000000000001 110.923 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.521 ' HB3' HD21 ' A' ' 32' ' ' LEU . 3.1 m-80 -119.44 131.24 55.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 70.329999999999998 110.855 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -159.0 161.0 36.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 111.155 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.37 -58.57 4.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 63.32 112.471 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 t -62.73 161.18 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 63.109999999999999 111.097 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 p -57.87 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 61.43 111.163 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -54.07 123.05 11.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 61.340000000000003 110.805 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 26' ' ' ASN . 4.2 mm? -64.73 151.97 43.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 65.120000000000005 110.95 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -116.51 -18.19 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.140000000000001 110.874 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.48 151.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 63.240000000000002 110.86 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.403 ' CE2' HG21 ' A' ' 79' ' ' VAL . 64.3 p-90 -132.37 127.64 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 110.98 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 65' ' ' LYS . 80.0 m -142.92 124.95 15.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 111.147 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' NE1' ' A' ' 39' ' ' TRP . 31.4 t -110.38 105.8 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 111.132 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.8 OUTLIER -117.17 150.98 37.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 73.439999999999998 110.871 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.474 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.43 166.54 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.941 -179.913 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.17 132.69 43.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 73.140000000000001 110.84 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.02 76.23 2.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.635 0.731 . . . . 65.420000000000002 110.859 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.251 . . . . 63.329999999999998 112.31 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 55.9 p -70.4 145.37 51.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 62.240000000000002 111.168 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.53 97.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.793 -0.718 . . . . 51.25 112.386 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.72 157.7 38.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.372 . . . . 61.030000000000001 111.134 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -173.59 130.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.099999999999994 110.934 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.705 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.2 t -84.17 104.14 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 51.219999999999999 111.17 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -47.39 83.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 62.109999999999999 111.185 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -141.51 164.43 30.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.926 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.87 140.71 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.049999999999997 111.13 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -127.57 143.6 51.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.957 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.31 14.86 9.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 64.150000000000006 110.892 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.62 100.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 111.151 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.9 m -60.43 95.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 55.240000000000002 111.112 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.9 t -87.29 134.26 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 111.114 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -124.28 170.09 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.040000000000006 111.156 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -131.33 154.2 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.93 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 t -159.42 85.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.82 -94.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.684 -0.77 . . . . 64.420000000000002 112.513 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.29 14.36 7.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 72.319999999999993 110.886 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -128.69 146.84 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 71.099999999999994 110.805 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -129.0 164.07 24.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 74.019999999999996 110.855 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 99.7 m -152.67 144.13 23.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 72.420000000000002 111.143 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -122.49 123.61 41.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 111.122 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.55 139.22 40.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.509999999999998 110.906 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -123.76 -37.74 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 65.329999999999998 110.916 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.98 42.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 71.310000000000002 111.115 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.56 2.0 69.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.703 -0.76 . . . . 72.010000000000005 112.492 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.86 -33.84 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 74.439999999999998 110.921 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.68 -71.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 71.010000000000005 110.952 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.71 -38.18 3.23 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 74.519999999999996 112.523 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -50.95 113.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 74.239999999999995 111.149 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -141.15 133.07 27.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.866 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.06 160.36 1.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.512 0.672 . . . . 72.329999999999998 111.155 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.7 Cg_endo -69.69 -15.93 37.58 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.672 2.248 . . . . 74.400000000000006 112.394 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.58 115.61 1.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.8 -0.715 . . . . 72.239999999999995 112.495 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.58 172.39 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.793 0.33 . . . . 62.130000000000003 111.073 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.62 131.24 52.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.801 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 24' ' ' VAL . 5.1 p -129.48 118.78 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 111.128 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.99 138.59 52.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.872 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 41.8 p90 -138.2 136.31 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 71.420000000000002 110.911 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.57 -178.62 19.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 71.239999999999995 112.502 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 47' ' ' VAL . 17.4 p90 -174.47 175.72 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 74.099999999999994 110.861 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -125.54 127.03 45.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 65.430000000000007 110.912 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.15 157.48 21.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 71.340000000000003 112.507 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -108.16 109.44 20.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 75.120000000000005 110.899 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.54 -158.74 29.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 64.319999999999993 112.502 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -35.22 12.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 73.349999999999994 112.327 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.97 26.78 28.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 40.030000000000001 112.448 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.22 76.49 1.89 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.588 0.709 . . . . 53.140000000000001 110.846 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 160.72 48.65 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.675 2.25 . . . . 71.329999999999998 112.299 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -148.53 174.21 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.891 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 51.88 64.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 64.200000000000003 110.921 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.8 t -86.51 130.3 34.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.894 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 144.0 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.140000000000001 110.946 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.67 156.73 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.89 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 67.28 40.51 2.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.040000000000006 110.895 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.09 42.13 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.677 -0.773 . . . . 63.030000000000001 112.543 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.31 71.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 50.149999999999999 112.493 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.6 138.03 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.341 . . . . 64.420000000000002 110.906 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 61.219999999999999 110.884 -179.934 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.788 0.328 . . . . 54.210000000000001 111.098 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -115.8 154.76 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 52.310000000000002 111.1 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 111.93 11.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 72.349999999999994 111.114 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -74.7 126.69 31.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 74.310000000000002 110.915 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.3 161.34 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 65.230000000000004 111.07 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.09 155.21 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.420000000000002 110.908 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.09 -57.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.019999999999996 111.101 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.38 130.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 74.349999999999994 110.825 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.91 127.51 55.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 70.439999999999998 110.843 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -110.5 82.05 1.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.439999999999998 110.901 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.74 -87.28 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 72.109999999999999 112.464 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 t -100.69 -17.55 16.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.73 0.3 . . . . 63.229999999999997 111.095 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.15 155.94 25.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.530000000000001 112.516 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.43 143.44 30.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 75.230000000000004 110.936 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 117.34 5.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 62.509999999999998 112.524 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 151.91 20.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.773 -0.727 . . . . 74.340000000000003 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.79 96.56 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 65.540000000000006 110.926 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -90.09 136.29 33.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 75.120000000000005 110.886 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -114.72 101.9 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 70.310000000000002 111.124 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 37' ' ' VAL . 17.0 t -88.88 131.72 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 75.040000000000006 111.119 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.75 128.19 36.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.150000000000006 110.868 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.43 132.24 54.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.899 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -172.07 121.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 70.409999999999997 111.138 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.74 -80.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 62.219999999999999 112.421 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.51 168.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.338 . . . . 64.439999999999998 111.228 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 p -60.54 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 74.549999999999997 111.144 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.92 121.73 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 72.129999999999995 110.827 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 75' ' ' PRO . 2.8 mm? -65.36 126.16 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 64.439999999999998 110.87 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.96 -23.99 28.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 72.209999999999994 110.876 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.0 170.13 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 110.825 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -136.04 136.71 40.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 110.906 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 64' ' ' ALA . 4.4 m -152.69 144.23 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 65.030000000000001 111.222 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 24' ' ' VAL . 21.4 t -129.91 105.83 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 72.329999999999998 111.147 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 63' ' ' THR . 9.4 pt-20 -117.9 134.24 55.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 110.911 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.472 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.08 173.32 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 72.030000000000001 110.849 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 130.35 44.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 75.140000000000001 110.906 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.45 73.92 2.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.647 0.737 . . . . 72.230000000000004 110.865 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.16 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 71.540000000000006 112.302 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.1 p -73.05 145.72 46.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 64.129999999999995 111.13 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 98.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.826 -0.702 . . . . 71.549999999999997 112.456 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -154.92 154.62 32.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 64.129999999999995 111.106 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 130.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 70.340000000000003 110.928 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.681 HG22 ' CE2' ' A' ' 83' ' ' PHE . 98.0 t -77.92 108.5 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 74.099999999999994 111.116 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -45.9 70.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 51.43 111.143 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -141.67 157.0 45.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 70.299999999999997 110.842 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.06 157.39 40.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 75.099999999999994 111.163 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -141.0 146.61 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.329999999999998 110.911 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.23 14.81 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.420000000000002 110.845 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 105.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 62.219999999999999 111.149 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -65.48 90.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 41.32 111.132 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 47' ' ' VAL . 60.0 t -80.9 118.42 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 111.122 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -110.9 175.14 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 61.149999999999999 111.085 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -134.21 160.15 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.86 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.17 85.88 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 54.299999999999997 110.866 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 -92.73 0.57 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 65.140000000000001 112.444 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -126.03 17.36 7.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 44.109999999999999 110.953 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -128.57 146.83 50.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.489 . . . . 73.200000000000003 110.809 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -132.13 150.08 52.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 38' ' ' GLU . 85.7 m -142.49 145.25 33.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 71.239999999999995 111.119 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -121.88 114.66 21.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.084 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 136.25 48.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.030000000000001 110.859 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -122.56 -51.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.95 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.66 40.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.120000000000005 111.152 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.22 -0.71 54.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 51.399999999999999 112.433 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 70' ' ' ASN . 3.5 p-90 -104.44 -27.83 11.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.778 0.323 . . . . 72.120000000000005 110.899 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 72' ' ' THR . 12.7 m-20 -132.89 -70.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 73.230000000000004 110.899 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.3 50.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 41.299999999999997 112.488 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.4 t -73.3 94.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 72.109999999999999 111.152 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -140.54 151.45 44.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.239999999999995 110.855 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -52.99 163.52 0.84 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.576 0.703 . . . . 55.43 111.115 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.14 22.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 72.140000000000001 112.327 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.22 115.75 1.81 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 63.399999999999999 112.524 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.48 172.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 63.299999999999997 111.083 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -137.22 131.71 32.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 71.120000000000005 110.919 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 t -143.42 110.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 111.068 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.0 p -103.99 135.0 46.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.905 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -118.39 126.44 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.82 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.81 173.59 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 65.010000000000005 112.495 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 47' ' ' VAL . 20.6 p90 -174.73 176.62 2.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.340000000000003 110.865 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.99 125.82 40.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.540000000000006 110.862 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -125.27 161.79 19.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.781 -0.723 . . . . 50.240000000000002 112.573 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 t -109.32 110.28 21.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 62.25 110.918 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.53 -158.7 28.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 74.120000000000005 112.435 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -36.08 11.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 60.509999999999998 112.382 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.83 27.08 30.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 75.010000000000005 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -112.36 77.02 2.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.728 0.775 . . . . 72.129999999999995 110.841 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 168.46 21.49 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.729 2.286 . . . . 63.43 112.335 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -148.43 169.17 20.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 42.329999999999998 110.84 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.07 48.92 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.818 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.2 m -65.46 96.53 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 61.229999999999997 110.897 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -121.2 121.29 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 74.129999999999995 110.937 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -124.74 155.71 38.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.210000000000001 110.957 179.876 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 63.33 27.22 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 75.150000000000006 110.866 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.06 42.05 7.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 43.229999999999997 112.493 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 70.1 1.12 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.701 -0.762 . . . . 63.130000000000003 112.469 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 131.59 9.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 40.340000000000003 110.85 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.884 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.86 0.362 . . . . 74.530000000000001 111.107 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.98 123.55 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 111.069 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -99.07 139.61 34.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 71.230000000000004 111.209 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.56 143.86 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 110.9 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.77 154.97 43.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 60.240000000000002 111.063 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.49 144.51 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.876 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 -59.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 63.039999999999999 111.171 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -179.99 149.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.100000000000001 110.896 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -117.73 126.46 52.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.898 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -111.74 86.71 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 110.916 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.94 -82.15 0.87 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 74.209999999999994 112.498 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -117.35 -17.56 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 72.109999999999999 111.136 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.17 166.63 38.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 23.210000000000001 112.472 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -148.59 157.54 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.219999999999999 110.876 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.59 130.62 9.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.797 -0.716 . . . . 73.540000000000006 112.537 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.91 145.89 17.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 43.119999999999997 112.473 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.22 95.46 3.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 72.219999999999999 110.841 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -89.81 125.58 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 71.510000000000005 110.921 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.3 m -110.9 101.85 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.040000000000006 111.159 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.1 t -94.12 131.22 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 111.099 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.2 117.89 11.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 110.889 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.61 125.51 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.209999999999994 110.91 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -164.91 139.18 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 75.030000000000001 111.158 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.44 9.81 54.63 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.683 -0.77 . . . . 71.349999999999994 112.445 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 t -130.98 174.53 9.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 111.206 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.39 165.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 75.209999999999994 111.142 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 p -69.07 99.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 71.150000000000006 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HB3' HD23 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -58.28 178.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 51.409999999999997 110.933 -179.996 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.56 -52.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 110.834 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -133.75 140.4 46.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 41.439999999999998 110.834 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -115.38 127.09 55.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 62.350000000000001 110.863 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 64' ' ' ALA . 8.1 m -134.09 116.94 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 74.209999999999994 111.098 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG12 ' NE1' ' A' ' 39' ' ' TRP . 17.3 t -103.88 105.5 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 111.142 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.741 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.2 pt-20 -120.38 136.86 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 70.129999999999995 110.861 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.468 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.38 170.26 16.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 73.420000000000002 110.823 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.45 129.83 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 55.25 110.85 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -113.1 76.41 2.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.678 0.752 . . . . 62.439999999999998 110.847 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -49.83 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 54.109999999999999 112.27 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 111.144 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.42 99.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 64.439999999999998 112.538 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -154.55 155.36 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 74.140000000000001 111.162 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -173.73 130.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 75.040000000000006 110.889 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 83' ' ' PHE . 98.0 t -85.44 97.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 111.098 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -44.15 94.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 74.299999999999997 111.139 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -136.8 161.25 36.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 53.130000000000003 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 162.08 41.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 55.420000000000002 111.12 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -148.63 142.59 25.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 75.129999999999995 110.962 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t0 64.39 14.55 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 72.430000000000007 110.883 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 111.097 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -62.72 97.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 53.219999999999999 111.134 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -87.13 128.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 45.399999999999999 111.093 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -117.2 168.8 9.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 72.040000000000006 111.171 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -130.43 153.24 48.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.010000000000005 110.879 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 m -159.43 85.66 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 61.32 110.849 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.34 -93.94 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 21.420000000000002 112.442 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.4 14.8 7.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 65.340000000000003 110.845 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -128.83 146.93 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.129999999999995 110.894 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -129.77 155.03 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.420000000000002 110.962 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.3 m -139.71 148.49 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 73.319999999999993 111.197 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' O ' HG23 ' A' ' 36' ' ' THR . . . -123.76 136.34 54.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 111.17 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.4 131.43 10.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.423 . . . . 74.530000000000001 110.828 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -114.31 -28.95 7.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.846 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 HD21 ' A' ' 70' ' ' ASN . 28.7 m -105.67 39.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 63.43 111.142 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.54 4.14 65.41 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.673 -0.775 . . . . 75.099999999999994 112.494 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.468 ' CE3' ' HB3' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -118.21 -32.94 4.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.782 0.325 . . . . 73.349999999999994 110.96 -179.965 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.468 ' HB3' ' CE3' ' A' ' 69' ' ' TRP . 6.1 p30 -105.48 -37.25 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 64.140000000000001 110.951 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.68 54.36 25.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.743 -0.741 . . . . 43.210000000000001 112.508 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -124.07 118.84 27.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 60.409999999999997 111.151 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 32' ' ' LEU . 22.6 tp -138.56 160.91 38.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 64.540000000000006 110.916 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -108.4 162.9 18.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.701 . . . . 60.009999999999998 111.064 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.8 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.637 2.225 . . . . 54.329999999999998 112.341 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -156.37 114.53 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.77 -0.729 . . . . 75.109999999999999 112.494 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 178.37 172.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 21.539999999999999 111.083 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -131.54 131.37 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.149999999999999 110.898 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.05 115.55 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 111.183 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.94 142.46 38.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 61.530000000000001 110.893 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HE2' HG21 ' A' ' 37' ' ' VAL . 48.1 p90 -136.27 133.8 37.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 74.030000000000001 110.909 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.32 -179.37 20.17 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 44.229999999999997 112.413 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 47' ' ' VAL . 31.7 p90 -171.84 176.77 3.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 75.019999999999996 110.842 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.62 125.68 36.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 75.310000000000002 110.931 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.78 161.92 26.67 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.678 -0.773 . . . . 61.329999999999998 112.491 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 p -105.61 125.47 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.37 . . . . 45.219999999999999 110.88 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.35 -163.3 30.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 72.319999999999993 112.484 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -36.16 11.53 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.697 2.265 . . . . 70.430000000000007 112.405 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.43 28.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 61.409999999999997 112.52 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -112.78 75.7 1.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.659 0.742 . . . . 72.120000000000005 110.834 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 157.0 61.88 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 71.030000000000001 112.321 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -145.88 177.09 9.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.889 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 m120 52.54 58.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.939 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.0 t -76.98 110.06 11.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.129999999999995 110.931 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -131.95 143.96 50.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 64.109999999999999 110.859 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 97' ' ' ASN . 2.1 pp -156.04 154.44 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.937 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.618 ' HB2' HD12 ' A' ' 96' ' ' LEU . 51.0 t30 63.31 47.33 4.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 75.349999999999994 110.874 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.35 18.51 73.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 70.409999999999997 112.517 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.96 69.74 1.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 61.130000000000003 112.513 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -156.05 104.7 2.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 73.430000000000007 110.846 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 75.140000000000001 110.913 -179.982 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.771 0.32 . . . . 63.210000000000001 111.164 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.86 31.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 64.239999999999995 111.064 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.03 147.52 47.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 63.43 111.175 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.43 142.4 31.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.430000000000007 110.937 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.52 152.01 40.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.116 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 147.93 25.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 52.049999999999997 110.932 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 -59.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 111.136 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.55 129.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 75.340000000000003 110.831 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.99 127.82 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.863 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.66 82.22 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.875 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.63 0.63 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 50.240000000000002 112.48 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -100.39 -17.68 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 61.340000000000003 111.113 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.9 152.81 22.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 62.219999999999999 112.431 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -141.95 142.51 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.002 0.43 . . . . 64.439999999999998 110.884 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.54 112.97 4.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 64.120000000000005 112.425 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.26 131.48 10.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.493 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 45.1 t -131.43 98.68 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 73.430000000000007 110.906 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -92.36 143.28 26.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.867 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 m -123.88 111.53 16.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 72.420000000000002 111.154 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 79' ' ' VAL . 15.7 t -109.57 132.58 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 54.229999999999997 111.12 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -137.68 130.28 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 70.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.497 ' HB2' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -107.68 144.91 34.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.120000000000005 110.881 179.979 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -172.67 162.23 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.109999999999999 111.13 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.05 -62.72 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 42.509999999999998 112.508 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 p -64.98 163.43 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 63.340000000000003 111.222 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -174.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 65.349999999999994 111.129 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -57.19 120.18 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 55.450000000000003 110.836 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 26' ' ' ASN . 1.2 mp -56.84 153.53 10.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.48 . . . . 42.329999999999998 110.87 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.14 -15.3 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.299999999999997 110.829 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.02 152.63 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 74.340000000000003 110.868 -179.746 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.46 ' HD1' HD13 ' A' ' 73' ' ' LEU . 59.4 p-90 -136.97 129.53 30.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 71.109999999999999 110.922 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -152.89 122.37 6.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 71.120000000000005 111.137 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.1 t -102.76 115.95 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 63.539999999999999 111.065 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.5 152.32 36.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 70.540000000000006 110.858 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.403 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -155.0 167.22 31.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 75.120000000000005 110.907 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.99 133.68 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 72.200000000000003 110.823 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -112.02 76.72 1.84 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.420000000000002 110.86 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -49.57 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.65 2.234 . . . . 74.129999999999995 112.335 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -73.38 144.74 46.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 73.319999999999993 111.124 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.19 96.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.150000000000006 112.466 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 43' ' ' THR . 6.5 m -156.66 155.95 32.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 111.116 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.26 131.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.853 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.6 t -75.06 99.79 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 61.329999999999998 111.133 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 t -67.53 -40.69 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 63.240000000000002 111.133 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -142.95 148.55 37.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 75.549999999999997 110.786 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.11 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 61.509999999999998 111.063 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -148.51 144.9 27.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 64.239999999999995 110.957 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 63.24 16.28 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 110.849 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.1 95.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 53.420000000000002 111.12 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -54.6 100.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 73.420000000000002 111.126 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.29 128.43 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 111.087 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -126.89 141.69 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 33.450000000000003 111.075 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -108.43 159.89 16.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.310000000000002 110.876 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 85.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.869 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.81 -90.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 54.109999999999999 112.521 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.22 7.51 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 75.409999999999997 110.822 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -119.15 146.89 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.852 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -128.06 160.09 33.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 65.519999999999996 110.86 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 t -148.77 149.48 31.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 73.209999999999994 111.103 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.86 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 35.210000000000001 111.103 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 142.84 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 110.889 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -120.26 -33.07 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.954 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.56 42.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 73.140000000000001 111.126 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.29 1.88 68.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 61.409999999999997 112.486 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.427 ' HE3' HD21 ' A' ' 70' ' ' ASN . 0.5 OUTLIER -116.74 -34.09 4.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.822 0.344 . . . . 75.519999999999996 110.976 -179.888 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.427 HD21 ' HE3' ' A' ' 69' ' ' TRP . 1.8 m-80 -108.24 -70.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 73.219999999999999 110.897 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.06 -37.65 3.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 64.540000000000006 112.487 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 t -49.92 117.66 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 71.109999999999999 111.122 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 ' HD1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -144.1 143.31 31.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.972 179.928 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -62.45 160.51 33.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.565 0.698 . . . . 52.039999999999999 111.121 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -18.31 36.74 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.739 2.292 . . . . 73.299999999999997 112.326 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.99 115.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 54.109999999999999 112.472 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.8 172.41 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 41.210000000000001 111.087 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -120.78 131.02 54.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.879 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.8 m -136.2 109.43 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 65.510000000000005 111.119 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.6 p -113.74 164.36 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 62.25 110.886 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 53.5 p90 -154.93 132.52 11.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.882 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.45 173.28 18.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 65.450000000000003 112.472 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 47' ' ' VAL . 26.3 p90 -174.83 176.73 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 75.329999999999998 110.85 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -129.92 139.04 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 61.350000000000001 110.906 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.2 159.49 27.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 42.200000000000003 112.493 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.43 112.08 24.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 63.119999999999997 110.888 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.5 -157.81 27.62 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.669 -0.777 . . . . 75.430000000000007 112.443 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -42.31 3.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 71.420000000000002 112.382 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.94 30.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 62.049999999999997 112.458 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.6 t -112.79 75.29 1.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.675 0.75 . . . . 52.310000000000002 110.842 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 159.02 54.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 51.340000000000003 112.343 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 m -142.72 165.92 26.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 52.210000000000001 110.938 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 m120 58.67 63.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 62.329999999999998 110.893 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.2 t -79.51 92.23 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.858 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 118.72 37.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 71.209999999999994 110.922 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.6 pp -130.27 155.76 45.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.925 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.603 ' HB2' HD12 ' A' ' 96' ' ' LEU . 42.4 t30 62.41 20.79 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 45.049999999999997 110.903 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.58 24.83 10.52 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.715 -0.755 . . . . 70.120000000000005 112.495 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.52 71.37 1.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.349999999999994 112.486 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 t -156.31 103.94 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 65.230000000000004 110.923 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 55.100000000000001 110.842 -179.904 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.819 0.343 . . . . 65.109999999999999 111.163 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -139.55 149.51 43.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 44.240000000000002 111.126 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 119.25 16.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.155 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -69.5 146.25 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 70.109999999999999 110.871 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.25 154.87 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 41.219999999999999 111.081 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.33 156.05 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 52.299999999999997 110.931 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -58.94 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 64.530000000000001 111.119 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 129.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 74.25 110.865 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -115.83 127.98 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 51.119999999999997 110.9 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.59 82.94 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 110.901 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.48 -85.12 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.741 . . . . 63.32 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -103.29 -17.57 15.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 64.209999999999994 111.123 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 156.11 26.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.804 -0.712 . . . . 33.240000000000002 112.515 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.16 142.91 30.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.885 0.374 . . . . 74.329999999999998 110.864 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.57 122.12 7.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 54.149999999999999 112.506 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.7 150.02 20.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 61.43 112.562 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -147.05 94.59 2.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.38 . . . . 71.340000000000003 110.816 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.27 134.87 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.902 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 m -113.12 102.1 10.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.140000000000001 111.111 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.68 131.59 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 62.450000000000003 111.162 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.48 118.12 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.895 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -116.0 133.21 56.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 75.150000000000006 110.884 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -172.04 153.72 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 111.08 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.93 -18.14 54.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.821 -0.704 . . . . 74.299999999999997 112.454 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 171.18 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 75.129999999999995 111.117 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -171.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 111.19 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.65 125.67 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 42.219999999999999 110.828 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.36 179.16 5.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 62.310000000000002 110.953 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -143.66 -52.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.109999999999999 110.84 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.91 174.42 14.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 110.923 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -140.25 127.35 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 54.240000000000002 110.907 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -113.74 102.14 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 70.109999999999999 111.116 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 81' ' ' PHE . 4.6 p -101.26 115.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 63.039999999999999 111.178 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.672 ' CG ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.92 151.45 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 110.865 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.12 169.68 18.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 110.937 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.19 128.11 44.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 63.140000000000001 110.898 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -112.59 77.15 2.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.633 0.73 . . . . 74.239999999999995 110.855 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.275 . . . . 75.439999999999998 112.264 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 26.5 m -71.93 145.35 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 71.140000000000001 111.163 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.36 98.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 70.209999999999994 112.433 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.75 153.49 31.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 71.239999999999995 111.163 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.75 130.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 74.299999999999997 110.882 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -79.53 96.59 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 65.340000000000003 111.154 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -63.57 -40.98 98.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 75.519999999999996 111.183 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 m -144.98 147.96 33.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.887 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.39 157.78 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 52.539999999999999 111.08 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -142.33 143.22 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 72.219999999999999 110.957 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.55 14.36 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 65.439999999999998 110.845 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.93 94.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.349999999999994 111.05 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -56.68 99.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.121 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 47' ' ' VAL . 96.6 t -90.27 121.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.129999999999995 111.095 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -111.56 172.05 7.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 74.140000000000001 111.142 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 155.26 48.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 110.927 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.85 85.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 110.821 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -93.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.675 -0.774 . . . . 75.230000000000004 112.443 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -126.25 10.25 7.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.400000000000006 110.795 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -124.3 147.02 48.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 110.876 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.77 159.86 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.319999999999993 110.959 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' CG ' ' A' ' 38' ' ' GLU . 15.5 m -147.8 148.82 31.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 73.010000000000005 111.133 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.88 135.18 48.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.129999999999995 111.071 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.88 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 61.340000000000003 110.889 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -131.47 -51.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.879 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.62 37.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 61.299999999999997 111.156 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.59 0.91 84.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 42.350000000000001 112.45 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -116.44 -24.27 7.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 72.340000000000003 110.889 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.636 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.17 -38.42 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 43.119999999999997 110.889 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.42 53.5 28.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.743 . . . . 75.409999999999997 112.487 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.3 t -130.18 94.95 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 74.340000000000003 111.212 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -138.61 160.72 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 63.210000000000001 110.897 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -85.12 161.31 52.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 71.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.9 Cg_endo -69.71 -8.45 23.63 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 74.540000000000006 112.351 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.21 115.54 0.75 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 74.040000000000006 112.484 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.53 172.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 62.240000000000002 111.11 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -134.19 131.62 38.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.120000000000005 110.849 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.88 116.98 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 52.299999999999997 111.164 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 p -108.41 125.95 52.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.872 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.9 p90 -111.55 137.31 49.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 74.5 110.818 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.64 174.5 17.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.310000000000002 112.458 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.9 p90 -174.32 179.07 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 71.230000000000004 110.878 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.5 140.86 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.856 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.65 159.9 28.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 72.450000000000003 112.48 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.1 m -105.37 113.72 27.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 74.230000000000004 110.87 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.52 31.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 71.400000000000006 112.501 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -37.35 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.655 2.237 . . . . 73.239999999999995 112.359 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.74 25.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 50.310000000000002 112.525 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -112.84 75.12 1.84 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.599 0.714 . . . . 73.510000000000005 110.834 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 156.71 62.74 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.652 2.234 . . . . 53.340000000000003 112.397 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 168.77 21.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 64.409999999999997 110.82 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 60.14 62.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 70.409999999999997 110.907 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t -84.9 95.55 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.150000000000006 110.812 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 125.52 48.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.904 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -135.3 155.61 50.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 73.530000000000001 110.988 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 63.08 25.76 15.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.140000000000001 110.88 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.58 28.66 13.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 73.140000000000001 112.458 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.35 74.79 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 52.439999999999998 112.476 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.18 104.35 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 64.319999999999993 110.862 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.88 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.916 0.389 . . . . 72.409999999999997 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 p 49.83 42.62 24.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 111.089 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.647 ' HA ' HG23 ' A' ' 29' ' ' THR . 3.8 p -174.62 -170.33 0.49 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 110.835 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.3 133.02 35.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 72.150000000000006 111.096 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.598 HG22 ' HB2' ' A' ' 102' ' ' ASP . 8.3 p -132.38 153.2 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 62.340000000000003 111.119 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.52 163.7 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 44.200000000000003 111.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.53 147.63 27.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 53.0 111.153 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -88.77 146.28 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.96 163.36 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 70.420000000000002 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.32 138.78 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 75.439999999999998 110.977 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.85 -60.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 61.340000000000003 111.165 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.27 131.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.94 127.3 53.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 75.040000000000006 110.908 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.25 88.17 2.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 71.019999999999996 110.983 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -93.22 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.75 . . . . 73.239999999999995 112.453 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.39 -17.7 17.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 73.439999999999998 111.141 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.61 148.59 20.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.778 -0.725 . . . . 52.200000000000003 112.489 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -138.08 143.75 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 70.400000000000006 110.881 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.29 3.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 73.019999999999996 112.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.77 139.27 21.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 42.420000000000002 112.504 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.34 95.51 3.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 40.420000000000002 110.815 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.25 145.13 25.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.17 -0.468 . . . . 53.009999999999998 110.932 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.27 124.73 52.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 111.085 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.08 131.56 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.116 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.77 118.1 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.883 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.73 101.54 9.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 62.409999999999997 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.9 p -146.05 134.06 21.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 42.43 111.101 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -57.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 62.539999999999999 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 3' ' ' SER . 0.7 OUTLIER -62.81 168.25 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 73.319999999999993 111.12 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.0 p -63.17 -174.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 70.129999999999995 111.125 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.53 125.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 64.439999999999998 110.857 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.65 -176.23 4.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.91 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.5 -52.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 45.229999999999997 110.821 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.79 157.54 38.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 55.340000000000003 110.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -114.46 126.84 55.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.888 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.47 100.79 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 62.020000000000003 111.142 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 37' ' ' VAL . 7.0 p -101.39 120.83 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 51.240000000000002 111.094 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.38 156.09 43.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 170.16 21.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.349999999999994 110.907 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.14 130.78 44.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 54.32 110.927 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -111.94 78.53 2.32 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.633 0.73 . . . . 74.120000000000005 110.928 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -49.28 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.734 2.289 . . . . 51.439999999999998 112.335 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -73.12 144.46 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 111.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.92 97.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.758 . . . . 75.430000000000007 112.478 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.428 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.4 m -156.07 154.55 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 60.240000000000002 111.195 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.99 131.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 72.530000000000001 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.3 t -74.23 95.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.452 . . . . 64.209999999999994 111.12 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.6 m -63.19 -42.51 99.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 71.430000000000007 111.189 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.68 140.13 31.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 60.549999999999997 110.782 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.85 137.89 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 54.420000000000002 111.125 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.39 142.48 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.951 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.84 13.99 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 73.319999999999993 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.73 120.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 64.030000000000001 111.131 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.2 99.98 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 62.039999999999999 111.136 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.703 HG11 HG21 ' A' ' 47' ' ' VAL . 42.5 t -89.29 119.5 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 44.439999999999998 111.116 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -106.82 171.13 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 64.010000000000005 111.156 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.85 156.37 46.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 73.239999999999995 110.953 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 t -158.23 85.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 64.409999999999997 110.858 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.37 0.89 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 55.439999999999998 112.515 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 51.25 110.902 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -108.73 146.92 32.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -131.28 155.6 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 73.129999999999995 110.96 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.8 m -148.46 149.05 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 75.209999999999994 111.12 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.9 124.61 37.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 71.409999999999997 111.071 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.27 157.77 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.150000000000006 110.916 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.35 -51.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 63.32 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.45 40.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.040000000000006 111.099 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.13 0.86 72.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 74.420000000000002 112.468 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.336 . . . . 52.530000000000001 110.878 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.55 -45.06 3.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 72.040000000000006 110.868 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.663 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.49 55.25 20.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.772 -0.728 . . . . 60.219999999999999 112.432 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.17 94.66 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.341 . . . . 72.329999999999998 111.205 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.51 160.83 38.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.099999999999994 110.846 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.43 162.31 54.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 44.229999999999997 111.075 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.71 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.708 2.272 . . . . 75.319999999999993 112.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.53 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 33.420000000000002 112.445 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 74.219999999999999 111.098 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.75 131.51 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 72.310000000000002 110.848 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.87 149.8 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 44.409999999999997 111.15 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.78 154.26 47.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.93 139.02 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 61.100000000000001 110.833 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.64 174.33 15.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 23.129999999999999 112.483 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.9 p90 -168.81 177.8 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 74.400000000000006 110.855 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.01 125.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.200000000000003 110.885 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.96 154.2 20.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 65.349999999999994 112.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -95.89 109.53 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.379 . . . . 34.409999999999997 110.837 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -160.28 30.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.79 -0.719 . . . . 53.340000000000003 112.481 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -41.73 4.12 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.712 2.274 . . . . 75.409999999999997 112.306 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.73 26.65 24.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 42.210000000000001 112.467 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 m -113.3 73.56 1.87 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.694 0.759 . . . . 44.240000000000002 110.891 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 163.31 38.75 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 74.219999999999999 112.381 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -148.26 173.37 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.299999999999997 110.87 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.23 49.31 3.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 65.340000000000003 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.5 m -68.57 97.34 0.77 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.409999999999997 110.854 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 118.97 25.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 65.239999999999995 110.915 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.93 155.94 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 110.858 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.34 13.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 44.350000000000001 110.807 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.15 42.15 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 43.329999999999998 112.479 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.7 70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 73.109999999999999 112.479 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.22 132.61 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 62.25 110.866 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.25 123.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.887 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.598 ' HB2' HG22 ' A' ' 5' ' ' THR . 3.8 t70 -116.72 156.88 26.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 64.319999999999993 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 104' ' ' THR . . . 65.14 19.53 66.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 30.43 112.559 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -178.12 178.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 73.129999999999995 111.175 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 64.319999999999993 110.84 -179.808 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.861 0.362 . . . . 70.549999999999997 111.16 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 p 49.88 42.56 24.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 64.239999999999995 111.179 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.646 ' HA ' HG23 ' A' ' 29' ' ' THR . 3.8 p -174.55 -170.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 50.409999999999997 110.88 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.36 133.1 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 60.130000000000003 111.055 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 102' ' ' ASP . 8.4 p -132.45 153.17 51.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.299999999999997 111.202 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.45 163.8 31.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 111.081 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 147.63 27.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 111.128 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.76 146.22 25.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.099999999999994 110.905 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.86 163.45 35.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 61.140000000000001 111.164 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 138.86 45.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 73.349999999999994 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.95 -60.92 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 75.049999999999997 111.11 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.32 131.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 64.239999999999995 110.868 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.99 127.24 53.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.847 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -111.28 88.23 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 70.230000000000004 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 -93.16 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 52.130000000000003 112.486 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.33 -17.74 17.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.784 0.326 . . . . 74.25 111.162 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.63 148.67 20.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 73.219999999999999 112.429 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.11 143.67 40.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 71.010000000000005 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.25 3.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 72.140000000000001 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 139.23 21.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 60.530000000000001 112.438 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.36 95.57 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.366 . . . . 73.219999999999999 110.894 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.31 145.2 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.857 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.3 124.66 52.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.200000000000003 111.22 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.98 131.59 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.149 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.84 118.12 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 62.119999999999997 110.888 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.74 101.46 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 65.409999999999997 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.7 p -146.0 134.12 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 71.040000000000006 111.096 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.87 -57.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.672 -0.775 . . . . 63.109999999999999 112.488 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.646 HG23 ' HA ' ' A' ' 3' ' ' SER . 0.7 OUTLIER -62.87 168.22 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 72.200000000000003 111.12 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -63.15 -174.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 71.099999999999994 111.204 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.52 125.58 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 60.219999999999999 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.64 -176.24 4.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 54.039999999999999 110.884 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.49 -52.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 110.892 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.84 157.55 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 75.329999999999998 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -114.45 126.94 55.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 71.510000000000005 110.917 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.62 100.75 6.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.456 . . . . 44.229999999999997 111.195 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 37' ' ' VAL . 7.1 p -101.33 120.78 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 72.109999999999999 111.148 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.37 156.1 43.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 72.209999999999994 110.886 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.2 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 72.540000000000006 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.13 130.88 44.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.851 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -112.09 78.55 2.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 73.329999999999998 110.92 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.2 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.615 2.21 . . . . 72.530000000000001 112.36 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.8 p -73.15 144.34 46.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 111.136 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.78 97.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 42.219999999999999 112.508 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.1 m -156.13 154.55 31.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 65.129999999999995 111.182 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 131.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 65.409999999999997 110.852 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.771 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.8 t -74.13 95.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 64.150000000000006 111.105 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -63.13 -42.65 99.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 60.350000000000001 111.138 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.6 140.03 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.299999999999997 110.864 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 137.97 48.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 44.219999999999999 111.091 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.41 142.48 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.299999999999997 110.907 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.82 14.04 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 73.409999999999997 110.866 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.76 120.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 51.240000000000002 111.111 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.21 100.0 5.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 63.130000000000003 111.146 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 47' ' ' VAL . 42.6 t -89.31 119.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 65.409999999999997 111.12 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -106.86 171.12 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.239999999999995 111.1 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.84 156.37 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 64.420000000000002 110.92 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -158.25 85.74 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.846 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 62.119999999999997 112.539 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 63.020000000000003 110.902 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -108.7 146.92 32.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -131.31 155.5 47.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.937 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.7 m -148.4 149.1 31.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 64.230000000000004 111.142 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.91 124.63 37.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 73.430000000000007 111.066 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.32 157.78 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 61.409999999999997 110.838 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.31 -51.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 72.219999999999999 110.965 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.44 40.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 73.519999999999996 111.138 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.14 0.86 72.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 73.239999999999995 112.486 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.69 -24.64 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 74.310000000000002 110.918 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.51 -45.05 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 61.049999999999997 110.929 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.662 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.44 55.27 20.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.705 -0.76 . . . . 63.140000000000001 112.485 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.23 94.7 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 75.420000000000002 111.088 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.46 160.88 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.420000000000002 110.954 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.49 162.33 53.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.569 0.7 . . . . 71.439999999999998 111.107 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.74 -8.45 23.64 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.711 2.274 . . . . 44.219999999999999 112.354 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.52 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 72.200000000000003 112.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 74.340000000000003 111.098 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.73 131.46 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 31.239999999999998 110.858 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.88 149.8 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 72.239999999999995 111.105 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.73 154.25 47.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.030000000000001 110.912 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -141.97 139.0 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.200000000000003 110.866 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.52 174.27 15.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 71.340000000000003 112.55 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.771 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.7 p90 -168.73 177.82 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 70.239999999999995 110.893 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.02 125.72 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 62.299999999999997 110.871 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.94 154.18 20.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.672 -0.775 . . . . 41.299999999999997 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -95.84 109.53 21.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.888 0.375 . . . . 72.319999999999993 110.901 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.03 -160.23 30.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.75 -0.738 . . . . 54.539999999999999 112.522 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -41.55 4.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 63.030000000000001 112.36 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 26.73 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 72.340000000000003 112.442 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 m -113.42 73.61 1.98 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.742 0.782 . . . . 73.519999999999996 110.897 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 163.35 38.64 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.693 2.262 . . . . 31.329999999999998 112.381 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.0 p -148.39 173.33 13.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 73.310000000000002 110.82 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.25 49.28 3.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.140000000000001 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.3 m -68.5 97.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 73.019999999999996 110.922 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.13 119.06 25.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.924 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.01 155.93 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.230000000000004 110.898 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.35 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 62.100000000000001 110.818 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.11 42.23 8.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.708 -0.758 . . . . 74.219999999999999 112.493 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.64 70.02 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 63.25 112.495 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.23 132.62 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 60.009999999999998 110.873 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.25 123.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.127 -0.488 . . . . 51.130000000000003 110.944 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.599 ' HB2' HG22 ' A' ' 5' ' ' THR . 3.8 t70 -116.82 156.89 26.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 73.219999999999999 110.819 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 104' ' ' THR . . . 65.23 19.45 66.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 75.049999999999997 112.447 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -178.02 178.61 0.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 55.100000000000001 111.171 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 63.520000000000003 110.842 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.883 0.373 . . . . 73.310000000000002 111.06 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -115.16 40.38 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 111.13 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.67 -170.26 3.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 64.209999999999994 110.893 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.53 136.59 33.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 64.540000000000006 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.44 HG21 ' HB3' ' A' ' 102' ' ' ASP . 6.6 p -146.06 159.96 42.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 75.230000000000004 111.092 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.71 163.83 33.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 72.230000000000004 111.09 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 m -139.91 137.38 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 52.399999999999999 111.093 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -76.76 139.03 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.430000000000007 110.856 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.14 150.75 41.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 111.123 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.67 142.11 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.848 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.51 -56.49 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 111.09 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.25 132.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 52.420000000000002 110.902 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.46 127.65 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 64.329999999999998 110.793 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.42 84.87 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 75.430000000000007 110.903 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 -91.11 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 64.209999999999994 112.46 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.5 -17.6 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.347 . . . . 62.140000000000001 111.092 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.16 148.41 20.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 75.120000000000005 112.504 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -135.15 141.69 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 74.420000000000002 110.832 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.84 108.83 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 75.109999999999999 112.453 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.54 130.51 10.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 64.340000000000003 112.496 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.85 99.46 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 71.25 110.899 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.29 117.93 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 70.120000000000005 110.893 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.5 m -95.52 110.09 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 53.210000000000001 111.164 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.4 t -106.71 131.89 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 74.319999999999993 111.161 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -143.4 127.97 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 73.239999999999995 110.888 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.25 133.44 55.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.129999999999995 110.873 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.47 151.67 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.150000000000006 111.172 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -41.08 2.36 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.645 -0.788 . . . . 75.510000000000005 112.535 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 169.1 14.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 74.329999999999998 111.163 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -172.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 65.430000000000007 111.083 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -51.43 129.71 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 55.119999999999997 110.867 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -176.24 4.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 62.420000000000002 110.93 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -52.94 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.049999999999997 110.904 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.77 176.23 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.837 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.492 ' CD1' HG21 ' A' ' 79' ' ' VAL . 29.2 p-90 -135.68 127.09 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 64.230000000000004 110.894 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -124.64 105.83 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 75.329999999999998 111.138 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 14.2 t -101.4 105.92 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 72.439999999999998 111.11 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' A' ' 63' ' ' THR . 11.4 pm0 -116.76 153.07 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.84 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.82 169.61 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.911 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.08 129.94 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.841 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.76 75.38 1.88 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 72.25 110.86 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -49.78 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.641 2.227 . . . . 64.230000000000004 112.407 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -71.07 144.56 50.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 111.202 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.9 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.150000000000006 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -156.57 154.71 30.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 72.400000000000006 111.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.67 131.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 74.329999999999998 110.913 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.733 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.6 t -75.18 101.41 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 45.350000000000001 111.063 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -45.69 91.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 72.239999999999995 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.12 148.5 33.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.150000000000006 110.846 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.62 137.08 39.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 111.093 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -119.51 148.17 43.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.903 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.52 14.53 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 65.120000000000005 110.871 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 134.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 41.240000000000002 111.092 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -86.56 95.01 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 111.137 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 64' ' ' ALA . 98.2 t -86.34 138.33 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 71.129999999999995 111.07 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -128.31 171.03 12.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 111.168 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -136.07 157.39 46.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 85.74 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 110.877 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.98 -91.77 0.71 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 44.340000000000003 112.522 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.21 8.23 7.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 73.140000000000001 110.916 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -119.23 146.68 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 72.420000000000002 110.873 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -130.88 157.53 42.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.894 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 38' ' ' GLU . 46.9 m -152.53 148.46 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 72.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -130.46 134.84 47.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 53.409999999999997 111.135 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.1 OUTLIER -145.36 160.84 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.923 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.95 -51.46 0.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.430000000000007 110.902 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -98.93 39.3 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.520000000000003 111.11 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.26 -0.73 72.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.772 -0.727 . . . . 53.229999999999997 112.535 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -113.53 -25.2 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.806 0.336 . . . . 71.230000000000004 110.947 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.04 -47.0 3.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 74.409999999999997 110.874 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.86 56.3 14.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.774 -0.726 . . . . 44.43 112.438 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.71 95.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 41.530000000000001 111.093 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.9 tt -137.24 160.55 38.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.109999999999999 110.922 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -70.17 161.97 72.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.718 . . . . 54.299999999999997 111.151 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.77 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.727 2.284 . . . . 74.349999999999994 112.29 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.9 119.0 1.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 44.530000000000001 112.498 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.41 172.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 74.409999999999997 111.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -131.02 131.64 44.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.848 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.1 m -134.31 114.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.188 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 p -111.83 134.36 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 71.129999999999995 110.89 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.67 138.64 45.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.450000000000003 110.918 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.16 -179.77 19.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.761 -0.733 . . . . 72.319999999999993 112.469 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.733 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.1 p90 -174.45 174.02 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 73.329999999999998 110.862 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -129.83 125.79 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.109999999999999 110.838 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.49 152.22 19.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 42.420000000000002 112.546 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.4 t -97.87 109.38 22.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 71.150000000000006 110.894 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.51 -156.52 27.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 72.549999999999997 112.457 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -42.04 3.66 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 74.200000000000003 112.314 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.11 26.49 31.02 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.702 -0.761 . . . . 32.149999999999999 112.55 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 m -113.09 74.74 1.91 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.678 0.752 . . . . 62.530000000000001 110.908 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 162.55 41.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 73.299999999999997 112.375 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -148.34 171.29 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.310000000000002 110.836 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 60.01 58.47 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 73.349999999999994 110.846 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.33 92.06 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 62.020000000000003 110.857 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 118.94 33.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.427 . . . . 72.409999999999997 110.9 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -128.71 155.78 44.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.230000000000004 110.944 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 64.12 22.69 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 110.828 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.34 41.85 5.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 75.109999999999999 112.474 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.65 71.54 1.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 53.520000000000003 112.485 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.1 m -156.23 104.15 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 63.32 110.885 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.8 t -149.56 137.56 20.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 64.120000000000005 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HB3' HG21 ' A' ' 5' ' ' THR . 21.9 t0 -127.15 154.76 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 65.219999999999999 110.798 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.78 -30.03 7.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.738 -0.744 . . . . 73.140000000000001 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.44 -178.64 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 62.32 111.087 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 70.430000000000007 110.865 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.883 0.373 . . . . 63.420000000000002 111.095 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.5 t -139.39 33.74 2.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 65.510000000000005 111.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.5 -177.81 2.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 61.240000000000002 110.836 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.33 135.18 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 33.119999999999997 111.064 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.7 p -143.4 177.83 8.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 54.409999999999997 111.185 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.35 163.82 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 44.509999999999998 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -141.79 147.69 37.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 111.154 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -91.21 145.4 24.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.439999999999998 110.839 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.68 149.86 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 74.209999999999994 111.105 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 147.33 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 54.5 110.888 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.27 -61.92 1.59 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 72.150000000000006 111.114 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -179.39 146.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.150000000000006 110.893 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -117.86 126.85 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.906 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -111.14 86.79 2.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.230000000000004 110.973 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.66 -82.97 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 51.039999999999999 112.508 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 t -115.66 -17.52 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 62.200000000000003 111.089 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.9 159.26 30.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 64.430000000000007 112.461 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HE2' HG23 ' A' ' 45' ' ' THR . 22.4 p90 -139.99 160.45 39.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 61.299999999999997 110.886 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.47 121.89 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 53.420000000000002 112.432 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.29 146.49 18.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 55.299999999999997 112.513 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -138.98 94.57 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 63.340000000000003 110.825 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.2 136.46 33.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 73.519999999999996 110.915 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -111.68 123.85 51.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 43.119999999999997 111.207 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.36 131.69 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 54.420000000000002 111.202 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.64 118.06 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 70.209999999999994 110.934 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -105.85 119.8 40.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 60.32 110.914 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -158.07 159.89 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 111.147 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -59.0 3.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 40.530000000000001 112.547 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 175.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.825 0.345 . . . . 61.539999999999999 111.173 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 175.04 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 71.340000000000003 111.165 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 p -52.58 131.66 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 41.340000000000003 110.857 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 33' ' ' SER . 0.9 OUTLIER -106.69 -169.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 63.32 110.961 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -133.47 -52.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 110.823 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.94 154.42 40.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 75.409999999999997 110.86 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -107.41 126.94 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 73.200000000000003 110.97 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 103.77 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 73.540000000000006 111.12 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 18.0 t -101.55 105.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 71.450000000000003 111.082 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.85 155.8 34.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 65.400000000000006 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -157.4 169.28 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 72.340000000000003 110.95 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -97.82 132.35 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 55.100000000000001 110.92 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.23 80.42 2.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.616 0.722 . . . . 73.099999999999994 110.807 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 44.020000000000003 112.394 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -73.37 144.56 46.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 64.129999999999995 111.158 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.48 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.815 -0.707 . . . . 62.310000000000002 112.448 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.608 HG23 ' HE2' ' A' ' 18' ' ' PHE . 86.4 m -156.24 143.5 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.361 . . . . 74.319999999999993 111.151 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -155.55 130.91 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.400000000000006 110.921 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 83' ' ' PHE . 57.5 t -77.94 92.5 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.129999999999995 111.099 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.9 m -77.08 -31.21 55.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 64.219999999999999 111.163 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.23 149.96 48.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 44.439999999999998 110.836 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.78 146.21 21.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 64.329999999999998 111.088 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -143.95 141.24 30.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.549999999999997 110.926 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.82 15.56 9.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.140000000000001 110.893 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.54 120.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 73.409999999999997 111.161 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.5 m -80.15 109.8 14.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 72.439999999999998 111.094 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 47' ' ' VAL . 15.7 t -93.65 138.63 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.140000000000001 111.101 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.0 m -128.13 142.27 51.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.340000000000003 111.228 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.69 157.08 18.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.875 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -160.6 85.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.130000000000003 110.816 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.44 -90.83 0.46 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 74.349999999999994 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.31 6.3 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 65.239999999999995 110.87 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -119.85 146.79 45.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.409999999999997 110.852 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -129.19 164.21 23.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.966 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -151.32 149.37 29.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.439999999999998 111.168 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.29 114.98 17.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 62.030000000000001 111.133 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 154.75 47.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 110.884 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -131.32 -51.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.878 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -97.05 39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 75.239999999999995 111.146 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.2 68.52 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.737 -0.744 . . . . 35.039999999999999 112.454 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -112.08 -30.45 7.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 73.450000000000003 110.919 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -102.49 -46.06 4.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 72.329999999999998 110.861 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.98 55.84 16.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.696 -0.764 . . . . 75.299999999999997 112.492 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -135.19 94.6 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.834 0.349 . . . . 63.409999999999997 111.194 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -135.37 161.17 36.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.120000000000005 110.939 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -92.3 163.45 26.78 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.534 0.683 . . . . 55.420000000000002 111.109 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -7.92 22.28 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.632 2.222 . . . . 64.329999999999998 112.352 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 115.17 1.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 72.299999999999997 112.492 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.75 172.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 75.019999999999996 111.12 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.89 131.58 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.430000000000007 110.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.8 t -149.41 137.39 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.515 . . . . 54.219999999999999 111.149 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -124.22 136.59 54.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.828 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 28.4 p90 -125.25 135.81 52.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 52.340000000000003 110.865 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.89 171.13 13.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 72.200000000000003 112.394 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.9 p90 -162.42 179.59 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 72.219999999999999 110.951 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -136.67 131.07 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 54.43 110.872 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 153.84 23.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 61.420000000000002 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -91.28 116.78 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 71.239999999999995 110.881 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -161.58 29.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 45.149999999999999 112.485 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -45.51 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 73.140000000000001 112.342 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 27.55 9.81 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 63.350000000000001 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 t -112.37 75.13 1.64 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.57 0.7 . . . . 73.030000000000001 110.867 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 165.29 31.43 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.705 2.27 . . . . 75.099999999999994 112.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -148.59 -177.42 5.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 55.450000000000003 110.834 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m120 51.85 60.98 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 110.901 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -76.66 105.88 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 110.91 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 144.16 41.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 60.329999999999998 110.954 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 pp -153.12 156.15 38.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.209999999999994 110.893 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.94 43.73 2.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 54.420000000000002 110.918 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.8 42.13 61.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.706 -0.759 . . . . 74.519999999999996 112.525 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 70.89 1.33 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.749 -0.738 . . . . 63.520000000000003 112.492 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -156.43 104.35 2.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 55.350000000000001 110.841 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 121.86 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 70.409999999999997 110.889 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.6 132.03 54.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 73.510000000000005 110.892 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.01 30.96 56.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 50.130000000000003 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.39 168.31 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 72.010000000000005 111.183 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 74.040000000000006 110.918 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.861 0.362 . . . . 71.439999999999998 111.125 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.462 HG22 ' HA3' ' A' ' 28' ' ' GLY . 27.4 p -96.5 95.34 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 73.209999999999994 111.125 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.65 -178.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 70.329999999999998 110.859 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.57 132.76 36.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 50.340000000000003 111.108 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.638 HG23 ' H ' ' A' ' 102' ' ' ASP . 96.7 m -149.96 144.62 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 71.140000000000001 111.18 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.85 29.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 53.420000000000002 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -137.46 132.89 34.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.530000000000001 111.185 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.09 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 63.5 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.91 154.0 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -99.2 145.58 27.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 61.420000000000002 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -105.85 -58.64 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 65.349999999999994 111.122 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -179.42 131.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 72.019999999999996 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.59 127.29 53.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.31 88.99 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.2 -92.96 0.76 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 62.439999999999998 112.462 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.51 -17.76 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 64.200000000000003 111.181 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.36 148.62 20.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 63.119999999999997 112.495 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -136.87 145.1 43.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 73.319999999999993 110.887 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.52 112.53 4.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 64.209999999999994 112.491 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.77 145.44 24.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 62.219999999999999 112.524 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.92 98.7 3.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 65.400000000000006 110.826 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.79 124.46 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.400000000000006 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.9 m -105.27 101.81 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 62.530000000000001 111.174 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 79' ' ' VAL . 32.5 t -99.37 131.98 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 111.075 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -139.81 118.19 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.200000000000003 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.86 101.46 9.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 62.210000000000001 110.866 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -131.15 136.22 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 111.193 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 2' ' ' THR . . . 93.36 -35.53 4.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.679 -0.772 . . . . 52.310000000000002 112.492 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 177.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 63.450000000000003 111.209 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.34 173.41 12.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 72.549999999999997 111.149 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.76 108.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 45.420000000000002 110.886 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.09 -177.66 6.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 75.129999999999995 110.957 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.7 p -141.71 -53.44 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 64.450000000000003 110.822 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.53 152.63 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 72.219999999999999 110.889 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -115.3 126.78 54.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 62.409999999999997 110.931 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -135.9 118.13 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 62.240000000000002 111.155 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -114.91 125.46 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 65.319999999999993 111.176 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.39 153.71 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 51.43 110.825 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.55 169.45 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 64.209999999999994 110.88 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 132.45 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 54.229999999999997 110.834 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.9 m-85 -111.83 79.5 2.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.603 0.716 . . . . 71.219999999999999 110.859 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 72.25 112.364 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' THR . 69.9 p -73.36 144.82 46.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 73.409999999999997 111.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.42 96.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 63.109999999999999 112.485 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' CE1' ' A' ' 41' ' ' PHE . 57.4 m -156.94 149.41 23.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 54.420000000000002 111.154 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.68 131.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.937 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 63.5 t -74.79 100.15 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 64.140000000000001 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.3 m -63.16 -46.02 89.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.124 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 m -141.44 142.12 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 60.25 110.897 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.46 147.69 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.239999999999995 111.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -131.58 143.99 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.219999999999999 110.925 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t0 64.8 14.07 8.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.530000000000001 110.935 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.41 ' HB3' ' CD1' ' A' ' 81' ' ' PHE . . . -172.96 106.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.450000000000003 111.068 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -64.95 91.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 73.0 111.141 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 64' ' ' ALA . 77.0 t -88.96 113.27 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 111.11 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 63' ' ' THR . 11.4 t -107.19 179.08 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 72.299999999999997 111.181 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.21 159.97 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.430000000000007 110.921 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -158.6 85.21 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 63.109999999999999 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.17 -90.99 1.01 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.748 -0.739 . . . . 73.200000000000003 112.442 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -126.75 2.0 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 61.109999999999999 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -111.56 146.88 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.120000000000005 110.88 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -130.29 152.9 49.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.903 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.599 HG23 HG22 ' A' ' 56' ' ' THR . 2.3 t -149.07 148.58 29.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.400000000000006 111.146 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -127.41 135.49 50.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.089 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.59 135.21 15.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 110.872 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -111.77 -32.09 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.109999999999999 110.907 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.32 40.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 71.329999999999998 111.152 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.03 1.89 72.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 72.310000000000002 112.52 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -117.78 -34.05 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 63.340000000000003 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.493 ' HB3' HG22 ' A' ' 72' ' ' THR . 2.0 m-20 -102.0 -68.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 64.430000000000007 110.89 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.96 45.44 8.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 70.219999999999999 112.479 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.03 120.72 29.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.816 0.341 . . . . 54.409999999999997 111.166 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -146.25 161.43 40.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 74.430000000000007 110.97 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.02 164.0 17.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.349999999999994 111.034 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.702 2.268 . . . . 65.120000000000005 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.63 114.29 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 71.120000000000005 112.484 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.99 172.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.711 0.291 . . . . 53.009999999999998 111.143 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -129.33 131.28 46.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 71.200000000000003 110.825 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.533 HG13 ' HB ' ' A' ' 24' ' ' VAL . 8.2 p -133.42 128.29 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 111.181 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -132.74 140.85 48.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 45.409999999999997 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 20.7 p90 -135.32 153.76 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 72.519999999999996 110.873 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.53 175.83 17.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.787 -0.721 . . . . 54.329999999999998 112.486 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 30.5 p90 -174.21 177.32 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 74.519999999999996 110.907 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -130.64 125.77 34.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.549999999999997 110.879 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.51 151.62 18.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 71.109999999999999 112.474 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 109.57 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 63.509999999999998 110.845 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.47 -157.22 27.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.706 -0.759 . . . . 72.420000000000002 112.426 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -42.49 3.33 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.591 2.194 . . . . 73.030000000000001 112.373 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.9 26.97 25.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 62.420000000000002 112.508 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -113.03 73.95 1.72 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.742 . . . . 71.150000000000006 110.828 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 156.02 64.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.669 2.246 . . . . 62.549999999999997 112.343 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 70.349999999999994 110.845 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 63.14 62.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 63.450000000000003 110.858 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.54 131.75 34.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 54.329999999999998 110.936 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 121.37 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 51.140000000000001 110.898 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.797 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.3 pp -136.48 155.88 49.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.400000000000006 110.935 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.797 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.6 t30 64.11 39.79 7.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.099999999999994 110.937 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 23.36 60.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 50.009999999999998 112.531 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.37 71.53 1.16 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 41.43 112.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -156.19 104.24 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 62.229999999999997 110.891 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.2 t -168.27 112.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 71.209999999999994 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.638 ' H ' HG23 ' A' ' 5' ' ' THR . 20.8 t70 -61.37 156.39 19.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 70.409999999999997 110.851 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.55 49.26 19.75 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.769 -0.729 . . . . 61.5 112.508 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -172.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.129999999999995 111.169 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 50.009999999999998 110.885 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.801 0.334 . . . . 63.240000000000002 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.431 ' CG2' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -129.66 169.84 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 111.147 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -118.88 97.5 5.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.429 . . . . 72.239999999999995 110.887 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.06 132.79 14.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 54.399999999999999 111.116 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -122.18 170.79 9.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 63.439999999999998 111.08 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.37 163.77 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.509999999999998 111.095 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.41 141.93 26.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.128 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -84.73 145.53 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 71.209999999999994 110.884 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.77 164.1 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 70.519999999999996 111.153 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.74 163.95 12.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.879 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -61.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 73.209999999999994 111.121 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.22 135.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 51.340000000000003 110.905 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.92 127.14 53.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 53.210000000000001 110.93 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.14 92.91 4.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.926 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -90.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.794 -0.717 . . . . 72.319999999999993 112.477 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -106.98 -17.56 14.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 70.010000000000005 111.127 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.82 153.56 27.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 64.409999999999997 112.516 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -140.94 146.55 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 63.399999999999999 110.928 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.22 127.93 9.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.774 -0.727 . . . . 70.349999999999994 112.543 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 145.95 16.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.758 . . . . 73.109999999999999 112.507 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.76 100.09 4.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 54.399999999999999 110.845 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.29 139.91 30.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 72.239999999999995 110.921 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -114.73 119.54 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 45.140000000000001 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.96 131.78 62.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.430000000000007 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -138.29 127.5 24.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.716 ' HB3' HD13 ' A' ' 32' ' ' LEU . 70.1 m-80 -118.2 129.73 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 60.439999999999998 110.899 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -172.6 159.76 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 74.310000000000002 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.1 9.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 71.510000000000005 112.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.431 HG21 ' CG2' ' A' ' 2' ' ' THR . 0.1 OUTLIER -102.48 171.01 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 62.329999999999998 111.144 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -172.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.019999999999996 111.152 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -51.54 128.06 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 70.430000000000007 110.844 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -86.1 -175.94 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 61.030000000000001 110.895 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.99 -53.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.129999999999995 110.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 p -155.82 176.38 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 65.040000000000006 110.864 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -139.66 126.89 21.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 72.329999999999998 110.878 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -114.04 104.55 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 64.099999999999994 111.099 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.0 p -101.45 108.31 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 53.039999999999999 111.144 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -130.15 136.17 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 61.310000000000002 110.833 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.58 169.89 15.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 74.120000000000005 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.21 129.19 44.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 51.340000000000003 110.862 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -113.03 76.43 2.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.200000000000003 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -49.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 64.109999999999999 112.394 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -72.03 145.19 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 75.409999999999997 111.132 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.39 98.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 35.119999999999997 112.471 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -154.56 155.07 34.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 64.409999999999997 111.115 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.55 130.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 73.329999999999998 110.864 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.657 HG22 ' CE2' ' A' ' 83' ' ' PHE . 92.7 t -82.02 109.08 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.120000000000005 111.114 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.04 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 65.109999999999999 111.085 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -145.85 154.56 42.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 71.219999999999999 110.811 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.73 143.9 35.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 72.25 111.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -128.07 145.38 51.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 62.229999999999997 110.99 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.98 13.8 8.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.306 -0.406 . . . . 74.030000000000001 110.84 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.84 101.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 51.020000000000003 111.083 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.0 m -60.29 96.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 72.409999999999997 111.158 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 64' ' ' ALA . 97.2 t -92.54 112.6 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 75.349999999999994 111.046 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 HG23 ' A' ' 63' ' ' THR . 14.0 t -105.51 174.84 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 63.240000000000002 111.146 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -135.9 158.14 45.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.84 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -158.51 85.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 71.019999999999996 110.918 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.04 -91.59 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 74.519999999999996 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.57 4.92 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 74.099999999999994 110.882 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 75.219999999999999 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -132.64 139.08 47.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 75.109999999999999 110.913 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 56' ' ' THR . 5.7 t -139.21 148.85 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 111.134 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -133.66 144.4 49.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 111.066 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 161.08 39.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 110.947 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -131.62 -51.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.896 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.1 39.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 64.319999999999993 111.117 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.6 1.17 83.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 64.439999999999998 112.491 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -115.13 -20.82 10.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.32 . . . . 71.340000000000003 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -115.33 -44.35 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 63.310000000000002 110.916 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.95 56.73 11.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.501 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -145.93 96.55 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.430000000000007 111.13 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.0 tt -138.27 160.27 39.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 72.140000000000001 111.021 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -66.74 161.52 60.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 62.130000000000003 111.036 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.3 Cg_endo -69.7 -19.73 36.03 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 63.25 112.329 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.08 116.24 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.779 -0.724 . . . . 71.540000000000006 112.528 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -177.82 172.08 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.420000000000002 111.108 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 86.7 p -136.24 131.63 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.876 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.08 117.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.549999999999997 111.106 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -110.4 134.8 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 61.109999999999999 110.868 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.645 ' CE2' HG11 ' A' ' 37' ' ' VAL . 27.8 p90 -122.74 146.44 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 52.149999999999999 110.918 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.02 173.32 14.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 73.409999999999997 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.7 p90 -171.18 -179.5 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.219999999999999 110.867 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -131.43 125.95 33.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 53.409999999999997 110.873 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.03 156.64 20.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 64.329999999999998 112.471 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.17 116.57 32.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 74.109999999999999 110.891 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.35 28.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 52.439999999999998 112.486 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -33.74 16.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.744 2.296 . . . . 74.329999999999998 112.324 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.46 26.93 28.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 72.030000000000001 112.494 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -112.28 76.03 1.82 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.727 0.775 . . . . 74.409999999999997 110.898 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 157.94 58.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 74.120000000000005 112.356 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -147.44 173.12 12.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 70.030000000000001 110.849 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.61 46.82 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 72.340000000000003 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.6 m -65.75 100.61 0.56 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.841 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.45 144.04 47.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.510000000000005 110.876 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.2 pp -160.19 145.84 15.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 64.540000000000006 110.92 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.68 ' HB2' HD12 ' A' ' 96' ' ' LEU . 2.9 t-20 60.67 54.82 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 64.439999999999998 110.885 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.9 39.53 46.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 65.299999999999997 112.514 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.56 65.24 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 70.299999999999997 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.73 104.62 2.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 72.420000000000002 110.852 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.35 132.49 19.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 72.230000000000004 110.908 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.66 156.49 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 51.119999999999997 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.96 -25.86 25.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 52.450000000000003 112.535 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.2 10.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.815 0.341 . . . . 72.239999999999995 111.146 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 53.420000000000002 110.856 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.864 0.364 . . . . 54.130000000000003 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 p 49.89 40.3 20.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 71.409999999999997 111.105 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 p -165.9 175.32 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 55.43 110.871 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 111.138 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 178.53 6.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 111.147 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -162.36 163.89 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 72.349999999999994 111.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -153.0 138.24 17.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 73.200000000000003 111.153 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -83.47 138.46 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.08 158.95 43.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 54.039999999999999 111.15 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -104.47 139.8 38.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 72.329999999999998 110.897 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -99.7 -62.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 72.040000000000006 111.16 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.82 143.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 75.450000000000003 110.865 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.15 125.9 51.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 75.019999999999996 110.851 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -112.2 107.04 15.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 73.109999999999999 110.989 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 64.510000000000005 112.511 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -117.61 -17.52 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 74.040000000000006 111.164 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 140.88 16.87 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 53.25 112.537 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.76 149.61 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.829 0.347 . . . . 74.129999999999995 110.888 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.1 106.14 2.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 64.239999999999995 112.469 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.27 138.22 18.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 52.350000000000001 112.453 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.34 100.67 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 71.349999999999994 110.819 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -90.17 132.67 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 74.439999999999998 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.5 m -110.48 122.99 49.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.129 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.47 131.78 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 53.310000000000002 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.71 126.95 18.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 71.049999999999997 110.921 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -119.42 135.02 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 71.129999999999995 110.885 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 t -168.2 140.65 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 64.450000000000003 111.141 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.29 -61.88 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 60.009999999999998 112.513 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -60.2 165.83 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 72.140000000000001 111.162 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.5 p -59.92 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 64.200000000000003 111.178 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 127.15 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 70.230000000000004 110.854 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -176.29 4.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 62.130000000000003 110.941 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -140.91 -52.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 72.349999999999994 110.885 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.47 174.51 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 44.109999999999999 110.854 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -132.2 126.99 34.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.498 . . . . 74.209999999999994 110.932 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.31 105.69 12.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 64.109999999999999 111.113 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 81' ' ' PHE . 5.2 p -105.0 120.66 55.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 61.310000000000002 111.13 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 63' ' ' THR . 6.3 pm0 -133.48 156.52 47.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 51.520000000000003 110.866 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.82 168.76 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 74.030000000000001 110.902 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.24 133.19 43.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 110.803 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -113.53 73.42 2.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 74.219999999999999 110.926 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -50.14 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.66 2.24 . . . . 62.32 112.387 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -74.05 145.56 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.400000000000006 111.115 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -38.24 99.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 41.100000000000001 112.504 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -154.82 157.86 38.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 72.430000000000007 111.186 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -173.34 130.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 60.5 110.97 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.644 HG22 ' CE2' ' A' ' 83' ' ' PHE . 81.3 t -81.69 107.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.299999999999997 111.119 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -48.34 79.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 44.25 111.165 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.32 156.22 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.420000000000002 110.787 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 134.56 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 64.420000000000002 111.128 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -118.59 145.66 45.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.349999999999994 110.863 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.27 13.49 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 71.019999999999996 110.854 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 103.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.030000000000001 111.153 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -63.2 97.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 55.119999999999997 111.139 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 64' ' ' ALA . 84.0 t -89.1 131.09 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.125 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -119.7 172.53 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 111.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -134.03 155.98 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 61.229999999999997 110.893 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.76 85.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 45.399999999999999 110.919 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.83 -93.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.229999999999997 112.52 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.26 17.09 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 73.310000000000002 110.823 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -129.56 146.71 51.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.209999999999994 110.869 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -130.67 160.46 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 110.894 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 38' ' ' GLU . 41.1 m -152.71 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 73.299999999999997 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.18 134.63 48.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 111.103 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 156.53 47.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 55.299999999999997 110.895 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -131.43 -51.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 63.100000000000001 110.884 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -101.9 39.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 73.129999999999995 111.11 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -0.29 75.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 33.039999999999999 112.496 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -114.2 -25.39 8.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 64.120000000000005 110.92 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.537 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -108.58 -47.36 3.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 55.43 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.79 55.6 19.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 72.530000000000001 112.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -136.51 94.84 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 62.25 111.175 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.6 tt -137.13 160.77 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 62.5 110.93 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -76.64 162.28 71.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 71.319999999999993 111.049 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.654 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.81 -8.37 23.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.633 2.222 . . . . 74.430000000000007 112.319 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.6 115.83 0.86 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.713 -0.756 . . . . 72.450000000000003 112.523 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.81 172.16 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 71.400000000000006 111.046 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -131.63 131.62 43.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 70.439999999999998 110.795 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.05 141.49 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 73.150000000000006 111.162 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -132.91 164.31 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 75.549999999999997 110.806 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 37' ' ' VAL . 29.3 p90 -156.33 143.15 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 73.409999999999997 110.886 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.41 172.29 14.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 73.409999999999997 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -170.0 178.91 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.369 . . . . 73.549999999999997 110.895 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.14 149.42 50.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 73.349999999999994 110.852 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.68 160.6 29.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.712 -0.756 . . . . 65.209999999999994 112.461 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 71.519999999999996 110.837 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.84 -159.9 29.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.783 -0.722 . . . . 23.140000000000001 112.488 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -37.24 9.66 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.724 2.283 . . . . 71.030000000000001 112.406 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.84 28.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 75.129999999999995 112.495 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 78.99 2.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.71 0.767 . . . . 74.439999999999998 110.785 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 168.14 22.43 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 74.409999999999997 112.386 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 m -146.68 170.33 17.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 63.130000000000003 110.869 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.37 44.35 9.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 73.239999999999995 110.917 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.2 m -64.53 92.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.400000000000006 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 144.06 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 62.310000000000002 110.922 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.1 pp -158.76 155.86 28.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.310000000000002 110.909 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' HB2' HD12 ' A' ' 96' ' ' LEU . 6.8 t-20 64.67 46.66 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 71.239999999999995 110.914 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.84 41.88 54.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 65.329999999999998 112.493 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.05 67.05 1.8 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.67 -0.776 . . . . 72.549999999999997 112.517 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.3 m -156.35 108.87 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 43.140000000000001 110.761 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 35.4 t -172.69 112.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 73.129999999999995 110.839 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 166.69 23.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 74.319999999999993 110.893 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.05 25.18 73.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 72.219999999999999 112.466 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.62 175.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 51.310000000000002 111.092 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 71.409999999999997 110.882 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.347 . . . . 64.310000000000002 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.6 p -137.89 32.51 2.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 42.549999999999997 111.139 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -176.88 -170.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 61.299999999999997 110.911 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.89 132.65 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 52.219999999999999 111.073 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -149.82 169.38 21.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 64.010000000000005 111.184 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.55 41.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 75.439999999999998 111.114 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -138.83 132.41 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.310000000000002 111.124 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -78.02 146.15 35.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.925 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.23 150.73 29.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 111.044 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -92.33 141.81 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.010000000000005 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -102.83 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 64.409999999999997 111.165 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -174.14 127.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 74.049999999999997 110.864 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.64 127.71 55.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 74.510000000000005 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -110.59 83.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.962 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.8 -87.02 0.65 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 64.329999999999998 112.505 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -102.31 -17.58 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 111.13 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.3 153.68 23.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 73.140000000000001 112.489 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -140.61 145.19 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 73.510000000000005 110.903 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.54 113.84 4.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 72.310000000000002 112.479 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.21 136.67 19.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 45.340000000000003 112.479 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.72 94.45 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 71.25 110.882 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.47 136.63 39.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.473 . . . . 73.430000000000007 110.964 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 m -113.87 105.19 12.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.120000000000005 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.37 131.72 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 75.439999999999998 111.061 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -136.48 121.29 18.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 110.868 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.47 119.75 37.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 73.519999999999996 110.889 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.701 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -166.93 157.91 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 72.219999999999999 111.138 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.25 -28.32 15.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 72.319999999999993 112.475 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.4 p -103.81 170.19 8.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 75.450000000000003 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -171.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 70.439999999999998 111.12 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 t -51.57 125.09 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.510000000000005 110.787 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 -176.31 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 65.430000000000007 110.902 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -142.88 -52.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 32.299999999999997 110.868 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.79 175.78 13.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 64.25 110.921 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -144.26 127.09 16.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 73.519999999999996 110.928 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 65' ' ' LYS . 5.4 m -118.34 100.78 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 72.439999999999998 111.116 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 81' ' ' PHE . 4.5 p -101.48 116.12 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.239999999999995 111.15 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.611 ' OE1' HG22 ' A' ' 36' ' ' THR . 7.5 pm0 -126.17 158.97 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.420000000000002 110.87 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.56 171.11 17.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 75.430000000000007 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 130.49 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 65.530000000000001 110.84 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.68 75.43 1.85 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.69 0.757 . . . . 70.140000000000001 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 -49.61 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 65.409999999999997 112.33 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.8 p -73.92 144.47 45.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 72.549999999999997 111.11 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.66 98.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 73.430000000000007 112.478 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -156.1 153.25 29.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 63.350000000000001 111.176 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.15 131.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.150000000000006 110.927 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.4 t -79.64 96.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.439999999999998 111.088 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -63.26 -41.22 99.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 61.329999999999998 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -135.58 148.92 49.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 64.230000000000004 110.787 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.89 160.48 39.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 71.299999999999997 111.085 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -147.55 142.07 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.877 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.36 20.28 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 110.86 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -171.97 107.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 53.509999999999998 111.1 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.5 m -68.34 95.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 73.25 111.216 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.6 140.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 64.420000000000002 111.17 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.9 m -129.96 141.67 50.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 60.229999999999997 111.192 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.93 156.58 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 64.239999999999995 110.909 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -161.7 85.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 64.109999999999999 110.884 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.86 -92.3 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 65.420000000000002 112.558 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.24 18.09 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 75.230000000000004 110.816 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -131.22 146.05 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.420000000000002 110.822 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -131.29 160.69 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.867 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -148.95 148.97 30.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 62.130000000000003 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -127.43 127.99 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 75.150000000000006 111.135 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.07 156.65 48.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 74.400000000000006 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.36 -49.28 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.977 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.71 38.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 55.439999999999998 111.146 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.79 1.38 83.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 32.240000000000002 112.461 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.76 -25.24 7.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.736 0.303 . . . . 74.420000000000002 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.19 -37.79 5.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.349999999999994 110.884 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.46 54.83 14.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 53.420000000000002 112.462 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.08 96.82 3.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 54.43 111.142 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.4 tt -138.78 160.35 39.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.530000000000001 110.928 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.99 160.86 81.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.541 0.686 . . . . 44.109999999999999 111.147 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -20.77 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.618 2.212 . . . . 74.230000000000004 112.343 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 27' ' ' THR . . . -135.9 116.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 75.049999999999997 112.47 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.43 172.05 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.326 . . . . 54.219999999999999 111.099 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -138.15 131.62 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.430000000000007 110.921 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.08 114.27 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.239999999999995 111.125 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -103.15 125.77 50.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 54.329999999999998 110.849 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.547 ' HE2' HG11 ' A' ' 37' ' ' VAL . 28.8 p90 -114.55 152.87 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 72.310000000000002 110.864 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.54 167.59 24.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.654 -0.784 . . . . 55.030000000000001 112.458 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CE1' HG22 ' A' ' 47' ' ' VAL . 9.0 p90 -160.42 -176.27 5.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.361 . . . . 54.149999999999999 110.93 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -132.04 133.62 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 63.43 110.886 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.67 158.65 27.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 74.120000000000005 112.499 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.19 117.82 35.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 75.109999999999999 110.918 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -161.65 29.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.78 -0.724 . . . . 73.450000000000003 112.542 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -39.9 5.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 63.140000000000001 112.328 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.61 26.68 26.73 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.722 -0.751 . . . . 72.109999999999999 112.497 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -111.91 78.45 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.674 0.749 . . . . 62.119999999999997 110.86 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 165.8 29.61 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.693 2.262 . . . . 74.409999999999997 112.43 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.6 p -148.48 174.85 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 73.200000000000003 110.838 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 58.13 49.54 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 54.530000000000001 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 m -64.59 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 35.229999999999997 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 143.98 49.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 63.340000000000003 110.897 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -157.21 155.79 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.89 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.2 t30 65.09 45.83 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 73.420000000000002 110.903 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.61 42.03 55.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 72.310000000000002 112.453 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.92 67.82 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.688 -0.767 . . . . 71.25 112.517 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.9 t -156.33 105.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 72.439999999999998 110.89 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.84 112.8 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 71.400000000000006 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 5' ' ' THR . 6.3 t0 -73.59 133.8 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 72.409999999999997 110.883 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.12 40.1 11.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 43.009999999999998 112.454 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.56 177.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 43.43 111.078 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 72.329999999999998 110.771 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.859 0.361 . . . . 74.230000000000004 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.582 ' CB ' HG23 ' A' ' 29' ' ' THR . 72.2 p -123.16 140.27 53.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 74.200000000000003 111.1 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.53 95.31 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 71.349999999999994 110.877 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 26' ' ' ASN . . . -144.73 132.97 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 111.124 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.6 p -150.01 165.74 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 75.450000000000003 111.176 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.76 162.25 35.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.319999999999993 111.111 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.5 147.64 32.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 111.112 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -88.26 146.19 25.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 110.855 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.6 173.03 11.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 30.309999999999999 111.125 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 159.8 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 51.229999999999997 110.96 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.81 -58.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.409 . . . . 55.009999999999998 111.111 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -178.59 132.14 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 110.88 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.22 127.85 55.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.839 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -110.57 82.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.109999999999999 110.924 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.56 -86.74 0.62 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 72.129999999999995 112.464 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -101.35 -17.46 16.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 64.540000000000006 111.218 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.4 155.48 25.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 54.530000000000001 112.443 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -143.22 143.3 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 72.049999999999997 110.948 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.62 117.51 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 64.420000000000002 112.533 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.36 143.58 16.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 43.340000000000003 112.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.4 112.81 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 64.219999999999999 110.873 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -97.33 134.42 40.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.987 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 m -116.3 108.41 16.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 74.450000000000003 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.3 t -107.14 131.96 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 64.519999999999996 111.145 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.63 118.41 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 55.0 m-20 -118.59 101.37 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 64.129999999999995 110.88 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.49 155.66 34.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 74.439999999999998 111.19 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 52.05 28.27 24.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 74.349999999999994 112.448 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 2' ' ' THR . 2.6 m -114.23 158.64 21.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 70.349999999999994 111.147 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.66 157.0 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 62.399999999999999 111.14 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 m -52.0 112.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 71.239999999999995 110.874 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HB2' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -91.11 174.62 7.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 110.956 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -137.42 -52.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.861 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.55 152.94 49.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 64.140000000000001 110.852 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -119.29 127.17 52.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 63.350000000000001 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -125.28 108.12 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.530000000000001 111.115 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.2 p -102.39 111.29 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 41.009999999999998 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.0 pt-20 -131.92 138.69 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 110.883 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.2 171.53 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.885 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.5 129.26 45.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 50.049999999999997 110.875 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -113.31 75.67 2.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 64.340000000000003 110.822 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -49.74 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.687 2.258 . . . . 51.130000000000003 112.3 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -71.36 145.05 49.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 53.43 111.153 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.26 100.07 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 73.439999999999998 112.515 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -154.61 155.81 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.847 0.356 . . . . 74.349999999999994 111.164 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -173.55 130.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 71.019999999999996 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG22 ' HE2' ' A' ' 83' ' ' PHE . 71.9 t -85.96 112.28 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.439999999999998 111.138 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -87.51 -32.71 19.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 63.140000000000001 111.143 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.05 149.55 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 63.200000000000003 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.27 133.23 5.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 111.116 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -133.06 147.96 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.937 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.77 16.42 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 74.420000000000002 110.868 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.04 95.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 51.329999999999998 111.148 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.5 m -56.17 99.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 53.450000000000003 111.1 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 53' ' ' ALA . 94.4 t -91.37 124.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 111.099 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -115.9 172.07 7.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.096 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -133.54 154.39 50.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 72.219999999999999 110.862 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.7 m -159.23 85.63 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.319999999999993 110.843 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.35 -93.33 0.79 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.239999999999995 112.546 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -126.51 15.0 7.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 72.109999999999999 110.825 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -126.83 146.86 50.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 72.530000000000001 110.838 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -131.54 150.6 52.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 64.010000000000005 111.002 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 38' ' ' GLU . 71.5 m -140.0 147.76 40.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.288 -0.414 . . . . 71.109999999999999 111.207 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -124.59 127.29 47.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 74.109999999999999 111.117 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 126.26 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 61.030000000000001 110.89 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -106.34 -45.38 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 73.430000000000007 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.08 39.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 73.25 111.081 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.17 -0.61 66.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 41.140000000000001 112.504 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -115.42 -33.78 5.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.793 0.33 . . . . 70.450000000000003 110.893 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.94 -48.09 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.209999999999994 110.902 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.58 52.12 54.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.200000000000003 112.506 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -124.66 117.66 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.94 0.4 . . . . 71.349999999999994 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -141.75 160.92 39.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 65.120000000000005 110.856 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -103.51 163.61 17.09 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 64.319999999999993 111.155 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.79 -7.89 22.22 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.746 2.297 . . . . 75.340000000000003 112.289 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -155.94 114.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.420000000000002 112.462 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.64 172.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 64.129999999999995 111.089 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -121.36 131.19 54.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.815 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 24' ' ' VAL . 31.6 m -131.4 125.88 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 50.32 111.083 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 p -129.86 156.59 44.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.209999999999994 110.827 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.715 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.4 p90 -149.41 139.19 21.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 71.540000000000006 110.856 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.46 168.84 15.7 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.729 -0.748 . . . . 52.350000000000001 112.42 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' HE2' HG22 ' A' ' 47' ' ' VAL . 12.4 p90 -173.81 176.2 2.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 74.409999999999997 110.891 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -125.84 173.12 9.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 65.230000000000004 110.823 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.34 167.66 40.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 72.329999999999998 112.486 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -120.05 109.52 15.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 51.32 110.844 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.02 -159.8 31.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 70.040000000000006 112.419 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.61 10.46 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.631 2.221 . . . . 70.25 112.368 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.32 26.67 29.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.752 . . . . 64.129999999999995 112.483 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 m -112.28 76.67 1.97 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.669 0.747 . . . . 74.430000000000007 110.879 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 159.26 54.1 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 61.509999999999998 112.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.58 171.37 15.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.240000000000002 110.884 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 58.68 47.61 12.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 62.310000000000002 110.893 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.0 m -66.61 101.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.030000000000001 110.827 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.25 141.76 51.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 110.953 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.5 pp -158.25 148.11 19.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 63.229999999999997 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.569 ' HB2' HD12 ' A' ' 96' ' ' LEU . 31.0 m-20 58.47 56.11 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.929 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.37 41.5 30.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 51.109999999999999 112.511 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.55 58.09 15.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 74.329999999999998 112.459 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.36 105.66 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 72.519999999999996 110.884 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 37.4 t -154.72 140.57 18.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 71.530000000000001 110.883 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.6 157.31 37.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 63.350000000000001 110.795 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.87 -24.76 20.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 41.32 112.449 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.98 155.16 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 73.299999999999997 111.141 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 75.150000000000006 110.857 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.95 0.405 . . . . 61.310000000000002 111.114 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.446 HG21 ' HG ' ' A' ' 32' ' ' LEU . 30.2 p -64.03 -176.96 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 74.099999999999994 111.144 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -112.29 96.64 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 71.030000000000001 110.882 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' CD1' ' A' ' 96' ' ' LEU . . . -127.41 144.96 50.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 44.109999999999999 111.094 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -130.31 151.93 50.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 51.030000000000001 111.161 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.758 ' HB2' HD23 ' A' ' 96' ' ' LEU . . . -122.69 141.35 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 44.439999999999998 111.1 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -130.81 109.7 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 60.32 111.116 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.75 141.05 57.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 73.540000000000006 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.55 32.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 43.140000000000001 111.119 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.74 122.71 41.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 75.239999999999995 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -58.47 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 62.420000000000002 111.169 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.52 138.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.409999999999997 110.877 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.58 127.06 54.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 72.310000000000002 110.892 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.66 85.96 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 75.349999999999994 110.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.55 -88.99 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 52.5 112.512 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -107.88 -17.59 14.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 45.509999999999998 111.126 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.7 144.9 19.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 65.040000000000006 112.493 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.52 ' HE2' HG23 ' A' ' 45' ' ' THR . 24.1 p90 -128.77 139.75 52.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 70.219999999999999 110.882 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.94 105.57 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 51.439999999999998 112.503 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.63 141.18 25.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 40.219999999999999 112.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.34 94.48 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 71.109999999999999 110.914 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -90.35 136.86 32.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.933 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -112.9 105.85 14.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 73.519999999999996 111.193 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG22 HG21 ' A' ' 37' ' ' VAL . 20.3 t -96.7 131.79 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 111.163 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.66 123.42 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 71.420000000000002 110.939 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.411 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.7 m-20 -116.96 103.88 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 71.120000000000005 110.888 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -159.59 130.33 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 74.299999999999997 111.134 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.48 -28.99 3.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 72.150000000000006 112.451 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -108.63 177.37 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 71.409999999999997 111.101 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -60.01 -172.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 74.510000000000005 111.133 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -51.19 131.54 27.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 63.140000000000001 110.874 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -94.94 -176.52 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 64.109999999999999 110.945 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 -53.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 54.020000000000003 110.902 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 p -153.55 176.11 12.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 64.319999999999993 110.81 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.477 ' HE3' HG23 ' A' ' 37' ' ' VAL . 42.1 p-90 -139.04 127.12 22.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 74.25 110.941 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.3 m -113.49 105.07 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.161 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' HE3' ' A' ' 35' ' ' TRP . 24.0 t -101.1 105.75 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 75.099999999999994 111.075 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.59 152.61 44.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.519999999999996 110.868 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.438 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.77 170.74 19.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 65.109999999999999 110.92 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.97 131.38 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.140000000000001 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.6 m-85 -111.75 78.99 2.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.656 0.741 . . . . 50.450000000000003 110.889 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.96 0.61 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.729 2.286 . . . . 74.230000000000004 112.401 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.0 p -72.72 144.47 47.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 61.439999999999998 111.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 64.219999999999999 112.548 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.52 HG23 ' HE2' ' A' ' 18' ' ' PHE . 99.5 m -156.49 142.69 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 73.340000000000003 111.122 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -154.87 130.84 10.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 54.509999999999998 110.933 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.761 HG22 ' CE1' ' A' ' 83' ' ' PHE . 84.5 t -76.04 97.43 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 72.310000000000002 111.13 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 m -62.64 -43.97 97.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.439999999999998 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 143.74 30.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 53.32 110.832 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.57 139.87 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 70.019999999999996 111.054 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -123.65 143.56 50.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 73.310000000000002 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.44 12.97 8.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 110.848 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.03 104.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 64.340000000000003 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.3 m -63.32 97.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 63.210000000000001 111.179 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 47' ' ' VAL . 85.1 t -87.34 134.19 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 64.120000000000005 111.111 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -122.9 171.14 9.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 71.230000000000004 111.178 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -131.79 153.67 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 110.899 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -158.62 85.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 54.200000000000003 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.23 -94.24 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.688 -0.768 . . . . 60.420000000000002 112.494 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.26 13.42 7.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.825 0.345 . . . . 75.230000000000004 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -128.03 146.88 50.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 44.219999999999999 110.879 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -128.57 159.16 36.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 73.310000000000002 110.843 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 38' ' ' GLU . 19.0 m -145.95 149.16 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 64.439999999999998 111.114 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.4 129.78 45.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 74.430000000000007 111.157 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.73 155.94 49.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 71.230000000000004 110.912 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -131.48 -52.01 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 74.019999999999996 110.913 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.07 39.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.099999999999994 111.134 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.25 0.14 75.35 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 74.439999999999998 112.495 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -114.55 -26.5 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 74.099999999999994 110.878 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.31 -46.95 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 73.239999999999995 110.905 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.76 55.55 20.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 73.120000000000005 112.452 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.05 95.61 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 72.439999999999998 111.083 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.5 tt -135.98 160.68 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.914 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -72.19 162.12 75.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.684 . . . . 74.310000000000002 111.119 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.43 23.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.713 2.275 . . . . 64.120000000000005 112.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.75 116.16 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.77 -0.729 . . . . 71.340000000000003 112.511 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.25 172.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 62.350000000000001 111.081 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 p -145.86 131.7 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 41.310000000000002 110.845 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.01 118.18 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 60.130000000000003 111.074 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 121.84 42.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 110.866 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.24 135.27 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.15 -179.95 19.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 72.400000000000006 112.483 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.761 ' CE1' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.07 175.74 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 70.209999999999994 110.907 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -131.15 125.82 34.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 71.150000000000006 110.849 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.45 151.02 19.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 55.350000000000001 112.451 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.6 112.17 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 42.439999999999998 110.842 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.85 -160.3 29.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 71.019999999999996 112.473 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -44.96 1.78 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.67 2.247 . . . . 72.510000000000005 112.384 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.02 27.15 11.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 52.520000000000003 112.477 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -112.17 76.09 1.78 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 54.329999999999998 110.848 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 166.7 26.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 71.430000000000007 112.323 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -148.53 179.86 7.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 110.867 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 51.87 62.44 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.450000000000003 110.851 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 16.1 m -79.13 102.99 8.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 51.409999999999997 110.878 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.91 140.43 42.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 63.539999999999999 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 6' ' ' ALA . 4.4 pp -148.82 155.94 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 61.039999999999999 110.954 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.29 43.66 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.210000000000001 110.914 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.42 42.03 50.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 73.420000000000002 112.435 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.24 71.78 1.25 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 63.43 112.477 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 t -156.16 104.52 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 70.230000000000004 110.87 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 47.8 t -155.44 138.13 15.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 73.129999999999995 110.907 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.675 ' H ' HG22 ' A' ' 5' ' ' THR . 17.1 t70 -103.06 104.03 14.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.911 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.67 44.21 0.91 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 34.539999999999999 112.524 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.6 176.31 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 64.239999999999995 111.144 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 63.119999999999997 110.859 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.859 0.361 . . . . 50.109999999999999 111.074 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.09 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 72.519999999999996 111.228 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.13 -174.15 4.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 55.509999999999998 110.894 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.87 141.62 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 73.310000000000002 111.135 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -133.23 176.13 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 62.409999999999997 111.141 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.52 163.77 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 111.083 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -153.03 147.66 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 111.194 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -85.97 146.34 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 63.210000000000001 110.845 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -142.41 175.94 9.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 64.349999999999994 111.1 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 166.74 12.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.420000000000002 110.867 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 75.099999999999994 111.145 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.72 134.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 64.340000000000003 110.847 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 127.54 55.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 74.140000000000001 110.79 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.8 p90 -110.51 82.67 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.487 . . . . 72.310000000000002 110.96 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.57 -85.87 0.63 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 72.340000000000003 112.546 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -102.82 -17.46 15.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.846 0.355 . . . . 43.219999999999999 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.07 154.31 24.36 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 71.530000000000001 112.534 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.41 143.42 31.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 73.540000000000006 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 122.87 7.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 63.240000000000002 112.467 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 139.13 14.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.746 . . . . 20.140000000000001 112.544 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -134.38 110.4 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 73.150000000000006 110.847 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.4 135.27 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 65.129999999999995 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -109.95 129.52 55.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 54.049999999999997 111.074 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.47 131.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 61.240000000000002 111.12 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -141.7 118.25 10.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.972 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.52 143.65 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 61.32 110.9 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 155.65 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.319999999999993 111.109 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.93 5.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 61.420000000000002 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.54 159.12 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 74.049999999999997 111.166 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.143 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -51.57 129.14 25.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.519999999999996 110.86 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.05 -176.61 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -141.01 -52.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 63.119999999999997 110.904 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 p -154.22 171.09 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 64.129999999999995 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -130.63 127.01 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 110.927 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.4 m -116.25 104.98 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 64.040000000000006 111.216 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.3 p -101.4 112.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 72.540000000000006 111.085 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -133.61 141.09 47.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 72.200000000000003 110.915 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.72 169.96 16.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 71.319999999999993 110.899 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.49 128.03 44.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 64.109999999999999 110.846 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.69 77.08 2.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 74.420000000000002 110.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -49.63 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 62.329999999999998 112.415 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -72.69 145.2 47.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 70.239999999999995 111.218 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 98.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 52.32 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -154.58 153.51 31.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.828 0.347 . . . . 64.040000000000006 111.098 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -173.68 131.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.549999999999997 110.917 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 83' ' ' PHE . 94.4 t -77.78 106.81 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 111.204 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -48.65 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 50.240000000000002 111.147 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 m -146.47 151.48 37.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 70.329999999999998 110.821 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.21 42.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 71.540000000000006 111.066 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -142.69 145.24 33.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 72.010000000000005 110.978 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.88 13.92 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.95 95.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 55.25 111.137 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.5 m -59.03 97.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 111.16 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 64' ' ' ALA . 23.7 t -92.69 112.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 75.040000000000006 111.135 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -102.35 175.01 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 73.209999999999994 111.16 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -133.51 157.51 45.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.030000000000001 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.5 m -158.69 85.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.430000000000007 110.854 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.49 0.9 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.239999999999995 112.538 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.76 11.75 7.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 74.239999999999995 110.835 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -120.45 147.0 45.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 64.329999999999998 110.848 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -132.98 142.66 48.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 110.93 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -141.14 147.12 37.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 72.530000000000001 111.131 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.853 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.35 140.77 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.153 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.53 159.0 43.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 74.430000000000007 110.939 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.45 -52.17 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.89 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.48 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.439999999999998 111.155 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.52 0.48 75.78 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 75.420000000000002 112.467 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -114.5 -22.8 9.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.312 . . . . 70.409999999999997 110.881 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -112.48 -47.18 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 110.897 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.62 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 52.01 55.04 23.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.668 -0.777 . . . . 71.239999999999995 112.542 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -137.04 95.1 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 65.420000000000002 111.123 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -136.18 160.73 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 61.43 110.868 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.59 162.21 64.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.63 0.728 . . . . 54.020000000000003 111.058 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.67 -8.46 23.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.722 2.282 . . . . 50.409999999999997 112.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.06 115.55 0.89 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 62.420000000000002 112.479 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.33 172.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 43.130000000000003 111.088 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.1 p -129.2 131.48 47.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 64.430000000000007 110.833 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.82 138.42 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 64.140000000000001 111.104 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 p -137.22 158.78 43.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.150000000000006 110.922 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' A' ' 37' ' ' VAL . 28.1 p90 -148.13 144.68 27.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 110.825 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.77 174.25 15.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.797 -0.716 . . . . 52.340000000000003 112.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.3 p90 -174.48 175.09 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 70.340000000000003 110.837 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -125.54 134.59 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 74.150000000000006 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.0 158.28 23.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 74.010000000000005 112.468 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 p -109.84 115.68 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 73.030000000000001 110.87 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.84 27.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 50.530000000000001 112.439 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -35.6 12.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 74.109999999999999 112.387 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.97 31.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.729 . . . . 41.509999999999998 112.519 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -112.5 75.45 1.78 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 64.519999999999996 110.831 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 155.85 64.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.645 2.23 . . . . 73.040000000000006 112.356 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.31 177.12 9.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.409999999999997 110.881 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 58.57 41.07 22.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 51.310000000000002 110.877 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.2 p -64.45 122.79 17.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 61.32 110.873 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 134.78 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 55.399999999999999 110.92 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.0 OUTLIER -146.06 149.07 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 64.230000000000004 110.94 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' HD12 ' A' ' 96' ' ' LEU . 40.9 t30 63.05 47.69 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.349999999999994 110.92 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.23 17.76 73.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.729 -0.748 . . . . 61.32 112.465 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.14 70.67 1.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.68 -0.772 . . . . 74.400000000000006 112.497 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.09 104.32 2.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 65.120000000000005 110.946 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.6 t -151.8 136.6 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 75.209999999999994 110.85 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -120.17 140.99 50.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.94 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.73 -19.6 23.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 50.299999999999997 112.508 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.29 172.14 14.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 62.130000000000003 111.122 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 71.540000000000006 110.874 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.8 0.333 . . . . 71.409999999999997 111.139 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.76 106.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 71.349999999999994 111.094 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.03 95.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 65.400000000000006 110.859 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.78 137.0 26.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 64.140000000000001 111.104 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.613 HG22 ' HB2' ' A' ' 102' ' ' ASP . 21.2 p -131.65 156.31 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 74.530000000000001 111.094 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.5 163.85 34.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.129999999999995 111.105 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.99 147.7 30.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.138 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -88.01 146.29 25.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.887 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.18 42.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 52.130000000000003 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 156.64 17.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.349999999999994 110.918 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 -60.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 74.310000000000002 111.126 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.58 145.72 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.821 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.64 126.87 53.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.239999999999995 110.917 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.2 86.1 2.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 75.450000000000003 110.875 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.59 -85.86 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 74.299999999999997 112.438 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -111.76 -17.6 12.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 53.140000000000001 111.126 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.76 151.03 22.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 62.340000000000003 112.463 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -131.53 154.95 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 75.409999999999997 110.869 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.93 118.86 4.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 71.439999999999998 112.508 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.32 148.78 18.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.685 -0.769 . . . . 33.409999999999997 112.498 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.95 102.29 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 72.129999999999995 110.837 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.18 144.29 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 61.420000000000002 110.939 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.7 m -120.52 121.57 38.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 43.450000000000003 111.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.09 131.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 111.118 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 118.18 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 74.010000000000005 110.905 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -111.26 137.76 48.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 73.040000000000006 110.909 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 t -172.36 135.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.120000000000005 111.098 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.96 -56.73 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.723 . . . . 71.239999999999995 112.531 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -63.88 172.26 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 65.230000000000004 111.098 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -66.45 -174.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 111.054 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 t -51.36 127.49 19.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 110.797 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 -176.52 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 75.400000000000006 110.933 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.63 -53.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 62.109999999999999 110.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.91 164.84 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 75.019999999999996 110.81 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -120.56 126.87 51.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 74.430000000000007 110.903 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.8 m -115.74 100.5 8.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.209999999999994 111.17 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.1 p -102.15 109.44 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 70.230000000000004 111.156 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.91 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 73.510000000000005 110.89 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.18 171.93 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 74.099999999999994 110.981 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.35 132.02 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 71.530000000000001 110.862 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.82 73.65 2.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 72.329999999999998 110.898 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -50.23 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 75.329999999999998 112.315 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.9 p -72.34 145.77 47.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 75.409999999999997 111.098 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.72 97.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.81 -0.71 . . . . 74.140000000000001 112.454 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -155.12 156.45 35.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.341 . . . . 72.040000000000006 111.078 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.58 131.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 73.420000000000002 110.916 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.66 HG22 ' CE2' ' A' ' 83' ' ' PHE . 80.4 t -80.08 103.12 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 52.420000000000002 111.18 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -75.38 -36.69 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.182 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.82 150.54 51.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 62.149999999999999 110.82 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.8 140.01 16.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 73.219999999999999 111.098 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -138.3 149.04 45.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 71.219999999999999 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.84 15.75 9.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 43.229999999999997 110.883 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.36 108.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.519999999999996 111.045 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.9 m -66.5 94.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 63.100000000000001 111.16 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.17 144.38 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 55.109999999999999 111.101 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 m -135.38 141.85 45.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.458 . . . . 62.549999999999997 111.209 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.89 155.24 21.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.439999999999998 110.927 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.18 85.72 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 43.119999999999997 110.878 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.37 -92.77 0.42 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.77 -0.728 . . . . 53.399999999999999 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -126.22 20.95 7.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.371 . . . . 72.099999999999994 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -134.15 146.45 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.841 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -133.34 150.55 51.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 110.922 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -138.04 149.38 45.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 74.120000000000005 111.207 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.829 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -126.25 125.39 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 75.099999999999994 111.094 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 134.16 32.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.938 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -111.0 -51.64 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.310000000000002 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.51 39.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 75.319999999999993 111.081 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.49 -0.82 74.13 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 61.240000000000002 112.506 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -113.59 -26.02 8.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 75.439999999999998 110.957 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 72' ' ' THR . 1.1 m-20 -107.23 -47.1 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.519999999999996 110.916 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.625 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.68 56.24 14.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 34.509999999999998 112.481 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' ASN . 70.6 p -136.94 95.04 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.339 . . . . 74.030000000000001 111.188 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.4 tt -137.16 160.87 37.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 31.140000000000001 110.966 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -78.92 162.53 64.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 72.400000000000006 111.109 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.76 -8.59 24.0 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 53.240000000000002 112.351 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.87 115.75 0.88 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 54.43 112.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.49 172.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.123 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -131.15 131.57 44.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 62.530000000000001 110.931 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.7 137.42 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.420000000000002 111.076 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.69 154.76 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 72.409999999999997 110.9 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 37' ' ' VAL . 24.1 p90 -145.31 142.21 29.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.898 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 176.32 17.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 75.030000000000001 112.501 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.66 ' CE2' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.34 179.12 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 75.120000000000005 110.872 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -133.8 144.53 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 74.450000000000003 110.884 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.92 160.38 28.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.799 -0.715 . . . . 63.439999999999998 112.531 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.96 109.63 21.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 61.32 110.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.6 -158.89 28.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 45.140000000000001 112.483 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -35.72 11.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 61.200000000000003 112.349 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.58 31.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 72.549999999999997 112.523 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 m -112.63 76.91 2.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 53.43 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 158.85 55.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.742 2.295 . . . . 73.010000000000005 112.35 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 174.76 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 64.040000000000006 110.879 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 m120 56.27 47.5 19.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 62.219999999999999 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -67.22 95.78 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.876 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 143.76 45.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 63.299999999999997 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -156.99 147.76 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 64.439999999999998 110.953 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.547 ' HB2' HD12 ' A' ' 96' ' ' LEU . 2.3 t-20 63.29 52.13 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.049999999999997 110.862 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.82 19.9 77.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.743 . . . . 41.399999999999999 112.458 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.13 68.26 1.33 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 51.130000000000003 112.468 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.0 105.07 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.019999999999996 110.871 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 t -146.42 141.76 27.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 65.540000000000006 110.877 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.613 ' HB2' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -123.88 148.2 47.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 70.340000000000003 110.905 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.07 20.22 59.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 71.129999999999995 112.512 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -177.12 4.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 75.129999999999995 111.15 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 73.120000000000005 110.851 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 72.140000000000001 111.126 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 t 179.3 116.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.099999999999994 111.175 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -139.16 95.23 2.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 73.400000000000006 110.885 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.855 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -129.08 132.68 47.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 111.112 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.724 HG22 ' HB2' ' A' ' 102' ' ' ASP . 19.4 p -109.58 127.2 54.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 74.109999999999999 111.187 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -117.31 112.56 20.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 64.209999999999994 111.118 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.84 118.7 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 64.310000000000002 111.165 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.16 143.75 48.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.923 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.14 161.36 38.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 73.150000000000006 111.125 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.17 151.11 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 64.420000000000002 110.893 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -63.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 111.109 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 p -178.79 149.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.903 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.69 126.74 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 62.299999999999997 110.884 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.4 p90 -111.42 87.19 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.129999999999995 110.933 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.65 -81.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.746 -0.74 . . . . 74.219999999999999 112.484 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -117.04 -17.51 10.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 74.140000000000001 111.202 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.09 161.57 33.09 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 53.109999999999999 112.484 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -143.78 161.07 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 72.340000000000003 110.843 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.3 133.38 9.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 34.329999999999998 112.527 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 154.45 17.64 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 63.350000000000001 112.529 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 t -141.8 95.74 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 73.340000000000003 110.854 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -90.24 124.83 35.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.902 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 84.4 m -110.26 101.68 10.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.310000000000002 111.181 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 131.52 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 63.450000000000003 111.172 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -135.7 118.05 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 53.520000000000003 110.806 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.21 127.52 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 54.039999999999999 110.947 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 27' ' ' THR . 4.9 t -172.71 120.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.520000000000003 111.165 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.73 -50.9 0.87 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 53.439999999999998 112.473 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -75.34 171.97 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 72.510000000000005 111.143 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.0 p -64.4 178.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -51.95 107.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 54.340000000000003 110.841 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.686 HD22 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.69 -173.59 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 75.219999999999999 110.879 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -143.56 -53.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.340000000000003 110.88 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.41 ' OG ' HG23 ' A' ' 67' ' ' VAL . 23.1 t -138.77 159.44 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 75.099999999999994 110.823 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -128.69 127.22 41.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.2 m -134.21 112.12 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 72.140000000000001 111.092 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.2 t -101.43 105.65 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.510000000000005 111.105 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.03 144.44 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.439999999999998 110.896 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.92 168.92 19.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 70.120000000000005 110.936 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.24 129.36 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 63.409999999999997 110.87 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.85 76.62 2.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.609 0.719 . . . . 74.340000000000003 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -49.91 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.697 2.265 . . . . 70.010000000000005 112.319 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 1.2 p -71.65 144.96 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 111.147 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.19 98.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 64.549999999999997 112.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -154.7 155.4 34.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 74.049999999999997 111.137 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.78 130.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 63.350000000000001 110.912 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 83' ' ' PHE . 97.0 t -80.58 91.76 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.510000000000005 111.126 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 t -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.34 154.1 50.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.530000000000001 110.883 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.37 146.17 25.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 51.420000000000002 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -135.99 143.52 44.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 110.922 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.06 15.25 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.109999999999999 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.5 109.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.540000000000006 111.081 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -69.49 103.26 2.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 111.089 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.52 137.37 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 63.299999999999997 111.091 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -129.25 141.38 51.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 62.119999999999997 111.162 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -104.77 156.92 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 53.43 110.907 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -160.47 85.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 55.520000000000003 110.942 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.49 -91.97 0.58 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 51.350000000000001 112.47 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -126.37 8.17 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 75.120000000000005 110.843 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -123.27 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 53.210000000000001 110.892 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -128.18 157.52 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 110.929 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -141.18 149.71 41.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 42.509999999999998 111.086 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.59 131.32 48.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.127 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.41 138.22 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 62.130000000000003 110.912 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -117.44 -25.12 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 55.420000000000002 110.885 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 ' OG ' ' A' ' 34' ' ' SER . 6.1 m -102.77 39.28 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 63.130000000000003 111.157 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.74 2.04 70.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 63.229999999999997 112.555 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -33.89 4.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 74.239999999999995 110.97 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -101.5 -55.24 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.85 47.44 60.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 71.109999999999999 112.532 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.577 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.8 120.3 27.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 72.120000000000005 111.115 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 HD22 ' A' ' 32' ' ' LEU . 26.6 tp -146.49 161.01 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 70.340000000000003 110.984 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.69 163.23 18.5 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.549 0.69 . . . . 71.209999999999994 111.106 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.78 -8.44 23.61 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.672 2.248 . . . . 74.340000000000003 112.318 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -147.72 114.52 0.7 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 43.329999999999998 112.517 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.93 172.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 73.409999999999997 111.137 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.69 131.45 43.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 62.119999999999997 110.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.56 110.17 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 111.089 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.84 132.84 50.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 110.867 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.18 132.96 48.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 63.039999999999999 110.826 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.29 175.94 19.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 73.109999999999999 112.521 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 47' ' ' VAL . 26.9 p90 -169.37 -175.31 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 71.310000000000002 110.858 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -139.0 138.31 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 63.409999999999997 110.893 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.79 163.96 28.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 63.420000000000002 112.507 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -105.81 110.33 22.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.319999999999993 110.866 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.0 -163.68 36.59 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.817 -0.706 . . . . 71.230000000000004 112.537 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -34.2 15.2 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.284 . . . . 65.409999999999997 112.309 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.49 26.38 27.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 74.239999999999995 112.468 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -112.61 76.27 2.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 75.129999999999995 110.861 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 159.93 51.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.628 2.219 . . . . 62.420000000000002 112.345 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 t -148.25 174.92 11.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.427 . . . . 72.510000000000005 110.908 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.87 54.51 5.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.439999999999998 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.94 108.36 3.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 72.329999999999998 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 143.89 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 74.340000000000003 110.893 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.855 HD11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 pp -157.08 153.71 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 110.888 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 96' ' ' LEU . 11.2 t-20 55.01 54.9 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 63.240000000000002 110.935 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.38 18.92 75.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.719 -0.753 . . . . 73.340000000000003 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 70.86 1.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.844 -0.693 . . . . 60.240000000000002 112.499 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.44 104.5 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 72.340000000000003 110.844 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.1 p -132.2 148.02 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 74.019999999999996 110.825 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.724 ' HB2' HG22 ' A' ' 5' ' ' THR . 0.3 OUTLIER -127.57 95.23 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 71.340000000000003 110.875 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.48 45.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.230000000000004 112.524 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.55 171.32 5.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 55.520000000000003 111.109 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 71.310000000000002 110.827 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.924 0.392 . . . . 65.129999999999995 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.1 t -136.07 141.56 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 53.520000000000003 111.153 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -160.96 95.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 110.843 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.93 139.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 74.439999999999998 111.111 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.548 HG21 ' CB ' ' A' ' 102' ' ' ASP . 1.1 m -150.13 155.62 40.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 55.229999999999997 111.153 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.39 115.52 21.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 64.439999999999998 111.084 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 131.56 34.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 70.409999999999997 111.155 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -76.23 139.87 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 61.030000000000001 110.886 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.32 166.61 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 70.340000000000003 111.145 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.91 163.78 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 64.519999999999996 110.981 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 -56.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 33.240000000000002 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 131.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.76 127.55 55.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 74.099999999999994 110.892 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.54 82.18 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.901 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.53 -86.77 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 61.32 112.494 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -101.36 -17.6 16.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 74.129999999999995 111.084 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 154.81 24.47 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.725 . . . . 54.210000000000001 112.457 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -143.11 143.85 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 75.120000000000005 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 120.94 7.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 64.340000000000003 112.45 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.83 145.24 17.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.752 . . . . 42.009999999999998 112.465 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -140.84 94.7 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 60.32 110.9 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -90.28 122.95 33.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 71.409999999999997 110.937 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 101.53 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 72.319999999999993 111.124 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 37' ' ' VAL . 21.3 t -93.47 131.58 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.120000000000005 111.195 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -137.89 117.99 13.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.329999999999998 110.938 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -111.88 131.3 55.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 65.109999999999999 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -168.97 126.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 74.329999999999998 111.198 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.65 -19.0 16.75 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.782 -0.723 . . . . 74.439999999999998 112.492 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 32' ' ' LEU . 14.1 t -95.27 175.2 6.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 75.209999999999994 111.102 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -70.17 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.47 108.5 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.109999999999999 110.824 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.41 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -74.34 -174.0 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.010000000000005 110.903 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.0 -54.19 0.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.794 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 159.04 43.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 71.340000000000003 110.847 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.402 ' HD1' HD13 ' A' ' 73' ' ' LEU . 51.4 p-90 -128.65 127.1 41.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.145 -0.48 . . . . 74.140000000000001 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -122.61 110.64 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.329999999999998 111.205 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' NE1' ' A' ' 39' ' ' TRP . 22.4 t -103.9 105.47 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 63.549999999999997 111.176 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -126.35 154.9 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 65.329999999999998 110.888 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.422 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -153.2 169.32 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 75.519999999999996 110.962 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.14 128.33 44.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 64.129999999999995 110.91 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.78 76.82 2.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 72.549999999999997 110.946 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -49.78 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.684 2.256 . . . . 70.409999999999997 112.292 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.99 145.23 48.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.310000000000002 111.117 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 61.43 112.475 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -154.58 154.32 32.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.797 0.332 . . . . 74.549999999999997 111.15 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.71 130.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 70.109999999999999 110.88 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 83' ' ' PHE . 93.7 t -79.98 100.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 51.539999999999999 111.12 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -45.86 89.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 64.030000000000001 111.136 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -144.77 147.43 32.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 64.140000000000001 110.946 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.62 161.83 36.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 64.010000000000005 111.04 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.47 145.33 31.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.931 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.34 14.65 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 60.25 110.85 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.98 103.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 111.12 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 m -61.67 94.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.109999999999999 111.148 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 64' ' ' ALA . 92.1 t -91.5 112.43 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 63.039999999999999 111.1 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.4 174.57 5.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 72.040000000000006 111.088 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.08 156.45 44.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 74.400000000000006 110.844 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.02 85.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 62.130000000000003 110.845 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.68 -92.48 0.8 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 55.310000000000002 112.513 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.2 12.66 7.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 73.049999999999997 110.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -124.24 147.01 48.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -131.45 146.33 52.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 65.310000000000002 110.904 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 56' ' ' THR . 2.7 t -141.53 144.16 34.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -119.96 133.26 55.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 72.010000000000005 111.033 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.08 127.65 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 72.230000000000004 110.889 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -108.61 -32.05 7.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 65.109999999999999 110.91 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -103.72 39.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.083 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.14 2.51 69.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.825 -0.702 . . . . 75.230000000000004 112.456 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 -33.97 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.979 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.56 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -102.44 -56.1 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 71.109999999999999 110.877 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.03 43.9 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 74.420000000000002 112.49 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.4 t -125.66 121.45 33.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.336 . . . . 75.430000000000007 111.196 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -149.68 161.16 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.430000000000007 110.897 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.14 163.6 18.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 72.010000000000005 111.118 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.2 22.98 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.677 2.251 . . . . 54.130000000000003 112.322 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -148.86 114.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 74.209999999999994 112.475 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.88 172.47 0.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.802 0.334 . . . . 55.100000000000001 111.11 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.1 p -128.63 131.3 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 52.030000000000001 110.872 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.4 111.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 111.137 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -110.46 141.56 43.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 54.119999999999997 110.892 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.421 ' HE1' HG21 ' A' ' 37' ' ' VAL . 51.9 p90 -132.58 129.2 38.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 63.140000000000001 110.887 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.59 174.48 22.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 62.439999999999998 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.4 p90 -174.45 175.95 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 73.549999999999997 110.935 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -124.55 126.75 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 110.872 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.64 151.86 19.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 61.119999999999997 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.84 117.3 34.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 70.430000000000007 110.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.44 -159.25 28.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 54.219999999999999 112.502 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -35.41 12.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.254 . . . . 72.239999999999995 112.34 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.85 26.89 30.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 41.299999999999997 112.46 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.73 75.15 1.8 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.636 0.731 . . . . 75.430000000000007 110.805 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 153.85 68.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 72.299999999999997 112.335 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 -177.53 5.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 70.530000000000001 110.83 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.0 52.49 14.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 110.819 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.18 128.45 34.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.859 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 123.01 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 96' ' ' LEU . 4.2 pp -133.97 155.75 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.875 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 t30 63.71 38.65 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 45.140000000000001 110.855 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.61 30.1 53.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 73.140000000000001 112.499 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 75.52 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.801 -0.714 . . . . 73.140000000000001 112.508 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.3 104.25 2.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 63.520000000000003 110.834 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -160.71 -173.04 3.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 72.209999999999994 110.882 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.548 ' CB ' HG21 ' A' ' 5' ' ' THR . 51.4 t0 -127.37 131.66 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.88 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.11 50.47 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.702 -0.761 . . . . 72.450000000000003 112.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 m -52.07 103.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 72.219999999999999 111.222 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 71.200000000000003 110.886 -179.84 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.823 0.344 . . . . 71.219999999999999 111.075 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.4 t -146.38 34.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 72.319999999999993 111.116 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -171.74 -169.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 72.340000000000003 110.884 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.65 132.74 44.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 64.450000000000003 111.064 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 102' ' ' ASP . 1.2 p -149.12 147.73 28.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 51.210000000000001 111.105 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -129.39 151.2 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 44.210000000000001 111.096 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.28 142.5 51.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.549999999999997 111.119 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -91.03 135.05 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.94 147.75 40.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 54.020000000000003 111.099 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.77 140.66 29.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 72.340000000000003 110.901 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 -56.13 2.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.439999999999998 111.112 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.96 147.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.310000000000002 110.823 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.94 126.58 52.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 70.319999999999993 110.836 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -111.71 86.55 2.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 64.310000000000002 110.96 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.86 -83.13 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 14.41 112.421 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 t -115.79 -17.71 10.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.420000000000002 111.15 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.47 164.65 38.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 55.439999999999998 112.499 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.06 157.99 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.947 0.403 . . . . 73.230000000000004 110.877 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.42 128.97 8.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 62.119999999999997 112.506 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.74 148.8 17.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 72.219999999999999 112.501 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.45 96.08 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 73.530000000000001 110.937 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -89.78 118.52 29.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -93.73 101.85 13.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.229999999999997 111.121 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.74 131.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 73.030000000000001 111.154 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -133.42 117.96 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.956 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -118.07 101.37 8.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 74.430000000000007 110.962 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.5 t -143.89 146.78 33.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 62.399999999999999 111.124 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.42 -65.11 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 75.5 112.563 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.0 p -61.43 167.5 3.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 65.230000000000004 111.107 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 60.25 111.116 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -51.5 123.41 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 55.119999999999997 110.904 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -176.02 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 74.209999999999994 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.17 -52.46 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.530000000000001 110.837 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.99 174.47 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 75.030000000000001 110.877 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -140.68 127.24 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 70.239999999999995 110.897 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 m -114.75 104.7 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 51.32 111.152 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.5 p -101.27 114.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 73.430000000000007 111.16 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -134.41 137.02 43.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 65.5 110.916 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.03 173.6 11.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 63.450000000000003 110.949 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -98.19 130.97 44.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.806 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.65 74.25 2.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.651 0.739 . . . . 75.400000000000006 110.871 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -50.05 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 62.049999999999997 112.339 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.6 p -72.77 145.95 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.109999999999999 111.207 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 97.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.757 . . . . 63.039999999999999 112.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -155.07 154.06 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 72.209999999999994 111.122 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 131.18 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 71.030000000000001 110.948 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 72.9 t -79.07 102.94 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 71.150000000000006 111.154 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -63.66 -40.12 96.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 54.020000000000003 111.142 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -148.0 161.98 40.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 70.329999999999998 110.883 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 160.65 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 71.349999999999994 111.127 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.99 144.51 30.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 72.409999999999997 110.92 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.05 13.97 9.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 63.140000000000001 110.833 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.0 99.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.019999999999996 111.046 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.1 m -59.19 97.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 61.329999999999998 111.111 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 64' ' ' ALA . 59.9 t -92.02 112.43 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.524 HG22 HG23 ' A' ' 63' ' ' THR . 13.9 t -105.12 175.09 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 73.540000000000006 111.079 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -136.2 160.03 39.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 71.530000000000001 110.871 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -161.02 85.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.866 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.16 -92.09 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.099999999999994 112.531 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.67 9.89 7.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 62.539999999999999 110.8 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -117.74 146.85 43.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.019999999999996 110.935 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -133.49 139.78 46.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.966 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 56' ' ' THR . 4.9 t -140.54 147.8 40.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 64.099999999999994 111.098 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.867 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.14 143.1 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 111.039 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 160.77 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 70.209999999999994 110.918 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -131.23 -51.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 73.030000000000001 110.895 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.16 38.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 70.150000000000006 111.14 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.89 1.51 83.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 64.109999999999999 112.511 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.98 -25.2 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 72.299999999999997 110.886 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.661 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -111.52 -38.06 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 65.120000000000005 110.883 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.56 53.78 23.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 71.439999999999998 112.461 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.661 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -131.61 94.58 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 54.340000000000003 111.186 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -138.25 160.57 39.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.96 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.98 161.82 64.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 72.299999999999997 111.12 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.69 -22.9 31.75 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.638 2.226 . . . . 71.409999999999997 112.374 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.24 115.47 1.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 54.240000000000002 112.466 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.54 172.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.761 0.315 . . . . 72.120000000000005 111.07 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -137.86 131.62 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 65.040000000000006 110.886 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.42 113.17 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 75.129999999999995 111.103 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' THR . 19.2 p -105.19 120.53 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 51.039999999999999 110.928 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.7 p90 -104.3 146.0 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.530000000000001 110.79 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.98 173.39 14.73 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.741 -0.742 . . . . 72.319999999999993 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.1 p90 -169.79 175.94 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 54.109999999999999 110.912 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 71.010000000000005 110.859 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.17 163.53 27.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.725 -0.75 . . . . 73.409999999999997 112.444 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -115.62 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 74.230000000000004 110.907 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.42 -159.79 30.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 34.509999999999998 112.488 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.63 10.46 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.707 2.271 . . . . 73.530000000000001 112.346 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.33 26.69 27.4 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.462 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.47 77.05 2.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.636 0.732 . . . . 63.140000000000001 110.9 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 162.6 41.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.737 2.291 . . . . 72.409999999999997 112.307 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.42 176.1 9.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.85 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 54.16 44.83 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.7 t -64.63 101.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.89 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 143.83 49.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 70.219999999999999 110.942 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.41 HD22 ' HB2' ' A' ' 6' ' ' ALA . 1.1 pp -155.76 153.07 29.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.439999999999998 110.863 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 58.68 52.04 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.865 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.48 41.26 45.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.73 . . . . 72.010000000000005 112.491 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.6 68.74 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.79 -0.719 . . . . 63.130000000000003 112.525 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.1 m -156.01 104.48 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 60.509999999999998 110.814 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.0 t -153.16 112.77 3.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.299999999999997 110.873 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.647 ' H ' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -76.91 105.96 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 62.109999999999999 110.865 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.96 37.4 1.54 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 64.430000000000007 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.4 t -86.55 163.68 17.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 72.230000000000004 111.131 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 71.439999999999998 110.848 -179.812 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.855 0.359 . . . . 70.549999999999997 111.071 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.652 HG22 ' OG1' ' A' ' 29' ' ' THR . 3.8 p -132.77 173.54 11.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.25 111.141 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -179.45 95.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.439999999999998 110.825 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.65 138.43 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 61.229999999999997 111.154 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -150.03 158.71 44.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 73.109999999999999 111.212 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 71.329999999999998 111.063 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.41 138.83 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 74.530000000000001 111.104 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.58 135.29 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 70.5 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.6 168.52 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.519999999999996 111.102 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.14 148.07 30.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 64.200000000000003 110.897 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.16 -57.62 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 73.530000000000001 111.13 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -179.42 132.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 63.0 110.816 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.08 127.13 53.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 72.239999999999995 110.845 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.41 90.48 3.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 73.230000000000004 110.93 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.97 -94.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 51.399999999999999 112.465 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -101.28 -17.63 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 74.299999999999997 111.17 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.25 148.15 20.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 51.200000000000003 112.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -135.93 148.0 48.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 75.230000000000004 110.901 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.94 115.18 4.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 52.5 112.496 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.24 147.35 20.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.698 -0.763 . . . . 42.32 112.494 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.57 98.6 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 73.129999999999995 110.855 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.18 123.62 34.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 63.409999999999997 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 m -102.84 101.88 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 61.100000000000001 111.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -96.83 131.81 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 50.039999999999999 111.17 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.84 123.75 15.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 73.239999999999995 110.909 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -119.54 127.58 53.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 65.430000000000007 110.93 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.9 t -152.9 170.39 20.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.489 . . . . 30.309999999999999 111.088 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.9 28.19 23.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 25.350000000000001 112.407 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.652 ' OG1' HG22 ' A' ' 2' ' ' THR . 9.5 t -128.56 165.03 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 72.319999999999993 111.173 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.5 p -67.05 -179.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.423 . . . . 75.019999999999996 111.12 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.52 129.86 26.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 64.019999999999996 110.831 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.51 -179.97 4.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 61.530000000000001 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.97 -53.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.420000000000002 110.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.52 164.84 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 64.239999999999995 110.848 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -125.26 126.98 46.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.409999999999997 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.91 106.34 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 45.109999999999999 111.169 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.4 t -105.57 105.53 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 70.030000000000001 111.089 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -119.56 153.42 35.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 73.219999999999999 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.453 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.74 169.11 23.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 110.886 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.33 128.19 44.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.240000000000002 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.37 77.77 2.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 73.329999999999998 110.872 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -49.84 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.653 2.236 . . . . 70.299999999999997 112.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 19.6 p -72.02 145.31 48.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 72.420000000000002 111.141 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.57 98.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 65.219999999999999 112.461 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.79 153.39 31.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 73.430000000000007 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.67 130.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 62.43 110.931 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.4 t -79.06 89.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 65.450000000000003 111.097 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.3 m -63.62 -39.12 93.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 63.240000000000002 111.101 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.32 147.11 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 70.319999999999993 110.901 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.92 130.0 17.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 73.420000000000002 111.067 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -128.55 142.93 50.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 64.450000000000003 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.08 15.19 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.420000000000002 110.863 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.54 120.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.530000000000001 111.061 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -79.26 106.33 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 64.409999999999997 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.72 140.05 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.239999999999995 111.133 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 m -128.1 142.08 51.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 45.329999999999998 111.148 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.97 156.13 20.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.409 . . . . 72.129999999999995 110.874 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.05 85.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 63.439999999999998 110.846 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.95 -91.51 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 41.130000000000003 112.511 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.36 9.14 7.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.530000000000001 110.852 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -122.15 146.75 46.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -129.7 162.24 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 74.549999999999997 110.901 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -149.54 149.67 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.420000000000002 111.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.88 128.36 45.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 63.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 153.88 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 110.918 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -131.2 -51.33 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.230000000000004 110.863 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.68 39.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 72.420000000000002 111.116 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.75 -0.49 74.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 75.5 112.462 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 -113.79 -29.43 7.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 62.420000000000002 110.951 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.2 m-20 -104.32 -41.05 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 110.871 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.02 54.28 23.51 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 74.099999999999994 112.5 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.612 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -129.43 94.85 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.323 . . . . 75.129999999999995 111.156 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -137.75 160.77 38.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.329999999999998 110.925 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -84.94 161.4 52.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 71.099999999999994 111.056 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.79 -8.35 23.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 62.119999999999997 112.368 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.88 115.36 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 71.25 112.482 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 179.88 172.27 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 71.430000000000007 111.118 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.22 131.47 48.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 60.039999999999999 110.841 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.2 m -133.72 119.54 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.14 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -117.19 135.53 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 71.239999999999995 110.855 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.7 p90 -130.06 142.05 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.837 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.7 162.39 12.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 54.329999999999998 112.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 23.1 p90 -156.66 177.84 11.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 72.349999999999994 110.913 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -133.24 127.44 33.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.200000000000003 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.4 151.79 20.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 64.340000000000003 112.512 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -93.57 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 72.030000000000001 110.89 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.21 -162.85 35.62 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.666 -0.778 . . . . 74.319999999999993 112.423 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -36.09 11.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 74.109999999999999 112.371 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.45 25.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 63.520000000000003 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m -112.74 76.24 2.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 71.439999999999998 110.844 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 155.66 65.26 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.655 2.237 . . . . 73.150000000000006 112.324 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -146.68 175.41 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.209999999999994 110.888 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 51.81 61.91 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.899 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.04 130.84 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.876 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.83 143.89 23.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 50.32 110.878 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 96' ' ' LEU . 4.2 pp -151.55 156.51 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.200000000000003 110.941 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 66.1 42.94 3.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 73.219999999999999 110.898 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.85 41.98 61.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 61.119999999999997 112.479 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.87 71.97 1.3 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.677 -0.773 . . . . 74.420000000000002 112.455 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.28 104.17 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 75.140000000000001 110.914 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.87 115.75 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 51.310000000000002 110.875 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.628 ' H ' HG22 ' A' ' 5' ' ' THR . 12.6 t0 -79.12 146.93 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 60.43 110.864 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 47.33 10.74 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.749 . . . . 74.319999999999993 112.507 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.92 159.87 2.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 55.030000000000001 111.173 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 75.319999999999993 110.845 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.762 0.315 . . . . 43.409999999999997 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.6 p -144.88 83.5 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 74.219999999999999 111.167 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 p -172.63 -170.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.813 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.45 134.41 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 43.420000000000002 111.123 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.05 168.63 23.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 40.240000000000002 111.127 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.84 36.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 73.239999999999995 111.09 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -141.32 128.97 21.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 45.310000000000002 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -67.03 143.98 56.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.230000000000004 110.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 21' ' ' SER . . . -149.53 156.75 42.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 62.399999999999999 111.127 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -106.74 116.61 32.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 73.319999999999993 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 74.140000000000001 111.174 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -179.72 141.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 74.030000000000001 110.832 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.49 126.32 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 63.200000000000003 110.835 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -112.46 107.06 15.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 72.120000000000005 110.928 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.21 -91.7 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 72.530000000000001 112.492 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -117.45 -17.5 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 63.210000000000001 111.171 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.57 147.41 21.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 34.030000000000001 112.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -128.53 155.0 45.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 63.240000000000002 110.936 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.36 106.94 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 71.349999999999994 112.514 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.48 116.94 5.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.724 -0.75 . . . . 60.329999999999998 112.454 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 1.1 t -106.85 95.96 6.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 61.409999999999997 110.849 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -95.07 121.19 36.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.329999999999998 110.917 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -100.44 115.74 30.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 74.340000000000003 111.195 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 79' ' ' VAL . 17.4 t -118.78 132.76 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 111.106 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.25 141.83 32.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.965 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -119.34 136.57 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.430000000000007 110.883 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.94 161.12 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 71.019999999999996 111.128 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.99 -101.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.792 -0.718 . . . . 73.109999999999999 112.467 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.33 177.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 72.239999999999995 111.094 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -58.49 -175.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 61.299999999999997 111.11 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.92 145.65 9.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 64.030000000000001 110.865 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.86 -175.98 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.530000000000001 110.891 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -28.99 9.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.340000000000003 110.875 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.8 163.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.329999999999998 110.848 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.464 ' CE2' HG21 ' A' ' 79' ' ' VAL . 61.3 p-90 -130.26 128.73 42.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 75.430000000000007 110.88 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.5 m -152.65 125.53 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.099999999999994 111.172 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.3 t -107.26 113.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.121 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' THR . 5.4 pm0 -120.79 152.02 38.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 64.430000000000007 110.819 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.448 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.29 167.2 30.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.540000000000006 110.911 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.24 130.03 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 55.119999999999997 110.896 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.23 78.5 2.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.63 0.729 . . . . 72.420000000000002 110.911 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 -49.82 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.65 2.233 . . . . 74.420000000000002 112.319 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' GLY . 21.9 p -72.82 145.27 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.439999999999998 111.153 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.59 98.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.310000000000002 112.45 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 p -154.74 152.77 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 73.519999999999996 111.107 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -173.83 131.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.926 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.579 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.9 t -79.73 108.18 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 73.329999999999998 111.06 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -50.48 70.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 71.140000000000001 111.175 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.01 139.61 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 53.109999999999999 110.899 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.2 143.85 48.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.088 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -130.96 140.87 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.912 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 t0 65.09 13.43 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.200000000000003 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.92 107.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 111.111 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -61.78 93.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.200000000000003 111.145 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.1 t -86.98 121.59 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 71.219999999999999 111.192 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -118.18 172.39 7.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.150000000000006 111.15 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.43 159.31 39.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 61.140000000000001 110.896 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.61 85.76 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.299999999999997 110.839 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 61.439999999999998 112.506 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.27 3.13 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.510000000000005 110.845 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -114.72 147.04 40.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.879 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -127.48 160.17 32.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 72.030000000000001 110.887 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 38' ' ' GLU . 30.0 m -152.62 149.17 28.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 54.329999999999998 111.146 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.99 115.87 15.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 50.509999999999998 111.114 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 147.95 50.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.94 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.35 -37.51 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 61.409999999999997 110.906 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.3 m -90.21 41.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 71.239999999999995 111.12 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.15 70.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 71.230000000000004 112.477 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -110.97 -19.57 12.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.74 0.305 . . . . 61.32 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -132.62 -70.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.219999999999999 110.882 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.28 -38.33 3.23 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.76 . . . . 41.119999999999997 112.425 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -51.43 103.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 71.310000000000002 111.077 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.24 160.21 23.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.329999999999998 110.91 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -71.61 161.65 77.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.703 . . . . 60.200000000000003 111.079 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.75 -15.83 37.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.617 2.211 . . . . 63.310000000000002 112.349 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.34 115.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 74.0 112.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.94 172.41 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 74.109999999999999 111.12 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -129.39 131.29 46.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 51.219999999999999 110.867 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 24' ' ' VAL . 3.7 p -127.42 113.96 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 111.105 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.93 134.66 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 110.857 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 17.9 p90 -139.36 137.16 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 110.886 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.55 170.92 21.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 70.219999999999999 112.495 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.579 ' CE1' HG22 ' A' ' 47' ' ' VAL . 12.0 p90 -159.08 -179.61 8.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.371 . . . . 64.519999999999996 110.901 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -125.25 126.04 44.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 73.219999999999999 110.866 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.78 158.22 22.74 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 75.530000000000001 112.458 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.0 m -103.36 109.43 21.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 75.409999999999997 110.832 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.73 -161.58 34.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 74.510000000000005 112.576 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -36.43 10.84 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.688 2.259 . . . . 74.25 112.324 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.62 27.04 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.701 -0.761 . . . . 74.319999999999993 112.432 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.25 76.9 2.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.695 0.759 . . . . 71.450000000000003 110.871 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 164.35 34.86 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.238 . . . . 60.299999999999997 112.33 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.35 169.59 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 65.019999999999996 110.89 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 58.9 56.75 3.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 54.43 110.861 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.1 m -75.74 92.49 3.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 71.349999999999994 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.95 120.85 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 64.230000000000004 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -125.91 155.7 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 110.881 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB2' HD12 ' A' ' 96' ' ' LEU . 5.2 t-20 62.79 26.7 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.239999999999995 110.843 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.44 42.77 7.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 52.25 112.447 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.3 70.74 1.11 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.819 -0.705 . . . . 41.399999999999999 112.479 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.19 129.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 52.219999999999999 110.872 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 p -158.28 167.58 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 45.399999999999999 110.837 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.55 69.91 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.89 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 23.71 45.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 73.319999999999993 112.478 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.41 157.35 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 72.140000000000001 111.153 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 110.798 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.896 0.379 . . . . 73.420000000000002 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.637 ' HA ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -168.53 108.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 72.010000000000005 111.143 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -117.8 95.43 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 74.219999999999999 110.896 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.78 138.65 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 60.240000000000002 111.071 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -141.58 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 62.43 111.112 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.52 152.88 47.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 62.119999999999997 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -135.51 121.0 19.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 111.163 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -65.66 146.33 54.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 74.030000000000001 110.871 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -146.27 160.24 42.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 70.150000000000006 111.079 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.3 141.93 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.67 -62.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 73.040000000000006 111.199 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -175.84 135.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 61.350000000000001 110.863 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -119.62 126.65 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 61.530000000000001 110.89 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -111.74 97.67 6.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.949 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.82 -92.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 42.350000000000001 112.529 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 t -108.15 -17.6 13.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 52.549999999999997 111.119 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.21 149.32 22.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 75.409999999999997 112.466 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -134.63 150.71 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 54.240000000000002 110.87 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.41 113.38 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 55.409999999999997 112.473 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.07 147.26 22.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 62.539999999999999 112.453 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -139.66 96.59 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 71.420000000000002 110.905 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.23 124.13 34.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.120000000000005 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 m -101.96 101.91 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 111.183 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.4 t -96.6 131.87 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 52.520000000000003 111.072 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -141.97 128.06 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.530000000000001 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -119.4 132.08 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.430000000000007 110.863 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.55 129.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 62.299999999999997 111.188 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -48.31 0.98 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 71.540000000000006 112.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.637 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -82.64 176.65 9.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 64.099999999999994 111.184 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -174.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.109999999999999 111.177 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -51.45 125.42 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 75.019999999999996 110.923 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.02 -174.74 5.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.969 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.68 -53.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 110.846 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.16 171.44 19.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 45.329999999999998 110.939 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' HG21 ' A' ' 79' ' ' VAL . 35.6 p-90 -129.0 127.03 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.919 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 101.93 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.319999999999993 111.138 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.8 t -101.45 105.63 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.140000000000001 111.176 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -120.08 151.6 38.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.120000000000005 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.42 168.13 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.91 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.31 128.79 44.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.409999999999997 110.892 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.44 77.46 2.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.644 0.735 . . . . 70.150000000000006 110.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.98 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.717 2.278 . . . . 75.409999999999997 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 7.1 m -71.94 145.26 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 70.209999999999994 111.162 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.684 -0.769 . . . . 70.019999999999996 112.509 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -154.82 153.5 31.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 74.040000000000006 111.127 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -173.67 130.63 0.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 45.219999999999999 110.883 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 83' ' ' PHE . 99.9 t -79.09 89.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 111.098 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.25 -39.54 94.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 64.329999999999998 111.192 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t -129.52 147.69 51.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.875 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.23 130.06 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.139 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -127.18 144.08 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.967 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.63 15.9 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 73.120000000000005 110.884 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.29 121.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.420000000000002 111.08 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -78.56 101.9 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.030000000000001 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' HB1' ' A' ' 50' ' ' ALA . 39.7 t -87.35 147.23 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 62.229999999999997 111.16 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 m -139.1 140.53 38.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 63.420000000000002 111.16 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -107.68 157.48 18.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 75.219999999999999 110.908 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -160.68 85.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 110.835 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.29 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 60.420000000000002 112.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.18 6.92 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.78 0.324 . . . . 52.039999999999999 110.862 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -120.74 146.99 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 65.109999999999999 110.853 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -128.9 159.09 36.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.898 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 t -145.99 149.83 34.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 70.209999999999994 111.066 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.23 120.31 24.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 43.439999999999998 111.078 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 153.62 51.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.439999999999998 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.18 -51.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 44.439999999999998 110.937 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.12 39.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.181 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.63 -1.07 75.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 63.130000000000003 112.489 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -113.76 -25.37 8.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 71.019999999999996 110.848 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.75 -47.17 3.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.129999999999995 110.857 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.36 56.37 13.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 54.219999999999999 112.484 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 96.35 2.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 74.420000000000002 111.161 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.6 tt -137.7 160.62 38.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 52.520000000000003 110.959 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.34 161.93 75.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.57 0.7 . . . . 63.409999999999997 111.1 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.87 24.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.697 2.265 . . . . 63.310000000000002 112.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.54 118.35 1.08 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 65.120000000000005 112.461 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.54 172.02 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 42.409999999999997 111.132 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.69 131.57 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.846 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.4 m -134.1 113.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 65.219999999999999 111.116 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 p -109.18 125.63 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 41.229999999999997 110.883 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -120.46 141.35 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 70.409999999999997 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.36 12.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 63.439999999999998 112.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -159.68 176.92 11.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 73.219999999999999 110.85 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -132.4 125.87 31.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 72.030000000000001 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.94 151.44 20.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.731 . . . . 44.020000000000003 112.501 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.19 109.55 20.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.030000000000001 110.88 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.65 -162.67 34.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 73.049999999999997 112.495 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.27 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.340000000000003 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.11 26.6 23.47 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 62.219999999999999 112.455 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.2 m -112.67 76.6 2.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.683 0.754 . . . . 73.340000000000003 110.879 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.95 55.26 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.420000000000002 112.298 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.48 174.56 11.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.87 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 m120 51.6 63.6 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 74.319999999999993 110.89 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.0 p -82.73 128.63 34.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 54.140000000000001 110.947 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 144.02 23.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 74.409999999999997 110.911 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -149.56 156.63 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.9 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 41.77 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 61.509999999999998 110.851 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.08 61.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.109999999999999 112.478 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.82 71.85 1.3 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 74.409999999999997 112.415 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.32 104.18 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 55.299999999999997 110.841 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 t -165.95 113.06 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 74.530000000000001 110.848 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 5' ' ' THR . 1.3 t70 -75.67 162.26 28.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.209999999999994 110.888 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.02 37.32 70.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.781 -0.723 . . . . 62.530000000000001 112.471 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.6 t -84.33 148.62 26.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 72.099999999999994 111.155 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.4 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.84 -179.799 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.865 0.364 . . . . 53.43 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.37 119.52 6.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 111.159 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.38 95.41 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 53.100000000000001 110.814 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.496 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -120.13 133.39 55.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 70.540000000000006 111.108 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 102' ' ' ASP . 21.1 p -114.0 143.82 44.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 63.509999999999998 111.103 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -125.3 139.7 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 34.329999999999998 111.142 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -134.48 115.76 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.319999999999993 111.114 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.54 145.4 54.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 75.200000000000003 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.36 164.07 33.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 40.43 111.109 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.23 140.28 40.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.229999999999997 110.81 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -107.01 -62.42 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 63.210000000000001 111.15 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.82 133.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 61.420000000000002 110.868 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.79 127.05 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 62.299999999999997 110.844 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -111.4 91.44 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 110.843 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 -93.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 72.310000000000002 112.498 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -103.11 -17.61 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 74.420000000000002 111.097 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.78 148.58 21.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.805 -0.712 . . . . 72.219999999999999 112.406 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -135.53 148.49 49.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 75.319999999999993 110.895 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.36 114.19 4.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 53.219999999999999 112.446 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.39 148.15 22.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 71.120000000000005 112.494 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 t -141.64 98.36 3.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 73.200000000000003 110.891 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.23 137.06 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 75.209999999999994 110.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.22 107.07 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 70.439999999999998 111.175 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.2 t -101.48 131.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.417 . . . . 71.239999999999995 111.188 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 123.08 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.209999999999994 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 32' ' ' LEU . 1.8 m120 -112.69 125.92 54.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 51.43 110.916 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -167.27 148.98 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 111.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.62 -39.63 2.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 72.120000000000005 112.517 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -88.86 169.5 11.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 75.209999999999994 111.109 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.7 p -60.66 -172.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 74.430000000000007 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -51.49 127.13 19.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 45.350000000000001 110.871 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD22 ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -86.84 -175.67 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 53.219999999999999 110.93 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.63 -53.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.25 -0.432 . . . . 62.020000000000003 110.872 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.99 176.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 24.510000000000002 110.779 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.42 ' CD1' HG21 ' A' ' 79' ' ' VAL . 34.1 p-90 -134.53 127.05 30.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 73.319999999999993 110.862 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 101.35 7.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 111.159 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG12 ' NE1' ' A' ' 39' ' ' TRP . 13.3 t -101.01 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 64.25 111.172 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.02 147.66 43.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 62.100000000000001 110.887 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.458 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -148.29 168.18 23.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 75.099999999999994 110.891 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.06 129.06 44.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 74.430000000000007 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.59 77.52 2.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.712 0.768 . . . . 71.150000000000006 110.906 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -50.03 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 64.200000000000003 112.321 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.82 145.35 48.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.219999999999999 111.14 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.49 98.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 71.209999999999994 112.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -154.74 153.78 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 75.140000000000001 111.114 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -173.74 130.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.844 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.2 t -79.37 88.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.209999999999994 111.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.1 m -63.48 -39.0 93.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 73.019999999999996 111.162 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.32 145.99 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.329999999999998 110.837 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.46 130.07 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 72.409999999999997 111.112 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -129.4 143.11 50.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.435 . . . . 74.310000000000002 110.922 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.78 15.66 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.39 119.34 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 111.074 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -77.55 105.34 8.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.430000000000007 111.13 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 HG23 ' HB1' ' A' ' 50' ' ' ALA . 17.0 t -92.95 139.94 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 111.152 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -131.7 141.62 49.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.210000000000001 111.122 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -109.51 155.59 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 53.030000000000001 110.86 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -158.9 85.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.299999999999997 110.836 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.43 -93.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 72.310000000000002 112.452 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.44 7.8 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 72.239999999999995 110.858 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -121.47 145.39 47.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 61.409999999999997 110.844 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -126.3 158.75 34.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.885 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -144.24 150.11 37.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 73.510000000000005 111.161 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.32 121.84 26.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 52.439999999999998 111.094 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 153.47 51.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 62.25 110.888 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -131.23 -51.51 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.43 39.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 71.140000000000001 111.086 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.92 -0.56 75.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 73.439999999999998 112.498 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -115.05 -22.36 9.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 65.409999999999997 110.901 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.56 -47.2 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 62.340000000000003 110.901 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.629 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.91 56.81 10.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.818 -0.706 . . . . 71.150000000000006 112.483 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 95.92 2.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 72.349999999999994 111.121 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.8 tt -137.99 160.64 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 64.030000000000001 110.942 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -70.79 162.0 74.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.614 0.721 . . . . 75.340000000000003 111.066 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -17.84 37.04 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.672 2.248 . . . . 72.120000000000005 112.37 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.75 115.94 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 63.240000000000002 112.535 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.66 172.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 54.32 111.049 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -133.12 131.65 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.030000000000001 110.857 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 35' ' ' TRP . 6.2 m -133.53 118.06 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 74.310000000000002 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.17 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 75.030000000000001 110.877 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 31.2 p90 -132.16 140.11 48.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.895 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.72 163.4 12.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 72.140000000000001 112.448 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -157.75 177.32 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 63.340000000000003 110.825 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -133.14 127.68 34.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 72.219999999999999 110.896 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.86 151.67 20.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 64.030000000000001 112.543 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.88 109.55 20.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 65.439999999999998 110.879 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.37 -163.03 35.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 61.200000000000003 112.48 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -36.48 10.75 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 75.549999999999997 112.353 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.97 26.49 24.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 60.140000000000001 112.512 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -112.78 75.94 2.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.636 0.731 . . . . 71.319999999999993 110.851 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 155.43 65.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.68 2.253 . . . . 61.509999999999998 112.32 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -147.97 169.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 63.030000000000001 110.806 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 56.3 65.33 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 70.040000000000006 110.862 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.5 t -89.27 104.84 17.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 52.340000000000003 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 118.98 27.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -126.88 155.8 42.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.905 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.7 t-20 63.74 27.79 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.240000000000002 110.871 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.23 42.06 8.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.736 . . . . 53.409999999999997 112.543 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.6 70.59 1.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 55.140000000000001 112.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.24 132.08 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 44.539999999999999 110.877 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.9 t -173.24 135.79 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.484 . . . . 75.340000000000003 110.871 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.622 ' HB2' HG22 ' A' ' 5' ' ' THR . 3.1 t70 -126.82 158.18 37.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 72.010000000000005 110.836 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.49 19.55 62.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 74.25 112.482 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.41 -176.61 2.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.32 . . . . 65.329999999999998 111.179 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 61.439999999999998 110.861 -179.874 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 72.430000000000007 111.05 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -129.74 38.27 3.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 72.5 111.186 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -159.18 -176.73 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 64.510000000000005 110.873 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.56 135.47 33.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 60.210000000000001 111.099 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.678 HG21 ' HB3' ' A' ' 102' ' ' ASP . 0.2 OUTLIER -147.17 165.67 29.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 63.350000000000001 111.151 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.66 159.38 42.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.030000000000001 111.079 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.78 147.72 37.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 73.510000000000005 111.126 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -87.23 146.22 26.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.409999999999997 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.33 175.98 9.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.420000000000002 111.115 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.82 156.87 23.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 70.540000000000006 110.92 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.66 -55.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 62.539999999999999 111.217 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.41 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 54.420000000000002 110.869 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -116.75 127.61 54.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 72.109999999999999 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.71 82.58 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 110.91 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 60.020000000000003 112.471 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -100.99 -17.57 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 63.5 111.128 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.79 156.12 26.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 43.039999999999999 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -144.52 145.28 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.855 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 121.14 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.32 112.458 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.37 149.05 19.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 51.420000000000002 112.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -141.65 99.1 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.92 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.24 118.85 30.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 72.25 110.985 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -99.97 113.95 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 71.329999999999998 111.073 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -106.51 131.77 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 70.140000000000001 111.203 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -141.07 118.48 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.827 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 77' ' ' ALA . 7.5 p30 -105.8 129.68 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 110.868 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -164.89 139.54 5.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 64.319999999999993 111.172 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.41 -46.59 3.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.667 -0.777 . . . . 73.120000000000005 112.48 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.55 177.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 54.039999999999999 111.18 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -79.78 173.12 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 52.0 111.157 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -51.72 109.18 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 64.230000000000004 110.848 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -175.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 74.439999999999998 110.941 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 m -145.87 -52.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.66 140.97 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 65.219999999999999 110.855 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -111.29 127.11 55.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 74.010000000000005 110.932 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.3 m -126.18 113.26 16.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.340000000000003 111.187 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HE1' ' A' ' 39' ' ' TRP . 9.0 t -101.14 105.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 71.409999999999997 111.119 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -123.21 154.23 39.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.874 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.45 ' HE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.72 168.43 26.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 44.020000000000003 110.89 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.17 130.64 44.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.209999999999994 110.848 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.09 75.77 2.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.61 0.719 . . . . 74.140000000000001 110.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.75 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.745 2.296 . . . . 71.200000000000003 112.338 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLY . 43.1 p -71.32 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 65.129999999999995 111.098 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 99.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 34.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -154.46 157.44 38.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 61.310000000000002 111.157 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 130.76 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 62.140000000000001 110.854 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.608 HG22 ' CE2' ' A' ' 83' ' ' PHE . 84.2 t -89.61 106.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 65.209999999999994 111.084 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -80.09 -36.0 36.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.076 -0.511 . . . . 55.450000000000003 111.146 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.42 147.6 49.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 55.439999999999998 110.832 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.2 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 111.085 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -142.65 152.57 42.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.129999999999995 110.93 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.68 14.51 9.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 50.219999999999999 110.84 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 64' ' ' ALA . . . -172.7 113.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.109999999999999 111.126 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -65.25 90.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.510000000000005 111.111 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 64' ' ' ALA . 47.2 t -81.37 112.34 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 111.114 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -116.26 118.87 33.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 111.141 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -78.86 161.02 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 74.450000000000003 110.933 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.02 85.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.129999999999995 110.862 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.29 -88.85 0.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 65.310000000000002 112.498 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -126.77 6.64 6.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 72.540000000000006 110.831 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -115.22 146.98 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 71.030000000000001 110.873 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -135.19 120.2 18.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 72.219999999999999 110.959 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 t -121.7 148.15 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.129999999999995 111.191 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -128.6 141.96 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 64.230000000000004 111.053 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.45 121.75 7.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 62.439999999999998 110.844 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -94.46 -31.66 13.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 70.129999999999995 110.898 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.78 38.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 62.420000000000002 111.134 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.42 81.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 62.119999999999997 112.521 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -115.84 -32.7 5.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.286 . . . . 71.239999999999995 110.914 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -102.66 -36.63 8.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.539999999999999 110.92 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.28 47.87 41.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 75.230000000000004 112.474 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 70' ' ' ASN . 12.8 p -124.84 116.89 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 60.329999999999998 111.172 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -149.29 161.11 42.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 73.409999999999997 110.949 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -106.11 163.45 17.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.609 0.718 . . . . 73.230000000000004 111.113 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.78 -8.1 22.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 74.329999999999998 112.346 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.05 114.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 52.340000000000003 112.515 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' HD21 ' A' ' 26' ' ' ASN . . . 178.84 172.49 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 72.120000000000005 111.098 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -133.37 131.54 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 63.340000000000003 110.837 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.3 132.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.219999999999999 111.172 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.0 p -127.86 137.98 52.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 110.862 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -129.53 134.98 48.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 110.915 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.24 178.57 22.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 45.32 112.487 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.608 ' CE2' HG22 ' A' ' 47' ' ' VAL . 18.5 p90 -174.58 173.54 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 75.209999999999994 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -124.99 133.93 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.519999999999996 110.896 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.41 153.47 23.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 63.420000000000002 112.455 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 117.87 35.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 71.010000000000005 110.844 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.34 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 71.420000000000002 112.499 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.01 13.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 70.239999999999995 112.336 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.1 27.18 29.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.762 -0.732 . . . . 72.109999999999999 112.464 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -112.48 75.35 1.74 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 60.409999999999997 110.896 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 160.04 51.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.641 2.228 . . . . 55.32 112.32 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 m -148.6 175.68 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.299999999999997 110.834 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 58.73 53.52 5.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 72.239999999999995 110.913 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.6 m -73.44 101.75 3.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 61.530000000000001 110.846 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 119.31 22.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 60.219999999999999 110.928 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.95 155.74 43.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 71.540000000000006 110.922 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 63.73 26.32 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.85 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.76 42.17 7.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 73.230000000000004 112.534 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.62 73.95 1.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.409999999999997 112.552 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 130.04 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 64.209999999999994 110.813 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.43 161.1 1.03 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 74.129999999999995 110.852 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 5' ' ' THR . 20.3 t0 -127.52 97.78 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.109999999999999 110.928 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 41.09 1.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.788 -0.72 . . . . 73.530000000000001 112.52 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.44 163.07 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 73.129999999999995 111.195 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 73.209999999999994 110.861 -179.859 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.859 0.361 . . . . 60.420000000000002 111.082 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.8 p -133.71 159.9 39.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 73.25 111.173 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -94.33 102.14 14.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 73.349999999999994 110.873 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.12 134.5 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 64.129999999999995 111.082 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 102' ' ' ASP . 1.0 OUTLIER -150.05 166.64 29.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 111.18 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.16 163.86 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.340000000000003 111.063 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -132.45 147.72 52.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 43.549999999999997 111.155 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -86.89 146.29 26.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 60.509999999999998 110.961 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.54 147.54 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 72.540000000000006 111.144 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.25 145.73 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 71.150000000000006 110.88 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 m -105.62 -63.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 70.340000000000003 111.181 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.39 127.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 53.520000000000003 110.834 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -116.04 127.62 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 71.219999999999999 110.859 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -110.53 81.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 64.420000000000002 110.971 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.67 -90.09 0.65 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 63.020000000000003 112.483 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -97.29 -16.36 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 63.049999999999997 111.192 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.14 155.52 23.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.726 -0.75 . . . . 75.430000000000007 112.463 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.73 143.72 31.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 71.239999999999995 110.888 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.27 115.44 4.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 74.409999999999997 112.527 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.2 140.62 24.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 63.329999999999998 112.493 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 94.54 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 63.409999999999997 110.859 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.03 149.93 22.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.902 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -129.81 108.15 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.141 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.53 132.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 65.299999999999997 111.12 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.43 127.07 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 110.892 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.6 122.61 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 110.861 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -172.59 156.7 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.229 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -21.36 17.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.699 -0.762 . . . . 63.530000000000001 112.507 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.85 177.18 7.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 63.219999999999999 111.196 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -171.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 74.030000000000001 111.19 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 120.18 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 110.854 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 179.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 71.310000000000002 110.896 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -120.8 -32.07 4.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 30.239999999999998 110.883 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 p 179.3 160.4 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 110.878 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -137.89 129.03 27.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 72.129999999999995 110.921 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.7 m -149.81 131.19 14.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 63.140000000000001 111.121 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG12 ' NE1' ' A' ' 39' ' ' TRP . 19.0 t -112.87 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 61.399999999999999 111.067 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.718 ' HB3' HG23 ' A' ' 63' ' ' THR . 18.9 pt-20 -118.28 135.07 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.040000000000006 110.861 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -135.2 173.76 11.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 74.319999999999993 110.92 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.16 134.34 41.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 60.399999999999999 110.92 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.44 77.73 27.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.669 0.747 . . . . 74.430000000000007 110.91 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -49.64 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 73.319999999999993 112.358 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 2.3 p -73.09 145.24 46.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.178 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.22 100.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 54.25 112.47 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -154.81 150.56 27.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.346 . . . . 62.439999999999998 111.192 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 130.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.150000000000006 110.924 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.9 t -84.26 98.03 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 111.136 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.4 HG23 ' N ' ' A' ' 49' ' ' SER . 6.3 t -63.5 -42.15 98.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 71.519999999999996 111.161 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.4 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 m -136.72 145.42 44.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.130000000000003 110.9 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.48 167.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 44.240000000000002 111.128 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -153.31 141.42 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 71.140000000000001 110.882 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.36 13.84 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.019999999999996 110.884 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.35 107.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.349999999999994 111.096 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -63.26 92.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 51.049999999999997 111.123 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 47' ' ' VAL . 59.8 t -81.78 112.55 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 71.140000000000001 111.135 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -105.1 172.27 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 111.056 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -134.19 158.53 43.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 70.319999999999993 110.852 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -162.5 85.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.903 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.63 -92.25 0.6 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 51.32 112.48 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -126.28 15.94 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 72.310000000000002 110.899 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -125.42 147.02 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 110.88 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -133.1 141.58 48.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 75.120000000000005 110.955 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HB3' ' A' ' 38' ' ' GLU . 39.0 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 64.230000000000004 111.164 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 36' ' ' THR . . . -128.09 116.74 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 62.219999999999999 111.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.09 142.15 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.873 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.84 -35.99 3.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 52.219999999999999 110.858 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -92.44 42.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.154 -0.475 . . . . 64.319999999999993 111.123 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 2.13 69.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.687 -0.768 . . . . 73.540000000000006 112.542 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.555 ' HZ3' HD21 ' A' ' 70' ' ' ASN . 0.4 OUTLIER -115.63 -33.81 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 75.430000000000007 110.905 -179.878 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.555 HD21 ' HZ3' ' A' ' 69' ' ' TRP . 2.6 m-80 -110.72 -70.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 73.030000000000001 110.879 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.96 -38.21 3.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 71.409999999999997 112.498 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -52.66 110.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.909 0.385 . . . . 72.510000000000005 111.179 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.23 144.23 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.942 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.02 160.38 1.55 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 74.230000000000004 111.115 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.747 2.298 . . . . 74.140000000000001 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 115.57 0.66 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.757 . . . . 63.219999999999999 112.532 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.55 172.34 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 63.0 111.166 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.24 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 65.140000000000001 110.803 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.05 110.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 73.310000000000002 111.082 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.0 p -99.83 148.87 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 71.109999999999999 110.812 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -146.58 135.12 22.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 71.129999999999995 110.917 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.32 177.3 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 51.329999999999998 112.434 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 47' ' ' VAL . 10.8 p90 -171.64 175.94 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 74.140000000000001 110.864 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -122.74 128.31 50.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 73.409999999999997 110.929 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.12 149.38 19.6 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 74.230000000000004 112.487 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 109.46 21.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 53.25 110.876 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.78 -162.15 34.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 45.509999999999998 112.475 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -36.7 10.55 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 71.519999999999996 112.349 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.56 26.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 70.540000000000006 112.508 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -112.36 77.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.698 0.761 . . . . 73.010000000000005 110.883 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 163.5 38.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.713 2.275 . . . . 62.340000000000003 112.288 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -148.31 170.23 18.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 55.539999999999999 110.86 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.76 50.53 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 73.239999999999995 110.866 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.8 m -66.48 96.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 74.409999999999997 110.896 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -121.31 143.84 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 61.5 110.899 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -155.48 155.55 33.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 110.968 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.563 ' HB2' HD12 ' A' ' 96' ' ' LEU . 38.4 t30 63.22 39.87 9.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 71.349999999999994 110.884 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.06 41.6 11.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.420000000000002 112.521 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 63.32 2.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 53.439999999999998 112.484 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.5 t -155.99 104.49 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 75.310000000000002 110.804 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.1 t -150.41 141.57 23.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 33.509999999999998 110.858 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 5' ' ' THR . 2.0 t0 -126.27 157.22 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 110.808 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.16 -25.02 24.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.76 -0.733 . . . . 74.099999999999994 112.456 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.16 171.09 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 64.409999999999997 111.204 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 63.149999999999999 110.842 -179.882 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 42.439999999999998 111.034 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.715 HG22 ' HA3' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 56.67 95.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 75.120000000000005 111.126 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -176.97 -170.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 62.43 110.856 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.63 134.59 34.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 64.129999999999995 111.098 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.51 171.35 14.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 72.219999999999999 111.116 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.79 163.44 39.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.450000000000003 111.077 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -140.68 141.69 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.439999999999998 111.137 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -79.38 140.45 37.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 64.239999999999995 110.891 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -139.41 162.19 35.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 62.020000000000003 111.129 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.29 154.54 22.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.852 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 -58.66 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 52.409999999999997 111.159 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.8 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 43.420000000000002 110.878 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -115.45 127.92 55.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 62.149999999999999 110.874 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.65 81.76 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 75.019999999999996 110.978 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.64 -87.27 0.63 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 73.430000000000007 112.473 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -100.32 -17.59 17.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 73.209999999999994 111.168 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 155.55 25.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 52.130000000000003 112.488 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -143.6 143.04 31.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.895 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.85 115.81 5.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.705 -0.76 . . . . 75.299999999999997 112.479 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 143.84 17.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.696 -0.764 . . . . 62.130000000000003 112.542 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.1 m -144.22 95.48 2.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 63.420000000000002 110.844 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.44 132.56 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.116 -0.493 . . . . 71.239999999999995 110.885 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.4 m -110.61 117.45 33.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.049999999999997 111.141 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.72 131.94 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 64.329999999999998 111.152 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -138.01 136.98 37.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 54.509999999999998 110.865 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -119.93 136.48 54.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.409999999999997 110.874 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -167.53 162.23 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.5 111.176 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.715 ' HA3' HG22 ' A' ' 2' ' ' THR . . . 97.37 -98.12 2.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 32.399999999999999 112.524 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 p -56.34 170.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 63.100000000000001 111.134 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 p -59.4 -175.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 32.210000000000001 111.176 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.2 144.45 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 71.430000000000007 110.792 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 26' ' ' ASN . 1.3 mp -84.44 -174.61 5.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.912 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 -27.64 6.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.847 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t 178.88 154.92 0.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.519999999999996 110.896 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.427 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.1 p-90 -125.05 129.41 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.921 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 64' ' ' ALA . 80.6 m -152.42 122.0 6.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 111.166 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.5 t -101.72 110.68 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 74.310000000000002 111.182 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -117.66 152.4 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.100000000000001 110.88 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.442 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.97 170.23 20.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 73.310000000000002 110.911 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.98 131.67 44.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.874 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.8 74.05 2.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.659 0.742 . . . . 74.030000000000001 110.85 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.691 2.261 . . . . 70.329999999999998 112.34 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -74.18 145.79 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.230000000000004 111.128 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.36 98.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 24.329999999999998 112.513 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 p -154.9 154.62 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.332 . . . . 55.149999999999999 111.166 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.76 131.13 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.408 . . . . 74.340000000000003 110.931 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.0 t -76.1 104.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 111.078 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -47.89 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 72.430000000000007 111.178 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -144.39 152.37 40.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 52.210000000000001 110.87 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.17 162.47 35.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 70.319999999999993 111.074 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -146.99 144.95 29.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.988 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 64.05 15.18 9.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 62.450000000000003 110.85 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.55 104.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 62.240000000000002 111.127 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 m -61.8 93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 72.540000000000006 111.201 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 64' ' ' ALA . 95.7 t -86.22 112.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 52.450000000000003 111.084 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.425 ' CG2' HG23 ' A' ' 63' ' ' THR . 7.4 t -113.44 164.28 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.519999999999996 111.172 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -121.79 160.98 23.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 62.119999999999997 110.942 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -159.26 85.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.049999999999997 110.799 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.72 -93.27 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.756 -0.735 . . . . 45.130000000000003 112.442 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -126.54 11.42 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 74.25 110.877 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -123.53 147.03 47.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 62.229999999999997 110.864 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -127.98 156.32 42.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 63.520000000000003 110.936 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.425 HG23 ' CG2' ' A' ' 56' ' ' THR . 1.9 t -150.35 148.7 29.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 64.049999999999997 111.149 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.97 119.95 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 42.100000000000001 111.083 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.32 144.4 40.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 61.210000000000001 110.881 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -123.08 -35.06 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.420000000000002 110.901 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.427 HG13 ' HE1' ' A' ' 35' ' ' TRP . 14.1 m -89.6 41.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 51.109999999999999 111.124 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.69 1.92 70.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 42.240000000000002 112.523 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.44 -21.49 11.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 72.299999999999997 110.918 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -129.54 -70.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 63.539999999999999 110.898 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.65 -38.07 3.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 70.510000000000005 112.535 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -50.74 107.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 54.43 111.097 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.407 HD23 HD13 ' A' ' 32' ' ' LEU . 8.4 tp -123.69 146.93 47.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 64.329999999999998 110.993 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -61.53 160.31 26.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 64.120000000000005 111.06 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.9 Cg_endo -69.8 -8.43 23.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 75.239999999999995 112.319 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.9 116.03 0.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 61.210000000000001 112.436 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.17 172.13 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.868 0.366 . . . . 64.439999999999998 111.072 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.68 131.33 43.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 45.420000000000002 110.85 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.25 109.9 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 71.120000000000005 111.114 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 t -109.98 134.38 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 50.140000000000001 110.88 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -123.47 134.88 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.899 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.3 175.52 19.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 63.5 112.532 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 47' ' ' VAL . 18.1 p90 -174.84 175.87 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.933 0.397 . . . . 65.400000000000006 110.899 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -124.97 125.89 44.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 74.519999999999996 110.873 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.56 152.98 17.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 50.130000000000003 112.496 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.82 109.49 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 54.409999999999997 110.814 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -158.02 27.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.209999999999994 112.449 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -37.26 9.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 71.0 112.409 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.24 27.04 29.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 73.439999999999998 112.443 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.71 78.92 2.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 71.400000000000006 110.849 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 171.79 13.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 65.200000000000003 112.374 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -148.5 170.4 18.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 44.350000000000001 110.818 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 m120 54.52 52.13 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 63.549999999999997 110.934 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.8 m -68.75 92.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 63.210000000000001 110.845 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.86 144.0 49.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 110.87 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.12 156.79 44.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.420000000000002 110.884 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 66.43 32.63 7.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 71.140000000000001 110.845 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.79 42.41 25.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 30.309999999999999 112.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 71.58 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 55.420000000000002 112.517 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.52 130.57 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.821 0.343 . . . . 73.439999999999998 110.841 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.26 150.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 55.25 110.811 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.453 ' HB3' HG21 ' A' ' 5' ' ' THR . 33.0 t0 -127.49 90.98 3.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.120000000000005 110.836 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.61 33.36 1.59 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.739 . . . . 63.119999999999997 112.45 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 t -79.73 162.37 25.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 73.540000000000006 111.083 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 71.420000000000002 110.844 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.91 0.386 . . . . 60.229999999999997 111.093 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.401 ' CB ' HG21 ' A' ' 29' ' ' THR . 29.9 p -89.21 134.36 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 111.099 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -97.17 95.31 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 62.100000000000001 110.833 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.18 139.17 51.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 73.25 111.122 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.57 155.47 32.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 111.129 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.92 163.93 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 33.329999999999998 111.105 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.38 144.89 27.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 55.5 111.164 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.41 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 75.049999999999997 110.93 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.45 152.56 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 64.420000000000002 111.094 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.03 146.66 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 72.409999999999997 110.965 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.29 -59.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 70.129999999999995 111.092 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.4 138.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 50.5 110.876 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.13 127.43 54.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 64.430000000000007 110.83 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.67 92.97 4.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 74.329999999999998 110.927 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.25 -90.34 0.71 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 75.010000000000005 112.504 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 t -110.6 -17.55 13.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 73.409999999999997 111.176 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.6 146.76 20.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.761 -0.733 . . . . 75.150000000000006 112.466 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -125.42 149.72 47.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 110.87 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.99 110.41 3.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.76 . . . . 42.329999999999998 112.499 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.75 142.62 21.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 71.439999999999998 112.454 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -139.54 94.66 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 55.399999999999999 110.839 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -90.37 149.28 22.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 75.439999999999998 110.933 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m -128.18 132.01 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 111.17 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 79' ' ' VAL . 14.9 t -130.37 132.42 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 111.095 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -142.38 129.17 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 71.510000000000005 110.933 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.6 m120 -104.53 148.99 25.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 64.25 110.851 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.4 t -172.57 162.59 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 65.040000000000006 111.155 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.89 -77.04 1.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 74.530000000000001 112.489 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 2' ' ' THR . 14.5 t -57.91 172.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 63.109999999999999 111.146 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.1 p -68.43 -172.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 63.509999999999998 111.059 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.12 122.79 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.842 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.557 HD22 ' CG ' ' A' ' 26' ' ' ASN . 6.2 mp -62.79 169.18 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 72.010000000000005 110.905 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.4 -16.89 10.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 110.798 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.87 147.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.450000000000003 110.815 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.435 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.6 p-90 -124.62 129.76 51.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.219999999999999 110.893 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 64' ' ' ALA . 93.0 m -151.24 123.26 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 111.083 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.4 t -103.69 105.83 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 111.092 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.21 151.09 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.209999999999994 110.925 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.433 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.03 171.17 17.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.926 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.95 130.25 44.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 72.349999999999994 110.856 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.59 73.67 2.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.717 0.77 . . . . 64.310000000000002 110.943 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -50.07 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.727 2.285 . . . . 65.299999999999997 112.39 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -72.77 145.59 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 62.130000000000003 111.134 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.16 98.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.714 . . . . 45.109999999999999 112.482 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -155.03 154.9 33.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 51.5 111.123 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -173.58 131.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 72.409999999999997 110.916 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -78.8 107.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 74.019999999999996 111.1 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 m -62.87 -49.54 74.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 111.116 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.28 140.42 27.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 63.039999999999999 110.871 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.13 137.16 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 71.030000000000001 111.08 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -121.52 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 70.120000000000005 110.88 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.53 12.62 8.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 65.109999999999999 110.907 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.16 102.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.219999999999999 111.151 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -60.05 95.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.510000000000005 111.153 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 64' ' ' ALA . 85.6 t -90.37 112.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.120000000000005 111.149 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.52 177.49 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 64.409999999999997 111.128 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -133.46 160.55 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 64.540000000000006 110.838 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -160.37 85.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 74.5 110.884 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.74 -93.3 0.83 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 23.199999999999999 112.45 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -126.53 14.55 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 75.230000000000004 110.857 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -126.94 146.89 50.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.120000000000005 110.861 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -129.45 155.95 44.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.239999999999995 110.908 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 56' ' ' THR . 1.8 t -149.02 143.45 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.25 111.127 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -120.4 122.73 41.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.109999999999999 111.095 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 137.79 34.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.878 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -119.41 -30.52 4.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.944 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG13 ' HE1' ' A' ' 35' ' ' TRP . 13.9 m -90.99 42.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 74.030000000000001 111.152 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.11 2.97 67.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 73.299999999999997 112.511 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.533 ' HZ3' HD21 ' A' ' 70' ' ' ASN . 0.4 OUTLIER -117.27 -34.08 4.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 74.299999999999997 110.881 -179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.533 HD21 ' HZ3' ' A' ' 69' ' ' TRP . 2.3 m-80 -109.79 -70.24 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 72.340000000000003 110.881 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.0 -37.75 3.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 50.32 112.509 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -49.43 117.41 2.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 71.120000000000005 111.156 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -136.46 131.79 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.099999999999994 110.957 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -56.87 160.65 5.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.566 0.698 . . . . 70.150000000000006 111.099 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.82 -16.14 37.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.693 2.262 . . . . 41.109999999999999 112.284 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.51 115.44 0.77 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 65.219999999999999 112.533 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.08 172.54 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 64.319999999999993 111.084 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.83 131.16 56.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 51.420000000000002 110.781 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.5 m -139.23 109.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 62.340000000000003 111.118 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 m -113.53 164.38 13.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 110.867 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 30.8 p90 -155.88 134.27 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.901 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.55 177.25 19.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 55.420000000000002 112.433 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.5 p90 -174.43 178.31 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 72.420000000000002 110.939 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -130.96 125.85 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 45.020000000000003 110.85 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.04 155.34 20.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 53.149999999999999 112.527 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.26 109.65 22.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 53.5 110.859 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.14 -157.58 27.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 62.439999999999998 112.495 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -39.0 7.03 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.231 . . . . 40.200000000000003 112.372 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.6 32.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 64.439999999999998 112.477 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 75.78 2.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.661 0.744 . . . . 54.130000000000003 110.903 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 160.61 49.05 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.725 2.283 . . . . 72.549999999999997 112.297 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 m -148.32 171.37 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 110.878 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 63.35 53.42 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.240000000000002 110.85 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.14 126.72 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.340000000000003 110.89 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 118.77 6.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 71.099999999999994 110.907 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -130.24 155.64 45.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 75.510000000000005 110.889 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 60.56 36.58 19.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 110.937 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.28 55.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 65.430000000000007 112.516 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.5 69.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 55.219999999999999 112.45 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 t -156.18 104.26 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 63.520000000000003 110.873 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.1 t -156.57 112.48 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 64.439999999999998 110.871 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.49 112.25 5.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 64.010000000000005 110.907 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.58 50.62 0.52 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.743 . . . . 74.209999999999994 112.519 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 t -52.02 163.56 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 72.329999999999998 111.097 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 71.010000000000005 110.881 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.878 0.37 . . . . 70.430000000000007 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 29' ' ' THR . 3.7 m -155.58 108.96 2.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 73.510000000000005 111.089 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.49 95.26 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 64.120000000000005 110.817 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.77 152.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 53.32 111.158 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p -146.97 163.02 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 63.25 111.14 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.27 163.84 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 32.310000000000002 111.09 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 142.99 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 53.539999999999999 111.198 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -94.35 125.75 39.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 72.120000000000005 110.852 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.48 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 43.229999999999997 111.117 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 170.21 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 62.32 110.863 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 -59.12 0.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.093 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.48 135.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 61.409999999999997 110.923 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.43 127.53 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 71.349999999999994 110.867 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.46 83.34 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.175 -0.466 . . . . 73.439999999999998 110.95 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.87 -86.32 0.66 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.72 -0.752 . . . . 61.109999999999999 112.533 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -103.97 -17.45 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 63.140000000000001 111.122 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.38 153.66 24.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 74.299999999999997 112.464 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -140.56 143.9 35.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 73.129999999999995 110.855 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.3 127.26 9.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 64.310000000000002 112.447 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.82 132.21 10.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 54.409999999999997 112.453 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.91 103.71 7.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 51.130000000000003 110.87 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -92.11 141.27 28.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 45.549999999999997 110.973 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 m -118.55 127.45 53.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 65.209999999999994 111.082 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.91 131.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 111.16 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -144.16 119.08 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 62.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -111.94 133.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.239999999999995 110.86 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -172.7 129.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 61.219999999999999 111.08 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.53 -19.49 19.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 62.549999999999997 112.445 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.1 OUTLIER -99.39 177.1 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.381 . . . . 73.510000000000005 111.118 -179.858 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -67.98 174.83 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 61.200000000000003 111.191 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 t -51.37 118.93 3.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 75.409999999999997 110.825 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -176.14 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.917 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -142.66 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 63.340000000000003 110.927 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 67' ' ' VAL . 1.4 t -152.38 147.52 26.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 74.239999999999995 110.863 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -110.36 126.44 54.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.905 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -118.86 108.61 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 63.140000000000001 111.149 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.734 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.6 p -101.46 109.56 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 74.310000000000002 111.116 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.22 136.92 47.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.875 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.01 172.19 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.420000000000002 110.992 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.93 130.42 44.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 75.439999999999998 110.855 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.51 80.1 2.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 71.519999999999996 110.829 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -48.59 0.68 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.729 2.286 . . . . 71.219999999999999 112.328 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -74.65 144.73 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 53.450000000000003 111.118 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.87 96.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.718 -0.753 . . . . 64.310000000000002 112.416 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 ' CE1' ' A' ' 41' ' ' PHE . 99.5 m -156.81 137.84 13.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 75.120000000000005 111.119 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -151.95 131.2 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 64.030000000000001 110.865 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG22 ' CE2' ' A' ' 83' ' ' PHE . 91.4 t -72.37 102.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 111.158 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -62.89 -46.78 86.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.104 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.64 147.77 34.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 61.240000000000002 110.885 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.17 144.31 40.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 111.062 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -129.41 142.59 50.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 73.230000000000004 110.91 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.42 13.04 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 110.816 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.2 92.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 41.0 111.08 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -55.39 99.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.549999999999997 111.086 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.981 HG22 ' HB2' ' A' ' 64' ' ' ALA . 63.9 t -94.47 112.6 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 73.319999999999993 111.118 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -102.59 175.43 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 64.129999999999995 111.16 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.33 157.34 45.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 53.140000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -159.25 85.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.883 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.69 -92.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 35.530000000000001 112.42 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.95 9.89 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 75.329999999999998 110.888 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -120.09 146.89 45.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.871 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -132.3 146.57 52.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 75.230000000000004 110.911 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -143.05 148.48 36.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.25 111.129 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.981 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.96 141.75 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 70.349999999999994 111.155 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 160.8 39.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 71.319999999999993 110.952 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -132.02 -52.43 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.842 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.762 HG22 ' H ' ' A' ' 71' ' ' GLY . 7.8 p -108.07 39.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 111.117 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.76 4.68 56.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 71.150000000000006 112.512 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -111.46 -25.68 9.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 74.420000000000002 110.82 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.651 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.11 -38.73 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.319999999999993 110.874 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.762 ' H ' HG22 ' A' ' 67' ' ' VAL . . . 48.32 56.87 8.71 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.792 -0.718 . . . . 64.420000000000002 112.495 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -135.07 94.85 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 74.439999999999998 111.198 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -134.3 160.96 36.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 71.349999999999994 110.939 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.703 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -85.2 162.76 47.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 55.039999999999999 111.051 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.76 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 64.230000000000004 112.352 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.88 115.59 0.94 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.727 . . . . 65.310000000000002 112.499 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.7 172.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 53.340000000000003 111.079 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 p -133.18 131.55 40.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 61.409999999999997 110.831 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.14 136.17 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.420000000000002 111.163 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -132.99 149.11 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.866 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 37' ' ' VAL . 25.6 p90 -139.43 156.47 46.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.099999999999994 110.873 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.84 175.47 18.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 54.299999999999997 112.467 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.694 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -173.41 -176.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 73.439999999999998 110.871 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -139.39 125.88 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 110.876 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.94 17.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 61.229999999999997 112.559 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.84 111.22 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.372 . . . . 71.150000000000006 110.838 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.56 26.54 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 62.130000000000003 112.456 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -40.27 5.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 72.200000000000003 112.337 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.59 27.56 21.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 73.030000000000001 112.526 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -112.07 76.07 1.72 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 73.400000000000006 110.859 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.41 57.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.643 2.229 . . . . 71.049999999999997 112.313 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.55 172.41 14.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.871 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 58.1 50.2 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 61.329999999999998 110.882 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.51 104.05 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 41.409999999999997 110.884 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.1 143.97 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.874 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.4 pp -160.32 146.61 15.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 72.209999999999994 110.938 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 96' ' ' LEU . 61.0 t30 60.83 55.33 3.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 110.852 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.1 39.81 36.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 51.299999999999997 112.418 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.44 62.91 5.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 73.219999999999999 112.493 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.3 107.74 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 71.420000000000002 110.935 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.12 138.51 25.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 74.329999999999998 110.979 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -118.53 147.28 43.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 70.219999999999999 110.814 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.08 -27.32 19.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.746 . . . . 54.520000000000003 112.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -170.26 159.38 7.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.77 0.319 . . . . 65.019999999999996 111.17 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 71.310000000000002 110.907 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 111.154 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.96 141.65 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 74.209999999999994 111.106 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -143.47 95.26 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 51.310000000000002 110.846 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.57 132.73 44.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.5 . . . . 62.409999999999997 111.133 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 102' ' ' ASP . 0.8 OUTLIER -113.89 147.8 37.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 65.310000000000002 111.11 -179.909 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -143.63 163.85 32.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 54.229999999999997 111.14 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -152.15 132.52 13.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.109999999999999 111.175 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -73.66 146.06 44.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 72.150000000000006 110.901 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.46 170.99 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 65.25 111.093 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -120.96 134.64 55.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.962 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 -60.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 63.140000000000001 111.191 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.47 145.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 110.869 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.59 125.99 49.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 72.239999999999995 110.819 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -112.28 102.23 10.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 74.319999999999993 110.972 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.22 -92.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.756 -0.735 . . . . 50.200000000000003 112.513 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -118.24 -17.47 9.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 53.100000000000001 111.04 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.68 117.93 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.792 -0.718 . . . . 73.420000000000002 112.45 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -99.06 156.74 16.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 62.009999999999998 110.847 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.71 109.22 2.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.761 -0.733 . . . . 75.420000000000002 112.424 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.67 141.13 20.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.742 . . . . 44.340000000000003 112.457 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.12 98.75 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 62.219999999999999 110.849 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -90.17 123.75 34.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 110.955 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 m -96.06 119.98 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 64.340000000000003 111.026 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.66 131.64 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 74.140000000000001 111.086 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -139.44 118.15 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.409999999999997 110.899 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.49 119.21 38.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.349999999999994 110.836 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.4 t -172.18 143.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.219999999999999 111.166 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.45 -30.83 7.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 72.439999999999998 112.467 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -100.8 173.58 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.351 . . . . 75.230000000000004 111.109 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 p -62.05 -174.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 73.219999999999999 111.124 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -51.36 121.97 7.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 53.219999999999999 110.807 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 -175.7 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 62.240000000000002 110.918 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -143.55 -53.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 65.230000000000004 110.882 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.31 166.6 32.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.230000000000004 110.845 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -122.94 126.64 47.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.519 . . . . 74.340000000000003 110.934 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 m -120.78 100.86 7.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 71.510000000000005 111.14 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 64' ' ' ALA . 7.7 p -102.8 119.17 50.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 71.040000000000006 111.151 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.41 141.22 49.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.838 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.85 167.61 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 54.530000000000001 110.914 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.08 130.07 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 71.409999999999997 110.826 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.76 76.21 2.1 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 73.030000000000001 110.93 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -50.06 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.694 2.263 . . . . 72.319999999999993 112.343 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 64.340000000000003 111.143 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.31 97.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 74.409999999999997 112.486 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.64 155.74 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 75.140000000000001 111.12 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.74 130.59 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.319999999999993 110.862 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG22 ' CE2' ' A' ' 83' ' ' PHE . 89.6 t -79.92 99.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 111.189 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -62.99 -44.68 95.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 71.340000000000003 111.186 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m -143.64 159.97 41.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 110.892 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.04 144.73 25.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.230000000000004 111.062 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -128.44 146.36 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 71.549999999999997 110.887 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 14.94 9.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.831 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.44 120.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 64.219999999999999 111.057 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -78.65 108.15 11.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.530000000000001 111.109 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.73 147.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 74.439999999999998 111.133 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -139.68 141.42 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.439999999999998 111.151 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.46 153.36 24.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 53.009999999999998 110.951 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -157.07 85.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 50.229999999999997 110.808 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.7 -93.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 73.329999999999998 112.489 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -126.46 6.31 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 74.230000000000004 110.876 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -120.09 145.7 46.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 110.812 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -126.79 152.87 46.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.894 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -138.48 150.4 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 74.299999999999997 111.111 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.86 125.9 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 111.111 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 141.04 32.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 73.349999999999994 110.928 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -116.99 -52.07 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 62.140000000000001 110.908 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -100.82 39.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.510000000000005 111.128 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.29 -1.59 70.26 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.753 -0.737 . . . . 75.209999999999994 112.432 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.47 -30.96 6.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 71.340000000000003 110.93 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.549 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -101.55 -47.06 4.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 73.530000000000001 110.931 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.39 55.77 18.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 65.040000000000006 112.488 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -132.65 94.8 3.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 74.329999999999998 111.128 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -137.64 160.9 37.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 75.230000000000004 110.896 179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -82.39 162.5 56.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 63.149999999999999 111.164 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.84 -8.36 23.41 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.61 2.207 . . . . 71.010000000000005 112.359 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.89 115.72 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 65.319999999999993 112.501 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.96 172.14 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.375 . . . . 71.209999999999994 111.02 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -145.51 131.68 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 62.049999999999997 110.761 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.07 149.19 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 72.219999999999999 111.111 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 p -130.52 135.93 48.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 71.549999999999997 110.874 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.4 p90 -122.79 135.18 54.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 73.299999999999997 110.862 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.86 178.26 20.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 54.020000000000003 112.491 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CE2' HG22 ' A' ' 47' ' ' VAL . 24.7 p90 -174.26 -179.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 72.239999999999995 110.882 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.03 149.66 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 34.140000000000001 110.893 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.67 157.36 27.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 73.310000000000002 112.515 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 m -102.48 109.62 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 65.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -160.73 30.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 42.140000000000001 112.522 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -38.36 7.95 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.647 2.232 . . . . 75.239999999999995 112.359 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.2 26.68 27.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 62.149999999999999 112.515 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.78 75.27 1.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.099999999999994 110.854 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 160.69 48.75 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.59 2.193 . . . . 63.219999999999999 112.372 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 p -148.52 161.71 41.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 70.450000000000003 110.9 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 62.99 65.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 60.539999999999999 110.832 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.9 t -91.4 94.05 9.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 70.420000000000002 110.946 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 118.73 35.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 73.519999999999996 110.882 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -126.72 155.81 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 110.93 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 63.9 19.94 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 60.210000000000001 110.892 179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.88 4.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 73.540000000000006 112.467 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.7 71.28 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 62.030000000000001 112.484 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -156.25 104.17 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.019999999999996 110.851 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -160.75 112.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 72.530000000000001 110.905 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.456 ' HB2' HG22 ' A' ' 5' ' ' THR . 1.6 m-20 -96.18 164.95 12.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 62.210000000000001 110.869 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.07 37.61 80.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 34.439999999999998 112.461 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.6 p -150.83 -176.39 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 71.340000000000003 111.154 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.219999999999999 110.826 -179.83 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.882 0.372 . . . . 73.129999999999995 111.12 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -145.01 43.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 64.049999999999997 111.181 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 p -157.73 -175.6 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 55.130000000000003 110.801 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.93 143.64 26.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 70.219999999999999 111.14 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.551 HG22 ' CB ' ' A' ' 102' ' ' ASP . 45.5 p -136.96 149.58 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 65.129999999999995 111.141 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.64 163.82 34.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 54.409999999999997 111.132 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.523 HG23 ' CG2' ' A' ' 104' ' ' THR . 40.4 m -153.5 147.7 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 73.140000000000001 111.161 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -80.61 144.27 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 75.099999999999994 110.898 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.18 165.16 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 73.129999999999995 111.135 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.09 136.24 50.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 40.130000000000003 110.924 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m -101.22 -68.3 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 74.420000000000002 111.125 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.85 138.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 50.530000000000001 110.909 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.24 126.24 51.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 74.200000000000003 110.919 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -111.92 105.74 14.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.948 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.44 -91.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.807 -0.711 . . . . 33.240000000000002 112.499 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -117.26 -17.49 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 71.540000000000006 111.223 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.76 146.87 20.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 63.399999999999999 112.424 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -128.85 145.73 51.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 70.109999999999999 110.851 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.17 109.69 3.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.752 . . . . 61.100000000000001 112.47 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.78 133.09 11.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.530000000000001 112.471 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -120.05 99.28 6.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 71.040000000000006 110.865 -179.697 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -90.24 129.73 36.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.409999999999997 110.916 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -105.99 128.16 53.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 55.140000000000001 111.077 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 79' ' ' VAL . 18.2 t -133.19 132.6 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 72.540000000000006 111.176 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -143.89 138.12 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 63.210000000000001 110.923 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.521 ' HB3' HD21 ' A' ' 32' ' ' LEU . 3.1 m-80 -119.44 131.24 55.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 70.329999999999998 110.855 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -159.0 161.0 36.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 111.155 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.37 -58.57 4.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 63.32 112.471 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 t -62.73 161.18 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 63.109999999999999 111.097 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 p -57.87 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 61.43 111.163 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -54.07 123.05 11.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 61.340000000000003 110.805 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 26' ' ' ASN . 4.2 mm? -64.73 151.97 43.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 65.120000000000005 110.95 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -116.51 -18.19 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.140000000000001 110.874 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.48 151.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 63.240000000000002 110.86 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.403 ' CE2' HG21 ' A' ' 79' ' ' VAL . 64.3 p-90 -132.37 127.64 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 110.98 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 65' ' ' LYS . 80.0 m -142.92 124.95 15.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 74.140000000000001 111.147 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' NE1' ' A' ' 39' ' ' TRP . 31.4 t -110.38 105.8 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.230000000000004 111.132 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.8 OUTLIER -117.17 150.98 37.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 73.439999999999998 110.871 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.474 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.43 166.54 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.941 -179.913 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.17 132.69 43.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 73.140000000000001 110.84 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.02 76.23 2.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.635 0.731 . . . . 65.420000000000002 110.859 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.251 . . . . 63.329999999999998 112.31 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 55.9 p -70.4 145.37 51.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 62.240000000000002 111.168 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.53 97.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.793 -0.718 . . . . 51.25 112.386 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.72 157.7 38.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.372 . . . . 61.030000000000001 111.134 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -173.59 130.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.099999999999994 110.934 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.705 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.2 t -84.17 104.14 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 51.219999999999999 111.17 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -47.39 83.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 62.109999999999999 111.185 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -141.51 164.43 30.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.926 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.87 140.71 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.049999999999997 111.13 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -127.57 143.6 51.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.957 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.31 14.86 9.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 64.150000000000006 110.892 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.62 100.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 72.319999999999993 111.151 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.9 m -60.43 95.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 55.240000000000002 111.112 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.9 t -87.29 134.26 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 111.114 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -124.28 170.09 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.040000000000006 111.156 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -131.33 154.2 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.93 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 t -159.42 85.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.82 -94.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.684 -0.77 . . . . 64.420000000000002 112.513 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.29 14.36 7.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 72.319999999999993 110.886 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -128.69 146.84 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 71.099999999999994 110.805 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -129.0 164.07 24.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 74.019999999999996 110.855 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 99.7 m -152.67 144.13 23.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 72.420000000000002 111.143 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -122.49 123.61 41.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 111.122 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.55 139.22 40.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.509999999999998 110.906 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -123.76 -37.74 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 65.329999999999998 110.916 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.98 42.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 71.310000000000002 111.115 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.56 2.0 69.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.703 -0.76 . . . . 72.010000000000005 112.492 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.86 -33.84 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 74.439999999999998 110.921 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.68 -71.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 71.010000000000005 110.952 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.71 -38.18 3.23 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 74.519999999999996 112.523 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -50.95 113.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 74.239999999999995 111.149 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -141.15 133.07 27.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.866 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.06 160.36 1.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.512 0.672 . . . . 72.329999999999998 111.155 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.7 Cg_endo -69.69 -15.93 37.58 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.672 2.248 . . . . 74.400000000000006 112.394 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.58 115.61 1.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.8 -0.715 . . . . 72.239999999999995 112.495 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.58 172.39 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.793 0.33 . . . . 62.130000000000003 111.073 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.62 131.24 52.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.801 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 24' ' ' VAL . 5.1 p -129.48 118.78 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 111.128 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.99 138.59 52.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.129999999999995 110.872 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 41.8 p90 -138.2 136.31 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 71.420000000000002 110.911 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.57 -178.62 19.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 71.239999999999995 112.502 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 47' ' ' VAL . 17.4 p90 -174.47 175.72 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 74.099999999999994 110.861 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -125.54 127.03 45.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 65.430000000000007 110.912 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.15 157.48 21.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 71.340000000000003 112.507 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -108.16 109.44 20.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 75.120000000000005 110.899 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.54 -158.74 29.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 64.319999999999993 112.502 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -35.22 12.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 73.349999999999994 112.327 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.97 26.78 28.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 40.030000000000001 112.448 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.22 76.49 1.89 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.588 0.709 . . . . 53.140000000000001 110.846 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 160.72 48.65 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.675 2.25 . . . . 71.329999999999998 112.299 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -148.53 174.21 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.409999999999997 110.891 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 51.88 64.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 64.200000000000003 110.921 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.8 t -86.51 130.3 34.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.894 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 144.0 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.140000000000001 110.946 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.67 156.73 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 72.239999999999995 110.89 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 67.28 40.51 2.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.040000000000006 110.895 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.09 42.13 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.677 -0.773 . . . . 63.030000000000001 112.543 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.31 71.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 50.149999999999999 112.493 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.6 138.03 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.341 . . . . 64.420000000000002 110.906 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.1 p -175.61 129.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 61.219999999999999 110.884 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.551 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -127.45 106.4 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 73.319999999999993 110.886 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 104' ' ' THR . . . 112.36 34.24 1.97 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 74.140000000000001 112.537 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.523 ' CG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -178.09 178.66 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.323 . . . . 55.340000000000003 111.091 -179.873 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 55.329999999999998 110.859 -179.818 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.891 0.376 . . . . 50.299999999999997 111.076 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.622 HG21 ' HB3' ' A' ' 97' ' ' ASN . 10.2 t -156.29 160.64 39.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 53.149999999999999 111.126 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.5 96.03 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.209999999999994 110.828 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' CB ' HD11 ' A' ' 96' ' ' LEU . . . -159.61 142.0 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 51.119999999999997 111.139 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -122.58 151.65 41.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 54.210000000000001 111.098 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -115.8 154.76 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 52.310000000000002 111.1 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 111.93 11.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 72.349999999999994 111.114 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -74.7 126.69 31.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 74.310000000000002 110.915 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.3 161.34 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 65.230000000000004 111.07 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.09 155.21 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.420000000000002 110.908 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.09 -57.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.019999999999996 111.101 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.38 130.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 74.349999999999994 110.825 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.91 127.51 55.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 70.439999999999998 110.843 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -110.5 82.05 1.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.439999999999998 110.901 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.74 -87.28 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 72.109999999999999 112.464 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 t -100.69 -17.55 16.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.73 0.3 . . . . 63.229999999999997 111.095 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.15 155.94 25.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.530000000000001 112.516 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.43 143.44 30.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 75.230000000000004 110.936 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 117.34 5.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 62.509999999999998 112.524 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 151.91 20.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.773 -0.727 . . . . 74.340000000000003 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.79 96.56 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 65.540000000000006 110.926 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -90.09 136.29 33.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 75.120000000000005 110.886 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -114.72 101.9 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 70.310000000000002 111.124 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 37' ' ' VAL . 17.0 t -88.88 131.72 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 75.040000000000006 111.119 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.75 128.19 36.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.150000000000006 110.868 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.43 132.24 54.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.899 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -172.07 121.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 70.409999999999997 111.138 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.74 -80.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 62.219999999999999 112.421 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.567 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -56.51 168.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.338 . . . . 64.439999999999998 111.228 -179.852 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 p -60.54 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 74.549999999999997 111.144 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.92 121.73 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 72.129999999999995 110.827 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 75' ' ' PRO . 2.8 mm? -65.36 126.16 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 64.439999999999998 110.87 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.96 -23.99 28.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 72.209999999999994 110.876 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.0 170.13 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 110.825 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -136.04 136.71 40.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 74.230000000000004 110.906 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 64' ' ' ALA . 4.4 m -152.69 144.23 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 65.030000000000001 111.222 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 24' ' ' VAL . 21.4 t -129.91 105.83 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 72.329999999999998 111.147 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 63' ' ' THR . 9.4 pt-20 -117.9 134.24 55.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 110.911 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.472 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.08 173.32 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 72.030000000000001 110.849 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 130.35 44.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 75.140000000000001 110.906 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.45 73.92 2.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.647 0.737 . . . . 72.230000000000004 110.865 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.16 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 71.540000000000006 112.302 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.1 p -73.05 145.72 46.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 64.129999999999995 111.13 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 98.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.826 -0.702 . . . . 71.549999999999997 112.456 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -154.92 154.62 32.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 64.129999999999995 111.106 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 130.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 70.340000000000003 110.928 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.681 HG22 ' CE2' ' A' ' 83' ' ' PHE . 98.0 t -77.92 108.5 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 74.099999999999994 111.116 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -45.9 70.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 51.43 111.143 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -141.67 157.0 45.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 70.299999999999997 110.842 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.06 157.39 40.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 75.099999999999994 111.163 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -141.0 146.61 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.329999999999998 110.911 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.23 14.81 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.420000000000002 110.845 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 105.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 62.219999999999999 111.149 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -65.48 90.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 41.32 111.132 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 47' ' ' VAL . 60.0 t -80.9 118.42 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 111.122 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -110.9 175.14 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 61.149999999999999 111.085 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -134.21 160.15 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.86 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.17 85.88 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 54.299999999999997 110.866 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 -92.73 0.57 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 65.140000000000001 112.444 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -126.03 17.36 7.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 44.109999999999999 110.953 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -128.57 146.83 50.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.489 . . . . 73.200000000000003 110.809 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -132.13 150.08 52.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 38' ' ' GLU . 85.7 m -142.49 145.25 33.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 71.239999999999995 111.119 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -121.88 114.66 21.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 111.084 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 136.25 48.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.030000000000001 110.859 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -122.56 -51.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.95 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.66 40.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.120000000000005 111.152 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.22 -0.71 54.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 51.399999999999999 112.433 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 70' ' ' ASN . 3.5 p-90 -104.44 -27.83 11.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.778 0.323 . . . . 72.120000000000005 110.899 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 72' ' ' THR . 12.7 m-20 -132.89 -70.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 73.230000000000004 110.899 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.3 50.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 41.299999999999997 112.488 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.4 t -73.3 94.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 72.109999999999999 111.152 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -140.54 151.45 44.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.239999999999995 110.855 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -52.99 163.52 0.84 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.576 0.703 . . . . 55.43 111.115 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.14 22.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 72.140000000000001 112.327 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.22 115.75 1.81 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 63.399999999999999 112.524 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.48 172.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 63.299999999999997 111.083 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -137.22 131.71 32.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 71.120000000000005 110.919 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 t -143.42 110.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.329999999999998 111.068 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.0 p -103.99 135.0 46.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.905 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -118.39 126.44 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 110.82 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.81 173.59 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 65.010000000000005 112.495 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 47' ' ' VAL . 20.6 p90 -174.73 176.62 2.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.340000000000003 110.865 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.99 125.82 40.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.540000000000006 110.862 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -125.27 161.79 19.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.781 -0.723 . . . . 50.240000000000002 112.573 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 t -109.32 110.28 21.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 62.25 110.918 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.53 -158.7 28.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 74.120000000000005 112.435 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -36.08 11.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 60.509999999999998 112.382 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.83 27.08 30.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 75.010000000000005 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -112.36 77.02 2.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.728 0.775 . . . . 72.129999999999995 110.841 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 168.46 21.49 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.729 2.286 . . . . 63.43 112.335 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -148.43 169.17 20.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 42.329999999999998 110.84 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.07 48.92 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.439999999999998 110.818 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.2 m -65.46 96.53 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 61.229999999999997 110.897 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -121.2 121.29 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 74.129999999999995 110.937 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -124.74 155.71 38.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.210000000000001 110.957 179.876 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.622 ' HB3' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER 63.33 27.22 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 75.150000000000006 110.866 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.06 42.05 7.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 43.229999999999997 112.493 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 70.1 1.12 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.701 -0.762 . . . . 63.130000000000003 112.469 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 131.59 9.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 40.340000000000003 110.85 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.4 172.9 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.150000000000006 110.884 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.26 83.13 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 65.430000000000007 110.889 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.06 48.03 0.68 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 43.130000000000003 112.49 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -70.72 154.96 41.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 72.319999999999993 111.112 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 62.210000000000001 110.885 -179.897 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.86 0.362 . . . . 35.329999999999998 111.149 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.78 172.92 6.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 71.340000000000003 111.102 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 m -164.7 95.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.200000000000003 110.906 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.78 134.61 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 71.450000000000003 111.094 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 102' ' ' ASP . 19.8 p -145.4 168.91 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 111.107 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.98 123.55 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 111.069 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -99.07 139.61 34.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 71.230000000000004 111.209 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.56 143.86 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 110.9 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.77 154.97 43.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 60.240000000000002 111.063 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.49 144.51 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.876 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 -59.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 63.039999999999999 111.171 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -179.99 149.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.100000000000001 110.896 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -117.73 126.46 52.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.898 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -111.74 86.71 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 110.916 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.94 -82.15 0.87 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 74.209999999999994 112.498 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -117.35 -17.56 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 72.109999999999999 111.136 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.17 166.63 38.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 23.210000000000001 112.472 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -148.59 157.54 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.219999999999999 110.876 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.59 130.62 9.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.797 -0.716 . . . . 73.540000000000006 112.537 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.91 145.89 17.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 43.119999999999997 112.473 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.22 95.46 3.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 72.219999999999999 110.841 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -89.81 125.58 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 71.510000000000005 110.921 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.3 m -110.9 101.85 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.040000000000006 111.159 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.1 t -94.12 131.22 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 111.099 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.2 117.89 11.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 110.889 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.61 125.51 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.209999999999994 110.91 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -164.91 139.18 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 75.030000000000001 111.158 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.44 9.81 54.63 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.683 -0.77 . . . . 71.349999999999994 112.445 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 t -130.98 174.53 9.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 111.206 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.39 165.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 75.209999999999994 111.142 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 p -69.07 99.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 71.150000000000006 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HB3' HD23 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -58.28 178.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 51.409999999999997 110.933 -179.996 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.56 -52.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 110.834 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -133.75 140.4 46.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 41.439999999999998 110.834 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -115.38 127.09 55.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 62.350000000000001 110.863 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 64' ' ' ALA . 8.1 m -134.09 116.94 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 74.209999999999994 111.098 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG12 ' NE1' ' A' ' 39' ' ' TRP . 17.3 t -103.88 105.5 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 111.142 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.741 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.2 pt-20 -120.38 136.86 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 70.129999999999995 110.861 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.468 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.38 170.26 16.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 73.420000000000002 110.823 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.45 129.83 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 55.25 110.85 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -113.1 76.41 2.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.678 0.752 . . . . 62.439999999999998 110.847 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -49.83 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 54.109999999999999 112.27 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 111.144 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.42 99.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 64.439999999999998 112.538 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -154.55 155.36 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 74.140000000000001 111.162 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -173.73 130.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 75.040000000000006 110.889 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 83' ' ' PHE . 98.0 t -85.44 97.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 111.098 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -44.15 94.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 74.299999999999997 111.139 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -136.8 161.25 36.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 53.130000000000003 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 162.08 41.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 55.420000000000002 111.12 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -148.63 142.59 25.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 75.129999999999995 110.962 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t0 64.39 14.55 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 72.430000000000007 110.883 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 111.097 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -62.72 97.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 53.219999999999999 111.134 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -87.13 128.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 45.399999999999999 111.093 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -117.2 168.8 9.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 72.040000000000006 111.171 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -130.43 153.24 48.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.010000000000005 110.879 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 m -159.43 85.66 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 61.32 110.849 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.34 -93.94 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 21.420000000000002 112.442 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.4 14.8 7.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 65.340000000000003 110.845 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -128.83 146.93 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.129999999999995 110.894 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -129.77 155.03 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.420000000000002 110.962 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.3 m -139.71 148.49 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 73.319999999999993 111.197 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' O ' HG23 ' A' ' 36' ' ' THR . . . -123.76 136.34 54.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 72.120000000000005 111.17 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.4 131.43 10.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.423 . . . . 74.530000000000001 110.828 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -114.31 -28.95 7.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 71.010000000000005 110.846 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 HD21 ' A' ' 70' ' ' ASN . 28.7 m -105.67 39.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 63.43 111.142 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.54 4.14 65.41 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.673 -0.775 . . . . 75.099999999999994 112.494 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.468 ' CE3' ' HB3' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -118.21 -32.94 4.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.782 0.325 . . . . 73.349999999999994 110.96 -179.965 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.468 ' HB3' ' CE3' ' A' ' 69' ' ' TRP . 6.1 p30 -105.48 -37.25 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 64.140000000000001 110.951 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.68 54.36 25.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.743 -0.741 . . . . 43.210000000000001 112.508 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -124.07 118.84 27.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 60.409999999999997 111.151 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 32' ' ' LEU . 22.6 tp -138.56 160.91 38.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 64.540000000000006 110.916 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -108.4 162.9 18.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.701 . . . . 60.009999999999998 111.064 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.8 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.637 2.225 . . . . 54.329999999999998 112.341 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -156.37 114.53 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.77 -0.729 . . . . 75.109999999999999 112.494 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 178.37 172.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 21.539999999999999 111.083 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -131.54 131.37 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.149999999999999 110.898 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.05 115.55 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 111.183 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.94 142.46 38.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 61.530000000000001 110.893 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HE2' HG21 ' A' ' 37' ' ' VAL . 48.1 p90 -136.27 133.8 37.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 74.030000000000001 110.909 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.32 -179.37 20.17 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 44.229999999999997 112.413 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 47' ' ' VAL . 31.7 p90 -171.84 176.77 3.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 75.019999999999996 110.842 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.62 125.68 36.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 75.310000000000002 110.931 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.78 161.92 26.67 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.678 -0.773 . . . . 61.329999999999998 112.491 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 p -105.61 125.47 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.37 . . . . 45.219999999999999 110.88 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.35 -163.3 30.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 72.319999999999993 112.484 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -36.16 11.53 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.697 2.265 . . . . 70.430000000000007 112.405 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.43 28.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 61.409999999999997 112.52 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -112.78 75.7 1.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.659 0.742 . . . . 72.120000000000005 110.834 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 157.0 61.88 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 71.030000000000001 112.321 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -145.88 177.09 9.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.889 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 m120 52.54 58.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.939 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.0 t -76.98 110.06 11.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.129999999999995 110.931 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -131.95 143.96 50.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 64.109999999999999 110.859 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 97' ' ' ASN . 2.1 pp -156.04 154.44 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.937 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.618 ' HB2' HD12 ' A' ' 96' ' ' LEU . 51.0 t30 63.31 47.33 4.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 75.349999999999994 110.874 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.35 18.51 73.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 70.409999999999997 112.517 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.96 69.74 1.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 61.130000000000003 112.513 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -156.05 104.7 2.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 73.430000000000007 110.846 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.6 t -151.42 112.6 4.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 75.140000000000001 110.913 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.563 ' H ' HG22 ' A' ' 5' ' ' THR . 0.5 OUTLIER -93.81 134.89 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 74.409999999999997 110.895 -179.951 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.07 -26.19 22.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.769 . . . . 54.130000000000003 112.493 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.58 142.04 29.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 62.130000000000003 111.156 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 62.119999999999997 110.858 -179.842 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.882 0.372 . . . . 71.319999999999993 111.134 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.1 p -109.31 38.23 2.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 61.509999999999998 111.174 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.437 ' HA ' HG23 ' A' ' 29' ' ' THR . 82.3 p -151.69 -172.96 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.400000000000006 110.862 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.45 134.29 35.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 60.420000000000002 111.122 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.11 158.67 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 63.210000000000001 111.164 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.86 31.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 64.239999999999995 111.064 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.03 147.52 47.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 63.43 111.175 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.43 142.4 31.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.430000000000007 110.937 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.52 152.01 40.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.116 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 147.93 25.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 52.049999999999997 110.932 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 -59.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 111.136 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.55 129.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 75.340000000000003 110.831 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.99 127.82 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.863 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.66 82.22 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.875 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.63 0.63 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 50.240000000000002 112.48 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -100.39 -17.68 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 61.340000000000003 111.113 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.9 152.81 22.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 62.219999999999999 112.431 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -141.95 142.51 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.002 0.43 . . . . 64.439999999999998 110.884 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.54 112.97 4.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 64.120000000000005 112.425 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.26 131.48 10.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.493 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 45.1 t -131.43 98.68 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 73.430000000000007 110.906 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -92.36 143.28 26.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.867 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 m -123.88 111.53 16.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 72.420000000000002 111.154 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 79' ' ' VAL . 15.7 t -109.57 132.58 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 54.229999999999997 111.12 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -137.68 130.28 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 70.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.497 ' HB2' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -107.68 144.91 34.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.120000000000005 110.881 179.979 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -172.67 162.23 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.109999999999999 111.13 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.05 -62.72 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 42.509999999999998 112.508 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 3' ' ' SER . 29.8 p -64.98 163.43 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 63.340000000000003 111.222 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -174.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 65.349999999999994 111.129 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -57.19 120.18 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 55.450000000000003 110.836 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 26' ' ' ASN . 1.2 mp -56.84 153.53 10.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.48 . . . . 42.329999999999998 110.87 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.14 -15.3 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.299999999999997 110.829 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.02 152.63 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 74.340000000000003 110.868 -179.746 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.46 ' HD1' HD13 ' A' ' 73' ' ' LEU . 59.4 p-90 -136.97 129.53 30.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 71.109999999999999 110.922 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -152.89 122.37 6.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 71.120000000000005 111.137 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.1 t -102.76 115.95 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 63.539999999999999 111.065 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.5 152.32 36.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 70.540000000000006 110.858 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.403 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -155.0 167.22 31.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 75.120000000000005 110.907 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.99 133.68 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 72.200000000000003 110.823 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -112.02 76.72 1.84 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.420000000000002 110.86 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -49.57 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.65 2.234 . . . . 74.129999999999995 112.335 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -73.38 144.74 46.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 73.319999999999993 111.124 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.19 96.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.150000000000006 112.466 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 43' ' ' THR . 6.5 m -156.66 155.95 32.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 111.116 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.26 131.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.853 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.6 t -75.06 99.79 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 61.329999999999998 111.133 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 t -67.53 -40.69 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 63.240000000000002 111.133 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -142.95 148.55 37.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 75.549999999999997 110.786 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.11 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 61.509999999999998 111.063 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -148.51 144.9 27.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 64.239999999999995 110.957 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 63.24 16.28 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 110.849 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.1 95.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 53.420000000000002 111.12 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -54.6 100.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 73.420000000000002 111.126 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.29 128.43 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 111.087 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -126.89 141.69 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 33.450000000000003 111.075 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -108.43 159.89 16.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.310000000000002 110.876 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 85.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 110.869 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.81 -90.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 54.109999999999999 112.521 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.22 7.51 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 75.409999999999997 110.822 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -119.15 146.89 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.852 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -128.06 160.09 33.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 65.519999999999996 110.86 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 t -148.77 149.48 31.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 73.209999999999994 111.103 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.86 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 35.210000000000001 111.103 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 142.84 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 110.889 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -120.26 -33.07 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.954 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.56 42.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 73.140000000000001 111.126 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.29 1.88 68.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 61.409999999999997 112.486 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.427 ' HE3' HD21 ' A' ' 70' ' ' ASN . 0.5 OUTLIER -116.74 -34.09 4.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.822 0.344 . . . . 75.519999999999996 110.976 -179.888 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.427 HD21 ' HE3' ' A' ' 69' ' ' TRP . 1.8 m-80 -108.24 -70.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 73.219999999999999 110.897 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.06 -37.65 3.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 64.540000000000006 112.487 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 t -49.92 117.66 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 71.109999999999999 111.122 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 ' HD1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -144.1 143.31 31.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.972 179.928 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -62.45 160.51 33.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.565 0.698 . . . . 52.039999999999999 111.121 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -18.31 36.74 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.739 2.292 . . . . 73.299999999999997 112.326 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.99 115.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 54.109999999999999 112.472 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.8 172.41 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 41.210000000000001 111.087 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -120.78 131.02 54.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 110.879 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.8 m -136.2 109.43 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 65.510000000000005 111.119 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.6 p -113.74 164.36 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 62.25 110.886 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 53.5 p90 -154.93 132.52 11.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.882 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.45 173.28 18.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 65.450000000000003 112.472 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 47' ' ' VAL . 26.3 p90 -174.83 176.73 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 75.329999999999998 110.85 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -129.92 139.04 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 61.350000000000001 110.906 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.2 159.49 27.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 42.200000000000003 112.493 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.43 112.08 24.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 63.119999999999997 110.888 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.5 -157.81 27.62 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.669 -0.777 . . . . 75.430000000000007 112.443 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -42.31 3.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 71.420000000000002 112.382 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.94 30.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 62.049999999999997 112.458 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.6 t -112.79 75.29 1.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.675 0.75 . . . . 52.310000000000002 110.842 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 159.02 54.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 51.340000000000003 112.343 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 m -142.72 165.92 26.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 52.210000000000001 110.938 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 m120 58.67 63.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 62.329999999999998 110.893 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.2 t -79.51 92.23 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.858 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 118.72 37.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 71.209999999999994 110.922 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.6 pp -130.27 155.76 45.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.925 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.603 ' HB2' HD12 ' A' ' 96' ' ' LEU . 42.4 t30 62.41 20.79 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 45.049999999999997 110.903 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.58 24.83 10.52 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.715 -0.755 . . . . 70.120000000000005 112.495 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.52 71.37 1.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.349999999999994 112.486 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 t -156.31 103.94 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 65.230000000000004 110.923 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.7 t -149.04 137.53 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 55.100000000000001 110.842 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -127.42 161.95 27.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.875 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.87 -29.61 8.42 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.85 -0.69 . . . . 74.409999999999997 112.522 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -172.8 2.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.8 0.334 . . . . 65.150000000000006 111.143 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 50.539999999999999 110.883 -179.864 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.895 0.379 . . . . 70.239999999999995 111.114 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.627 ' HA ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -165.98 85.86 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 73.049999999999997 111.114 -179.897 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -100.7 95.38 6.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 34.450000000000003 110.88 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.21 133.55 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 64.510000000000005 111.167 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.87 150.64 52.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 65.109999999999999 111.163 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -139.55 149.51 43.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 44.240000000000002 111.126 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 119.25 16.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.155 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -69.5 146.25 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 70.109999999999999 110.871 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.25 154.87 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 41.219999999999999 111.081 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.33 156.05 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 52.299999999999997 110.931 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -58.94 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 64.530000000000001 111.119 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 129.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 74.25 110.865 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -115.83 127.98 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 51.119999999999997 110.9 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.59 82.94 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 110.901 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.48 -85.12 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.741 . . . . 63.32 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -103.29 -17.57 15.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 64.209999999999994 111.123 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 156.11 26.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.804 -0.712 . . . . 33.240000000000002 112.515 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.16 142.91 30.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.885 0.374 . . . . 74.329999999999998 110.864 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.57 122.12 7.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 54.149999999999999 112.506 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.7 150.02 20.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 61.43 112.562 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -147.05 94.59 2.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.38 . . . . 71.340000000000003 110.816 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.27 134.87 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.902 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 m -113.12 102.1 10.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.140000000000001 111.111 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.68 131.59 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 62.450000000000003 111.162 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.48 118.12 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.895 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -116.0 133.21 56.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 75.150000000000006 110.884 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -172.04 153.72 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 111.08 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.93 -18.14 54.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.821 -0.704 . . . . 74.299999999999997 112.454 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -98.5 171.18 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 75.129999999999995 111.117 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -171.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 111.19 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.65 125.67 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 42.219999999999999 110.828 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.36 179.16 5.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 62.310000000000002 110.953 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -143.66 -52.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.109999999999999 110.84 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.91 174.42 14.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 110.923 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -140.25 127.35 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 54.240000000000002 110.907 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -113.74 102.14 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 70.109999999999999 111.116 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 81' ' ' PHE . 4.6 p -101.26 115.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 63.039999999999999 111.178 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.672 ' CG ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.92 151.45 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.299999999999997 110.865 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.12 169.68 18.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 110.937 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.19 128.11 44.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 63.140000000000001 110.898 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -112.59 77.15 2.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.633 0.73 . . . . 74.239999999999995 110.855 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.275 . . . . 75.439999999999998 112.264 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 26.5 m -71.93 145.35 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 71.140000000000001 111.163 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.36 98.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 70.209999999999994 112.433 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.75 153.49 31.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 71.239999999999995 111.163 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.75 130.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 74.299999999999997 110.882 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -79.53 96.59 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 65.340000000000003 111.154 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -63.57 -40.98 98.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 75.519999999999996 111.183 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 m -144.98 147.96 33.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.887 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.39 157.78 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 52.539999999999999 111.08 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -142.33 143.22 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 72.219999999999999 110.957 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.55 14.36 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 65.439999999999998 110.845 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.93 94.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.349999999999994 111.05 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -56.68 99.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.121 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 47' ' ' VAL . 96.6 t -90.27 121.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.129999999999995 111.095 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -111.56 172.05 7.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 74.140000000000001 111.142 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 155.26 48.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.010000000000005 110.927 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.85 85.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 110.821 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -93.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.675 -0.774 . . . . 75.230000000000004 112.443 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -126.25 10.25 7.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.400000000000006 110.795 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -124.3 147.02 48.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 110.876 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.77 159.86 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.319999999999993 110.959 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' CG ' ' A' ' 38' ' ' GLU . 15.5 m -147.8 148.82 31.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 73.010000000000005 111.133 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.88 135.18 48.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.129999999999995 111.071 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.88 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 61.340000000000003 110.889 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -131.47 -51.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.879 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.62 37.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 61.299999999999997 111.156 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.59 0.91 84.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 42.350000000000001 112.45 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -116.44 -24.27 7.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 72.340000000000003 110.889 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.636 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.17 -38.42 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 43.119999999999997 110.889 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.42 53.5 28.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.743 . . . . 75.409999999999997 112.487 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.3 t -130.18 94.95 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 74.340000000000003 111.212 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -138.61 160.72 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 63.210000000000001 110.897 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -85.12 161.31 52.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 71.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.9 Cg_endo -69.71 -8.45 23.63 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 74.540000000000006 112.351 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.21 115.54 0.75 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 74.040000000000006 112.484 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.53 172.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 62.240000000000002 111.11 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -134.19 131.62 38.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.120000000000005 110.849 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.88 116.98 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 52.299999999999997 111.164 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 p -108.41 125.95 52.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.872 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.9 p90 -111.55 137.31 49.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 74.5 110.818 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.64 174.5 17.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.310000000000002 112.458 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.9 p90 -174.32 179.07 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 71.230000000000004 110.878 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.5 140.86 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.856 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.65 159.9 28.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 72.450000000000003 112.48 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.1 m -105.37 113.72 27.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 74.230000000000004 110.87 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.52 31.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 71.400000000000006 112.501 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -37.35 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.655 2.237 . . . . 73.239999999999995 112.359 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.74 25.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 50.310000000000002 112.525 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -112.84 75.12 1.84 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.599 0.714 . . . . 73.510000000000005 110.834 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 156.71 62.74 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.652 2.234 . . . . 53.340000000000003 112.397 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 168.77 21.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 64.409999999999997 110.82 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 60.14 62.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 70.409999999999997 110.907 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t -84.9 95.55 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.150000000000006 110.812 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 125.52 48.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.904 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -135.3 155.61 50.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 73.530000000000001 110.988 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 63.08 25.76 15.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.140000000000001 110.88 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.58 28.66 13.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 73.140000000000001 112.458 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.35 74.79 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 52.439999999999998 112.476 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.18 104.35 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 64.319999999999993 110.862 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.0 t -154.82 138.87 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.88 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.45 106.09 8.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 110.864 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.17 50.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.82 -0.705 . . . . 74.239999999999995 112.458 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -142.22 173.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 71.310000000000002 111.159 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 62.399999999999999 110.829 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.802 0.334 . . . . 62.34 111.119 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.52 163.7 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 44.2 111.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.53 147.63 27.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 53.0 111.153 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -88.77 146.28 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.96 163.36 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 70.42 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.32 138.78 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 75.44 110.977 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.85 -60.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 61.34 111.165 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.27 131.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.43 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.94 127.3 53.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 75.04 110.908 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.25 88.17 2.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.983 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -93.22 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.75 . . . . 73.24 112.453 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.39 -17.7 17.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 73.44 111.141 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.61 148.59 20.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.778 -0.725 . . . . 52.2 112.489 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -138.08 143.75 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 70.4 110.881 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.29 3.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.77 139.27 21.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 42.42 112.504 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.34 95.51 3.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 40.42 110.815 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.25 145.13 25.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.17 -0.468 . . . . 53.01 110.932 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.27 124.73 52.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.12 111.085 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.08 131.56 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.42 111.116 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.77 118.1 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.883 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.73 101.54 9.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.9 p -146.05 134.06 21.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 42.43 111.101 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -57.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 62.54 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.81 168.25 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 73.32 111.12 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.0 p -63.17 -174.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 70.13 111.125 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.53 125.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 64.44 110.857 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.65 -176.23 4.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.91 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.5 -52.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 45.23 110.821 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.79 157.54 38.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 55.34 110.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -114.46 126.84 55.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.888 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.47 100.79 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 62.02 111.142 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.0 p -101.39 120.83 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 51.24 111.094 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.38 156.09 43.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 170.16 21.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.35 110.907 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.14 130.78 44.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 54.32 110.927 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -111.94 78.53 2.32 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.633 0.73 . . . . 74.12 110.928 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -49.28 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.734 2.289 . . . . 51.44 112.335 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -73.12 144.46 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.92 97.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.478 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.428 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.4 m -156.07 154.55 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 60.24 111.195 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.99 131.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 72.53 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.3 t -74.23 95.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.452 . . . . 64.21 111.12 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.6 m -63.19 -42.51 99.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 71.43 111.189 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.68 140.13 31.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 60.55 110.782 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.85 137.89 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 54.42 111.125 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.39 142.48 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.951 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.84 13.99 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.73 120.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 64.03 111.131 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.2 99.98 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 62.04 111.136 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.703 HG11 HG21 ' A' ' 47' ' ' VAL . 42.5 t -89.29 119.5 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 44.44 111.116 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -106.82 171.13 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 64.01 111.156 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.85 156.37 46.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 73.24 110.953 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 t -158.23 85.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.858 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.37 0.89 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 55.44 112.515 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 51.25 110.902 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -108.73 146.92 32.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -131.28 155.6 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.96 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.8 m -148.46 149.05 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 75.21 111.12 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.9 124.61 37.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 71.41 111.071 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.27 157.77 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.15 110.916 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.35 -51.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 63.32 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.45 40.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.099 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.13 0.86 72.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.468 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.336 . . . . 52.53 110.878 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.55 -45.06 3.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 72.04 110.868 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.663 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.49 55.25 20.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.772 -0.728 . . . . 60.22 112.432 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.17 94.66 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.341 . . . . 72.33 111.205 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.51 160.83 38.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.1 110.846 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.43 162.31 54.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 44.23 111.075 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.71 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.708 2.272 . . . . 75.32 112.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.53 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 33.42 112.445 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 74.22 111.098 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.75 131.51 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.848 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.87 149.8 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 44.41 111.15 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.78 154.26 47.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.14 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.93 139.02 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 61.1 110.833 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.64 174.33 15.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 23.13 112.483 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.9 p90 -168.81 177.8 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 74.4 110.855 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.01 125.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.2 110.885 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.96 154.2 20.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 65.35 112.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -95.89 109.53 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.379 . . . . 34.41 110.837 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -160.28 30.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.79 -0.719 . . . . 53.34 112.481 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -41.73 4.12 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.712 2.274 . . . . 75.41 112.306 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.73 26.65 24.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 42.21 112.467 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 m -113.3 73.56 1.87 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.694 0.759 . . . . 44.24 110.891 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 163.31 38.75 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 74.22 112.381 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -148.26 173.37 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.3 110.87 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.23 49.31 3.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 65.34 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.5 m -68.57 97.34 0.77 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.41 110.854 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 118.97 25.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 65.24 110.915 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.93 155.94 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.858 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.34 13.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 44.35 110.807 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.15 42.15 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 43.33 112.479 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.7 70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 73.11 112.479 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.22 132.61 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 62.25 110.866 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.887 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.803 0.335 . . . . 73.3 111.202 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.45 163.8 31.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 64.33 111.081 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 147.63 27.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.128 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.76 146.22 25.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.905 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.86 163.45 35.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 61.14 111.164 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 138.86 45.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 73.35 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.95 -60.92 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 75.05 111.11 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.32 131.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.868 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.99 127.24 53.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.847 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -111.28 88.23 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 -93.16 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 52.13 112.486 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.33 -17.74 17.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.784 0.326 . . . . 74.25 111.162 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.63 148.67 20.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 73.22 112.429 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.11 143.67 40.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 71.01 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.25 3.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 72.14 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 139.23 21.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 60.53 112.438 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.36 95.57 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.366 . . . . 73.22 110.894 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.31 145.2 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.857 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.3 124.66 52.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.2 111.22 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.98 131.59 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.149 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.84 118.12 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 62.12 110.888 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.74 101.46 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 65.41 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.7 p -146.0 134.12 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 71.04 111.096 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.87 -57.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.672 -0.775 . . . . 63.11 112.488 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.87 168.22 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 72.2 111.12 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -63.15 -174.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 71.1 111.204 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.52 125.58 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 60.22 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.64 -176.24 4.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 54.04 110.884 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.49 -52.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.34 110.892 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.84 157.55 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 75.33 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -114.45 126.94 55.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 71.51 110.917 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.62 100.75 6.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.456 . . . . 44.23 111.195 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.1 p -101.33 120.78 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 72.11 111.148 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.37 156.1 43.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.886 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.2 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 72.54 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.13 130.88 44.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.851 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -112.09 78.55 2.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 73.33 110.92 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.2 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.615 2.21 . . . . 72.53 112.36 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.8 p -73.15 144.34 46.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 73.51 111.136 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.78 97.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 42.22 112.508 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.43 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.1 m -156.13 154.55 31.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 65.13 111.182 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 131.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 65.41 110.852 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.771 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.8 t -74.13 95.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 64.15 111.105 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -63.13 -42.65 99.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 60.35 111.138 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.6 140.03 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.864 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 137.97 48.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 44.22 111.091 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.41 142.48 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.3 110.907 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.82 14.04 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 73.41 110.866 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.76 120.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 51.24 111.111 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.21 100.0 5.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 63.13 111.146 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 47' ' ' VAL . 42.6 t -89.31 119.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 65.41 111.12 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -106.86 171.12 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 111.1 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.84 156.37 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.92 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -158.25 85.74 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.846 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 62.12 112.539 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 63.02 110.902 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -108.7 146.92 32.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -131.31 155.5 47.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.937 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.7 m -148.4 149.1 31.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 64.23 111.142 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.91 124.63 37.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.066 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.32 157.78 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 61.41 110.838 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.31 -51.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 72.22 110.965 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.44 40.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 73.52 111.138 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.14 0.86 72.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 73.24 112.486 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.69 -24.64 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 74.31 110.918 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.51 -45.05 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 61.05 110.929 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.662 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.44 55.27 20.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.705 -0.76 . . . . 63.14 112.485 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.23 94.7 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 75.42 111.088 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.46 160.88 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.42 110.954 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.49 162.33 53.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.569 0.7 . . . . 71.44 111.107 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.74 -8.45 23.64 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.711 2.274 . . . . 44.22 112.354 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.52 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 72.2 112.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 74.34 111.098 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.73 131.46 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 31.24 110.858 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.88 149.8 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.105 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.73 154.25 47.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.912 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -141.97 139.0 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.2 110.866 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.52 174.27 15.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 71.34 112.55 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.771 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.7 p90 -168.73 177.82 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 70.24 110.893 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.02 125.72 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 62.3 110.871 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.94 154.18 20.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.672 -0.775 . . . . 41.3 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -95.84 109.53 21.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.888 0.375 . . . . 72.32 110.901 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.03 -160.23 30.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.75 -0.738 . . . . 54.54 112.522 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -41.55 4.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 63.03 112.36 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 26.73 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 72.34 112.442 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 m -113.42 73.61 1.98 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.742 0.782 . . . . 73.52 110.897 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 163.35 38.64 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.693 2.262 . . . . 31.33 112.381 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.0 p -148.39 173.33 13.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 73.31 110.82 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.25 49.28 3.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.3 m -68.5 97.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.922 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.13 119.06 25.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.01 155.93 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.23 110.898 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.35 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 62.1 110.818 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.11 42.23 8.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.708 -0.758 . . . . 74.22 112.493 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.64 70.02 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 63.25 112.495 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.23 132.62 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 60.01 110.873 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.127 -0.488 . . . . 51.13 110.944 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.789 0.328 . . . . 75.23 111.092 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.71 163.83 33.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 72.23 111.09 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 m -139.91 137.38 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 52.4 111.093 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -76.76 139.03 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.43 110.856 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.14 150.75 41.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 71.13 111.123 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.67 142.11 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.848 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.51 -56.49 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.09 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.25 132.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 52.42 110.902 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.46 127.65 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 64.33 110.793 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.42 84.87 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.903 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 -91.11 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 64.21 112.46 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.5 -17.6 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.347 . . . . 62.14 111.092 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.16 148.41 20.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 75.12 112.504 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -135.15 141.69 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 74.42 110.832 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.84 108.83 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 75.11 112.453 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.54 130.51 10.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 64.34 112.496 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.85 99.46 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 71.25 110.899 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.29 117.93 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 70.12 110.893 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.5 m -95.52 110.09 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 53.21 111.164 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.4 t -106.71 131.89 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 74.32 111.161 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -143.4 127.97 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 73.24 110.888 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.25 133.44 55.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.873 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.47 151.67 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.15 111.172 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -41.08 2.36 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.645 -0.788 . . . . 75.51 112.535 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 169.1 14.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 74.33 111.163 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -172.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 65.43 111.083 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -51.43 129.71 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 55.12 110.867 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -176.24 4.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 62.42 110.93 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -52.94 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.05 110.904 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.77 176.23 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.837 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.492 ' CD1' HG21 ' A' ' 79' ' ' VAL . 29.2 p-90 -135.68 127.09 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 64.23 110.894 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -124.64 105.83 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 75.33 111.138 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 14.2 t -101.4 105.92 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 72.44 111.11 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' A' ' 63' ' ' THR . 11.4 pm0 -116.76 153.07 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.84 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.82 169.61 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.911 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.08 129.94 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.841 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.76 75.38 1.88 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 72.25 110.86 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -49.78 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.641 2.227 . . . . 64.23 112.407 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -71.07 144.56 50.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.202 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.9 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.15 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -156.57 154.71 30.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 72.4 111.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.67 131.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 74.33 110.913 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.733 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.6 t -75.18 101.41 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 45.35 111.063 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -45.69 91.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 72.24 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.12 148.5 33.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.15 110.846 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.62 137.08 39.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.093 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -119.51 148.17 43.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.903 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.52 14.53 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 65.12 110.871 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 134.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 41.24 111.092 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -86.56 95.01 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.137 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 64' ' ' ALA . 98.2 t -86.34 138.33 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 71.13 111.07 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -128.31 171.03 12.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.168 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -136.07 157.39 46.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 63.23 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 85.74 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 74.14 110.877 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.98 -91.77 0.71 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 44.34 112.522 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.21 8.23 7.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 73.14 110.916 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -119.23 146.68 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 72.42 110.873 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -130.88 157.53 42.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.894 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 38' ' ' GLU . 46.9 m -152.53 148.46 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 72.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -130.46 134.84 47.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 53.41 111.135 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.1 OUTLIER -145.36 160.84 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.923 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.95 -51.46 0.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.43 110.902 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -98.93 39.3 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.52 111.11 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.26 -0.73 72.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.772 -0.727 . . . . 53.23 112.535 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -113.53 -25.2 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.806 0.336 . . . . 71.23 110.947 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.04 -47.0 3.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 74.41 110.874 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.86 56.3 14.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.774 -0.726 . . . . 44.43 112.438 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.71 95.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 41.53 111.093 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.9 tt -137.24 160.55 38.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.11 110.922 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -70.17 161.97 72.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.718 . . . . 54.3 111.151 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.77 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.727 2.284 . . . . 74.35 112.29 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.9 119.0 1.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 44.53 112.498 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.41 172.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 74.41 111.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -131.02 131.64 44.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.848 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.1 m -134.31 114.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.188 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 p -111.83 134.36 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.89 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.67 138.64 45.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.45 110.918 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.16 -179.77 19.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.761 -0.733 . . . . 72.32 112.469 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.733 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.1 p90 -174.45 174.02 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 73.33 110.862 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -129.83 125.79 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.838 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.49 152.22 19.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 42.42 112.546 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.4 t -97.87 109.38 22.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 71.15 110.894 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.51 -156.52 27.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.457 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -42.04 3.66 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 74.2 112.314 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.11 26.49 31.02 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.702 -0.761 . . . . 32.15 112.55 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 m -113.09 74.74 1.91 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.678 0.752 . . . . 62.53 110.908 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 162.55 41.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 73.3 112.375 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -148.34 171.29 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.836 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 60.01 58.47 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 73.35 110.846 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.33 92.06 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 62.02 110.857 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 118.94 33.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.427 . . . . 72.41 110.9 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -128.71 155.78 44.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.944 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 64.12 22.69 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.828 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.34 41.85 5.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 75.11 112.474 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.65 71.54 1.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 53.52 112.485 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.1 m -156.23 104.15 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 63.32 110.885 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.8 t . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 64.12 110.857 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.7 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.789 0.328 . . . . 54.41 111.185 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.35 163.82 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 44.51 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -141.79 147.69 37.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 72.2 111.154 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -91.21 145.4 24.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.839 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.68 149.86 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 74.21 111.105 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 147.33 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 54.5 110.888 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.27 -61.92 1.59 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 72.15 111.114 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -179.39 146.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.15 110.893 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -117.86 126.85 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.906 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -111.14 86.79 2.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.973 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.66 -82.97 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 51.04 112.508 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 t -115.66 -17.52 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 62.2 111.089 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.9 159.26 30.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 64.43 112.461 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HE2' HG23 ' A' ' 45' ' ' THR . 22.4 p90 -139.99 160.45 39.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 61.3 110.886 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.47 121.89 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 53.42 112.432 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.29 146.49 18.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 55.3 112.513 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -138.98 94.57 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 63.34 110.825 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.2 136.46 33.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 73.52 110.915 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -111.68 123.85 51.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 43.12 111.207 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.36 131.69 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 54.42 111.202 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.64 118.06 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 70.21 110.934 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -105.85 119.8 40.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 60.32 110.914 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -158.07 159.89 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.147 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -59.0 3.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 40.53 112.547 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 175.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.825 0.345 . . . . 61.54 111.173 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 175.04 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 71.34 111.165 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 p -52.58 131.66 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 41.34 110.857 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 33' ' ' SER . 0.9 OUTLIER -106.69 -169.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 63.32 110.961 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -133.47 -52.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.823 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.94 154.42 40.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 75.41 110.86 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -107.41 126.94 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 73.2 110.97 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 103.77 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 73.54 111.12 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 18.0 t -101.55 105.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 71.45 111.082 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.85 155.8 34.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -157.4 169.28 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.95 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -97.82 132.35 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 55.1 110.92 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.23 80.42 2.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.616 0.722 . . . . 73.1 110.807 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 44.02 112.394 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -73.37 144.56 46.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 64.13 111.158 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.48 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.815 -0.707 . . . . 62.31 112.448 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.608 HG23 ' HE2' ' A' ' 18' ' ' PHE . 86.4 m -156.24 143.5 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.361 . . . . 74.32 111.151 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -155.55 130.91 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.4 110.921 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 83' ' ' PHE . 57.5 t -77.94 92.5 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.13 111.099 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.9 m -77.08 -31.21 55.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.163 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.23 149.96 48.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 44.44 110.836 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.78 146.21 21.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 64.33 111.088 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -143.95 141.24 30.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.926 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.82 15.56 9.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.893 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.54 120.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 73.41 111.161 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.5 m -80.15 109.8 14.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 72.44 111.094 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 47' ' ' VAL . 15.7 t -93.65 138.63 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.14 111.101 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.0 m -128.13 142.27 51.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.34 111.228 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.69 157.08 18.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.875 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -160.6 85.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.13 110.816 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.44 -90.83 0.46 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 74.35 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.31 6.3 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 65.24 110.87 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -119.85 146.79 45.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.852 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -129.19 164.21 23.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.966 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -151.32 149.37 29.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.44 111.168 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.29 114.98 17.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 62.03 111.133 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 154.75 47.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 72.03 110.884 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -131.32 -51.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.878 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -97.05 39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 75.24 111.146 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.2 68.52 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.737 -0.744 . . . . 35.04 112.454 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -112.08 -30.45 7.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 73.45 110.919 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -102.49 -46.06 4.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.861 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.98 55.84 16.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.696 -0.764 . . . . 75.3 112.492 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -135.19 94.6 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.834 0.349 . . . . 63.41 111.194 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -135.37 161.17 36.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.939 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -92.3 163.45 26.78 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.534 0.683 . . . . 55.42 111.109 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -7.92 22.28 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.632 2.222 . . . . 64.33 112.352 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 115.17 1.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 72.3 112.492 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.75 172.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 75.02 111.12 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.89 131.58 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.43 110.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.8 t -149.41 137.39 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.515 . . . . 54.22 111.149 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -124.22 136.59 54.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.828 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 28.4 p90 -125.25 135.81 52.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 52.34 110.865 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.89 171.13 13.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 72.2 112.394 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.9 p90 -162.42 179.59 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 72.22 110.951 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -136.67 131.07 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 54.43 110.872 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 153.84 23.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 61.42 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -91.28 116.78 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 71.24 110.881 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -161.58 29.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 45.15 112.485 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -45.51 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 73.14 112.342 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 27.55 9.81 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 63.35 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 t -112.37 75.13 1.64 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.57 0.7 . . . . 73.03 110.867 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 165.29 31.43 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.705 2.27 . . . . 75.1 112.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -148.59 -177.42 5.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 55.45 110.834 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m120 51.85 60.98 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.901 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -76.66 105.88 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.91 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 144.16 41.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 60.33 110.954 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 pp -153.12 156.15 38.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.893 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.94 43.73 2.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 54.42 110.918 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.8 42.13 61.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.706 -0.759 . . . . 74.52 112.525 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 70.89 1.33 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.749 -0.738 . . . . 63.52 112.492 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -156.43 104.35 2.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 55.35 110.841 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.889 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.7 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.747 0.308 . . . . 71.14 111.18 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.85 29.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 53.42 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -137.46 132.89 34.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.53 111.185 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.09 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 63.5 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.91 154.0 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -99.2 145.58 27.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 61.42 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -105.85 -58.64 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 65.35 111.122 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -179.42 131.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 72.02 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.59 127.29 53.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.31 88.99 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.2 -92.96 0.76 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 62.44 112.462 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.51 -17.76 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 64.2 111.181 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.36 148.62 20.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 63.12 112.495 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -136.87 145.1 43.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 73.32 110.887 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.52 112.53 4.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 64.21 112.491 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.77 145.44 24.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 62.22 112.524 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.92 98.7 3.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 65.4 110.826 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.79 124.46 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.4 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.9 m -105.27 101.81 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 62.53 111.174 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 79' ' ' VAL . 32.5 t -99.37 131.98 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 75.33 111.075 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -139.81 118.19 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.86 101.46 9.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 62.21 110.866 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -131.15 136.22 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.15 111.193 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.36 -35.53 4.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.679 -0.772 . . . . 52.31 112.492 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 177.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 63.45 111.209 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.34 173.41 12.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 72.55 111.149 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.76 108.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 45.42 110.886 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.09 -177.66 6.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 75.13 110.957 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.7 p -141.71 -53.44 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 64.45 110.822 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.53 152.63 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.889 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -115.3 126.78 54.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 62.41 110.931 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -135.9 118.13 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 62.24 111.155 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -114.91 125.46 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.176 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.39 153.71 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 51.43 110.825 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.55 169.45 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 64.21 110.88 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 132.45 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 54.23 110.834 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.9 m-85 -111.83 79.5 2.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.603 0.716 . . . . 71.22 110.859 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 72.25 112.364 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' THR . 69.9 p -73.36 144.82 46.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.42 96.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 63.11 112.485 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' CE1' ' A' ' 41' ' ' PHE . 57.4 m -156.94 149.41 23.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 54.42 111.154 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.68 131.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.937 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 63.5 t -74.79 100.15 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 64.14 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.3 m -63.16 -46.02 89.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.124 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 m -141.44 142.12 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 60.25 110.897 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.46 147.69 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -131.58 143.99 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.925 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t0 64.8 14.07 8.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.935 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.41 ' HB3' ' CD1' ' A' ' 81' ' ' PHE . . . -172.96 106.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.068 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -64.95 91.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 73.0 111.141 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 64' ' ' ALA . 77.0 t -88.96 113.27 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 71.4 111.11 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 63' ' ' THR . 11.4 t -107.19 179.08 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 72.3 111.181 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.21 159.97 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.921 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -158.6 85.21 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 63.11 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.17 -90.99 1.01 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.442 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -126.75 2.0 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 61.11 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -111.56 146.88 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.12 110.88 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -130.29 152.9 49.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.903 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.599 HG23 HG22 ' A' ' 56' ' ' THR . 2.3 t -149.07 148.58 29.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.4 111.146 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -127.41 135.49 50.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.089 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.59 135.21 15.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.872 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -111.77 -32.09 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.11 110.907 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.32 40.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.152 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.03 1.89 72.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 72.31 112.52 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -117.78 -34.05 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 63.34 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.493 ' HB3' HG22 ' A' ' 72' ' ' THR . 2.0 m-20 -102.0 -68.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 64.43 110.89 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.96 45.44 8.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 70.22 112.479 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.03 120.72 29.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.816 0.341 . . . . 54.41 111.166 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -146.25 161.43 40.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 74.43 110.97 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.02 164.0 17.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.35 111.034 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.702 2.268 . . . . 65.12 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.63 114.29 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 71.12 112.484 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.99 172.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.711 0.291 . . . . 53.01 111.143 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -129.33 131.28 46.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 71.2 110.825 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.533 HG13 ' HB ' ' A' ' 24' ' ' VAL . 8.2 p -133.42 128.29 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.181 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -132.74 140.85 48.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 45.41 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 20.7 p90 -135.32 153.76 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 72.52 110.873 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.53 175.83 17.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.787 -0.721 . . . . 54.33 112.486 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 30.5 p90 -174.21 177.32 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 74.52 110.907 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -130.64 125.77 34.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.55 110.879 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.51 151.62 18.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 71.11 112.474 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 109.57 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 63.51 110.845 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.47 -157.22 27.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.706 -0.759 . . . . 72.42 112.426 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -42.49 3.33 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.591 2.194 . . . . 73.03 112.373 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.9 26.97 25.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 62.42 112.508 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -113.03 73.95 1.72 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.742 . . . . 71.15 110.828 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 156.02 64.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.669 2.246 . . . . 62.55 112.343 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.845 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 63.14 62.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 63.45 110.858 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.54 131.75 34.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 54.33 110.936 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 121.37 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 51.14 110.898 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.797 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.3 pp -136.48 155.88 49.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.4 110.935 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.797 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.6 t30 64.11 39.79 7.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.1 110.937 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 23.36 60.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 50.01 112.531 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.37 71.53 1.16 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 41.43 112.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -156.19 104.24 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 62.23 110.891 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.2 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 71.21 110.873 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.742 0.306 . . . . 63.44 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.37 163.77 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.51 111.095 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.41 141.93 26.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.128 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -84.73 145.53 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 71.21 110.884 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.77 164.1 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 70.52 111.153 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.74 163.95 12.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.879 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -61.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 73.21 111.121 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.22 135.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 51.34 110.905 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.92 127.14 53.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 53.21 110.93 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.14 92.91 4.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 73.23 110.926 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -90.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.794 -0.717 . . . . 72.32 112.477 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -106.98 -17.56 14.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 70.01 111.127 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.82 153.56 27.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 64.41 112.516 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -140.94 146.55 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 63.4 110.928 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.22 127.93 9.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.774 -0.727 . . . . 70.35 112.543 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 145.95 16.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.758 . . . . 73.11 112.507 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.76 100.09 4.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 54.4 110.845 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.29 139.91 30.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 72.24 110.921 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -114.73 119.54 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 45.14 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.96 131.78 62.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -138.29 127.5 24.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 73.11 110.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.716 ' HB3' HD13 ' A' ' 32' ' ' LEU . 70.1 m-80 -118.2 129.73 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 60.44 110.899 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -172.6 159.76 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 74.31 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.1 9.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 71.51 112.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.48 171.01 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 62.33 111.144 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -172.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.152 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -51.54 128.06 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 70.43 110.844 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -86.1 -175.94 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 61.03 110.895 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.99 -53.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.13 110.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 p -155.82 176.38 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 65.04 110.864 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -139.66 126.89 21.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 72.33 110.878 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -114.04 104.55 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 64.1 111.099 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.0 p -101.45 108.31 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 53.04 111.144 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -130.15 136.17 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 61.31 110.833 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.58 169.89 15.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 74.12 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.21 129.19 44.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 51.34 110.862 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -113.03 76.43 2.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.2 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -49.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 64.11 112.394 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -72.03 145.19 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 75.41 111.132 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.39 98.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 35.12 112.471 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -154.56 155.07 34.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 64.41 111.115 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.55 130.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.864 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.657 HG22 ' CE2' ' A' ' 83' ' ' PHE . 92.7 t -82.02 109.08 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.12 111.114 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.04 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 65.11 111.085 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -145.85 154.56 42.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 71.22 110.811 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.73 143.9 35.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 72.25 111.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -128.07 145.38 51.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 62.23 110.99 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.98 13.8 8.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.306 -0.406 . . . . 74.03 110.84 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.84 101.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 51.02 111.083 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.0 m -60.29 96.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 72.41 111.158 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 64' ' ' ALA . 97.2 t -92.54 112.6 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 75.35 111.046 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 HG23 ' A' ' 63' ' ' THR . 14.0 t -105.51 174.84 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 63.24 111.146 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -135.9 158.14 45.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.84 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -158.51 85.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 71.02 110.918 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.04 -91.59 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 74.52 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.57 4.92 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 74.1 110.882 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -132.64 139.08 47.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.913 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 56' ' ' THR . 5.7 t -139.21 148.85 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.134 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -133.66 144.4 49.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 73.51 111.066 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 161.08 39.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.33 110.947 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -131.62 -51.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.896 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.1 39.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 64.32 111.117 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.6 1.17 83.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 64.44 112.491 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -115.13 -20.82 10.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.32 . . . . 71.34 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -115.33 -44.35 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 63.31 110.916 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.521 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.95 56.73 11.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.501 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -145.93 96.55 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.43 111.13 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.0 tt -138.27 160.27 39.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 72.14 111.021 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -66.74 161.52 60.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 62.13 111.036 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.3 Cg_endo -69.7 -19.73 36.03 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 63.25 112.329 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.08 116.24 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.779 -0.724 . . . . 71.54 112.528 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -177.82 172.08 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.42 111.108 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 86.7 p -136.24 131.63 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.876 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.08 117.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.106 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -110.4 134.8 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 61.11 110.868 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.645 ' CE2' HG11 ' A' ' 37' ' ' VAL . 27.8 p90 -122.74 146.44 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 52.15 110.918 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.02 173.32 14.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 73.41 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.7 p90 -171.18 -179.5 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.22 110.867 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -131.43 125.95 33.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 53.41 110.873 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.03 156.64 20.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 64.33 112.471 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.17 116.57 32.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 74.11 110.891 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.35 28.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.486 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -33.74 16.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.744 2.296 . . . . 74.33 112.324 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.46 26.93 28.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 72.03 112.494 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -112.28 76.03 1.82 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.727 0.775 . . . . 74.41 110.898 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 157.94 58.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 74.12 112.356 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -147.44 173.12 12.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 70.03 110.849 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.61 46.82 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 72.34 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.6 m -65.75 100.61 0.56 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.841 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.45 144.04 47.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.876 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.2 pp -160.19 145.84 15.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.92 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.68 ' HB2' HD12 ' A' ' 96' ' ' LEU . 6.4 t30 60.67 54.82 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 64.44 110.885 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.9 39.53 46.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 65.3 112.514 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.56 65.24 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.73 104.62 2.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 72.42 110.852 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 72.23 110.908 -179.886 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 71.4 111.147 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -162.36 163.89 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 72.35 111.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -153.0 138.24 17.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 73.2 111.153 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -83.47 138.46 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.08 158.95 43.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 54.04 111.15 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -104.47 139.8 38.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 72.33 110.897 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -99.7 -62.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 72.04 111.16 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.82 143.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.865 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.15 125.9 51.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 75.02 110.851 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -112.2 107.04 15.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 73.11 110.989 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 64.51 112.511 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -117.61 -17.52 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 74.04 111.164 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 140.88 16.87 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 53.25 112.537 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.76 149.61 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.829 0.347 . . . . 74.13 110.888 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.1 106.14 2.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 64.24 112.469 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.27 138.22 18.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 52.35 112.453 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.34 100.67 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 71.35 110.819 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -90.17 132.67 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 74.44 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.5 m -110.48 122.99 49.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.129 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.47 131.78 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 53.31 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.71 126.95 18.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.921 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -119.42 135.02 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 71.13 110.885 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 t -168.2 140.65 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 64.45 111.141 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.29 -61.88 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 60.01 112.513 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -60.2 165.83 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 72.14 111.162 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.5 p -59.92 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 64.2 111.178 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 127.15 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 70.23 110.854 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -176.29 4.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 62.13 110.941 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -140.91 -52.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 72.35 110.885 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.47 174.51 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 44.11 110.854 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -132.2 126.99 34.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.498 . . . . 74.21 110.932 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.31 105.69 12.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 64.11 111.113 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 81' ' ' PHE . 5.2 p -105.0 120.66 55.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 61.31 111.13 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 63' ' ' THR . 6.3 pm0 -133.48 156.52 47.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 51.52 110.866 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.82 168.76 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.902 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.24 133.19 43.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.24 110.803 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -113.53 73.42 2.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 74.22 110.926 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -50.14 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.66 2.24 . . . . 62.32 112.387 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -74.05 145.56 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.4 111.115 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -38.24 99.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 41.1 112.504 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -154.82 157.86 38.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 72.43 111.186 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -173.34 130.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 60.5 110.97 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.644 HG22 ' CE2' ' A' ' 83' ' ' PHE . 81.3 t -81.69 107.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.3 111.119 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -48.34 79.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 44.25 111.165 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.32 156.22 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.787 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 134.56 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 64.42 111.128 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -118.59 145.66 45.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.35 110.863 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.27 13.49 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 71.02 110.854 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 103.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.03 111.153 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -63.2 97.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 55.12 111.139 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 64' ' ' ALA . 84.0 t -89.1 131.09 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 65.21 111.125 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -119.7 172.53 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -134.03 155.98 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 61.23 110.893 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.76 85.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 45.4 110.919 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.83 -93.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.23 112.52 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.26 17.09 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 73.31 110.823 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -129.56 146.71 51.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.869 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -130.67 160.46 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.894 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 38' ' ' GLU . 41.1 m -152.71 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 73.3 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.18 134.63 48.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.103 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 156.53 47.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 55.3 110.895 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -131.43 -51.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 63.1 110.884 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -101.9 39.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 73.13 111.11 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -0.29 75.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 33.04 112.496 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -114.2 -25.39 8.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 64.12 110.92 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.537 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -108.58 -47.36 3.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 55.43 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.79 55.6 19.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 72.53 112.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -136.51 94.84 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 62.25 111.175 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.6 tt -137.13 160.77 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 62.5 110.93 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -76.64 162.28 71.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 71.32 111.049 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.654 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.81 -8.37 23.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.633 2.222 . . . . 74.43 112.319 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.6 115.83 0.86 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.713 -0.756 . . . . 72.45 112.523 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.81 172.16 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 71.4 111.046 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -131.63 131.62 43.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.795 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.05 141.49 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 73.15 111.162 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -132.91 164.31 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.806 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 37' ' ' VAL . 29.3 p90 -156.33 143.15 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 73.41 110.886 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.41 172.29 14.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 73.41 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -170.0 178.91 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.369 . . . . 73.55 110.895 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.14 149.42 50.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 73.35 110.852 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.68 160.6 29.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.712 -0.756 . . . . 65.21 112.461 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 71.52 110.837 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.84 -159.9 29.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.783 -0.722 . . . . 23.14 112.488 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -37.24 9.66 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.724 2.283 . . . . 71.03 112.406 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.84 28.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 75.13 112.495 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 78.99 2.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.71 0.767 . . . . 74.44 110.785 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 168.14 22.43 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 74.41 112.386 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 m -146.68 170.33 17.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 63.13 110.869 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.37 44.35 9.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.917 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.2 m -64.53 92.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 144.06 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 62.31 110.922 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.1 pp -158.76 155.86 28.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.31 110.909 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.556 ' HB2' HD12 ' A' ' 96' ' ' LEU . 6.8 t-20 64.67 46.66 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 71.24 110.914 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.84 41.88 54.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 65.33 112.493 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.05 67.05 1.8 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.67 -0.776 . . . . 72.55 112.517 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.3 m -156.35 108.87 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 43.14 110.761 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 35.4 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 73.13 110.839 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.779 0.323 . . . . 64.01 111.184 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.55 41.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 75.44 111.114 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -138.83 132.41 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.124 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -78.02 146.15 35.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.925 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.23 150.73 29.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 64.33 111.044 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -92.33 141.81 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.01 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -102.83 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 64.41 111.165 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -174.14 127.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 74.05 110.864 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.64 127.71 55.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -110.59 83.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.962 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.8 -87.02 0.65 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 64.33 112.505 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -102.31 -17.58 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 72.44 111.13 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.3 153.68 23.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.489 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -140.61 145.19 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 73.51 110.903 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.54 113.84 4.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 72.31 112.479 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.21 136.67 19.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 45.34 112.479 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.72 94.45 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 71.25 110.882 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.47 136.63 39.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.473 . . . . 73.43 110.964 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 m -113.87 105.19 12.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.12 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.37 131.72 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 75.44 111.061 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -136.48 121.29 18.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.03 110.868 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.47 119.75 37.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 73.52 110.889 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.701 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -166.93 157.91 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 72.22 111.138 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.25 -28.32 15.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 72.32 112.475 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.4 p -103.81 170.19 8.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 75.45 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -171.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 70.44 111.12 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 t -51.57 125.09 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.787 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 -176.31 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 65.43 110.902 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -142.88 -52.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 32.3 110.868 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.79 175.78 13.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 64.25 110.921 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -144.26 127.09 16.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.928 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 65' ' ' LYS . 5.4 m -118.34 100.78 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 72.44 111.116 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 81' ' ' PHE . 4.5 p -101.48 116.12 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.15 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.611 ' OE1' HG22 ' A' ' 36' ' ' THR . 7.5 pm0 -126.17 158.97 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.42 110.87 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.56 171.11 17.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 130.49 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 65.53 110.84 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.68 75.43 1.85 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.69 0.757 . . . . 70.14 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 -49.61 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 65.41 112.33 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.8 p -73.92 144.47 45.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 72.55 111.11 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.66 98.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.478 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -156.1 153.25 29.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 63.35 111.176 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.15 131.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.927 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.4 t -79.64 96.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.44 111.088 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -63.26 -41.22 99.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 61.33 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -135.58 148.92 49.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 64.23 110.787 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.89 160.48 39.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 71.3 111.085 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -147.55 142.07 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.877 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.36 20.28 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.86 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -171.97 107.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 53.51 111.1 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.5 m -68.34 95.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 73.25 111.216 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.6 140.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 64.42 111.17 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.9 m -129.96 141.67 50.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 60.23 111.192 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.93 156.58 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 64.24 110.909 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -161.7 85.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 64.11 110.884 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.86 -92.3 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 65.42 112.558 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.24 18.09 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 75.23 110.816 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -131.22 146.05 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.822 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -131.29 160.69 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.867 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -148.95 148.97 30.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 62.13 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -127.43 127.99 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 75.15 111.135 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.07 156.65 48.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 74.4 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.36 -49.28 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.977 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.71 38.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 55.44 111.146 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.79 1.38 83.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 32.24 112.461 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.76 -25.24 7.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.736 0.303 . . . . 74.42 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.19 -37.79 5.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.884 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.46 54.83 14.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.462 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.08 96.82 3.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 54.43 111.142 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.4 tt -138.78 160.35 39.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.928 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.99 160.86 81.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.541 0.686 . . . . 44.11 111.147 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -20.77 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.618 2.212 . . . . 74.23 112.343 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 27' ' ' THR . . . -135.9 116.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 75.05 112.47 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.43 172.05 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.326 . . . . 54.22 111.099 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -138.15 131.62 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.43 110.921 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.08 114.27 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.125 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -103.15 125.77 50.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 54.33 110.849 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.547 ' HE2' HG11 ' A' ' 37' ' ' VAL . 28.8 p90 -114.55 152.87 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 72.31 110.864 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.54 167.59 24.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.654 -0.784 . . . . 55.03 112.458 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CE1' HG22 ' A' ' 47' ' ' VAL . 9.0 p90 -160.42 -176.27 5.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.361 . . . . 54.15 110.93 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -132.04 133.62 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 63.43 110.886 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.67 158.65 27.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 74.12 112.499 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.19 117.82 35.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 75.11 110.918 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -161.65 29.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.78 -0.724 . . . . 73.45 112.542 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -39.9 5.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 63.14 112.328 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.61 26.68 26.73 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.722 -0.751 . . . . 72.11 112.497 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -111.91 78.45 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.674 0.749 . . . . 62.12 110.86 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 165.8 29.61 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.693 2.262 . . . . 74.41 112.43 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.6 p -148.48 174.85 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 73.2 110.838 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 58.13 49.54 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 54.53 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 m -64.59 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 35.23 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 143.98 49.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 63.34 110.897 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -157.21 155.79 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.89 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 96' ' ' LEU . 8.8 t-20 65.09 45.83 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.903 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.61 42.03 55.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 72.31 112.453 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.92 67.82 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.688 -0.767 . . . . 71.25 112.517 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.9 t -156.33 105.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 72.44 110.89 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.928 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.714 0.292 . . . . 75.45 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.76 162.25 35.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.32 111.111 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.5 147.64 32.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 111.112 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -88.26 146.19 25.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.855 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.6 173.03 11.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 30.31 111.125 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 159.8 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 51.23 110.96 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.81 -58.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.409 . . . . 55.01 111.111 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -178.59 132.14 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.88 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.22 127.85 55.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.839 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -110.57 82.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.924 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.56 -86.74 0.62 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 72.13 112.464 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -101.35 -17.46 16.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 64.54 111.218 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.4 155.48 25.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 54.53 112.443 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -143.22 143.3 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 72.05 110.948 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.62 117.51 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 64.42 112.533 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.36 143.58 16.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 43.34 112.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.4 112.81 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 64.22 110.873 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -97.33 134.42 40.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.987 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 m -116.3 108.41 16.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 74.45 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.3 t -107.14 131.96 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 64.52 111.145 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.63 118.41 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -118.59 101.37 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 64.13 110.88 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.49 155.66 34.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 74.44 111.19 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 52.05 28.27 24.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 74.35 112.448 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -114.23 158.64 21.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 70.35 111.147 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.66 157.0 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 62.4 111.14 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 m -52.0 112.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 71.24 110.874 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HB2' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -91.11 174.62 7.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.956 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -137.42 -52.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.861 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.55 152.94 49.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 64.14 110.852 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -119.29 127.17 52.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 63.35 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -125.28 108.12 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.53 111.115 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.2 p -102.39 111.29 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 41.01 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.0 pt-20 -131.92 138.69 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 64.24 110.883 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.2 171.53 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.885 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.5 129.26 45.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 50.05 110.875 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -113.31 75.67 2.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 64.34 110.822 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -49.74 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.687 2.258 . . . . 51.13 112.3 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -71.36 145.05 49.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 53.43 111.153 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.26 100.07 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 73.44 112.515 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -154.61 155.81 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.847 0.356 . . . . 74.35 111.164 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -173.55 130.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 71.02 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG22 ' HE2' ' A' ' 83' ' ' PHE . 71.9 t -85.96 112.28 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.44 111.138 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -87.51 -32.71 19.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 63.14 111.143 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.05 149.55 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 63.2 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.27 133.23 5.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.116 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -133.06 147.96 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.937 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.77 16.42 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 74.42 110.868 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.04 95.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 51.33 111.148 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.5 m -56.17 99.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 53.45 111.1 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 53' ' ' ALA . 94.4 t -91.37 124.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.099 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -115.9 172.07 7.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.096 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -133.54 154.39 50.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.862 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.7 m -159.23 85.63 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.843 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.35 -93.33 0.79 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.24 112.546 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -126.51 15.0 7.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 72.11 110.825 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -126.83 146.86 50.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.838 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -131.54 150.6 52.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 64.01 111.002 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 38' ' ' GLU . 71.5 m -140.0 147.76 40.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.288 -0.414 . . . . 71.11 111.207 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -124.59 127.29 47.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.117 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 126.26 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 61.03 110.89 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -106.34 -45.38 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 73.43 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.08 39.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 73.25 111.081 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.17 -0.61 66.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 41.14 112.504 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -115.42 -33.78 5.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.793 0.33 . . . . 70.45 110.893 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.94 -48.09 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.21 110.902 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.58 52.12 54.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.2 112.506 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -124.66 117.66 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.94 0.4 . . . . 71.35 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -141.75 160.92 39.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 65.12 110.856 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -103.51 163.61 17.09 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 64.32 111.155 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.79 -7.89 22.22 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.746 2.297 . . . . 75.34 112.289 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -155.94 114.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.42 112.462 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.64 172.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 64.13 111.089 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -121.36 131.19 54.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.815 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 24' ' ' VAL . 31.6 m -131.4 125.88 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 50.32 111.083 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 p -129.86 156.59 44.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.827 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.715 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.4 p90 -149.41 139.19 21.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 71.54 110.856 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.46 168.84 15.7 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.729 -0.748 . . . . 52.35 112.42 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.512 ' HE2' HG22 ' A' ' 47' ' ' VAL . 12.4 p90 -173.81 176.2 2.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 74.41 110.891 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -125.84 173.12 9.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 65.23 110.823 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.34 167.66 40.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 72.33 112.486 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -120.05 109.52 15.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 51.32 110.844 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.02 -159.8 31.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 70.04 112.419 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.61 10.46 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.631 2.221 . . . . 70.25 112.368 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.32 26.67 29.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.752 . . . . 64.13 112.483 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 m -112.28 76.67 1.97 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.669 0.747 . . . . 74.43 110.879 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 159.26 54.1 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 61.51 112.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.58 171.37 15.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.24 110.884 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 58.68 47.61 12.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 62.31 110.893 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.0 m -66.61 101.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.03 110.827 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.25 141.76 51.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.953 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.5 pp -158.25 148.11 19.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 63.23 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.569 ' HB2' HD12 ' A' ' 96' ' ' LEU . 31.0 m-20 58.47 56.11 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 72.23 110.929 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.37 41.5 30.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 51.11 112.511 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.55 58.09 15.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 74.33 112.459 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.36 105.66 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 72.52 110.884 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 71.53 110.883 -179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.791 0.329 . . . . 51.03 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.758 ' HB2' HD23 ' A' ' 96' ' ' LEU . . . -122.69 141.35 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 44.44 111.1 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -130.81 109.7 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 60.32 111.116 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.75 141.05 57.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 73.54 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.55 32.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 43.14 111.119 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.74 122.71 41.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 75.24 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -58.47 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 62.42 111.169 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.52 138.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.877 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.58 127.06 54.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 72.31 110.892 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.66 85.96 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 75.35 110.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.55 -88.99 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 52.5 112.512 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -107.88 -17.59 14.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 45.51 111.126 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.7 144.9 19.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.493 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.52 ' HE2' HG23 ' A' ' 45' ' ' THR . 24.1 p90 -128.77 139.75 52.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 70.22 110.882 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.94 105.57 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 51.44 112.503 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.63 141.18 25.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 40.22 112.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.34 94.48 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 71.11 110.914 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -90.35 136.86 32.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.933 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -112.9 105.85 14.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 73.52 111.193 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG22 HG21 ' A' ' 37' ' ' VAL . 20.3 t -96.7 131.79 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.13 111.163 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.66 123.42 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.939 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.411 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.6 m120 -116.96 103.88 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 71.12 110.888 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -159.59 130.33 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.48 -28.99 3.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 72.15 112.451 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -108.63 177.37 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 71.41 111.101 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -60.01 -172.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.133 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -51.19 131.54 27.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 63.14 110.874 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.411 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -94.94 -176.52 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 64.11 110.945 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 -53.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 54.02 110.902 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 p -153.55 176.11 12.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.81 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.477 ' HE3' HG23 ' A' ' 37' ' ' VAL . 42.1 p-90 -139.04 127.12 22.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 74.25 110.941 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.3 m -113.49 105.07 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.22 111.161 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' HE3' ' A' ' 35' ' ' TRP . 24.0 t -101.1 105.75 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 75.1 111.075 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.59 152.61 44.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.868 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.438 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.77 170.74 19.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 65.11 110.92 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.97 131.38 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.14 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.6 m-85 -111.75 78.99 2.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.656 0.741 . . . . 50.45 110.889 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.96 0.61 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.729 2.286 . . . . 74.23 112.401 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.0 p -72.72 144.47 47.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 61.44 111.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 64.22 112.548 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.52 HG23 ' HE2' ' A' ' 18' ' ' PHE . 99.5 m -156.49 142.69 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 73.34 111.122 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -154.87 130.84 10.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 54.51 110.933 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.761 HG22 ' CE1' ' A' ' 83' ' ' PHE . 84.5 t -76.04 97.43 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 72.31 111.13 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 m -62.64 -43.97 97.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.44 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 143.74 30.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 53.32 110.832 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.57 139.87 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 70.02 111.054 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -123.65 143.56 50.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.44 12.97 8.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.848 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.03 104.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 64.34 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.3 m -63.32 97.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 63.21 111.179 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 47' ' ' VAL . 85.1 t -87.34 134.19 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 64.12 111.111 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -122.9 171.14 9.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 71.23 111.178 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -131.79 153.67 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.44 110.899 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -158.62 85.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 54.2 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.23 -94.24 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.688 -0.768 . . . . 60.42 112.494 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.26 13.42 7.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.825 0.345 . . . . 75.23 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -128.03 146.88 50.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 44.22 110.879 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -128.57 159.16 36.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 73.31 110.843 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 38' ' ' GLU . 19.0 m -145.95 149.16 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 64.44 111.114 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.4 129.78 45.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 74.43 111.157 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.73 155.94 49.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 71.23 110.912 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -131.48 -52.01 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 74.02 110.913 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.07 39.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.1 111.134 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.25 0.14 75.35 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.495 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -114.55 -26.5 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 74.1 110.878 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.31 -46.95 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 73.24 110.905 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.76 55.55 20.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.452 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.05 95.61 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 72.44 111.083 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.5 tt -135.98 160.68 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.914 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -72.19 162.12 75.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.684 . . . . 74.31 111.119 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.43 23.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.713 2.275 . . . . 64.12 112.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.75 116.16 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.77 -0.729 . . . . 71.34 112.511 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.25 172.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 62.35 111.081 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 p -145.86 131.7 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 41.31 110.845 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.01 118.18 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 60.13 111.074 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 121.84 42.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.866 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.24 135.27 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.32 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.15 -179.95 19.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 72.4 112.483 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.761 ' CE1' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.07 175.74 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 70.21 110.907 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -131.15 125.82 34.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 71.15 110.849 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.45 151.02 19.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 55.35 112.451 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.6 112.17 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 42.44 110.842 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.85 -160.3 29.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 71.02 112.473 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -44.96 1.78 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.67 2.247 . . . . 72.51 112.384 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.02 27.15 11.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 52.52 112.477 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -112.17 76.09 1.78 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 54.33 110.848 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 166.7 26.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 71.43 112.323 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -148.53 179.86 7.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 71.04 110.867 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 51.87 62.44 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.45 110.851 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 16.1 m -79.13 102.99 8.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 51.41 110.878 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.91 140.43 42.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 63.54 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 6' ' ' ALA . 4.4 pp -148.82 155.94 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 61.04 110.954 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.29 43.66 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.21 110.914 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.42 42.03 50.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 73.42 112.435 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.24 71.78 1.25 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 63.43 112.477 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 t -156.16 104.52 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 70.23 110.87 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 73.13 110.907 -179.967 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.774 0.321 . . . . 62.41 111.141 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.52 163.77 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.083 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -153.03 147.66 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.55 111.194 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -85.97 146.34 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 63.21 110.845 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -142.41 175.94 9.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 64.35 111.1 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 166.74 12.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.42 110.867 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 75.1 111.145 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.72 134.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.847 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 127.54 55.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 74.14 110.79 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.8 p90 -110.51 82.67 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.96 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.57 -85.87 0.63 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 72.34 112.546 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -102.82 -17.46 15.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.846 0.355 . . . . 43.22 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.07 154.31 24.36 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 71.53 112.534 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.41 143.42 31.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 73.54 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 122.87 7.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 63.24 112.467 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 139.13 14.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.746 . . . . 20.14 112.544 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -134.38 110.4 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 73.15 110.847 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.4 135.27 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 65.13 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -109.95 129.52 55.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 54.05 111.074 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.47 131.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 61.24 111.12 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -141.7 118.25 10.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.972 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.52 143.65 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 61.32 110.9 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 155.65 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.109 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.93 5.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 61.42 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.54 159.12 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 74.05 111.166 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.01 111.143 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -51.57 129.14 25.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.52 110.86 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.05 -176.61 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 73.45 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -141.01 -52.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.904 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 p -154.22 171.09 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 64.13 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -130.63 127.01 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.927 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.4 m -116.25 104.98 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 64.04 111.216 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.3 p -101.4 112.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 72.54 111.085 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -133.61 141.09 47.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.915 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.72 169.96 16.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 71.32 110.899 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.49 128.03 44.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 64.11 110.846 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.69 77.08 2.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 74.42 110.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -49.63 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 62.33 112.415 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -72.69 145.2 47.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 70.24 111.218 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 98.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 52.32 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -154.58 153.51 31.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.828 0.347 . . . . 64.04 111.098 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -173.68 131.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.55 110.917 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 83' ' ' PHE . 94.4 t -77.78 106.81 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 75.21 111.204 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -48.65 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 50.24 111.147 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 m -146.47 151.48 37.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 70.33 110.821 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.21 42.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 71.54 111.066 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -142.69 145.24 33.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 72.01 110.978 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.88 13.92 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 73.35 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.95 95.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 55.25 111.137 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.5 m -59.03 97.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.16 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 64' ' ' ALA . 23.7 t -92.69 112.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 75.04 111.135 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -102.35 175.01 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 73.21 111.16 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -133.51 157.51 45.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.03 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.5 m -158.69 85.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.43 110.854 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.49 0.9 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.24 112.538 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.76 11.75 7.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 74.24 110.835 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -120.45 147.0 45.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 64.33 110.848 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -132.98 142.66 48.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 72.22 110.93 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -141.14 147.12 37.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 72.53 111.131 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.853 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.35 140.77 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.153 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.53 159.0 43.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 74.43 110.939 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.45 -52.17 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.89 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.48 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.155 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.52 0.48 75.78 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 75.42 112.467 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -114.5 -22.8 9.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.312 . . . . 70.41 110.881 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -112.48 -47.18 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.52 110.897 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.62 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 52.01 55.04 23.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.668 -0.777 . . . . 71.24 112.542 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -137.04 95.1 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 65.42 111.123 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -136.18 160.73 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 61.43 110.868 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.59 162.21 64.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.63 0.728 . . . . 54.02 111.058 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.67 -8.46 23.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.722 2.282 . . . . 50.41 112.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.06 115.55 0.89 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 62.42 112.479 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.33 172.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 43.13 111.088 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.1 p -129.2 131.48 47.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 64.43 110.833 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.82 138.42 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 64.14 111.104 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 p -137.22 158.78 43.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.15 110.922 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' A' ' 37' ' ' VAL . 28.1 p90 -148.13 144.68 27.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.825 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.77 174.25 15.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.797 -0.716 . . . . 52.34 112.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.3 p90 -174.48 175.09 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 70.34 110.837 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -125.54 134.59 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 74.15 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.0 158.28 23.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.468 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 p -109.84 115.68 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 73.03 110.87 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.84 27.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 50.53 112.439 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -35.6 12.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 74.11 112.387 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.97 31.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.729 . . . . 41.51 112.519 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -112.5 75.45 1.78 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 64.52 110.831 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 155.85 64.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.645 2.23 . . . . 73.04 112.356 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.31 177.12 9.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.881 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 58.57 41.07 22.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 51.31 110.877 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.2 p -64.45 122.79 17.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 61.32 110.873 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 134.78 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 55.4 110.92 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.0 OUTLIER -146.06 149.07 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 64.23 110.94 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' HD12 ' A' ' 96' ' ' LEU . 40.9 t30 63.05 47.69 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.92 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.23 17.76 73.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.729 -0.748 . . . . 61.32 112.465 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.14 70.67 1.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.68 -0.772 . . . . 74.4 112.497 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.09 104.32 2.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 65.12 110.946 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.6 t . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.85 -179.865 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.862 0.363 . . . . 74.53 111.094 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.5 163.85 34.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.13 111.105 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.99 147.7 30.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.138 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -88.01 146.29 25.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.887 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.18 42.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 52.13 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 156.64 17.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.918 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 -60.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 74.31 111.126 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.58 145.72 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.821 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.64 126.87 53.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.917 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.2 86.1 2.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 75.45 110.875 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.59 -85.86 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 74.3 112.438 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -111.76 -17.6 12.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 53.14 111.126 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.76 151.03 22.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 62.34 112.463 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -131.53 154.95 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 75.41 110.869 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.93 118.86 4.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 71.44 112.508 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.32 148.78 18.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.685 -0.769 . . . . 33.41 112.498 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.95 102.29 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 72.13 110.837 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.18 144.29 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 61.42 110.939 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.7 m -120.52 121.57 38.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 43.45 111.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.09 131.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.11 111.118 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 118.18 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.905 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -111.26 137.76 48.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 73.04 110.909 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 t -172.36 135.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.12 111.098 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.96 -56.73 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.723 . . . . 71.24 112.531 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -63.88 172.26 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 65.23 111.098 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -66.45 -174.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.054 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 t -51.36 127.49 19.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.797 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 -176.52 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 75.4 110.933 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.63 -53.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 62.11 110.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.91 164.84 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.81 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -120.56 126.87 51.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.903 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.8 m -115.74 100.5 8.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.17 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.1 p -102.15 109.44 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 70.23 111.156 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.91 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 73.51 110.89 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.18 171.93 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 74.1 110.981 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.35 132.02 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 71.53 110.862 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.82 73.65 2.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 72.33 110.898 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -50.23 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 75.33 112.315 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.9 p -72.34 145.77 47.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 75.41 111.098 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.72 97.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.81 -0.71 . . . . 74.14 112.454 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -155.12 156.45 35.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.341 . . . . 72.04 111.078 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.58 131.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 73.42 110.916 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.66 HG22 ' CE2' ' A' ' 83' ' ' PHE . 80.4 t -80.08 103.12 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 52.42 111.18 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -75.38 -36.69 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.182 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.82 150.54 51.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 62.15 110.82 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.8 140.01 16.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.098 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -138.3 149.04 45.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.84 15.75 9.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 43.23 110.883 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.36 108.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.045 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.9 m -66.5 94.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 63.1 111.16 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.17 144.38 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 55.11 111.101 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 m -135.38 141.85 45.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.458 . . . . 62.55 111.209 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.89 155.24 21.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.44 110.927 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.18 85.72 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 43.12 110.878 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.37 -92.77 0.42 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.77 -0.728 . . . . 53.4 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -126.22 20.95 7.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.371 . . . . 72.1 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -134.15 146.45 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.841 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -133.34 150.55 51.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -138.04 149.38 45.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.207 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.829 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -126.25 125.39 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 75.1 111.094 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 134.16 32.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.938 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -111.0 -51.64 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.51 39.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 75.32 111.081 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.49 -0.82 74.13 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 61.24 112.506 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -113.59 -26.02 8.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 75.44 110.957 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 72' ' ' THR . 1.1 m-20 -107.23 -47.1 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.52 110.916 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.625 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.68 56.24 14.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 34.51 112.481 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' ASN . 70.6 p -136.94 95.04 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.339 . . . . 74.03 111.188 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.4 tt -137.16 160.87 37.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 31.14 110.966 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -78.92 162.53 64.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 72.4 111.109 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.76 -8.59 24.0 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 53.24 112.351 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.87 115.75 0.88 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 54.43 112.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.49 172.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 73.34 111.123 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -131.15 131.57 44.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 62.53 110.931 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.7 137.42 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.42 111.076 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.69 154.76 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.9 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 37' ' ' VAL . 24.1 p90 -145.31 142.21 29.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.898 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 176.32 17.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.501 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.66 ' CE2' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.34 179.12 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 75.12 110.872 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -133.8 144.53 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 74.45 110.884 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.92 160.38 28.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.799 -0.715 . . . . 63.44 112.531 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.96 109.63 21.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 61.32 110.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.6 -158.89 28.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 45.14 112.483 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -35.72 11.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 61.2 112.349 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.58 31.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 72.55 112.523 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 m -112.63 76.91 2.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 53.43 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 158.85 55.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.742 2.295 . . . . 73.01 112.35 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 174.76 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 64.04 110.879 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 m120 56.27 47.5 19.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 62.22 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -67.22 95.78 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 143.76 45.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 63.3 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -156.99 147.76 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 64.44 110.953 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.547 ' HB2' HD12 ' A' ' 96' ' ' LEU . 2.3 t-20 63.29 52.13 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.05 110.862 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.82 19.9 77.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.743 . . . . 41.4 112.458 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.13 68.26 1.33 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 51.13 112.468 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.0 105.07 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.02 110.871 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 65.54 110.877 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.807 0.337 . . . . 74.11 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -117.31 112.56 20.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 64.21 111.118 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.84 118.7 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 64.31 111.165 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.16 143.75 48.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.923 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.14 161.36 38.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.125 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.17 151.11 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 64.42 110.893 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -63.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 72.15 111.109 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 p -178.79 149.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.903 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.69 126.74 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 62.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.4 p90 -111.42 87.19 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.933 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.65 -81.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.746 -0.74 . . . . 74.22 112.484 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -117.04 -17.51 10.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 74.14 111.202 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.09 161.57 33.09 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 53.11 112.484 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -143.78 161.07 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 72.34 110.843 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.3 133.38 9.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 34.33 112.527 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 154.45 17.64 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 63.35 112.529 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 t -141.8 95.74 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 73.34 110.854 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -90.24 124.83 35.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.902 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 84.4 m -110.26 101.68 10.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.31 111.181 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 131.52 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 63.45 111.172 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -135.7 118.05 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 53.52 110.806 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.21 127.52 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 54.04 110.947 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 27' ' ' THR . 4.9 t -172.71 120.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.52 111.165 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.73 -50.9 0.87 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 53.44 112.473 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -75.34 171.97 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 72.51 111.143 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.0 p -64.4 178.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -51.95 107.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 54.34 110.841 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.686 HD22 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.69 -173.59 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 75.22 110.879 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -143.56 -53.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.88 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.41 ' OG ' HG23 ' A' ' 67' ' ' VAL . 23.1 t -138.77 159.44 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 75.1 110.823 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -128.69 127.22 41.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.2 m -134.21 112.12 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 72.14 111.092 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.2 t -101.43 105.65 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.105 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.03 144.44 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.44 110.896 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.92 168.92 19.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 70.12 110.936 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.24 129.36 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 63.41 110.87 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.85 76.62 2.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.609 0.719 . . . . 74.34 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -49.91 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.697 2.265 . . . . 70.01 112.319 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 1.2 p -71.65 144.96 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 75.3 111.147 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.19 98.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 64.55 112.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -154.7 155.4 34.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 74.05 111.137 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.78 130.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 63.35 110.912 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 83' ' ' PHE . 97.0 t -80.58 91.76 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.126 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 t -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.34 154.1 50.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.53 110.883 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.37 146.17 25.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 51.42 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -135.99 143.52 44.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.922 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.06 15.25 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.5 109.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.54 111.081 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -69.49 103.26 2.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.11 111.089 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.52 137.37 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 63.3 111.091 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -129.25 141.38 51.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 62.12 111.162 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -104.77 156.92 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 53.43 110.907 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -160.47 85.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 55.52 110.942 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.49 -91.97 0.58 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 51.35 112.47 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -126.37 8.17 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 75.12 110.843 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -123.27 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 53.21 110.892 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -128.18 157.52 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.929 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -141.18 149.71 41.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 42.51 111.086 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.59 131.32 48.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.127 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.41 138.22 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 62.13 110.912 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -117.44 -25.12 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 55.42 110.885 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 ' OG ' ' A' ' 34' ' ' SER . 6.1 m -102.77 39.28 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 63.13 111.157 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.74 2.04 70.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 63.23 112.555 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -33.89 4.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 74.24 110.97 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -101.5 -55.24 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.85 47.44 60.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 71.11 112.532 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.577 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.8 120.3 27.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 72.12 111.115 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 HD22 ' A' ' 32' ' ' LEU . 26.6 tp -146.49 161.01 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 70.34 110.984 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.69 163.23 18.5 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.549 0.69 . . . . 71.21 111.106 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.78 -8.44 23.61 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.672 2.248 . . . . 74.34 112.318 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -147.72 114.52 0.7 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 43.33 112.517 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.93 172.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 73.41 111.137 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.69 131.45 43.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 62.12 110.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.56 110.17 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 72.31 111.089 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.84 132.84 50.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.867 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.18 132.96 48.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 63.04 110.826 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.29 175.94 19.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 73.11 112.521 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 47' ' ' VAL . 26.9 p90 -169.37 -175.31 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 71.31 110.858 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -139.0 138.31 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 63.41 110.893 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.79 163.96 28.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 63.42 112.507 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -105.81 110.33 22.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.32 110.866 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.0 -163.68 36.59 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.817 -0.706 . . . . 71.23 112.537 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -34.2 15.2 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.284 . . . . 65.41 112.309 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.49 26.38 27.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.468 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -112.61 76.27 2.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 75.13 110.861 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 159.93 51.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.628 2.219 . . . . 62.42 112.345 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 t -148.25 174.92 11.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.427 . . . . 72.51 110.908 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.87 54.51 5.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.44 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.94 108.36 3.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 72.33 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 143.89 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 74.34 110.893 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.4 pp -157.08 153.71 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.888 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 96' ' ' LEU . 11.2 t-20 55.01 54.9 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 63.24 110.935 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.38 18.92 75.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.719 -0.753 . . . . 73.34 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 70.86 1.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.844 -0.693 . . . . 60.24 112.499 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.44 104.5 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 72.34 110.844 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 74.02 110.825 -179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 101' ' ' CYS . 1.1 m . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.796 0.331 . . . . 55.23 111.153 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.39 115.52 21.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 64.44 111.084 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 131.56 34.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 70.41 111.155 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -76.23 139.87 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 61.03 110.886 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.32 166.61 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 70.34 111.145 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.91 163.78 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 64.52 110.981 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 -56.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 33.24 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 131.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.76 127.55 55.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 74.1 110.892 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.54 82.18 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.901 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.53 -86.77 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 61.32 112.494 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -101.36 -17.6 16.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 74.13 111.084 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 154.81 24.47 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.725 . . . . 54.21 112.457 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -143.11 143.85 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 75.12 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 120.94 7.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 64.34 112.45 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.83 145.24 17.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.752 . . . . 42.01 112.465 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -140.84 94.7 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 60.32 110.9 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -90.28 122.95 33.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 71.41 110.937 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 101.53 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 72.32 111.124 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 37' ' ' VAL . 21.3 t -93.47 131.58 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.12 111.195 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -137.89 117.99 13.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.938 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -111.88 131.3 55.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 65.11 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -168.97 126.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 74.33 111.198 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.65 -19.0 16.75 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.782 -0.723 . . . . 74.44 112.492 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 32' ' ' LEU . 14.1 t -95.27 175.2 6.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 75.21 111.102 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -70.17 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 73.12 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.47 108.5 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.11 110.824 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.41 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -74.34 -174.0 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.903 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.0 -54.19 0.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.794 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 159.04 43.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 71.34 110.847 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.402 ' HD1' HD13 ' A' ' 73' ' ' LEU . 51.4 p-90 -128.65 127.1 41.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -122.61 110.64 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.33 111.205 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' NE1' ' A' ' 39' ' ' TRP . 22.4 t -103.9 105.47 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 63.55 111.176 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -126.35 154.9 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 65.33 110.888 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.422 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -153.2 169.32 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 75.52 110.962 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.14 128.33 44.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 64.13 110.91 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.78 76.82 2.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 72.55 110.946 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -49.78 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.684 2.256 . . . . 70.41 112.292 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.99 145.23 48.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.31 111.117 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 61.43 112.475 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -154.58 154.32 32.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.797 0.332 . . . . 74.55 111.15 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.71 130.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.88 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 83' ' ' PHE . 93.7 t -79.98 100.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 51.54 111.12 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -45.86 89.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 64.03 111.136 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -144.77 147.43 32.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 64.14 110.946 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.62 161.83 36.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 64.01 111.04 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.47 145.33 31.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.931 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.34 14.65 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 60.25 110.85 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.98 103.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.12 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 m -61.67 94.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.148 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 64' ' ' ALA . 92.1 t -91.5 112.43 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 63.04 111.1 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.4 174.57 5.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 72.04 111.088 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.08 156.45 44.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.844 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.02 85.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 62.13 110.845 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.68 -92.48 0.8 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 55.31 112.513 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.2 12.66 7.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 73.05 110.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -124.24 147.01 48.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -131.45 146.33 52.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 65.31 110.904 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 56' ' ' THR . 2.7 t -141.53 144.16 34.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -119.96 133.26 55.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 72.01 111.033 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.08 127.65 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.889 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -108.61 -32.05 7.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 65.11 110.91 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -103.72 39.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.083 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.14 2.51 69.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.825 -0.702 . . . . 75.23 112.456 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 -33.97 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.772 0.32 . . . . 74.23 110.979 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.56 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -102.44 -56.1 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.877 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.03 43.9 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.49 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.4 t -125.66 121.45 33.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.336 . . . . 75.43 111.196 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -149.68 161.16 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.43 110.897 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.14 163.6 18.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 72.01 111.118 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.2 22.98 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.677 2.251 . . . . 54.13 112.322 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -148.86 114.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 74.21 112.475 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.88 172.47 0.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.802 0.334 . . . . 55.1 111.11 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.1 p -128.63 131.3 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 52.03 110.872 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.4 111.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.137 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -110.46 141.56 43.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 54.12 110.892 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.421 ' HE1' HG21 ' A' ' 37' ' ' VAL . 51.9 p90 -132.58 129.2 38.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 63.14 110.887 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.59 174.48 22.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 62.44 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.4 p90 -174.45 175.95 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 73.55 110.935 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -124.55 126.75 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 72.23 110.872 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.64 151.86 19.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 61.12 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.84 117.3 34.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 70.43 110.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.44 -159.25 28.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 54.22 112.502 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -35.41 12.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.254 . . . . 72.24 112.34 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.85 26.89 30.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 41.3 112.46 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.73 75.15 1.8 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.636 0.731 . . . . 75.43 110.805 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 153.85 68.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 72.3 112.335 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 -177.53 5.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 70.53 110.83 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 52.0 52.49 14.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 73.51 110.819 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.18 128.45 34.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.11 110.859 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 123.01 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 96' ' ' LEU . 4.2 pp -133.97 155.75 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.875 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 t30 63.71 38.65 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 45.14 110.855 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.61 30.1 53.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 73.14 112.499 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 75.52 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.801 -0.714 . . . . 73.14 112.508 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.3 104.25 2.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 63.52 110.834 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 72.21 110.882 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.807 0.337 . . . . 51.21 111.105 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -129.39 151.2 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 44.21 111.096 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.28 142.5 51.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.55 111.119 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -91.03 135.05 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.94 147.75 40.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 54.02 111.099 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.77 140.66 29.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 72.34 110.901 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 -56.13 2.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.112 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.96 147.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.823 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.94 126.58 52.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.836 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -111.71 86.55 2.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 64.31 110.96 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.86 -83.13 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 14.41 112.421 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 t -115.79 -17.71 10.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.42 111.15 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.47 164.65 38.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 55.44 112.499 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.06 157.99 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.947 0.403 . . . . 73.23 110.877 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.42 128.97 8.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 62.12 112.506 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.74 148.8 17.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 72.22 112.501 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.45 96.08 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 73.53 110.937 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -89.78 118.52 29.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -93.73 101.85 13.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.23 111.121 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.74 131.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 73.03 111.154 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -133.42 117.96 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.956 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -118.07 101.37 8.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 74.43 110.962 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.5 t -143.89 146.78 33.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 62.4 111.124 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.42 -65.11 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 75.5 112.563 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.0 p -61.43 167.5 3.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 65.23 111.107 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 60.25 111.116 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -51.5 123.41 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 55.12 110.904 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -176.02 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 74.21 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.17 -52.46 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.53 110.837 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.99 174.47 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 75.03 110.877 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -140.68 127.24 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 70.24 110.897 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 m -114.75 104.7 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 51.32 111.152 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.5 p -101.27 114.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 73.43 111.16 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -134.41 137.02 43.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 65.5 110.916 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.03 173.6 11.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 63.45 110.949 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -98.19 130.97 44.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 74.41 110.806 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.65 74.25 2.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.651 0.739 . . . . 75.4 110.871 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -50.05 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 62.05 112.339 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.6 p -72.77 145.95 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.11 111.207 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 97.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.757 . . . . 63.04 112.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -155.07 154.06 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 72.21 111.122 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 131.18 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 71.03 110.948 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 72.9 t -79.07 102.94 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 71.15 111.154 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -63.66 -40.12 96.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 54.02 111.142 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -148.0 161.98 40.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.883 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 160.65 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 71.35 111.127 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.99 144.51 30.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 72.41 110.92 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.05 13.97 9.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 63.14 110.833 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.0 99.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.02 111.046 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.1 m -59.19 97.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 61.33 111.111 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 64' ' ' ALA . 59.9 t -92.02 112.43 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.524 HG22 HG23 ' A' ' 63' ' ' THR . 13.9 t -105.12 175.09 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 73.54 111.079 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -136.2 160.03 39.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 71.53 110.871 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -161.02 85.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.31 110.866 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.16 -92.09 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.531 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.67 9.89 7.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 62.54 110.8 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -117.74 146.85 43.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.02 110.935 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -133.49 139.78 46.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.966 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 56' ' ' THR . 4.9 t -140.54 147.8 40.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 64.1 111.098 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.867 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.14 143.1 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.54 111.039 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 160.77 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 70.21 110.918 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -131.23 -51.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 73.03 110.895 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.16 38.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 70.15 111.14 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.89 1.51 83.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 64.11 112.511 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.98 -25.2 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 72.3 110.886 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.661 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -111.52 -38.06 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 65.12 110.883 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.56 53.78 23.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 71.44 112.461 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.661 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -131.61 94.58 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 54.34 111.186 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -138.25 160.57 39.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.96 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.98 161.82 64.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 72.3 111.12 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.69 -22.9 31.75 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.638 2.226 . . . . 71.41 112.374 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.24 115.47 1.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 54.24 112.466 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.54 172.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.761 0.315 . . . . 72.12 111.07 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -137.86 131.62 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 65.04 110.886 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.42 113.17 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 75.13 111.103 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' THR . 19.2 p -105.19 120.53 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 51.04 110.928 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.7 p90 -104.3 146.0 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.53 110.79 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.98 173.39 14.73 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.741 -0.742 . . . . 72.32 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.1 p90 -169.79 175.94 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 54.11 110.912 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 71.01 110.859 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.17 163.53 27.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.725 -0.75 . . . . 73.41 112.444 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -115.62 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 74.23 110.907 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.42 -159.79 30.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 34.51 112.488 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.63 10.46 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.707 2.271 . . . . 73.53 112.346 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.33 26.69 27.4 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 62.22 112.462 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.47 77.05 2.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.636 0.732 . . . . 63.14 110.9 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 162.6 41.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.737 2.291 . . . . 72.41 112.307 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.42 176.1 9.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.85 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 54.16 44.83 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.7 t -64.63 101.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.89 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 143.83 49.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.942 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.41 HD22 ' HB2' ' A' ' 6' ' ' ALA . 1.1 pp -155.76 153.07 29.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 110.863 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 58.68 52.04 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.865 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.48 41.26 45.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.73 . . . . 72.01 112.491 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.6 68.74 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.79 -0.719 . . . . 63.13 112.525 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.1 m -156.01 104.48 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 60.51 110.814 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.0 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.3 110.873 -179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.733 0.301 . . . . 73.11 111.212 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 71.33 111.063 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.41 138.83 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 74.53 111.104 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.58 135.29 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 70.5 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.6 168.52 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.52 111.102 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.14 148.07 30.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 64.2 110.897 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.16 -57.62 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 73.53 111.13 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -179.42 132.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 63.0 110.816 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.08 127.13 53.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 72.24 110.845 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.41 90.48 3.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 73.23 110.93 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.97 -94.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 51.4 112.465 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -101.28 -17.63 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 74.3 111.17 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.25 148.15 20.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 51.2 112.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -135.93 148.0 48.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 75.23 110.901 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.94 115.18 4.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 52.5 112.496 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.24 147.35 20.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.698 -0.763 . . . . 42.32 112.494 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.57 98.6 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 73.13 110.855 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.18 123.62 34.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 63.41 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 m -102.84 101.88 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 61.1 111.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -96.83 131.81 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 50.04 111.17 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.84 123.75 15.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.909 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -119.54 127.58 53.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 65.43 110.93 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.9 t -152.9 170.39 20.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.489 . . . . 30.31 111.088 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.9 28.19 23.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 25.35 112.407 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.5 t -128.56 165.03 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 72.32 111.173 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.5 p -67.05 -179.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.423 . . . . 75.02 111.12 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.52 129.86 26.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 64.02 110.831 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.51 -179.97 4.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 61.53 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.97 -53.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.52 164.84 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 64.24 110.848 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -125.26 126.98 46.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.91 106.34 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 45.11 111.169 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.4 t -105.57 105.53 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 70.03 111.089 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -119.56 153.42 35.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.453 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.74 169.11 23.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.44 110.886 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.33 128.19 44.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.24 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.37 77.77 2.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 73.33 110.872 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -49.84 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.653 2.236 . . . . 70.3 112.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 19.6 p -72.02 145.31 48.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.141 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.57 98.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 65.22 112.461 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.79 153.39 31.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 73.43 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.67 130.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 62.43 110.931 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.4 t -79.06 89.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 65.45 111.097 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.3 m -63.62 -39.12 93.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 63.24 111.101 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.32 147.11 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 70.32 110.901 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.92 130.0 17.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 73.42 111.067 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -128.55 142.93 50.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 64.45 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.08 15.19 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.863 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.54 120.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.53 111.061 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -79.26 106.33 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 64.41 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.72 140.05 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.24 111.133 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 m -128.1 142.08 51.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 45.33 111.148 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.97 156.13 20.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.409 . . . . 72.13 110.874 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.05 85.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.846 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.95 -91.51 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 41.13 112.511 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.36 9.14 7.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.53 110.852 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -122.15 146.75 46.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.33 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -129.7 162.24 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 74.55 110.901 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -149.54 149.67 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.42 111.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.88 128.36 45.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 63.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 153.88 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.918 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -131.2 -51.33 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.23 110.863 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.68 39.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.116 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.75 -0.49 74.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 75.5 112.462 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 -113.79 -29.43 7.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 62.42 110.951 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.2 m-20 -104.32 -41.05 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.871 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.02 54.28 23.51 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 74.1 112.5 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.612 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -129.43 94.85 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.323 . . . . 75.13 111.156 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -137.75 160.77 38.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.925 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -84.94 161.4 52.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 71.1 111.056 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.79 -8.35 23.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 62.12 112.368 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.88 115.36 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 71.25 112.482 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 179.88 172.27 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 71.43 111.118 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.22 131.47 48.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 60.04 110.841 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.2 m -133.72 119.54 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.14 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -117.19 135.53 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 71.24 110.855 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.7 p90 -130.06 142.05 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.837 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.7 162.39 12.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 54.33 112.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 23.1 p90 -156.66 177.84 11.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 72.35 110.913 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -133.24 127.44 33.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.2 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.4 151.79 20.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 64.34 112.512 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -93.57 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 72.03 110.89 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.21 -162.85 35.62 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.666 -0.778 . . . . 74.32 112.423 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -36.09 11.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 74.11 112.371 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.45 25.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 63.52 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m -112.74 76.24 2.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 71.44 110.844 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 155.66 65.26 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.655 2.237 . . . . 73.15 112.324 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -146.68 175.41 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.888 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 51.81 61.91 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.2 110.899 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.04 130.84 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.23 110.876 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.83 143.89 23.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 50.32 110.878 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 96' ' ' LEU . 4.2 pp -151.55 156.51 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.2 110.941 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 66.1 42.94 3.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.898 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.85 41.98 61.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 61.12 112.479 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.87 71.97 1.3 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.677 -0.773 . . . . 74.42 112.455 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.28 104.17 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 75.14 110.914 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 51.31 110.875 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.799 0.333 . . . . 40.24 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.84 36.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 73.24 111.09 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -141.32 128.97 21.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 45.31 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -67.03 143.98 56.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.23 110.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 21' ' ' SER . . . -149.53 156.75 42.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 62.4 111.127 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -106.74 116.61 32.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 73.32 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 74.14 111.174 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -179.72 141.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 74.03 110.832 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.49 126.32 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 63.2 110.835 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -112.46 107.06 15.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 72.12 110.928 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.21 -91.7 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 72.53 112.492 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -117.45 -17.5 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 63.21 111.171 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.57 147.41 21.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 34.03 112.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -128.53 155.0 45.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 63.24 110.936 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.36 106.94 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 71.35 112.514 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.48 116.94 5.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.724 -0.75 . . . . 60.33 112.454 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 1.1 t -106.85 95.96 6.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 61.41 110.849 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -95.07 121.19 36.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.917 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -100.44 115.74 30.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 74.34 111.195 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 79' ' ' VAL . 17.4 t -118.78 132.76 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.106 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.25 141.83 32.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.965 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -119.34 136.57 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.883 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.94 161.12 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 71.02 111.128 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.99 -101.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.792 -0.718 . . . . 73.11 112.467 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.33 177.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 72.24 111.094 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -58.49 -175.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 61.3 111.11 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.92 145.65 9.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 64.03 110.865 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.86 -175.98 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.53 110.891 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -28.99 9.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.875 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.8 163.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.33 110.848 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.464 ' CE2' HG21 ' A' ' 79' ' ' VAL . 61.3 p-90 -130.26 128.73 42.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.88 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.5 m -152.65 125.53 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.1 111.172 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.3 t -107.26 113.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.121 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' THR . 5.4 pm0 -120.79 152.02 38.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 64.43 110.819 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.448 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.29 167.2 30.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.54 110.911 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.24 130.03 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.896 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.23 78.5 2.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.63 0.729 . . . . 72.42 110.911 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 -49.82 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.65 2.233 . . . . 74.42 112.319 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' GLY . 21.9 p -72.82 145.27 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.44 111.153 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.59 98.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.31 112.45 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 p -154.74 152.77 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 73.52 111.107 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -173.83 131.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.926 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.579 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.9 t -79.73 108.18 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 73.33 111.06 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -50.48 70.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 71.14 111.175 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.01 139.61 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 53.11 110.899 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.2 143.85 48.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.088 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -130.96 140.87 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 64.22 110.912 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 t0 65.09 13.43 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.2 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.92 107.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.14 111.111 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -61.78 93.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.2 111.145 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.1 t -86.98 121.59 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.192 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -118.18 172.39 7.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.15 111.15 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.43 159.31 39.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 61.14 110.896 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.61 85.76 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.839 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 61.44 112.506 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.27 3.13 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.51 110.845 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -114.72 147.04 40.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 64.34 110.879 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -127.48 160.17 32.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 72.03 110.887 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 38' ' ' GLU . 30.0 m -152.62 149.17 28.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 54.33 111.146 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.99 115.87 15.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 50.51 111.114 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 147.95 50.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.94 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.35 -37.51 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 61.41 110.906 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.3 m -90.21 41.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 71.24 111.12 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.15 70.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 71.23 112.477 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -110.97 -19.57 12.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.74 0.305 . . . . 61.32 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -132.62 -70.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.22 110.882 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.28 -38.33 3.23 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.76 . . . . 41.12 112.425 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -51.43 103.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 71.31 111.077 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.24 160.21 23.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.33 110.91 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -71.61 161.65 77.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.703 . . . . 60.2 111.079 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.75 -15.83 37.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.617 2.211 . . . . 63.31 112.349 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.34 115.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 74.0 112.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.94 172.41 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 74.11 111.12 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -129.39 131.29 46.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 51.22 110.867 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 24' ' ' VAL . 3.7 p -127.42 113.96 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.105 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.93 134.66 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.857 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 17.9 p90 -139.36 137.16 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.886 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.55 170.92 21.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 70.22 112.495 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.579 ' CE1' HG22 ' A' ' 47' ' ' VAL . 12.0 p90 -159.08 -179.61 8.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.371 . . . . 64.52 110.901 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.25 126.04 44.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.866 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.78 158.22 22.74 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 75.53 112.458 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.0 m -103.36 109.43 21.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 75.41 110.832 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.73 -161.58 34.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.576 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -36.43 10.84 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.688 2.259 . . . . 74.25 112.324 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.62 27.04 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.701 -0.761 . . . . 74.32 112.432 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.25 76.9 2.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.695 0.759 . . . . 71.45 110.871 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 164.35 34.86 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.238 . . . . 60.3 112.33 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.35 169.59 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 65.02 110.89 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 58.9 56.75 3.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 54.43 110.861 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.1 m -75.74 92.49 3.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 71.35 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.95 120.85 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 64.23 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -125.91 155.7 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 73.42 110.881 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB2' HD12 ' A' ' 96' ' ' LEU . 5.2 t-20 62.79 26.7 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.843 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.44 42.77 7.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 52.25 112.447 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.3 70.74 1.11 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.819 -0.705 . . . . 41.4 112.479 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.19 129.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 52.22 110.872 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 45.4 110.837 -179.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.867 0.365 . . . . 62.43 111.112 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.52 152.88 47.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 62.12 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -135.51 121.0 19.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.163 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -65.66 146.33 54.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 74.03 110.871 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -146.27 160.24 42.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 70.15 111.079 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.3 141.93 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.43 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.67 -62.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 73.04 111.199 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -175.84 135.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 61.35 110.863 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -119.62 126.65 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 61.53 110.89 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -111.74 97.67 6.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.949 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.82 -92.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 42.35 112.529 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 t -108.15 -17.6 13.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 52.55 111.119 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.21 149.32 22.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 75.41 112.466 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -134.63 150.71 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 54.24 110.87 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.41 113.38 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 55.41 112.473 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.07 147.26 22.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 62.54 112.453 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -139.66 96.59 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 71.42 110.905 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.23 124.13 34.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 m -101.96 101.91 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.183 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.4 t -96.6 131.87 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 52.52 111.072 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -141.97 128.06 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.53 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -119.4 132.08 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.863 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.55 129.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 62.3 111.188 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -48.31 0.98 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 71.54 112.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.64 176.65 9.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 64.1 111.184 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -174.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.11 111.177 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -51.45 125.42 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 75.02 110.923 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.02 -174.74 5.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.969 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.68 -53.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.846 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.16 171.44 19.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 45.33 110.939 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' HG21 ' A' ' 79' ' ' VAL . 35.6 p-90 -129.0 127.03 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.919 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 101.93 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.32 111.138 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.8 t -101.45 105.63 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.14 111.176 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -120.08 151.6 38.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.12 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.42 168.13 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 73.12 110.91 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.31 128.79 44.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.41 110.892 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.44 77.46 2.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.644 0.735 . . . . 70.15 110.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.98 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.717 2.278 . . . . 75.41 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 7.1 m -71.94 145.26 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 70.21 111.162 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.684 -0.769 . . . . 70.02 112.509 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -154.82 153.5 31.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 74.04 111.127 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -173.67 130.63 0.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 45.22 110.883 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 83' ' ' PHE . 99.9 t -79.09 89.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.098 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.25 -39.54 94.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 64.33 111.192 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t -129.52 147.69 51.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.875 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.23 130.06 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.139 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -127.18 144.08 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.967 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.63 15.9 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.884 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.29 121.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.42 111.08 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -78.56 101.9 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.03 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' HB1' ' A' ' 50' ' ' ALA . 39.7 t -87.35 147.23 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 62.23 111.16 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 m -139.1 140.53 38.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 63.42 111.16 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -107.68 157.48 18.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 75.22 110.908 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -160.68 85.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.33 110.835 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.29 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 60.42 112.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.18 6.92 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.78 0.324 . . . . 52.04 110.862 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -120.74 146.99 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 65.11 110.853 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -128.9 159.09 36.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.898 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 t -145.99 149.83 34.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 70.21 111.066 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.23 120.31 24.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 43.44 111.078 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 153.62 51.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.18 -51.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 44.44 110.937 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.12 39.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.01 111.181 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.63 -1.07 75.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 63.13 112.489 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -113.76 -25.37 8.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 71.02 110.848 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.75 -47.17 3.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.13 110.857 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.36 56.37 13.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 54.22 112.484 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 96.35 2.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 74.42 111.161 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.6 tt -137.7 160.62 38.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 52.52 110.959 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.34 161.93 75.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.57 0.7 . . . . 63.41 111.1 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.87 24.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.697 2.265 . . . . 63.31 112.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.54 118.35 1.08 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 65.12 112.461 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.54 172.02 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 42.41 111.132 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.69 131.57 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.846 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.4 m -134.1 113.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 65.22 111.116 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 p -109.18 125.63 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 41.23 110.883 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -120.46 141.35 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 70.41 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.36 12.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 63.44 112.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -159.68 176.92 11.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 73.22 110.85 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -132.4 125.87 31.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 72.03 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.94 151.44 20.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.731 . . . . 44.02 112.501 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.19 109.55 20.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.03 110.88 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.65 -162.67 34.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 73.05 112.495 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.27 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.34 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.11 26.6 23.47 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 62.22 112.455 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.2 m -112.67 76.6 2.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.683 0.754 . . . . 73.34 110.879 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.95 55.26 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.42 112.298 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.48 174.56 11.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.87 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 m120 51.6 63.6 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 74.32 110.89 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.0 p -82.73 128.63 34.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 54.14 110.947 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 144.02 23.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.911 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -149.56 156.63 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 72.35 110.9 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 41.77 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 61.51 110.851 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.08 61.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.11 112.478 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.82 71.85 1.3 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 74.41 112.415 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.32 104.18 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 55.3 110.841 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.848 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.802 0.334 . . . . 63.51 111.103 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -125.3 139.7 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 34.33 111.142 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -134.48 115.76 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.32 111.114 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.54 145.4 54.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.36 164.07 33.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 40.43 111.109 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.23 140.28 40.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.23 110.81 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -107.01 -62.42 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 63.21 111.15 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.82 133.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 61.42 110.868 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.79 127.05 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 62.3 110.844 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -111.4 91.44 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.843 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 -93.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 72.31 112.498 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -103.11 -17.61 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 74.42 111.097 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.78 148.58 21.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.805 -0.712 . . . . 72.22 112.406 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -135.53 148.49 49.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 75.32 110.895 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.36 114.19 4.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 53.22 112.446 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.39 148.15 22.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 71.12 112.494 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 t -141.64 98.36 3.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 73.2 110.891 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.23 137.06 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 75.21 110.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.22 107.07 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 70.44 111.175 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.2 t -101.48 131.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.417 . . . . 71.24 111.188 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 123.08 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 32' ' ' LEU . 1.8 m120 -112.69 125.92 54.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 51.43 110.916 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -167.27 148.98 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.21 111.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.62 -39.63 2.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 72.12 112.517 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -88.86 169.5 11.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 75.21 111.109 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.7 p -60.66 -172.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 74.43 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -51.49 127.13 19.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 45.35 110.871 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD22 ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -86.84 -175.67 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 53.22 110.93 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.63 -53.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.25 -0.432 . . . . 62.02 110.872 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.99 176.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 24.51 110.779 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.42 ' CD1' HG21 ' A' ' 79' ' ' VAL . 34.1 p-90 -134.53 127.05 30.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 73.32 110.862 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 101.35 7.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.52 111.159 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG12 ' NE1' ' A' ' 39' ' ' TRP . 13.3 t -101.01 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 64.25 111.172 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.02 147.66 43.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 62.1 110.887 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.458 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -148.29 168.18 23.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.891 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.06 129.06 44.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 74.43 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.59 77.52 2.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.712 0.768 . . . . 71.15 110.906 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -50.03 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 64.2 112.321 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.82 145.35 48.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.22 111.14 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.49 98.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 71.21 112.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -154.74 153.78 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 75.14 111.114 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -173.74 130.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 71.41 110.844 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.2 t -79.37 88.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.21 111.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.1 m -63.48 -39.0 93.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 73.02 111.162 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.32 145.99 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.33 110.837 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.46 130.07 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.112 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -129.4 143.11 50.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.78 15.66 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.39 119.34 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.31 111.074 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -77.55 105.34 8.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.43 111.13 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 HG23 ' HB1' ' A' ' 50' ' ' ALA . 17.0 t -92.95 139.94 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 64.12 111.152 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -131.7 141.62 49.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.21 111.122 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -109.51 155.59 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 53.03 110.86 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -158.9 85.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.3 110.836 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.43 -93.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 72.31 112.452 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.44 7.8 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 72.24 110.858 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -121.47 145.39 47.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 61.41 110.844 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -126.3 158.75 34.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.885 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -144.24 150.11 37.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 73.51 111.161 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.32 121.84 26.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 52.44 111.094 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 153.47 51.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 62.25 110.888 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -131.23 -51.51 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.43 39.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 71.14 111.086 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.92 -0.56 75.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 73.44 112.498 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -115.05 -22.36 9.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 65.41 110.901 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.56 -47.2 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 62.34 110.901 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.629 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.91 56.81 10.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.818 -0.706 . . . . 71.15 112.483 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 95.92 2.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 72.35 111.121 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.8 tt -137.99 160.64 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 64.03 110.942 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -70.79 162.0 74.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.614 0.721 . . . . 75.34 111.066 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -17.84 37.04 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.672 2.248 . . . . 72.12 112.37 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.75 115.94 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 63.24 112.535 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.66 172.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 54.32 111.049 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -133.12 131.65 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.03 110.857 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 35' ' ' TRP . 6.2 m -133.53 118.06 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 74.31 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.17 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 75.03 110.877 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 31.2 p90 -132.16 140.11 48.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.895 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.72 163.4 12.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 72.14 112.448 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -157.75 177.32 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 63.34 110.825 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -133.14 127.68 34.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 72.22 110.896 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.86 151.67 20.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 64.03 112.543 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.88 109.55 20.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 65.44 110.879 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.37 -163.03 35.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 61.2 112.48 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -36.48 10.75 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 75.55 112.353 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.97 26.49 24.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 60.14 112.512 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -112.78 75.94 2.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.636 0.731 . . . . 71.32 110.851 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 155.43 65.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.68 2.253 . . . . 61.51 112.32 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -147.97 169.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 63.03 110.806 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 56.3 65.33 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 70.04 110.862 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.5 t -89.27 104.84 17.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 52.34 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 118.98 27.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -126.88 155.8 42.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.905 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.7 t-20 63.74 27.79 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.24 110.871 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.23 42.06 8.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.736 . . . . 53.41 112.543 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.6 70.59 1.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 55.14 112.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.24 132.08 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 44.54 110.877 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.871 -179.932 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.796 0.332 . . . . 63.35 111.151 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.66 159.38 42.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.03 111.079 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.78 147.72 37.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 73.51 111.126 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -87.23 146.22 26.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.33 175.98 9.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.42 111.115 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.82 156.87 23.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 70.54 110.92 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.66 -55.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 62.54 111.217 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.41 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 54.42 110.869 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -116.75 127.61 54.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 72.11 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.71 82.58 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.91 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 60.02 112.471 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -100.99 -17.57 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 63.5 111.128 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.79 156.12 26.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 43.04 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -144.52 145.28 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 75.24 110.855 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 121.14 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.32 112.458 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.37 149.05 19.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 51.42 112.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -141.65 99.1 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 74.12 110.92 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.24 118.85 30.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 72.25 110.985 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -99.97 113.95 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 71.33 111.073 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -106.51 131.77 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 70.14 111.203 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -141.07 118.48 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.827 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 77' ' ' ALA . 7.5 p30 -105.8 129.68 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.868 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -164.89 139.54 5.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.172 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.41 -46.59 3.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.667 -0.777 . . . . 73.12 112.48 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.55 177.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 54.04 111.18 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -79.78 173.12 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 52.0 111.157 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -51.72 109.18 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 64.23 110.848 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -175.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.941 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 m -145.87 -52.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.66 140.97 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 65.22 110.855 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -111.29 127.11 55.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 74.01 110.932 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.3 m -126.18 113.26 16.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.34 111.187 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HE1' ' A' ' 39' ' ' TRP . 9.0 t -101.14 105.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 71.41 111.119 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -123.21 154.23 39.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.874 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' HE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.72 168.43 26.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 44.02 110.89 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.17 130.64 44.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.21 110.848 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.09 75.77 2.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.61 0.719 . . . . 74.14 110.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.75 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.745 2.296 . . . . 71.2 112.338 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLY . 43.1 p -71.32 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.098 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 99.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 34.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -154.46 157.44 38.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 61.31 111.157 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 130.76 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 62.14 110.854 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.608 HG22 ' CE2' ' A' ' 83' ' ' PHE . 84.2 t -89.61 106.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 65.21 111.084 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -80.09 -36.0 36.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.076 -0.511 . . . . 55.45 111.146 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.42 147.6 49.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 55.44 110.832 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.2 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.085 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -142.65 152.57 42.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.93 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.68 14.51 9.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 50.22 110.84 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 64' ' ' ALA . . . -172.7 113.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.11 111.126 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -65.25 90.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.51 111.111 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 64' ' ' ALA . 47.2 t -81.37 112.34 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 72.41 111.114 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -116.26 118.87 33.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.141 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -78.86 161.02 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 74.45 110.933 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.02 85.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.13 110.862 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.29 -88.85 0.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 65.31 112.498 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -126.77 6.64 6.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 72.54 110.831 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -115.22 146.98 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 71.03 110.873 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -135.19 120.2 18.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.959 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 t -121.7 148.15 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.13 111.191 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -128.6 141.96 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 64.23 111.053 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.45 121.75 7.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 62.44 110.844 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -94.46 -31.66 13.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 70.13 110.898 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.78 38.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 62.42 111.134 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.42 81.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 62.12 112.521 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -115.84 -32.7 5.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.286 . . . . 71.24 110.914 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -102.66 -36.63 8.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.54 110.92 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.28 47.87 41.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 75.23 112.474 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 70' ' ' ASN . 12.8 p -124.84 116.89 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 60.33 111.172 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -149.29 161.11 42.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 73.41 110.949 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -106.11 163.45 17.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.609 0.718 . . . . 73.23 111.113 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.78 -8.1 22.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 74.33 112.346 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.05 114.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 52.34 112.515 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' HD21 ' A' ' 26' ' ' ASN . . . 178.84 172.49 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 72.12 111.098 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -133.37 131.54 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 63.34 110.837 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.3 132.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.22 111.172 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.0 p -127.86 137.98 52.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.862 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -129.53 134.98 48.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.915 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.24 178.57 22.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 45.32 112.487 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.608 ' CE2' HG22 ' A' ' 47' ' ' VAL . 18.5 p90 -174.58 173.54 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 75.21 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -124.99 133.93 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.52 110.896 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.41 153.47 23.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 63.42 112.455 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 117.87 35.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 71.01 110.844 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.34 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 71.42 112.499 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.01 13.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 70.24 112.336 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.1 27.18 29.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.762 -0.732 . . . . 72.11 112.464 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -112.48 75.35 1.74 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 60.41 110.896 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 160.04 51.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.641 2.228 . . . . 55.32 112.32 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 m -148.6 175.68 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.834 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 58.73 53.52 5.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 72.24 110.913 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.6 m -73.44 101.75 3.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 61.53 110.846 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 119.31 22.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 60.22 110.928 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.95 155.74 43.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 71.54 110.922 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 63.73 26.32 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.85 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.76 42.17 7.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 73.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.62 73.95 1.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.552 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 130.04 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 64.21 110.813 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.852 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.744 0.307 . . . . 74.14 111.18 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.16 163.86 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.063 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -132.45 147.72 52.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 43.55 111.155 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -86.89 146.29 26.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 60.51 110.961 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.54 147.54 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 72.54 111.144 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.25 145.73 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 71.15 110.88 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 m -105.62 -63.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.181 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.39 127.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 53.52 110.834 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -116.04 127.62 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 71.22 110.859 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -110.53 81.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 64.42 110.971 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.67 -90.09 0.65 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 63.02 112.483 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -97.29 -16.36 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 63.05 111.192 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.14 155.52 23.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.726 -0.75 . . . . 75.43 112.463 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.73 143.72 31.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 71.24 110.888 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.27 115.44 4.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 74.41 112.527 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.2 140.62 24.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 63.33 112.493 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 94.54 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 63.41 110.859 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.03 149.93 22.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.902 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -129.81 108.15 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.141 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.53 132.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 65.3 111.12 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.43 127.07 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.892 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.6 122.61 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.3 110.861 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -172.59 156.7 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.229 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -21.36 17.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.699 -0.762 . . . . 63.53 112.507 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.85 177.18 7.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 63.22 111.196 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -171.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 74.03 111.19 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 120.18 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.12 110.854 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 179.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 71.31 110.896 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -120.8 -32.07 4.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 30.24 110.883 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 p 179.3 160.4 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.878 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -137.89 129.03 27.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.921 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.7 m -149.81 131.19 14.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 63.14 111.121 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG12 ' NE1' ' A' ' 39' ' ' TRP . 19.0 t -112.87 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 61.4 111.067 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.718 ' HB3' HG23 ' A' ' 63' ' ' THR . 18.9 pt-20 -118.28 135.07 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.861 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -135.2 173.76 11.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 74.32 110.92 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.16 134.34 41.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 60.4 110.92 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.44 77.73 27.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.669 0.747 . . . . 74.43 110.91 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -49.64 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 73.32 112.358 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 2.3 p -73.09 145.24 46.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.178 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.22 100.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 54.25 112.47 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -154.81 150.56 27.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.346 . . . . 62.44 111.192 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 130.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.15 110.924 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.9 t -84.26 98.03 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.136 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.4 HG23 ' N ' ' A' ' 49' ' ' SER . 6.3 t -63.5 -42.15 98.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 71.52 111.161 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.4 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 m -136.72 145.42 44.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.13 110.9 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.48 167.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 44.24 111.128 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -153.31 141.42 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 71.14 110.882 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.36 13.84 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.884 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.35 107.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.096 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -63.26 92.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 51.05 111.123 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 47' ' ' VAL . 59.8 t -81.78 112.55 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 71.14 111.135 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -105.1 172.27 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.12 111.056 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -134.19 158.53 43.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 70.32 110.852 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -162.5 85.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.903 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.63 -92.25 0.6 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 51.32 112.48 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -126.28 15.94 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 72.31 110.899 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -125.42 147.02 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.88 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -133.1 141.58 48.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.955 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HB3' ' A' ' 38' ' ' GLU . 39.0 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 64.23 111.164 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 36' ' ' THR . . . -128.09 116.74 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 62.22 111.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.09 142.15 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.873 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.84 -35.99 3.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 52.22 110.858 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -92.44 42.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.154 -0.475 . . . . 64.32 111.123 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 2.13 69.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.687 -0.768 . . . . 73.54 112.542 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.63 -33.81 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 75.43 110.905 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.72 -70.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.879 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.96 -38.21 3.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 71.41 112.498 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -52.66 110.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.909 0.385 . . . . 72.51 111.179 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.23 144.23 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.942 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.02 160.38 1.55 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 74.23 111.115 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.747 2.298 . . . . 74.14 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 115.57 0.66 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.757 . . . . 63.22 112.532 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.55 172.34 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 63.0 111.166 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.24 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 65.14 110.803 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.05 110.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 73.31 111.082 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.0 p -99.83 148.87 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.812 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -146.58 135.12 22.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 71.13 110.917 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.32 177.3 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 51.33 112.434 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 47' ' ' VAL . 10.8 p90 -171.64 175.94 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 74.14 110.864 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -122.74 128.31 50.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 73.41 110.929 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.12 149.38 19.6 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 74.23 112.487 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 109.46 21.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 53.25 110.876 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.78 -162.15 34.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 45.51 112.475 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -36.7 10.55 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 71.52 112.349 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.56 26.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 70.54 112.508 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -112.36 77.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.698 0.761 . . . . 73.01 110.883 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 163.5 38.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.713 2.275 . . . . 62.34 112.288 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -148.31 170.23 18.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 55.54 110.86 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.76 50.53 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.866 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.8 m -66.48 96.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 74.41 110.896 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -121.31 143.84 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 61.5 110.899 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -155.48 155.55 33.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.968 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.563 ' HB2' HD12 ' A' ' 96' ' ' LEU . 38.4 t30 63.22 39.87 9.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 71.35 110.884 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.06 41.6 11.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.42 112.521 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 63.32 2.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 53.44 112.484 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.5 t -155.99 104.49 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 75.31 110.804 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.1 t . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 33.51 110.858 -179.968 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.773 0.321 . . . . 72.22 111.116 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.79 163.44 39.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.45 111.077 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -140.68 141.69 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.44 111.137 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -79.38 140.45 37.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 64.24 110.891 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -139.41 162.19 35.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 62.02 111.129 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.29 154.54 22.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.852 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 -58.66 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 52.41 111.159 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.8 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 43.42 110.878 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -115.45 127.92 55.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 62.15 110.874 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.65 81.76 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.978 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.64 -87.27 0.63 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 73.43 112.473 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -100.32 -17.59 17.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 73.21 111.168 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 155.55 25.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 52.13 112.488 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -143.6 143.04 31.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 75.51 110.895 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.85 115.81 5.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.705 -0.76 . . . . 75.3 112.479 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 143.84 17.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.696 -0.764 . . . . 62.13 112.542 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.1 m -144.22 95.48 2.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 63.42 110.844 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.44 132.56 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.116 -0.493 . . . . 71.24 110.885 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.4 m -110.61 117.45 33.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.141 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.72 131.94 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 64.33 111.152 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -138.01 136.98 37.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 54.51 110.865 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -119.93 136.48 54.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.874 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -167.53 162.23 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.5 111.176 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.37 -98.12 2.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 32.4 112.524 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 p -56.34 170.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 63.1 111.134 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 p -59.4 -175.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 32.21 111.176 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.2 144.45 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 71.43 110.792 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 26' ' ' ASN . 1.3 mp -84.44 -174.61 5.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.912 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 -27.64 6.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.847 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t 178.88 154.92 0.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.52 110.896 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.427 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.1 p-90 -125.05 129.41 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 75.11 110.921 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 64' ' ' ALA . 80.6 m -152.42 122.0 6.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.166 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.5 t -101.72 110.68 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 74.31 111.182 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -117.66 152.4 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.1 110.88 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.442 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.97 170.23 20.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 73.31 110.911 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.98 131.67 44.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.874 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.8 74.05 2.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.659 0.742 . . . . 74.03 110.85 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.691 2.261 . . . . 70.33 112.34 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -74.18 145.79 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.23 111.128 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.36 98.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 24.33 112.513 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 p -154.9 154.62 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.332 . . . . 55.15 111.166 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.76 131.13 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.408 . . . . 74.34 110.931 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.0 t -76.1 104.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.13 111.078 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -47.89 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.178 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -144.39 152.37 40.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 52.21 110.87 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.17 162.47 35.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 70.32 111.074 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -146.99 144.95 29.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.988 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 64.05 15.18 9.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 62.45 110.85 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.55 104.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 62.24 111.127 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 m -61.8 93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 72.54 111.201 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 64' ' ' ALA . 95.7 t -86.22 112.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 52.45 111.084 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.425 ' CG2' HG23 ' A' ' 63' ' ' THR . 7.4 t -113.44 164.28 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.52 111.172 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -121.79 160.98 23.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 62.12 110.942 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -159.26 85.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.799 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.72 -93.27 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.756 -0.735 . . . . 45.13 112.442 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -126.54 11.42 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 74.25 110.877 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -123.53 147.03 47.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 62.23 110.864 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -127.98 156.32 42.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 63.52 110.936 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.425 HG23 ' CG2' ' A' ' 56' ' ' THR . 1.9 t -150.35 148.7 29.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 64.05 111.149 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.97 119.95 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 42.1 111.083 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.32 144.4 40.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 61.21 110.881 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -123.08 -35.06 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.42 110.901 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.427 HG13 ' HE1' ' A' ' 35' ' ' TRP . 14.1 m -89.6 41.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 51.11 111.124 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.69 1.92 70.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 42.24 112.523 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.44 -21.49 11.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 72.3 110.918 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -129.54 -70.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 63.54 110.898 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.65 -38.07 3.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 70.51 112.535 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -50.74 107.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 54.43 111.097 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.407 HD23 HD13 ' A' ' 32' ' ' LEU . 8.4 tp -123.69 146.93 47.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.993 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -61.53 160.31 26.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 64.12 111.06 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.9 Cg_endo -69.8 -8.43 23.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 75.24 112.319 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.9 116.03 0.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 61.21 112.436 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.17 172.13 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.868 0.366 . . . . 64.44 111.072 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.68 131.33 43.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 45.42 110.85 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.25 109.9 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 71.12 111.114 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 t -109.98 134.38 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 50.14 110.88 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -123.47 134.88 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.899 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.3 175.52 19.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 63.5 112.532 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 47' ' ' VAL . 18.1 p90 -174.84 175.87 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.933 0.397 . . . . 65.4 110.899 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -124.97 125.89 44.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 74.52 110.873 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.56 152.98 17.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 50.13 112.496 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.82 109.49 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 54.41 110.814 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -158.02 27.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.21 112.449 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -37.26 9.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 71.0 112.409 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.24 27.04 29.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.443 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.71 78.92 2.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 71.4 110.849 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 171.79 13.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 65.2 112.374 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -148.5 170.4 18.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 44.35 110.818 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 54.52 52.13 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 63.55 110.934 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.8 m -68.75 92.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 63.21 110.845 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.86 144.0 49.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.13 110.87 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.12 156.79 44.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.42 110.884 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 66.43 32.63 7.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.845 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.79 42.41 25.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 30.31 112.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 71.58 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 55.42 112.517 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.52 130.57 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.821 0.343 . . . . 73.44 110.841 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 55.25 110.811 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.828 0.347 . . . . 74.22 111.129 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.92 163.93 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 33.33 111.105 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.38 144.89 27.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 55.5 111.164 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.41 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 75.05 110.93 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.45 152.56 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 64.42 111.094 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.03 146.66 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 72.41 110.965 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.29 -59.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 70.13 111.092 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.4 138.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 50.5 110.876 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.13 127.43 54.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 64.43 110.83 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.67 92.97 4.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.927 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.25 -90.34 0.71 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 75.01 112.504 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 t -110.6 -17.55 13.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 73.41 111.176 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.6 146.76 20.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.761 -0.733 . . . . 75.15 112.466 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -125.42 149.72 47.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 74.34 110.87 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.99 110.41 3.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.76 . . . . 42.33 112.499 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.75 142.62 21.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 71.44 112.454 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -139.54 94.66 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 55.4 110.839 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -90.37 149.28 22.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 75.44 110.933 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m -128.18 132.01 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.17 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 79' ' ' VAL . 14.9 t -130.37 132.42 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.32 111.095 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -142.38 129.17 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 71.51 110.933 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.557 ' CG ' HD22 ' A' ' 32' ' ' LEU . 3.2 m-20 -104.53 148.99 25.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 64.25 110.851 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.4 t -172.57 162.59 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 65.04 111.155 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.89 -77.04 1.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 74.53 112.489 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -57.91 172.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 63.11 111.146 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.1 p -68.43 -172.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 63.51 111.059 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.12 122.79 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 64.22 110.842 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.557 HD22 ' CG ' ' A' ' 26' ' ' ASN . 6.2 mp -62.79 169.18 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 72.01 110.905 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.4 -16.89 10.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.43 110.798 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.87 147.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.45 110.815 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.435 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.6 p-90 -124.62 129.76 51.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.22 110.893 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 64' ' ' ALA . 93.0 m -151.24 123.26 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.42 111.083 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.4 t -103.69 105.83 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 65.23 111.092 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.21 151.09 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.21 110.925 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.433 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.03 171.17 17.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.926 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.95 130.25 44.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 72.35 110.856 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.59 73.67 2.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.717 0.77 . . . . 64.31 110.943 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -50.07 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.727 2.285 . . . . 65.3 112.39 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -72.77 145.59 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 62.13 111.134 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.16 98.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.714 . . . . 45.11 112.482 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -155.03 154.9 33.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 51.5 111.123 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -173.58 131.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 72.41 110.916 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -78.8 107.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.1 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 m -62.87 -49.54 74.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.116 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.28 140.42 27.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 63.04 110.871 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.13 137.16 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 71.03 111.08 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -121.52 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.88 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.53 12.62 8.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 65.11 110.907 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.16 102.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.22 111.151 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -60.05 95.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.51 111.153 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 64' ' ' ALA . 85.6 t -90.37 112.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.12 111.149 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.52 177.49 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.128 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -133.46 160.55 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 64.54 110.838 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -160.37 85.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 74.5 110.884 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.74 -93.3 0.83 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 23.2 112.45 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -126.53 14.55 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 75.23 110.857 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -126.94 146.89 50.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.12 110.861 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -129.45 155.95 44.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.908 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 56' ' ' THR . 1.8 t -149.02 143.45 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.25 111.127 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -120.4 122.73 41.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.11 111.095 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 137.79 34.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.878 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -119.41 -30.52 4.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.944 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG13 ' HE1' ' A' ' 35' ' ' TRP . 13.9 m -90.99 42.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 74.03 111.152 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.11 2.97 67.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 73.3 112.511 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.27 -34.08 4.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 74.3 110.881 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.79 -70.24 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 72.34 110.881 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.0 -37.75 3.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 50.32 112.509 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -49.43 117.41 2.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 71.12 111.156 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -136.46 131.79 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.1 110.957 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -56.87 160.65 5.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.566 0.698 . . . . 70.15 111.099 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.82 -16.14 37.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.693 2.262 . . . . 41.11 112.284 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.51 115.44 0.77 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 65.22 112.533 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.08 172.54 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 64.32 111.084 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.83 131.16 56.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 51.42 110.781 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.5 m -139.23 109.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 62.34 111.118 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 m -113.53 164.38 13.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.867 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 30.8 p90 -155.88 134.27 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.901 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.55 177.25 19.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.433 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.5 p90 -174.43 178.31 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 72.42 110.939 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -130.96 125.85 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 45.02 110.85 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.04 155.34 20.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 53.15 112.527 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.26 109.65 22.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 53.5 110.859 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.14 -157.58 27.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 62.44 112.495 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -39.0 7.03 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.231 . . . . 40.2 112.372 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.6 32.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 64.44 112.477 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 75.78 2.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.661 0.744 . . . . 54.13 110.903 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 160.61 49.05 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.725 2.283 . . . . 72.55 112.297 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 m -148.32 171.37 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.01 110.878 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 63.35 53.42 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.24 110.85 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.14 126.72 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.89 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 118.77 6.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 71.1 110.907 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -130.24 155.64 45.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 75.51 110.889 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 60.56 36.58 19.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.937 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.28 55.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 65.43 112.516 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.5 69.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 55.22 112.45 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 t -156.18 104.26 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 63.52 110.873 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.1 t . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 64.44 110.871 -179.957 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.775 0.321 . . . . 63.25 111.14 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.27 163.84 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 32.31 111.09 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 142.99 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 53.54 111.198 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -94.35 125.75 39.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 72.12 110.852 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.48 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 43.23 111.117 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 170.21 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 62.32 110.863 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 -59.12 0.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.093 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.48 135.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 61.41 110.923 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.43 127.53 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 71.35 110.867 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.46 83.34 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.175 -0.466 . . . . 73.44 110.95 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.87 -86.32 0.66 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.72 -0.752 . . . . 61.11 112.533 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -103.97 -17.45 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 63.14 111.122 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.38 153.66 24.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 74.3 112.464 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -140.56 143.9 35.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 73.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.3 127.26 9.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 64.31 112.447 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.82 132.21 10.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 54.41 112.453 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.91 103.71 7.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 51.13 110.87 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -92.11 141.27 28.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 45.55 110.973 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 m -118.55 127.45 53.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 65.21 111.082 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.91 131.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.13 111.16 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -144.16 119.08 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 62.53 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -111.94 133.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.86 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -172.7 129.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 61.22 111.08 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.53 -19.49 19.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 62.55 112.445 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.39 177.1 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.381 . . . . 73.51 111.118 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -67.98 174.83 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 61.2 111.191 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 t -51.37 118.93 3.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.825 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -176.14 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.917 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -142.66 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 63.34 110.927 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 67' ' ' VAL . 1.4 t -152.38 147.52 26.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 74.24 110.863 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -110.36 126.44 54.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.905 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -118.86 108.61 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 63.14 111.149 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.734 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.6 p -101.46 109.56 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 74.31 111.116 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.22 136.92 47.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.875 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.01 172.19 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.42 110.992 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.93 130.42 44.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 75.44 110.855 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.51 80.1 2.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 71.52 110.829 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -48.59 0.68 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.729 2.286 . . . . 71.22 112.328 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -74.65 144.73 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 53.45 111.118 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.87 96.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.718 -0.753 . . . . 64.31 112.416 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 ' CE1' ' A' ' 41' ' ' PHE . 99.5 m -156.81 137.84 13.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 75.12 111.119 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -151.95 131.2 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 64.03 110.865 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.694 HG22 ' CE2' ' A' ' 83' ' ' PHE . 91.4 t -72.37 102.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.158 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -62.89 -46.78 86.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.104 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.64 147.77 34.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 61.24 110.885 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.17 144.31 40.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.062 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -129.41 142.59 50.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.91 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.42 13.04 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.816 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.2 92.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 41.0 111.08 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -55.39 99.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.55 111.086 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.981 HG22 ' HB2' ' A' ' 64' ' ' ALA . 63.9 t -94.47 112.6 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 73.32 111.118 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -102.59 175.43 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 64.13 111.16 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.33 157.34 45.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 53.14 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -159.25 85.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.883 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.69 -92.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 35.53 112.42 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.95 9.89 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 75.33 110.888 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -120.09 146.89 45.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.871 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -132.3 146.57 52.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.911 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -143.05 148.48 36.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.25 111.129 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.981 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.96 141.75 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 70.35 111.155 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 160.8 39.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 71.32 110.952 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -132.02 -52.43 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.842 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.762 HG22 ' H ' ' A' ' 71' ' ' GLY . 7.8 p -108.07 39.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.117 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.76 4.68 56.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 71.15 112.512 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -111.46 -25.68 9.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 74.42 110.82 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.651 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.11 -38.73 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.32 110.874 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.762 ' H ' HG22 ' A' ' 67' ' ' VAL . . . 48.32 56.87 8.71 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.792 -0.718 . . . . 64.42 112.495 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -135.07 94.85 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 74.44 111.198 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -134.3 160.96 36.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 71.35 110.939 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.703 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -85.2 162.76 47.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 55.04 111.051 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.76 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 64.23 112.352 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.88 115.59 0.94 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.727 . . . . 65.31 112.499 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.7 172.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 53.34 111.079 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 p -133.18 131.55 40.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.831 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.14 136.17 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.42 111.163 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -132.99 149.11 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.866 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 37' ' ' VAL . 25.6 p90 -139.43 156.47 46.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.1 110.873 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.84 175.47 18.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 54.3 112.467 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.694 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -173.41 -176.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 73.44 110.871 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -139.39 125.88 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 72.13 110.876 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.94 17.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 61.23 112.559 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.84 111.22 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.372 . . . . 71.15 110.838 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.56 26.54 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 62.13 112.456 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -40.27 5.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 72.2 112.337 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.59 27.56 21.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 73.03 112.526 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -112.07 76.07 1.72 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 73.4 110.859 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.41 57.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.643 2.229 . . . . 71.05 112.313 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.55 172.41 14.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.871 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 58.1 50.2 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 61.33 110.882 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.51 104.05 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 41.41 110.884 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.1 143.97 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.874 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.4 pp -160.32 146.61 15.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 72.21 110.938 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 96' ' ' LEU . 61.0 t30 60.83 55.33 3.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.852 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.1 39.81 36.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 51.3 112.418 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.44 62.91 5.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 73.22 112.493 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.3 107.74 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 71.42 110.935 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.979 -179.929 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.804 0.335 . . . . 65.31 111.11 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -143.63 163.85 32.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 54.23 111.14 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -152.15 132.52 13.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.175 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -73.66 146.06 44.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 72.15 110.901 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.46 170.99 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 65.25 111.093 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -120.96 134.64 55.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.962 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 -60.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 63.14 111.191 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.47 145.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 64.31 110.869 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.59 125.99 49.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 72.24 110.819 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -112.28 102.23 10.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.972 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.22 -92.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.756 -0.735 . . . . 50.2 112.513 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -118.24 -17.47 9.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 53.1 111.04 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.68 117.93 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.792 -0.718 . . . . 73.42 112.45 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -99.06 156.74 16.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 62.01 110.847 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.71 109.22 2.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.761 -0.733 . . . . 75.42 112.424 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.67 141.13 20.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.742 . . . . 44.34 112.457 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.12 98.75 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 62.22 110.849 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -90.17 123.75 34.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.955 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 m -96.06 119.98 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 64.34 111.026 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.66 131.64 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.086 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -139.44 118.15 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.41 110.899 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.49 119.21 38.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.35 110.836 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.4 t -172.18 143.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.22 111.166 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.45 -30.83 7.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.467 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -100.8 173.58 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.351 . . . . 75.23 111.109 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 p -62.05 -174.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 73.22 111.124 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -51.36 121.97 7.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 53.22 110.807 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 -175.7 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 62.24 110.918 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -143.55 -53.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 65.23 110.882 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.31 166.6 32.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.845 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -122.94 126.64 47.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.519 . . . . 74.34 110.934 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 m -120.78 100.86 7.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 71.51 111.14 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 64' ' ' ALA . 7.7 p -102.8 119.17 50.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 71.04 111.151 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.41 141.22 49.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.35 110.838 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.85 167.61 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 54.53 110.914 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.08 130.07 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 71.41 110.826 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.76 76.21 2.1 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 73.03 110.93 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -50.06 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.694 2.263 . . . . 72.32 112.343 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 64.34 111.143 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.31 97.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 74.41 112.486 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.64 155.74 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 75.14 111.12 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.74 130.59 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.862 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG22 ' CE2' ' A' ' 83' ' ' PHE . 89.6 t -79.92 99.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 72.21 111.189 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -62.99 -44.68 95.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 71.34 111.186 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m -143.64 159.97 41.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.892 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.04 144.73 25.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.23 111.062 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -128.44 146.36 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 71.55 110.887 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 14.94 9.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.831 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.44 120.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 64.22 111.057 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -78.65 108.15 11.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.53 111.109 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.73 147.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.133 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -139.68 141.42 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.151 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.46 153.36 24.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 53.01 110.951 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -157.07 85.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 50.23 110.808 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.7 -93.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 73.33 112.489 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -126.46 6.31 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 74.23 110.876 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -120.09 145.7 46.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.812 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -126.79 152.87 46.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 72.23 110.894 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -138.48 150.4 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 74.3 111.111 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.86 125.9 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.111 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 141.04 32.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 73.35 110.928 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -116.99 -52.07 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 62.14 110.908 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -100.82 39.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.128 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.29 -1.59 70.26 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.753 -0.737 . . . . 75.21 112.432 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.47 -30.96 6.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 71.34 110.93 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.549 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -101.55 -47.06 4.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 73.53 110.931 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.39 55.77 18.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.488 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -132.65 94.8 3.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 74.33 111.128 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -137.64 160.9 37.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 75.23 110.896 179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -82.39 162.5 56.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 63.15 111.164 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.84 -8.36 23.41 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.61 2.207 . . . . 71.01 112.359 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.89 115.72 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 65.32 112.501 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.96 172.14 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.375 . . . . 71.21 111.02 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -145.51 131.68 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 62.05 110.761 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.07 149.19 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 72.22 111.111 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 p -130.52 135.93 48.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.874 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.4 p90 -122.79 135.18 54.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 73.3 110.862 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.86 178.26 20.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 54.02 112.491 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CE2' HG22 ' A' ' 47' ' ' VAL . 24.7 p90 -174.26 -179.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 72.24 110.882 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.03 149.66 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 34.14 110.893 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.67 157.36 27.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 73.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 m -102.48 109.62 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 65.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -160.73 30.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 42.14 112.522 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -38.36 7.95 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.647 2.232 . . . . 75.24 112.359 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.2 26.68 27.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 62.15 112.515 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.78 75.27 1.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.1 110.854 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 160.69 48.75 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.59 2.193 . . . . 63.22 112.372 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 p -148.52 161.71 41.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 70.45 110.9 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 62.99 65.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 60.54 110.832 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.9 t -91.4 94.05 9.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 70.42 110.946 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 118.73 35.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 73.52 110.882 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -126.72 155.81 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.04 110.93 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 63.9 19.94 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 60.21 110.892 179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.88 4.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.467 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.7 71.28 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 62.03 112.484 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -156.25 104.17 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.02 110.851 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 72.53 110.905 -179.998 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 45.5 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.78 0.324 . . . . 65.13 111.141 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.64 163.82 34.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 54.41 111.132 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 m -153.5 147.7 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.161 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -80.61 144.27 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 75.1 110.898 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.18 165.16 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 73.13 111.135 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.09 136.24 50.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 40.13 110.924 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m -101.22 -68.3 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 74.42 111.125 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.85 138.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 50.53 110.909 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.24 126.24 51.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.919 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -111.92 105.74 14.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.948 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.44 -91.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.807 -0.711 . . . . 33.24 112.499 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -117.26 -17.49 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 71.54 111.223 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.76 146.87 20.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 63.4 112.424 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -128.85 145.73 51.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 70.11 110.851 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.17 109.69 3.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.752 . . . . 61.1 112.47 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.78 133.09 11.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.471 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -120.05 99.28 6.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 71.04 110.865 -179.697 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -90.24 129.73 36.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.41 110.916 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -105.99 128.16 53.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 55.14 111.077 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 79' ' ' VAL . 18.2 t -133.19 132.6 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 72.54 111.176 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -143.89 138.12 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 63.21 110.923 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.521 ' HB3' HD21 ' A' ' 32' ' ' LEU . 3.1 m-80 -119.44 131.24 55.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 70.33 110.855 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -159.0 161.0 36.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 72.51 111.155 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.37 -58.57 4.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 63.32 112.471 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 t -62.73 161.18 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 63.11 111.097 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 p -57.87 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 61.43 111.163 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -54.07 123.05 11.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 61.34 110.805 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 26' ' ' ASN . 4.2 mm? -64.73 151.97 43.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 65.12 110.95 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -116.51 -18.19 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.14 110.874 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.48 151.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 63.24 110.86 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.403 ' CE2' HG21 ' A' ' 79' ' ' VAL . 64.3 p-90 -132.37 127.64 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.98 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 65' ' ' LYS . 80.0 m -142.92 124.95 15.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 74.14 111.147 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' NE1' ' A' ' 39' ' ' TRP . 31.4 t -110.38 105.8 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.23 111.132 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.8 OUTLIER -117.17 150.98 37.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.871 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.474 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.43 166.54 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.941 -179.913 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.17 132.69 43.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 73.14 110.84 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.02 76.23 2.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.635 0.731 . . . . 65.42 110.859 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.251 . . . . 63.33 112.31 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 55.9 p -70.4 145.37 51.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 62.24 111.168 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.53 97.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.793 -0.718 . . . . 51.25 112.386 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.72 157.7 38.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.372 . . . . 61.03 111.134 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -173.59 130.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.1 110.934 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.705 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.2 t -84.17 104.14 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 51.22 111.17 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -47.39 83.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 62.11 111.185 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -141.51 164.43 30.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.926 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.87 140.71 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.05 111.13 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -127.57 143.6 51.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.957 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.31 14.86 9.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 64.15 110.892 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.62 100.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.151 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.9 m -60.43 95.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 55.24 111.112 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.9 t -87.29 134.26 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.114 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -124.28 170.09 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.04 111.156 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -131.33 154.2 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.93 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 t -159.42 85.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.845 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.82 -94.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.684 -0.77 . . . . 64.42 112.513 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.29 14.36 7.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 72.32 110.886 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -128.69 146.84 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 71.1 110.805 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -129.0 164.07 24.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 74.02 110.855 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 99.7 m -152.67 144.13 23.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.143 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -122.49 123.61 41.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 73.41 111.122 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.55 139.22 40.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.51 110.906 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.76 -37.74 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 65.33 110.916 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.98 42.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 71.31 111.115 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.56 2.0 69.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.703 -0.76 . . . . 72.01 112.492 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.86 -33.84 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 74.44 110.921 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.68 -71.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 71.01 110.952 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.71 -38.18 3.23 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 74.52 112.523 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -50.95 113.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 74.24 111.149 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -141.15 133.07 27.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.866 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.06 160.36 1.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.512 0.672 . . . . 72.33 111.155 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.7 Cg_endo -69.69 -15.93 37.58 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.672 2.248 . . . . 74.4 112.394 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.58 115.61 1.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.8 -0.715 . . . . 72.24 112.495 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.58 172.39 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.793 0.33 . . . . 62.13 111.073 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.62 131.24 52.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.801 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 24' ' ' VAL . 5.1 p -129.48 118.78 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 111.128 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.99 138.59 52.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.13 110.872 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 41.8 p90 -138.2 136.31 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 71.42 110.911 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.57 -178.62 19.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.502 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 47' ' ' VAL . 17.4 p90 -174.47 175.72 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 74.1 110.861 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.54 127.03 45.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 65.43 110.912 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.15 157.48 21.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 71.34 112.507 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -108.16 109.44 20.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 75.12 110.899 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.54 -158.74 29.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 64.32 112.502 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -35.22 12.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 73.35 112.327 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.97 26.78 28.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 40.03 112.448 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.22 76.49 1.89 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.588 0.709 . . . . 53.14 110.846 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 160.72 48.65 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.675 2.25 . . . . 71.33 112.299 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -148.53 174.21 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.41 110.891 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 51.88 64.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 64.2 110.921 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.8 t -86.51 130.3 34.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.894 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 144.0 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.14 110.946 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.67 156.73 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.89 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 67.28 40.51 2.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.04 110.895 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.09 42.13 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.677 -0.773 . . . . 63.03 112.543 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.31 71.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 50.15 112.493 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.6 138.03 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.341 . . . . 64.42 110.906 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.1 p . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 61.22 110.884 -179.934 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.788 0.328 . . . . 54.21 111.098 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -115.8 154.76 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 52.31 111.1 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 111.93 11.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 72.35 111.114 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -74.7 126.69 31.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 74.31 110.915 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.3 161.34 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.07 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.09 155.21 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.42 110.908 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.09 -57.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.101 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.38 130.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 74.35 110.825 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.91 127.51 55.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.843 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -110.5 82.05 1.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.901 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.74 -87.28 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 72.11 112.464 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 t -100.69 -17.55 16.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.73 0.3 . . . . 63.23 111.095 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.15 155.94 25.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.53 112.516 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.43 143.44 30.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 75.23 110.936 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 117.34 5.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 62.51 112.524 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 151.91 20.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.773 -0.727 . . . . 74.34 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.79 96.56 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 65.54 110.926 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -90.09 136.29 33.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 75.12 110.886 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -114.72 101.9 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 70.31 111.124 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 37' ' ' VAL . 17.0 t -88.88 131.72 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 75.04 111.119 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.75 128.19 36.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.15 110.868 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.43 132.24 54.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.21 110.899 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -172.07 121.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 70.41 111.138 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.74 -80.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 62.22 112.421 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.51 168.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.338 . . . . 64.44 111.228 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 p -60.54 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 74.55 111.144 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.92 121.73 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 72.13 110.827 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 75' ' ' PRO . 2.8 mm? -65.36 126.16 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 64.44 110.87 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.96 -23.99 28.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.876 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.0 170.13 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.825 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -136.04 136.71 40.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.906 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 64' ' ' ALA . 4.4 m -152.69 144.23 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 65.03 111.222 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 24' ' ' VAL . 21.4 t -129.91 105.83 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 72.33 111.147 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 63' ' ' THR . 9.4 pt-20 -117.9 134.24 55.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.911 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.472 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.08 173.32 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 72.03 110.849 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 130.35 44.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 75.14 110.906 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.45 73.92 2.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.647 0.737 . . . . 72.23 110.865 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.16 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 71.54 112.302 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.1 p -73.05 145.72 46.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 64.13 111.13 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 98.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.826 -0.702 . . . . 71.55 112.456 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -154.92 154.62 32.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 64.13 111.106 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 130.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 70.34 110.928 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.681 HG22 ' CE2' ' A' ' 83' ' ' PHE . 98.0 t -77.92 108.5 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 74.1 111.116 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -45.9 70.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 51.43 111.143 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -141.67 157.0 45.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 70.3 110.842 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.06 157.39 40.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 75.1 111.163 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -141.0 146.61 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.911 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.23 14.81 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.42 110.845 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 105.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 62.22 111.149 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -65.48 90.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 41.32 111.132 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 47' ' ' VAL . 60.0 t -80.9 118.42 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.122 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -110.9 175.14 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 61.15 111.085 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -134.21 160.15 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.86 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.17 85.88 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 54.3 110.866 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 -92.73 0.57 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 65.14 112.444 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -126.03 17.36 7.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 44.11 110.953 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -128.57 146.83 50.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.489 . . . . 73.2 110.809 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -132.13 150.08 52.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 38' ' ' GLU . 85.7 m -142.49 145.25 33.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.119 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -121.88 114.66 21.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.33 111.084 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 136.25 48.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.03 110.859 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.56 -51.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.95 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.66 40.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.12 111.152 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.22 -0.71 54.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 51.4 112.433 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 70' ' ' ASN . 3.5 p-90 -104.44 -27.83 11.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.778 0.323 . . . . 72.12 110.899 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 72' ' ' THR . 12.7 m-20 -132.89 -70.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.899 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.3 50.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 41.3 112.488 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.4 t -73.3 94.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 72.11 111.152 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -140.54 151.45 44.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.855 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -52.99 163.52 0.84 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.576 0.703 . . . . 55.43 111.115 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.14 22.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 72.14 112.327 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.22 115.75 1.81 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.524 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.48 172.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 63.3 111.083 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -137.22 131.71 32.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 71.12 110.919 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 t -143.42 110.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.33 111.068 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.0 p -103.99 135.0 46.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.905 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -118.39 126.44 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.4 110.82 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.81 173.59 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.495 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 47' ' ' VAL . 20.6 p90 -174.73 176.62 2.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.34 110.865 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.99 125.82 40.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.54 110.862 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -125.27 161.79 19.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.781 -0.723 . . . . 50.24 112.573 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 t -109.32 110.28 21.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 62.25 110.918 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.53 -158.7 28.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 74.12 112.435 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -36.08 11.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 60.51 112.382 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.83 27.08 30.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -112.36 77.02 2.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.728 0.775 . . . . 72.13 110.841 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 168.46 21.49 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.729 2.286 . . . . 63.43 112.335 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -148.43 169.17 20.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 42.33 110.84 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.07 48.92 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.818 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.2 m -65.46 96.53 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 61.23 110.897 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -121.2 121.29 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.937 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -124.74 155.71 38.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.21 110.957 179.876 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 63.33 27.22 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.866 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.06 42.05 7.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 43.23 112.493 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 70.1 1.12 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.701 -0.762 . . . . 63.13 112.469 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 131.59 9.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 40.34 110.85 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.884 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.86 0.362 . . . . 74.53 111.107 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.98 123.55 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 73.33 111.069 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -99.07 139.61 34.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 71.23 111.209 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.56 143.86 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.9 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.77 154.97 43.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 60.24 111.063 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.49 144.51 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.876 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 -59.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 63.04 111.171 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -179.99 149.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.1 110.896 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -117.73 126.46 52.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 71.33 110.898 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -111.74 86.71 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 73.45 110.916 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.94 -82.15 0.87 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 74.21 112.498 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -117.35 -17.56 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 72.11 111.136 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.17 166.63 38.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 23.21 112.472 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -148.59 157.54 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.22 110.876 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.59 130.62 9.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.797 -0.716 . . . . 73.54 112.537 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.91 145.89 17.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 43.12 112.473 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.22 95.46 3.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 72.22 110.841 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -89.81 125.58 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 71.51 110.921 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.3 m -110.9 101.85 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.04 111.159 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.1 t -94.12 131.22 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 71.32 111.099 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.2 117.89 11.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.889 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.61 125.51 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.21 110.91 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -164.91 139.18 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 75.03 111.158 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.44 9.81 54.63 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.683 -0.77 . . . . 71.35 112.445 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 t -130.98 174.53 9.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 73.33 111.206 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.39 165.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 75.21 111.142 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 p -69.07 99.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HB3' HD23 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -58.28 178.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 51.41 110.933 -179.996 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.56 -52.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.834 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -133.75 140.4 46.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 41.44 110.834 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -115.38 127.09 55.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 62.35 110.863 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 64' ' ' ALA . 8.1 m -134.09 116.94 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 74.21 111.098 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG12 ' NE1' ' A' ' 39' ' ' TRP . 17.3 t -103.88 105.5 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.31 111.142 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.741 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.2 pt-20 -120.38 136.86 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 70.13 110.861 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.468 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.38 170.26 16.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 73.42 110.823 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.45 129.83 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 55.25 110.85 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -113.1 76.41 2.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.678 0.752 . . . . 62.44 110.847 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -49.83 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 54.11 112.27 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.42 99.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 64.44 112.538 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -154.55 155.36 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 74.14 111.162 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -173.73 130.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 75.04 110.889 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 83' ' ' PHE . 98.0 t -85.44 97.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 74.14 111.098 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -44.15 94.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.139 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -136.8 161.25 36.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 53.13 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 162.08 41.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 55.42 111.12 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -148.63 142.59 25.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 75.13 110.962 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t0 64.39 14.55 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 72.43 110.883 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.097 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -62.72 97.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 53.22 111.134 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -87.13 128.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 45.4 111.093 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -117.2 168.8 9.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 72.04 111.171 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -130.43 153.24 48.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.879 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 m -159.43 85.66 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 61.32 110.849 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.34 -93.94 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 21.42 112.442 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.4 14.8 7.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 65.34 110.845 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -128.83 146.93 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.13 110.894 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -129.77 155.03 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.42 110.962 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.3 m -139.71 148.49 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 73.32 111.197 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.435 ' O ' HG23 ' A' ' 36' ' ' THR . . . -123.76 136.34 54.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 72.12 111.17 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.4 131.43 10.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.423 . . . . 74.53 110.828 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -114.31 -28.95 7.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 71.01 110.846 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 HD21 ' A' ' 70' ' ' ASN . 28.7 m -105.67 39.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 63.43 111.142 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.54 4.14 65.41 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.673 -0.775 . . . . 75.1 112.494 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.468 ' CE3' ' HB3' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -118.21 -32.94 4.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.782 0.325 . . . . 73.35 110.96 -179.965 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.468 ' HB3' ' CE3' ' A' ' 69' ' ' TRP . 6.1 p30 -105.48 -37.25 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 64.14 110.951 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.68 54.36 25.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.743 -0.741 . . . . 43.21 112.508 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -124.07 118.84 27.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 60.41 111.151 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 32' ' ' LEU . 22.6 tp -138.56 160.91 38.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 64.54 110.916 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -108.4 162.9 18.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.701 . . . . 60.01 111.064 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.8 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.637 2.225 . . . . 54.33 112.341 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -156.37 114.53 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.77 -0.729 . . . . 75.11 112.494 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 178.37 172.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 21.54 111.083 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -131.54 131.37 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.15 110.898 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.05 115.55 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.34 111.183 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.94 142.46 38.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 61.53 110.893 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HE2' HG21 ' A' ' 37' ' ' VAL . 48.1 p90 -136.27 133.8 37.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 74.03 110.909 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.32 -179.37 20.17 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 44.23 112.413 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 47' ' ' VAL . 31.7 p90 -171.84 176.77 3.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 75.02 110.842 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.62 125.68 36.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 75.31 110.931 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.78 161.92 26.67 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.678 -0.773 . . . . 61.33 112.491 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 p -105.61 125.47 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.37 . . . . 45.22 110.88 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.35 -163.3 30.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 72.32 112.484 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -36.16 11.53 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.697 2.265 . . . . 70.43 112.405 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.43 28.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 61.41 112.52 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -112.78 75.7 1.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.659 0.742 . . . . 72.12 110.834 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 157.0 61.88 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 71.03 112.321 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -145.88 177.09 9.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.889 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 m120 52.54 58.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.939 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.0 t -76.98 110.06 11.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.13 110.931 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -131.95 143.96 50.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.859 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 97' ' ' ASN . 2.1 pp -156.04 154.44 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.937 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.618 ' HB2' HD12 ' A' ' 96' ' ' LEU . 51.0 t30 63.31 47.33 4.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 75.35 110.874 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.35 18.51 73.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 70.41 112.517 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.96 69.74 1.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 61.13 112.513 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -156.05 104.7 2.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 73.43 110.846 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 75.14 110.913 -179.982 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.771 0.32 . . . . 63.21 111.164 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.86 31.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 64.24 111.064 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.03 147.52 47.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 63.43 111.175 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.43 142.4 31.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.43 110.937 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.52 152.01 40.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.116 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 147.93 25.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 52.05 110.932 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 -59.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.21 111.136 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.55 129.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 75.34 110.831 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.99 127.82 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 74.33 110.863 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.66 82.22 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.875 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.63 0.63 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 50.24 112.48 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -100.39 -17.68 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 61.34 111.113 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.9 152.81 22.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 62.22 112.431 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -141.95 142.51 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.002 0.43 . . . . 64.44 110.884 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.54 112.97 4.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 64.12 112.425 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.26 131.48 10.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.493 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 45.1 t -131.43 98.68 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 73.43 110.906 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -92.36 143.28 26.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.867 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 m -123.88 111.53 16.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 72.42 111.154 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 79' ' ' VAL . 15.7 t -109.57 132.58 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 54.23 111.12 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -137.68 130.28 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 70.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.497 ' HB2' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -107.68 144.91 34.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.881 179.979 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -172.67 162.23 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.11 111.13 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.05 -62.72 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 42.51 112.508 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 29.8 p -64.98 163.43 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 63.34 111.222 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -174.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 65.35 111.129 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -57.19 120.18 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 55.45 110.836 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 26' ' ' ASN . 1.2 mp -56.84 153.53 10.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.48 . . . . 42.33 110.87 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.14 -15.3 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.3 110.829 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.02 152.63 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.868 -179.746 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.46 ' HD1' HD13 ' A' ' 73' ' ' LEU . 59.4 p-90 -136.97 129.53 30.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 71.11 110.922 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -152.89 122.37 6.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 71.12 111.137 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.1 t -102.76 115.95 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 63.54 111.065 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.5 152.32 36.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 70.54 110.858 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.403 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -155.0 167.22 31.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 75.12 110.907 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.99 133.68 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 72.2 110.823 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -112.02 76.72 1.84 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.42 110.86 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -49.57 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.65 2.234 . . . . 74.13 112.335 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -73.38 144.74 46.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.124 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.19 96.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.15 112.466 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 43' ' ' THR . 6.5 m -156.66 155.95 32.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 72.04 111.116 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.26 131.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.853 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.6 t -75.06 99.79 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 61.33 111.133 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 t -67.53 -40.69 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 63.24 111.133 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -142.95 148.55 37.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 75.55 110.786 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.11 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 61.51 111.063 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -148.51 144.9 27.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 64.24 110.957 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 63.24 16.28 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 74.31 110.849 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.1 95.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 53.42 111.12 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -54.6 100.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 73.42 111.126 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.29 128.43 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.24 111.087 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -126.89 141.69 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 33.45 111.075 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -108.43 159.89 16.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.31 110.876 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 85.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.869 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.81 -90.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 54.11 112.521 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.22 7.51 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 75.41 110.822 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -119.15 146.89 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.41 110.852 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -128.06 160.09 33.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 65.52 110.86 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 t -148.77 149.48 31.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 73.21 111.103 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.86 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 35.21 111.103 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 142.84 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.889 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -120.26 -33.07 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.954 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.56 42.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 73.14 111.126 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.29 1.88 68.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 61.41 112.486 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.74 -34.09 4.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.822 0.344 . . . . 75.52 110.976 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.24 -70.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 73.22 110.897 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.06 -37.65 3.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 64.54 112.487 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 t -49.92 117.66 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 71.11 111.122 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 ' HD1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -144.1 143.31 31.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.972 179.928 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -62.45 160.51 33.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.565 0.698 . . . . 52.04 111.121 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -18.31 36.74 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.739 2.292 . . . . 73.3 112.326 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.99 115.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 54.11 112.472 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.8 172.41 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 41.21 111.087 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -120.78 131.02 54.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.879 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.8 m -136.2 109.43 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 65.51 111.119 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.6 p -113.74 164.36 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 62.25 110.886 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 53.5 p90 -154.93 132.52 11.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.882 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.45 173.28 18.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 65.45 112.472 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 47' ' ' VAL . 26.3 p90 -174.83 176.73 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 75.33 110.85 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -129.92 139.04 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 61.35 110.906 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.2 159.49 27.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 42.2 112.493 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.43 112.08 24.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 63.12 110.888 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.5 -157.81 27.62 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.669 -0.777 . . . . 75.43 112.443 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -42.31 3.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 71.42 112.382 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.94 30.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 62.05 112.458 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.6 t -112.79 75.29 1.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.675 0.75 . . . . 52.31 110.842 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 159.02 54.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 51.34 112.343 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 m -142.72 165.92 26.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 52.21 110.938 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 m120 58.67 63.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 62.33 110.893 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.2 t -79.51 92.23 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.858 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 118.72 37.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 71.21 110.922 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.6 pp -130.27 155.76 45.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.925 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.603 ' HB2' HD12 ' A' ' 96' ' ' LEU . 42.4 t30 62.41 20.79 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 45.05 110.903 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.58 24.83 10.52 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.715 -0.755 . . . . 70.12 112.495 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.52 71.37 1.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.35 112.486 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 t -156.31 103.94 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 65.23 110.923 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.7 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 55.1 110.842 -179.904 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.819 0.343 . . . . 65.11 111.163 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -139.55 149.51 43.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 44.24 111.126 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 119.25 16.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.155 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -69.5 146.25 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.871 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.25 154.87 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 41.22 111.081 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.33 156.05 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 52.3 110.931 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -58.94 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 64.53 111.119 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 129.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 74.25 110.865 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -115.83 127.98 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 51.12 110.9 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.59 82.94 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.48 -85.12 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.741 . . . . 63.32 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -103.29 -17.57 15.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 64.21 111.123 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 156.11 26.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.804 -0.712 . . . . 33.24 112.515 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.16 142.91 30.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.885 0.374 . . . . 74.33 110.864 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.57 122.12 7.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 54.15 112.506 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.7 150.02 20.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 61.43 112.562 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -147.05 94.59 2.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.38 . . . . 71.34 110.816 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.27 134.87 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.902 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 m -113.12 102.1 10.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.111 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.68 131.59 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 62.45 111.162 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.48 118.12 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.895 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -116.0 133.21 56.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 75.15 110.884 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -172.04 153.72 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.44 111.08 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.93 -18.14 54.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.821 -0.704 . . . . 74.3 112.454 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.5 171.18 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 75.13 111.117 -179.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -171.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.13 111.19 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.65 125.67 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 42.22 110.828 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.36 179.16 5.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 62.31 110.953 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -143.66 -52.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.84 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.91 174.42 14.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.923 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -140.25 127.35 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 54.24 110.907 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -113.74 102.14 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 70.11 111.116 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 81' ' ' PHE . 4.6 p -101.26 115.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 63.04 111.178 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.672 ' CG ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.92 151.45 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.3 110.865 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.12 169.68 18.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 74.32 110.937 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.19 128.11 44.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 63.14 110.898 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -112.59 77.15 2.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.633 0.73 . . . . 74.24 110.855 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.275 . . . . 75.44 112.264 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 26.5 m -71.93 145.35 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 71.14 111.163 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.36 98.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 70.21 112.433 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.75 153.49 31.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 71.24 111.163 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.75 130.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 74.3 110.882 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -79.53 96.59 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 65.34 111.154 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -63.57 -40.98 98.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 75.52 111.183 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 m -144.98 147.96 33.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.887 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.39 157.78 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 52.54 111.08 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -142.33 143.22 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 72.22 110.957 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.55 14.36 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 65.44 110.845 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.93 94.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.35 111.05 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -56.68 99.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.121 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 47' ' ' VAL . 96.6 t -90.27 121.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.13 111.095 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -111.56 172.05 7.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 74.14 111.142 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 155.26 48.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.01 110.927 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.85 85.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.821 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -93.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.675 -0.774 . . . . 75.23 112.443 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -126.25 10.25 7.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.4 110.795 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -124.3 147.02 48.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 75.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.77 159.86 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.959 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' CG ' ' A' ' 38' ' ' GLU . 15.5 m -147.8 148.82 31.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 73.01 111.133 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.88 135.18 48.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.13 111.071 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.88 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 61.34 110.889 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -131.47 -51.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.879 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.62 37.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 61.3 111.156 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.59 0.91 84.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 42.35 112.45 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -116.44 -24.27 7.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 72.34 110.889 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.636 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.17 -38.42 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 43.12 110.889 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.42 53.5 28.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.743 . . . . 75.41 112.487 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.3 t -130.18 94.95 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 74.34 111.212 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -138.61 160.72 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 63.21 110.897 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -85.12 161.31 52.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 71.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.9 Cg_endo -69.71 -8.45 23.63 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 74.54 112.351 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.21 115.54 0.75 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 74.04 112.484 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.53 172.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 62.24 111.11 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -134.19 131.62 38.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.849 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.88 116.98 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 52.3 111.164 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 p -108.41 125.95 52.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 72.12 110.872 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.9 p90 -111.55 137.31 49.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 74.5 110.818 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.64 174.5 17.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.31 112.458 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.9 p90 -174.32 179.07 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 71.23 110.878 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.5 140.86 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.856 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.65 159.9 28.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 72.45 112.48 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.1 m -105.37 113.72 27.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 74.23 110.87 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.52 31.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 71.4 112.501 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -37.35 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.655 2.237 . . . . 73.24 112.359 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.74 25.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 50.31 112.525 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -112.84 75.12 1.84 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.599 0.714 . . . . 73.51 110.834 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 156.71 62.74 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.652 2.234 . . . . 53.34 112.397 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 168.77 21.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 64.41 110.82 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 60.14 62.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 70.41 110.907 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t -84.9 95.55 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.812 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 125.52 48.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.904 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -135.3 155.61 50.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 73.53 110.988 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 63.08 25.76 15.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.88 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.58 28.66 13.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 73.14 112.458 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.35 74.79 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 52.44 112.476 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.18 104.35 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 64.32 110.862 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.88 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.916 0.389 . . . . 72.41 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 p 49.83 42.62 24.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 74.32 111.089 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.647 ' HA ' HG23 ' A' ' 29' ' ' THR . 3.8 p -174.62 -170.33 0.49 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 73.34 110.835 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.3 133.02 35.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 72.15 111.096 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.598 HG22 ' HB2' ' A' ' 102' ' ' ASP . 8.3 p -132.38 153.2 51.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 62.34 111.119 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.52 163.7 32.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 44.2 111.144 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.53 147.63 27.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 53.0 111.153 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -88.77 146.28 25.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.96 163.36 35.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 70.42 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.32 138.78 45.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 75.44 110.977 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.85 -60.97 1.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 61.34 111.165 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.27 131.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 75.43 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.94 127.3 53.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 75.04 110.908 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.25 88.17 2.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 71.02 110.983 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -93.22 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.726 -0.75 . . . . 73.24 112.453 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.39 -17.7 17.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 73.44 111.141 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.61 148.59 20.57 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.778 -0.725 . . . . 52.2 112.489 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -138.08 143.75 40.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 70.4 110.881 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.29 3.35 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 73.02 112.486 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.77 139.27 21.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.751 -0.738 . . . . 42.42 112.504 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.34 95.51 3.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 40.42 110.815 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.25 145.13 25.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.17 -0.468 . . . . 53.01 110.932 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.27 124.73 52.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 72.12 111.085 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.08 131.56 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.42 111.116 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.77 118.1 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 73.33 110.883 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.73 101.54 9.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.903 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.9 p -146.05 134.06 21.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 42.43 111.101 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.82 -57.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 62.54 112.547 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 3' ' ' SER . 0.7 OUTLIER -62.81 168.25 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.869 0.366 . . . . 73.32 111.12 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.0 p -63.17 -174.59 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.443 . . . . 70.13 111.125 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.53 125.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 64.44 110.857 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.65 -176.23 4.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 71.25 110.91 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.5 -52.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 45.23 110.821 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.79 157.54 38.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 55.34 110.873 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -114.46 126.84 55.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.888 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.47 100.79 6.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 62.02 111.142 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.0 p -101.39 120.83 51.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 51.24 111.094 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.38 156.09 43.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.879 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 170.16 21.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 73.35 110.907 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -98.14 130.78 44.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 54.32 110.927 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.428 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -111.94 78.53 2.32 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.633 0.73 . . . . 74.12 110.928 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -49.28 0.58 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.734 2.289 . . . . 51.44 112.335 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -73.12 144.46 46.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 73.21 111.161 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.92 97.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.758 . . . . 75.43 112.478 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.428 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.4 m -156.07 154.55 31.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 60.24 111.195 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.99 131.19 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 72.53 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.3 t -74.23 95.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.452 . . . . 64.21 111.12 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.6 m -63.19 -42.51 99.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 71.43 111.189 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.68 140.13 31.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 60.55 110.782 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.85 137.89 48.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 54.42 111.125 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.39 142.48 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.225 -0.443 . . . . 71.4 110.951 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.84 13.99 8.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.43 . . . . 73.32 110.87 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.73 120.35 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 64.03 111.131 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.2 99.98 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 62.04 111.136 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.703 HG11 HG21 ' A' ' 47' ' ' VAL . 42.5 t -89.29 119.5 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 44.44 111.116 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -106.82 171.13 7.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 64.01 111.156 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.85 156.37 46.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.421 . . . . 73.24 110.953 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.7 t -158.23 85.77 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 64.41 110.858 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.37 0.89 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 55.44 112.515 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 51.25 110.902 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -108.73 146.92 32.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 74.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -131.28 155.6 46.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.96 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.483 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.8 m -148.46 149.05 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 75.21 111.12 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.9 124.61 37.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 71.41 111.071 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.27 157.77 45.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.15 110.916 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.35 -51.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 63.32 110.898 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.45 40.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 74.04 111.099 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.13 0.86 72.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.468 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.336 . . . . 52.53 110.878 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.55 -45.06 3.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.321 -0.4 . . . . 72.04 110.868 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.663 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.49 55.25 20.68 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.772 -0.728 . . . . 60.22 112.432 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.17 94.66 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.815 0.341 . . . . 72.33 111.205 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.51 160.83 38.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 72.1 110.846 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.43 162.31 54.03 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 44.23 111.075 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.71 -8.48 23.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.708 2.272 . . . . 75.32 112.341 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.53 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 33.42 112.445 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 74.22 111.098 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.75 131.51 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 72.31 110.848 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.87 149.8 16.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 44.41 111.15 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.78 154.26 47.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 74.14 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.93 139.02 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 61.1 110.833 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.64 174.33 15.17 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 23.13 112.483 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.9 p90 -168.81 177.8 4.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.904 0.383 . . . . 74.4 110.855 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.01 125.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 75.2 110.885 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.96 154.2 20.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.714 -0.755 . . . . 65.35 112.485 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 t -95.89 109.53 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.897 0.379 . . . . 34.41 110.837 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.96 -160.28 30.64 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.79 -0.719 . . . . 53.34 112.481 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -41.73 4.12 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.712 2.274 . . . . 75.41 112.306 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.73 26.65 24.21 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 42.21 112.467 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 m -113.3 73.56 1.87 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.694 0.759 . . . . 44.24 110.891 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 163.31 38.75 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.659 2.239 . . . . 74.22 112.381 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -148.26 173.37 13.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.3 110.87 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.23 49.31 3.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 65.34 110.896 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.5 m -68.57 97.34 0.77 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 71.41 110.854 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 118.97 25.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 65.24 110.915 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.93 155.94 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.858 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.34 13.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.491 . . . . 44.35 110.807 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.15 42.15 8.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 43.33 112.479 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.7 70.02 1.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.742 . . . . 73.11 112.479 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.22 132.61 10.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.883 0.373 . . . . 62.25 110.866 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.25 123.29 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.887 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.598 ' HB2' HG22 ' A' ' 5' ' ' THR . 3.8 t70 -116.72 156.88 26.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 64.32 110.856 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 104' ' ' THR . . . 65.14 19.53 66.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.71 -0.757 . . . . 30.43 112.559 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -178.12 178.49 0.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.757 0.313 . . . . 73.13 111.175 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 64.32 110.84 -179.808 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.861 0.362 . . . . 70.55 111.16 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 p 49.88 42.56 24.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 64.24 111.179 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.646 ' HA ' HG23 ' A' ' 29' ' ' THR . 3.8 p -174.55 -170.34 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 50.41 110.88 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.36 133.1 35.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 60.13 111.055 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.599 HG22 ' HB2' ' A' ' 102' ' ' ASP . 8.4 p -132.45 153.17 51.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 73.3 111.202 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.45 163.8 31.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 64.33 111.081 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 m -150.67 147.63 27.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.128 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -88.76 146.22 25.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.1 110.905 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -145.86 163.45 35.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 61.14 111.164 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.42 138.86 45.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 73.35 110.874 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -101.95 -60.92 1.45 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 75.05 111.11 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -178.32 131.36 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.868 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.99 127.24 53.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.847 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -111.28 88.23 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.904 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.06 -93.16 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.733 . . . . 52.13 112.486 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -100.33 -17.74 17.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.784 0.326 . . . . 74.25 111.162 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.63 148.67 20.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 73.22 112.429 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.11 143.67 40.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 71.01 110.941 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.06 109.25 3.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.737 -0.744 . . . . 72.14 112.513 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.8 139.23 21.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.729 . . . . 60.53 112.438 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -136.36 95.57 3.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.87 0.366 . . . . 73.22 110.894 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.31 145.2 25.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.857 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 m -114.3 124.66 52.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 71.2 111.22 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.98 131.59 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.149 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -142.84 118.12 10.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 62.12 110.888 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.3 m120 -111.74 101.46 9.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 65.41 110.89 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.7 p -146.0 134.12 21.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 71.04 111.096 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.87 -57.26 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.672 -0.775 . . . . 63.11 112.488 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.646 HG23 ' HA ' ' A' ' 3' ' ' SER . 0.7 OUTLIER -62.87 168.22 4.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.834 0.349 . . . . 72.2 111.12 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -63.15 -174.66 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 71.1 111.204 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 p -51.52 125.58 14.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 60.22 110.842 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.428 HD22 ' CB ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -91.64 -176.24 4.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.063 -0.517 . . . . 54.04 110.884 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.49 -52.95 0.4 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.34 110.892 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 p -154.84 157.55 38.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 75.33 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.8 p-90 -114.45 126.94 55.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.51 . . . . 71.51 110.917 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -127.62 100.75 6.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.456 . . . . 44.23 111.195 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 37' ' ' VAL . 7.1 p -101.33 120.78 51.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 72.11 111.148 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 1.1 pm0 -128.37 156.1 43.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 72.21 110.886 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.97 170.2 21.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 72.54 110.901 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -98.13 130.88 44.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.851 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.43 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.8 m-85 -112.09 78.55 2.43 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 73.33 110.92 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.2 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.615 2.21 . . . . 72.53 112.36 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.8 p -73.15 144.34 46.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 73.51 111.136 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -39.78 97.7 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.725 -0.75 . . . . 42.22 112.508 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 HG21 ' CE1' ' A' ' 41' ' ' PHE . 15.1 m -156.13 154.55 31.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.833 0.349 . . . . 65.13 111.182 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.04 131.14 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 65.41 110.852 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.771 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.8 t -74.13 95.46 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 64.15 111.105 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -63.13 -42.65 99.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 60.35 111.138 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.8 m -142.6 140.03 31.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.864 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.84 137.97 48.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 44.22 111.091 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -122.41 142.48 50.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.3 110.907 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 64.82 14.04 8.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 73.41 110.866 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.76 120.33 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 51.24 111.111 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -77.21 100.0 5.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.186 -0.461 . . . . 63.13 111.146 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 47' ' ' VAL . 42.6 t -89.31 119.52 36.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 65.41 111.12 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.4 t -106.86 171.12 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 74.24 111.1 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -139.84 156.37 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.92 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -158.25 85.74 0.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.846 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.06 -90.39 0.89 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 62.12 112.539 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -0.14 7.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.902 0.382 . . . . 63.02 110.902 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -108.7 146.92 32.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 75.32 110.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -131.31 155.5 47.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.43 110.937 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.7 m -148.4 149.1 31.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 64.23 111.142 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.91 124.63 37.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 73.43 111.066 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.32 157.78 45.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 61.41 110.838 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -131.31 -51.85 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 72.22 110.965 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -101.44 40.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 73.52 111.138 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.14 0.86 72.06 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.743 -0.741 . . . . 73.24 112.486 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -112.69 -24.64 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 74.31 110.918 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.579 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -110.51 -45.05 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 61.05 110.929 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.662 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.44 55.27 20.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.705 -0.76 . . . . 63.14 112.485 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.579 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -133.23 94.7 3.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.787 0.327 . . . . 75.42 111.088 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -137.46 160.88 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 61.42 110.954 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -83.49 162.33 53.79 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.569 0.7 . . . . 71.44 111.107 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.74 -8.45 23.64 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.711 2.274 . . . . 44.22 112.354 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.52 115.67 1.19 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 72.2 112.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.41 172.09 1.21 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 74.34 111.098 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -147.73 131.46 16.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 31.24 110.858 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.0 t -145.88 149.8 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 72.24 111.105 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.73 154.25 47.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.03 110.912 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -141.97 139.0 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 75.2 110.866 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.52 174.27 15.15 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 71.34 112.55 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.771 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.7 p90 -168.73 177.82 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 70.24 110.893 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -131.02 125.72 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 62.3 110.871 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.94 154.18 20.66 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.672 -0.775 . . . . 41.3 112.45 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 t -95.84 109.53 21.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.888 0.375 . . . . 72.32 110.901 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.03 -160.23 30.62 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.75 -0.738 . . . . 54.54 112.522 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -41.55 4.06 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 63.03 112.36 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.72 26.73 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.762 -0.732 . . . . 72.34 112.442 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 m -113.42 73.61 1.98 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.742 0.782 . . . . 73.52 110.897 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 163.35 38.64 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.693 2.262 . . . . 31.33 112.381 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.0 p -148.39 173.33 13.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.43 . . . . 73.31 110.82 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 63.25 49.28 3.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.14 110.93 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 20.3 m -68.5 97.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.213 -0.449 . . . . 73.02 110.922 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.13 119.06 25.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 64.41 110.924 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.01 155.93 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 64.23 110.898 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 64.38 28.35 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 62.1 110.818 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.11 42.23 8.89 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.708 -0.758 . . . . 74.22 112.493 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.64 70.02 1.11 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 63.25 112.495 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.23 132.62 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 60.01 110.873 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.25 123.33 0.08 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.127 -0.488 . . . . 51.13 110.944 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.599 ' HB2' HG22 ' A' ' 5' ' ' THR . 3.8 t70 -116.82 156.89 26.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 73.22 110.819 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 104' ' ' THR . . . 65.23 19.45 66.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.711 -0.757 . . . . 75.05 112.447 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -178.02 178.61 0.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 55.1 111.171 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.236 -0.438 . . . . 63.52 110.842 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.883 0.373 . . . . 73.31 111.06 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -115.16 40.38 2.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 64.51 111.13 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.67 -170.26 3.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 64.21 110.893 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.53 136.59 33.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 64.54 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.44 HG21 ' HB3' ' A' ' 102' ' ' ASP . 6.6 p -146.06 159.96 42.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 75.23 111.092 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.71 163.83 33.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 72.23 111.09 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 m -139.91 137.38 34.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 52.4 111.093 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -76.76 139.03 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.43 110.856 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.14 150.75 41.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 71.13 111.123 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.67 142.11 27.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 74.52 110.848 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.51 -56.49 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.09 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.25 132.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 52.42 110.902 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.46 127.65 55.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.462 . . . . 64.33 110.793 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.42 84.87 2.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 75.43 110.903 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.08 -91.11 0.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.75 -0.738 . . . . 64.21 112.46 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.5 -17.6 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.347 . . . . 62.14 111.092 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.16 148.41 20.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 75.12 112.504 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -135.15 141.69 46.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.871 0.367 . . . . 74.42 110.832 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.84 108.83 3.6 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.701 -0.762 . . . . 75.11 112.453 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.54 130.51 10.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 64.34 112.496 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.85 99.46 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 71.25 110.899 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.29 117.93 29.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 70.12 110.893 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.5 m -95.52 110.09 22.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 53.21 111.164 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.4 t -106.71 131.89 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 74.32 111.161 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -143.4 127.97 18.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 73.24 110.888 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -114.25 133.44 55.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.873 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.47 151.67 2.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 74.15 111.172 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.55 -41.08 2.36 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.645 -0.788 . . . . 75.51 112.535 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.05 169.1 14.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.806 0.336 . . . . 74.33 111.163 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -172.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 65.43 111.083 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.3 p -51.43 129.71 25.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 55.12 110.867 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.24 -176.24 4.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 62.42 110.93 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.51 -52.94 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 75.05 110.904 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.77 176.23 12.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.837 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.492 ' CD1' HG21 ' A' ' 79' ' ' VAL . 29.2 p-90 -135.68 127.09 28.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 64.23 110.894 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -124.64 105.83 9.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 75.33 111.138 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 14.2 t -101.4 105.92 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 72.44 111.11 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HB3' HG23 ' A' ' 63' ' ' THR . 11.4 pm0 -116.76 153.07 33.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.84 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.82 169.61 21.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.911 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.08 129.94 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.841 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.76 75.38 1.88 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.612 0.72 . . . . 72.25 110.86 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -49.78 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.641 2.227 . . . . 64.23 112.407 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 p -71.07 144.56 50.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.202 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.9 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 72.15 112.475 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 m -156.57 154.71 30.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 72.4 111.13 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.67 131.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 74.33 110.913 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.733 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.6 t -75.18 101.41 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 45.35 111.063 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -45.69 91.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 72.24 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.12 148.5 33.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 73.15 110.846 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.62 137.08 39.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.34 111.093 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -119.51 148.17 43.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.903 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.52 14.53 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 65.12 110.871 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 134.26 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 41.24 111.092 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -86.56 95.01 9.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.137 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 64' ' ' ALA . 98.2 t -86.34 138.33 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 71.13 111.07 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -128.31 171.03 12.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 74.41 111.168 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -136.07 157.39 46.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 63.23 110.84 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -159.79 85.74 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.094 -0.503 . . . . 74.14 110.877 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.98 -91.77 0.71 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.701 -0.761 . . . . 44.34 112.522 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.21 8.23 7.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.858 0.361 . . . . 73.14 110.916 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.6 t60 -119.23 146.68 45.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 72.42 110.873 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -130.88 157.53 42.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.894 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 38' ' ' GLU . 46.9 m -152.53 148.46 27.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 72.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -130.46 134.84 47.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 53.41 111.135 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HB3' HG23 ' A' ' 36' ' ' THR . 0.1 OUTLIER -145.36 160.84 40.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.41 110.923 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -131.95 -51.46 0.97 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 71.43 110.902 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -98.93 39.3 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 62.52 111.11 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.26 -0.73 72.31 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.772 -0.727 . . . . 53.23 112.535 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -113.53 -25.2 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.806 0.336 . . . . 71.23 110.947 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -108.04 -47.0 3.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.238 -0.437 . . . . 74.41 110.874 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.628 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.86 56.3 14.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.774 -0.726 . . . . 44.43 112.438 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.71 95.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.819 0.343 . . . . 41.53 111.093 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.9 tt -137.24 160.55 38.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.11 110.922 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.645 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -70.17 161.97 72.35 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.718 . . . . 54.3 111.151 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.77 -8.62 24.07 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.727 2.284 . . . . 74.35 112.29 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.9 119.0 1.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.788 -0.72 . . . . 44.53 112.498 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.41 172.03 1.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.863 0.363 . . . . 74.41 111.022 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -131.02 131.64 44.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.848 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.566 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.1 m -134.31 114.21 18.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.188 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 p -111.83 134.36 53.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 71.13 110.89 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -133.67 138.64 45.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 73.45 110.918 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.16 -179.77 19.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.761 -0.733 . . . . 72.32 112.469 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.733 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.1 p90 -174.45 174.02 2.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.885 0.374 . . . . 73.33 110.862 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -129.83 125.79 36.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 75.11 110.838 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.49 152.22 19.14 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 42.42 112.546 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.4 t -97.87 109.38 22.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 71.15 110.894 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.51 -156.52 27.51 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 72.55 112.457 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 -42.04 3.66 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.654 2.236 . . . . 74.2 112.314 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.11 26.49 31.02 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.702 -0.761 . . . . 32.15 112.55 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 m -113.09 74.74 1.91 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.678 0.752 . . . . 62.53 110.908 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 162.55 41.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.693 2.262 . . . . 73.3 112.375 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.1 p -148.34 171.29 16.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 73.31 110.836 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 60.01 58.47 2.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.511 . . . . 73.35 110.846 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.33 92.06 2.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 62.02 110.857 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.58 118.94 33.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.427 . . . . 72.41 110.9 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -128.71 155.78 44.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 75.23 110.944 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 64.12 22.69 12.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 72.21 110.828 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.34 41.85 5.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 75.11 112.474 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.65 71.54 1.31 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.764 -0.731 . . . . 53.52 112.485 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 67.1 m -156.23 104.15 2.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 63.32 110.885 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.8 t -149.56 137.56 20.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 64.12 110.857 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' HB3' HG21 ' A' ' 5' ' ' THR . 21.9 t0 -127.15 154.76 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 65.22 110.798 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.78 -30.03 7.91 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.738 -0.744 . . . . 73.14 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.44 -178.64 2.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 62.32 111.087 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 70.43 110.865 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.883 0.373 . . . . 63.42 111.095 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.5 t -139.39 33.74 2.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 65.51 111.122 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.5 -177.81 2.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 61.24 110.836 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.33 135.18 34.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 33.12 111.064 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.7 p -143.4 177.83 8.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 54.41 111.185 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -152.35 163.82 38.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 44.51 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -141.79 147.69 37.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 72.2 111.154 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -91.21 145.4 24.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.44 110.839 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.68 149.86 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 74.21 111.105 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.69 147.33 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 54.5 110.888 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.27 -61.92 1.59 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 72.15 111.114 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -179.39 146.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 73.15 110.893 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -117.86 126.85 53.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 73.25 110.906 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 p90 -111.14 86.79 2.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 74.23 110.973 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.66 -82.97 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 51.04 112.508 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 t -115.66 -17.52 11.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.789 0.328 . . . . 62.2 111.089 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.9 159.26 30.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 64.43 112.461 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HE2' HG23 ' A' ' 45' ' ' THR . 22.4 p90 -139.99 160.45 39.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.861 0.362 . . . . 61.3 110.886 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -118.47 121.89 5.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 53.42 112.432 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.29 146.49 18.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.737 -0.744 . . . . 55.3 112.513 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -138.98 94.57 2.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 63.34 110.825 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.2 136.46 33.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 73.52 110.915 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -111.68 123.85 51.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 43.12 111.207 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.36 131.69 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 54.42 111.202 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -144.64 118.06 9.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 70.21 110.934 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -105.85 119.8 40.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.284 -0.416 . . . . 60.32 110.914 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.9 t -158.07 159.89 36.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.13 111.147 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 -59.0 3.79 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 40.53 112.547 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -57.94 175.2 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.825 0.345 . . . . 61.54 111.173 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.93 175.04 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 71.34 111.165 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.7 p -52.58 131.66 34.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 41.34 110.857 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 33' ' ' SER . 0.9 OUTLIER -106.69 -169.89 1.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 63.32 110.961 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.483 ' N ' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -133.47 -52.49 0.88 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.823 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.94 154.42 40.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 75.41 110.86 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.9 p-90 -107.41 126.94 53.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.136 -0.484 . . . . 73.2 110.97 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.49 103.77 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.42 . . . . 73.54 111.12 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG12 ' NE1' ' A' ' 39' ' ' TRP . 18.0 t -101.55 105.75 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.438 . . . . 71.45 111.082 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -121.85 155.8 34.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 65.4 110.894 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.445 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -157.4 169.28 25.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.95 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -97.82 132.35 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 55.1 110.92 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.23 80.42 2.46 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.616 0.722 . . . . 73.1 110.807 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -48.76 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.69 2.26 . . . . 44.02 112.394 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -73.37 144.56 46.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 64.13 111.158 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.48 97.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.815 -0.707 . . . . 62.31 112.448 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.608 HG23 ' HE2' ' A' ' 18' ' ' PHE . 86.4 m -156.24 143.5 19.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.361 . . . . 74.32 111.151 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -155.55 130.91 9.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 70.4 110.921 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.75 HG22 ' CE2' ' A' ' 83' ' ' PHE . 57.5 t -77.94 92.5 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.13 111.099 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.9 m -77.08 -31.21 55.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.163 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -126.23 149.96 48.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 44.44 110.836 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.78 146.21 21.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 64.33 111.088 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -143.95 141.24 30.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.55 110.926 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.82 15.56 9.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.14 110.893 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.54 120.72 0.41 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 73.41 111.161 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.5 m -80.15 109.8 14.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 72.44 111.094 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 47' ' ' VAL . 15.7 t -93.65 138.63 19.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.14 111.101 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.0 m -128.13 142.27 51.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 73.34 111.228 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.69 157.08 18.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 73.21 110.875 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -160.6 85.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 62.13 110.816 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.44 -90.83 0.46 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 74.35 112.497 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.31 6.3 7.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.821 0.343 . . . . 65.24 110.87 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -119.85 146.79 45.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.852 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -129.19 164.21 23.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 75.21 110.966 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 t -151.32 149.37 29.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 75.44 111.168 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.29 114.98 17.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 62.03 111.133 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 154.75 47.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 72.03 110.884 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -131.32 -51.39 1.01 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.878 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -97.05 39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 75.24 111.146 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.23 -1.2 68.52 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.737 -0.744 . . . . 35.04 112.454 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.8 p-90 -112.08 -30.45 7.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 73.45 110.919 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.562 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -102.49 -46.06 4.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 72.33 110.861 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.98 55.84 16.76 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.696 -0.764 . . . . 75.3 112.492 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -135.19 94.6 3.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.834 0.349 . . . . 63.41 111.194 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -135.37 161.17 36.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.12 110.939 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -92.3 163.45 26.78 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.534 0.683 . . . . 55.42 111.109 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -7.92 22.28 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.632 2.222 . . . . 64.33 112.352 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -136.81 115.17 1.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 72.3 112.492 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.75 172.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.789 0.328 . . . . 75.02 111.12 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.89 131.58 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 74.43 110.819 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 66.8 t -149.41 137.39 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.066 -0.515 . . . . 54.22 111.149 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -124.22 136.59 54.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 72.41 110.828 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 28.4 p90 -125.25 135.81 52.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.093 -0.503 . . . . 52.34 110.865 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.89 171.13 13.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 72.2 112.394 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.75 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.9 p90 -162.42 179.59 7.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 72.22 110.951 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -136.67 131.07 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 54.43 110.872 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.79 153.84 23.41 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.773 -0.727 . . . . 61.42 112.517 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.6 t -91.28 116.78 29.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.959 0.409 . . . . 71.24 110.881 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -161.58 29.82 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.721 -0.752 . . . . 45.15 112.485 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -45.51 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.717 2.278 . . . . 73.14 112.342 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.41 27.55 9.81 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 63.35 112.448 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 t -112.37 75.13 1.64 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.57 0.7 . . . . 73.03 110.867 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 165.29 31.43 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.705 2.27 . . . . 75.1 112.379 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -148.59 -177.42 5.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 55.45 110.834 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m120 51.85 60.98 3.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.901 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -76.66 105.88 7.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.91 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.9 144.16 41.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 60.33 110.954 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.0 pp -153.12 156.15 38.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.893 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 t30 65.94 43.73 2.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 54.42 110.918 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.8 42.13 61.82 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.706 -0.759 . . . . 74.52 112.525 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 70.89 1.33 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.749 -0.738 . . . . 63.52 112.492 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 m -156.43 104.35 2.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.932 0.396 . . . . 55.35 110.841 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -146.59 121.86 10.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 70.41 110.889 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.6 132.03 54.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.892 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.01 30.96 56.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.791 -0.719 . . . . 50.13 112.493 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.39 168.31 26.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 72.01 111.183 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 74.04 110.918 -179.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.861 0.362 . . . . 71.44 111.125 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.462 HG22 ' HA3' ' A' ' 28' ' ' GLY . 27.4 p -96.5 95.34 7.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 73.21 111.125 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.65 -178.99 0.94 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 70.33 110.859 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.57 132.76 36.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 50.34 111.108 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.638 HG23 ' H ' ' A' ' 102' ' ' ASP . 96.7 m -149.96 144.62 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 71.14 111.18 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.85 29.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 53.42 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -137.46 132.89 34.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 74.53 111.185 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.09 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 63.5 110.889 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.91 154.0 48.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 72.25 111.135 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -99.2 145.58 27.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 61.42 110.893 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -105.85 -58.64 1.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 65.35 111.122 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -179.42 131.11 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 72.02 110.87 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.59 127.29 53.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 73.44 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -111.31 88.99 2.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.902 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.2 -92.96 0.76 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.777 -0.725 . . . . 62.44 112.462 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 t -101.51 -17.76 16.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 64.2 111.181 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.36 148.62 20.76 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 63.12 112.495 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -136.87 145.1 43.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.878 0.37 . . . . 73.32 110.887 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.52 112.53 4.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 64.21 112.491 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.77 145.44 24.86 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 62.22 112.524 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.92 98.7 3.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 65.4 110.826 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -92.79 124.46 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 71.4 110.907 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 78.9 m -105.27 101.81 11.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 62.53 111.174 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 79' ' ' VAL . 32.5 t -99.37 131.98 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 75.33 111.075 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -139.81 118.19 12.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.868 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -114.86 101.46 9.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 62.21 110.866 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -131.15 136.22 48.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.15 111.193 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 2' ' ' THR . . . 93.36 -35.53 4.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.679 -0.772 . . . . 52.31 112.492 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.73 177.33 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.793 0.33 . . . . 63.45 111.209 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.34 173.41 12.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 72.55 111.149 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.76 108.28 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 45.42 110.886 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.09 -177.66 6.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 75.13 110.957 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.7 p -141.71 -53.44 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.259 -0.428 . . . . 64.45 110.822 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.53 152.63 44.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.889 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.7 p-90 -115.3 126.78 54.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.486 . . . . 62.41 110.931 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -135.9 118.13 15.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 62.24 111.155 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.4 p -114.91 125.46 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 65.32 111.176 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -134.39 153.71 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 51.43 110.825 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.55 169.45 22.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 64.21 110.88 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.88 132.45 43.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 54.23 110.834 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.9 m-85 -111.83 79.5 2.59 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.603 0.716 . . . . 71.22 110.859 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.711 2.274 . . . . 72.25 112.364 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' THR . 69.9 p -73.36 144.82 46.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 73.41 111.12 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -41.42 96.11 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.744 -0.741 . . . . 63.11 112.485 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' CE1' ' A' ' 41' ' ' PHE . 57.4 m -156.94 149.41 23.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 54.42 111.154 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.68 131.24 1.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.937 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 63.5 t -74.79 100.15 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 64.14 111.157 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.3 m -63.16 -46.02 89.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.124 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.9 m -141.44 142.12 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 60.25 110.897 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.46 147.69 51.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 72.24 111.08 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.5 p90 -131.58 143.99 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.925 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t0 64.8 14.07 8.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 73.53 110.935 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.41 ' HB3' ' CD1' ' A' ' 81' ' ' PHE . . . -172.96 106.49 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.068 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 95.0 m -64.95 91.31 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 73.0 111.141 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 64' ' ' ALA . 77.0 t -88.96 113.27 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 71.4 111.11 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.599 HG22 HG23 ' A' ' 63' ' ' THR . 11.4 t -107.19 179.08 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 72.3 111.181 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.21 159.97 40.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.921 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.5 m -158.6 85.21 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 63.11 110.924 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.17 -90.99 1.01 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.748 -0.739 . . . . 73.2 112.442 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -126.75 2.0 6.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.907 0.384 . . . . 61.11 110.937 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -111.56 146.88 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.12 110.88 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -130.29 152.9 49.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 75.43 110.903 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.599 HG23 HG22 ' A' ' 56' ' ' THR . 2.3 t -149.07 148.58 29.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 74.4 111.146 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.765 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -127.41 135.49 50.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 70.25 111.089 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.59 135.21 15.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.872 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -111.77 -32.09 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 74.11 110.907 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 m -93.32 40.43 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 71.33 111.152 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.03 1.89 72.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.687 -0.768 . . . . 72.31 112.52 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -117.78 -34.05 4.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 63.34 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.493 ' HB3' HG22 ' A' ' 72' ' ' THR . 2.0 m-20 -102.0 -68.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.264 -0.426 . . . . 64.43 110.89 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.96 45.44 8.34 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.734 -0.746 . . . . 70.22 112.479 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.03 120.72 29.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.816 0.341 . . . . 54.41 111.166 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -146.25 161.43 40.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.256 -0.429 . . . . 74.43 110.97 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.683 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.02 164.0 17.28 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.611 0.72 . . . . 65.35 111.034 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.683 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.04 22.59 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.702 2.268 . . . . 65.12 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.63 114.29 0.75 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.749 -0.739 . . . . 71.12 112.484 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.99 172.47 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.711 0.291 . . . . 53.01 111.143 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 p -129.33 131.28 46.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 71.2 110.825 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.533 HG13 ' HB ' ' A' ' 24' ' ' VAL . 8.2 p -133.42 128.29 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.35 111.181 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 p -132.74 140.85 48.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 45.41 110.876 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 20.7 p90 -135.32 153.76 51.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 72.52 110.873 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.53 175.83 17.04 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.787 -0.721 . . . . 54.33 112.486 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 30.5 p90 -174.21 177.32 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.798 0.332 . . . . 74.52 110.907 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -130.64 125.77 34.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 73.55 110.879 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.51 151.62 18.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.748 . . . . 71.11 112.474 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.54 109.57 22.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 63.51 110.845 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.47 -157.22 27.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.706 -0.759 . . . . 72.42 112.426 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -42.49 3.33 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.591 2.194 . . . . 73.03 112.373 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.9 26.97 25.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.74 -0.743 . . . . 62.42 112.508 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -113.03 73.95 1.72 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.742 . . . . 71.15 110.828 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 156.02 64.24 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.669 2.246 . . . . 62.55 112.343 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 m -148.33 164.08 35.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.845 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 63.14 62.8 0.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 63.45 110.858 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.54 131.75 34.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 54.33 110.936 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 121.37 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 51.14 110.898 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.797 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.3 pp -136.48 155.88 49.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.4 110.935 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.797 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.6 t30 64.11 39.79 7.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.1 110.937 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.53 23.36 60.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 50.01 112.531 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.37 71.53 1.16 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 41.43 112.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.2 p -156.19 104.24 2.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 62.23 110.891 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 32.2 t -168.27 112.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 71.21 110.873 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.638 ' H ' HG23 ' A' ' 5' ' ' THR . 20.8 t70 -61.37 156.39 19.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 70.41 110.851 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 72.55 49.26 19.75 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.769 -0.729 . . . . 61.5 112.508 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.99 -172.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.13 111.169 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 50.01 110.885 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.801 0.334 . . . . 63.24 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.431 ' CG2' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -129.66 169.84 14.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 72.41 111.147 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.9 m -118.88 97.5 5.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.429 . . . . 72.24 110.887 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.06 132.79 14.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 54.4 111.116 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.7 p -122.18 170.79 9.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 63.44 111.08 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -159.37 163.77 35.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 54.51 111.095 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.41 141.93 26.49 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 64.0 111.128 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -84.73 145.53 27.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 71.21 110.884 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.77 164.1 33.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.5 . . . . 70.52 111.153 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.74 163.95 12.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.879 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.43 -61.85 1.24 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 73.21 111.121 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.22 135.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 51.34 110.905 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.92 127.14 53.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.172 -0.467 . . . . 53.21 110.93 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.14 92.91 4.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 73.23 110.926 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.24 -90.55 0.71 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.794 -0.717 . . . . 72.32 112.477 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.4 t -106.98 -17.56 14.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.789 0.328 . . . . 70.01 111.127 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.82 153.56 27.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 64.41 112.516 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -140.94 146.55 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.371 . . . . 63.4 110.928 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.22 127.93 9.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.774 -0.727 . . . . 70.35 112.543 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.49 145.95 16.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.707 -0.758 . . . . 73.11 112.507 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.76 100.09 4.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 54.4 110.845 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.29 139.91 30.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 72.24 110.921 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -114.73 119.54 37.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 45.14 111.139 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.96 131.78 62.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.43 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -138.29 127.5 24.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 73.11 110.831 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.716 ' HB3' HD13 ' A' ' 32' ' ' LEU . 70.1 m-80 -118.2 129.73 55.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 60.44 110.899 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -172.6 159.76 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 74.31 111.12 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.1 9.15 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.7 -0.762 . . . . 71.51 112.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.431 HG21 ' CG2' ' A' ' 2' ' ' THR . 0.1 OUTLIER -102.48 171.01 7.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 62.33 111.144 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -172.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 73.02 111.152 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -51.54 128.06 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 70.43 110.844 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.716 HD13 ' HB3' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -86.1 -175.94 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 61.03 110.895 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.99 -53.45 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.13 110.802 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 p -155.82 176.38 12.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 65.04 110.864 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -139.66 126.89 21.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 72.33 110.878 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -114.04 104.55 12.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 64.1 111.099 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.0 p -101.45 108.31 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 53.04 111.144 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -130.15 136.17 48.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.179 -0.464 . . . . 61.31 110.833 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.58 169.89 15.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 74.12 110.92 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.21 129.19 44.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 51.34 110.862 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -113.03 76.43 2.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.69 0.757 . . . . 73.2 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -49.67 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 64.11 112.394 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -72.03 145.19 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 75.41 111.132 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.39 98.71 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 35.12 112.471 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.9 p -154.56 155.07 34.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 64.41 111.115 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.55 130.81 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.864 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.657 HG22 ' CE2' ' A' ' 83' ' ' PHE . 92.7 t -82.02 109.08 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.12 111.114 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.83 -50.04 72.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 65.11 111.085 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -145.85 154.56 42.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 71.22 110.811 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.73 143.9 35.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.118 -0.492 . . . . 72.25 111.078 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -128.07 145.38 51.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 62.23 110.99 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.98 13.8 8.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.306 -0.406 . . . . 74.03 110.84 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.84 101.88 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 51.02 111.083 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.0 m -60.29 96.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 72.41 111.158 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 64' ' ' ALA . 97.2 t -92.54 112.6 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 75.35 111.046 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.508 HG22 HG23 ' A' ' 63' ' ' THR . 14.0 t -105.51 174.84 5.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 63.24 111.146 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -135.9 158.14 45.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.84 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 m -158.51 85.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 71.02 110.918 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.04 -91.59 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 74.52 112.472 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.57 4.92 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.828 0.347 . . . . 74.1 110.882 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -132.64 139.08 47.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 75.11 110.913 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 56' ' ' THR . 5.7 t -139.21 148.85 43.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.134 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -133.66 144.4 49.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 73.51 111.066 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 161.08 39.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 75.33 110.947 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -131.62 -51.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.24 110.896 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.1 39.14 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 64.32 111.117 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.6 1.17 83.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 64.44 112.491 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -115.13 -20.82 10.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.771 0.32 . . . . 71.34 110.871 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -115.33 -44.35 3.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 63.31 110.916 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.95 56.73 11.23 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 61.32 112.501 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 95.6 m -145.93 96.55 2.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.839 0.352 . . . . 64.43 111.13 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.0 tt -138.27 160.27 39.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.424 . . . . 72.14 111.021 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -66.74 161.52 60.09 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.613 0.721 . . . . 62.13 111.036 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.3 Cg_endo -69.7 -19.73 36.03 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 63.25 112.329 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.08 116.24 1.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.779 -0.724 . . . . 71.54 112.528 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -177.82 172.08 1.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.797 0.332 . . . . 74.42 111.108 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 86.7 p -136.24 131.63 34.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.876 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.08 117.13 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 74.55 111.106 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.9 m -110.4 134.8 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 61.11 110.868 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.645 ' CE2' HG11 ' A' ' 37' ' ' VAL . 27.8 p90 -122.74 146.44 47.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 52.15 110.918 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.02 173.32 14.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 73.41 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.7 p90 -171.18 -179.5 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.22 110.867 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -131.43 125.95 33.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 53.41 110.873 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.03 156.64 20.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 64.33 112.471 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.17 116.57 32.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 74.11 110.891 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.43 -159.35 28.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 52.44 112.486 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -33.74 16.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.744 2.296 . . . . 74.33 112.324 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.46 26.93 28.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 72.03 112.494 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -112.28 76.03 1.82 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.727 0.775 . . . . 74.41 110.898 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 157.94 58.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.596 2.197 . . . . 74.12 112.356 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 m -147.44 173.12 12.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 70.03 110.849 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.61 46.82 14.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 72.34 110.934 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.6 m -65.75 100.61 0.56 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.841 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -119.45 144.04 47.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.876 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.2 pp -160.19 145.84 15.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 64.54 110.92 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.68 ' HB2' HD12 ' A' ' 96' ' ' LEU . 6.4 t30 60.67 54.82 3.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 64.44 110.885 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.9 39.53 46.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 65.3 112.514 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.56 65.24 3.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 70.3 112.463 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.73 104.62 2.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 72.42 110.852 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.35 132.49 19.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 72.23 110.908 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.66 156.49 20.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 51.12 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.96 -25.86 25.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 52.45 112.535 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.2 10.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.815 0.341 . . . . 72.24 111.146 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 53.42 110.856 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.864 0.364 . . . . 54.13 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.9 p 49.89 40.3 20.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.469 . . . . 71.41 111.105 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.2 p -165.9 175.32 8.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 55.43 110.871 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.73 134.17 34.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 72.13 111.138 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 178.53 6.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 71.4 111.147 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -162.36 163.89 27.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.184 -0.462 . . . . 72.35 111.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 m -153.0 138.24 17.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.26 -0.427 . . . . 73.2 111.153 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -83.47 138.46 33.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.22 110.908 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.08 158.95 43.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 54.04 111.15 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -104.47 139.8 38.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 72.33 110.897 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -99.7 -62.43 1.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 72.04 111.16 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.82 143.2 0.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 75.45 110.865 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.15 125.9 51.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.118 -0.492 . . . . 75.02 110.851 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -112.2 107.04 15.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 73.11 110.989 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.44 -93.58 0.62 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.704 -0.76 . . . . 64.51 112.511 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -117.61 -17.52 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 74.04 111.164 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.68 140.88 16.87 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 53.25 112.537 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -117.76 149.61 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.829 0.347 . . . . 74.13 110.888 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.1 106.14 2.43 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.729 -0.748 . . . . 64.24 112.469 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.27 138.22 18.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.777 -0.725 . . . . 52.35 112.453 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.34 100.67 6.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 71.35 110.819 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -90.17 132.67 35.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 74.44 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.5 m -110.48 122.99 49.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 72.45 111.129 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.47 131.78 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 53.31 111.09 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.71 126.95 18.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.921 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -119.42 135.02 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 71.13 110.885 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 t -168.2 140.65 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 64.45 111.141 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.29 -61.88 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.733 -0.746 . . . . 60.01 112.513 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -60.2 165.83 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 72.14 111.162 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.5 p -59.92 -172.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 64.2 111.178 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.49 127.15 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 70.23 110.854 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.8 -176.29 4.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 62.13 110.941 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -140.91 -52.78 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 72.35 110.885 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.47 174.51 14.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 44.11 110.854 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 38.6 p-90 -132.2 126.99 34.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.103 -0.498 . . . . 74.21 110.932 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.31 105.69 12.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 64.11 111.113 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 81' ' ' PHE . 5.2 p -105.0 120.66 55.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 61.31 111.13 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' A' ' 63' ' ' THR . 6.3 pm0 -133.48 156.52 47.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 51.52 110.866 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.82 168.76 23.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 74.03 110.902 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.24 133.19 43.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 64.24 110.803 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -113.53 73.42 2.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 74.22 110.926 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -50.14 0.5 Allowed 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.66 2.24 . . . . 62.32 112.387 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -74.05 145.56 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 72.4 111.115 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -38.24 99.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 41.1 112.504 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -154.82 157.86 38.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 72.43 111.186 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -173.34 130.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.243 -0.435 . . . . 60.5 110.97 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.644 HG22 ' CE2' ' A' ' 83' ' ' PHE . 81.3 t -81.69 107.0 13.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 73.3 111.119 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -48.34 79.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 44.25 111.165 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.32 156.22 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.42 110.787 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 134.56 26.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 64.42 111.128 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 20.8 p90 -118.59 145.66 45.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 72.35 110.863 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.27 13.49 8.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 71.02 110.854 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.93 103.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 64.03 111.153 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.6 m -63.2 97.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 55.12 111.139 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 64' ' ' ALA . 84.0 t -89.1 131.09 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 65.21 111.125 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -119.7 172.53 7.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.34 111.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -134.03 155.98 49.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.422 . . . . 61.23 110.893 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.76 85.86 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 45.4 110.919 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.83 -93.7 0.75 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.23 112.52 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.26 17.09 7.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 73.31 110.823 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -129.56 146.71 51.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 73.21 110.869 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -130.67 160.46 34.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 75.42 110.894 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 38' ' ' GLU . 41.1 m -152.71 148.67 27.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.217 -0.447 . . . . 73.3 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.655 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.18 134.63 48.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 75.34 111.103 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 156.53 47.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 55.3 110.895 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -131.43 -51.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 63.1 110.884 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -101.9 39.15 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 73.13 111.11 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.98 -0.29 75.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.739 . . . . 33.04 112.496 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -114.2 -25.39 8.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.818 0.342 . . . . 64.12 110.92 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.537 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -108.58 -47.36 3.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.231 -0.441 . . . . 55.43 110.841 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.79 55.6 19.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 72.53 112.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -136.51 94.84 3.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 62.25 111.175 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.6 tt -137.13 160.77 38.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 62.5 110.93 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -76.64 162.28 71.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.579 0.704 . . . . 71.32 111.049 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.654 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.81 -8.37 23.44 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.633 2.222 . . . . 74.43 112.319 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.6 115.83 0.86 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.713 -0.756 . . . . 72.45 112.523 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.81 172.16 1.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.903 0.382 . . . . 71.4 111.046 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -131.63 131.62 43.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.795 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.05 141.49 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 73.15 111.162 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -132.91 164.31 27.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 75.55 110.806 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.558 ' CE2' HG11 ' A' ' 37' ' ' VAL . 29.3 p90 -156.33 143.15 18.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.06 -0.518 . . . . 73.41 110.886 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.41 172.29 14.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 73.41 112.497 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -170.0 178.91 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.876 0.369 . . . . 73.55 110.895 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -129.14 149.42 50.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 73.35 110.852 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -153.68 160.6 29.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.712 -0.756 . . . . 65.21 112.461 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.53 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 71.52 110.837 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.84 -159.9 29.01 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.783 -0.722 . . . . 23.14 112.488 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -37.24 9.66 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.724 2.283 . . . . 71.03 112.406 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.84 26.84 28.19 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 75.13 112.495 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -111.77 78.99 2.33 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.71 0.767 . . . . 74.44 110.785 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 168.14 22.43 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.687 2.258 . . . . 74.41 112.386 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.8 m -146.68 170.33 17.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 63.13 110.869 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 61.37 44.35 9.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 73.24 110.917 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.2 m -64.53 92.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 144.06 49.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 62.31 110.922 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.556 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.1 pp -158.76 155.86 28.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 73.31 110.909 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.556 ' HB2' HD12 ' A' ' 96' ' ' LEU . 6.8 t-20 64.67 46.66 3.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 71.24 110.914 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.84 41.88 54.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 65.33 112.493 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.05 67.05 1.8 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.67 -0.776 . . . . 72.55 112.517 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 66.3 m -156.35 108.87 2.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 43.14 110.761 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 6' ' ' ALA . 35.4 t -172.69 112.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 73.13 110.839 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 166.69 23.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 74.32 110.893 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 67.05 25.18 73.35 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.684 -0.77 . . . . 72.22 112.466 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.62 175.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 51.31 111.092 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.5 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.212 -0.449 . . . . 71.41 110.882 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.347 . . . . 64.31 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.6 p -137.89 32.51 2.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 42.55 111.139 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -176.88 -170.0 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 61.3 110.911 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.89 132.65 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 52.22 111.073 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -149.82 169.38 21.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 64.01 111.184 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.94 161.55 41.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 75.44 111.114 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -138.83 132.41 30.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 74.31 111.124 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -78.02 146.15 35.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.925 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.23 150.73 29.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 64.33 111.044 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -92.33 141.81 28.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 71.01 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -102.83 -62.87 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 64.41 111.165 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -174.14 127.6 0.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 74.05 110.864 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -115.64 127.71 55.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 74.51 110.897 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -110.59 83.1 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.962 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.8 -87.02 0.65 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 64.33 112.505 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -102.31 -17.58 15.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 72.44 111.13 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.3 153.68 23.66 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.489 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -140.61 145.19 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 73.51 110.903 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.54 113.84 4.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 72.31 112.479 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.21 136.67 19.14 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 45.34 112.479 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.72 94.45 3.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 71.25 110.882 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -99.47 136.63 39.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.158 -0.473 . . . . 73.43 110.964 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.9 m -113.87 105.19 12.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.12 111.134 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.37 131.72 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 75.44 111.061 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -136.48 121.29 18.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 74.03 110.868 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.47 119.75 37.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.248 -0.433 . . . . 73.52 110.889 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.701 HG23 ' HA2' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -166.93 157.91 12.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.117 -0.492 . . . . 72.22 111.138 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.25 -28.32 15.26 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 72.32 112.475 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.4 p -103.81 170.19 8.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.877 0.37 . . . . 75.45 111.169 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.0 -171.94 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 70.44 111.12 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 t -51.57 125.09 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 72.51 110.787 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.37 -176.31 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 65.43 110.902 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -142.88 -52.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 32.3 110.868 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.79 175.78 13.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 64.25 110.921 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -144.26 127.09 16.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.928 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.646 HG23 ' HG3' ' A' ' 65' ' ' LYS . 5.4 m -118.34 100.78 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 72.44 111.116 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.547 HG11 ' HE2' ' A' ' 81' ' ' PHE . 4.5 p -101.48 116.12 44.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.15 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.611 ' OE1' HG22 ' A' ' 36' ' ' THR . 7.5 pm0 -126.17 158.97 34.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.42 110.87 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.56 171.11 17.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 130.49 44.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 65.53 110.84 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.68 75.43 1.85 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.69 0.757 . . . . 70.14 110.896 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 -49.61 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.707 2.271 . . . . 65.41 112.33 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.8 p -73.92 144.47 45.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 72.55 111.11 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.66 98.36 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.478 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -156.1 153.25 29.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.814 0.34 . . . . 63.35 111.176 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -173.15 131.11 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.15 110.927 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 83' ' ' PHE . 85.4 t -79.64 96.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.44 111.088 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 t -63.26 -41.22 99.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 61.33 111.139 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -135.58 148.92 49.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 64.23 110.787 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.89 160.48 39.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.504 . . . . 71.3 111.085 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -147.55 142.07 26.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.877 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.36 20.28 8.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 73.54 110.86 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -171.97 107.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 53.51 111.1 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.5 m -68.34 95.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 73.25 111.216 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.6 140.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 64.42 111.17 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.9 m -129.96 141.67 50.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 60.23 111.192 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.93 156.58 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 64.24 110.909 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -161.7 85.98 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 64.11 110.884 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.86 -92.3 0.37 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 65.42 112.558 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -126.24 18.09 7.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 75.23 110.816 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -131.22 146.05 52.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.42 110.822 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -131.29 160.69 34.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.867 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -148.95 148.97 30.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 62.13 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -127.43 127.99 45.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 75.15 111.135 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.646 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.07 156.65 48.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 74.4 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.36 -49.28 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.977 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.71 38.28 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 55.44 111.146 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.79 1.38 83.85 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.752 -0.737 . . . . 32.24 112.461 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.76 -25.24 7.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.736 0.303 . . . . 74.42 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.19 -37.79 5.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.35 110.884 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.46 54.83 14.87 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 53.42 112.462 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.08 96.82 3.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 54.43 111.142 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.4 tt -138.78 160.35 39.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 64.53 110.928 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.99 160.86 81.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.541 0.686 . . . . 44.11 111.147 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.594 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.4 Cg_endo -69.78 -20.77 34.33 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.618 2.212 . . . . 74.23 112.343 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 27' ' ' THR . . . -135.9 116.68 1.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 75.05 112.47 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.43 172.05 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.786 0.326 . . . . 54.22 111.099 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 t -138.15 131.62 30.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.43 110.921 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 93.8 t -136.08 114.27 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.125 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -103.15 125.77 50.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 54.33 110.849 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.547 ' HE2' HG11 ' A' ' 37' ' ' VAL . 28.8 p90 -114.55 152.87 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 72.31 110.864 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.54 167.59 24.45 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.654 -0.784 . . . . 55.03 112.458 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.456 ' CE1' HG22 ' A' ' 47' ' ' VAL . 9.0 p90 -160.42 -176.27 5.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.361 . . . . 54.15 110.93 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -132.04 133.62 44.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 63.43 110.886 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.67 158.65 27.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.749 . . . . 74.12 112.499 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.19 117.82 35.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 75.11 110.918 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -161.65 29.89 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.78 -0.724 . . . . 73.45 112.542 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -39.9 5.95 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.697 2.265 . . . . 63.14 112.328 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.61 26.68 26.73 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.722 -0.751 . . . . 72.11 112.497 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -111.91 78.45 2.28 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.674 0.749 . . . . 62.12 110.86 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.64 165.8 29.61 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.693 2.262 . . . . 74.41 112.43 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.6 p -148.48 174.85 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 73.2 110.838 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 58.13 49.54 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 54.53 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 m -64.59 92.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 35.23 110.919 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.61 143.98 49.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 63.34 110.897 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -157.21 155.79 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.89 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.452 ' HB2' HD12 ' A' ' 96' ' ' LEU . 8.8 t-20 65.09 45.83 2.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.903 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.61 42.03 55.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.728 -0.749 . . . . 72.31 112.453 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.92 67.82 1.61 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.688 -0.767 . . . . 71.25 112.517 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.9 t -156.33 105.98 2.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 72.44 110.89 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.84 112.8 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.928 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 5' ' ' THR . 6.3 t0 -73.59 133.8 43.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.478 . . . . 72.41 110.883 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.12 40.1 11.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.749 . . . . 43.01 112.454 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.56 177.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 43.43 111.078 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 72.33 110.771 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.859 0.361 . . . . 74.23 111.036 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.582 ' CB ' HG23 ' A' ' 29' ' ' THR . 72.2 p -123.16 140.27 53.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 74.2 111.1 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.53 95.31 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 71.35 110.877 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 26' ' ' ASN . . . -144.73 132.97 21.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 72.33 111.124 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.6 p -150.01 165.74 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.425 . . . . 75.45 111.176 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.76 162.25 35.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.271 -0.422 . . . . 71.32 111.111 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.5 147.64 32.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 75.25 111.112 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -88.26 146.19 25.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.855 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -141.6 173.03 11.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.122 -0.49 . . . . 30.31 111.125 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.84 159.8 21.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 51.23 110.96 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.81 -58.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.409 . . . . 55.01 111.111 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -178.59 132.14 0.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.88 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -115.22 127.85 55.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.839 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -110.57 82.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.924 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.56 -86.74 0.62 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.736 -0.745 . . . . 72.13 112.464 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -101.35 -17.46 16.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 64.54 111.218 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.4 155.48 25.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.727 -0.749 . . . . 54.53 112.443 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -143.22 143.3 31.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 72.05 110.948 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.62 117.51 5.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 64.42 112.533 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.36 143.58 16.74 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 43.34 112.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.4 112.81 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.861 0.363 . . . . 64.22 110.873 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -97.33 134.42 40.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.987 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.0 m -116.3 108.41 16.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 74.45 111.166 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' A' ' 79' ' ' VAL . 20.3 t -107.14 131.96 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 64.52 111.145 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.63 118.41 12.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.933 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 4' ' ' ALA . 55.0 m-20 -118.59 101.37 8.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 64.13 110.88 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -121.49 155.66 34.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.107 -0.497 . . . . 74.44 111.19 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 52.05 28.27 24.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.772 -0.728 . . . . 74.35 112.448 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.582 HG23 ' CB ' ' A' ' 2' ' ' THR . 2.6 m -114.23 158.64 21.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 70.35 111.147 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.66 157.0 1.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 62.4 111.14 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.9 m -52.0 112.51 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.417 . . . . 71.24 110.874 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.433 ' HB2' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -91.11 174.62 7.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 74.32 110.956 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -137.42 -52.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.861 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.55 152.94 49.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 64.14 110.852 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 46.6 p-90 -119.29 127.17 52.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 63.35 110.934 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -125.28 108.12 11.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 75.53 111.115 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.2 p -102.39 111.29 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 41.01 111.067 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.674 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.0 pt-20 -131.92 138.69 48.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 64.24 110.883 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.2 171.53 14.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.885 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.5 129.26 45.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.233 -0.44 . . . . 50.05 110.875 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -113.31 75.67 2.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 64.34 110.822 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -49.74 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.687 2.258 . . . . 51.13 112.3 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.7 OUTLIER -71.36 145.05 49.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 53.43 111.153 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.26 100.07 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 73.44 112.515 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.9 p -154.61 155.81 35.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.847 0.356 . . . . 74.35 111.164 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -173.55 130.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 71.02 110.892 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG22 ' HE2' ' A' ' 83' ' ' PHE . 71.9 t -85.96 112.28 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 63.44 111.138 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 t -87.51 -32.71 19.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 63.14 111.143 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.05 149.55 50.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 63.2 110.857 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -162.27 133.23 5.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 74.34 111.116 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -133.06 147.96 52.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.937 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 62.77 16.42 9.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 74.42 110.868 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.04 95.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 51.33 111.148 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.5 m -56.17 99.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 53.45 111.1 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 53' ' ' ALA . 94.4 t -91.37 124.16 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 74.11 111.099 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -115.9 172.07 7.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.096 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -133.54 154.39 50.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.862 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.7 m -159.23 85.63 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.843 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.35 -93.33 0.79 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 70.24 112.546 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -126.51 15.0 7.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 72.11 110.825 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -126.83 146.86 50.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.838 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -131.54 150.6 52.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 64.01 111.002 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.674 HG23 ' HB3' ' A' ' 38' ' ' GLU . 71.5 m -140.0 147.76 40.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.288 -0.414 . . . . 71.11 111.207 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.827 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -124.59 127.29 47.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 74.11 111.117 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.96 126.26 18.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 61.03 110.89 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -106.34 -45.38 4.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 73.43 110.834 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.8 m -93.08 39.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 73.25 111.081 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.17 -0.61 66.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 41.14 112.504 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -115.42 -33.78 5.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.793 0.33 . . . . 70.45 110.893 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -99.94 -48.09 4.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 73.21 110.902 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.58 52.12 54.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 71.2 112.506 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 p -124.66 117.66 24.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.94 0.4 . . . . 71.35 111.112 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -141.75 160.92 39.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 65.12 110.856 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -103.51 163.61 17.09 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.509 0.671 . . . . 64.32 111.155 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.79 -7.89 22.22 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.746 2.297 . . . . 75.34 112.289 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -155.94 114.33 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.42 112.462 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.64 172.49 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 64.13 111.089 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.7 p -121.36 131.19 54.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.815 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' A' ' 24' ' ' VAL . 31.6 m -131.4 125.88 57.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 50.32 111.083 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 p -129.86 156.59 44.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.21 110.827 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.715 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.4 p90 -149.41 139.19 21.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 71.54 110.856 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.46 168.84 15.7 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.729 -0.748 . . . . 52.35 112.42 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.512 ' HE2' HG22 ' A' ' 47' ' ' VAL . 12.4 p90 -173.81 176.2 2.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 74.41 110.891 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -125.84 173.12 9.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 65.23 110.823 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -174.34 167.66 40.11 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.681 -0.771 . . . . 72.33 112.486 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.6 m -120.05 109.52 15.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.907 0.384 . . . . 51.32 110.844 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.02 -159.8 31.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.704 -0.76 . . . . 70.04 112.419 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -36.61 10.46 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.631 2.221 . . . . 70.25 112.368 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.32 26.67 29.99 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.752 . . . . 64.13 112.483 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 m -112.28 76.67 1.97 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.669 0.747 . . . . 74.43 110.879 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 159.26 54.1 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.702 2.268 . . . . 61.51 112.338 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.58 171.37 15.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.24 110.884 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 58.68 47.61 12.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 62.31 110.893 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.0 m -66.61 101.5 0.79 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.03 110.827 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.25 141.76 51.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 74.3 110.953 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.5 pp -158.25 148.11 19.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 63.23 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.569 ' HB2' HD12 ' A' ' 96' ' ' LEU . 31.0 m-20 58.47 56.11 4.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 72.23 110.929 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.37 41.5 30.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 51.11 112.511 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 60.55 58.09 15.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.794 -0.717 . . . . 74.33 112.459 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.36 105.66 5.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 72.52 110.884 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 37.4 t -154.72 140.57 18.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 71.53 110.883 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.6 157.31 37.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 63.35 110.795 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.87 -24.76 20.86 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.739 -0.743 . . . . 41.32 112.449 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.98 155.16 13.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 73.3 111.141 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 75.15 110.857 -179.853 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.95 0.405 . . . . 61.31 111.114 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.446 HG21 ' HG ' ' A' ' 32' ' ' LEU . 30.2 p -64.03 -176.96 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 74.1 111.144 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 m -112.29 96.64 6.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.441 . . . . 71.03 110.882 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' CD1' ' A' ' 96' ' ' LEU . . . -127.41 144.96 50.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.092 -0.504 . . . . 44.11 111.094 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.675 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -130.31 151.93 50.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 51.03 111.161 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.758 ' HB2' HD23 ' A' ' 96' ' ' LEU . . . -122.69 141.35 51.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 44.44 111.1 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 m -130.81 109.7 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 60.32 111.116 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.75 141.05 57.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 73.54 110.935 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.55 32.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 43.14 111.119 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.74 122.71 41.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 75.24 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.12 -58.47 2.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 62.42 111.169 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.52 138.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.41 110.877 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.58 127.06 54.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 72.31 110.892 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.66 85.96 2.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 75.35 110.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.55 -88.99 0.73 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 52.5 112.512 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.8 t -107.88 -17.59 14.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.871 0.367 . . . . 45.51 111.126 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.7 144.9 19.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.493 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.52 ' HE2' HG23 ' A' ' 45' ' ' THR . 24.1 p90 -128.77 139.75 52.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.958 0.409 . . . . 70.22 110.882 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.94 105.57 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 51.44 112.503 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.63 141.18 25.23 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 40.22 112.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.34 94.48 3.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 71.11 110.914 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -90.35 136.86 32.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.933 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -112.9 105.85 14.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 73.52 111.193 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG22 HG21 ' A' ' 37' ' ' VAL . 20.3 t -96.7 131.79 42.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 74.13 111.163 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.66 123.42 19.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 71.42 110.939 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.411 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.6 m120 -116.96 103.88 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 71.12 110.888 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.0 t -159.59 130.33 5.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 74.3 111.134 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.48 -28.99 3.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.775 -0.726 . . . . 72.15 112.451 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 p -108.63 177.37 4.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 71.41 111.101 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 p -60.01 -172.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 74.51 111.133 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -51.19 131.54 27.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 63.14 110.874 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HG ' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER -94.94 -176.52 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 64.11 110.945 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 -53.05 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 54.02 110.902 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.3 p -153.55 176.11 12.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 64.32 110.81 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.477 ' HE3' HG23 ' A' ' 37' ' ' VAL . 42.1 p-90 -139.04 127.12 22.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.111 -0.495 . . . . 74.25 110.941 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.3 m -113.49 105.07 12.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.22 111.161 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' HE3' ' A' ' 35' ' ' TRP . 24.0 t -101.1 105.75 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 75.1 111.075 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.59 152.61 44.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.868 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.438 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.77 170.74 19.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 65.11 110.92 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.97 131.38 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 74.14 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.6 m-85 -111.75 78.99 2.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.656 0.741 . . . . 50.45 110.889 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.96 0.61 Allowed 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.729 2.286 . . . . 74.23 112.401 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 72.0 p -72.72 144.47 47.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 61.44 111.174 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.56 96.92 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 64.22 112.548 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.52 HG23 ' HE2' ' A' ' 18' ' ' PHE . 99.5 m -156.49 142.69 18.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.865 0.364 . . . . 73.34 111.122 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -154.87 130.84 10.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 54.51 110.933 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.761 HG22 ' CE1' ' A' ' 83' ' ' PHE . 84.5 t -76.04 97.43 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 72.31 111.13 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 m -62.64 -43.97 97.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 62.44 111.178 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 143.74 30.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 53.32 110.832 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.57 139.87 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 70.02 111.054 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -123.65 143.56 50.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 73.31 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.44 12.97 8.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.848 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.03 104.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 64.34 111.079 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.3 m -63.32 97.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 63.21 111.179 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 47' ' ' VAL . 85.1 t -87.34 134.19 28.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 64.12 111.111 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.3 t -122.9 171.14 9.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.485 . . . . 71.23 111.178 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -131.79 153.67 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.44 110.899 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -158.62 85.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 54.2 110.842 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.23 -94.24 0.91 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.688 -0.768 . . . . 60.42 112.494 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -126.26 13.42 7.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.825 0.345 . . . . 75.23 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -128.03 146.88 50.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 44.22 110.879 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.4 m95 -128.57 159.16 36.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.426 . . . . 73.31 110.843 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 38' ' ' GLU . 19.0 m -145.95 149.16 33.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 64.44 111.114 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.4 129.78 45.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 74.43 111.157 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.73 155.94 49.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 71.23 110.912 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -131.48 -52.01 1.01 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 74.02 110.913 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.07 39.36 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.1 111.134 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.25 0.14 75.35 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.495 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -114.55 -26.5 7.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 74.1 110.878 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -107.31 -46.95 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.288 -0.415 . . . . 73.24 110.905 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.619 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.76 55.55 20.03 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 73.12 112.452 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.05 95.61 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 72.44 111.083 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.5 tt -135.98 160.68 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.914 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -72.19 162.12 75.34 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.684 . . . . 74.31 111.119 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.43 23.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.713 2.275 . . . . 64.12 112.332 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.75 116.16 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.77 -0.729 . . . . 71.34 112.511 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.25 172.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 62.35 111.081 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 p -145.86 131.7 19.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 41.31 110.845 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.01 118.18 20.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 60.13 111.074 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.02 121.84 42.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 71.33 110.866 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -113.24 135.27 54.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 71.32 110.891 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.15 -179.95 19.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 72.4 112.483 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.761 ' CE1' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.07 175.74 2.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.829 0.347 . . . . 70.21 110.907 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -131.15 125.82 34.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 71.15 110.849 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.45 151.02 19.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 55.35 112.451 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.6 112.17 23.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 42.44 110.842 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.85 -160.3 29.91 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.757 -0.735 . . . . 71.02 112.473 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -44.96 1.78 Allowed 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.67 2.247 . . . . 72.51 112.384 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.02 27.15 11.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 52.52 112.477 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.5 m -112.17 76.09 1.78 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.608 0.718 . . . . 54.33 110.848 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 166.7 26.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 71.43 112.323 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.1 m -148.53 179.86 7.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 71.04 110.867 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 51.87 62.44 2.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.45 110.851 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 16.1 m -79.13 102.99 8.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 51.41 110.878 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.91 140.43 42.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 63.54 110.897 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.758 HD23 ' HB2' ' A' ' 6' ' ' ALA . 4.4 pp -148.82 155.94 41.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 61.04 110.954 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 64.29 43.66 4.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 55.21 110.914 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.42 42.03 50.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 73.42 112.435 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.24 71.78 1.25 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.719 -0.753 . . . . 63.43 112.477 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.3 t -156.16 104.52 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 70.23 110.87 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 47.8 t -155.44 138.13 15.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 73.13 110.907 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.675 ' H ' HG22 ' A' ' 5' ' ' THR . 17.1 t70 -103.06 104.03 14.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.911 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.67 44.21 0.91 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 34.54 112.524 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.6 176.31 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.777 0.322 . . . . 64.24 111.144 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 63.12 110.859 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.859 0.361 . . . . 50.11 111.074 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.09 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 72.52 111.228 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.13 -174.15 4.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 55.51 110.894 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.87 141.62 28.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 73.31 111.135 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -133.23 176.13 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 62.41 111.141 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -161.52 163.77 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.083 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -153.03 147.66 26.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.55 111.194 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -85.97 146.34 26.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 63.21 110.845 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -142.41 175.94 9.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 64.35 111.1 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 166.74 12.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 53.42 110.867 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.89 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 75.1 111.145 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.72 134.47 0.13 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 64.34 110.847 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.01 127.54 55.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 74.14 110.79 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.8 p90 -110.51 82.67 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.96 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.57 -85.87 0.63 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 72.34 112.546 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.4 t -102.82 -17.46 15.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.846 0.355 . . . . 43.22 111.114 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.07 154.31 24.36 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.77 -0.729 . . . . 71.53 112.534 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -143.41 143.42 31.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 73.54 110.896 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.17 122.87 7.74 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 63.24 112.467 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 139.13 14.63 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.746 . . . . 20.14 112.544 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -134.38 110.4 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 73.15 110.847 -179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -94.4 135.27 36.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 65.13 110.919 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.5 m -109.95 129.52 55.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 54.05 111.074 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.47 131.79 70.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 61.24 111.12 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -141.7 118.25 10.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.972 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -104.52 143.65 32.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 61.32 110.9 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.48 155.65 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 71.32 111.109 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -58.93 5.02 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 61.42 112.444 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.54 159.12 3.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.86 0.362 . . . . 74.05 111.166 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 74.01 111.143 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.0 p -51.57 129.14 25.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.52 110.86 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.05 -176.61 3.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 73.45 110.909 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -141.01 -52.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 63.12 110.904 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 p -154.22 171.09 19.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 64.13 110.857 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 43.1 p-90 -130.63 127.01 38.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.927 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.4 m -116.25 104.98 12.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 64.04 111.216 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.638 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.3 p -101.4 112.9 35.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 72.54 111.085 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -133.61 141.09 47.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.915 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.72 169.96 16.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 71.32 110.899 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.49 128.03 44.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 64.11 110.846 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.69 77.08 2.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 74.42 110.927 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -49.63 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.685 2.257 . . . . 62.33 112.415 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -72.69 145.2 47.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 70.24 111.218 179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 98.41 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 52.32 112.468 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.7 p -154.58 153.51 31.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.828 0.347 . . . . 64.04 111.098 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -173.68 131.06 0.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.55 110.917 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 ' CE2' ' A' ' 83' ' ' PHE . 94.4 t -77.78 106.81 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 75.21 111.204 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -48.65 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 50.24 111.147 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.6 m -146.47 151.48 37.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 70.33 110.821 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.37 159.21 42.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 71.54 111.066 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.9 p90 -142.69 145.24 33.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 72.01 110.978 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 t70 64.88 13.92 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 73.35 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.95 95.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 55.25 111.137 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.5 m -59.03 97.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.16 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 64' ' ' ALA . 23.7 t -92.69 112.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 75.04 111.135 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.6 t -102.35 175.01 5.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 73.21 111.16 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -133.51 157.51 45.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 73.03 110.893 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 74.5 m -158.69 85.68 0.84 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 71.43 110.854 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.49 0.9 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 74.24 112.538 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -126.76 11.75 7.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.808 0.337 . . . . 74.24 110.835 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -120.45 147.0 45.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 64.33 110.848 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -132.98 142.66 48.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 72.22 110.93 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -141.14 147.12 37.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 72.53 111.131 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.853 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.35 140.77 51.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.153 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.53 159.0 43.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.242 -0.435 . . . . 74.43 110.939 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -131.45 -52.17 1.01 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.89 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -102.48 39.24 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.155 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.52 0.48 75.78 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.815 -0.707 . . . . 75.42 112.467 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.5 p-90 -114.5 -22.8 9.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.756 0.312 . . . . 70.41 110.881 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.3 m-20 -112.48 -47.18 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 72.52 110.897 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.62 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 52.01 55.04 23.08 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.668 -0.777 . . . . 71.24 112.542 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.554 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -137.04 95.1 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 65.42 111.123 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -136.18 160.73 37.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 61.43 110.868 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.59 162.21 64.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.63 0.728 . . . . 54.02 111.058 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.4 Cg_endo -69.67 -8.46 23.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.722 2.282 . . . . 50.41 112.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.06 115.55 0.89 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 62.42 112.479 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.33 172.3 1.21 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.782 0.325 . . . . 43.13 111.088 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 85.1 p -129.2 131.48 47.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 64.43 110.833 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.3 m -137.82 138.42 44.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 64.14 111.104 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 p -137.22 158.78 43.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.15 110.922 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.638 ' CE2' HG11 ' A' ' 37' ' ' VAL . 28.1 p90 -148.13 144.68 27.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.825 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.77 174.25 15.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.797 -0.716 . . . . 52.34 112.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 47' ' ' VAL . 23.3 p90 -174.48 175.09 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 70.34 110.837 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -125.54 134.59 51.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 74.15 110.919 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.0 158.28 23.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.704 -0.76 . . . . 74.01 112.468 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 p -109.84 115.68 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 73.03 110.87 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.48 -157.84 27.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.727 -0.749 . . . . 50.53 112.439 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -35.6 12.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.657 2.238 . . . . 74.11 112.387 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.97 31.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.729 . . . . 41.51 112.519 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 m -112.5 75.45 1.78 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 64.52 110.831 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 155.85 64.88 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.645 2.23 . . . . 73.04 112.356 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.31 177.12 9.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.41 110.881 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 58.57 41.07 22.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 51.31 110.877 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 18.2 p -64.45 122.79 17.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 61.32 110.873 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 134.78 21.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.123 -0.49 . . . . 55.4 110.92 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.0 OUTLIER -146.06 149.07 33.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 64.23 110.94 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' HD12 ' A' ' 96' ' ' LEU . 40.9 t30 63.05 47.69 4.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.92 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.23 17.76 73.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.729 -0.748 . . . . 61.32 112.465 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.14 70.67 1.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.68 -0.772 . . . . 74.4 112.497 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.09 104.32 2.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.823 0.344 . . . . 65.12 110.946 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.6 t -151.8 136.6 17.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.85 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.446 ' HB2' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -120.17 140.99 50.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.94 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.73 -19.6 23.39 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.779 -0.724 . . . . 50.3 112.508 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.29 172.14 14.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 62.13 111.122 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.3 p . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 71.54 110.874 -179.838 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.8 0.333 . . . . 71.41 111.139 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.76 106.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 71.35 111.094 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.03 95.62 1.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 65.4 110.859 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.78 137.0 26.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 64.14 111.104 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.613 HG22 ' HB2' ' A' ' 102' ' ' ASP . 21.2 p -131.65 156.31 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 74.53 111.094 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.5 163.85 34.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 73.13 111.105 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.99 147.7 30.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 63.43 111.138 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -88.01 146.29 25.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.887 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.44 159.18 42.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 52.13 111.138 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.55 156.64 17.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.918 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.65 -60.13 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 74.31 111.126 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.58 145.72 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.821 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.64 126.87 53.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 74.24 110.917 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.2 86.1 2.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 75.45 110.875 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.59 -85.86 0.74 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.749 -0.739 . . . . 74.3 112.438 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -111.76 -17.6 12.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.801 0.334 . . . . 53.14 111.126 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.76 151.03 22.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.739 . . . . 62.34 112.463 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -131.53 154.95 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 75.41 110.869 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.93 118.86 4.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.711 -0.757 . . . . 71.44 112.508 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.32 148.78 18.98 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.685 -0.769 . . . . 33.41 112.498 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.95 102.29 3.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 72.13 110.837 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -90.18 144.29 26.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.088 -0.505 . . . . 61.42 110.939 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.7 m -120.52 121.57 38.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 43.45 111.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -116.09 131.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 74.11 111.118 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 118.18 10.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 74.01 110.905 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -111.26 137.76 48.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 73.04 110.909 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.8 t -172.36 135.63 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 73.12 111.098 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.96 -56.73 0.46 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.781 -0.723 . . . . 71.24 112.531 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 t -63.88 172.26 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 65.23 111.098 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.4 p -66.45 -174.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.054 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.1 t -51.36 127.49 19.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 71.24 110.797 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.49 -176.52 4.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.028 -0.533 . . . . 75.4 110.933 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.63 -53.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 62.11 110.854 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.91 164.84 37.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.81 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -120.56 126.87 51.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.143 -0.48 . . . . 74.43 110.903 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.8 m -115.74 100.5 8.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 71.21 111.17 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.829 HG13 ' HB3' ' A' ' 64' ' ' ALA . 3.1 p -102.15 109.44 26.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 70.23 111.156 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.02 139.91 51.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 73.51 110.89 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.18 171.93 13.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 74.1 110.981 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -98.35 132.02 44.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 71.53 110.862 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.82 73.65 2.31 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.671 0.748 . . . . 72.33 110.898 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -50.23 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.614 2.21 . . . . 75.33 112.315 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 42.9 p -72.34 145.77 47.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 75.41 111.098 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.72 97.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.81 -0.71 . . . . 74.14 112.454 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 p -155.12 156.45 35.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.341 . . . . 72.04 111.078 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -173.58 131.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 73.42 110.916 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.66 HG22 ' CE2' ' A' ' 83' ' ' PHE . 80.4 t -80.08 103.12 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 52.42 111.18 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -75.38 -36.69 60.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.182 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.82 150.54 51.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.162 -0.472 . . . . 62.15 110.82 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.8 140.01 16.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 73.22 111.098 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -138.3 149.04 45.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 71.22 110.926 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.84 15.75 9.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 43.23 110.883 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.36 108.22 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 64.52 111.045 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.9 m -66.5 94.88 0.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 63.1 111.16 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.17 144.38 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 55.11 111.101 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.1 m -135.38 141.85 45.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.458 . . . . 62.55 111.209 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -108.89 155.24 21.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.313 -0.403 . . . . 73.44 110.927 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.18 85.72 0.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 43.12 110.878 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.37 -92.77 0.42 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.77 -0.728 . . . . 53.4 112.48 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -126.22 20.95 7.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.878 0.371 . . . . 72.1 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -134.15 146.45 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.841 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -133.34 150.55 51.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.9 t -138.04 149.38 45.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 74.12 111.207 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.829 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -126.25 125.39 42.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 75.1 111.094 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.87 134.16 32.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.938 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -111.0 -51.64 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.51 39.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 75.32 111.081 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.49 -0.82 74.13 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 61.24 112.506 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -113.59 -26.02 8.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 75.44 110.957 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 72' ' ' THR . 1.1 m-20 -107.23 -47.1 3.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.52 110.916 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.625 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.68 56.24 14.35 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.763 -0.732 . . . . 34.51 112.481 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 70' ' ' ASN . 70.6 p -136.94 95.04 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.339 . . . . 74.03 111.188 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.4 tt -137.16 160.87 37.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 31.14 110.966 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.655 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -78.92 162.53 64.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.536 0.684 . . . . 72.4 111.109 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.655 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.76 -8.59 24.0 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 53.24 112.351 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.87 115.75 0.88 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 54.43 112.454 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.49 172.13 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 73.34 111.123 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 p -131.15 131.57 44.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 62.53 110.931 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.7 137.42 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.42 111.076 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.69 154.76 46.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.473 . . . . 72.41 110.9 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 37' ' ' VAL . 24.1 p90 -145.31 142.21 29.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.898 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.36 176.32 17.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 75.03 112.501 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.66 ' CE2' HG22 ' A' ' 47' ' ' VAL . 21.5 p90 -174.34 179.12 1.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 75.12 110.872 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -133.8 144.53 49.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 74.45 110.884 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.92 160.38 28.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.799 -0.715 . . . . 63.44 112.531 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.96 109.63 21.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 61.32 110.87 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 155.6 -158.89 28.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 45.14 112.483 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 -35.72 11.81 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.705 2.27 . . . . 61.2 112.349 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.58 31.83 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.719 . . . . 72.55 112.523 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 m -112.63 76.91 2.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.661 0.743 . . . . 53.43 110.837 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 158.85 55.62 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.742 2.295 . . . . 73.01 112.35 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.08 174.76 10.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 64.04 110.879 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.4 m120 56.27 47.5 19.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 62.22 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.0 t -67.22 95.78 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.23 143.76 45.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 63.3 110.91 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.7 OUTLIER -156.99 147.76 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.436 . . . . 64.44 110.953 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.547 ' HB2' HD12 ' A' ' 96' ' ' LEU . 2.3 t-20 63.29 52.13 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 72.05 110.862 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.82 19.9 77.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.743 . . . . 41.4 112.458 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.13 68.26 1.33 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.697 -0.763 . . . . 51.13 112.468 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.3 t -156.0 105.07 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 73.02 110.871 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 t -146.42 141.76 27.48 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 65.54 110.877 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.613 ' HB2' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -123.88 148.2 47.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 70.34 110.905 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.07 20.22 59.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 71.13 112.512 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.73 -177.12 4.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.851 0.357 . . . . 75.13 111.15 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 73.12 110.851 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 72.14 111.126 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 t 179.3 116.96 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 73.1 111.175 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.8 m -139.16 95.23 2.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 73.4 110.885 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.855 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -129.08 132.68 47.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 73.41 111.112 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.724 HG22 ' HB2' ' A' ' 102' ' ' ASP . 19.4 p -109.58 127.2 54.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 74.11 111.187 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.542 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -117.31 112.56 20.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 64.21 111.118 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.84 118.7 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 64.31 111.165 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -72.16 143.75 48.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.923 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.14 161.36 38.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 73.15 111.125 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.17 151.11 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 64.42 110.893 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.22 -63.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 72.15 111.109 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 p -178.79 149.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.903 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.69 126.74 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 62.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.4 p90 -111.42 87.19 2.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.933 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.65 -81.8 0.85 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.746 -0.74 . . . . 74.22 112.484 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 t -117.04 -17.51 10.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 74.14 111.202 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.09 161.57 33.09 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 53.11 112.484 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -143.78 161.07 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.908 0.385 . . . . 72.34 110.843 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.3 133.38 9.54 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.778 -0.725 . . . . 34.33 112.527 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.2 154.45 17.64 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 63.35 112.529 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 t -141.8 95.74 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 73.34 110.854 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -90.24 124.83 35.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.902 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 84.4 m -110.26 101.68 10.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.31 111.181 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.9 131.52 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 63.45 111.172 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -135.7 118.05 15.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 53.52 110.806 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -104.21 127.52 51.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 54.04 110.947 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 27' ' ' THR . 4.9 t -172.71 120.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 53.52 111.165 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.73 -50.9 0.87 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.729 -0.748 . . . . 53.44 112.473 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 t -75.34 171.97 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.847 0.356 . . . . 72.51 111.143 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 54.0 p -64.4 178.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.33 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 91.0 p -51.95 107.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 54.34 110.841 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.686 HD22 HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -67.69 -173.59 0.35 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 75.22 110.879 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -143.56 -53.94 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.88 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.41 ' OG ' HG23 ' A' ' 67' ' ' VAL . 23.1 t -138.77 159.44 42.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 75.1 110.823 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -128.69 127.22 41.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.91 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.2 m -134.21 112.12 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 72.14 111.092 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.2 t -101.43 105.65 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.51 111.105 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.03 144.44 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.44 110.896 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -145.92 168.92 19.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 70.12 110.936 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.24 129.36 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 63.41 110.87 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.85 76.62 2.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.609 0.719 . . . . 74.34 110.868 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -49.91 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.697 2.265 . . . . 70.01 112.319 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 1.2 p -71.65 144.96 49.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 75.3 111.147 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.19 98.72 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.687 -0.768 . . . . 64.55 112.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.4 p -154.7 155.4 34.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 74.05 111.137 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.78 130.23 0.42 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.258 -0.428 . . . . 63.35 110.912 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 83' ' ' PHE . 97.0 t -80.58 91.76 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.51 111.126 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 t -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.151 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.34 154.1 50.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 71.53 110.883 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.37 146.17 25.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 51.42 111.096 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -135.99 143.52 44.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 74.31 110.922 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.06 15.25 9.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.858 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.5 109.47 0.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.54 111.081 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 79.1 m -69.49 103.26 2.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 72.11 111.089 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -88.52 137.37 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 63.3 111.091 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.8 m -129.25 141.38 51.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 62.12 111.162 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -104.77 156.92 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 53.43 110.907 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -160.47 85.55 0.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 55.52 110.942 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.49 -91.97 0.58 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 51.35 112.47 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -126.37 8.17 7.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 75.12 110.843 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -123.27 147.01 47.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 53.21 110.892 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -128.18 157.52 40.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.929 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -141.18 149.71 41.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 42.51 111.086 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.59 131.32 48.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.25 111.127 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.41 138.22 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 62.13 110.912 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -117.44 -25.12 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 55.42 110.885 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 ' OG ' ' A' ' 34' ' ' SER . 6.1 m -102.77 39.28 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 63.13 111.157 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.74 2.04 70.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 63.23 112.555 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -33.89 4.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.744 0.307 . . . . 74.24 110.97 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.577 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -101.5 -55.24 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.85 47.44 60.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 71.11 112.532 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.577 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.2 t -127.8 120.3 27.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.798 0.332 . . . . 72.12 111.115 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 HD22 ' A' ' 32' ' ' LEU . 26.6 tp -146.49 161.01 41.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.199 -0.455 . . . . 70.34 110.984 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.69 163.23 18.5 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.549 0.69 . . . . 71.21 111.106 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.78 -8.44 23.61 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.672 2.248 . . . . 74.34 112.318 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -147.72 114.52 0.7 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 43.33 112.517 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.93 172.35 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.838 0.352 . . . . 73.41 111.137 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.69 131.45 43.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 62.12 110.829 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.6 t -137.56 110.17 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 72.31 111.089 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.84 132.84 50.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.31 110.867 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -128.18 132.96 48.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 63.04 110.826 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.29 175.94 19.32 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.723 . . . . 73.11 112.521 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 47' ' ' VAL . 26.9 p90 -169.37 -175.31 2.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 71.31 110.858 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -139.0 138.31 37.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 63.41 110.893 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -146.79 163.96 28.54 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 63.42 112.507 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -105.81 110.33 22.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.973 0.416 . . . . 74.32 110.866 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.0 -163.68 36.59 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.817 -0.706 . . . . 71.23 112.537 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -34.2 15.2 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.725 2.284 . . . . 65.41 112.309 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.49 26.38 27.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.468 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -112.61 76.27 2.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.62 0.724 . . . . 75.13 110.861 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 159.93 51.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.628 2.219 . . . . 62.42 112.345 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 t -148.25 174.92 11.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.427 . . . . 72.51 110.908 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 58.87 54.51 5.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.44 110.926 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 40.5 t -69.94 108.36 3.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 72.33 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.35 143.89 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 74.34 110.893 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.855 HD11 ' HB3' ' A' ' 4' ' ' ALA . 1.4 pp -157.08 153.71 28.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.888 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.624 ' HB2' HD12 ' A' ' 96' ' ' LEU . 11.2 t-20 55.01 54.9 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 63.24 110.935 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.38 18.92 75.17 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.719 -0.753 . . . . 73.34 112.509 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.62 70.86 1.32 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.844 -0.693 . . . . 60.24 112.499 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.44 104.5 2.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 72.34 110.844 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.1 p -132.2 148.02 52.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 74.02 110.825 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.724 ' HB2' HG22 ' A' ' 5' ' ' THR . 0.3 OUTLIER -127.57 95.23 4.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.875 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.48 45.32 0.73 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 64.23 112.524 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -171.55 171.32 5.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 55.52 111.109 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 71.31 110.827 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.924 0.392 . . . . 65.13 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.1 t -136.07 141.56 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 53.52 111.153 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -160.96 95.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 75.11 110.843 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.93 139.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 74.44 111.111 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.548 HG21 ' CB ' ' A' ' 102' ' ' ASP . 1.1 m -150.13 155.62 40.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 55.23 111.153 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.39 115.52 21.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 64.44 111.084 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 131.56 34.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 70.41 111.155 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -76.23 139.87 41.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 61.03 110.886 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -140.32 166.61 24.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 70.34 111.145 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.91 163.78 12.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 64.52 110.981 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 -56.85 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.311 -0.404 . . . . 33.24 111.145 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 131.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.76 127.55 55.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 74.1 110.892 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 p90 -110.54 82.18 1.55 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.901 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.53 -86.77 0.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.73 -0.748 . . . . 61.32 112.494 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -101.36 -17.6 16.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 74.13 111.084 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.46 154.81 24.47 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.725 . . . . 54.21 112.457 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -143.11 143.85 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.847 0.356 . . . . 75.12 110.901 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.43 120.94 7.0 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.746 . . . . 64.34 112.45 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.83 145.24 17.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.72 -0.752 . . . . 42.01 112.465 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -140.84 94.7 2.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 60.32 110.9 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -90.28 122.95 33.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 71.41 110.937 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.65 101.53 10.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 72.32 111.124 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 37' ' ' VAL . 21.3 t -93.47 131.58 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 73.12 111.195 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -137.89 117.99 13.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.938 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -111.88 131.3 55.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 65.11 110.834 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.3 t -168.97 126.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.463 . . . . 74.33 111.198 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.65 -19.0 16.75 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.782 -0.723 . . . . 74.44 112.492 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.41 HG21 ' CD1' ' A' ' 32' ' ' LEU . 14.1 t -95.27 175.2 6.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 75.21 111.102 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -70.17 172.23 8.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 73.12 111.123 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.47 108.5 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 54.11 110.824 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.41 ' CD1' HG21 ' A' ' 29' ' ' THR . 0.2 OUTLIER -74.34 -174.0 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.903 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.0 -54.19 0.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.794 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.41 159.04 43.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 71.34 110.847 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.402 ' HD1' HD13 ' A' ' 73' ' ' LEU . 51.4 p-90 -128.65 127.1 41.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -122.61 110.64 15.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.33 111.205 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' NE1' ' A' ' 39' ' ' TRP . 22.4 t -103.9 105.47 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 63.55 111.176 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -126.35 154.9 42.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 65.33 110.888 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.422 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -153.2 169.32 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 75.52 110.962 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.14 128.33 44.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.414 . . . . 64.13 110.91 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.78 76.82 2.28 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.648 0.737 . . . . 72.55 110.946 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -49.78 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.684 2.256 . . . . 70.41 112.292 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.99 145.23 48.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 64.31 111.117 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 61.43 112.475 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -154.58 154.32 32.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.797 0.332 . . . . 74.55 111.15 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.71 130.72 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.261 -0.427 . . . . 70.11 110.88 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 83' ' ' PHE . 93.7 t -79.98 100.78 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 51.54 111.12 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.19 -45.86 89.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 64.03 111.136 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -144.77 147.43 32.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 64.14 110.946 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.62 161.83 36.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 64.01 111.04 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.47 145.33 31.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.931 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.34 14.65 8.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 60.25 110.85 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.98 103.6 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 74.53 111.12 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 m -61.67 94.54 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 73.11 111.148 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 64' ' ' ALA . 92.1 t -91.5 112.43 25.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 63.04 111.1 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.627 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.4 174.57 5.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 72.04 111.088 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -130.08 156.45 44.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 74.4 110.844 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.02 85.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 62.13 110.845 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.68 -92.48 0.8 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 55.31 112.513 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.2 12.66 7.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 73.05 110.871 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -124.24 147.01 48.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.817 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -131.45 146.33 52.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 65.31 110.904 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.627 HG23 HG22 ' A' ' 56' ' ' THR . 2.7 t -141.53 144.16 34.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 72.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.816 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -119.96 133.26 55.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 72.01 111.033 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.08 127.65 17.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 72.23 110.889 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -108.61 -32.05 7.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 65.11 110.91 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.1 m -103.72 39.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 74.5 111.083 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.14 2.51 69.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.825 -0.702 . . . . 75.23 112.456 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.24 -33.97 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.772 0.32 . . . . 74.23 110.979 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.56 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -102.44 -56.1 2.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 71.11 110.877 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.03 43.9 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.73 . . . . 74.42 112.49 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.4 t -125.66 121.45 33.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.336 . . . . 75.43 111.196 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -149.68 161.16 42.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.442 . . . . 72.43 110.897 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -100.14 163.6 18.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 72.01 111.118 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.666 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.2 22.98 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.677 2.251 . . . . 54.13 112.322 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -148.86 114.5 0.67 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 74.21 112.475 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 177.88 172.47 0.62 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.802 0.334 . . . . 55.1 111.11 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.1 p -128.63 131.3 48.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 52.03 110.872 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.9 t -137.4 111.8 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.23 111.137 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.5 p -110.46 141.56 43.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 54.12 110.892 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.421 ' HE1' HG21 ' A' ' 37' ' ' VAL . 51.9 p90 -132.58 129.2 38.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 63.14 110.887 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -103.59 174.48 22.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.749 -0.738 . . . . 62.44 112.492 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 47' ' ' VAL . 20.4 p90 -174.45 175.95 2.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.839 0.352 . . . . 73.55 110.935 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -124.55 126.75 46.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 72.23 110.872 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.64 151.86 19.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.739 . . . . 61.12 112.493 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.84 117.3 34.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.394 . . . . 70.43 110.901 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.44 -159.25 28.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.729 -0.748 . . . . 54.22 112.502 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -35.41 12.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.68 2.254 . . . . 72.24 112.34 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.85 26.89 30.57 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 41.3 112.46 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.73 75.15 1.8 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.636 0.731 . . . . 75.43 110.805 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 153.85 68.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.704 2.269 . . . . 72.3 112.335 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.59 -177.53 5.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 70.53 110.83 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 52.0 52.49 14.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 73.51 110.819 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 25.5 p -76.18 128.45 34.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 70.11 110.859 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.86 123.01 7.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.86 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 96' ' ' LEU . 4.2 pp -133.97 155.75 49.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.875 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.1 t30 63.71 38.65 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 45.14 110.855 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.61 30.1 53.81 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 73.14 112.499 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.25 75.52 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.801 -0.714 . . . . 73.14 112.508 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.3 104.25 2.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.38 . . . . 63.52 110.834 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.4 ' HA ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -160.71 -173.04 3.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 72.21 110.882 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.548 ' CB ' HG21 ' A' ' 5' ' ' THR . 51.4 t0 -127.37 131.66 50.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.88 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.11 50.47 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.702 -0.761 . . . . 72.45 112.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.4 m -52.07 103.22 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.82 0.343 . . . . 72.22 111.222 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 71.2 110.886 -179.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.2 0 CA-C-O 120.823 0.344 . . . . 71.22 111.075 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.4 t -146.38 34.3 0.97 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 72.32 111.116 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -171.74 -169.92 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 72.34 110.884 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.65 132.74 44.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 64.45 111.064 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 102' ' ' ASP . 1.2 p -149.12 147.73 28.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 51.21 111.105 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -129.39 151.2 50.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 44.21 111.096 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.28 142.5 51.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 75.55 111.119 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -91.03 135.05 34.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.881 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -139.94 147.75 40.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 54.02 111.099 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.77 140.66 29.48 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 72.34 110.901 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.65 -56.13 2.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.44 111.112 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.96 147.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.823 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.94 126.58 52.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.836 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -111.71 86.55 2.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 64.31 110.96 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.86 -83.13 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.745 . . . . 14.41 112.421 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.3 t -115.79 -17.71 10.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 73.42 111.15 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.47 164.65 38.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.7 -0.762 . . . . 55.44 112.499 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -145.06 157.99 43.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.947 0.403 . . . . 73.23 110.877 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.42 128.97 8.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.802 -0.713 . . . . 62.12 112.506 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.74 148.8 17.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 72.22 112.501 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.45 96.08 2.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 73.53 110.937 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -89.78 118.52 29.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 80' ' ' SER . 0.2 OUTLIER -93.73 101.85 13.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.23 111.121 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.74 131.6 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 73.03 111.154 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -133.42 117.96 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 74.25 110.956 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -118.07 101.37 8.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.427 . . . . 74.43 110.962 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.5 t -143.89 146.78 33.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 62.4 111.124 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.42 -65.11 0.25 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.753 -0.737 . . . . 75.5 112.563 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.0 p -61.43 167.5 3.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 65.23 111.107 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.87 -172.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 60.25 111.116 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -51.5 123.41 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 55.12 110.904 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -176.02 6.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 74.21 110.955 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.17 -52.46 0.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.53 110.837 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.99 174.47 14.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 75.03 110.877 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 35.4 p-90 -140.68 127.24 20.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 70.24 110.897 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.7 m -114.75 104.7 12.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 51.32 111.152 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.5 p -101.27 114.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 73.43 111.16 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -134.41 137.02 43.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 65.5 110.916 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.03 173.6 11.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 63.45 110.949 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -98.19 130.97 44.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 74.41 110.806 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -113.65 74.25 2.31 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.651 0.739 . . . . 75.4 110.871 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -50.05 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 62.05 112.339 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.6 p -72.77 145.95 46.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 71.11 111.207 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 97.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.757 . . . . 63.04 112.539 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.2 p -155.07 154.06 31.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.841 0.353 . . . . 72.21 111.122 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.7 131.18 0.43 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 71.03 110.948 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' CE1' ' A' ' 83' ' ' PHE . 72.9 t -79.07 102.94 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 71.15 111.154 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -63.66 -40.12 96.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 54.02 111.142 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.4 m -148.0 161.98 40.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 70.33 110.883 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 160.65 42.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.087 -0.506 . . . . 71.35 111.127 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -145.99 144.51 30.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 72.41 110.92 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 65.05 13.97 9.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 63.14 110.833 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.0 99.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.238 -0.437 . . . . 74.02 111.046 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 92.1 m -59.19 97.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 61.33 111.111 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.867 HG22 ' HB2' ' A' ' 64' ' ' ALA . 59.9 t -92.02 112.43 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 73.25 111.166 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.524 HG22 HG23 ' A' ' 63' ' ' THR . 13.9 t -105.12 175.09 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 73.54 111.079 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -136.2 160.03 39.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 71.53 110.871 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.3 t -161.02 85.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 64.31 110.866 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.16 -92.09 0.94 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.531 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.67 9.89 7.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.827 0.346 . . . . 62.54 110.8 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -117.74 146.85 43.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 73.02 110.935 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -133.49 139.78 46.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 75.3 110.966 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.524 HG23 HG22 ' A' ' 56' ' ' THR . 4.9 t -140.54 147.8 40.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.415 . . . . 64.1 111.098 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.867 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.14 143.1 49.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.54 111.039 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.54 160.77 39.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 70.21 110.918 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -131.23 -51.28 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 73.03 110.895 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.16 38.28 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 70.15 111.14 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.89 1.51 83.84 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.748 -0.739 . . . . 64.11 112.511 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -116.98 -25.2 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 72.3 110.886 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.661 ' HB3' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -111.52 -38.06 5.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 65.12 110.883 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.56 53.78 23.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 71.44 112.461 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.661 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -131.61 94.58 3.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 54.34 111.186 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -138.25 160.57 39.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.209 -0.45 . . . . 74.42 110.96 179.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.635 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -79.98 161.82 64.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.599 0.714 . . . . 72.3 111.12 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.635 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.69 -22.9 31.75 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.638 2.226 . . . . 71.41 112.374 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.24 115.47 1.47 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.776 -0.726 . . . . 54.24 112.466 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.54 172.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.761 0.315 . . . . 72.12 111.07 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 p -137.86 131.62 31.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 65.04 110.886 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.2 t -139.42 113.17 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 75.13 111.103 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 23' ' ' THR . 19.2 p -105.19 120.53 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 51.04 110.928 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.7 p90 -104.3 146.0 29.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 71.53 110.79 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.98 173.39 14.73 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.741 -0.742 . . . . 72.32 112.492 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CE1' HG22 ' A' ' 47' ' ' VAL . 29.1 p90 -169.79 175.94 5.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 54.11 110.912 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.07 138.21 54.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 71.01 110.859 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.17 163.53 27.41 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.725 -0.75 . . . . 73.41 112.444 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 t -115.62 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.912 0.387 . . . . 74.23 110.907 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.42 -159.79 30.05 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.752 -0.737 . . . . 34.51 112.488 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -36.63 10.46 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.707 2.271 . . . . 73.53 112.346 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.33 26.69 27.4 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 62.22 112.462 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.47 77.05 2.17 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.636 0.732 . . . . 63.14 110.9 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 162.6 41.41 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.737 2.291 . . . . 72.41 112.307 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.42 176.1 9.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.85 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 54.16 44.83 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.904 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.7 t -64.63 101.27 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 73.14 110.89 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.12 143.83 49.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 70.22 110.942 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.41 HD22 ' HB2' ' A' ' 6' ' ' ALA . 1.1 pp -155.76 153.07 29.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 63.44 110.863 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 58.68 52.04 7.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.865 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.48 41.26 45.21 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.768 -0.73 . . . . 72.01 112.491 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.6 68.74 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.79 -0.719 . . . . 63.13 112.525 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.1 m -156.01 104.48 2.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 60.51 110.814 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 39.0 t -153.16 112.77 3.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 75.3 110.873 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.647 ' H ' HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -76.91 105.96 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 62.11 110.865 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 111.96 37.4 1.54 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 64.43 112.492 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.4 t -86.55 163.68 17.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.808 0.337 . . . . 72.23 111.131 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 71.44 110.848 -179.812 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.855 0.359 . . . . 70.55 111.071 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.652 HG22 ' OG1' ' A' ' 29' ' ' THR . 3.8 p -132.77 173.54 11.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 74.25 111.141 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -179.45 95.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 63.44 110.825 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -140.65 138.43 34.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 61.23 111.154 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER -150.03 158.71 44.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 73.11 111.212 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.78 143.41 34.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 71.33 111.063 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.41 138.83 54.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 74.53 111.104 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -81.58 135.29 35.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 70.5 110.862 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.6 168.52 18.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 71.52 111.102 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.14 148.07 30.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 64.2 110.897 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.16 -57.62 2.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 73.53 111.13 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 t -179.42 132.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 63.0 110.816 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.08 127.13 53.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.093 -0.503 . . . . 72.24 110.845 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -111.41 90.48 3.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 73.23 110.93 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.97 -94.25 0.78 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 51.4 112.465 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -101.28 -17.63 16.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 74.3 111.17 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.25 148.15 20.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 51.2 112.547 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -135.93 148.0 48.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.901 0.381 . . . . 75.23 110.901 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.94 115.18 4.41 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 52.5 112.496 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.24 147.35 20.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.698 -0.763 . . . . 42.32 112.494 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.57 98.6 3.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 73.13 110.855 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.18 123.62 34.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 63.41 110.918 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.6 m -102.84 101.88 11.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 61.1 111.151 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.6 t -96.83 131.81 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 50.04 111.17 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.84 123.75 15.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.909 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -119.54 127.58 53.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 65.43 110.93 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.9 t -152.9 170.39 20.48 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.125 -0.489 . . . . 30.31 111.088 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.9 28.19 23.48 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.729 -0.748 . . . . 25.35 112.407 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.652 ' OG1' HG22 ' A' ' 2' ' ' THR . 9.5 t -128.56 165.03 21.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 72.32 111.173 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.5 p -67.05 -179.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.423 . . . . 75.02 111.12 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.52 129.86 26.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 64.02 110.831 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.51 -179.97 4.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.097 -0.501 . . . . 61.53 110.924 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.97 -53.12 0.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.842 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.52 164.84 35.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 64.24 110.848 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -125.26 126.98 46.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.41 110.918 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.91 106.34 11.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 45.11 111.169 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.4 t -105.57 105.53 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 70.03 111.089 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -119.56 153.42 35.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 73.22 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.453 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.74 169.11 23.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 73.44 110.886 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -98.33 128.19 44.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 63.24 110.878 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -112.37 77.77 2.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 73.33 110.872 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -49.84 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.653 2.236 . . . . 70.3 112.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 19.6 p -72.02 145.31 48.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 72.42 111.141 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.57 98.04 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.734 -0.746 . . . . 65.22 112.461 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.79 153.39 31.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 73.43 111.123 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.67 130.66 0.43 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 62.43 110.931 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.774 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.4 t -79.06 89.13 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 65.45 111.097 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.3 m -63.62 -39.12 93.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.489 . . . . 63.24 111.101 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.32 147.11 50.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 70.32 110.901 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.92 130.0 17.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.125 -0.488 . . . . 73.42 111.067 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -128.55 142.93 50.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 64.45 110.88 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 64.08 15.19 9.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.863 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.54 120.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 61.53 111.061 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.0 m -79.26 106.33 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 64.41 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.72 140.05 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 64.24 111.133 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.2 m -128.1 142.08 51.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 45.33 111.148 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.97 156.13 20.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.299 -0.409 . . . . 72.13 110.874 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.05 85.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 63.44 110.846 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.95 -91.51 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 41.13 112.511 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.36 9.14 7.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 72.53 110.852 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -122.15 146.75 46.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.33 110.893 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 40.1 m95 -129.7 162.24 28.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.24 -0.436 . . . . 74.55 110.901 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -149.54 149.67 31.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 64.42 111.084 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.88 128.36 45.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 63.0 111.067 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 153.88 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.32 110.918 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -131.2 -51.33 1.02 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 74.23 110.863 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.68 39.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 72.42 111.116 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.75 -0.49 74.54 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.776 -0.726 . . . . 75.5 112.462 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 -113.79 -29.43 7.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.811 0.338 . . . . 62.42 110.951 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.612 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.2 m-20 -104.32 -41.05 5.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.871 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.02 54.28 23.51 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.715 -0.755 . . . . 74.1 112.5 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.612 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -129.43 94.85 3.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.323 . . . . 75.13 111.156 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.555 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -137.75 160.77 38.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 72.33 110.925 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -84.94 161.4 52.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.639 0.733 . . . . 71.1 111.056 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.5 Cg_endo -69.79 -8.35 23.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 62.12 112.368 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.88 115.36 0.78 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 71.25 112.482 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 179.88 172.27 1.03 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 71.43 111.118 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -128.22 131.47 48.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 60.04 110.841 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.2 m -133.72 119.54 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.14 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 m -117.19 135.53 53.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 71.24 110.855 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.7 p90 -130.06 142.05 50.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.837 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -115.7 162.39 12.56 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 54.33 112.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' CE1' HG22 ' A' ' 47' ' ' VAL . 23.1 p90 -156.66 177.84 11.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 72.35 110.913 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -133.24 127.44 33.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 73.2 110.854 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.4 151.79 20.43 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 64.34 112.512 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -93.57 109.42 21.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 72.03 110.89 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.21 -162.85 35.62 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.666 -0.778 . . . . 74.32 112.423 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -36.09 11.42 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 74.11 112.371 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.45 25.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 63.52 112.466 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.2 m -112.74 76.24 2.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 71.44 110.844 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 155.66 65.26 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.655 2.237 . . . . 73.15 112.324 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -146.68 175.41 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.888 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 51.81 61.91 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 71.2 110.899 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -83.04 130.84 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 73.23 110.876 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.83 143.89 23.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 50.32 110.878 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 96' ' ' LEU . 4.2 pp -151.55 156.51 40.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 65.2 110.941 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 66.1 42.94 3.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.898 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.85 41.98 61.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 61.12 112.479 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.87 71.97 1.3 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.677 -0.773 . . . . 74.42 112.455 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.28 104.17 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.866 0.365 . . . . 75.14 110.914 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.87 115.75 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 51.31 110.875 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.628 ' H ' HG22 ' A' ' 5' ' ' THR . 12.6 t0 -79.12 146.93 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 60.43 110.864 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.38 47.33 10.74 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.749 . . . . 74.32 112.507 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.92 159.87 2.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 55.03 111.173 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 75.32 110.845 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.762 0.315 . . . . 43.41 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.6 p -144.88 83.5 1.7 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 74.22 111.167 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.7 p -172.63 -170.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.813 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.45 134.41 34.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 43.42 111.123 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.05 168.63 23.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 40.24 111.127 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.84 36.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 73.24 111.09 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -141.32 128.97 21.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 45.31 111.154 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -67.03 143.98 56.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 74.23 110.888 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB3' ' OG ' ' A' ' 21' ' ' SER . . . -149.53 156.75 42.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 62.4 111.127 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -106.74 116.61 32.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 73.32 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 -63.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 74.14 111.174 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -179.72 141.33 0.15 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 74.03 110.832 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.49 126.32 48.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 63.2 110.835 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -112.46 107.06 15.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.174 -0.467 . . . . 72.12 110.928 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.21 -91.7 0.63 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 72.53 112.492 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 t -117.45 -17.5 10.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 63.21 111.171 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.57 147.41 21.32 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.757 . . . . 34.03 112.497 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -128.53 155.0 45.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 63.24 110.936 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.36 106.94 1.97 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.78 -0.724 . . . . 71.35 112.514 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.48 116.94 5.34 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.724 -0.75 . . . . 60.33 112.454 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.451 ' OG ' ' HB3' ' A' ' 9' ' ' ALA . 1.1 t -106.85 95.96 6.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.891 0.377 . . . . 61.41 110.849 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -95.07 121.19 36.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.33 110.917 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.6 m -100.44 115.74 30.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 74.34 111.195 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 79' ' ' VAL . 17.4 t -118.78 132.76 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.14 111.106 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.25 141.83 32.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 74.25 110.965 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -119.34 136.57 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.883 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.94 161.12 10.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 71.02 111.128 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.99 -101.23 1.68 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.792 -0.718 . . . . 73.11 112.467 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.33 177.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 72.24 111.094 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -58.49 -175.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 61.3 111.11 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.92 145.65 9.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 64.03 110.865 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.86 -175.98 5.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.53 110.891 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -28.99 9.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.34 110.875 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.8 163.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.33 110.848 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.464 ' CE2' HG21 ' A' ' 79' ' ' VAL . 61.3 p-90 -130.26 128.73 42.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.179 -0.464 . . . . 75.43 110.88 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.5 m -152.65 125.53 8.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.1 111.172 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' NE1' ' A' ' 39' ' ' TRP . 21.3 t -107.26 113.88 44.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 73.25 111.121 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' THR . 5.4 pm0 -120.79 152.02 38.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 64.43 110.819 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.448 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.29 167.2 30.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 74.54 110.911 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.24 130.03 44.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 55.12 110.896 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.23 78.5 2.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.63 0.729 . . . . 72.42 110.911 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.77 -49.82 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.65 2.233 . . . . 74.42 112.319 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 44' ' ' GLY . 21.9 p -72.82 145.27 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.44 111.153 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.59 98.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.714 -0.755 . . . . 54.31 112.45 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 p -154.74 152.77 30.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 73.52 111.107 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -173.83 131.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.926 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.579 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.9 t -79.73 108.18 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 73.33 111.06 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -50.48 70.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 71.14 111.175 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.01 139.61 32.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 53.11 110.899 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.2 143.85 48.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.088 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -130.96 140.87 50.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 64.22 110.912 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.9 t0 65.09 13.43 8.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.2 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 81' ' ' PHE . . . -172.92 107.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 72.14 111.111 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -61.78 93.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.2 111.145 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.1 t -86.98 121.59 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.192 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -118.18 172.39 7.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 73.15 111.15 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.43 159.31 39.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 61.14 110.896 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.61 85.76 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.839 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.12 -91.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 61.44 112.506 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.27 3.13 7.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 74.51 110.845 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -114.72 147.04 40.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 64.34 110.879 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 31.2 m95 -127.48 160.17 32.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 72.03 110.887 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.639 HG23 ' HB3' ' A' ' 38' ' ' GLU . 30.0 m -152.62 149.17 28.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 54.33 111.146 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -132.99 115.87 15.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 50.51 111.114 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 147.95 50.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.94 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -126.35 -37.51 2.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.274 -0.421 . . . . 61.41 110.906 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.3 m -90.21 41.1 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 71.24 111.12 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.12 1.15 70.8 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 71.23 112.477 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -110.97 -19.57 12.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.74 0.305 . . . . 61.32 110.901 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -132.62 -70.66 0.55 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 71.22 110.882 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.28 -38.33 3.23 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.703 -0.76 . . . . 41.12 112.425 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.6 t -51.43 103.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 71.31 111.077 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.24 160.21 23.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.33 110.91 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -71.61 161.65 77.39 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.703 . . . . 60.2 111.079 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.75 -15.83 37.31 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.617 2.211 . . . . 63.31 112.349 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.34 115.52 0.88 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 74.0 112.476 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.94 172.41 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 74.11 111.12 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m -129.39 131.29 46.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 51.22 110.867 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 24' ' ' VAL . 3.7 p -127.42 113.96 34.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.105 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.93 134.66 51.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.857 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 17.9 p90 -139.36 137.16 35.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.886 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.55 170.92 21.78 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.739 . . . . 70.22 112.495 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.579 ' CE1' HG22 ' A' ' 47' ' ' VAL . 12.0 p90 -159.08 -179.61 8.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.371 . . . . 64.52 110.901 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.25 126.04 44.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.866 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -131.78 158.22 22.74 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.74 -0.743 . . . . 75.53 112.458 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.0 m -103.36 109.43 21.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 75.41 110.832 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.73 -161.58 34.33 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.576 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -36.43 10.84 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.688 2.259 . . . . 74.25 112.324 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.56 26.62 27.04 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.701 -0.761 . . . . 74.32 112.432 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.25 76.9 2.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.695 0.759 . . . . 71.45 110.871 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 164.35 34.86 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.238 . . . . 60.3 112.33 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.35 169.59 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.456 . . . . 65.02 110.89 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 58.9 56.75 3.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 54.43 110.861 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.1 m -75.74 92.49 3.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.128 -0.487 . . . . 71.35 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.95 120.85 34.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 64.23 110.898 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.501 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.5 OUTLIER -125.91 155.7 40.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 73.42 110.881 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB2' HD12 ' A' ' 96' ' ' LEU . 5.2 t-20 62.79 26.7 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.843 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.44 42.77 7.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 52.25 112.447 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.3 70.74 1.11 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.819 -0.705 . . . . 41.4 112.479 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.19 129.29 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.337 . . . . 52.22 110.872 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 p -158.28 167.58 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 45.4 110.837 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.55 69.91 10.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.89 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 23.71 45.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 73.32 112.478 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.41 157.35 19.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 72.14 111.153 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 74.53 110.798 -179.795 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.896 0.379 . . . . 73.42 111.142 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.637 ' HA ' HG21 ' A' ' 29' ' ' THR . 0.0 OUTLIER -168.53 108.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 72.01 111.143 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -117.8 95.43 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.896 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.78 138.65 2.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 60.24 111.071 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -141.58 167.84 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 62.43 111.112 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.52 152.88 47.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 62.12 111.08 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 m -135.51 121.0 19.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.13 111.163 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -65.66 146.33 54.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 74.03 110.871 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' SER . . . -146.27 160.24 42.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.098 -0.501 . . . . 70.15 111.079 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.3 141.93 35.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.43 110.9 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.67 -62.83 1.38 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.459 . . . . 73.04 111.199 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.6 p -175.84 135.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 61.35 110.863 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -119.62 126.65 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 61.53 110.89 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -111.74 97.67 6.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.949 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.82 -92.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 42.35 112.529 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 t -108.15 -17.6 13.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.885 0.374 . . . . 52.55 111.119 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.21 149.32 22.85 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.787 -0.72 . . . . 75.41 112.466 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -134.63 150.71 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 54.24 110.87 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.41 113.38 3.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 55.41 112.473 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.07 147.26 22.45 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 62.54 112.453 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -139.66 96.59 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 71.42 110.905 -179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.23 124.13 34.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.953 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 m -101.96 101.91 12.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.183 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.4 t -96.6 131.87 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 52.52 111.072 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -141.97 128.06 19.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.53 110.871 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -119.4 132.08 55.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.863 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.55 129.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 62.3 111.188 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.53 -48.31 0.98 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 71.54 112.486 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.637 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -82.64 176.65 9.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 64.1 111.184 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -174.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 74.11 111.177 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 t -51.45 125.42 14.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 75.02 110.923 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.02 -174.74 5.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.969 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.68 -53.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.846 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.2 p -154.16 171.44 19.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 45.33 110.939 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CD1' HG21 ' A' ' 79' ' ' VAL . 35.6 p-90 -129.0 127.03 40.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 71.34 110.919 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.76 101.93 8.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 75.32 111.138 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' NE1' ' A' ' 39' ' ' TRP . 10.8 t -101.45 105.63 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 70.14 111.176 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -120.08 151.6 38.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.12 110.867 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.42 168.13 26.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 73.12 110.91 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.31 128.79 44.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.41 110.892 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.44 77.46 2.3 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.644 0.735 . . . . 70.15 110.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 -49.98 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.717 2.278 . . . . 75.41 112.338 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 7.1 m -71.94 145.26 48.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 70.21 111.162 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.37 98.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.684 -0.769 . . . . 70.02 112.509 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.1 p -154.82 153.5 31.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 74.04 111.127 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -173.67 130.63 0.43 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 45.22 110.883 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 83' ' ' PHE . 99.9 t -79.09 89.75 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 73.33 111.098 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -63.25 -39.54 94.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 64.33 111.192 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.1 t -129.52 147.69 51.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.875 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.468 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.23 130.06 18.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 73.5 111.139 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -127.18 144.08 51.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.967 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.63 15.9 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.884 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.29 121.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 64.42 111.08 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.6 m -78.56 101.9 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 63.03 111.156 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' HB1' ' A' ' 50' ' ' ALA . 39.7 t -87.35 147.23 5.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 62.23 111.16 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.2 m -139.1 140.53 38.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.222 -0.444 . . . . 63.42 111.16 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -107.68 157.48 18.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.291 -0.413 . . . . 75.22 110.908 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.3 t -160.68 85.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 71.33 110.835 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.84 -91.29 0.5 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 60.42 112.503 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.18 6.92 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.78 0.324 . . . . 52.04 110.862 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -120.74 146.99 45.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 65.11 110.853 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.2 m95 -128.9 159.09 36.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.898 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 t -145.99 149.83 34.88 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.221 -0.445 . . . . 70.21 111.066 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.23 120.31 24.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 43.44 111.078 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.97 153.62 51.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 74.44 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.18 -51.58 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 44.44 110.937 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.12 39.19 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.01 111.181 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.63 -1.07 75.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.749 . . . . 63.13 112.489 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -113.76 -25.37 8.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.319 . . . . 71.02 110.848 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -107.75 -47.17 3.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 64.13 110.857 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 50.36 56.37 13.14 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.778 -0.725 . . . . 54.22 112.484 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.81 96.35 2.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 74.42 111.161 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.6 tt -137.7 160.62 38.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.164 -0.471 . . . . 52.52 110.959 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -71.34 161.93 75.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.57 0.7 . . . . 63.41 111.1 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.73 -8.87 24.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.697 2.265 . . . . 63.31 112.41 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -145.54 118.35 1.08 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 65.12 112.461 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.54 172.02 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 42.41 111.132 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.69 131.57 43.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.42 110.846 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.509 HG23 ' HB ' ' A' ' 24' ' ' VAL . 6.4 m -134.1 113.22 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 65.22 111.116 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.1 p -109.18 125.63 52.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 41.23 110.883 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -120.46 141.35 50.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 70.41 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.36 12.34 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 63.44 112.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.785 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.6 p90 -159.68 176.92 11.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.911 0.386 . . . . 73.22 110.85 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -132.4 125.87 31.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 72.03 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.94 151.44 20.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.764 -0.731 . . . . 44.02 112.501 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.19 109.55 20.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 63.03 110.88 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.65 -162.67 34.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.733 -0.746 . . . . 73.05 112.495 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -38.27 8.02 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 74.34 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.11 26.6 23.47 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 62.22 112.455 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.2 m -112.67 76.6 2.16 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.683 0.754 . . . . 73.34 110.879 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 158.95 55.26 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.42 112.298 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.48 174.56 11.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.87 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.0 m120 51.6 63.6 2.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 74.32 110.89 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.0 p -82.73 128.63 34.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 54.14 110.947 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.99 144.02 23.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 74.41 110.911 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -149.56 156.63 42.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 72.35 110.9 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.8 41.77 2.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 61.51 110.851 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 70.82 42.08 61.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 71.11 112.478 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.82 71.85 1.3 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.705 -0.76 . . . . 74.41 112.415 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.32 104.18 2.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 55.3 110.841 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.2 t -165.95 113.06 0.91 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.848 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 5' ' ' THR . 1.3 t70 -75.67 162.26 28.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.888 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.02 37.32 70.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.781 -0.723 . . . . 62.53 112.471 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.6 t -84.33 148.62 26.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 72.1 111.155 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 54.4 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.84 -179.799 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.865 0.364 . . . . 53.43 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.37 119.52 6.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 73.14 111.159 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.38 95.41 5.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 53.1 110.814 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.496 ' HB3' HD11 ' A' ' 96' ' ' LEU . . . -120.13 133.39 55.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 70.54 111.108 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 102' ' ' ASP . 21.1 p -114.0 143.82 44.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 63.51 111.103 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -125.3 139.7 53.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 34.33 111.142 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -134.48 115.76 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 75.32 111.114 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -67.54 145.4 54.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 75.2 110.869 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.36 164.07 33.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 40.43 111.109 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.23 140.28 40.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.23 110.81 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 m -107.01 -62.42 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 63.21 111.15 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.82 133.13 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 61.42 110.868 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -118.79 127.05 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 62.3 110.844 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -111.4 91.44 3.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.843 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.0 -93.3 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.749 -0.739 . . . . 72.31 112.498 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -103.11 -17.61 15.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 74.42 111.097 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.78 148.58 21.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.805 -0.712 . . . . 72.22 112.406 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -135.53 148.49 49.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 75.32 110.895 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.36 114.19 4.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.812 -0.709 . . . . 53.22 112.446 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.39 148.15 22.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.757 -0.735 . . . . 71.12 112.494 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 t -141.64 98.36 3.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 73.2 110.891 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -90.23 137.06 32.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.141 -0.482 . . . . 75.21 110.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.22 107.07 15.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.286 -0.416 . . . . 70.44 111.175 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' HG23 ' A' ' 79' ' ' VAL . 21.2 t -101.48 131.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.417 . . . . 71.24 111.188 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.13 123.08 17.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.937 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.451 ' OD1' HD22 ' A' ' 32' ' ' LEU . 1.8 m120 -112.69 125.92 54.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 51.43 110.916 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -167.27 148.98 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 71.21 111.17 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.62 -39.63 2.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.729 -0.748 . . . . 72.12 112.517 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -88.86 169.5 11.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 75.21 111.109 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.7 p -60.66 -172.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.3 -0.409 . . . . 74.43 111.147 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -51.49 127.13 19.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 45.35 110.871 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD22 ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -86.84 -175.67 5.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 53.22 110.93 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.63 -53.37 0.45 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.25 -0.432 . . . . 62.02 110.872 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.3 p -153.99 176.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 24.51 110.779 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.42 ' CD1' HG21 ' A' ' 79' ' ' VAL . 34.1 p-90 -134.53 127.05 30.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.04 -0.527 . . . . 73.32 110.862 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.29 101.35 7.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.52 111.159 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG12 ' NE1' ' A' ' 39' ' ' TRP . 13.3 t -101.01 105.16 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 64.25 111.172 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.02 147.66 43.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 62.1 110.887 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.458 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -148.29 168.18 23.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.148 -0.478 . . . . 75.1 110.891 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -98.06 129.06 44.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 74.43 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -112.59 77.52 2.4 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.712 0.768 . . . . 71.15 110.906 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -50.03 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.667 2.245 . . . . 64.2 112.321 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.82 145.35 48.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 63.22 111.14 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.49 98.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.742 . . . . 71.21 112.491 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.5 p -154.74 153.78 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 75.14 111.114 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -173.74 130.6 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 71.41 110.844 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.783 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.2 t -79.37 88.19 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 71.21 111.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 96.1 m -63.48 -39.0 93.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 73.02 111.162 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.32 145.99 50.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 61.33 110.837 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB1' HG23 ' A' ' 55' ' ' VAL . . . -145.46 130.07 17.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 72.41 111.112 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -129.4 143.11 50.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.78 15.66 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.892 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.39 119.34 0.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 73.31 111.074 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -77.55 105.34 8.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 72.43 111.13 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 HG23 ' HB1' ' A' ' 50' ' ' ALA . 17.0 t -92.95 139.94 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 64.12 111.152 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.8 m -131.7 141.62 49.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.21 111.122 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -109.51 155.59 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 53.03 110.86 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -158.9 85.68 0.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 73.3 110.836 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.43 -93.15 1.0 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 72.31 112.452 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.44 7.8 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 72.24 110.858 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -121.47 145.39 47.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 61.41 110.844 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -126.3 158.75 34.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.885 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -144.24 150.11 37.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 73.51 111.161 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -130.32 121.84 26.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 52.44 111.094 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.04 153.47 51.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.447 . . . . 62.25 110.888 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -131.23 -51.51 1.02 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.901 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -99.43 39.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 71.14 111.086 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.92 -0.56 75.92 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.709 -0.757 . . . . 73.44 112.498 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -115.05 -22.36 9.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.745 0.307 . . . . 65.41 110.901 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -110.56 -47.2 3.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 62.34 110.901 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.629 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 49.91 56.81 10.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.818 -0.706 . . . . 71.15 112.483 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.3 95.92 2.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 72.35 111.121 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 74' ' ' ALA . 2.8 tt -137.99 160.64 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 64.03 110.942 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.636 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -70.79 162.0 74.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.614 0.721 . . . . 75.34 111.066 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.636 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -17.84 37.04 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.672 2.248 . . . . 72.12 112.37 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -135.75 115.94 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 63.24 112.535 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 73' ' ' LEU . . . -178.66 172.05 1.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.788 0.328 . . . . 54.32 111.049 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 p -133.12 131.65 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 72.03 110.857 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG21 ' CD1' ' A' ' 35' ' ' TRP . 6.2 m -133.53 118.06 29.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.484 . . . . 74.31 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.66 139.17 47.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 75.03 110.877 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 31.2 p90 -132.16 140.11 48.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.895 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.72 163.4 12.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 72.14 112.448 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.783 ' CE1' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -157.75 177.32 11.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.915 0.388 . . . . 63.34 110.825 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -133.14 127.68 34.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 72.22 110.896 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.86 151.67 20.49 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.758 -0.734 . . . . 64.03 112.543 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.88 109.55 20.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.005 0.431 . . . . 65.44 110.879 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.37 -163.03 35.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 61.2 112.48 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -36.48 10.75 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.645 2.23 . . . . 75.55 112.353 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.97 26.49 24.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.776 -0.726 . . . . 60.14 112.512 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -112.78 75.94 2.04 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.636 0.731 . . . . 71.32 110.851 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 155.43 65.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.68 2.253 . . . . 61.51 112.32 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.3 m -147.97 169.9 18.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 63.03 110.806 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.0 m-20 56.3 65.33 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 70.04 110.862 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 38.5 t -89.27 104.84 17.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 52.34 110.876 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.71 118.98 27.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 74.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -126.88 155.8 42.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.905 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.47 ' HB2' HD12 ' A' ' 96' ' ' LEU . 1.7 t-20 63.74 27.79 14.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.24 110.871 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.23 42.06 8.19 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.753 -0.736 . . . . 53.41 112.543 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.6 70.59 1.13 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.737 . . . . 55.14 112.474 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.24 132.08 9.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.871 0.367 . . . . 44.54 110.877 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.9 t -173.24 135.79 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.871 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.622 ' HB2' HG22 ' A' ' 5' ' ' THR . 3.1 t70 -126.82 158.18 37.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 72.01 110.836 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.49 19.55 62.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 74.25 112.482 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.41 -176.61 2.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.773 0.32 . . . . 65.33 111.179 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 61.44 110.861 -179.874 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.877 0.37 . . . . 72.43 111.05 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -129.74 38.27 3.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 72.5 111.186 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.2 m -159.18 -176.73 6.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 64.51 110.873 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.56 135.47 33.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 60.21 111.099 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.678 HG21 ' HB3' ' A' ' 102' ' ' ASP . 0.2 OUTLIER -147.17 165.67 29.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 63.35 111.151 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.66 159.38 42.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 72.03 111.079 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.78 147.72 37.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 73.51 111.126 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -87.23 146.22 26.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.889 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.33 175.98 9.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 65.42 111.115 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.82 156.87 23.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 70.54 110.92 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.66 -55.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 62.54 111.217 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.41 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 54.42 110.869 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -116.75 127.61 54.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 72.11 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.71 82.58 1.62 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.91 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.82 0.63 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.789 -0.72 . . . . 60.02 112.471 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -100.99 -17.57 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.819 0.343 . . . . 63.5 111.128 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.79 156.12 26.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 43.04 112.506 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -144.52 145.28 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 75.24 110.855 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.71 121.14 6.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 62.32 112.458 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -96.37 149.05 19.2 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.768 -0.73 . . . . 51.42 112.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -141.65 99.1 3.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 74.12 110.92 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -90.24 118.85 30.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.102 -0.499 . . . . 72.25 110.985 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.2 m -99.97 113.95 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 71.33 111.073 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.1 t -106.51 131.77 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 70.14 111.203 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -141.07 118.48 11.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.827 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 77' ' ' ALA . 7.5 p30 -105.8 129.68 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.2 110.868 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.8 t -164.89 139.54 5.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.172 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.41 -46.59 3.21 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.667 -0.777 . . . . 73.12 112.48 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.55 177.35 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 54.04 111.18 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -79.78 173.12 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 52.0 111.157 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -51.72 109.18 0.33 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 64.23 110.848 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.85 -175.3 5.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.941 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.5 m -145.87 -52.88 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.804 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.66 140.97 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 65.22 110.855 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.0 p-90 -111.29 127.11 55.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 74.01 110.932 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.3 m -126.18 113.26 16.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 75.34 111.187 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HE1' ' A' ' 39' ' ' TRP . 9.0 t -101.14 105.53 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 71.41 111.119 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -123.21 154.23 39.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.14 110.874 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.45 ' HE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -154.72 168.43 26.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 44.02 110.89 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -98.17 130.64 44.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 65.21 110.848 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -113.09 75.77 2.19 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.61 0.719 . . . . 74.14 110.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -49.75 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.745 2.296 . . . . 71.2 112.338 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 44' ' ' GLY . 43.1 p -71.32 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 65.13 111.098 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.45 99.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.751 . . . . 34.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.8 p -154.46 157.44 38.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 61.31 111.157 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.59 130.76 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 62.14 110.854 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.608 HG22 ' CE2' ' A' ' 83' ' ' PHE . 84.2 t -89.61 106.14 16.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 65.21 111.084 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -80.09 -36.0 36.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.076 -0.511 . . . . 55.45 111.146 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.42 147.6 49.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 55.44 110.832 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.2 18.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.085 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -142.65 152.57 42.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.93 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.68 14.51 9.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 50.22 110.84 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 64' ' ' ALA . . . -172.7 113.05 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 54.11 111.126 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.0 m -65.25 90.83 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 75.51 111.111 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 64' ' ' ALA . 47.2 t -81.37 112.34 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 72.41 111.114 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 t -116.26 118.87 33.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.141 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -78.86 161.02 27.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 74.45 110.933 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.02 85.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.13 110.862 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 70.29 -88.85 0.33 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 65.31 112.498 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -126.77 6.64 6.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 72.54 110.831 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -115.22 146.98 40.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 71.03 110.873 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -135.19 120.2 18.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 72.22 110.959 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 t -121.7 148.15 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 73.13 111.191 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -128.6 141.96 51.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 64.23 111.053 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.45 121.75 7.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 62.44 110.844 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.1 t30 -94.46 -31.66 13.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 70.13 110.898 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.78 38.43 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 62.42 111.134 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.61 0.42 81.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 62.12 112.521 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -115.84 -32.7 5.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.702 0.286 . . . . 71.24 110.914 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 72' ' ' THR . 0.3 OUTLIER -102.66 -36.63 8.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.54 110.92 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.28 47.87 41.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.772 -0.728 . . . . 75.23 112.474 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 70' ' ' ASN . 12.8 p -124.84 116.89 22.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.754 0.311 . . . . 60.33 111.172 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.9 tp -149.29 161.11 42.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 73.41 110.949 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -106.11 163.45 17.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.609 0.718 . . . . 73.23 111.113 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.1 Cg_endo -69.78 -8.1 22.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.738 2.292 . . . . 74.33 112.346 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -145.05 114.73 0.79 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.771 -0.728 . . . . 52.34 112.515 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' HD21 ' A' ' 26' ' ' ASN . . . 178.84 172.49 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.854 0.359 . . . . 72.12 111.098 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 79.7 p -133.37 131.54 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 63.34 110.837 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.8 t -145.3 132.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 71.22 111.172 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.0 p -127.86 137.98 52.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 75.4 110.862 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -129.53 134.98 48.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 72.11 110.915 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.24 178.57 22.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.803 -0.713 . . . . 45.32 112.487 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.608 ' CE2' HG22 ' A' ' 47' ' ' VAL . 18.5 p90 -174.58 173.54 2.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.86 0.362 . . . . 75.21 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -124.99 133.93 52.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.52 110.896 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.41 153.47 23.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 63.42 112.455 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.08 117.87 35.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.873 0.368 . . . . 71.01 110.844 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.34 29.1 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 71.42 112.499 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -35.01 13.47 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 70.24 112.336 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.1 27.18 29.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.762 -0.732 . . . . 72.11 112.464 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 m -112.48 75.35 1.74 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.686 0.755 . . . . 60.41 110.896 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 160.04 51.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.641 2.228 . . . . 55.32 112.32 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 m -148.6 175.68 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.834 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 58.73 53.52 5.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 72.24 110.913 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.6 m -73.44 101.75 3.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.132 -0.485 . . . . 61.53 110.846 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.14 119.31 22.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 60.22 110.928 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.95 155.74 43.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 71.54 110.922 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 63.73 26.32 14.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.85 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.76 42.17 7.37 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.779 -0.724 . . . . 73.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.62 73.95 1.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 73.41 112.552 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 130.04 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.929 0.395 . . . . 64.21 110.813 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -179.43 161.1 1.03 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.852 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.678 ' HB3' HG21 ' A' ' 5' ' ' THR . 20.3 t0 -127.52 97.78 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 71.11 110.928 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.98 41.09 1.46 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.788 -0.72 . . . . 73.53 112.52 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.44 163.07 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.782 0.325 . . . . 73.13 111.195 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 73.21 110.861 -179.859 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.859 0.361 . . . . 60.42 111.082 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.8 p -133.71 159.9 39.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 73.25 111.173 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -94.33 102.14 14.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 73.35 110.873 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.12 134.5 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 64.13 111.082 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 102' ' ' ASP . 1.0 OUTLIER -150.05 166.64 29.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 74.14 111.18 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.16 163.86 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 75.34 111.063 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -132.45 147.72 52.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 43.55 111.155 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -86.89 146.29 26.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 60.51 110.961 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.54 147.54 25.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 72.54 111.144 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.25 145.73 24.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 71.15 110.88 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 m -105.62 -63.81 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 70.34 111.181 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.39 127.24 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 53.52 110.834 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -116.04 127.62 55.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 71.22 110.859 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -110.53 81.14 1.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 64.42 110.971 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.67 -90.09 0.65 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 63.02 112.483 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -97.29 -16.36 20.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 63.05 111.192 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -91.14 155.52 23.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.726 -0.75 . . . . 75.43 112.463 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -143.73 143.72 31.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.849 0.357 . . . . 71.24 110.888 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.27 115.44 4.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 74.41 112.527 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -78.2 140.62 24.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 63.33 112.493 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 94.54 2.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 63.41 110.859 -179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.03 149.93 22.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.902 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 m -129.81 108.15 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 70.25 111.141 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -100.53 132.16 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 65.3 111.12 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.43 127.07 34.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.892 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -119.6 122.61 41.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 73.3 110.861 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.6 t -172.59 156.7 3.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.25 111.229 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -21.36 17.91 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.699 -0.762 . . . . 63.53 112.507 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.85 177.18 7.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 63.22 111.196 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.17 -171.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.257 -0.429 . . . . 74.03 111.19 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.71 120.18 4.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 75.12 110.854 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 179.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 71.31 110.896 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.6 p -120.8 -32.07 4.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 30.24 110.883 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 p 179.3 160.4 0.73 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.878 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -137.89 129.03 27.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 72.13 110.921 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 64' ' ' ALA . 40.7 m -149.81 131.19 14.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 63.14 111.121 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG12 ' NE1' ' A' ' 39' ' ' TRP . 19.0 t -112.87 105.97 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 61.4 111.067 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.718 ' HB3' HG23 ' A' ' 63' ' ' THR . 18.9 pt-20 -118.28 135.07 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.861 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -135.2 173.76 11.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 74.32 110.92 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -98.16 134.34 41.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 60.4 110.92 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -120.44 77.73 27.17 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.669 0.747 . . . . 74.43 110.91 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -49.64 0.54 Allowed 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.664 2.243 . . . . 73.32 112.358 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 2.3 p -73.09 145.24 46.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.178 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.22 100.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 54.25 112.47 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.0 p -154.81 150.56 27.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.346 . . . . 62.44 111.192 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.64 130.89 0.43 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.15 110.924 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.474 HG22 ' CE1' ' A' ' 83' ' ' PHE . 92.9 t -84.26 98.03 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.136 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.4 HG23 ' N ' ' A' ' 49' ' ' SER . 6.3 t -63.5 -42.15 98.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 71.52 111.161 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.4 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 m -136.72 145.42 44.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.13 110.9 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.48 167.95 20.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 44.24 111.128 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -153.31 141.42 20.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 71.14 110.882 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 64.36 13.84 8.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.02 110.884 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -173.35 107.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 75.35 111.096 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -63.26 92.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 51.05 111.123 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 47' ' ' VAL . 59.8 t -81.78 112.55 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.431 . . . . 71.14 111.135 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -105.1 172.27 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 71.12 111.056 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -134.19 158.53 43.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 70.32 110.852 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 m -162.5 85.6 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 73.34 110.903 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.63 -92.25 0.6 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.78 -0.724 . . . . 51.32 112.48 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -126.28 15.94 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 72.31 110.899 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -125.42 147.02 49.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.88 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 44.7 m95 -133.1 141.58 48.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 75.12 110.955 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.718 HG23 ' HB3' ' A' ' 38' ' ' GLU . 39.0 m -131.37 148.51 52.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 64.23 111.164 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 36' ' ' THR . . . -128.09 116.74 20.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 62.22 111.136 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.09 142.15 38.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 75.5 110.873 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -120.84 -35.99 3.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 52.22 110.858 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -92.44 42.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.154 -0.475 . . . . 64.32 111.123 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 2.13 69.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.687 -0.768 . . . . 73.54 112.542 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -115.63 -33.81 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.715 0.293 . . . . 75.43 110.905 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.72 -70.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 73.03 110.879 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.96 -38.21 3.26 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.779 -0.724 . . . . 71.41 112.498 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -52.66 110.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.909 0.385 . . . . 72.51 111.179 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.5 tp -124.23 144.23 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.942 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.02 160.38 1.55 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.637 0.732 . . . . 74.23 111.115 179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.1 Cg_endo -69.7 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.747 2.298 . . . . 74.14 112.321 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.14 115.57 0.66 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.757 . . . . 63.22 112.532 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.55 172.34 1.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.727 0.299 . . . . 63.0 111.166 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.24 49.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.292 -0.413 . . . . 65.14 110.803 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.4 t -127.05 110.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 73.31 111.082 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.0 p -99.83 148.87 23.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.812 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -146.58 135.12 22.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 71.13 110.917 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -124.32 177.3 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.705 -0.76 . . . . 51.33 112.434 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 47' ' ' VAL . 10.8 p90 -171.64 175.94 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.942 0.401 . . . . 74.14 110.864 -179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -122.74 128.31 50.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.482 . . . . 73.41 110.929 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.12 149.38 19.6 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.737 -0.744 . . . . 74.23 112.487 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 109.46 21.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 53.25 110.876 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.78 -162.15 34.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 45.51 112.475 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -36.7 10.55 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 71.52 112.349 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.83 26.56 26.51 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 70.54 112.508 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 m -112.36 77.07 2.11 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.698 0.761 . . . . 73.01 110.883 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 163.5 38.11 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.713 2.275 . . . . 62.34 112.288 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -148.31 170.23 18.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.23 -0.441 . . . . 55.54 110.86 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.76 50.53 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.866 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 24.8 m -66.48 96.68 0.38 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.483 . . . . 74.41 110.896 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -121.31 143.84 48.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 61.5 110.899 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -155.48 155.55 33.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.968 179.927 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.563 ' HB2' HD12 ' A' ' 96' ' ' LEU . 38.4 t30 63.22 39.87 9.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 71.35 110.884 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.06 41.6 11.98 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.42 112.521 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 63.32 2.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.747 -0.739 . . . . 53.44 112.484 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.5 t -155.99 104.49 2.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.819 0.342 . . . . 75.31 110.804 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.1 t -150.41 141.57 23.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.484 . . . . 33.51 110.858 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.531 ' H ' HG22 ' A' ' 5' ' ' THR . 2.0 t0 -126.27 157.22 38.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 74.02 110.808 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 94.16 -25.02 24.28 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.76 -0.733 . . . . 74.1 112.456 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.16 171.09 20.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 64.41 111.204 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.2 t . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.429 . . . . 63.15 110.842 -179.882 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.895 0.378 . . . . 42.44 111.034 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.715 HG22 ' HA3' ' A' ' 28' ' ' GLY . 0.2 OUTLIER 56.67 95.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 75.12 111.126 -179.939 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -176.97 -170.61 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 62.43 110.856 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.63 134.59 34.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 64.13 111.098 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -136.51 171.35 14.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 72.22 111.116 -179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -151.79 163.44 39.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 62.45 111.077 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 t -140.68 141.69 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.44 111.137 -179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -79.38 140.45 37.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 64.24 110.891 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -139.41 162.19 35.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 62.02 111.129 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.29 154.54 22.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.852 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 -58.66 1.94 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 52.41 111.159 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -179.8 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 43.42 110.878 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -115.45 127.92 55.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 62.15 110.874 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.65 81.76 1.49 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.172 -0.467 . . . . 75.02 110.978 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.64 -87.27 0.63 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 73.43 112.473 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 t -100.32 -17.59 17.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 73.21 111.168 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 155.55 25.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.815 -0.707 . . . . 52.13 112.488 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -143.6 143.04 31.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 75.51 110.895 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.85 115.81 5.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.705 -0.76 . . . . 75.3 112.479 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.42 143.84 17.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.696 -0.764 . . . . 62.13 112.542 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.1 m -144.22 95.48 2.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.871 0.367 . . . . 63.42 110.844 -179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -90.44 132.56 35.57 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.116 -0.493 . . . . 71.24 110.885 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.4 m -110.61 117.45 33.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.141 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.72 131.94 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 64.33 111.152 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -138.01 136.98 37.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 54.51 110.865 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.677 ' HB2' HD11 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -119.93 136.48 54.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.874 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -167.53 162.23 14.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.5 111.176 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.715 ' HA3' HG22 ' A' ' 2' ' ' THR . . . 97.37 -98.12 2.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 32.4 112.524 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.4 p -56.34 170.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 63.1 111.134 -179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.5 p -59.4 -175.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.459 . . . . 32.21 111.176 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.2 144.45 9.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 71.43 110.792 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 26' ' ' ASN . 1.3 mp -84.44 -174.61 5.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.912 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -116.37 -27.64 6.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.847 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t 178.88 154.92 0.43 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.52 110.896 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.427 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.1 p-90 -125.05 129.41 50.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 75.11 110.921 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 64' ' ' ALA . 80.6 m -152.42 122.0 6.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.166 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.5 t -101.72 110.68 29.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 74.31 111.182 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -117.66 152.4 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.1 110.88 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.442 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.97 170.23 20.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 73.31 110.911 -179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.98 131.67 44.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.874 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.8 74.05 2.4 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.659 0.742 . . . . 74.03 110.85 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.691 2.261 . . . . 70.33 112.34 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.5 p -74.18 145.79 43.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.23 111.128 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.36 98.75 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 24.33 112.513 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.7 p -154.9 154.62 32.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.332 . . . . 55.15 111.166 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.76 131.13 0.42 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.301 -0.408 . . . . 74.34 110.931 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.721 HG22 ' CE1' ' A' ' 83' ' ' PHE . 96.0 t -76.1 104.91 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 65.13 111.078 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -47.89 80.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.138 -0.483 . . . . 72.43 111.178 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -144.39 152.37 40.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 52.21 110.87 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.17 162.47 35.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 70.32 111.074 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -146.99 144.95 29.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.988 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 t0 64.05 15.18 9.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 62.45 110.85 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.55 104.86 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 62.24 111.127 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.2 m -61.8 93.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.453 . . . . 72.54 111.201 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 64' ' ' ALA . 95.7 t -86.22 112.44 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 52.45 111.084 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.425 ' CG2' HG23 ' A' ' 63' ' ' THR . 7.4 t -113.44 164.28 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 74.52 111.172 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -121.79 160.98 23.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 62.12 110.942 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -159.26 85.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.799 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.72 -93.27 0.93 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.756 -0.735 . . . . 45.13 112.442 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -126.54 11.42 7.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 74.25 110.877 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -123.53 147.03 47.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 62.23 110.864 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.2 m95 -127.98 156.32 42.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 63.52 110.936 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.425 HG23 ' CG2' ' A' ' 56' ' ' THR . 1.9 t -150.35 148.7 29.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 64.05 111.149 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.569 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.97 119.95 24.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 42.1 111.083 179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.32 144.4 40.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 61.21 110.881 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -123.08 -35.06 3.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.42 110.901 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.427 HG13 ' HE1' ' A' ' 35' ' ' TRP . 14.1 m -89.6 41.62 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 51.11 111.124 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.69 1.92 70.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 42.24 112.523 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.44 -21.49 11.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 72.3 110.918 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -129.54 -70.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 63.54 110.898 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.65 -38.07 3.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 70.51 112.535 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 t -50.74 107.16 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 54.43 111.097 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.407 HD23 HD13 ' A' ' 32' ' ' LEU . 8.4 tp -123.69 146.93 47.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.993 179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -61.53 160.31 26.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.625 0.726 . . . . 64.12 111.06 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.9 Cg_endo -69.8 -8.43 23.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.728 2.285 . . . . 75.24 112.319 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.9 116.03 0.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.673 -0.775 . . . . 61.21 112.436 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.17 172.13 1.61 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.868 0.366 . . . . 64.44 111.072 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.68 131.33 43.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 45.42 110.85 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.25 109.9 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 71.12 111.114 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 t -109.98 134.38 52.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 50.14 110.88 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -123.47 134.88 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 72.5 110.899 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -109.3 175.52 19.05 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 63.5 112.532 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.721 ' CE1' HG22 ' A' ' 47' ' ' VAL . 18.1 p90 -174.84 175.87 2.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.933 0.397 . . . . 65.4 110.899 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -124.97 125.89 44.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 74.52 110.873 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -124.56 152.98 17.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 50.13 112.496 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.82 109.49 21.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 54.41 110.814 -179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.4 -158.02 27.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.21 112.449 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -37.26 9.4 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.66 2.24 . . . . 71.0 112.409 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.24 27.04 29.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 73.44 112.443 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.71 78.92 2.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.651 0.739 . . . . 71.4 110.849 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 171.79 13.83 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 65.2 112.374 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.7 m -148.5 170.4 18.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 44.35 110.818 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 54.52 52.13 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.106 -0.497 . . . . 63.55 110.934 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.8 m -68.75 92.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 63.21 110.845 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.86 144.0 49.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 75.13 110.87 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.12 156.79 44.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 73.42 110.884 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 66.43 32.63 7.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 71.14 110.845 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.79 42.41 25.89 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.805 -0.712 . . . . 30.31 112.517 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.71 71.58 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 55.42 112.517 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.52 130.57 8.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.821 0.343 . . . . 73.44 110.841 -179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.26 150.09 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 55.25 110.811 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.453 ' HB3' HG21 ' A' ' 5' ' ' THR . 33.0 t0 -127.49 90.98 3.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 65.12 110.836 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 115.61 33.36 1.59 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.739 . . . . 63.12 112.45 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 t -79.73 162.37 25.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 73.54 111.083 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.844 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.91 0.386 . . . . 60.23 111.093 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.401 ' CB ' HG21 ' A' ' 29' ' ' THR . 29.9 p -89.21 134.36 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 74.52 111.099 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -97.17 95.31 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.225 -0.443 . . . . 62.1 110.833 -179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.18 139.17 51.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 73.25 111.122 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.57 155.47 32.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 74.22 111.129 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.92 163.93 36.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 33.33 111.105 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.38 144.89 27.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 55.5 111.164 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -89.41 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 75.05 110.93 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.45 152.56 38.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 64.42 111.094 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.03 146.66 24.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 72.41 110.965 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.29 -59.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 70.13 111.092 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.4 138.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 50.5 110.876 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.13 127.43 54.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.098 -0.501 . . . . 64.43 110.83 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -110.67 92.97 4.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.927 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.25 -90.34 0.71 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.685 -0.769 . . . . 75.01 112.504 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 t -110.6 -17.55 13.38 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 73.41 111.176 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.6 146.76 20.93 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.761 -0.733 . . . . 75.15 112.466 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -125.42 149.72 47.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.883 0.373 . . . . 74.34 110.87 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -105.99 110.41 3.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.705 -0.76 . . . . 42.33 112.499 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.75 142.62 21.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.693 -0.765 . . . . 71.44 112.454 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -139.54 94.66 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 55.4 110.839 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -90.37 149.28 22.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.501 . . . . 75.44 110.933 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m -128.18 132.01 48.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.34 111.17 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.62 ' HB ' HG23 ' A' ' 79' ' ' VAL . 14.9 t -130.37 132.42 64.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.32 111.095 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -142.38 129.17 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 71.51 110.933 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' CG ' HD22 ' A' ' 32' ' ' LEU . 3.2 m-20 -104.53 148.99 25.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 64.25 110.851 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.4 t -172.57 162.59 5.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 65.04 111.155 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.89 -77.04 1.95 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 74.53 112.489 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 2' ' ' THR . 14.5 t -57.91 172.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 63.11 111.146 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.1 p -68.43 -172.07 0.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 63.51 111.059 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.12 122.79 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 64.22 110.842 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.557 HD22 ' CG ' ' A' ' 26' ' ' ASN . 6.2 mp -62.79 169.18 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 72.01 110.905 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.4 -16.89 10.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 64.43 110.798 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.87 147.26 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.45 110.815 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.435 ' HE1' HG13 ' A' ' 67' ' ' VAL . 61.6 p-90 -124.62 129.76 51.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 64.22 110.893 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 64' ' ' ALA . 93.0 m -151.24 123.26 8.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 71.42 111.083 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.4 t -103.69 105.83 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 65.23 111.092 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -112.21 151.09 29.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 64.21 110.925 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.433 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -151.03 171.17 17.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.926 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.95 130.25 44.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 72.35 110.856 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.59 73.67 2.13 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.717 0.77 . . . . 64.31 110.943 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -50.07 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.727 2.285 . . . . 65.3 112.39 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -72.77 145.59 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 62.13 111.134 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.16 98.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.802 -0.714 . . . . 45.11 112.482 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 p -155.03 154.9 33.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.881 0.372 . . . . 51.5 111.123 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -173.58 131.07 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 72.41 110.916 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -78.8 107.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.1 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 m -62.87 -49.54 74.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.116 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.28 140.42 27.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 63.04 110.871 -179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.13 137.16 53.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 71.03 111.08 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.6 p90 -121.52 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 70.12 110.88 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.53 12.62 8.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 65.11 110.907 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.16 102.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.22 111.151 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.9 m -60.05 95.45 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.51 111.153 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.715 HG22 ' HB2' ' A' ' 64' ' ' ALA . 85.6 t -90.37 112.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.12 111.149 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.59 HG22 HG23 ' A' ' 63' ' ' THR . 12.3 t -106.52 177.49 4.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 64.41 111.128 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -133.46 160.55 37.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 64.54 110.838 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 m -160.37 85.64 0.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 74.5 110.884 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.74 -93.3 0.83 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 23.2 112.45 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -126.53 14.55 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.814 0.34 . . . . 75.23 110.857 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -126.94 146.89 50.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 70.12 110.861 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -129.45 155.95 44.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.908 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.59 HG23 HG22 ' A' ' 56' ' ' THR . 1.8 t -149.02 143.45 26.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 54.25 111.127 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.715 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -120.4 122.73 41.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 72.11 111.095 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.39 137.79 34.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.878 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -119.41 -30.52 4.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.944 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG13 ' HE1' ' A' ' 35' ' ' TRP . 13.9 m -90.99 42.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 74.03 111.152 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.11 2.97 67.53 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 73.3 112.511 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -117.27 -34.08 4.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 74.3 110.881 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.79 -70.24 0.82 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 72.34 110.881 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.0 -37.75 3.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.776 -0.726 . . . . 50.32 112.509 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -49.43 117.41 2.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.859 0.361 . . . . 71.12 111.156 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.478 HD13 ' N ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -136.46 131.79 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 72.1 110.957 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -56.87 160.65 5.6 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.566 0.698 . . . . 70.15 111.099 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 52.8 Cg_endo -69.82 -16.14 37.18 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.693 2.262 . . . . 41.11 112.284 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.51 115.44 0.77 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.767 -0.73 . . . . 65.22 112.533 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.08 172.54 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 64.32 111.084 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.83 131.16 56.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 51.42 110.781 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.62 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.5 m -139.23 109.93 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 62.34 111.118 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 m -113.53 164.38 13.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.21 110.867 -179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 30.8 p90 -155.88 134.27 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.901 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.55 177.25 19.38 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.727 -0.749 . . . . 55.42 112.433 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.719 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.5 p90 -174.43 178.31 2.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 72.42 110.939 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -130.96 125.85 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 45.02 110.85 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.04 155.34 20.23 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 53.15 112.527 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.26 109.65 22.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 53.5 110.859 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.14 -157.58 27.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.731 -0.747 . . . . 62.44 112.495 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -39.0 7.03 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.647 2.231 . . . . 40.2 112.372 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.5 26.6 32.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.706 -0.759 . . . . 64.44 112.477 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.8 75.78 2.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.661 0.744 . . . . 54.13 110.903 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 160.61 49.05 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.725 2.283 . . . . 72.55 112.297 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 m -148.32 171.37 16.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 63.01 110.878 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 63.35 53.42 2.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 62.24 110.85 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 22.6 p -67.14 126.72 30.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 71.34 110.89 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.5 118.77 6.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 71.1 110.907 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 97' ' ' ASN . 0.9 OUTLIER -130.24 155.64 45.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 75.51 110.889 -179.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 60.56 36.58 19.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 73.22 110.937 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.38 20.28 55.03 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 65.43 112.516 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.5 69.49 1.11 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.713 -0.756 . . . . 55.22 112.45 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.2 t -156.18 104.26 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 63.52 110.873 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 38.1 t -156.57 112.48 2.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 64.44 110.871 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.49 112.25 5.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 64.01 110.907 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 113.58 50.62 0.52 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.741 -0.743 . . . . 74.21 112.519 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.3 t -52.02 163.56 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 72.33 111.097 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 71.01 110.881 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.878 0.37 . . . . 70.43 111.04 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.441 ' HA ' HG21 ' A' ' 29' ' ' THR . 3.7 m -155.58 108.96 2.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.48 . . . . 73.51 111.089 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.49 95.26 3.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.817 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.77 152.47 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 53.32 111.158 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.4 p -146.97 163.02 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 63.25 111.14 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.27 163.84 31.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 32.31 111.09 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 142.99 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 53.54 111.198 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -94.35 125.75 39.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 72.12 110.852 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.61 165.48 20.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 43.23 111.117 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 170.21 8.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 62.32 110.863 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 -59.12 0.98 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 71.25 111.093 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.48 135.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 61.41 110.923 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.43 127.53 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 71.35 110.867 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.46 83.34 1.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.175 -0.466 . . . . 73.44 110.95 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.87 -86.32 0.66 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.72 -0.752 . . . . 61.11 112.533 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 t -103.97 -17.45 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 63.14 111.122 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.38 153.66 24.45 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.758 -0.734 . . . . 74.3 112.464 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -140.56 143.9 35.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.979 0.419 . . . . 73.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -99.3 127.26 9.19 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.729 -0.748 . . . . 64.31 112.447 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.82 132.21 10.98 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 54.41 112.453 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.91 103.71 7.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 51.13 110.87 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -92.11 141.27 28.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.168 -0.469 . . . . 45.55 110.973 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 m -118.55 127.45 53.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 65.21 111.082 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.91 131.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 74.13 111.16 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.0 ttmt -144.16 119.08 9.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 62.53 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -111.94 133.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.86 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -172.7 129.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 61.22 111.08 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.53 -19.49 19.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 62.55 112.445 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.1 OUTLIER -99.39 177.1 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.899 0.381 . . . . 73.51 111.118 -179.858 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -67.98 174.83 3.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 61.2 111.191 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.4 t -51.37 118.93 3.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 75.41 110.825 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 -176.14 5.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 55.32 110.917 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -142.66 -53.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 63.34 110.927 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.719 ' HB2' HG13 ' A' ' 67' ' ' VAL . 1.4 t -152.38 147.52 26.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 74.24 110.863 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.9 p-90 -110.36 126.44 54.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.905 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.7 m -118.86 108.61 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 63.14 111.149 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.734 HG11 ' CE2' ' A' ' 81' ' ' PHE . 3.6 p -101.46 109.56 26.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 74.31 111.116 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.22 136.92 47.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.875 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.01 172.19 13.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 72.42 110.992 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -97.93 130.42 44.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 75.44 110.855 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.445 ' CE1' HG21 ' A' ' 45' ' ' THR . 1.7 m-85 -111.51 80.1 2.58 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.66 0.743 . . . . 71.52 110.829 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -48.59 0.68 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.729 2.286 . . . . 71.22 112.328 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -74.65 144.73 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 53.45 111.118 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -42.87 96.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.718 -0.753 . . . . 64.31 112.416 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.445 HG21 ' CE1' ' A' ' 41' ' ' PHE . 99.5 m -156.81 137.84 13.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 75.12 111.119 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -151.95 131.2 12.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 64.03 110.865 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.694 HG22 ' CE2' ' A' ' 83' ' ' PHE . 91.4 t -72.37 102.95 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 73.43 111.158 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.2 m -62.89 -46.78 86.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.104 -179.892 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.64 147.77 34.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 61.24 110.885 -179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.17 144.31 40.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.156 -0.475 . . . . 72.42 111.062 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -129.41 142.59 50.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 73.23 110.91 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.42 13.04 8.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 75.14 110.816 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -173.2 92.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 41.0 111.08 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -55.39 99.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.55 111.086 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.981 HG22 ' HB2' ' A' ' 64' ' ' ALA . 63.9 t -94.47 112.6 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 73.32 111.118 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.3 t -102.59 175.43 5.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 64.13 111.16 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -133.33 157.34 45.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 53.14 110.881 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.6 t -159.25 85.15 0.79 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.883 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.69 -92.29 0.9 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.743 -0.742 . . . . 35.53 112.42 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.95 9.89 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 75.33 110.888 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -120.09 146.89 45.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.871 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -132.3 146.57 52.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 75.23 110.911 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 t -143.05 148.48 36.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.25 111.129 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.981 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -129.96 141.75 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 70.35 111.155 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.52 160.8 39.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 71.32 110.952 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -132.02 -52.43 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.842 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.762 HG22 ' H ' ' A' ' 71' ' ' GLY . 7.8 p -108.07 39.97 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 74.01 111.117 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.76 4.68 56.17 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 71.15 112.512 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -111.46 -25.68 9.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.756 0.312 . . . . 74.42 110.82 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.651 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.11 -38.73 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 64.32 110.874 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.762 ' H ' HG22 ' A' ' 67' ' ' VAL . . . 48.32 56.87 8.71 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.792 -0.718 . . . . 64.42 112.495 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.8 t -135.07 94.85 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.767 0.318 . . . . 74.44 111.198 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.703 HD23 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -134.3 160.96 36.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 71.35 110.939 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.703 ' O ' HD23 ' A' ' 73' ' ' LEU . . . -85.2 162.76 47.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.65 0.738 . . . . 55.04 111.051 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.653 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.76 -8.41 23.54 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 64.23 112.352 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -142.88 115.59 0.94 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.772 -0.727 . . . . 65.31 112.499 179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.7 172.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.816 0.341 . . . . 53.34 111.079 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.9 p -133.18 131.55 40.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 61.41 110.831 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -138.14 136.17 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 72.42 111.163 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.6 p -132.99 149.11 52.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.23 110.866 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 37' ' ' VAL . 25.6 p90 -139.43 156.47 46.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 72.1 110.873 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.84 175.47 18.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 54.3 112.467 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.694 ' CE2' HG22 ' A' ' 47' ' ' VAL . 22.4 p90 -173.41 -176.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 73.44 110.871 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -139.39 125.88 20.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 72.13 110.876 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -123.95 152.94 17.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.824 -0.703 . . . . 61.23 112.559 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.84 111.22 23.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.372 . . . . 71.15 110.838 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -155.56 26.54 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.713 -0.756 . . . . 62.13 112.456 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 -40.27 5.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.705 2.27 . . . . 72.2 112.337 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.59 27.56 21.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 73.03 112.526 180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -112.07 76.07 1.72 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 73.4 110.859 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 158.41 57.04 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.643 2.229 . . . . 71.05 112.313 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.55 172.41 14.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.871 -179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 58.1 50.2 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 61.33 110.882 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.51 104.05 1.48 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.179 -0.464 . . . . 41.41 110.884 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.1 143.97 50.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.874 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.604 HD12 ' HB2' ' A' ' 97' ' ' ASN . 1.4 pp -160.32 146.61 15.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 72.21 110.938 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.604 ' HB2' HD12 ' A' ' 96' ' ' LEU . 61.0 t30 60.83 55.33 3.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 73.4 110.852 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.1 39.81 36.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.782 -0.723 . . . . 51.3 112.418 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 61.44 62.91 5.33 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 73.22 112.493 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.3 107.74 3.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 71.42 110.935 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 44.0 t -146.12 138.51 25.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.979 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -118.53 147.28 43.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.276 -0.42 . . . . 70.22 110.814 -179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.08 -27.32 19.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.746 . . . . 54.52 112.499 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 t -170.26 159.38 7.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.77 0.319 . . . . 65.02 111.17 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 71.31 110.907 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.908 0.385 . . . . 74.22 111.154 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.96 141.65 52.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.106 -179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.0 m -143.47 95.26 2.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 51.31 110.846 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.57 132.73 44.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.5 . . . . 62.41 111.133 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 102' ' ' ASP . 0.8 OUTLIER -113.89 147.8 37.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 65.31 111.11 -179.909 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -143.63 163.85 32.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 54.23 111.14 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -152.15 132.52 13.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.175 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -73.66 146.06 44.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.435 . . . . 72.15 110.901 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -147.46 170.99 16.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 65.25 111.093 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -120.96 134.64 55.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.962 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.1 -60.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 63.14 111.191 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.47 145.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 64.31 110.869 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.59 125.99 49.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 72.24 110.819 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.3 p90 -112.28 102.23 10.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.154 -0.475 . . . . 74.32 110.972 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.22 -92.28 0.65 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.756 -0.735 . . . . 50.2 112.513 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -118.24 -17.47 9.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.742 0.306 . . . . 53.1 111.04 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.68 117.93 5.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.792 -0.718 . . . . 73.42 112.45 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -99.06 156.74 16.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.983 0.42 . . . . 62.01 110.847 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.71 109.22 2.32 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.761 -0.733 . . . . 75.42 112.424 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.67 141.13 20.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.742 . . . . 44.34 112.457 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.12 98.75 5.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.849 0.357 . . . . 62.22 110.849 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -90.17 123.75 34.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.955 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.5 m -96.06 119.98 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 64.34 111.026 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.66 131.64 66.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 74.14 111.086 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -139.44 118.15 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.41 110.899 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -108.49 119.21 38.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.35 110.836 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.4 t -172.18 143.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 61.22 111.166 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.45 -30.83 7.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 72.44 112.467 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.7 t -100.8 173.58 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.836 0.351 . . . . 75.23 111.109 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.5 p -62.05 -174.17 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 73.22 111.124 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -51.36 121.97 7.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 53.22 110.807 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.91 -175.7 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 62.24 110.918 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -143.55 -53.38 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 65.23 110.882 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.31 166.6 32.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.845 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -122.94 126.64 47.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.519 . . . . 74.34 110.934 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.4 m -120.78 100.86 7.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 71.51 111.14 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.583 HG13 ' HB3' ' A' ' 64' ' ' ALA . 7.7 p -102.8 119.17 50.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.302 -0.408 . . . . 71.04 111.151 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -131.41 141.22 49.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.35 110.838 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.85 167.61 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 54.53 110.914 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.08 130.07 44.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.266 -0.425 . . . . 71.41 110.826 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -112.76 76.21 2.1 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.643 0.735 . . . . 73.03 110.93 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -50.06 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.694 2.263 . . . . 72.32 112.343 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 64.34 111.143 -179.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.31 97.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 74.41 112.486 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.64 155.74 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.837 0.351 . . . . 75.14 111.12 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.74 130.59 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.32 110.862 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG22 ' CE2' ' A' ' 83' ' ' PHE . 89.6 t -79.92 99.06 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 72.21 111.189 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.7 m -62.99 -44.68 95.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 71.34 111.186 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.7 m -143.64 159.97 41.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.24 110.892 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.04 144.73 25.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.23 111.062 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -128.44 146.36 50.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 71.55 110.887 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 14.94 9.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.831 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.44 120.33 0.41 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 64.22 111.057 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.7 m -78.65 108.15 11.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 72.53 111.109 -179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.73 147.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.133 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.1 m -139.68 141.42 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.151 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -109.46 153.36 24.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 53.01 110.951 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 m -157.07 85.62 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 50.23 110.808 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.7 -93.07 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.729 -0.748 . . . . 73.33 112.489 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -126.46 6.31 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 74.23 110.876 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -120.09 145.7 46.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 75.13 110.812 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -126.79 152.87 46.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 72.23 110.894 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.3 t -138.48 150.4 46.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.443 . . . . 74.3 111.111 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.583 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.86 125.9 36.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.111 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 141.04 32.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 73.35 110.928 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -116.99 -52.07 2.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 62.14 110.908 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -100.82 39.17 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 74.51 111.128 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -76.29 -1.59 70.26 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.753 -0.737 . . . . 75.21 112.432 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -112.47 -30.96 6.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.762 0.315 . . . . 71.34 110.93 -179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.549 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.1 m-20 -101.55 -47.06 4.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 73.53 110.931 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.614 ' H ' HG12 ' A' ' 67' ' ' VAL . . . 51.39 55.77 18.11 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 65.04 112.488 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 70' ' ' ASN . 1.7 t -132.65 94.8 3.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 74.33 111.128 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -137.64 160.9 37.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 75.23 110.896 179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -82.39 162.5 56.04 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 63.15 111.164 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.652 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.6 Cg_endo -69.84 -8.36 23.41 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.61 2.207 . . . . 71.01 112.359 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.89 115.72 1.01 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 65.32 112.501 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.96 172.14 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.375 . . . . 71.21 111.02 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m -145.51 131.68 19.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 62.05 110.761 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.07 149.19 18.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.498 . . . . 72.22 111.111 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.9 p -130.52 135.93 48.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 71.55 110.874 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CE2' HG11 ' A' ' 37' ' ' VAL . 26.4 p90 -122.79 135.18 54.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 73.3 110.862 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -108.86 178.26 20.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 54.02 112.491 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CE2' HG22 ' A' ' 47' ' ' VAL . 24.7 p90 -174.26 -179.97 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.899 0.38 . . . . 72.24 110.882 -179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.03 149.66 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 34.14 110.893 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.67 157.36 27.69 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.77 -0.729 . . . . 73.31 112.515 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.3 m -102.48 109.62 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 65.0 110.858 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.9 -160.73 30.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 42.14 112.522 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -38.36 7.95 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.647 2.232 . . . . 75.24 112.359 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.2 26.68 27.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.736 -0.745 . . . . 62.15 112.515 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.78 75.27 1.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.641 0.734 . . . . 74.1 110.854 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 160.69 48.75 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.59 2.193 . . . . 63.22 112.372 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.2 p -148.52 161.71 41.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 70.45 110.9 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 62.99 65.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 60.54 110.832 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 34.9 t -91.4 94.05 9.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 70.42 110.946 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.71 118.73 35.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.245 -0.434 . . . . 73.52 110.882 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.2 pp -126.72 155.81 42.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.04 110.93 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.463 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER 63.9 19.94 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 60.21 110.892 179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.16 41.88 4.79 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.725 -0.75 . . . . 73.54 112.467 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.7 71.28 1.32 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 62.03 112.484 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 t -156.25 104.17 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.02 110.851 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -160.75 112.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 72.53 110.905 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.456 ' HB2' HG22 ' A' ' 5' ' ' THR . 1.6 m-20 -96.18 164.95 12.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 62.21 110.869 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.07 37.61 80.73 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 34.44 112.461 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 71.6 p -150.83 -176.39 5.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.78 0.324 . . . . 71.34 111.154 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 62.22 110.826 -179.83 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.882 0.372 . . . . 73.13 111.12 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.8 t -145.01 43.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 64.05 111.181 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 p -157.73 -175.6 5.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 55.13 110.801 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.93 143.64 26.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 70.22 111.14 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.551 HG22 ' CB ' ' A' ' 102' ' ' ASP . 45.5 p -136.96 149.58 47.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 65.13 111.141 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.64 163.82 34.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 54.41 111.132 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.523 HG23 ' CG2' ' A' ' 104' ' ' THR . 40.4 m -153.5 147.7 25.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.161 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -80.61 144.27 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 75.1 110.898 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.18 165.16 28.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 73.13 111.135 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -111.09 136.24 50.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 40.13 110.924 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.9 m -101.22 -68.3 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 74.42 111.125 179.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.85 138.89 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 50.53 110.909 -179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -118.24 126.24 51.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.919 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -111.92 105.74 14.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.948 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.44 -91.5 0.65 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.807 -0.711 . . . . 33.24 112.499 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 t -117.26 -17.49 10.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.92 0.39 . . . . 71.54 111.223 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.76 146.87 20.86 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 63.4 112.424 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -128.85 145.73 51.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 70.11 110.851 -179.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.17 109.69 3.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.722 -0.752 . . . . 61.1 112.47 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.78 133.09 11.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 72.53 112.471 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -120.05 99.28 6.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 71.04 110.865 -179.697 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -90.24 129.73 36.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 71.41 110.916 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -105.99 128.16 53.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 55.14 111.077 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.681 ' HB ' HG13 ' A' ' 79' ' ' VAL . 18.2 t -133.19 132.6 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 72.54 111.176 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tttp -143.89 138.12 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 63.21 110.923 179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.521 ' HB3' HD21 ' A' ' 32' ' ' LEU . 3.1 m-80 -119.44 131.24 55.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 70.33 110.855 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -159.0 161.0 36.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 72.51 111.155 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.37 -58.57 4.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.77 -0.729 . . . . 63.32 112.471 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 t -62.73 161.18 12.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 63.11 111.097 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 p -57.87 -178.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 61.43 111.163 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -54.07 123.05 11.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.278 -0.419 . . . . 61.34 110.805 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 26' ' ' ASN . 4.2 mm? -64.73 151.97 43.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 65.12 110.95 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.9 t -116.51 -18.19 10.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 53.14 110.874 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.48 151.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 63.24 110.86 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.403 ' CE2' HG21 ' A' ' 79' ' ' VAL . 64.3 p-90 -132.37 127.64 35.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.98 179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 65' ' ' LYS . 80.0 m -142.92 124.95 15.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 74.14 111.147 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' NE1' ' A' ' 39' ' ' TRP . 31.4 t -110.38 105.8 19.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 72.23 111.132 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.8 OUTLIER -117.17 150.98 37.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 73.44 110.871 -179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.474 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -152.43 166.54 31.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.941 -179.913 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.17 132.69 43.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.272 -0.422 . . . . 73.14 110.84 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -113.02 76.23 2.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.635 0.731 . . . . 65.42 110.859 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -50.1 0.5 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.677 2.251 . . . . 63.33 112.31 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 55.9 p -70.4 145.37 51.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 62.24 111.168 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.53 97.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.793 -0.718 . . . . 51.25 112.386 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.9 p -154.72 157.7 38.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.372 . . . . 61.03 111.134 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 ptpt -173.59 130.9 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 72.1 110.934 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.705 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.2 t -84.17 104.14 12.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 51.22 111.17 179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -47.39 83.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 62.11 111.185 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 m -141.51 164.43 30.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.926 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.87 140.71 21.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 74.05 111.13 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 17.4 p90 -127.57 143.6 51.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.957 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.31 14.86 9.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.298 -0.41 . . . . 64.15 110.892 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.62 100.04 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.151 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.9 m -60.43 95.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.204 -0.453 . . . . 55.24 111.112 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 64' ' ' ALA . 87.9 t -87.29 134.26 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.114 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -124.28 170.09 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.04 111.156 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -131.33 154.2 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.93 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.7 t -159.42 85.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 73.22 110.845 -179.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.82 -94.28 0.87 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.684 -0.77 . . . . 64.42 112.513 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.29 14.36 7.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 72.32 110.886 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -128.69 146.84 50.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 71.1 110.805 -179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 34.5 m95 -129.0 164.07 24.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 74.02 110.855 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 38' ' ' GLU . 99.7 m -152.67 144.13 23.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 72.42 111.143 -179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.464 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -122.49 123.61 41.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 73.41 111.122 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HG3' HG23 ' A' ' 36' ' ' THR . 0.0 OUTLIER -137.55 139.22 40.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 62.51 110.906 179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.76 -37.74 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 65.33 110.916 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 m -91.98 42.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 71.31 111.115 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.56 2.0 69.56 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.703 -0.76 . . . . 72.01 112.492 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.86 -33.84 4.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.754 0.312 . . . . 74.44 110.921 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.68 -71.26 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 71.01 110.952 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.71 -38.18 3.23 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.7 -0.762 . . . . 74.52 112.523 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 t -50.95 113.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.851 0.358 . . . . 74.24 111.149 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -141.15 133.07 27.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.866 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -53.06 160.36 1.59 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.512 0.672 . . . . 72.33 111.155 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 54.7 Cg_endo -69.69 -15.93 37.58 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.672 2.248 . . . . 74.4 112.394 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -138.58 115.61 1.18 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.8 -0.715 . . . . 72.24 112.495 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -177.58 172.39 1.78 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.793 0.33 . . . . 62.13 111.073 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.62 131.24 52.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.801 -179.774 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.681 HG13 ' HB ' ' A' ' 24' ' ' VAL . 5.1 p -129.48 118.78 46.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 73.43 111.128 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.99 138.59 52.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 73.13 110.872 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 41.8 p90 -138.2 136.31 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 71.42 110.911 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.57 -178.62 19.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.502 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.705 ' CE1' HG22 ' A' ' 47' ' ' VAL . 17.4 p90 -174.47 175.72 2.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 74.1 110.861 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -125.54 127.03 45.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 65.43 110.912 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.15 157.48 21.98 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 71.34 112.507 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -108.16 109.44 20.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 75.12 110.899 -179.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.54 -158.74 29.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.78 -0.724 . . . . 64.32 112.502 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -35.22 12.76 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 73.35 112.327 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.97 26.78 28.05 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 40.03 112.448 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.1 m -112.22 76.49 1.89 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.588 0.709 . . . . 53.14 110.846 -179.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 160.72 48.65 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.675 2.25 . . . . 71.33 112.299 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -148.53 174.21 12.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.41 110.891 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 51.88 64.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.492 . . . . 64.2 110.921 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 27.8 t -86.51 130.3 34.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.894 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 144.0 23.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 73.14 110.946 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -147.67 156.73 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.89 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 67.28 40.51 2.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 64.04 110.895 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 71.09 42.13 59.32 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.677 -0.773 . . . . 63.03 112.543 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.31 71.81 1.26 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 50.15 112.493 -179.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.6 138.03 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.341 . . . . 64.42 110.906 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 25.1 p -175.61 129.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 61.22 110.884 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.551 ' CB ' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -127.45 106.4 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.886 179.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.491 ' O ' HG23 ' A' ' 104' ' ' THR . . . 112.36 34.24 1.97 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.745 -0.74 . . . . 74.14 112.537 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.523 ' CG2' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -178.09 178.66 0.9 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.777 0.323 . . . . 55.34 111.091 -179.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 55.33 110.859 -179.818 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.891 0.376 . . . . 50.3 111.076 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.622 HG21 ' HB3' ' A' ' 97' ' ' ASN . 10.2 t -156.29 160.64 39.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 53.15 111.126 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.5 96.03 3.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.828 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' CB ' HD11 ' A' ' 96' ' ' LEU . . . -159.61 142.0 13.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.105 -0.498 . . . . 51.12 111.139 179.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -122.58 151.65 41.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 54.21 111.098 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.75 ' HB2' HD22 ' A' ' 96' ' ' LEU . . . -115.8 154.76 29.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 52.31 111.1 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.66 111.93 11.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 72.35 111.114 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -74.7 126.69 31.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.253 -0.43 . . . . 74.31 110.915 179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.3 161.34 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 65.23 111.07 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.09 155.21 18.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 70.42 110.908 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.09 -57.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 75.02 111.101 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.38 130.9 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 74.35 110.825 -179.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.91 127.51 55.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 70.44 110.843 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -110.5 82.05 1.53 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.44 110.901 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.74 -87.28 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 72.11 112.464 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 t -100.69 -17.55 16.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.73 0.3 . . . . 63.23 111.095 -179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.15 155.94 25.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.53 112.516 179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -144.43 143.44 30.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.89 0.376 . . . . 75.23 110.936 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 117.34 5.83 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 62.51 112.524 -179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 151.91 20.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.773 -0.727 . . . . 74.34 112.449 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.79 96.56 2.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.87 0.367 . . . . 65.54 110.926 -179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -90.09 136.29 33.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 75.12 110.886 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 m -114.72 101.9 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 70.31 111.124 179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.49 HG22 HG21 ' A' ' 37' ' ' VAL . 17.0 t -88.88 131.72 35.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 75.04 111.119 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -132.75 128.19 36.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 71.15 110.868 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -109.43 132.24 54.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.21 110.899 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.9 t -172.07 121.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 70.41 111.138 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.74 -80.29 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 62.22 112.421 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.567 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.0 OUTLIER -56.51 168.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.338 . . . . 64.44 111.228 -179.852 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.4 p -60.54 -169.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.287 -0.415 . . . . 74.55 111.144 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.92 121.73 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 72.13 110.827 -179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' A' ' 75' ' ' PRO . 2.8 mm? -65.36 126.16 27.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 64.44 110.87 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.96 -23.99 28.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 72.21 110.876 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.0 170.13 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.22 110.825 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -136.04 136.71 40.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.906 180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 64' ' ' ALA . 4.4 m -152.69 144.23 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 65.03 111.222 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 24' ' ' VAL . 21.4 t -129.91 105.83 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 72.33 111.147 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.649 ' HB3' HG23 ' A' ' 63' ' ' THR . 9.4 pt-20 -117.9 134.24 55.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.911 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.472 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.08 173.32 11.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 72.03 110.849 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 130.35 44.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 75.14 110.906 179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -113.45 73.92 2.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.647 0.737 . . . . 72.23 110.865 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -50.16 0.49 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.702 2.268 . . . . 71.54 112.302 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.1 p -73.05 145.72 46.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 64.13 111.13 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -38.49 98.75 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.826 -0.702 . . . . 71.55 112.456 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 p -154.92 154.62 32.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 64.13 111.106 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.51 130.86 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 70.34 110.928 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.681 HG22 ' CE2' ' A' ' 83' ' ' PHE . 98.0 t -77.92 108.5 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 74.1 111.116 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.73 -45.9 70.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 51.43 111.143 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -141.67 157.0 45.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 70.3 110.842 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.06 157.39 40.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 75.1 111.163 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.8 p90 -141.0 146.61 37.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.911 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.23 14.81 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 71.42 110.845 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.57 105.76 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 62.22 111.149 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -65.48 90.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 41.32 111.132 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG11 HG21 ' A' ' 47' ' ' VAL . 60.0 t -80.9 118.42 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.23 111.122 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.1 t -110.9 175.14 5.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 61.15 111.085 -179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -134.21 160.15 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 74.44 110.86 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.17 85.88 0.6 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 54.3 110.866 -179.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.17 -92.73 0.57 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 65.14 112.444 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -126.03 17.36 7.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.963 0.411 . . . . 44.11 110.953 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -128.57 146.83 50.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.489 . . . . 73.2 110.809 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -132.13 150.08 52.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.92 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.649 HG23 ' HB3' ' A' ' 38' ' ' GLU . 85.7 m -142.49 145.25 33.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 71.24 111.119 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.457 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -121.88 114.66 21.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.33 111.084 179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.25 136.25 48.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 70.03 110.859 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.56 -51.4 1.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.42 110.95 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.2 m -93.66 40.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.12 111.152 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -73.22 -0.71 54.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.814 -0.708 . . . . 51.4 112.433 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 70' ' ' ASN . 3.5 p-90 -104.44 -27.83 11.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.778 0.323 . . . . 72.12 110.899 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 72' ' ' THR . 12.7 m-20 -132.89 -70.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 73.23 110.899 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.62 13.3 50.55 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 41.3 112.488 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.473 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.4 t -73.3 94.15 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 72.11 111.152 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -140.54 151.45 44.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.855 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -52.99 163.52 0.84 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.576 0.703 . . . . 55.43 111.115 179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.685 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -8.14 22.85 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 2.248 . . . . 72.14 112.327 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.22 115.75 1.81 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.765 -0.731 . . . . 63.4 112.524 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.48 172.37 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.767 0.318 . . . . 63.3 111.083 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.9 m -137.22 131.71 32.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 71.12 110.919 -179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 t -143.42 110.29 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.33 111.068 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.0 p -103.99 135.0 46.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.905 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -118.39 126.44 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.4 110.82 -179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.81 173.59 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 65.01 112.495 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.681 ' CE2' HG22 ' A' ' 47' ' ' VAL . 20.6 p90 -174.73 176.62 2.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.34 110.865 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -127.99 125.82 40.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 74.54 110.862 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -125.27 161.79 19.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.781 -0.723 . . . . 50.24 112.573 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.2 t -109.32 110.28 21.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.912 0.387 . . . . 62.25 110.918 -179.744 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.53 -158.7 28.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.722 -0.752 . . . . 74.12 112.435 -179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -36.08 11.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.251 . . . . 60.51 112.382 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.83 27.08 30.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.488 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 m -112.36 77.02 2.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.728 0.775 . . . . 72.13 110.841 -179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 168.46 21.49 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.729 2.286 . . . . 63.43 112.335 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.8 m -148.43 169.17 20.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 42.33 110.84 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.4 m120 59.07 48.92 10.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.818 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.2 m -65.46 96.53 0.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.231 -0.44 . . . . 61.23 110.897 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -121.2 121.29 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 74.13 110.937 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 6' ' ' ALA . 0.6 OUTLIER -124.74 155.71 38.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 63.21 110.957 179.876 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.622 ' HB3' HG21 ' A' ' 2' ' ' THR . 0.1 OUTLIER 63.33 27.22 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.866 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.06 42.05 7.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.684 -0.769 . . . . 43.23 112.493 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 70.1 1.12 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.701 -0.762 . . . . 63.13 112.469 -179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.11 131.59 9.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 40.34 110.85 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -177.4 172.9 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.884 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.26 83.13 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 65.43 110.889 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.06 48.03 0.68 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 43.13 112.49 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -70.72 154.96 41.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 72.32 111.112 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 62.21 110.885 -179.897 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.86 0.362 . . . . 35.33 111.149 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.78 172.92 6.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 71.34 111.102 -179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 m -164.7 95.21 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 71.2 110.906 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.78 134.61 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 71.45 111.094 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.563 HG22 ' H ' ' A' ' 102' ' ' ASP . 19.8 p -145.4 168.91 19.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.53 111.107 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.98 123.55 23.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 73.33 111.069 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.3 t -99.07 139.61 34.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 71.23 111.209 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -87.56 143.86 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.9 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.77 154.97 43.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 60.24 111.063 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.49 144.51 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.32 110.876 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 -59.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 63.04 111.171 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 t -179.99 149.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.1 110.896 -179.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -117.73 126.46 52.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.137 -0.483 . . . . 71.33 110.898 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -111.74 86.71 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 73.45 110.916 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 74.94 -82.15 0.87 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.711 -0.757 . . . . 74.21 112.498 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.9 t -117.35 -17.56 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.845 0.355 . . . . 72.11 111.136 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.17 166.63 38.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.704 -0.76 . . . . 23.21 112.472 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -148.59 157.54 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.22 110.876 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.59 130.62 9.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.797 -0.716 . . . . 73.54 112.537 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.91 145.89 17.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.76 -0.733 . . . . 43.12 112.473 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.22 95.46 3.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 72.22 110.841 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -89.81 125.58 35.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.071 -0.513 . . . . 71.51 110.921 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 97.3 m -110.9 101.85 10.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 74.04 111.159 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.1 t -94.12 131.22 41.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 71.32 111.099 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.2 117.89 11.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.889 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.61 125.51 48.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 72.21 110.91 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -164.91 139.18 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 75.03 111.158 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.44 9.81 54.63 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.683 -0.77 . . . . 71.35 112.445 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.4 t -130.98 174.53 9.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 73.33 111.206 -179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.39 165.43 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 75.21 111.142 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.2 p -69.07 99.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.712 ' HB3' HD23 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -58.28 178.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 51.41 110.933 -179.996 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.56 -52.8 0.71 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.834 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 m -133.75 140.4 46.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 41.44 110.834 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -115.38 127.09 55.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 62.35 110.863 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.435 HG23 ' O ' ' A' ' 64' ' ' ALA . 8.1 m -134.09 116.94 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 74.21 111.098 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG12 ' NE1' ' A' ' 39' ' ' TRP . 17.3 t -103.88 105.5 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.31 111.142 179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.741 ' HB3' HG23 ' A' ' 63' ' ' THR . 21.2 pt-20 -120.38 136.86 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 70.13 110.861 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.468 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -137.38 170.26 16.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 73.42 110.823 -179.936 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.45 129.83 45.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 55.25 110.85 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -113.1 76.41 2.39 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.678 0.752 . . . . 62.44 110.847 -179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 -49.83 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 54.11 112.27 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -71.35 145.12 49.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.144 -179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.42 99.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.735 -0.745 . . . . 64.44 112.538 179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.7 p -154.55 155.36 34.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 74.14 111.162 -179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 ptpp? -173.73 130.65 0.42 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.317 -0.401 . . . . 75.04 110.889 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 83' ' ' PHE . 98.0 t -85.44 97.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 74.14 111.098 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -44.15 94.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 74.3 111.139 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.2 m -136.8 161.25 36.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 53.13 110.861 -179.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.01 162.08 41.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 55.42 111.12 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -148.63 142.59 25.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.448 . . . . 75.13 110.962 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t0 64.39 14.55 8.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 72.43 110.883 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -172.84 101.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.097 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.8 m -62.72 97.54 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 53.22 111.134 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -87.13 128.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 45.4 111.093 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -117.2 168.8 9.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 72.04 111.171 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -130.43 153.24 48.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.01 110.879 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 m -159.43 85.66 0.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 61.32 110.849 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.34 -93.94 0.81 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.717 -0.754 . . . . 21.42 112.442 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -126.4 14.8 7.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.8 0.333 . . . . 65.34 110.845 -179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -128.83 146.93 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.13 110.894 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -129.77 155.03 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 63.42 110.962 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.741 HG23 ' HB3' ' A' ' 38' ' ' GLU . 43.3 m -139.71 148.49 42.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 73.32 111.197 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.435 ' O ' HG23 ' A' ' 36' ' ' THR . . . -123.76 136.34 54.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 72.12 111.17 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.4 131.43 10.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.423 . . . . 74.53 110.828 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -114.31 -28.95 7.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 71.01 110.846 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 HD21 ' A' ' 70' ' ' ASN . 28.7 m -105.67 39.53 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 63.43 111.142 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.54 4.14 65.41 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.673 -0.775 . . . . 75.1 112.494 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.468 ' CE3' ' HB3' ' A' ' 70' ' ' ASN . 0.6 OUTLIER -118.21 -32.94 4.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.782 0.325 . . . . 73.35 110.96 -179.965 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.468 ' HB3' ' CE3' ' A' ' 69' ' ' TRP . 6.1 p30 -105.48 -37.25 6.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 64.14 110.951 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.68 54.36 25.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.743 -0.741 . . . . 43.21 112.508 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.1 p -124.07 118.84 27.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.818 0.342 . . . . 60.41 111.151 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 32' ' ' LEU . 22.6 tp -138.56 160.91 38.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 64.54 110.916 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -108.4 162.9 18.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.573 0.701 . . . . 60.01 111.064 179.797 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.8 Cg_endo -69.8 -8.43 23.58 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.637 2.225 . . . . 54.33 112.341 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -156.37 114.53 0.62 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.77 -0.729 . . . . 75.11 112.494 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 178.37 172.34 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 21.54 111.083 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.1 p -131.54 131.37 43.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 62.15 110.898 -179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.05 115.55 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 71.34 111.183 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.94 142.46 38.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 61.53 110.893 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HE2' HG21 ' A' ' 37' ' ' VAL . 48.1 p90 -136.27 133.8 37.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 74.03 110.909 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -111.32 -179.37 20.17 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 44.23 112.413 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 47' ' ' VAL . 31.7 p90 -171.84 176.77 3.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.929 0.395 . . . . 75.02 110.842 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.62 125.68 36.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 75.31 110.931 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.78 161.92 26.67 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.678 -0.773 . . . . 61.33 112.491 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 p -105.61 125.47 51.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.878 0.37 . . . . 45.22 110.88 -179.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.35 -163.3 30.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 72.32 112.484 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -36.16 11.53 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.697 2.265 . . . . 70.43 112.405 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.43 28.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.775 -0.726 . . . . 61.41 112.52 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -112.78 75.7 1.97 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.659 0.742 . . . . 72.12 110.834 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 157.0 61.88 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 71.03 112.321 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -145.88 177.09 9.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.889 -179.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.8 m120 52.54 58.8 5.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 74.43 110.939 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.0 t -76.98 110.06 11.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 73.13 110.931 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -131.95 143.96 50.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 64.11 110.859 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.618 HD12 ' HB2' ' A' ' 97' ' ' ASN . 2.1 pp -156.04 154.44 31.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.937 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.618 ' HB2' HD12 ' A' ' 96' ' ' LEU . 51.0 t30 63.31 47.33 4.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 75.35 110.874 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.35 18.51 73.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.723 -0.751 . . . . 70.41 112.517 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.96 69.74 1.19 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 61.13 112.513 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 m -156.05 104.7 2.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 73.43 110.846 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.6 t -151.42 112.6 4.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 75.14 110.913 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.563 ' H ' HG22 ' A' ' 5' ' ' THR . 0.5 OUTLIER -93.81 134.89 35.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.895 -179.951 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.07 -26.19 22.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.769 . . . . 54.13 112.493 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.58 142.04 29.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.845 0.355 . . . . 62.13 111.156 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 62.12 110.858 -179.842 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.882 0.372 . . . . 71.32 111.134 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 71.1 p -109.31 38.23 2.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 61.51 111.174 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.437 ' HA ' HG23 ' A' ' 29' ' ' THR . 82.3 p -151.69 -172.96 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 72.4 110.862 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.45 134.29 35.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.127 -0.488 . . . . 60.42 111.122 179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.11 158.67 43.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 63.21 111.164 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.86 31.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 64.24 111.064 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.03 147.52 47.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 63.43 111.175 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.43 142.4 31.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 64.43 110.937 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 21' ' ' SER . . . -143.52 152.01 40.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 61.43 111.116 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.89 147.93 25.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.259 -0.428 . . . . 52.05 110.932 179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 -59.98 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.21 111.136 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.55 129.95 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.442 . . . . 75.34 110.831 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.99 127.82 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 74.33 110.863 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 p90 -110.66 82.22 1.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.875 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.61 -87.63 0.63 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.725 -0.75 . . . . 50.24 112.48 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -100.39 -17.68 17.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.798 0.332 . . . . 61.34 111.113 -179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.9 152.81 22.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.704 -0.76 . . . . 62.22 112.431 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -141.95 142.51 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.002 0.43 . . . . 64.44 110.884 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.54 112.97 4.51 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 64.12 112.425 -179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -87.26 131.48 10.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.493 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 45.1 t -131.43 98.68 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 73.43 110.906 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -92.36 143.28 26.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 72.41 110.867 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.9 m -123.88 111.53 16.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 72.42 111.154 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.535 ' HB ' HG23 ' A' ' 79' ' ' VAL . 15.7 t -109.57 132.58 57.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 54.23 111.12 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 ttpp -137.68 130.28 29.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 70.0 110.927 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.497 ' HB2' HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -107.68 144.91 34.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.12 110.881 179.979 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -172.67 162.23 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 75.11 111.13 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.05 -62.72 3.3 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.713 -0.756 . . . . 42.51 112.508 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 3' ' ' SER . 29.8 p -64.98 163.43 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.803 0.335 . . . . 63.34 111.222 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -174.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 65.35 111.129 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 m -57.19 120.18 7.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 55.45 110.836 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 26' ' ' ASN . 1.2 mp -56.84 153.53 10.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.48 . . . . 42.33 110.87 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.14 -15.3 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.3 110.829 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.02 152.63 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.868 -179.746 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.46 ' HD1' HD13 ' A' ' 73' ' ' LEU . 59.4 p-90 -136.97 129.53 30.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 71.11 110.922 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -152.89 122.37 6.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 71.12 111.137 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' NE1' ' A' ' 39' ' ' TRP . 11.1 t -102.76 115.95 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 63.54 111.065 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -118.5 152.32 36.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 70.54 110.858 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.403 ' NE1' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -155.0 167.22 31.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 75.12 110.907 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.99 133.68 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 72.2 110.823 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -112.02 76.72 1.84 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 74.42 110.86 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -49.57 0.55 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.65 2.234 . . . . 74.13 112.335 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' THR . 0.2 OUTLIER -73.38 144.74 46.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 73.32 111.124 -179.96 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -40.19 96.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.15 112.466 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 ' N ' ' O ' ' A' ' 43' ' ' THR . 6.5 m -156.66 155.95 32.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 72.04 111.116 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.26 131.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.853 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.727 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.6 t -75.06 99.79 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 61.33 111.133 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 t -67.53 -40.69 85.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 63.24 111.133 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.5 m -142.95 148.55 37.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 75.55 110.786 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.01 163.11 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 61.51 111.063 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -148.51 144.9 27.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 64.24 110.957 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 63.24 16.28 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 74.31 110.849 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' A' ' 81' ' ' PHE . . . -172.1 95.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 53.42 111.12 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.2 m -54.6 100.84 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 73.42 111.126 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.2 t -84.29 128.43 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.24 111.087 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 m -126.89 141.69 51.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 33.45 111.075 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -108.43 159.89 16.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.474 . . . . 74.31 110.876 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 85.82 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 74.41 110.869 -179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.81 -90.73 0.49 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.746 . . . . 54.11 112.521 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.22 7.51 7.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 75.41 110.822 -179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -119.15 146.89 44.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.41 110.852 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -128.06 160.09 33.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 65.52 110.86 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.2 t -148.77 149.48 31.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 73.21 111.103 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.32 110.86 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 35.21 111.103 179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.39 142.84 48.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 72.13 110.889 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -120.26 -33.07 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.954 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 m -92.56 42.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 73.14 111.126 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.29 1.88 68.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.763 -0.732 . . . . 61.41 112.486 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -116.74 -34.09 4.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.822 0.344 . . . . 75.52 110.976 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.24 -70.86 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 73.22 110.897 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 90.06 -37.65 3.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 64.54 112.487 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 t -49.92 117.66 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.806 0.336 . . . . 71.11 111.122 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 ' HD1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -144.1 143.31 31.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.972 179.928 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -62.45 160.51 33.04 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.565 0.698 . . . . 52.04 111.121 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.7 Cg_endo -69.83 -18.31 36.74 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.739 2.292 . . . . 73.3 112.326 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.99 115.48 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 54.11 112.472 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.8 172.41 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.811 0.339 . . . . 41.21 111.087 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -120.78 131.02 54.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 72.31 110.879 -179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG23 ' HB ' ' A' ' 24' ' ' VAL . 5.8 m -136.2 109.43 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 65.51 111.119 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.6 p -113.74 164.36 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 62.25 110.886 -179.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.478 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 53.5 p90 -154.93 132.52 11.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.882 -179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.45 173.28 18.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.752 -0.737 . . . . 65.45 112.472 -179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.727 ' CE1' HG22 ' A' ' 47' ' ' VAL . 26.3 p90 -174.83 176.73 2.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.349 . . . . 75.33 110.85 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -129.92 139.04 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 61.35 110.906 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.2 159.49 27.08 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 42.2 112.493 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.43 112.08 24.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 63.12 110.888 -179.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.5 -157.81 27.62 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.669 -0.777 . . . . 75.43 112.443 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -42.31 3.49 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.672 2.248 . . . . 71.42 112.382 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.73 26.94 30.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.748 -0.739 . . . . 62.05 112.458 179.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.6 t -112.79 75.29 1.87 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.675 0.75 . . . . 52.31 110.842 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.76 159.02 54.96 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 51.34 112.343 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.9 m -142.72 165.92 26.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 52.21 110.938 -179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.9 m120 58.67 63.77 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 62.33 110.893 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 39.2 t -79.51 92.23 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 44.32 110.858 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 118.72 37.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 71.21 110.922 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 97' ' ' ASN . 3.6 pp -130.27 155.76 45.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.925 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.603 ' HB2' HD12 ' A' ' 96' ' ' LEU . 42.4 t30 62.41 20.79 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 45.05 110.903 179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.58 24.83 10.52 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.715 -0.755 . . . . 70.12 112.495 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.52 71.37 1.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.35 112.486 -179.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 t -156.31 103.94 2.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 65.23 110.923 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.7 t -149.04 137.53 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 55.1 110.842 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -127.42 161.95 27.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.875 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 93.87 -29.61 8.42 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.85 -0.69 . . . . 74.41 112.522 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.48 -172.8 2.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.8 0.334 . . . . 65.15 111.143 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 50.54 110.883 -179.864 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 2' ' ' THR . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.895 0.379 . . . . 70.24 111.114 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.627 ' HA ' HG21 ' A' ' 29' ' ' THR . 0.1 OUTLIER -165.98 85.86 0.34 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 73.05 111.114 -179.897 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 m -100.7 95.38 6.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 34.45 110.88 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.21 133.55 42.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 64.51 111.167 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.87 150.64 52.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 65.11 111.163 -179.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 96' ' ' LEU . . . -139.55 149.51 43.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 44.24 111.126 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.87 119.25 16.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.155 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -69.5 146.25 52.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.871 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -149.25 154.87 39.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 41.22 111.081 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.33 156.05 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 52.3 110.931 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -58.94 1.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 64.53 111.119 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.94 129.25 0.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.421 . . . . 74.25 110.865 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -115.83 127.98 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 51.12 110.9 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.7 p90 -110.59 82.94 1.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.901 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.48 -85.12 0.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.741 . . . . 63.32 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 t -103.29 -17.57 15.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 64.21 111.123 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.6 156.11 26.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.804 -0.712 . . . . 33.24 112.515 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -145.16 142.91 30.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.885 0.374 . . . . 74.33 110.864 -179.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -102.57 122.12 7.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 54.15 112.506 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.7 150.02 20.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 61.43 112.562 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -147.05 94.59 2.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.897 0.38 . . . . 71.34 110.816 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -90.27 134.87 34.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 73.34 110.902 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.9 m -113.12 102.1 10.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.14 111.111 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.7 t -91.68 131.59 38.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 62.45 111.162 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.48 118.12 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.25 110.895 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -116.0 133.21 56.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 75.15 110.884 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.8 t -172.04 153.72 3.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.44 111.08 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.93 -18.14 54.41 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.821 -0.704 . . . . 74.3 112.454 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 2' ' ' THR . 0.2 OUTLIER -98.5 171.18 8.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 75.13 111.117 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -171.35 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.13 111.19 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.65 125.67 13.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 42.22 110.828 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.36 179.16 5.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 62.31 110.953 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -143.66 -52.65 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.84 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.91 174.42 14.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.923 -179.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -140.25 127.35 20.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 54.24 110.907 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.7 m -113.74 102.14 9.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 70.11 111.116 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 81' ' ' PHE . 4.6 p -101.26 115.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 63.04 111.178 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.672 ' CG ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -131.92 151.45 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 74.3 110.865 -179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.12 169.68 18.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 74.32 110.937 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.19 128.11 44.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 63.14 110.898 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -112.59 77.15 2.28 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.633 0.73 . . . . 74.24 110.855 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -49.95 0.51 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.275 . . . . 75.44 112.264 -179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 44' ' ' GLY . 26.5 m -71.93 145.35 48.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 71.14 111.163 -179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 43' ' ' THR . . . -36.36 98.56 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.769 -0.729 . . . . 70.21 112.433 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.7 p -154.75 153.49 31.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 71.24 111.163 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.75 130.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 74.3 110.882 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 83' ' ' PHE . 97.7 t -79.53 96.59 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 65.34 111.154 179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.1 t -63.57 -40.98 98.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 75.52 111.183 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.6 m -144.98 147.96 33.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.887 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.39 157.78 44.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 52.54 111.08 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -142.33 143.22 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.458 . . . . 72.22 110.957 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.55 14.36 8.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 65.44 110.845 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.466 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -172.93 94.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 75.35 111.05 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 90.2 m -56.68 99.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.121 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG11 HG21 ' A' ' 47' ' ' VAL . 96.6 t -90.27 121.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 72.13 111.095 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.7 t -111.56 172.05 7.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 74.14 111.142 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -132.37 155.26 48.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.01 110.927 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.85 85.86 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.821 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.66 -93.77 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.675 -0.774 . . . . 75.23 112.443 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -126.25 10.25 7.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.4 110.795 -179.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -124.3 147.02 48.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 75.33 110.876 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 37.1 m95 -127.77 159.86 33.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 75.32 110.959 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' CG ' ' A' ' 38' ' ' GLU . 15.5 m -147.8 148.82 31.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 73.01 111.133 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HB3' HG13 ' A' ' 37' ' ' VAL . . . -129.88 135.18 48.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 64.13 111.071 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.79 155.88 48.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 61.34 110.889 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -131.47 -51.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 61.43 110.879 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.62 37.93 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 61.3 111.156 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.59 0.91 84.58 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.792 -0.718 . . . . 42.35 112.45 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -116.44 -24.27 7.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 72.34 110.889 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.636 ' HB3' HG22 ' A' ' 72' ' ' THR . 1.7 m-20 -112.17 -38.42 4.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.322 -0.399 . . . . 43.12 110.889 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 51.42 53.5 28.09 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.743 . . . . 75.41 112.487 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.636 HG22 ' HB3' ' A' ' 70' ' ' ASN . 2.3 t -130.18 94.95 3.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 74.34 111.212 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 74' ' ' ALA . 1.1 tt -138.61 160.72 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 63.21 110.897 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 75' ' ' PRO . . . -85.12 161.31 52.78 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.574 0.702 . . . . 71.0 111.089 179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 74' ' ' ALA . 53.9 Cg_endo -69.71 -8.45 23.63 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.732 2.288 . . . . 74.54 112.351 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.21 115.54 0.75 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.72 -0.752 . . . . 74.04 112.484 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.53 172.12 1.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 62.24 111.11 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.1 p -134.19 131.62 38.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.849 -179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.0 t -139.88 116.98 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 52.3 111.164 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 63.3 p -108.41 125.95 52.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 72.12 110.872 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.619 ' CE2' HG11 ' A' ' 37' ' ' VAL . 31.9 p90 -111.55 137.31 49.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 74.5 110.818 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.64 174.5 17.25 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.766 -0.731 . . . . 75.31 112.458 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.76 ' CE1' HG22 ' A' ' 47' ' ' VAL . 24.9 p90 -174.32 179.07 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 71.23 110.878 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -129.5 140.86 51.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.856 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.65 159.9 28.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 72.45 112.48 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.1 m -105.37 113.72 27.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 74.23 110.87 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.85 -161.52 31.94 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 71.4 112.501 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -37.35 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.655 2.237 . . . . 73.24 112.359 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.21 26.74 25.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 50.31 112.525 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.0 m -112.84 75.12 1.84 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.599 0.714 . . . . 73.51 110.834 -179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 156.71 62.74 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.652 2.234 . . . . 53.34 112.397 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.35 168.77 21.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 64.41 110.82 -179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 60.14 62.14 1.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 70.41 110.907 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.1 t -84.9 95.55 9.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.812 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.1 125.52 48.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.904 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 97' ' ' ASN . 4.5 pp -135.3 155.61 50.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.266 -0.425 . . . . 73.53 110.988 179.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' HB2' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER 63.08 25.76 15.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.88 179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.58 28.66 13.75 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.735 -0.745 . . . . 73.14 112.458 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.35 74.79 1.27 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.774 -0.727 . . . . 52.44 112.476 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -156.18 104.35 2.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 64.32 110.862 -179.725 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 35.0 t -154.82 138.87 16.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.88 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.45 106.09 8.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 75.42 110.864 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.17 50.57 0.58 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.82 -0.705 . . . . 74.24 112.458 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.6 t -142.22 173.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 71.31 111.159 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 62.4 110.829 -179.83 . . . . . . . . 1 1 . 1 stop_ save_